Citrus Sinensis ID: 003237
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 837 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LPZ3 | 845 | G-type lectin S-receptor- | yes | no | 0.965 | 0.956 | 0.528 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.935 | 0.939 | 0.531 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.928 | 0.914 | 0.478 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.935 | 0.928 | 0.464 | 0.0 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.951 | 0.928 | 0.443 | 0.0 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.930 | 0.925 | 0.447 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.916 | 0.905 | 0.459 | 0.0 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.903 | 0.965 | 0.453 | 0.0 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.928 | 0.947 | 0.444 | 0.0 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.942 | 0.924 | 0.450 | 0.0 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function desciption |
|---|
Score = 880 bits (2273), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/827 (52%), Positives = 586/827 (70%), Gaps = 19/827 (2%)
Query: 18 QISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVAN 77
Q S +TI SQ +KDGDVI S K +A GFFS GNS RYVGIWY Q+S+ T++WVAN
Sbjct: 17 QSCYSDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVAN 76
Query: 78 RNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEA-SAGNTVAQLLDTGNLVLVR 136
R++PINDTSG++ + +GNL ++ T P+W ++ + VA+L D GNLVL+
Sbjct: 77 RDHPINDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLD 136
Query: 137 NDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFP 196
TG++ W+SF+HPT+T+LP M+FG+ +++G++R +T+W+SP DPGSGN ++ ++ GFP
Sbjct: 137 PVTGKSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFP 196
Query: 197 QPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARM 256
Q ++YK WR G WTGQR+SG PEMT FIFNI++++N DEV + G+ D S RM
Sbjct: 197 QMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRM 256
Query: 257 ILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFE 316
+LNETG LQRF WN RD++WIG+W+AP ++CD Y HCG N C+ T+ FEC+CLPG+E
Sbjct: 257 VLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYE 316
Query: 317 PKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEK 376
PK P++WFLRD S GC R + S C EGF KL+R+K+P+TS A NVDMN+ LK CE++
Sbjct: 317 PKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTS-AVNVDMNITLKECEQR 375
Query: 377 CLSNCSCVAYASASAETNRGI-GCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNN 435
CL NCSCVAYASA E+ G GCL +HG++ DTR Y ++GQD ++R + +ELA N
Sbjct: 376 CLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNG 435
Query: 436 SKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRF 495
+ K+RL LI+++++ V+LL + F R+ R + R R+ F SS F
Sbjct: 436 ASG----KKRLVLILISLIAVVMLLLISFHCYLRKRRQRT-QSNRLRKAPSSFAPSS--F 488
Query: 496 SEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI 555
++ I + + R ++ FELST+ AT+NF+ NKLG GGFGPVYKG L NG EI
Sbjct: 489 DLEDSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEI 548
Query: 556 AVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI 615
AVKRLS +SGQG+EE KNEV LI+KLQHRNLV++LGCC+E +E ML+YE++PNKSLDYFI
Sbjct: 549 AVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFI 608
Query: 616 FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
F E ++ LDW KR II GI RG+LYLHQDSRLRIIHRDLKASN+LLD +M P+I+DFG
Sbjct: 609 FHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFG 668
Query: 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIF 735
AR+FGG +I T RVVGTYGYMSPEYA+DG FS KSDV+SFGV++LEIITGK+N+ +
Sbjct: 669 LARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFY 728
Query: 736 NDDDSSNLIKYAWELWSDNKALEIVDSSMANSCL-ASEALRCIQVGLLCVQDRTTDRPSM 794
++S NL+K+ W+ W + +A+EI+D M E ++C+ +GLLCVQ+ ++DRP M
Sbjct: 729 --EESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDM 786
Query: 795 STVVFMLSNETF-VPSPKQPTFSVRR-----TEIDTDNSSSGIKSSV 835
S+VVFML + +PSPK P F+ R T +DN SG SS
Sbjct: 787 SSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSST 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 877 bits (2267), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/802 (53%), Positives = 572/802 (71%), Gaps = 19/802 (2%)
Query: 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNP 81
S+DTI Q ++DG+VI+S+ K +A GFFS G+S RYVGIWY QISQ T++WVANR++P
Sbjct: 18 SVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHP 77
Query: 82 INDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNT-VAQLLDTGNLVLVRNDTG 140
INDTSG++ + +GNL ++ + T +W N+S++ T VA L D GNLVL TG
Sbjct: 78 INDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTG 137
Query: 141 ETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLL 200
+ W+SFDHPTDT LP MR G+ ++ GL+R +T+WKS DPGSG+ ++ GFPQ +L
Sbjct: 138 RSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLIL 197
Query: 201 YKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNE 260
YK WR G WTG R+SG PEM +IFN ++++N+DEV G+ D S I R ++NE
Sbjct: 198 YKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNE 257
Query: 261 TGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKYP 320
TG + RFTW RD+RW +W+ P E+CD Y HCGPN C+ + FECTCLPGFEPK+P
Sbjct: 258 TGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFP 317
Query: 321 KEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSN 380
+ WFLRD SGGC +K+ S C + +GF+KL+RMK+PDTS A+VDMN+ LK C+++CL N
Sbjct: 318 RHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTS-DASVDMNITLKECKQRCLKN 376
Query: 381 CSCVAYASASAETNRG-IGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKSN 439
CSCVAYASA E+ RG IGCL +HG + D R Y N+GQD ++R + ELA +++
Sbjct: 377 CSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARW----NRNG 432
Query: 440 RARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRFSERE 499
+ KRR+ LI+++++ V+LL + F + R ER++ R N + + +
Sbjct: 433 LSGKRRVLLILISLIAAVMLLTVILFCVVR-------ERRKSNRHRSSSANFAPVPFDFD 485
Query: 500 ASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR 559
S + +K R ++ F+L+T++AAT+NFS+ NKLG GGFGPVYKG L N EIAVKR
Sbjct: 486 ESFRFEQDKA-RNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKR 544
Query: 560 LSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDES 619
LS SGQG+EE KNEV LI+KLQHRNLV++LGCC+E +E ML+YE++PNKSLDYFIF E
Sbjct: 545 LSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEE 604
Query: 620 RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
++ LDW KR +I+ GIARG+LYLHQDSRLRIIHRDLKASNILLD +M P+ISDFG AR+
Sbjct: 605 QRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARI 664
Query: 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD 739
FGG ++ T RVVGT+GYM+PEYA++G FS KSDV+SFGV++LEIITGKKN+ ++
Sbjct: 665 FGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAF--HEE 722
Query: 740 SSNLIKYAWELWSDNKALEIVDSSMANSCL-ASEALRCIQVGLLCVQDRTTDRPSMSTVV 798
SSNL+ + W+LW + +A EI+D+ M E ++CIQ+GLLCVQ+ +DR MS+VV
Sbjct: 723 SSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVV 782
Query: 799 FML-SNETFVPSPKQPTFSVRR 819
ML N T +P+PK P F+ R
Sbjct: 783 IMLGHNATNLPNPKHPAFTSAR 804
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 733 bits (1892), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/817 (47%), Positives = 524/817 (64%), Gaps = 40/817 (4%)
Query: 20 STSIDTISLSQP--IKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVAN 77
S S +T+S S+ I + IVS ++ LGFF PG + Y+GIWY IS+ T +WVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 78 RNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNT-VAQLLDTGNLVL-- 134
R+ P++ + G L ++ +VL +QS PVW N++ + VA+LLD GN VL
Sbjct: 86 RDTPLSSSIGTLKISDSNLVVL---DQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD 142
Query: 135 VRNDTGE-TLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLA 193
+N + LWQSFD PTDT+LP M+ GWD +TG NR++ +WKSPDDP SG+FSF L+
Sbjct: 143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202
Query: 194 GFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMT--RTFIFNITYIDNQDEVYLCDGLNDLS 251
GFP+ L+ + +++R+GPW G RFSG PEM +FN T +++EV +
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFT--TSKEEVTYSFRITKSD 260
Query: 252 TIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTC 311
+R+ ++ +G LQRFTW + W +W AP ++CD Y CG C+ N + C C
Sbjct: 261 VYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSP--VCNC 318
Query: 312 LPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLK 371
+ GF+P+ P+ W LRDGS GC RK S C G+GF++L++MKLPDT+ A+ VD +G+K
Sbjct: 319 IKGFKPRNPQVWGLRDGSDGCVRKTLLS-CGGGDGFVRLKKMKLPDTTTAS-VDRGIGVK 376
Query: 372 ACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAE 431
CE+KCL +C+C A+A+ + G GC+ + G+L D R Y GQDL+VR A +L
Sbjct: 377 ECEQKCLRDCNCTAFANTDIRGS-GSGCVTWTGELFDIRNYAKGGQDLYVRLAATDL--- 432
Query: 432 ALNNSKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATR-----IGERKRQRRREL 486
K NR+ K + I V+++L LL FFL +R R Q R
Sbjct: 433 ---EDKRNRSAKIIGSSIGVSVLL---LLSFIIFFLWKRKQKRSILIETPIVDHQLRSRD 486
Query: 487 LFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYK 546
L +N S R IS + N + +++ E + AT+NFS +NKLGQGGFG VYK
Sbjct: 487 LLMNEVVISSRRH--ISRENNTD--DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYK 542
Query: 547 GKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606
GKL +GQE+AVKRLS TS QG +E KNEV LIA+LQH NLV+LL CC++ E MLIYE++
Sbjct: 543 GKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYL 602
Query: 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK 666
N SLD +FD+SR L+W+ RFDII GIARG+LYLHQDSR RIIHRDLKASNILLD+
Sbjct: 603 ENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKY 662
Query: 667 MNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEII 726
M P+ISDFG AR+FG +E A T++VVGTYGYMSPEYA+DG+FS KSDVFSFGV+LLEII
Sbjct: 663 MTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 722
Query: 727 TGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLA---SEALRCIQVGLLC 783
+ K+N +N D NL+ W W + K LEI+D + +S E LRCIQ+GLLC
Sbjct: 723 SSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLC 782
Query: 784 VQDRTTDRPSMSTVVFMLSNE-TFVPSPKQPTFSVRR 819
VQ+R DRP+MS V+ ML +E T +P PK P + + R
Sbjct: 783 VQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLER 819
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 702 bits (1812), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/827 (46%), Positives = 520/827 (62%), Gaps = 44/827 (5%)
Query: 20 STSIDTISLSQP--IKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVAN 77
S S +T+S ++ I I+S +I+ LGFF+P +S + Y+GIWY I T +WVAN
Sbjct: 24 SVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVAN 83
Query: 78 RNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVA-QLLDTGNLVLVR 136
R+NP++ ++G L ++ NLV+ + QS PVW NI+ + VA +LLD GN +L R
Sbjct: 84 RDNPLSSSNGTLKIS-GNNLVIFD--QSDRPVWSTNITGGDVRSPVAAELLDNGNFLL-R 139
Query: 137 NDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFP 196
+ LWQSFD PTDT+L M+ GWD++TG NR + +WK+ DDP SG FS L+ + FP
Sbjct: 140 DSNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFP 199
Query: 197 QPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARM 256
+ + + L+R+GPW G RFS P + + +++EV +N + +R+
Sbjct: 200 EFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRL 259
Query: 257 ILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFE 316
LN G LQR TW + W W +P + CD Y CG C+ N C C+ GF+
Sbjct: 260 YLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPN--CYCIKGFK 317
Query: 317 PKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEK 376
P + W LRDGS GC RK S C +GF +L+RMKLPDT+ A VD +GLK C+E+
Sbjct: 318 PVNEQAWDLRDGSAGCMRKTRLS-CDGRDGFTRLKRMKLPDTT-ATIVDREIGLKVCKER 375
Query: 377 CLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNS 436
CL +C+C A+A+A N G GC+++ ++ D R Y GQDL+VR AAEL + + N
Sbjct: 376 CLEDCNCTAFANADIR-NGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNE 434
Query: 437 KSNRARKRRLALIIVAIVLGV-ILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRF 495
K I+ +GV ILL L F +RK++R + N
Sbjct: 435 K------------IIGSSIGVSILLLLSFVIFH------FWKRKQKRSITIQTPNVDQVR 476
Query: 496 SE----REASISTKG----NKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKG 547
S+ + +S +G K+ +++ EL L AT+NFS NKLGQGGFG VYKG
Sbjct: 477 SQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKG 536
Query: 548 KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607
+L +G+EIAVKRLS S QG +E NEV LIAKLQH NLV+LLGCC+++ E MLIYE++
Sbjct: 537 RLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLE 596
Query: 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667
N SLD +FD++R L+W+KRFDII GIARG+LYLHQDSR RIIHRDLKASN+LLD+ M
Sbjct: 597 NLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNM 656
Query: 668 NPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
P+ISDFG AR+FG EE A T+RVVGTYGYMSPEYA+DG+FS KSDVFSFGV+LLEII+
Sbjct: 657 TPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIIS 716
Query: 728 GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD----SSMANSCLASEALRCIQVGLLC 783
GK+N +N + NL+ + W W + LEIVD S+++ E LRCIQ+GLLC
Sbjct: 717 GKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLC 776
Query: 784 VQDRTTDRPSMSTVVFMLSNE-TFVPSPKQPTFSVRRTEIDTDNSSS 829
VQ+R DRP MS+V+ ML +E T +P PK+P F + R+ ++ D+SSS
Sbjct: 777 VQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSS 823
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 695 bits (1793), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/848 (44%), Positives = 546/848 (64%), Gaps = 52/848 (6%)
Query: 6 LLLNTLLFFQFSQISTSIDTISLSQP--IKDGDVIVSSRKIYALGFFSPGNSVKRYVGIW 63
LL+ ++ +S I+T+S ++ I +VS I+ +GFF + + Y+G+W
Sbjct: 16 LLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFFRTNS--RWYLGMW 73
Query: 64 YNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGN-T 122
Y ++S T +WVANR+NP+++ G L ++ NLVL + S PVW N++ + +
Sbjct: 74 YKKVSDRTYVWVANRDNPLSNAIGTLKIS-GNNLVLLD--HSNKPVWWTNLTRGNERSPV 130
Query: 123 VAQLLDTGNLVL---VRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPD 179
VA+LL GN V+ ND E LWQSFD+PTDT+LP M+ G++ +TGLNR++T+W+S D
Sbjct: 131 VAELLANGNFVMRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSD 190
Query: 180 DPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQD 239
DP SGNFS+ L+ P+ L +++ + R+GPW G RFSG PE + +I+N +
Sbjct: 191 DPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNE 250
Query: 240 EVYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAE-RCDYYGHCGPNSN 298
EV + + S +R+ L G+ QR TW R W +W++P + +CD Y CGP +
Sbjct: 251 EVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAY 310
Query: 299 CNLNLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDT 358
C++N + C C+ GF P+ ++W R +GGC R+ S G+GF ++++MKLP+T
Sbjct: 311 CDVNTSP--VCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSC--SGDGFTRMKKMKLPET 366
Query: 359 SVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKY-TNA-- 415
++A VD ++G+K C+++C+S+C+C A+A+A N G GC+++ L D R Y T+A
Sbjct: 367 TMAT-VDRSIGVKECKKRCISDCNCTAFANADIR-NGGSGCVIWTERLEDIRNYATDAID 424
Query: 416 GQDLFVRANAAELAAEALNNSKSNRARKRRLALIIVAIVLGV-ILLGLCFFFL-----RR 469
GQDL+VR AA++A +KR + I+++ +GV +LL L F L +R
Sbjct: 425 GQDLYVRLAAADIA------------KKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKR 472
Query: 470 RLATRIGERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDN 529
A+ I QR + L +N S+RE S G + ++++ E+ T++ AT+N
Sbjct: 473 AKASAISIANTQRNQNLP-MNEMVLSSKREFS----GEYKFEELELPLIEMETVVKATEN 527
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
FS+ NKLGQGGFG VYKG+L +G+EIAVKRLS TS QG +E NEV LIA+LQH NLV++
Sbjct: 528 FSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQV 587
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
LGCC+E DE MLIYE++ N SLD ++F ++R+ L+W +RFDI G+ARG+LYLHQDSR
Sbjct: 588 LGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRF 647
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVF 709
RIIHRDLK SNILLD+ M P+ISDFG AR+F +E A T +VVGTYGYMSPEYA+ G+F
Sbjct: 648 RIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIF 707
Query: 710 STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCL 769
S KSDVFSFGVI+LEI++GKKN +N D ++L+ Y W W + +ALEIVD + +S
Sbjct: 708 SEKSDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLS 767
Query: 770 A-------SEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE-TFVPSPKQPTFSVRRTE 821
+ E L+CIQ+GLLCVQ+ RP+MS+VV+M +E T +P PK P + VRR+
Sbjct: 768 SQPSIFQPQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSP 827
Query: 822 IDTDNSSS 829
+ D SSS
Sbjct: 828 YELDPSSS 835
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 689 bits (1778), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/838 (44%), Positives = 519/838 (61%), Gaps = 59/838 (7%)
Query: 24 DTISLSQPIKDGD--VIVSSRKIYALGFFSPGNSVKR--YVGIWYNQISQLTLLWVANRN 79
D I+ S PIKD + ++ I+ GFF+P NS R YVGIWY +I T++WVAN++
Sbjct: 31 DRITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQTVVWVANKD 90
Query: 80 NPINDTSGVLSVNIQGNLVLHE-RNQSTVPVWQANISEASAGN-TVAQLLDTGNLVLVRN 137
+PINDTSGV+S+ GNL + + RN+ VW N+S A N T QL+D+GNL+L N
Sbjct: 91 SPINDTSGVISIYQDGNLAVTDGRNRL---VWSTNVSVPVAPNATWVQLMDSGNLMLQDN 147
Query: 138 -DTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFP 196
+ GE LW+SF HP D+ +P M G D RTG N +T+W S DDP +GN++ + FP
Sbjct: 148 RNNGEILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFP 207
Query: 197 QPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFI---FNITYIDNQDEVYLCDGLNDLSTI 253
+ L++K++V WR+GPW GQ F G P M FN+ DNQ + + ND S +
Sbjct: 208 ELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNS-DNQGTISMSYA-ND-SFM 264
Query: 254 ARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLP 313
L+ G + + W+ R W P CD YG CG +C+ + C C+
Sbjct: 265 YHFNLDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAG--ENPPCKCVK 322
Query: 314 GFEPKYPKEWFLRDGSGGCKRK-----------QGTSTCQKGEGFIKLERMKLPDTSVAA 362
GF PK EW + S GC RK K +GF+KL++MK+P ++ +
Sbjct: 323 GFVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVPISAERS 382
Query: 363 NVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVR 422
+ C + CL NCSC AYA +RGIGC+++ GDL D + + +G DLF+R
Sbjct: 383 EASE----QVCPKVCLDNCSCTAYA-----YDRGIGCMLWSGDLVDMQSFLGSGIDLFIR 433
Query: 423 ANAAELAAEALNNSKSNRARKRRLALIIVAIVLGVILLG-LCFFFLRRRLATRIGERKRQ 481
+EL + LA++I A V+GV+L+ +C R+ R K
Sbjct: 434 VAHSELKTHS------------NLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAK-D 480
Query: 482 RRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGF 541
R EL+F S+ E++ + +I+ ++ FE L +TD+FS NKLGQGGF
Sbjct: 481 RSAELMFKRMEALTSDNESA-----SNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGF 535
Query: 542 GPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601
GPVYKGKL GQEIAVKRLS SGQG+EEL NEV++I+KLQHRNLVKLLGCC+E +E ML
Sbjct: 536 GPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERML 595
Query: 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNI 661
+YE+MP KSLD ++FD ++++LDWK RF+I+ GI RG+LYLH+DSRL+IIHRDLKASNI
Sbjct: 596 VYEYMPKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNI 655
Query: 662 LLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVI 721
LLDE +NP+ISDFG AR+F E A T+RVVGTYGYMSPEYA++G FS KSDVFS GVI
Sbjct: 656 LLDENLNPKISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVI 715
Query: 722 LLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGL 781
LEII+G++N+ ++++ NL+ YAW+LW+D +A + D ++ + C E +C+ +GL
Sbjct: 716 FLEIISGRRNSSSHKEENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGL 775
Query: 782 LCVQDRTTDRPSMSTVVFMLSNETF-VPSPKQPTFSVRRTEIDTDNS-SSGIKSSVNE 837
LCVQ+ DRP++S V++ML+ E + PKQP F VRR + ++S S K S+N+
Sbjct: 776 LCVQEVANDRPNVSNVIWMLTTENMSLADPKQPAFIVRRGASEAESSDQSSQKVSIND 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 687 bits (1774), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/807 (45%), Positives = 508/807 (62%), Gaps = 40/807 (4%)
Query: 29 SQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGV 88
S I I+S +I+ LGFF+P +S + Y+GIWY I T +WVANR+NP++ ++G
Sbjct: 35 SLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGT 94
Query: 89 LSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVA-QLLDTGNLVL---VRNDTGETLW 144
L ++ NLV+ + QS PVW NI+ + VA +LLD GN VL N LW
Sbjct: 95 LKIS-DNNLVIFD--QSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLW 151
Query: 145 QSFDHPTDTVLPNMRFGWDKRTG-LNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKD 203
QSFD PTDT+L +M+ GWD ++G NR + +WK+ DDP SG+FS L +GFP+ +Y
Sbjct: 152 QSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNK 211
Query: 204 DVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNETGF 263
+ +R+GPW G RFS P M + ++ +N +V +N + + + L+ TG
Sbjct: 212 ESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGL 271
Query: 264 LQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKYPKEW 323
LQR TW + W W +P + CD Y CG C+ N + C C+ GFEP ++
Sbjct: 272 LQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSP--ICNCIKGFEP-MNEQA 328
Query: 324 FLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSNCSC 383
LRD S GC RK S C +GF++L++M+LPDT+ +VD +GLK CEE+CL C+C
Sbjct: 329 ALRDDSVGCVRKTKLS-CDGRDGFVRLKKMRLPDTT-ETSVDKGIGLKECEERCLKGCNC 386
Query: 384 VAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKSNRARK 443
A+A+ N G GC+++ G L D R Y GQDL+VR A +L + R +
Sbjct: 387 TAFANTDIR-NGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDL--------EDKRIKS 437
Query: 444 RRLALIIVAIVLGVILLGLCFFFLRRR------LATRIGERKRQRRRELLFLNSSTRFSE 497
+++ + + + ++L + F F +R+ + T I + R + + L ++R
Sbjct: 438 KKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASR--- 494
Query: 498 REASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAV 557
S ++K NK +++ E L AT+NFST NKLGQGGFG VYKG L +G+EIAV
Sbjct: 495 ---SYTSKENK-TDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAV 550
Query: 558 KRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD 617
KRLS S QG +E NEV LIAKLQH NLV+LLGCC+++ E MLIYE++ N SLD +FD
Sbjct: 551 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 610
Query: 618 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
++R L+W+KRFDII GIARG+LYLHQDSR RIIHRDLKASN+LLD+ M P+ISDFG A
Sbjct: 611 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 670
Query: 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFND 737
R+FG EE A T+RVVGTYGYMSPEYA+DG+FS KSDVFSFGV+LLEII+GK+N +N
Sbjct: 671 RIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNS 730
Query: 738 DDSSNLIKYAWELWSDNKALEIVD----SSMANSCLASEALRCIQVGLLCVQDRTTDRPS 793
+ NL+ + W W + K LEIVD ++++ E LRCIQ+GLLCVQ+R DRP
Sbjct: 731 NRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPV 790
Query: 794 MSTVVFMLSNE-TFVPSPKQPTFSVRR 819
MS+V+ ML +E T +P PK+P F V R
Sbjct: 791 MSSVMVMLGSETTAIPQPKRPGFCVGR 817
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/841 (45%), Positives = 517/841 (61%), Gaps = 85/841 (10%)
Query: 7 LLNTLLFFQFSQI--STSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWY 64
+L+ L+ FS I + + D + +Q +KDGD IVS + +GFFSPG S RY+GIWY
Sbjct: 6 VLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWY 65
Query: 65 NQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVL-HERNQSTVPVWQANI----SEASA 119
+IS T++WVANR++P+ D SG L V+ G+L L ++RN +W ++ +AS
Sbjct: 66 KKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHI---IWSSSSSPSSQKASL 122
Query: 120 GNTVAQLLDTGNLVLVRN--DTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKS 177
N + Q+LDTGNLV VRN D + +WQS D+P D LP M++G + TGLNR++T+W++
Sbjct: 123 RNPIVQILDTGNLV-VRNSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRA 181
Query: 178 PDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDN 237
DDP +GN++ +D G PQ L K+ V ++R GPW G RF+G P + I+ Y+
Sbjct: 182 IDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFT 241
Query: 238 QDEVYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNS 297
++EVY L + S + RM LN G LQR+TW + + W Y +A + CD Y CG
Sbjct: 242 EEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYG 301
Query: 298 NCNLNLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGE-GFIKLERMKLP 356
+CN+N + C CL GF K P+ W D S GC R+ C KGE GF+K+ ++KLP
Sbjct: 302 SCNINESPA--CRCLKGFVAKTPQAWVAGDWSEGCVRRVKLD-CGKGEDGFLKISKLKLP 358
Query: 357 DTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAG 416
DT + D N+ L C++ CL NC+C AY+ + G GC+++ GDL D R+Y G
Sbjct: 359 DTRTSW-YDKNMDLNECKKVCLRNCTCSAYSPFDIR-DGGKGCILWFGDLIDIREYNENG 416
Query: 417 QDLFVRANAAELAAEALNNSKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIG 476
QDL+VR ++E+ E L +R ++R+
Sbjct: 417 QDLYVRLASSEI--ETL-----------------------------------QRESSRVS 439
Query: 477 ERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKL 536
RK+ E +++ F +L T+ AT FS NKL
Sbjct: 440 SRKQ----------------------------EEEDLELPFLDLDTVSEATSGFSAGNKL 471
Query: 537 GQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE 596
GQGGFGPVYKG L+ GQE+AVKRLS TS QG+EE KNE+ LIAKLQHRNLVK+LG C++E
Sbjct: 472 GQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDE 531
Query: 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL 656
+E MLIYE+ PNKSLD FIFD+ R++ LDW KR +II GIARG+LYLH+DSRLRIIHRDL
Sbjct: 532 EERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDL 591
Query: 657 KASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVF 716
KASN+LLD MN +ISDFG AR GG+E A T RVVGTYGYMSPEY +DG FS KSDVF
Sbjct: 592 KASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVF 651
Query: 717 SFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCL-ASEALR 775
SFGV++LEI++G++N N++ NL+ +AW + ++KA EI+D ++ SC SE LR
Sbjct: 652 SFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLR 711
Query: 776 CIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVPSPKQPTFSVRRTEIDTDNSSSGIKSSV 835
I +GLLCVQ DRP+MS VV MLS+E + P+QP F R + +D S ++
Sbjct: 712 VIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPS 771
Query: 836 N 836
N
Sbjct: 772 N 772
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 672 bits (1734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/835 (44%), Positives = 514/835 (61%), Gaps = 58/835 (6%)
Query: 16 FSQISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWV 75
F +S + + S + D + IVSS + + GFFSP NS RY GIWYN +S T++WV
Sbjct: 20 FLSVSLAQERAFFSGKLNDSETIVSSFRTFRFGFFSPVNSTSRYAGIWYNSVSVQTVIWV 79
Query: 76 ANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANIS-EASAGNTVAQLLDTGNLVL 134
AN++ PIND+SGV+SV+ GNLV+ + + + W N+S +ASA +TVA+LLD+GNLVL
Sbjct: 80 ANKDKPINDSSGVISVSQDGNLVVTDGQRRVL--WSTNVSTQASANSTVAELLDSGNLVL 137
Query: 135 VRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGL-NRYVTAWKSPDDPGSGNFSFTLDLA 193
+ LW+SF +PTD+ LPNM G + R G N +T+WKSP DP G+++ L LA
Sbjct: 138 KEASSDAYLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDPSPGSYTAALVLA 197
Query: 194 GFPQPLLYKDDVK---LWRAGPWTGQRFSGTPEM-TRTFIFNITYIDNQDEVYLCDGLND 249
+P+ + ++ +WR+GPW GQ F+G P++ F++ D+ + ND
Sbjct: 198 AYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGVFLYRFIVNDDTNGSVTMSYAND 257
Query: 250 LSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFEC 309
ST+ ++ G + R W+ R W PA CD Y CG + CN C
Sbjct: 258 -STLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPATECDNYRRCGEFATCNPRKNP--LC 314
Query: 310 TCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQK------GEGFIKLERMKLPDTSVAAN 363
+C+ GF P+ EW + SGGC R+ C++ +GF++L RMKLPD + +
Sbjct: 315 SCIRGFRPRNLIEWNNGNWSGGCTRRVPLQ-CERQNNNGSADGFLRLRRMKLPDFARRSE 373
Query: 364 VDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRA 423
C CL CSC+A A G GC++++G L D+++ + +G DL++R
Sbjct: 374 ASE----PECLRTCLQTCSCIAAAHG-----LGYGCMIWNGSLVDSQELSASGLDLYIRL 424
Query: 424 NAAELAAEALNNSKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRR 483
+E+ + + +R LI + G+ ++ C L RR+ + +K+ R
Sbjct: 425 AHSEI-----------KTKDKRPILIGTILAGGIFVVAACVL-LARRIVMKKRAKKKGRD 472
Query: 484 RELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGP 543
E +F ER +++ GNK K ++ FE L AAT+NFS NKLGQGGFGP
Sbjct: 473 AEQIF--------ERVEALA-GGNKGKLK-ELPLFEFQVLAAATNNFSLRNKLGQGGFGP 522
Query: 544 VYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603
VYKGKL GQEIAVKRLS SGQG+EEL NEV++I+KLQHRNLVKLLGCC+ +E ML+Y
Sbjct: 523 VYKGKLQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVY 582
Query: 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663
EFMP KSLDY++FD R +LLDWK RF+II GI RG+LYLH+DSRLRIIHRDLKASNILL
Sbjct: 583 EFMPKKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILL 642
Query: 664 DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILL 723
DE + P+ISDFG AR+F G E A T+RVVGTYGYM+PEYA+ G+FS KSDVFS GVILL
Sbjct: 643 DENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILL 702
Query: 724 EIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLC 783
EII+G++N+ +S L+ Y W +W++ + +VD + + E +CI +GLLC
Sbjct: 703 EIISGRRNS-------NSTLLAYVWSIWNEGEINSLVDPEIFDLLFEKEIHKCIHIGLLC 755
Query: 784 VQDRTTDRPSMSTVVFMLSNETF-VPSPKQPTFSVRRTEIDTDNS-SSGIKSSVN 836
VQ+ DRPS+STV MLS+E +P PKQP F R + ++S +S +K S+N
Sbjct: 756 VQEAANDRPSVSTVCSMLSSEIADIPEPKQPAFISRNNVPEAESSENSDLKDSIN 810
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/832 (45%), Positives = 520/832 (62%), Gaps = 43/832 (5%)
Query: 19 ISTSIDTISLSQP--IKDGDVIVSSRKIYALGFFSP-GNSVKRYVGIWYNQISQLTLLWV 75
+S S++T+S ++ I IVS ++ LGFF G+S Y+GIWY +ISQ T +WV
Sbjct: 28 LSISVNTLSATESLTISSNKTIVSPGGVFELGFFRILGDSW--YLGIWYKKISQRTYVWV 85
Query: 76 ANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLV 135
ANR+ P+++ G+L ++ NLV+ + S VW N++ A + VA+LLD GN VL
Sbjct: 86 ANRDTPLSNPIGILKIS-NANLVILD--NSDTHVWSTNLTGAVRSSVVAELLDNGNFVLR 142
Query: 136 R---NDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDL 192
N++ E LWQSFD PTDT+LP M+ G D + GLNR+VT+WKS DP SG+F F L+
Sbjct: 143 GSKINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLET 202
Query: 193 AGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTR--TFIFNITYIDNQDEVYLCDGLNDL 250
G P+ + ++++R+GPW G RFSG EM + I+N T +N++EV + D
Sbjct: 203 LGLPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNFT--ENREEVAYTFRVTDH 260
Query: 251 STIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECT 310
++ +R+ +N G L+ F W + W +W P + CD YG CGP + C+++ + C
Sbjct: 261 NSYSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSP--TCN 318
Query: 311 CLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGL 370
C+ GF+P P++W D +G C+RK TC + + F +L MK+P T+ AA VD +GL
Sbjct: 319 CIKGFQPLSPQDWASGDVTGRCRRKTQL-TCGE-DRFFRLMNMKIPATT-AAIVDKRIGL 375
Query: 371 KACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAA 430
K CEEKC ++C+C AYA++ N G GC+++ G+ D R Y GQDLFVR AAE
Sbjct: 376 KECEEKCKTHCNCTAYANSDIR-NGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGE 434
Query: 431 EALNNSKSNRARKRRLALIIVAIVLGVILLGLCFFF--LRRRLATRIGERKRQRRRELLF 488
K +++++ ++ CF+ +R AT R R +EL+
Sbjct: 435 RRTIRGKIIGLIIGISLMLVLSFII------YCFWKKKQKRARATAAPIGYRDRIQELII 488
Query: 489 LNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK 548
N S R + + FE T++ AT+NFS SN LG+GGFG VYKG+
Sbjct: 489 TNGVVMSSGRRLLGEEEDLELPLTE----FE--TVVMATENFSDSNILGRGGFGIVYKGR 542
Query: 549 LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608
L +GQEIAVKRLS S QG E KNEV LIA+LQH NLV+LL CC+ DE +LIYE++ N
Sbjct: 543 LLDGQEIAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLEN 602
Query: 609 KSLDYFIFDESRKQ-LLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667
SLD +F+ ++ L+W+ RF II GIARG+LYLHQDSR +IIHRDLKASN+LLD+ M
Sbjct: 603 GSLDSHLFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNM 662
Query: 668 NPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
P+ISDFG AR+F +E A T++VVGTYGYMSPEYA++G+FS KSDVFSFGV++LEI++
Sbjct: 663 TPKISDFGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVS 722
Query: 728 GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCL------ASEALRCIQVGL 781
GK+N N +NL+ Y WE W + K LEIVDS + +S E LRCIQ+GL
Sbjct: 723 GKRNRGFHNSGQDNNLLGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGL 782
Query: 782 LCVQDRTTDRPSMSTVVFMLSNETF-VPSPKQPTFSVRRTEIDTDNSSSGIK 832
LCVQ+R DRP MS+VV ML +E +P PK+P + V R+ +DT +SSS K
Sbjct: 783 LCVQERAEDRPKMSSVVLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTK 834
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 837 | ||||||
| 356527947 | 838 | PREDICTED: G-type lectin S-receptor-like | 0.971 | 0.970 | 0.538 | 0.0 | |
| 255555113 | 1480 | Negative regulator of the PHO system, pu | 0.956 | 0.541 | 0.562 | 0.0 | |
| 224076623 | 793 | predicted protein [Populus trichocarpa] | 0.934 | 0.986 | 0.536 | 0.0 | |
| 359496273 | 1576 | PREDICTED: G-type lectin S-receptor-like | 0.949 | 0.504 | 0.538 | 0.0 | |
| 359496850 | 2807 | PREDICTED: uncharacterized protein LOC10 | 0.942 | 0.281 | 0.530 | 0.0 | |
| 147804673 | 950 | hypothetical protein VITISV_035828 [Viti | 0.960 | 0.846 | 0.529 | 0.0 | |
| 297843970 | 842 | hypothetical protein ARALYDRAFT_471279 [ | 0.952 | 0.946 | 0.533 | 0.0 | |
| 359496631 | 1146 | PREDICTED: G-type lectin S-receptor-like | 0.946 | 0.691 | 0.532 | 0.0 | |
| 359496633 | 830 | PREDICTED: G-type lectin S-receptor-like | 0.948 | 0.956 | 0.525 | 0.0 | |
| 359497115 | 822 | PREDICTED: G-type lectin S-receptor-like | 0.951 | 0.968 | 0.535 | 0.0 |
| >gi|356527947|ref|XP_003532567.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 943 bits (2438), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/835 (53%), Positives = 604/835 (72%), Gaps = 22/835 (2%)
Query: 5 KLLLNTLLFFQFSQISTSID-TISLSQPIKDGDVIVSS-RKIYALGFFSPGNSVKRYVGI 62
+ L + L+ F S+D TI+++ PI+DGDV+VS+ +ALGFFSP NS RYVGI
Sbjct: 8 EFLSSFLVLMFFYPFCHSLDNTITINHPIRDGDVLVSNGLGNFALGFFSPRNSTNRYVGI 67
Query: 63 WYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTV-PVWQANISEASAGN 121
WYN+IS+ T++WVANR+ P+NDTSGVL ++ GNLVLH+ + ++ PVW +N+S S N
Sbjct: 68 WYNKISEQTVVWVANRDTPLNDTSGVLKISNNGNLVLHDNSTRSLNPVWSSNVSIESTNN 127
Query: 122 TVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDP 181
A+LLDTGNLVL++ + LWQSFD+P +T+LP M+ G +++TGL+R++ +WKSP+DP
Sbjct: 128 ISAKLLDTGNLVLIQTNNNNILWQSFDYPGNTMLPFMKLGLNRKTGLDRFLVSWKSPNDP 187
Query: 182 GSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEV 241
G+GN ++ +D GFPQ LYKD + LWR G WTGQR+SG PEMT FIF + Y++N+ EV
Sbjct: 188 GTGNMTYKIDPTGFPQLFLYKDKIPLWRVGSWTGQRWSGVPEMTPNFIFTVNYVNNESEV 247
Query: 242 YLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNL 301
+ G+ D S +RM+L+E+G + R TW + RW W AP E CD + CG N+NC+
Sbjct: 248 SIMYGVKDPSVFSRMVLDESGHVARSTWQAHEHRWFQIWDAPKEECDNFRRCGSNANCDP 307
Query: 302 NLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVA 361
D FEC CLPGFEPK+ +EWFLRDGSGGC RK STC+ GEGF+++ R+K+PDTS
Sbjct: 308 YHADKFECECLPGFEPKFEREWFLRDGSGGCVRKSNVSTCRSGEGFVEVTRVKVPDTS-K 366
Query: 362 ANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFV 421
A V +G++ C+E+CL +CSCVAY SA+ + G GC+ +HG++ DTR Y GQ LFV
Sbjct: 367 ARVAATIGMRECKERCLRDCSCVAYTSANESS--GSGCVTWHGNMEDTRTYMQVGQSLFV 424
Query: 422 RANAAELAAEALNNSKSNRARKRRLALIIVAIVLGVIL-LGLCFFFLRRRLATRIGERKR 480
R + ELA A + + +K +A++ AI L ++L + ++F++ R R G R+
Sbjct: 425 RVDKLELAKYA-KHPYGSLGKKGMVAVLTAAIFLFLLLAITFVYWFVKTR---RQGIRRD 480
Query: 481 QRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGG 540
++ L + ST E + + + D+ FFELS++ AATDNFS +NKLGQGG
Sbjct: 481 RKYSFRLTFDDSTDLQEFDTT---------KNSDLPFFELSSIAAATDNFSDANKLGQGG 531
Query: 541 FGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600
FG VYKG L NG EIAVKRLS SGQGIEE KNEV+LI+KLQHRNLV++LGCC++ +E M
Sbjct: 532 FGSVYKGLLINGMEIAVKRLSKYSGQGIEEFKNEVVLISKLQHRNLVRILGCCIQGEEKM 591
Query: 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 660
LIYE++PNKSLD IFDES++ LDWKKRFDII G+ARG+LYLHQDSRLRIIHRDLKASN
Sbjct: 592 LIYEYLPNKSLDSLIFDESKRSQLDWKKRFDIICGVARGMLYLHQDSRLRIIHRDLKASN 651
Query: 661 ILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGV 720
+L+D +NP+I+DFG AR+FGG++I A T RVVGTYGYMSPEYA++G FS KSDV+SFGV
Sbjct: 652 VLMDSSLNPKIADFGMARIFGGDQIAANTNRVVGTYGYMSPEYAMEGQFSVKSDVYSFGV 711
Query: 721 ILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVG 780
+LLEI+TG+KN+ ++ D ++NL+ + W+LW + K +EIVD S+ SC E RCIQ+G
Sbjct: 712 LLLEIVTGRKNSGLYEDITATNLVGHIWDLWREGKTMEIVDQSLGESCSDHEVQRCIQIG 771
Query: 781 LLCVQDRTTDRPSMSTVVFMLSNETFVPSPKQPTFSVRRTEIDTDN--SSSGIKS 833
LLCVQD DRPSMS VVFML N++ +P PKQP F ++T ++ N +S GI S
Sbjct: 772 LLCVQDYAADRPSMSAVVFMLGNDSTLPDPKQPAFVFKKTNYESSNPSTSEGIYS 826
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555113|ref|XP_002518594.1| Negative regulator of the PHO system, putative [Ricinus communis] gi|223542439|gb|EEF43981.1| Negative regulator of the PHO system, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 920 bits (2378), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/821 (56%), Positives = 600/821 (73%), Gaps = 20/821 (2%)
Query: 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSP-GNSVKRYVGIWYNQISQLTLLWVANRNNP 81
IDTI+ IKDGD++VSS + +ALGFFSP GN +RYVGIWYN++++ T++WVANR+NP
Sbjct: 665 IDTITSRNSIKDGDILVSSGQGFALGFFSPAGNPARRYVGIWYNKVTEKTVVWVANRDNP 724
Query: 82 INDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEAS--AGNTVAQLLDTGNLVLVRNDT 139
INDTSGVL++N +GNLVL+ NQ T+PVW AN+S +S N++ QLL+TGNL+L++ D+
Sbjct: 725 INDTSGVLAINSKGNLVLYGHNQ-TIPVWSANVSLSSLNKNNSIVQLLETGNLLLLQQDS 783
Query: 140 GETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPL 199
LWQSFDHPTDT+LP M+ G D++TG N ++++WKS DDPG+GN + +D G+PQ
Sbjct: 784 NTVLWQSFDHPTDTMLPYMKLGLDRKTGKNWFLSSWKSKDDPGTGNIFYRIDPTGYPQLF 843
Query: 200 LYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTI-ARMIL 258
LYK ++ WR GPWTGQR+SG PEMTR +IFN ++++ +DEV++ GL +TI +RM++
Sbjct: 844 LYKGSLRWWRGGPWTGQRWSGVPEMTRNYIFNASFVNTEDEVFITYGLTTNATIFSRMMV 903
Query: 259 NETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPK 318
NE+G +QR TWN+RD RWIG+W+AP E CD YG CG NSNC+ +D F C CLPGF PK
Sbjct: 904 NESGTVQRATWNDRDGRWIGFWSAPKEPCDNYGECGANSNCDPYDSDNFICKCLPGFYPK 963
Query: 319 YPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCL 378
P W+LRDGS GC RK G STC+ GEGF++L +K+PDT+ A V+M+L LKACE++CL
Sbjct: 964 SPGSWYLRDGSDGCNRKAGVSTCRDGEGFVRLALVKVPDTA-TARVNMSLSLKACEQECL 1022
Query: 379 SNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKS 438
NCSC AY SA GIGCL ++GDL D R Y++ GQD++VR +A ELA + S
Sbjct: 1023 RNCSCTAYTSA---YESGIGCLTWYGDLVDIRTYSSVGQDIYVRVDAVELAKYGKSKS-- 1077
Query: 439 NRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELL-FLNSSTRFSE 497
R K A++I ++ + L + L + R R R+R + L F S T +
Sbjct: 1078 -RLTKGVQAILIASVSVASFLAVFVVYCL---VKKRRKARDRRRSKSLFSFTQSPTDLGD 1133
Query: 498 REASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAV 557
KGN E D+ FF+LS + AT NFS NKLG+GGFG VYKG L G+EIAV
Sbjct: 1134 SHGG---KGNDEDGIPDLPFFDLSAIATATSNFSDDNKLGEGGFGSVYKGLLHGGKEIAV 1190
Query: 558 KRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD 617
KRLS SGQG EE KNEV LIAKLQHRNLV+++G C++E E MLIYE++PNKSLD FIFD
Sbjct: 1191 KRLSRYSGQGTEEFKNEVALIAKLQHRNLVRMIGYCVQEPEKMLIYEYLPNKSLDSFIFD 1250
Query: 618 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
E+++ LLDW R II GIARG+LYLHQDSRLRIIHRDLKASN+LLD MNP+ISDFG A
Sbjct: 1251 EAKRSLLDWSIRHSIICGIARGILYLHQDSRLRIIHRDLKASNVLLDASMNPKISDFGMA 1310
Query: 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFND 737
R+ G ++I A T RVVGTYGYMSPEYA+ G+FS KSDV+SFGV+L+EIITG+KN+ + +
Sbjct: 1311 RIVGVDQIEANTNRVVGTYGYMSPEYAMQGLFSVKSDVYSFGVLLIEIITGRKNSSFYEE 1370
Query: 738 DDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTV 797
SSNL+ Y W+LW + +ALEIVD S+ ++ E LRCIQ+GLLCVQ+ DRP+M+TV
Sbjct: 1371 STSSNLVGYVWDLWREGRALEIVDISLGDAYPEHEVLRCIQIGLLCVQESAVDRPAMTTV 1430
Query: 798 VFMLSNETFVPSPKQPTFSVRRTEIDTDN-SSSGIKSSVNE 837
VFMLSN T +PSP QP F ++R+ + S+S +SVNE
Sbjct: 1431 VFMLSNHTILPSPNQPAFIMKRSYNSGEPVSASDGGNSVNE 1471
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076623|ref|XP_002304971.1| predicted protein [Populus trichocarpa] gi|222847935|gb|EEE85482.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 915 bits (2365), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/839 (53%), Positives = 583/839 (69%), Gaps = 57/839 (6%)
Query: 1 MNPAKLLLNTLLFFQFSQISTSIDTISLSQPIKDGDVIVSS-RKIYALGFFSPG-NSVKR 58
MNP + L+ L F SID I+ +Q IKDGDV+VSS + Y LGFFS G + +R
Sbjct: 1 MNPIERFLSALFLFLVFSSCLSIDIIAPNQSIKDGDVLVSSGSQSYELGFFSSGIDYTRR 60
Query: 59 YVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEAS 118
YVGIWY ++S+ T++WVANR+NPIN TSGVL++N QGNLV++E N+S+VPVW N++ +S
Sbjct: 61 YVGIWYRKVSERTVVWVANRDNPINGTSGVLAINKQGNLVIYENNRSSVPVWSTNVAASS 120
Query: 119 AGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSP 178
N AQL D+GNLVLV+ D+ LWQSFDH TDT+LP M+ G D + GLNR +++WKS
Sbjct: 121 MTNCTAQLQDSGNLVLVQQDSKRVLWQSFDHATDTLLPGMKLGLDLKIGLNRSLSSWKSK 180
Query: 179 DDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQ 238
DDPG+G +D +GFPQ LYK + WR GPWTG R+SG P+M T+IF T++ +
Sbjct: 181 DDPGTGTIVLGIDPSGFPQLFLYKSQTRRWRVGPWTGLRWSGVPQMATTYIFGNTFVSSV 240
Query: 239 DEVYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSN 298
DEV +N+ S I+RM++NE+G +QR TWN+ D++W G W AP E CD YG CGPNSN
Sbjct: 241 DEVSYSYSINNPSLISRMVVNESGVVQRLTWNDPDKQWFGIWYAPKEPCDTYGQCGPNSN 300
Query: 299 CNLNLTDGFECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDT 358
C+ T+ F C CLPGFEPK P+EW+LR+GS GC RK STC GEGF+KL R+K+PDT
Sbjct: 301 CDPYQTNNFMCKCLPGFEPKSPQEWYLREGSRGCVRKPNVSTCHGGEGFVKLARVKVPDT 360
Query: 359 SVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQD 418
S+A+ +M+L LK C +CL NCSC AYASA RG+GCL ++GDL DTR +++ GQ+
Sbjct: 361 SMAS-ANMSLRLKECARECLRNCSCTAYASAD---ERGLGCLRWYGDLVDTRTFSDVGQE 416
Query: 419 LFVRANAAELAAEALNNSKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGER 478
+++R + AEL EA+N +L+ C F R L +
Sbjct: 417 IYIRVDRAEL--EAMN-------------------WFNKVLIVFCRCFGWRDLPIK---- 451
Query: 479 KRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQ 538
F E S D+ F+LS + AAT+NFS +NKLG+
Sbjct: 452 ---------------EFEEGTTS-----------SDLPLFDLSVVAAATNNFSGANKLGE 485
Query: 539 GGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598
GGFG VYKG L +G+EIAVKRL+ SGQGI E +NEV LIAKLQHRNLV++LGCC++ E
Sbjct: 486 GGFGSVYKGLLHDGKEIAVKRLAKYSGQGINEFRNEVELIAKLQHRNLVRILGCCIQGRE 545
Query: 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658
MLIYE++PNKSLD FIF+E R+ LDW R +II GIARG+LYLH+DSRLRIIHRDLKA
Sbjct: 546 KMLIYEYLPNKSLDSFIFNEPRRSQLDWSTRHNIICGIARGILYLHEDSRLRIIHRDLKA 605
Query: 659 SNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSF 718
SN+LLD MNP+ISDFG AR+FG ++I A T RVVGTYGYMSPEYA+ G+FS KSDV+SF
Sbjct: 606 SNVLLDASMNPKISDFGMARIFGVDQIEANTNRVVGTYGYMSPEYAMQGLFSVKSDVYSF 665
Query: 719 GVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQ 778
GV+LLE+ITG+KN ++ +SSNL+ Y W+LW + +ALE+VD+ M +S + LRCIQ
Sbjct: 666 GVLLLEVITGRKNINFYDKSNSSNLVGYVWDLWREGRALELVDTLMGDSYPEDQVLRCIQ 725
Query: 779 VGLLCVQDRTTDRPSMSTVVFMLSNETFVPSPKQPTFSVRRTEIDTDNSSSGIKSSVNE 837
+GLLCVQ+ DRPSMS VVFMLSN+T +PSPKQP F ++++ D S+S S+NE
Sbjct: 726 IGLLCVQESAMDRPSMSNVVFMLSNDTTLPSPKQPAFILKKSYNSGDPSTSEGSHSINE 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496273|ref|XP_002270694.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RKS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 905 bits (2338), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/812 (53%), Positives = 581/812 (71%), Gaps = 17/812 (2%)
Query: 19 ISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANR 78
I S DTI+ +QP +DGD++VS + +ALGFFSP NS RY+G+WYN I + T++WV NR
Sbjct: 765 ICISTDTITPNQPFRDGDLLVSKQSRFALGFFSPRNSTLRYIGVWYNTIREQTVVWVLNR 824
Query: 79 NNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRND 138
++PINDTSGVLS+N GNL+LH N VW N+S +S TVAQLLDTGNLVL+ N
Sbjct: 825 DDPINDTSGVLSINTSGNLLLHRGNTH---VWSTNVSISSVNPTVAQLLDTGNLVLIHNG 881
Query: 139 TGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQP 198
+WQ FD+PTD+ LP M+ G ++RTG NR++T+WKSP DPG+G +S +++G PQ
Sbjct: 882 DKRVVWQGFDYPTDSWLPYMKLGLNRRTGFNRFLTSWKSPTDPGTGKYSLGFNVSGSPQI 941
Query: 199 LLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMIL 258
LY+ LWR G W G R+SG P M I +++NQDE+ + + S + R+ +
Sbjct: 942 FLYQGSEPLWRTGNWNGLRWSGLPVMKYIIQHKIIFLNNQDEISEMFTMANASFLERVTV 1001
Query: 259 NETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPK 318
+ G+LQR W R+ +W ++TAP +RCD YG CGPNSNC+ + + FECTCL GFEPK
Sbjct: 1002 DHDGYLQRNMWQEREDKWFSFYTAPRDRCDRYGLCGPNSNCDDSQAE-FECTCLAGFEPK 1060
Query: 319 YPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCL 378
P++WFL+DGS GC RK+G C GEGF+K+ R K PDTSVA V+MN+ ++AC E+CL
Sbjct: 1061 SPRDWFLKDGSAGCLRKEGAKVCGNGEGFVKVGRAKPPDTSVA-RVNMNISMEACREECL 1119
Query: 379 SNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKS 438
CSC YA+A+ + G GCL +HGDL DTR + GQDL+VR +A L A SK
Sbjct: 1120 KECSCSGYAAANV-SGSGSGCLSWHGDLVDTRVFPEGGQDLYVRVDAITLGMLA---SKG 1175
Query: 439 NRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRFSER 498
A+K +A+++V + ++LL F+FLR+++ R + R +L S E
Sbjct: 1176 FLAKKGMMAVLVVGAAVIMVLLVSSFWFLRKKMKGRQNKMLYNSRPGATWLQDSLGAKEH 1235
Query: 499 EASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVK 558
+ S + N E++ FF+L+T++AAT+NFS N+LG+GGFG VYKG+L NGQEIAVK
Sbjct: 1236 DESTT---NSELQ-----FFDLNTIVAATNNFSFENELGRGGFGSVYKGQLYNGQEIAVK 1287
Query: 559 RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE 618
+LS SGQG EE KNEV LIAKLQH NLV+LLGCC++E+E ML+YE++PNKSLD FIFDE
Sbjct: 1288 KLSKDSGQGKEEFKNEVTLIAKLQHVNLVRLLGCCIQEEEKMLVYEYLPNKSLDSFIFDE 1347
Query: 619 SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
+++ LLDW+KRF+II+GIARG+LYLH+DSRLRIIHRDLKASN+LLD +M P+ISDFG AR
Sbjct: 1348 TKRSLLDWRKRFEIIVGIARGILYLHEDSRLRIIHRDLKASNVLLDAEMLPKISDFGLAR 1407
Query: 679 VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDD 738
+FGG ++ T RVVGTYGYMSPEYA++G+FSTKSDV+SFGV+LLEIITG+KN+ + D+
Sbjct: 1408 IFGGNQMEGNTNRVVGTYGYMSPEYAMEGLFSTKSDVYSFGVLLLEIITGRKNSTHYRDN 1467
Query: 739 DSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798
S NL+ W LW ++KAL+I+DSS+ S E LRCIQ+GLLCVQ+ DRP+M T++
Sbjct: 1468 PSMNLVGNVWNLWEEDKALDIIDSSLEKSYPTDEVLRCIQIGLLCVQESAIDRPTMLTII 1527
Query: 799 FMLSNETFVPSPKQPTFSVRRTEIDTDNSSSG 830
FML N + +P PK+PTF + T D SSSG
Sbjct: 1528 FMLGNNSALPFPKRPTFISKTTHKSQDLSSSG 1559
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496850|ref|XP_003635354.1| PREDICTED: uncharacterized protein LOC100854728 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 899 bits (2323), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/813 (53%), Positives = 583/813 (71%), Gaps = 24/813 (2%)
Query: 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNP 81
S DTI+ +QP +DGD++VS + +ALGFFSP NS RY+G+WYN I + T++WV NR++P
Sbjct: 1998 STDTITPNQPFRDGDLLVSKQSRFALGFFSPRNSTLRYIGVWYNTIREQTVVWVLNRDHP 2057
Query: 82 INDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGE 141
IND+SGVLS+N GNL+LH N VW N+S +S TVAQLLDTGNLVL++N
Sbjct: 2058 INDSSGVLSINTSGNLLLHRGNTR---VWSTNVSISSVNPTVAQLLDTGNLVLIQNGDKR 2114
Query: 142 TLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLY 201
+WQ FD+PTD ++P+M+ G ++RTG NR++T+WKSP DPG+G SF ++ +G PQ LY
Sbjct: 2115 VVWQGFDYPTDNLIPHMKLGLNRRTGFNRFLTSWKSPTDPGTGENSFGINASGSPQLCLY 2174
Query: 202 KDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNET 261
+ +LWR G W G R+SG P M I N ++++NQDE+ + + S ++RM +
Sbjct: 2175 QGSERLWRTGHWNGLRWSGVPRMMHNMIINTSFLNNQDEISYMFVMANASVLSRMTVELD 2234
Query: 262 GFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKYPK 321
G+LQR+TW + +W ++T P ++CD YG CG N NC+ N FECTCL GFEPK P+
Sbjct: 2235 GYLQRYTWQETEGKWFSFYTVPRDQCDRYGRCGLNGNCD-NSRAEFECTCLAGFEPKSPR 2293
Query: 322 EWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSNC 381
+W L+DGS GC RK+G C GEGF+K+E +K PDTSVA V+MN+ L+AC E CL C
Sbjct: 2294 DWSLKDGSAGCLRKEGAKVCGNGEGFVKVEGVKPPDTSVA-RVNMNMSLEACREGCLKEC 2352
Query: 382 SCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKSNRA 441
SC YA+A+ + G GCL +HGDL DTR + GQDL+VR +A L + SK A
Sbjct: 2353 SCSGYAAANV-SGSGSGCLSWHGDLVDTRVFPEGGQDLYVRVDAITLG---MLQSKGFLA 2408
Query: 442 RKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQR----RRELLFLNSSTRFSE 497
+K +A+++V + ++LL ++FLR+++ G +K+ + +L S E
Sbjct: 2409 KKGMMAVLVVGATVIMVLLISTYWFLRKKMK---GNQKKNSYGSFKPGATWLQDSPGAKE 2465
Query: 498 REASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAV 557
+ S + N E++ FF+L+T+ AAT+NFS+ N+LG+GGFG VYKG+L NGQEIAV
Sbjct: 2466 HDESTT---NSELQ-----FFDLNTIAAATNNFSSENELGRGGFGSVYKGQLYNGQEIAV 2517
Query: 558 KRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD 617
K+LS SGQG EE KNEV LIAKLQH NLV+LLGCC++E+E ML+YE++PNKSLD FIFD
Sbjct: 2518 KKLSKDSGQGKEEFKNEVTLIAKLQHVNLVRLLGCCIQEEEKMLVYEYLPNKSLDSFIFD 2577
Query: 618 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
E+++ LLDW+KRF+II+GIARG+LYLH+DSRLRIIHRDLKASN+LLD +M P+ISDFG A
Sbjct: 2578 ETKRSLLDWRKRFEIIVGIARGILYLHEDSRLRIIHRDLKASNVLLDAEMLPKISDFGLA 2637
Query: 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFND 737
R+FGG ++ T RVVGTYGYMSPEYA++G+FSTKSDV+SFGV+LLEIITG+KN+ + D
Sbjct: 2638 RIFGGNQMEGNTNRVVGTYGYMSPEYAMEGLFSTKSDVYSFGVLLLEIITGRKNSTHYRD 2697
Query: 738 DDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTV 797
+ S NL+ W LW ++KAL+I+DSS+ S E LRCIQ+GLLCVQ+ D+P+M T+
Sbjct: 2698 NPSMNLVGNVWNLWEEDKALDIIDSSLEKSYPTDEVLRCIQIGLLCVQESAIDQPTMLTI 2757
Query: 798 VFMLSNETFVPSPKQPTFSVRRTEIDTDNSSSG 830
+FML N + +P PK+PTF + T D SSSG
Sbjct: 2758 IFMLGNNSALPFPKRPTFISKTTHKGEDLSSSG 2790
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147804673|emb|CAN66867.1| hypothetical protein VITISV_035828 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2318), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/825 (52%), Positives = 585/825 (70%), Gaps = 21/825 (2%)
Query: 13 FFQFSQIST------SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQ 66
F F Q++T S DTI+ +QP +DGD++VS + +ALGFFSP NS RY+G+WYN
Sbjct: 123 FEWFEQLATAKHLFNSTDTITPNQPFRDGDLLVSKQSRFALGFFSPRNSTLRYIGVWYNT 182
Query: 67 ISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQL 126
I + T++WV NR+ PIND SGVLS+N GNL+LH N VW N+S +S TVAQL
Sbjct: 183 IREQTVVWVLNRDXPINDXSGVLSINTSGNLLLHRGNTX---VWSTNVSISSVNPTVAQL 239
Query: 127 LDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNF 186
LDTGNLVL+ N +WQ FD+PTD LP M+ G ++RTG NR++T+WKSP DPG+G
Sbjct: 240 LDTGNLVLIHNGDKRVVWQGFDYPTDXXLPYMKLGLNRRTGFNRFLTSWKSPTDPGTGKX 299
Query: 187 SFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDG 246
S +++G PQ LY+ LWR G W G R+SG P M I +++NQDE+
Sbjct: 300 SLGFNVSGSPQIFLYQGSEPLWRTGNWNGLRWSGLPVMKYIIQHKIIFLNNQDEISEMFT 359
Query: 247 LNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDG 306
+ + S + R+ ++ G+LQR W R+ +W ++TAP +RCD YG CGPNSNC+ + +
Sbjct: 360 MANASFLXRVTVDHDGYLQRNMWQEREDKWFSFYTAPRDRCDRYGLCGPNSNCDDSQAE- 418
Query: 307 FECTCLPGFEPKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDM 366
FECTCL GFEPK P++WFL+DGS GC RK+G C GEGF+K+ R K PDTSVA V+M
Sbjct: 419 FECTCLAGFEPKSPRDWFLKDGSAGCLRKEGAKVCGNGEGFVKVGRAKPPDTSVA-RVNM 477
Query: 367 NLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAA 426
N+ ++AC E+CL CSC YA+A+ + G GCL +HGDL DTR + GQDL+VR +A
Sbjct: 478 NISMEACREECLKECSCSGYAAANV-SGSGSGCLSWHGDLVDTRVFPEGGQDLYVRVDAI 536
Query: 427 ELAAEALNNSKSNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRREL 486
LA E SK A+K +A+++V + ++LL F+FLR+++ + R R+ ++
Sbjct: 537 TLA-ENQKQSKGFLAKKGMMAVLVVGAAVIMVLLVSSFWFLRKKM------KGRGRQNKM 589
Query: 487 LFLNSSTRFSEREASISTKGNKE-IRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVY 545
L+ NS + + S+ K + E ++ FF+L+T++AAT+NFS N+LG+GGFG VY
Sbjct: 590 LY-NSRPGATWLQDSLGAKEHDESTTNSELQFFDLNTIVAATNNFSFENELGRGGFGSVY 648
Query: 546 KGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605
KG+L NGQEIAVK+LS SGQG EE KN V LIAKLQH NLV+LL CC++E+E ML+YE+
Sbjct: 649 KGQLYNGQEIAVKKLSKDSGQGKEEFKNXVTLIAKLQHVNLVRLLXCCIQEEEKMLVYEY 708
Query: 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE 665
+PNKSLD FIFDE+++ LLDW+KRF+II+GIAR +LYLH+DSRLRIIHRDLKASN+LLD
Sbjct: 709 LPNKSLDSFIFDETKRSLLDWRKRFEIIVGIARXILYLHEDSRLRIIHRDLKASNVLLDA 768
Query: 666 KMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEI 725
+M P+ISDFG AR+FGG ++ T RVVGTYGYMSPEYA++G+FSTKSDV+SFGV+LLEI
Sbjct: 769 EMLPKISDFGLARIFGGNQMEXNTNRVVGTYGYMSPEYAMEGLFSTKSDVYSFGVLLLEI 828
Query: 726 ITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQ 785
ITG+KN+ + D+ S NL+ W LW ++KAL+I+DSS+ S E LRCIQ+GLLCVQ
Sbjct: 829 ITGRKNSTHYRDNPSMNLVGNVWNLWEEDKALDIIDSSLEKSYPIDEVLRCIQIGLLCVQ 888
Query: 786 DRTTDRPSMSTVVFMLSNETFVPSPKQPTFSVRRTEIDTDNSSSG 830
+ DRP+M T++FML N + +P PK+PTF + T D SSSG
Sbjct: 889 ESAIDRPTMLTIIFMLGNNSALPFPKRPTFISKTTHKGEDLSSSG 933
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843970|ref|XP_002889866.1| hypothetical protein ARALYDRAFT_471279 [Arabidopsis lyrata subsp. lyrata] gi|297335708|gb|EFH66125.1| hypothetical protein ARALYDRAFT_471279 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2314), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/817 (53%), Positives = 582/817 (71%), Gaps = 20/817 (2%)
Query: 18 QISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVAN 77
Q S +TI Q +KDGDVI S K +A GFFS GNS RYVGIWY Q+S+ T++WVAN
Sbjct: 17 QSCYSDNTILRRQSLKDGDVIFSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTVVWVAN 76
Query: 78 RNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEA-SAGNTVAQLLDTGNLVLVR 136
R++PINDTSG++ + +GNL ++ T P+W ++ + VA+L D GNLVL+
Sbjct: 77 RDHPINDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLTDLGNLVLLD 136
Query: 137 NDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFP 196
TG++ W+SF+HPT+T+LP M+ G+ ++ G++R +T+W+SP DPGSGN ++ ++ GFP
Sbjct: 137 PVTGKSFWESFNHPTNTLLPFMKLGFTRQNGVDRIMTSWRSPGDPGSGNITYRIERRGFP 196
Query: 197 QPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARM 256
Q ++YK WR G WTGQR+SG PEMT FIFNI+++ N DEV + G+ D S I RM
Sbjct: 197 QMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVSNPDEVSITYGVFDASVITRM 256
Query: 257 ILNETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFE 316
+LNETG LQRF WN RD++WIG+W+AP ++CD Y HCG N C+ TD FEC+CLPG+E
Sbjct: 257 VLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDPTSTDKFECSCLPGYE 316
Query: 317 PKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEK 376
PK P++WFLRD S GC R + S C EGF KL+R+K+P+TS A NVDMN+ LK CE++
Sbjct: 317 PKTPRDWFLRDASDGCTRIKAASICNGKEGFAKLKRVKIPNTS-AVNVDMNITLKECEQR 375
Query: 377 CLSNCSCVAYASASAETNRGI-GCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNN 435
CL NCSCVAYASA E+ G GCL +HG++ DTR Y ++GQD ++R + +EL N
Sbjct: 376 CLKNCSCVAYASAYHESENGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELVRWNGNG 435
Query: 436 SKSNRARKRRLALIIVAIVLGVILLGLCFF-FLRRRLATRIGERKRQRRRELLFLNSSTR 494
S K RL LI+++++ V+LL + F F+R+R R+ +R R+ +
Sbjct: 436 SSG----KMRLFLILISLLAVVMLLMISLFCFIRKR-------RQFKRLRKAPSSFAPCS 484
Query: 495 FSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQE 554
F ++ I + + R ++ FELST+ AAT+NF+ NKLG GGFGPVYKG L NG E
Sbjct: 485 FDLEDSFILEELEDKSRTRELPLFELSTIAAATNNFAFQNKLGAGGFGPVYKGVLQNGME 544
Query: 555 IAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF 614
IAVKRLS +SGQG+EE KNEV LI+KLQHRNLV++LGCC+E +E ML+YE++PNKSLDYF
Sbjct: 545 IAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYF 604
Query: 615 IFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674
IF++ + LDW KR II GIARG+LYLHQDSRLRIIHRDLKASN+LLD +M P+I+DF
Sbjct: 605 IFNDEHRVELDWPKRMGIIRGIARGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADF 664
Query: 675 GTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRI 734
G AR+FGG +I T RVVGTYGYMSPEYA+DG FS KSDV+SFGV++LEIITGKKN+
Sbjct: 665 GLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKKNSAF 724
Query: 735 FNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCL-ASEALRCIQVGLLCVQDRTTDRPS 793
+ ++S NL+K+ W+ W +A+EI+D M+ SE ++C+ +GLLCVQ+ +DRP
Sbjct: 725 Y--EESLNLVKHIWDRWEKGEAIEIIDKLMSEDTYDVSEVMKCLHIGLLCVQENASDRPD 782
Query: 794 MSTVVFMLSNETF-VPSPKQPTFSV-RRTEIDTDNSS 828
MS+VVFML + +PSPK P F+ RR + T SS
Sbjct: 783 MSSVVFMLGHNAIDLPSPKHPAFTAGRRRNVKTGGSS 819
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496631|ref|XP_003635285.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2298), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/812 (53%), Positives = 578/812 (71%), Gaps = 20/812 (2%)
Query: 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNP 81
S DTI+ +QP++DGD++VS + +ALGFFSP NS RY+G+WYN I + T++WV NR++P
Sbjct: 335 STDTITPNQPLRDGDLLVSKQSRFALGFFSPRNSTLRYIGVWYNTIREQTVVWVLNRDHP 394
Query: 82 INDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGE 141
IND+SGVLS+N GNL+LH N VW N+S +SA TVAQLLDTGNLVL++ND
Sbjct: 395 INDSSGVLSINTSGNLLLHRGNTH---VWSTNVSISSANATVAQLLDTGNLVLIQNDGNR 451
Query: 142 TLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLY 201
+WQ FD+PTD+++P M+ G D+RTG NR++T+WKSP DPG+G S T++ +G PQ LY
Sbjct: 452 VVWQGFDYPTDSLIPYMKLGLDRRTGFNRFLTSWKSPTDPGTGKNSLTINASGSPQFFLY 511
Query: 202 KDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNET 261
+ LWR+G W G R+SG P M I N+++++NQDE+ L ++ + ++
Sbjct: 512 QGSKPLWRSGNWNGFRWSGVPTMMHGTIVNVSFLNNQDEISYMYSLINVWLPTTLTIDVD 571
Query: 262 GFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKYPK 321
G++QR +W + +WI WT P +RCD YG CG N NC+ N FECTCL GFEPK P+
Sbjct: 572 GYIQRNSWLETEGKWINSWTVPTDRCDRYGRCGVNGNCD-NSRAEFECTCLAGFEPKSPR 630
Query: 322 EWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSNC 381
+W L+DGS GC RK+G C GEGF+K+E K PDTSVA V+ N+ L+AC E CL C
Sbjct: 631 DWSLKDGSAGCLRKEGAKVCGNGEGFVKVEGAKPPDTSVA-RVNTNMSLEACREGCLKEC 689
Query: 382 SCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKSNRA 441
SC YA+A+ + G GCL +HGDL DTR + GQDL+VR +A L + SK A
Sbjct: 690 SCSGYAAANV-SGSGSGCLSWHGDLVDTRVFPEGGQDLYVRVDAITLG---MLQSKGFLA 745
Query: 442 RKRRLALIIVAIVLGVILLGLCFFFLRRRLA---TRIGERKRQRRRELLFLNSSTRFSER 498
+K +A+++V + ++LL F+FLR+++ T+I + R +L S E
Sbjct: 746 KKGMMAVLVVGATVIMVLLVSTFWFLRKKMKGNQTKILKMLYNSRLGATWLQDSPGAKEH 805
Query: 499 EASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVK 558
+ S + N E++ FF+L+T+ AAT+NFS+ N+LG+GGFG VYKG+LSNGQEIAVK
Sbjct: 806 DESTT---NSELQ-----FFDLNTIAAATNNFSSENELGRGGFGSVYKGQLSNGQEIAVK 857
Query: 559 RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE 618
+LS SGQG EE KNE LIAKLQH NLV+LLGCC+ E+E ML+YE++PNKSLD FIFDE
Sbjct: 858 KLSKDSGQGKEEFKNEATLIAKLQHVNLVRLLGCCITEEEKMLVYEYLPNKSLDSFIFDE 917
Query: 619 SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
++K LLDW+KRF+II+GIARG+LYLH+DSRLRIIHRDLKASN+LLD +M P+ISDFG AR
Sbjct: 918 TKKSLLDWRKRFEIIVGIARGILYLHEDSRLRIIHRDLKASNVLLDAEMFPKISDFGLAR 977
Query: 679 VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDD 738
+F G ++ T RVVGTYGYMSPEYA++G+FSTKSDV+SFGV+LLEIITG+KN+ + D+
Sbjct: 978 IFRGNQMEGNTNRVVGTYGYMSPEYAMEGLFSTKSDVYSFGVLLLEIITGRKNSTYYQDN 1037
Query: 739 DSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798
S +LI W LW ++KAL+++D S+ S A E LRCIQ+GLLCVQ+ TDRP+M T++
Sbjct: 1038 PSMSLIGNVWNLWEEDKALDLIDPSLEKSYPADEVLRCIQIGLLCVQESITDRPTMLTII 1097
Query: 799 FMLSNETFVPSPKQPTFSVRRTEIDTDNSSSG 830
FML N + + PK+P F + T D S SG
Sbjct: 1098 FMLGNNSALSFPKRPAFISKTTHKGEDLSCSG 1129
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496633|ref|XP_002269297.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RKS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2291), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/811 (52%), Positives = 577/811 (71%), Gaps = 17/811 (2%)
Query: 20 STSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRN 79
S S DTI+ +QP +DGD++VS +ALGFFSP NS RY+G+WYN I + T++WV NR+
Sbjct: 20 SRSTDTITPNQPFRDGDLLVSKESRFALGFFSPRNSTLRYIGVWYNTIREQTVVWVLNRD 79
Query: 80 NPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDT 139
+PINDTSGVLS+N GNL+LH N VW ++S +S TVAQLLDTGNLVL++ D
Sbjct: 80 HPINDTSGVLSINTSGNLLLHRGNTH---VWSTDVSISSVNPTVAQLLDTGNLVLIQKDD 136
Query: 140 GETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPL 199
+WQ FD+PTD ++P+M+ G ++RTG NR++T+WKSP DP +G +S +++G PQ
Sbjct: 137 KMVVWQGFDYPTDNLIPHMKLGLNRRTGYNRFLTSWKSPTDPATGKYSLGFNVSGSPQIF 196
Query: 200 LYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILN 259
LY+ LWR+G W G R+SG P M F +++++NQDE+Y + + S + R+ ++
Sbjct: 197 LYQGSEPLWRSGHWNGLRWSGLPVMMYRFQHKVSFLNNQDEIYYMFIMVNASFLERLTVD 256
Query: 260 ETGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKY 319
G++QR W + +W ++TAP +RCD YG CGPNSNC+ N FECTCL GFEPK
Sbjct: 257 HEGYIQRNMWQETEGKWFSFYTAPRDRCDRYGRCGPNSNCD-NSQAEFECTCLAGFEPKS 315
Query: 320 PKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLS 379
P++ FL+DGS GC RK+G C GEGF+K+ K PDTSVA V+MN+ ++AC E+CL
Sbjct: 316 PRDLFLKDGSAGCLRKEGAKVCGNGEGFVKVGGAKPPDTSVA-RVNMNISMEACREECLK 374
Query: 380 NCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKSN 439
CSC YA+A+ + G GCL +HGDL DTR + GQ+L+VR +A L + SK
Sbjct: 375 ECSCSGYAAANV-SGSGSGCLSWHGDLVDTRVFPEGGQNLYVRVDAITLG---MLQSKGF 430
Query: 440 RARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRFSERE 499
A+K +A+++V + ++LL F+FLR+++ R + R +L S E +
Sbjct: 431 LAKKGMMAVLVVGATVIMVLLVSTFWFLRKKMKGRQNKMLYNSRPGATWLQDSPGAKEHD 490
Query: 500 ASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR 559
S + N E++ FF+L+T++AAT+NFS+ N+LG+GGFG V+KG+LSNGQEIAVK+
Sbjct: 491 ESTT---NSELQ-----FFDLNTIVAATNNFSSENELGRGGFGSVFKGQLSNGQEIAVKK 542
Query: 560 LSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDES 619
LS SGQG EE KNE LIAKLQH NLV+L+GCC+ E+ENML+YE++ NKSLD FIFDE+
Sbjct: 543 LSKDSGQGKEEFKNEATLIAKLQHVNLVRLVGCCITEEENMLVYEYLSNKSLDSFIFDET 602
Query: 620 RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
+K LLDW+KRF+II+GIARG+LYLH+DSRLRIIHRDLKASN+LLD +M P+ISDFG AR+
Sbjct: 603 KKSLLDWRKRFEIIVGIARGILYLHEDSRLRIIHRDLKASNVLLDAEMFPKISDFGLARI 662
Query: 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD 739
F G ++ T RVVGTYGYMSPEYA++G+FSTKSDV+SFGV+LLEIITG+KN+ + D
Sbjct: 663 FRGNQMEGNTNRVVGTYGYMSPEYAMEGLFSTKSDVYSFGVLLLEIITGRKNSTYYRDGP 722
Query: 740 SSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799
S +L+ W LW + KAL+I+D S+ S E LRCIQ+GLLCVQ+ TDRP+M T++F
Sbjct: 723 SISLVGNVWNLWEEGKALDIIDLSLQKSYPTDEVLRCIQIGLLCVQESVTDRPTMLTIIF 782
Query: 800 MLSNETFVPSPKQPTFSVRRTEIDTDNSSSG 830
ML N + +P PK+P F + T D SSSG
Sbjct: 783 MLGNNSALPFPKRPAFISKTTHKGEDLSSSG 813
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497115|ref|XP_002270258.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RKS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2291), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/820 (53%), Positives = 581/820 (70%), Gaps = 24/820 (2%)
Query: 21 TSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNN 80
T +TI+ +QP++DGDV+VS +ALGFFSP NS RYVG+WY IS T++WV NR++
Sbjct: 16 TPAETITPTQPLRDGDVLVSKGARFALGFFSPSNSSHRYVGLWYYSIST-TVVWVLNRDD 74
Query: 81 PINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTG 140
PINDTSGVLS+N +GNLVL+ R+ +W N+S +S NT+AQLLDTGNLVL++ND
Sbjct: 75 PINDTSGVLSINTRGNLVLYRRDSL---IWSTNVSVSSVNNTIAQLLDTGNLVLIQNDGK 131
Query: 141 ETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLL 200
+WQ FD+PTDT+LP M+ G D+RTGLNR++T+WKS DPG+G +S + ++G PQ
Sbjct: 132 RVVWQGFDYPTDTMLPYMKLGLDRRTGLNRFLTSWKSQGDPGTGEYSHKMGVSGSPQMFF 191
Query: 201 YKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNE 260
K LWR PW G ++ PE+ IFN T+++N DEV + + S ++R+ +
Sbjct: 192 RKGFQPLWRTDPWNGLGWASVPEVDSGSIFNTTFLNNTDEVSVVYNVMQPSVLSRLTADS 251
Query: 261 TGFLQRFTWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKYP 320
GFLQ +T D +W+ +W APAERCD YG CGPN NCNL D FECTCL GFEPK
Sbjct: 252 DGFLQFYTAQKSDSKWVAFWFAPAERCDTYGRCGPNGNCNLITADFFECTCLAGFEPKSA 311
Query: 321 KEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSN 380
++W L DGS GC R G+S C+ GEGFIK+ MK+PDTS AA VD +L L+ C E+CL+N
Sbjct: 312 RDWSLADGSQGCVRIHGSSVCRSGEGFIKMAHMKVPDTS-AARVDTSLSLEECREECLNN 370
Query: 381 CSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRANAAELAAEALNNSKSNR 440
C+C AY AS G GCL ++GDL DTR + GQDLF+R +A LA N K N
Sbjct: 371 CNCSAYTRASVS---GSGCLSWYGDLMDTRVLSVGGQDLFLRVDAITLAQ---NKRKKNI 424
Query: 441 ARKRRLALIIVA--IVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLF-LNSSTRFSE 497
K+ L +I+ ++ V+++ L + +++R + + R+ +LLF LN S +
Sbjct: 425 FHKKWLMVILTVGLALVTVLMVSLSWLAMKKR-------KGKGRQHKLLFNLNLSDTWLA 477
Query: 498 REASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAV 557
S + +GN+ + F+LST++AAT+N S +NKLG+GGFG VYKG+LSNGQEIAV
Sbjct: 478 -HYSKAKQGNESRTPSKLQLFDLSTIVAATNNLSFTNKLGRGGFGSVYKGQLSNGQEIAV 536
Query: 558 KRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD 617
KRLS SGQG+EE KNEV L A+LQHRNLVKLLGCC+EE+E +LIYE+MPNKSLD FIFD
Sbjct: 537 KRLSNDSGQGVEEFKNEVTLTAELQHRNLVKLLGCCIEEEEKVLIYEYMPNKSLDSFIFD 596
Query: 618 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
E+++ +L W+K F+II+GIARG+LYLHQDSRLRIIHRDLKASN+LLD M P+ISDFG A
Sbjct: 597 ETKRSMLTWEKCFEIIIGIARGILYLHQDSRLRIIHRDLKASNVLLDVDMIPKISDFGMA 656
Query: 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFND 737
R+FGG +I T RVVGTYGYMSPEYA++G+FS KSDV+SF V+LLEIITG++NT +
Sbjct: 657 RLFGGNQIEGSTNRVVGTYGYMSPEYAMEGLFSIKSDVYSFRVLLLEIITGRRNTTYYCG 716
Query: 738 DDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTV 797
S NL+ Y W LW+++KAL+IVD S+ S +E LRCI +GLLCVQ+ DRP+M T+
Sbjct: 717 SPSFNLVGYVWSLWTESKALDIVDLSLEKSNHTNEVLRCIHIGLLCVQEFAIDRPTMLTI 776
Query: 798 VFMLSNETFVPSPKQPTFSVRRTEIDTDNSSSGIKSSVNE 837
+ ML N + +P P QP F V+ D ++SS +++S+NE
Sbjct: 777 ISMLGNNSTLPPPNQPAFVVKPCHNDANSSS--VEASINE 814
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 837 | ||||||
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.405 | 0.398 | 0.579 | 4.1e-197 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.406 | 0.434 | 0.580 | 4.4e-191 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.389 | 0.386 | 0.595 | 2.2e-189 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.391 | 0.387 | 0.598 | 4.1e-186 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.414 | 0.418 | 0.554 | 6.5e-177 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.394 | 0.404 | 0.589 | 5.3e-173 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.409 | 0.404 | 0.572 | 6.7e-173 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.385 | 0.383 | 0.579 | 2.1e-167 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.378 | 0.392 | 0.590 | 1.4e-163 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.390 | 0.406 | 0.583 | 2.2e-163 |
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 4.1e-197, Sum P(2) = 4.1e-197
Identities = 201/347 (57%), Positives = 252/347 (72%)
Query: 487 LFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYK 546
L +N S R IS + N + +++ E + AT+NFS +NKLGQGGFG VYK
Sbjct: 487 LLMNEVVISSRRH--ISRENNTD--DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYK 542
Query: 547 GKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606
GKL +GQE+AVKRLS TS QG +E KNEV LIA+LQH NLV+LL CC++ E MLIYE++
Sbjct: 543 GKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYL 602
Query: 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK 666
N SLD +FD+SR L+W+ RFDII GIARG+LYLHQDSR RIIHRDLKASNILLD+
Sbjct: 603 ENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKY 662
Query: 667 MNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEII 726
M P+ISDFG AR+FG +E A T++VVGTYGYMSPEYA+DG+FS KSDVFSFGV+LLEII
Sbjct: 663 MTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 722
Query: 727 TGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLA---SEALRCIQVGLLC 783
+ K+N +N D NL+ W W + K LEI+D + +S E LRCIQ+GLLC
Sbjct: 723 SSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLC 782
Query: 784 VQDRTTDRPSMSTVVFMLSNE-TFVPSPKQPTFSVRRTEIDTDNSSS 829
VQ+R DRP+MS V+ ML +E T +P PK P + + R+ +DTD+SSS
Sbjct: 783 VQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSS 829
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1010 (360.6 bits), Expect = 4.4e-191, Sum P(2) = 4.4e-191
Identities = 198/341 (58%), Positives = 251/341 (73%)
Query: 497 EREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIA 556
+RE+S + +E +++ F +L T+ AT FS NKLGQGGFGPVYKG L+ GQE+A
Sbjct: 432 QRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVA 491
Query: 557 VKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIF 616
VKRLS TS QG+EE KNE+ LIAKLQHRNLVK+LG C++E+E MLIYE+ PNKSLD FIF
Sbjct: 492 VKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIF 551
Query: 617 DESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676
D+ R++ LDW KR +II GIARG+LYLH+DSRLRIIHRDLKASN+LLD MN +ISDFG
Sbjct: 552 DKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGL 611
Query: 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFN 736
AR GG+E A T RVVGTYGYMSPEY +DG FS KSDVFSFGV++LEI++G++N N
Sbjct: 612 ARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRN 671
Query: 737 DDDSSNLIKYAWELWSDNKALEIVDSSMANSCL-ASEALRCIQVGLLCVQDRTTDRPSMS 795
++ NL+ +AW + ++KA EI+D ++ SC SE LR I +GLLCVQ DRP+MS
Sbjct: 672 EEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMS 731
Query: 796 TVVFMLSNETFVPSPKQPTFSVRRTEIDTDNSSSGIKSSVN 836
VV MLS+E + P+QP F R + +D S ++ N
Sbjct: 732 VVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPSN 772
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1012 (361.3 bits), Expect = 2.2e-189, Sum P(2) = 2.2e-189
Identities = 197/331 (59%), Positives = 248/331 (74%)
Query: 504 TKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT 563
T K+ +++ EL L AT+NFS NKLGQGGFG VYKG+L +G+EIAVKRLS
Sbjct: 493 TSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKM 552
Query: 564 SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQL 623
S QG +E NEV LIAKLQH NLV+LLGCC+++ E MLIYE++ N SLD +FD++R
Sbjct: 553 SSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN 612
Query: 624 LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683
L+W+KRFDII GIARG+LYLHQDSR RIIHRDLKASN+LLD+ M P+ISDFG AR+FG E
Sbjct: 613 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 672
Query: 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNL 743
E A T+RVVGTYGYMSPEYA+DG+FS KSDVFSFGV+LLEII+GK+N +N + NL
Sbjct: 673 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 732
Query: 744 IKYAWELWSDNKALEIVD----SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799
+ + W W + LEIVD S+++ E LRCIQ+GLLCVQ+R DRP MS+V+
Sbjct: 733 LGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMV 792
Query: 800 MLSNETF-VPSPKQPTFSVRRTEIDTDNSSS 829
ML +ET +P PK+P F + R+ ++ D+SSS
Sbjct: 793 MLGSETTAIPQPKRPGFCIGRSPLEADSSSS 823
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1011 (360.9 bits), Expect = 4.1e-186, Sum P(2) = 4.1e-186
Identities = 200/334 (59%), Positives = 251/334 (75%)
Query: 501 SISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL 560
S ++K NK +++ E L AT+NFST NKLGQGGFG VYKG L +G+EIAVKRL
Sbjct: 495 SYTSKENKT-DYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRL 553
Query: 561 STTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR 620
S S QG +E NEV LIAKLQH NLV+LLGCC+++ E MLIYE++ N SLD +FD++R
Sbjct: 554 SKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTR 613
Query: 621 KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
L+W+KRFDII GIARG+LYLHQDSR RIIHRDLKASN+LLD+ M P+ISDFG AR+F
Sbjct: 614 SSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIF 673
Query: 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDS 740
G EE A T+RVVGTYGYMSPEYA+DG+FS KSDVFSFGV+LLEII+GK+N +N +
Sbjct: 674 GREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRD 733
Query: 741 SNLIKYAWELWSDNKALEIVD----SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMST 796
NL+ + W W + K LEIVD ++++ E LRCIQ+GLLCVQ+R DRP MS+
Sbjct: 734 LNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSS 793
Query: 797 VVFMLSNETF-VPSPKQPTFSVRRTEIDTDNSSS 829
V+ ML +ET +P PK+P F V R+ ++ D+SSS
Sbjct: 794 VMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSS 827
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1012 (361.3 bits), Expect = 6.5e-177, Sum P(2) = 6.5e-177
Identities = 197/355 (55%), Positives = 261/355 (73%)
Query: 490 NSSTRF-SEREASISTK--GN---KEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGP 543
N +TR +ER ++S+ G + + ++ FE L AT+NFS +NKLGQGGFG
Sbjct: 466 NRNTRLLNERMEALSSNDVGAILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGA 525
Query: 544 VYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603
VYKG+L G +IAVKRLS TSGQG+EE NEV++I+KLQHRNLV+LLG C+E +E ML+Y
Sbjct: 526 VYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVY 585
Query: 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663
EFMP LD ++FD +++LLDWK RF+II GI RG++YLH+DSRL+IIHRDLKASNILL
Sbjct: 586 EFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILL 645
Query: 664 DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILL 723
DE +NP+ISDFG AR+F G E T RVVGTYGYM+PEYA+ G+FS KSDVFS GVILL
Sbjct: 646 DENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILL 705
Query: 724 EIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLC 783
EI++G++N+ +ND + NL YAW+LW+ + + +VD + C +E RC+ VGLLC
Sbjct: 706 EIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLC 765
Query: 784 VQDRTTDRPSMSTVVFMLSNETF-VPSPKQPTFSVRRTEIDTDNSS-SGIKSSVN 836
VQD DRPS++TV++MLS+E +P PKQP F RR + ++S S ++S+N
Sbjct: 766 VQDHANDRPSVATVIWMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASIN 820
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1011 (360.9 bits), Expect = 5.3e-173, Sum P(2) = 5.3e-173
Identities = 197/334 (58%), Positives = 249/334 (74%)
Query: 505 KGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS 564
KG +E +D+ F+ T+ ATD+FS N LG+GGFGPVYKGKL +GQEIAVKRLS S
Sbjct: 476 KGIEE-EDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANS 534
Query: 565 GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLL 624
GQG+EE KNEV LIAKLQHRNLV+LLGCC++ +E MLIYE+MPNKSLD+FIFDE R L
Sbjct: 535 GQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTEL 594
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
DWKKR +II G+ARG+LYLHQDSRLRIIHRDLKA N+LLD MNP+ISDFG A+ FGG++
Sbjct: 595 DWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQ 654
Query: 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744
+ T RVVGTYGYM PEYA+DG FS KSDVFSFGV++LEIITGK N + D NL+
Sbjct: 655 SESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLL 714
Query: 745 KYAWELWSDNKALEIVDSS-MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
+ W++W +++ +E+ + + + + E LRCI V LLCVQ + DRP+M++VV M +
Sbjct: 715 GHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGS 774
Query: 804 ETFVPSPKQPTFSVRRTEIDTDNSSSGIKSSVNE 837
++ +P P QP F R D +S S ++S NE
Sbjct: 775 DSSLPHPTQPGFFTNRNVPDISSSLS-LRSQ-NE 806
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1025 (365.9 bits), Expect = 6.7e-173, Sum P(2) = 6.7e-173
Identities = 202/353 (57%), Positives = 268/353 (75%)
Query: 491 SSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLS 550
+++ FS I +G K + ++ F L+ + AT++F N+LG+GGFGPVYKG L
Sbjct: 492 TTSAFSG-SVDIMIEG-KAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLE 549
Query: 551 NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610
+G+EIAVKRLS SGQG++E KNE++LIAKLQHRNLV+LLGCC E +E ML+YE+MPNKS
Sbjct: 550 DGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKS 609
Query: 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670
LD+F+FDE+++ L+DWK RF II GIARG+LYLH+DSRLRIIHRDLK SN+LLD +MNP+
Sbjct: 610 LDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPK 669
Query: 671 ISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKK 730
ISDFG AR+FGG + A T RVVGTYGYMSPEYA++G+FS KSDV+SFGV+LLEI++GK+
Sbjct: 670 ISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKR 729
Query: 731 NTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTD 790
NT + + + S LI YAW L++ ++ E+VD + +C EALRCI V +LCVQD +
Sbjct: 730 NTSLRSSEHGS-LIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAE 788
Query: 791 RPSMSTVVFMLSNETF-VPSPKQPTF-SVRRTEIDT----DNSSSGIKSSVNE 837
RP+M++V+ ML ++T + +P+QPTF S RR ID D+S I SS NE
Sbjct: 789 RPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSS-NE 840
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 986 (352.1 bits), Expect = 2.1e-167, Sum P(2) = 2.1e-167
Identities = 189/326 (57%), Positives = 248/326 (76%)
Query: 514 DVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKN 573
D+ F ++ +AT +F+ NKLGQGGFG VYKG S G+EIAVKRLS S QG+EE KN
Sbjct: 509 DLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKN 568
Query: 574 EVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 633
E+LLIAKLQHRNLV+LLGCC+E++E ML+YE+MPNKSLD F+FDES++ LDW+KR+++I
Sbjct: 569 EILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVI 628
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
GIARG+LYLH+DSRL+IIHRDLKASNILLD +MNP+ISDFG AR+F + A T RVV
Sbjct: 629 GGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVV 688
Query: 694 GTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD 753
GTYGYM+PEYA++G+FS KSDV+SFGV++LEI++G+KN F D +LI YAW LWS
Sbjct: 689 GTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVS-FRGTDHGSLIGYAWHLWSQ 747
Query: 754 NKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF-VPSPKQ 812
K E++D + ++ +EA+RCI VG+LC QD RP+M +V+ ML ++T +P P+Q
Sbjct: 748 GKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQ 807
Query: 813 PTFSVRRTEIDTDNSSSGIK-SSVNE 837
PTF D + + G +SVN+
Sbjct: 808 PTFHSFLNSGDIELNFDGHDVASVND 833
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 986 (352.1 bits), Expect = 1.4e-163, Sum P(2) = 1.4e-163
Identities = 190/322 (59%), Positives = 246/322 (76%)
Query: 517 FFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVL 576
FF++ T+ AT+NFS SNKLGQGGFGPVYKGKL +G+EIAVKRLS++SGQG EE NE++
Sbjct: 481 FFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIV 540
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQL-LDWKKRFDIILG 635
LI+KLQH+NLV++LGCC+E +E +LIYEFM N SLD F+FD SRK+L +DW KR DII G
Sbjct: 541 LISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFD-SRKRLEIDWPKRLDIIQG 599
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
IARG+ YLH+DS L++IHRDLK SNILLDEKMNP+ISDFG AR++ G E T+RVVGT
Sbjct: 600 IARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGT 659
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK 755
GYM+PEYA G+FS KSD++SFGV++LEII+G+K +R + LI YAWE W D
Sbjct: 660 LGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGKEEKTLIAYAWESWCDTG 719
Query: 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVPSPKQPTF 815
++++D +A+SC E RC+Q+GLLCVQ + DRP+ ++ ML+ + +P P+QPTF
Sbjct: 720 GIDLLDKDVADSCRPLEVERCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPPPEQPTF 779
Query: 816 SVRRTEIDTDNSSSGIKSSVNE 837
V R + D SSS +VNE
Sbjct: 780 VVHRRD---DKSSSEDLITVNE 798
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1009 (360.2 bits), Expect = 2.2e-163, Sum P(2) = 2.2e-163
Identities = 193/331 (58%), Positives = 254/331 (76%)
Query: 507 NKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ 566
+KE+ ++ FFE++T+ AT+NFS SNKLGQGGFG VYKGKL +G+EIAVK+LS++SGQ
Sbjct: 469 SKEVPGLE--FFEMNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQ 526
Query: 567 GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDW 626
G EE NE++LI+KLQHRNLV++LGCC+E +E +LIYEFM NKSLD F+FD +K +DW
Sbjct: 527 GKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDW 586
Query: 627 KKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686
KRFDI+ GIARG+LYLH+DSRL++IHRDLK SNILLDEKMNP+ISDFG AR++ G +
Sbjct: 587 PKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQ 646
Query: 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKY 746
T+RVVGT GYMSPEYA GVFS KSD++SFGV+LLEII G+K +R ++ L+ Y
Sbjct: 647 DKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAY 706
Query: 747 AWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806
AWE W + K ++++D +A+SC E RC+Q+GLLCVQ + DRP+ ++ ML+ +
Sbjct: 707 AWESWGETKGIDLLDQDLADSCRPLEVGRCVQIGLLCVQHQPADRPNTLELLAMLTTTSD 766
Query: 807 VPSPKQPTFSVRRTEIDTDNSSSGIKSSVNE 837
+PSPKQPTF V D ++S S +VNE
Sbjct: 767 LPSPKQPTFVVHSR--DDESSLSKDLFTVNE 795
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LPZ3 | Y1141_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5284 | 0.9653 | 0.9562 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 837 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-40 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 8e-39 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 6e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-32 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 1e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-29 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-29 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 4e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-25 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-24 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 2e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-21 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 9e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-18 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 3e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-05 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-04 | |
| cd00054 | 38 | cd00054, EGF_CA, Calcium-binding EGF-like domain, | 0.002 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| COG1718 | 268 | COG1718, RIO1, Serine/threonine protein kinase inv | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| smart00179 | 39 | smart00179, EGF_CA, Calcium-binding EGF-like domai | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 | |
| cd00053 | 36 | cd00053, EGF, Epidermal growth factor domain, foun | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 1e-52
Identities = 82/217 (37%), Positives = 113/217 (52%), Gaps = 20/217 (9%)
Query: 535 KLGQGGFGPVYKGKLSNG-----QEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
KLG+G FG VYKG L E+AVK L S Q IEE E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
LLG C EE+ M++ E+MP L ++ +R + L L IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTAR-VFGGEEILAITKRVVGTYGYMSPEYALDG 707
IHRDL A N L+ E + +ISDFG +R ++ + ++ +M+PE +G
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179
Query: 708 VFSTKSDVFSFGVILLEIIT-------GKKNTRIFND 737
F++KSDV+SFGV+L EI T G N +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY 216
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 5e-52
Identities = 80/217 (36%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 535 KLGQGGFGPVYKGKL-----SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
KLG+G FG VYKGKL E+AVK L S Q IEE E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
LLG C EE+ ++ E+M L ++ + L L IARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTAR-VFGGEEILAITKRVVGTYGYMSPEYALDG 707
IHRDL A N L+ E + +ISDFG +R ++ + ++ +M+PE +G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178
Query: 708 VFSTKSDVFSFGVILLEIIT-------GKKNTRIFND 737
F++KSDV+SFGV+L EI T G N +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEY 215
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 77/206 (37%), Positives = 110/206 (53%), Gaps = 16/206 (7%)
Query: 534 NKLGQGGFGPVYKGKLSNGQ----EIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
KLG+G FG VYKGKL E+AVK L S + ++ E ++ KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFI------FDESRKQLLDWKKRFDIILGIARGVLY 642
LLG C EE+ L+ E+M L ++ F K L K + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-VFGGEEILAITKRVVGTYGYMSP 701
L + +HRDL A N L+ E + +ISDFG +R V+ + T + +M+P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 702 EYALDGVFSTKSDVFSFGVILLEIIT 727
E DG+F++KSDV+SFGV+L EI T
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 72/194 (37%), Positives = 108/194 (55%), Gaps = 11/194 (5%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLST-TSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
LG+GGFG VY + G+++A+K + S +EEL E+ ++ KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
+E+ L+ E+ SL + + + L + I+L I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 654 RDLKASNILLDEK-MNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV-FST 711
RDLK NILLD +++DFG +++ ++ L K +VGT YM+PE L +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 712 KSDVFSFGVILLEI 725
KSD++S GVIL E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 1e-48
Identities = 76/220 (34%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 535 KLGQGGFGPVYKGKL-----SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
KLG+G FG VYKG L ++AVK L S + EE E ++ KL H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
LLG C + + ++ E+MP L F+ + L K + L IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY-----MSPEY 703
+HRDL A N L+ E + +ISDFG +R ++ G M+PE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----RKRGGGKLPIKWMAPES 175
Query: 704 ALDGVFSTKSDVFSFGVILLEIIT-------GKKNTRIFN 736
DG F++KSDV+SFGV+L EI T G N +
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE 215
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 72/217 (33%), Positives = 110/217 (50%), Gaps = 14/217 (6%)
Query: 530 FSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHRNLV 587
+ KLG+G FG VY + G+ +A+K + + E + E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L +ED+ L+ E+ L + + R +L + + RF + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
I+HRDLK NILLDE + +++DFG AR E L VGT YM+PE L
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPEVLLGK 171
Query: 708 VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744
+ D++S GVIL E++TGK F DD +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK---PPFPGDDQLLEL 205
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 4e-47
Identities = 75/199 (37%), Positives = 105/199 (52%), Gaps = 12/199 (6%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
KLG G FG VYK K G+ +AVK L + + + + E+ ++ +L H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
++D L+ E+ L ++ SR L + I L I RG+ YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG-VFS 710
IHRDLK NILLDE +I+DFG A+ + VGT YM+PE L G +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 711 TKSDVFSFGVILLEIITGK 729
K DV+S GVIL E++TGK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 31/211 (14%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
LG+G FG VY G+ +AVK LS S + +E L+ E+ +++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 591 GCCLEEDENML-IY-EFMPNKSLDYFI-----FDESR-----KQLLDWKKRFDIILGIAR 638
G +E++N L I+ E++ SL + E +Q+L
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-------------E 112
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
G+ YLH I+HRD+K +NIL+D +++DFG A+ G E T V GT +
Sbjct: 113 GLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
M+PE + +D++S G ++E+ TGK
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 530 FSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
F K+G+GGFG VYK + G+E+A+K + S + E++ NE+ ++ K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLD-WKKRFD------IILGIARGVL 641
G L++DE ++ EF SL K LL + + + +G+
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSL---------KDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
YLH IIHRD+KA+NILL ++ DFG + +VGT +M+P
Sbjct: 113 YLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAP 166
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGK 729
E + K+D++S G+ +E+ GK
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 8e-39
Identities = 46/111 (41%), Positives = 66/111 (59%), Gaps = 2/111 (1%)
Query: 208 WRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNETGFLQRF 267
WR+GPW G RFSG PEM + + + +N +EVY + + S +R+ L+ G L+RF
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60
Query: 268 TWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPK 318
TW + W +W+AP ++CD YG CGP C++N T C C+ GF PK
Sbjct: 61 TWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVN-TSPK-CNCIKGFVPK 109
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 53/114 (46%), Positives = 71/114 (62%), Gaps = 5/114 (4%)
Query: 69 QLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLD 128
T++WVANR NP+ D+S L + GNLVL++ N VW +N S VA L D
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGR--VVWSSNTSG-KGSGCVAVLQD 57
Query: 129 TGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPG 182
GNLVL +++G+ LWQSFDHPTDT+LP + G + G +R +T+WKS DP
Sbjct: 58 DGNLVL-YDNSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 74/198 (37%), Positives = 105/198 (53%), Gaps = 16/198 (8%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
KLG G FG V+ G + ++AVK L T S E E ++ KL+H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 593 CLEEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
C EE+ ++ E+M SL D+ E +K L + D+ IA G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLE---SRNY 124
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI--TKRVVGTYGYMSPEYALDGVF 709
IHRDL A NIL+ E + +I+DFG AR+ +E A K + + +PE A G F
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI---KWTAPEAANYGRF 181
Query: 710 STKSDVFSFGVILLEIIT 727
+ KSDV+SFG++L EI+T
Sbjct: 182 TIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
++G+G FG VY + S+G+ +K LS S + E+ NEV ++ KL H N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFI---------FDESRKQLLDWKKRFDIILGIARGVL 641
E+ + ++ E+ L I F E +Q+LDW + + +
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE--EQILDW------FVQLCLALK 117
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
YLH SR +I+HRD+K NI L ++ DFG ++V LA T VVGT Y+SP
Sbjct: 118 YLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSP 172
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGKK 730
E + ++ KSD++S G +L E+ T K
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 68/198 (34%), Positives = 107/198 (54%), Gaps = 6/198 (3%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
F+ KLG G FG V++G N +A+K L + ++ + EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
C + +I E M SL F+ Q+L D+ +A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVF 709
IHRDL A NIL+ E + +++DFG AR+ + L+ K++ Y + +PE A G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 710 STKSDVFSFGVILLEIIT 727
STKSDV+SFG++L E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 529 NFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRN 585
N+ + +G+G FG VYKG L G +A+K++S + ++ + E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD---------IILGI 636
+VK +G D +I E+ N SL +Q++ K+F + +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL---------RQII---KKFGPFPESLVAVYVYQV 108
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY 696
+G+ YLH+ +IHRD+KA+NIL + +++DFG A + VVGT
Sbjct: 109 LQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTP 163
Query: 697 GYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+M+PE ST SD++S G ++E++TG
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 72/211 (34%), Positives = 111/211 (52%), Gaps = 25/211 (11%)
Query: 536 LGQGGFGPVYKGKL------SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
LG+G FG VYKG+L + +A+K L + +E + E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIF-------------DESRKQLLDWKKRFDIILG 635
LLG C +E +++E++ + L F+ DE+ K LD I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-VFGGEEILAITKRVVG 694
IA G+ YL S +HRDL A N L+ E + +ISDFG +R ++ + +K ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVILLEI 725
+M PE L G F+T+SD++SFGV+L EI
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 52/122 (42%), Positives = 73/122 (59%), Gaps = 6/122 (4%)
Query: 29 SQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGV 88
S P+ G +VSS ++ LGFF + Y I Y S+ T++WVANR+NP + +S
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSR-TVVWVANRDNP-SGSSCT 58
Query: 89 LSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFD 148
L++ GNLV++ + S VW +N + + GN V LLD GNLVL +D G LWQSFD
Sbjct: 59 LTLQSDGNLVIY--DGSGTVVWSSNTTRVN-GNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114
Query: 149 HP 150
+P
Sbjct: 115 YP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 38/222 (17%)
Query: 536 LGQGGFGPVYKGKLSNGQE------IAVKRLS-TTSGQGIEELKNEVLLIAKLQHRNLVK 588
LG+G FG V+ G+ + + +AVK L T S ++ + E L+ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYF-----------IFDESRKQLLDWKKRFDIILGIA 637
G C E D ++++E+M + L+ F +S L + I + IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-VF-------GGEEILAIT 689
G++YL + +HRDL N L+ + +I DFG +R V+ GG +L I
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 690 KRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKK 730
+M PE + F+T+SDV+SFGV+L EI T GK+
Sbjct: 190 --------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 31/211 (14%)
Query: 536 LGQGGFGPVYKG-----KLSNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKL 589
LG G FG VYKG +A+K L + + +E+ +E ++A + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQ 645
LG CL + LI + MP L ++ + + LL+W + IA+G+ YL +
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG-----YMS 700
R++HRDL A N+L+ + +I+DFG A++ +E K G +M+
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE-----KEYHAEGGKVPIKWMA 179
Query: 701 PEYALDGVFSTKSDVFSFGVILLEIIT-GKK 730
E L +++ KSDV+S+GV + E++T G K
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (315), Expect = 4e-31
Identities = 81/324 (25%), Positives = 133/324 (41%), Gaps = 23/324 (7%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQH-R 584
++ KLG+G FG VY + + + +A+K L+ + + +E E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N+VKL +E L+ E++ SL+ + RK L + I+ I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 645 QDSRLRIIHRDLKASNILLDEKMN-PRISDFGTARVFGGE----EILAITKRVVGTYGYM 699
IIHRD+K NILLD ++ DFG A++ I A+ VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 700 SPEYALDGVF---STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE-LWSDNK 755
+PE L S+ SD++S G+ L E++TG F + +S+ + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL---PPFEGEKNSSATSQTLKIILELPT 232
Query: 756 ALEIVDSSMANSCLASEALRCIQVGLLCV--QDRTTDRPSMSTVVFMLSNETFVPSPKQP 813
S +N L S+A + LL ++R + +S +
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 814 TFSVRRTEIDTDNSSSGIKSSVNE 837
+ S S
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLN 316
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
+ + K+G+G G VYK G+E+A+K++ Q E + NE+L++ +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL---- 641
+V L DE ++ E+M SL I ++ ++ + I + R VL
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNE-----PQIAYVCREVLQGLE 130
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYM 699
YLH +IHRD+K+ NILL + + +++DFG F + +KR VVGT +M
Sbjct: 131 YLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPYWM 183
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITG 728
+PE + K D++S G++ +E+ G
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKG--KLSNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHR 584
+ LGQG G VYK K + G+ A+K++ + ++L E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPT-GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESP 59
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL--- 641
+VK G +E E ++ E+M SL + K++ + ++ IAR +L
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP--VLAYIARQILKGL 112
Query: 642 -YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMS 700
YLH IIHRD+K SN+L++ K +I+DFG ++V E L VGT YMS
Sbjct: 113 DYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMS 168
Query: 701 PEYALDGVFSTKSDVFSFGVILLEIITGK 729
PE +S +D++S G+ LLE GK
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 81/220 (36%), Positives = 109/220 (49%), Gaps = 42/220 (19%)
Query: 536 LGQGGFGPVYKGKL-------SNGQEIAVKRLSTTSGQGIEELKN---EVLLIAKLQHRN 585
LG G FG VY+G S +AVK L G +E K E L++ H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR--KGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQ-----LLDWKKRFDIILGIARGV 640
+VKLLG CL + +I E M L ++ D +R + LL K+ DI L +A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRD-ARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPR-----ISDFGTARVF--------GGEEILA 687
+YL Q + IHRDL A N L+ EK I DFG AR GE +L
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ +M+PE LDG F+T+SDV+SFGV++ EI+T
Sbjct: 177 VR--------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTSG-QGIEELKNEVLLIAKL 581
+ +LG+G FG V + G+++AVK L+ + Q + + E+ ++ L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 582 QHRNLVKLLGCCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
H N+VK G C + LI E++P+ SL ++ + L F I +G
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKG 121
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVGTYG 697
+ YL R IHRDL A NIL++ + +ISDFG A+V + +
Sbjct: 122 MDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 698 YMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
Y +PE FS+ SDV+SFGV L E+ T
Sbjct: 179 Y-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 50/121 (41%), Positives = 71/121 (58%), Gaps = 7/121 (5%)
Query: 29 SQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGV 88
S + G +VS ++ LGFF+ Y I Y S+ T++WVANR+NP++D S
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSR-TVVWVANRDNPVSD-SCT 57
Query: 89 LSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFD 148
L++ GNLVL+ + VW +N + A+ GN V LLD GNLV+ +D G LWQSFD
Sbjct: 58 LTLQSDGNLVLY--DGDGRVVWSSNTTGAN-GNYVLVLLDDGNLVIYDSD-GNFLWQSFD 113
Query: 149 H 149
+
Sbjct: 114 Y 114
|
Length = 114 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 68/197 (34%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
KLG G FG V++G +N +AVK L + + L E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLA-EAQIMKKLRHPKLIQLYAVCT 71
Query: 595 EEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
E+ ++ E M SL +Y R L + D+ +A G+ YL + IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 654 RDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT---YGYMSPEYALDGVFS 710
RDL A N+L+ E +++DFG ARV + A G + +PE AL FS
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFS 182
Query: 711 TKSDVFSFGVILLEIIT 727
KSDV+SFG++L EI+T
Sbjct: 183 IKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 65/207 (31%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 529 NFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRN 585
+F NK+G+G FG V+K + ++ + A+K+ LS + + EE +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLD---WKKRFDIILGIARGVLY 642
+++ L++ + ++ E+ N L + + + L + W+ I+LG+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
LH +I+HRD+K+ N+ LD N +I D G A++ A T +VGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 703 YALDGVFSTKSDVFSFGVILLEIITGK 729
D ++ KSDV++ GV+L E TGK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 71/230 (30%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKGKLSNG------QEIAVKRL-STTSGQGIEELKNEVLLI 578
D+ + LG G FG VY+G ++AVK L + S Q + E L++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIIL 634
+K H+N+V+L+G E ++ E M L F+ + R L K
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR---ISDFGTARVFGGEEILAITKR 691
+A+G YL ++ IHRD+ A N LL K R I+DFG AR R
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEII-------TGKKNTRI 734
+ +M PE LDG+F++K+DV+SFGV+L EI G+ N +
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 65/192 (33%), Positives = 101/192 (52%), Gaps = 15/192 (7%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE 595
+G+G FG V G GQ++AVK L S + E ++ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 596 EDENMLIYEFMPNKSL-DYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
+ ++ E+M SL DY SR + ++ ++ L + G+ YL + +H
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 654 RDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKS 713
RDL A N+L+ E + ++SDFG A+ + K V + +PE + FSTKS
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPV---KWTAPEALREKKFSTKS 180
Query: 714 DVFSFGVILLEI 725
DV+SFG++L EI
Sbjct: 181 DVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 39/230 (16%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLST---TSGQGIEELKNEVLLIAKL-Q 582
D+F +G+G F V K +E A+K L + ++ +K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIA 637
H ++KL +E+ + E+ PN L +I DE + I
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--------YAAEIL 112
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV----- 692
+ YLH IIHRDLK NILLD+ M+ +I+DFGTA+V K
Sbjct: 113 LALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 693 -------------VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
VGT Y+SPE + SD+++ G I+ +++TGK
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 9/201 (4%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ KLG G FG V+ G + ++A+K L S E E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64
Query: 588 KLLGCCLEEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+L +E +I E+M N SL D+ E K L K D+ IA G+ ++
Sbjct: 65 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE-- 119
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD 706
R IHRDL+A+NIL+ E + +I+DFG AR+ E A + + +PE
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINY 177
Query: 707 GVFSTKSDVFSFGVILLEIIT 727
G F+ KSDV+SFG++L EI+T
Sbjct: 178 GTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 536 LGQGGFGPVYK-GKLSNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG+G FG V K G+ A+K L + +E E +++++ H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 592 CCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQDS 647
+ +E + L+ E+ P L + + + + RF +I+L + YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLALE----YLH--- 110
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
L II+RDLK NILLD + +++DFG A+ E T GT Y++PE L
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168
Query: 708 VFSTKSDVFSFGVILLEIITGK 729
+ D +S GV+L E++TGK
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 530 FSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
F KLG+G +G VYK GQ +A+K + ++E+ E+ ++ + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFD--ESRKQLLDWKKRFDIILGIARGVLYLHQD 646
G + + ++ E+ S + D + + L ++ I+ +G+ YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS- 117
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD 706
+ IHRD+KA NILL+E+ +++DFG + +A V+GT +M+PE +
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGTPFWMAPEVIQE 173
Query: 707 GVFSTKSDVFSFGVILLEIITGK 729
++ K+D++S G+ +E+ GK
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 8e-27
Identities = 74/196 (37%), Positives = 105/196 (53%), Gaps = 12/196 (6%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
KLG G FG V+ G +N ++AVK L + ++ E L+ LQH LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 595 EEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
+E+ +I E+M SL D+ DE K LL K D IA G+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 654 RDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY--GYMSPEYALDGVFST 711
RDL+A+N+L+ E + +I+DFG ARV E T R + + +PE G F+
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTI 183
Query: 712 KSDVFSFGVILLEIIT 727
KSDV+SFG++L EI+T
Sbjct: 184 KSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 68/203 (33%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 534 NKLGQGGFGPVYKG--KLSNGQEI--AVKRLS-TTSGQGIEELKNEVLLIAKLQHRNLVK 588
+LG G FG V KG + +G+E+ AVK L G +E E ++A+L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
L+G C E ML+ E P L ++ + D K ++ +A G+ YL
Sbjct: 61 LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLESK-- 114
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARV--FGGEEILAIT--KRVVGTYGYMSPEYA 704
+HRDL A N+LL + +ISDFG +R G + A T + + Y +PE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APECI 170
Query: 705 LDGVFSTKSDVFSFGVILLEIIT 727
G FS+KSDV+S+GV L E +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 44/237 (18%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQHRNL 586
++G+G +G VYK + G+ +A+K++ + I E+K L+ KL+H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLRHPNI 60
Query: 587 VKLLGCCLEEDEN--MLIYEFMPN--KSLDY---FIFDESR-----KQLLDWKKRFDIIL 634
V+L + + +++E+M + L F ES+ KQLL
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---------- 110
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
G+ YLH + I+HRD+K SNIL++ +++DFG AR + T RV+
Sbjct: 111 ---EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163
Query: 695 TYGYMSPEYAL-DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750
T Y PE L + + D++S G IL E+ GK IF ++ +EL
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKP---IFQGSTELEQLEKIFEL 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 76/267 (28%), Positives = 120/267 (44%), Gaps = 27/267 (10%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
K+G+G FG VYKG L E+AVK R + + L+ +L + H N+VKL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIGV 60
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
C+++ ++ E +P SL F+ +K L KK + L A G+ YL + I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 653 HRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTK 712
HRDL A N L+ E +ISDFG +R G + +PE G ++++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 713 SDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC--LA 770
SDV+S+G++L E + D S+ + E ++S L
Sbjct: 176 SDVWSYGILLWETFS-------LGDTPYPG--------MSNQQTRERIESGYRMPAPQLC 220
Query: 771 SEALRCIQVGLLCVQDRTTDRPSMSTV 797
E + ++ L C +RPS S +
Sbjct: 221 PEEIY--RLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 73/280 (26%), Positives = 133/280 (47%), Gaps = 32/280 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ ++G G FG V+ G +++A+K + E+ E ++ KL H LV
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLV 62
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L G C E L++EFM + L ++ +++ + + L + G+ YL +
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT---YGYMSPEYA 704
+IHRDL A N L+ E ++SDFG R ++ + T GT + SPE
Sbjct: 121 ---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVF 173
Query: 705 LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS- 763
+S+KSDV+SFGV++ E+ + K +E S+++ +E +++
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEG---------------KTPYENRSNSEVVETINAGF 218
Query: 764 -MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802
+ LAS+++ ++ C ++R DRPS S ++ L+
Sbjct: 219 RLYKPRLASQSV--YELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIE-ELKNEVLLIAKLQHRN 585
+ ++LG+G G V K +L N I A+K ++T ++ ++ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 586 LVKLLGCCLEEDENML--IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL-- 641
+VK G L+E + + E+ SLD I+ + +K+ ++ ++ IA VL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEK--VLGKIAESVLKG 117
Query: 642 --YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
YLH +IIHRD+K SNILL K ++ DFG + GE + ++ GT YM
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYM 170
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+PE +S SDV+S G+ LLE+ +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 70/212 (33%), Positives = 107/212 (50%), Gaps = 38/212 (17%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRLS-----TTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG G FG VY+G L +G AVK +S T + +++L+ E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 590 LGCCLEEDENMLIY-EFMPNKSL-----DYFIFDES-----RKQLLDWKKRFDIILGIAR 638
LG EED N+ I+ E +P SL Y F E +Q+L
Sbjct: 68 LGTEREED-NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------- 113
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
G+ YLH +HRD+K +NIL+D +++DFG A+ + K G+ +
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYW 167
Query: 699 MSPEYALD-GVFSTKSDVFSFGVILLEIITGK 729
M+PE G + +D++S G +LE+ TGK
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 24/205 (11%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLIAKLQHRN 585
KLG+G +G VYK + G+ +A+K++ ++ + E+ L+ +L+H N
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR------LDNEEEGIPSTALREISLLKELKHPN 59
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+VKLL E + L++E+ + L ++ + R L I+ + RG+ Y H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
RI+HRDLK NIL++ +++DFG AR F G + T VV T Y +PE L
Sbjct: 117 H---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILL 171
Query: 706 -DGVFSTKSDVFSFGVILLEIITGK 729
+ST D++S G I E+ITGK
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
LG+G +G VY + LS IA+K + + ++ L E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 595 EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYLHQDSRLRII 652
E + E +P SL + S+ L ++ I I G+ YLH +I+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130
Query: 653 HRDLKASNILLDEKMNP-RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV--F 709
HRD+K N+L++ +ISDFGT++ G I T+ GT YM+PE G +
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 710 STKSDVFSFGVILLEIITGK 729
+D++S G ++E+ TGK
Sbjct: 189 GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR-- 584
D+ +LG G G V K G+ +AVK + E ++ ++L + H+
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN---EAIQKQILRELDILHKCN 57
Query: 585 --NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL- 641
+V G + + E+M SLD I E + ++ + I+ IA VL
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPE-----RILGKIAVAVLK 111
Query: 642 ---YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
YLH + +IIHRD+K SNIL++ + ++ DFG + G+ + ++ K VGT Y
Sbjct: 112 GLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSY 165
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
M+PE +S KSD++S G+ L+E+ TG+
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 27/208 (12%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKR-----LSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LGQG FG VY + G+E+AVK+ S + + + L+ E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 590 LGCCLEEDENMLIY-EFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
GC L +DE + I+ E+MP S+ D + + + K I+ GV YLH +
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN- 123
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI------TKRVVGTYGYMSP 701
I+HRD+K +NIL D N ++ DFG ++ + I K V GT +MSP
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASK-----RLQTICSSGTGMKSVTGTPYWMSP 176
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGK 729
E + K+DV+S G ++E++T K
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 54/245 (22%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLS--TTSGQGIEELKNEVLLIA 579
+ + +LGQG FG VY+G +A+K ++ + + IE L NE ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFL-NEASVMK 64
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFM-------------PNKSLDYFIFDESRKQLLDW 626
+ ++V+LLG +++ E M P + + + ++ +
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 627 KKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-VF----- 680
IA G+ YL + +HRDL A N ++ E + +I DFG R ++
Sbjct: 125 ------AAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175
Query: 681 --GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-------GKKN 731
GG+ +L + +M+PE DGVF+TKSDV+SFGV+L E+ T G N
Sbjct: 176 RKGGKGLLPVR--------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
Query: 732 TRIFN 736
+
Sbjct: 228 EEVLK 232
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 70/226 (30%), Positives = 110/226 (48%), Gaps = 31/226 (13%)
Query: 536 LGQGGFGPVYKGKLSNG----QEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+G FG V +G+LS ++AVK +L + IEE +E + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 590 LGCCLEEDEN------MLIYEFMPNKSLDYFIFD---ESRKQLLDWKKRFDIILGIARGV 640
+G C E M+I FM + L F+ + L + ++ IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-VFGGEEILA--ITKRVVGTYG 697
YL S IHRDL A N +L E M ++DFG ++ ++ G+ I K V
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---K 180
Query: 698 YMSPEYALDGVFSTKSDVFSFGVILLEIIT-------GKKNTRIFN 736
+++ E D V+++KSDV++FGV + EI T G +N I++
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD 226
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 70/207 (33%), Positives = 114/207 (55%), Gaps = 14/207 (6%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTS-GQGIEELK-NEVLLIAKLQHRN 585
+++ K+G+G +G VYKG+ GQ +A+K++ S +G+ E+ L+ +LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDES--RKQLLDWKKRFDIILGIARGVLYL 643
+V L ++E LI+EF+ S+D + +S + Q +D + + I +G+L+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703
H R++HRDLK N+L+D K +++DFG AR F G + T VV T Y +PE
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEV 172
Query: 704 ALDGV-FSTKSDVFSFGVILLEIITGK 729
L +ST D++S G I E+ T K
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-24
Identities = 38/69 (55%), Positives = 50/69 (72%), Gaps = 3/69 (4%)
Query: 341 CQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCL 400
C G+GF++L MKLPDT+ AA VD ++GLK CE++CLSNCSC AY A A+ G GCL
Sbjct: 1 CGGGDGFLRLPNMKLPDTT-AAIVDRSIGLKECEQRCLSNCSCTAY--AYADIRGGSGCL 57
Query: 401 MYHGDLNDT 409
++ G+L D
Sbjct: 58 IWTGELVDM 66
|
Length = 66 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 70/210 (33%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 535 KLGQGGFGPVYKG--KLSNGQEI--AVKRLSTTSGQGI-EELKNEVLLIAKLQHRNLVKL 589
KLG G FG V +G S G+ I AVK L + I ++ E ++ L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQ---------LLDWKKRFDIILGIARGV 640
G L M++ E P SL D RK L D+ + IA G+
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYA------VQIANGM 110
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE---ILAITKRVVGTYG 697
YL R IHRDL A NILL +I DFG R E ++ +V +
Sbjct: 111 RYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFA 165
Query: 698 YMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ +PE FS SDV+ FGV L E+ T
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 19/203 (9%)
Query: 536 LGQGGFGPVYKGKL--SNGQEI--AVKRLS-TTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
+G+G FG VY G L S+GQ+I AVK L+ T + +E+ E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 591 GCCL-EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII---LGIARGVLYLHQD 646
G CL E +++ +M + L FI E+ + D+I L +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEYLASK 117
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY--GYMSPEYA 704
+ +HRDL A N +LDE +++DFG AR +E ++ +M+ E
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 705 LDGVFSTKSDVFSFGVILLEIIT 727
F+TKSDV+SFGV+L E++T
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 30/207 (14%)
Query: 536 LGQGGFGPVYKG--KLSNGQEI--AVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKL 589
+G G FG V +G KL +EI A+K L S Q ++ L E ++ + H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLT-EASIMGQFDHPNIIRL 70
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
G + M+I E+M N SLD F+ + ++ GIA G+ YL S +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEM 125
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMS--------- 700
+HRDL A NIL++ + ++SDFG +R E TY
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---------ATYTTKGGKIPIRWTA 176
Query: 701 PEYALDGVFSTKSDVFSFGVILLEIIT 727
PE F++ SDV+SFG+++ E+++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--EVLLIAKLQHRNLVKLLG 591
K+G+G +G VYK + G+ +A+K++ E+ L+ +L H N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
+ + L++EFM + L I D R L + + +G+ + H I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL-DGVFS 710
+HRDLK N+L++ + +++DFG AR FG T VV T Y +PE L D +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYS 177
Query: 711 TKSDVFSFGVILLEIITGK 729
T D++S G I E+++ +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
LG G FG V+ GK ++A+K + + + IEE K ++ KL H NLV+L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAK----VMMKLSHPNLVQLYGV 67
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
C ++ ++ E+M N L ++ RK L + D+ + + YL + I
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122
Query: 653 HRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT---YGYMSPEYALDGVF 709
HRDL A N L+ E ++SDFG AR ++ + GT + PE F
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS----SQGTKFPVKWAPPEVFDYSRF 178
Query: 710 STKSDVFSFGVILLEIITGKK 730
S+KSDV+SFGV++ E+ + K
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 67/215 (31%), Positives = 113/215 (52%), Gaps = 34/215 (15%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQG---------IEELKNEVLLIAKLQHRN 585
+G G FG VY G S+G+ +AVK++ S ++ L E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGIARGV 640
+V+ LG L+ D + E++P S+ +Y F+E+ + + + I +G+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR------VVG 694
YLH IIHRD+K +NIL+D K +ISDFG ++ E TK + G
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQG 174
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+ +M+PE ++ K+D++S G +++E++TGK
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 23/213 (10%)
Query: 535 KLGQGGFGPVYKGKL-----SNGQEIAVKRLST-TSGQGIEELKNEVLLIAKLQHRNLVK 588
+LG+ FG +YKG L + Q +A+K L + Q E + E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIF--------------DESRKQLLDWKKRFDIIL 634
LLG +E +++E++ L F+ D + K LD I +
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
IA G+ YL S +H+DL A NIL+ E+++ +ISD G +R + + + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+M PE + G FS+ SD++SFGV+L EI +
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 535 KLGQGGFGPVYKGKLSN---GQE---IAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
+LG+G FG V+ + N Q+ +AVK L S ++ + E L+ LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYF---------IFDESRKQL---LDWKKRFDIILGI 636
G C E ++++E+M + L+ F I L + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY 696
A G++YL + L +HRDL N L+ + + +I DFG +R + + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 697 GYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKK 730
+M PE L F+T+SD++SFGV+L EI T GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 66/196 (33%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 534 NKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
+KLG G +G VY+G +AVK L + +EE E ++ +++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 593 CLEEDENMLIYEFMPNKS-LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
C E +I EFM + LDY E +Q ++ + I+ + YL + +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFST 711
IHRDL A N L+ E +++DFG +R+ G+ A + +PE FS
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 184
Query: 712 KSDVFSFGVILLEIIT 727
KSDV++FGV+L EI T
Sbjct: 185 KSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 68/195 (34%), Positives = 105/195 (53%), Gaps = 11/195 (5%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
KLGQG FG V+ G + +A+K L + E E ++ KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 595 EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHR 654
E+ ++ E+M SL F+ E K L + D+ IA G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 655 DLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY--GYMSPEYALDGVFSTK 712
DL+A+NIL+ E + +++DFG AR+ E T R + + +PE AL G F+ K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 713 SDVFSFGVILLEIIT 727
SDV+SFG++L E+ T
Sbjct: 184 SDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 42/219 (19%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLS------TTSGQGIEELKNEVLLIAKLQHRNLV 587
LG+G +G VY G + GQ IAVK++ + + E+L+ EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 588 KLLGCCLEEDENMLIYEFMPNKS----LDYF------IFDESRKQLLDWKKRFDIILGIA 637
+ LG CL+++ + EF+P S L+ F +F + KQ+LD
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG-------GEEILAITK 690
GV YLH + ++HRD+K +N++L ++ DFG AR +L K
Sbjct: 114 -GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML---K 166
Query: 691 RVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+ GT +M+PE + + KSD++S G + E+ TGK
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 31/212 (14%)
Query: 530 FSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQHRNLV 587
F+ +G+G FG VYK Q +A+K + + IE+++ E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 588 KLLGCCLEEDENMLIYEFMPNKS----LDYFIFDESRKQLLDWKKRFDIILGIARGVL-- 641
K G L+ + +I E+ S L DE I I R VL
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE------------TYIAFILREVLLG 110
Query: 642 --YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYG 697
YLH++ IHRD+KA+NILL E+ + +++DFG + G+ ++KR VGT
Sbjct: 111 LEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPF 163
Query: 698 YMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+M+PE + K+D++S G+ +E+ G+
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 23/213 (10%)
Query: 535 KLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSGQGI-EELKNEVLLIAKLQHRNLV 587
+LG+ FG VYKG L Q +A+K L + + EE K+E ++ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIF-------------DESRKQLLDWKKRFDIIL 634
LLG +E +I+ + + L F+ D++ K L+ I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
IA G+ +L S ++H+DL N+L+ +K+N +ISD G R + + +
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+MSPE + G FS SD++S+GV+L E+ +
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 33/289 (11%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQE------IAVKRLSTTSGQGIE-ELKNEVLLIAKL 581
N LG+G FG V+ K +E + VK L T + ++ E + E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI------FDESRKQLLDWKKRFDIILG 635
H+N+V+LLG C E + + +I E+ L F+ ++ + L K++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
IA G+ +L S R +HRDL A N L+ + ++S ++ E + ++
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDN 754
+++PE + FSTKSDV+SFGV++ E+ T G+ +D++ N ++
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ--------A 233
Query: 755 KALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
LE+ S L RC V DRPS S +V L
Sbjct: 234 GKLELPVPEGCPSRLYKLMTRCWAVNP-------KDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 65/249 (26%), Positives = 120/249 (48%), Gaps = 26/249 (10%)
Query: 536 LGQGGFGP--VYKGKLSNGQ----EIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+G FG +Y+ + E+ + RLS + + NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAY 64
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
++++ ++ E+ +L Y + QL + + + I V Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVF 709
I+HRD+K NI L + ++ DFG +++ G E +A T VVGT YMSPE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 710 STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS-----M 764
+ KSD+++ G +L E++T K R F D++N + ++ N + S +
Sbjct: 179 NFKSDIWALGCVLYELLTLK---RTF---DATNPLNLVVKIVQGNYTPVVSVYSSELISL 232
Query: 765 ANSCLASEA 773
+S L +
Sbjct: 233 VHSLLQQDP 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLS--TTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
+G+G FG V K + S+G+ + K + + + ++L +EV ++ +L+H N+V+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 591 GCCLEEDENMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRF--DIILGIARGVL---- 641
++ N +Y E+ L I + +K+ +K + I I +L
Sbjct: 66 DRIIDR-SNQTLYIVMEYCEGGDLAQLI-QKCKKE----RKYIEEEFIWRILTQLLLALY 119
Query: 642 YLH--QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
H D ++HRDLK +NI LD N ++ DFG A++ G + A T VGT YM
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYM 177
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITGK 729
SPE + KSD++S G ++ E+
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 536 LGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
LG+G FG V + + G+ +AVK+L ++ + + + + E+ ++ LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 591 GCCLEEDEN--MLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
G C L+ E++P SL DY R LD +K I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVF-GGEEILAITKRVVGTYGYMSPEYALD 706
R +HRDL NIL++ + +I DFG +V +E + + + +PE +
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 707 GVFSTKSDVFSFGVILLEIIT 727
FS SDV+SFGV+L E+ T
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 68/205 (33%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
++ KLG G FG V+ G + ++AVK L + E E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYLH 644
LV+L + E+ ++ E+M SL F+ D E R L D+ +A G+ Y+
Sbjct: 63 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAYIE 119
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY--GYMSPE 702
R+ IHRDL+++NIL+ + + +I+DFG AR+ E T R + + +PE
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPE 173
Query: 703 YALDGVFSTKSDVFSFGVILLEIIT 727
AL G F+ KSDV+SFG++L E++T
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 5e-23
Identities = 69/195 (35%), Positives = 106/195 (54%), Gaps = 11/195 (5%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
KLGQG FG V+ G + ++A+K L + E E ++ KL+H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAV-V 70
Query: 595 EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHR 654
E+ ++ EFM SL F+ E + L + D+ IA G+ Y+ R+ IHR
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 655 DLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY--GYMSPEYALDGVFSTK 712
DL+A+NIL+ + + +I+DFG AR+ E T R + + +PE AL G F+ K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 713 SDVFSFGVILLEIIT 727
SDV+SFG++L E++T
Sbjct: 184 SDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 8e-23
Identities = 78/275 (28%), Positives = 133/275 (48%), Gaps = 44/275 (16%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLS----TTSGQG--IEELKNEVLLIAKLQHRNLVK 588
LG G F Y+ + + G +AVK+++ T+S Q +E L+ E+ L+A+L H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 589 LLGCCLEEDENMLIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
+LG E+ L E+M S+ Y F E+ + + RG+ YL
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI--------INYTEQLLRGLSYL 119
Query: 644 HQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTA-----RVFGGEEILAITKRVVGTYG 697
H++ +IIHRD+K +N+L+D RI+DFG A + G E +++GT
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIA 173
Query: 698 YMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757
+M+PE + DV+S G +++E+ T K +N + SN + +++ S A
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAEKHSNHLALIFKIASATTAP 230
Query: 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRP 792
I + S LR V L C++ + DRP
Sbjct: 231 SIPEH-------LSPGLR--DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 73/203 (35%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 536 LGQGGFGPV--YKGKLSN---GQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHRNLVKL 589
LG+G FG V Y +N G+ +AVK L GQ K E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 590 LGCCLEEDEN--MLIYEFMPNKSL-DYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQ 645
GCC E+ LI E++P SL DY + + QLL + ++ I G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAYLHS 125
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-VFGGEEILAITKRVVGTYGYMSPEYA 704
IHRDL A N+LLD +I DFG A+ V G E + + + + E
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 705 LDGVFSTKSDVFSFGVILLEIIT 727
+ FS SDV+SFGV L E++T
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 72/194 (37%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
KLG G FG V+ + ++AVK + S +E E ++ LQH LVKL
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 595 EEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
+E +I EFM SL D+ DE KQ L K D IA G+ ++ Q + IH
Sbjct: 72 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 654 RDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKS 713
RDL+A+NIL+ + +I+DFG ARV E A + + +PE G F+ KS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKS 184
Query: 714 DVFSFGVILLEIIT 727
DV+SFG++L+EI+T
Sbjct: 185 DVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 536 LGQGGFGPVY------KGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GK+ +++ KRL G+ + + ++L K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL--EKVSSRFIVSL 58
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQD 646
+D+ L+ M L Y I++ + + F II G+ +LHQ
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL----EHLHQ- 113
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD 706
RI++RDLK N+LLD+ N RISD G A G + K GT GYM+PE
Sbjct: 114 --RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQG 168
Query: 707 GVFSTKSDVFSFGVILLEIITGK 729
V+ D F+ G L E+I G+
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 66/219 (30%), Positives = 119/219 (54%), Gaps = 9/219 (4%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELK-NEVLLIAKLQHRNL 586
NF KLG+G + VYKG+ + G+ +A+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
V+L E++ ML++E+M +K L ++ + LD + +G+ + H++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD 706
R++HRDLK N+L++++ +++DFG AR F G + + VV T Y +P+ L
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVV-TLWYRAPDVLLG 174
Query: 707 G-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744
+ST D++S G I+ E+ITG+ N++D I
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 5e-22
Identities = 71/225 (31%), Positives = 115/225 (51%), Gaps = 21/225 (9%)
Query: 530 FSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN---EVLLIAKLQHRN 585
FS ++G G FG VY + + N + +A+K++S + Q E+ ++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
++ GC L E L+ E+ + D E K+ L + + G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
+ +IHRD+KA NILL E ++ DFG+A I+A VGT +M+PE L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 184
Query: 706 ---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYA 747
+G + K DV+S G+ +E+ ++ +FN + S L A
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 19/213 (8%)
Query: 529 NFSTSNKLGQGGFGPVYK-GKLSNGQEI-AVKRLSTT----------SGQGIEELKNEVL 576
++ LG G FG VYK K +NGQ + A+K ++ + I ++ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 577 LIAK-LQHRNLVKLLGCCLEEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIIL 634
+I + L+H N+V+ LE D ++ + + L ++F + +KQ ++ ++I +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ + YLH++ R I+HRDL +NI+L E I+DFG A+ E L VVG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVG 175
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
T Y PE + + K+DV++FG IL ++ T
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 529 NFSTSNKLGQGGFGPVYK-GKLSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHR 584
+F +G+G FG V K + A+K ++ + + NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 585 NLVKLLGCCLEEDENM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIAR 638
LV L +++ENM L+ + + L Y + F E + + I I
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIVL 111
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
+ YLH IIHRD+K NILLDE+ + I+DF A + +T GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGY 165
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEIITGKK 730
M+PE +S D +S GV E + GK+
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLST---TSGQGIEELKNEVLLIAKLQ 582
NF K+G+G F VYK L +G+ +A+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-FDESRKQLLDWKKRFDIILGIARGVL 641
H N++K L +E +E ++ E L I + +K+L+ + + + + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
++H RI+HRD+K +N+ + ++ D G R F + A + VGT YMSP
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSP 175
Query: 702 EYALDGVFSTKSDVFSFGVILLEI 725
E + ++ KSD++S G +L E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 7e-22
Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 21/210 (10%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRN 585
+F KLG+G +G VYK K LS+ Q A+K L + S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 586 LVK-----LLGCCLEEDENMLIYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARG 639
++ L G L ++ E+ P L I + ++L+ ++ + I + + RG
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
+ LH+ +I+HRDLK++NILL +I D G ++V + K +GT YM
Sbjct: 116 LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYM 168
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+PE +S KSD++S G +L E+ T
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 70/199 (35%), Positives = 106/199 (53%), Gaps = 25/199 (12%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLST-TSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
+G+G FG V +G+ + GQ++AVK + + Q E E ++ KL H+NLV+LLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLGVI 68
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRK-----QLLDWKKRFDIILGIARGVLYLHQDSR 648
L ++ E M +L F+ R QLL +F L +A G+ YL
Sbjct: 69 LHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLL----QFS--LDVAEGMEYLESK-- 119
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV 708
+++HRDL A NIL+ E ++SDFG ARV G + +K V + +PE
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAPEALKHKK 173
Query: 709 FSTKSDVFSFGVILLEIIT 727
FS+KSDV+S+GV+L E+ +
Sbjct: 174 FSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 68/223 (30%), Positives = 109/223 (48%), Gaps = 37/223 (16%)
Query: 536 LGQGGFGPVYKGK------LSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLVK 588
LG+G FG V K + +AVK L + + +L +E L+ ++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRK----------------------QLLDW 626
L G C ++ +LI E+ SL F+ ESRK + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFL-RESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 627 KKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686
I+RG+ YL + ++++HRDL A N+L+ E +ISDFG +R E+
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED-- 181
Query: 687 AITKRVVG--TYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ KR G +M+ E D +++T+SDV+SFGV+L EI+T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 38/218 (17%)
Query: 533 SNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQG--IEELKNEVLLIAKLQHRNLVKL 589
NK+G G FG VY L G+ +AVK + I+E+ +E+ ++ L+H NLVK
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 590 LGCCLE-EDENMLIY-EFMPNKSLDYF-----IFDES-----RKQLLDWKKRFDIILGIA 637
G +E E + I+ E+ +L+ I DE QLL
Sbjct: 65 YG--VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL------------- 109
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT--KRVVGT 695
G+ YLH I+HRD+K +NI LD ++ DFG A + + GT
Sbjct: 110 EGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 696 YGYMSPEYALDGVFSTK---SDVFSFGVILLEIITGKK 730
YM+PE G +D++S G ++LE+ TGK+
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEE---LKNEVLLIAKLQHRNLVKLLGC 592
+G+G FG V+ + Q++ + + +E +NE ++ L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
LE+ M++ E+ P +L +I LLD + I + ++H I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---IL 123
Query: 653 HRDLKASNILLDE-KMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFST 711
HRDLK NILLD+ KM +I DFG +++ + A T VVGT Y+SPE ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAYT--VVGTPCYISPELCEGKPYNQ 180
Query: 712 KSDVFSFGVILLEIITGKK 730
KSD+++ G +L E+ + K+
Sbjct: 181 KSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 69/207 (33%), Positives = 115/207 (55%), Gaps = 30/207 (14%)
Query: 536 LGQGGFGPVYKGK-LSNGQEI----AVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKL 589
LG G FG VYKG + G+ + A+K L+ T+G + E +E L++A + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQ 645
LG CL L+ + MP+ L ++ + + LL+W + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY-A 704
R++HRDL A N+L+ + +I+DFG AR+ G+E K G M ++ A
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-----KEYNADGGKMPIKWMA 179
Query: 705 LDGV----FSTKSDVFSFGVILLEIIT 727
L+ + F+ +SDV+S+GV + E++T
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 41/232 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK---LSNGQE---IAVKRLST-TSGQGIEELKNEVLLIAK 580
+N +GQG FG V++ + L + +AVK L S + + E L+A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQL----------------- 623
H N+VKLLG C L++E+M L+ F+ S +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 624 --LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR--- 678
L ++ I +A G+ YL S + +HRDL N L+ E M +I+DFG +R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 679 ---VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ E AI R +M PE ++T+SDV+++GV+L EI +
Sbjct: 182 SADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 13/206 (6%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELK-NEVLLIAKLQHR 584
NF K+G+G +G VYK + G+ +A+K RL T + +G+ E+ L+ +L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHP 59
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N+VKLL E++ L++EF+ ++ L F+ D S + + + +G+ + H
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYA 704
R++HRDLK N+L++ + +++DFG AR F G + T VV T Y +PE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 172
Query: 705 LDGVF-STKSDVFSFGVILLEIITGK 729
L + ST D++S G I E++T +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 529 NFSTSNKLGQGGFGPVY--KGKLSNGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHR 584
+ K+G+G FG +Y K K S+ + +K + T + E K EV+L+AK++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE-----SRKQLLDWKKRFDIILGIARG 639
N+V E ++ E+ L I + S Q+L W + I+ G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLG 113
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
+ ++H +I+HRD+K+ NI L + M ++ DFG AR LA T VGT Y
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYY 168
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+SPE + ++ K+D++S G +L E+ T K
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 43/215 (20%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRL----------STTSGQGIEELKNEVLLIAKLQH 583
K+G+G +G VYK + G+ +A+K++ ST I E+ L+ +L H
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA----IREIS----LLKELNH 57
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF----DIILG---- 635
N+V+LL E++ L++EF+ D K+ +D +I
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFL----------DLDLKKYMDSSPLTGLDPPLIKSYLYQ 107
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ +G+ Y H R++HRDLK N+L+D + +++DFG AR F G + T VV T
Sbjct: 108 LLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-T 162
Query: 696 YGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGK 729
Y +PE L +ST D++S G I E++ +
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 5e-21
Identities = 93/369 (25%), Positives = 156/369 (42%), Gaps = 56/369 (15%)
Query: 440 RARKRRLALIIVAIVLGVILL----GLCFFFLRRRLATRIGERKRQRRR----ELLFLNS 491
R RK + LG L+ F F+R R E KR EL F +S
Sbjct: 621 RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGR---NNLELKRVENEDGTWELQFFDS 677
Query: 492 STRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LS 550
+ S+ SI+ L + + N + +G G YKGK +
Sbjct: 678 --KVSK---SITIND---------------ILSSLKEE----NVISRGKKGASYKGKSIK 713
Query: 551 NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610
NG + VK ++ + I +E+ + KLQH N+VKL+G C E LI+E++ K+
Sbjct: 714 NGMQFVVKEINDVNS--IPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769
Query: 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670
L + + L W++R I +GIA+ + +LH ++ +L I++D K P
Sbjct: 770 LSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH 823
Query: 671 ISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKK 730
+ +L + + Y++PE + KSD++ FG+IL+E++TGK
Sbjct: 824 L-------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKS 876
Query: 731 NTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN--SCLASEALRCIQVGLLCVQDRT 788
S ++++A +SD +D S+ S +E + + + L C
Sbjct: 877 PADAEFGVHGS-IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDP 935
Query: 789 TDRPSMSTV 797
T RP + V
Sbjct: 936 TARPCANDV 944
|
Length = 968 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 6e-21
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSN---GQE---IAVKRLSTTSGQGIEELKNEVLLIAKLQ 582
N +LG+G FG V+ + N Q+ +AVK L S ++ E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQL----------LDWKKRFDI 632
H ++VK G C+E D ++++E+M + L+ F+ + L + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV 692
IA G++YL + +HRDL N L+ E + +I DFG +R + +
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 693 VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKK 730
+ +M PE + F+T+SDV+S GV+L EI T GK+
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRL-STTSGQGI-EELKNEVLLIAKLQHRNLVKLLG 591
++G+G G V+K K G+ +A+K++ GI + E+ + QH +VKLL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
+L+ E+MP+ L + DE R K + +L +GV Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHA---NGI 120
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV--F 709
+HRDLK +N+L+ +I+DFG AR+F EE + + V T Y +PE L G +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPEL-LYGARKY 178
Query: 710 STKSDVFSFGVILLEIITG 728
D+++ G I E++ G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 9e-21
Identities = 34/88 (38%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 338 TSTCQKGE---GFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETN 394
C GF+KL +KLPD + A + L+ C E CLSNCSC AYA N
Sbjct: 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI---TAISLEECREACLSNCSCTAYAY----NN 54
Query: 395 RGIGCLMYHGDLNDTRKYTNAGQDLFVR 422
GCL+++G LN+ R ++ G L++R
Sbjct: 55 GSGGCLLWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 74/235 (31%), Positives = 122/235 (51%), Gaps = 32/235 (13%)
Query: 536 LGQGGFGPVYKGKLSNGQEI---AVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
LG+G FG V +G+L+ I AVK +++ + +E+ +E + + + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 591 GCCLEEDEN------MLIYEFMPNKSLDYFIFDESR----KQLLDWKKRFDIILGIARGV 640
G CL+ E+ ++I FM + L F+ SR Q L + + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG-TARVFGGEEILA--ITKRVVGTYG 697
YL S IHRDL A N +L+E MN ++DFG + +++ G+ I K V
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV---K 179
Query: 698 YMSPEYALDGVFSTKSDVFSFGVILLEIIT-------GKKNTRIFNDDDSSNLIK 745
+++ E D V++TKSDV+SFGV + EI T G +N+ I++ N +K
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 51/237 (21%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKL 581
++ KLG+G FG VYK ++ G+ +A+K++ + G I L+ E+ ++ KL
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64
Query: 582 QHRNLVKLLGCCLEEDENML-----IYEFMPNKSLDY--------FIFDESR-----KQL 623
+H N+V L+ +E + +Y P D ES+ QL
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 624 LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--- 680
L+ G+ YLH++ I+HRD+KA+NIL+D + +I+DFG AR +
Sbjct: 125 LE-------------GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
Query: 681 -------GGEEILAITKRVVGTYGYMSPEYAL-DGVFSTKSDVFSFGVILLEIITGK 729
GG T VV T Y PE L + ++T D++ G + E+ T +
Sbjct: 169 PPNPKGGGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 32/213 (15%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
+G G VY L N +++A+KR+ ++EL+ EV +++ H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 592 CCLEEDENMLIYEFMPNKSLDYFI--------FDESRKQLLDWKKRFDIILGIARGVL-- 641
+ DE L+ ++ SL + DE+ II + + VL
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEA------------IIATVLKEVLKG 114
Query: 642 --YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVGTYG 697
YLH + + IHRD+KA NILL E + +I+DFG + GG+ + K VGT
Sbjct: 115 LEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 698 YMSPEYALDGV-FSTKSDVFSFGVILLEIITGK 729
+M+PE + K+D++SFG+ +E+ TG
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-20
Identities = 68/225 (30%), Positives = 113/225 (50%), Gaps = 21/225 (9%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKN---EVLLIAKLQHRN 585
F+ ++G G FG VY + E+ A+K++S + Q E+ ++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
++ GC L E L+ E+ + D E K+ L + I G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
+ +IHRD+KA NILL E +++DFG+A I + VGT +M+PE L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194
Query: 706 ---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYA 747
+G + K DV+S G+ +E+ ++ +FN + S L A
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA 237
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 70/207 (33%), Positives = 102/207 (49%), Gaps = 31/207 (14%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELK-NEVL-------LIAKLQHRNL 586
+LG+G FG VY + + + +A +RL + EL NE + L++KL H +
Sbjct: 7 RLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRK--------QLLDWKKRFDIILGIAR 638
VK LE D +I E+ + LD +E + Q+ +W + +
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLD-CKLEELKHTGKTLSENQVCEW------FIQLLL 117
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
GV Y+HQ RI+HRDLKA NI L + +I DFG +R+ G LA T GT Y
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYY 171
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEI 725
MSPE + +KSD++S G IL E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 3e-20
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--EVLLIAKLQ-HRNLVKLL 590
+LG G FG VY + G+ +A+K++ EE N EV + KL H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
E DE ++E+M +L Y + + + + II I +G+ ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV----VGTYGYMSPEYAL- 705
HRDLK N+L+ +I+DFG AR EI + + V T Y +PE L
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRS--RPPYTDYVSTRWYRAPEILLR 172
Query: 706 DGVFSTKSDVFSFGVILLEIITGK 729
+S+ D+++ G I+ E+ T +
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 69/201 (34%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 536 LGQGGFGPV----YKGKLSN-GQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLVKL 589
LG+G FG V Y + N G+++AVK L SG I +LK E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 590 LGCCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
G C E+ N LI EF+P+ SL ++ K ++ K++ + I +G+ YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--GS 127
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFG-TARVFGGEEILAITKRVVGTYGYMSPEYALD 706
R + +HRDL A N+L++ + +I DFG T + +E + + + +PE +
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 707 GVFSTKSDVFSFGVILLEIIT 727
F SDV+SFGV L E++T
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 27/207 (13%)
Query: 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKN---EVLLIAKLQHRN 585
F+ ++G G FG VY + + +A+K++S + Q E+ ++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL---- 641
++ GC L E L+ E+ + D I + +K L + I I G L
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPL-----QEVEIAAICHGALQGLA 129
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
YLH R IHRD+KA NILL E +++DFG+A +++ VGT +M+P
Sbjct: 130 YLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAP 180
Query: 702 EYAL---DGVFSTKSDVFSFGVILLEI 725
E L +G + K DV+S G+ +E+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 43/229 (18%)
Query: 535 KLGQGGFGPVYKGKLSNGQE-----------------IAVKRLSTTSGQGIE-ELKNEVL 576
KLG+G FG V+ ++ N Q+ +AVK L + + + EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLD----------- 625
++++L+ N+++LLG C++ED +I E+M N L+ F+ S L D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128
Query: 626 --------WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
+ + L IA G+ YL S L +HRDL N L+ E + +I+DFG +
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEII 726
R + I R V +M+ E L G F+T SDV++FGV L EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKG------KLSNGQEIAVKRL-STTSGQGIEELKNEVLLIAK 580
D + LG+G FG V K + +AVK L + + + +L +E+ ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 581 L-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG---- 635
+ +H+N++ LLG C +E ++ E+ + +L F+ R
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLT 130
Query: 636 ----------IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685
+ARG+ +L + IHRDL A N+L+ E +I+DFG AR I
Sbjct: 131 QKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHI 185
Query: 686 LAITKRVVG--TYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
K G +M+PE D V++ +SDV+SFGV+L EI T
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 65/207 (31%), Positives = 112/207 (54%), Gaps = 19/207 (9%)
Query: 530 FSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-TTSGQGI-EELKNEVLLIAKLQ---H 583
+ ++G+G +G VYK + L+ G+ +A+K++ S +GI E+ L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 584 RNLVKLLGCCL-----EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
N+V+LL C E + L++E + ++ L ++ + L + D++ + R
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLR 118
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
GV +LH RI+HRDLK NIL+ +I+DFG AR++ E +A+T VV T Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTSVVV-TLWY 172
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEI 725
+PE L ++T D++S G I E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 57/217 (26%), Positives = 111/217 (51%), Gaps = 37/217 (17%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRL---STTSGQG-------IEELKNEVLLIAKLQHR 584
+G+G +G VY ++ G+ +AVK++ +T +G+ ++ L++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGIARG 639
N+V+ LG E+ + E++P S+ Y F+E + + + G
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLEG 120
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR----VFGGEEILAITKRVVGT 695
+ YLH I+HRDLKA N+L+D +ISDFG ++ ++ ++ +++ G+
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ----GS 173
Query: 696 YGYMSPEY-ALDGV-FSTKSDVFSFGVILLEIITGKK 730
+M+PE +S K D++S G ++LE+ G++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 6e-20
Identities = 70/225 (31%), Positives = 114/225 (50%), Gaps = 21/225 (9%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKN---EVLLIAKLQHRN 585
F +++G G FG VY S+ E+ AVK++S + Q E+ ++ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
++ GC L+E L+ E+ + D E K+ L + I G +G+ YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
+ +IHRD+KA NILL E +++DFG+A + VGT +M+PE L
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVIL 190
Query: 706 ---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYA 747
+G + K DV+S G+ +E+ ++ +FN + S L A
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-20
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELK----NEVLLIAKLQHRNLVKLLG 591
LG+G FG V+KG L + +AVK T +ELK +E ++ + H N+VKL+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVK---TCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
C + ++ E +P D+ F +K L K+ L A G+ YL +
Sbjct: 60 VCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 652 IHRDLKASNILLDEKMNPRISDFGTAR-----VFGGEEILAITKRVVGTYGYMSPEYALD 706
IHRDL A N L+ E +ISDFG +R ++ + I + + +PE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPEALNY 168
Query: 707 GVFSTKSDVFSFGVILLEIIT 727
G +S++SDV+S+G++L E +
Sbjct: 169 GRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 8e-20
Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 29/245 (11%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
+LG G FG V GK ++A+K + S + + IEE K ++ KL H LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMKLSHEKLVQLYG 66
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRK----QLLDWKKRFDIILGIARGVLYLHQDS 647
C ++ ++ E+M N L ++ + ++ QLL+ K + G+ YL
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK------DVCEGMAYLESK- 119
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT---YGYMSPEYA 704
+ IHRDL A N L+D++ ++SDFG +R +E + VG+ + PE
Sbjct: 120 --QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS----SVGSKFPVRWSPPEVL 173
Query: 705 LDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763
L FS+KSDV++FGV++ E+ + GK FN+ ++ + L+ + A E V +
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAI 233
Query: 764 MANSC 768
M SC
Sbjct: 234 MY-SC 237
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 9e-20
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 535 KLGQGGFGPVYKGKLSN------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
+LG+G FG V+ + N +AVK L + ++ + E L+ LQH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYF----------IFDESRKQL---LDWKKRFDIILG 635
G C + D ++++E+M + L+ F + D +Q L + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
IA G++YL + +HRDL N L+ + +I DFG +R + + +
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKK 730
+M PE + F+T+SDV+SFGVIL EI T GK+
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQH---RNLVKLL 590
+G+G +G VY+GK + G+ +A+K ++ T + +++ EV L+++L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL----YLHQD 646
G L+ +I E+ S+ + + K I I R VL Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTL----MKAGPIAEK----YISVIIREVLVALKYIHKV 120
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD 706
+IHRD+KA+NIL+ N ++ DFG A + T VGT +M+PE +
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITE 175
Query: 707 GV-FSTKSDVFSFGVILLEIITG 728
G + TK+D++S G+ + E+ TG
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 73/238 (30%), Positives = 115/238 (48%), Gaps = 43/238 (18%)
Query: 530 FSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
F+ LG+G FG V + +L + Q++AVK L S IEE E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 584 RNLVKLLGCCLEEDEN------MLIYEFMPNKSLDYFI---------FDESRKQLLDWKK 628
N++KL+G L M+I FM + L F+ F + L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-VFGGEEIL- 686
RF ++ IA G+ YL S IHRDL A N +L+E M ++DFG ++ ++ G+
Sbjct: 117 RF--MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 687 -AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-------GKKNTRIFN 736
+K V +++ E D V++T SDV++FGV + EI+T G +N+ I+N
Sbjct: 172 GCASKLPV---KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 61/206 (29%), Positives = 111/206 (53%), Gaps = 19/206 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
DNF K+G+G G V S G+++AVK++ Q E L NEV+++ QH N+
Sbjct: 22 DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
V++ L DE ++ EF+ +L D I +R ++ ++ + L + + + +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTD--IVTHTR---MNEEQIATVCLAVLKALSFLHA 133
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMSPEY 703
+IHRD+K+ +ILL ++SDFG F + + +R +VGT +M+PE
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEV 186
Query: 704 ALDGVFSTKSDVFSFGVILLEIITGK 729
+ T+ D++S G++++E++ G+
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 20/208 (9%)
Query: 530 FSTSNKLGQGGFGPVYKGK-LSNGQEI----AVKRL-STTSGQGIEELKNEVLLIAKLQH 583
F LG G FG VYKG + G+++ A+K L TS + +E+ +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSL-DYFIFDESR---KQLLDWKKRFDIILGIARG 639
++ +LLG CL LI + MP L DY + + LL+W + IA+G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
+ YL + R++HRDL A N+L+ + +I+DFG A++ G +E + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ E L +++ +SDV+S+GV + E++T
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
D + +LG G FG VYK + G A K + S + +E+ E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+V L E++ ++ EF +LD I E + L + + R+ + + + +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHS 121
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMSPEY 703
++IHRDLKA NILL + +++DFG + + KR +GT +M+PE
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST----LQKRDTFIGTPYWMAPEV 174
Query: 704 AL-----DGVFSTKSDVFSFGVILLEI 725
D + K+D++S G+ L+E+
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 25/203 (12%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
+LG G FG VYK K G A K + T S + +E+ E+ ++A H +VKLLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL----YLHQDSRL 649
+ + ++ EF P ++D + + LD I I R +L YLH +
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVICRQMLEALQYLHS---M 129
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMSPEYAL-- 705
+IIHRDLKA N+LL + +++DFG + + + + +R +GT +M+PE +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 706 ---DGVFSTKSDVFSFGVILLEI 725
D + K+D++S G+ L+E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 62/205 (30%), Positives = 108/205 (52%), Gaps = 25/205 (12%)
Query: 536 LGQGGFGPVYKG--KLSNGQEIAVKRLSTTSGQGIEELKNEVL----LIAKLQHRNLVKL 589
+G G FG V++G K+ +E+AV + T E+ + + L ++ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVA-IKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILGIARGVLYLHQ 645
G + M+I E+M N +LD ++ D S QL+ ++ GIA G+ YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLRGIAAGMKYL-- 123
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG---TYGYMSPE 702
S + +HRDL A NIL++ + ++SDFG +RV E+ T G + +PE
Sbjct: 124 -SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPE 180
Query: 703 YALDGVFSTKSDVFSFGVILLEIIT 727
F++ SDV+SFG+++ E+++
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 535 KLGQGGFGPVYKGKLSNGQE---------------IAVKRL-STTSGQGIEELKNEVLLI 578
KLG+G FG V+ + E +AVK L + + + E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD-ESRKQL--------LDWKKR 629
++L++ N+++LLG C+ +D +I E+M N L+ F+ E +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 630 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689
+ + IA G+ YL + L +HRDL N L+ +I+DFG +R + I
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 690 KRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
R V +M+ E L G F+T SDV++FGV L E+ T
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 62/193 (32%), Positives = 96/193 (49%), Gaps = 17/193 (8%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE 595
+G+G FG V G G ++AVK + + + E ++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 596 EDENMLIY-EFMPNKSL-DYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
E + I E+M SL DY SR + +L L + + YL ++ +
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124
Query: 653 HRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTK 712
HRDL A N+L+ E ++SDFG + E + + +PE + FSTK
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 713 SDVFSFGVILLEI 725
SDV+SFG++L EI
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
+LG G FG V+ GK ++A+K + + + IEE K ++ KL H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQLYG 66
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR----GVLYLHQDS 647
C ++ ++ EFM N L ++ + + +L D++L + + G+ YL ++S
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYL-RQRQGKL-----SKDMLLSMCQDVCEGMEYLERNS 120
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG------YMSP 701
IHRDL A N L+ ++SDFG R + + G + P
Sbjct: 121 ---FIHRDLAARNCLVSSTGVVKVSDFGMTR-------YVLDDEYTSSSGAKFPVKWSPP 170
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGKK 730
E +S+KSDV+SFGV++ E+ T K
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-19
Identities = 70/225 (31%), Positives = 112/225 (49%), Gaps = 30/225 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRLS-TTSGQGIEELKNEVLLI 578
D LG+G FG V + + +AVK L + + + +L +E+ L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 579 AKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----------FD--ESRKQLL 624
+ +H+N++ LLG C +E +I E+ +L F+ FD + ++ L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+K +ARG+ YL +SR R IHRDL A N+L+ E +I+DFG AR G +
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHD 186
Query: 685 ILAITKRVVGTY--GYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
I K G +M+PE D V++ +SDV+SFG+++ EI T
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 35/225 (15%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKG------KLSNGQEIAVKRLSTTSG--QGIEELKNEVLL 577
A + + S +LGQG FG VY+G K +A+K ++ + + IE L NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASV 62
Query: 578 IAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIF-------DESRKQLLDWKKRF 630
+ + ++V+LLG + ++I E M L ++ + + KK
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 631 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--------GG 682
+ IA G+ YL+ + + +HRDL A N ++ E +I DFG R GG
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ +L + +MSPE DGVF+T SDV+SFGV+L EI T
Sbjct: 180 KGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-19
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR-- 584
++ T + LG G G V K K + G +A K ++ ++L ++ H
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKK---VVHIGAKSSVRKQILRELQIMHECR 61
Query: 585 --NLVKLLGCCLEEDENMLIYEFMPNKSLD--YFIFDESRKQLLDWKKRFDIILGIARGV 640
+V G L E+ + EFM SLD Y ++L I + + G+
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGL 116
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMS 700
YL+ + RI+HRD+K SNIL++ + ++ DFG + GE I +I VGT YMS
Sbjct: 117 TYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMS 170
Query: 701 PEYALDGVFSTKSDVFSFGVILLEIITGK 729
PE G ++ KSDV+S G+ ++E+ GK
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 8e-19
Identities = 68/221 (30%), Positives = 104/221 (47%), Gaps = 40/221 (18%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-IAVKRLS-TTSGQGIEELK-NEVLLIAKLQHR 584
D + K+G+G +G VYK + E IA+K++ +G+ E+ L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------------- 631
N+V+L E L++E+ LD LD KK D
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LD-----------LDLKKHMDSSPDFAKNPRLIK 105
Query: 632 -IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTARVFGGEEILAIT 689
+ I RG+ Y H R++HRDLK N+L+D + N +++DFG AR F G + T
Sbjct: 106 TYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFT 161
Query: 690 KRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGK 729
VV T Y +PE L +ST D++S G I E++ K
Sbjct: 162 HEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 35/226 (15%)
Query: 531 STSNKLGQGGFGPVYKGKLSNGQEI-----------------AVKRL-STTSGQGIEELK 572
+ KLG+G FG V+ + Q+ AVK L S E+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 573 NEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD- 631
EV ++++L N+ +LLG C + +I E+M N L+ F+ + +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL---QKHVAETSGLACNS 124
Query: 632 ----------IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
+ IA G+ YL L +HRDL N L+ + +I+DFG +R
Sbjct: 125 KSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ + R +M+ E L G F+TKSDV++FGV L EI+T
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 34/228 (14%)
Query: 523 LLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL 581
L T F +G+G +G VYK + GQ +A+K + EE+K E ++ K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59
Query: 582 -QHRNLVKLLGCCL------EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD--- 631
H N+ G + +D+ L+ E S+ + K L KR
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEW 114
Query: 632 ---IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688
I+ RG+ YLH++ ++IHRD+K NILL + ++ DFG + + +
Sbjct: 115 IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTL 167
Query: 689 TKR--VVGTYGYMSPE-----YALDGVFSTKSDVFSFGVILLEIITGK 729
+R +GT +M+PE D + +SDV+S G+ +E+ GK
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 58/208 (27%), Positives = 107/208 (51%), Gaps = 25/208 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+++ ++G G +G VYK + ++ G+ +A+K + G E ++ E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR----GVLY 642
V G L D+ ++ E+ SL I+ +R L + I + R G+ Y
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE-----LQIAYVCRETLKGLAY 116
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA-ITKR--VVGTYGYM 699
LH+ IHRD+K +NILL E + +++DFG + ++ A I KR +GT +M
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWM 168
Query: 700 SPEYA---LDGVFSTKSDVFSFGVILLE 724
+PE A G + K D+++ G+ +E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 67/213 (31%), Positives = 115/213 (53%), Gaps = 24/213 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQH 583
D + N++ +G +G VY+ + G+ +A+K+L G I L+ E+ ++ KLQH
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 584 RNLVKL----LGCCLEEDENMLIYEFMPN--KSLDYFIFDESRKQLLDWKKRFDIILGIA 637
N+V + +G L D+ ++ E++ + KSL + ++ L + + ++L +
Sbjct: 64 PNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSL----METMKQPFLQSEVKC-LMLQLL 116
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG 697
GV +LH + I+HRDLK SN+LL+ + +I DFG AR + G + T+ VV T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TLW 171
Query: 698 YMSPEYALD-GVFSTKSDVFSFGVILLEIITGK 729
Y +PE L +ST D++S G I E++T K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 58/202 (28%), Positives = 105/202 (51%), Gaps = 22/202 (10%)
Query: 535 KLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
K+GQG G VY ++ GQE+A+K+++ E + NE+L++ + +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL----YLHQDSRL 649
L DE ++ E++ SL + + + I + R L +LH +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAAVCRECLQALEFLHSN--- 134
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMSPEYALDG 707
++IHRD+K+ NILL + +++DFG E+ +KR +VGT +M+PE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRSTMVGTPYWMAPEVVTRK 190
Query: 708 VFSTKSDVFSFGVILLEIITGK 729
+ K D++S G++ +E++ G+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 15/204 (7%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLV 587
F+ K+G+G FG V+KG + Q++ A+K + + IE+++ E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
K G L++ + +I E++ S D LD + I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMSPEYAL 705
+ IHRD+KA+N+LL E +++DFG A +I KR VGT +M+PE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----KRNTFVGTPFWMAPEVIK 174
Query: 706 DGVFSTKSDVFSFGVILLEIITGK 729
+ +K+D++S G+ +E+ G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 18/204 (8%)
Query: 536 LGQGGFGPVYKGKLSN-GQEIAVKRL-STTSGQGIEELKNEVLLIAKLQH-RNLVKLLGC 592
+G+G FG V K G +AVKR+ ST + + L ++ ++ + +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 593 CLEEDENMLIYEFMPNKSLD--YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
E + + E M + SLD Y E K ++ + I + + + YL ++ L+
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LK 128
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK-RVVGTYGYMSPE----YAL 705
IIHRD+K SNILLD N ++ DFG + G+ + +I K R G YM+PE A
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERIDPSAR 184
Query: 706 DGVFSTKSDVFSFGVILLEIITGK 729
DG + +SDV+S G+ L E+ TGK
Sbjct: 185 DG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 58/220 (26%), Positives = 112/220 (50%), Gaps = 31/220 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKL 581
D + S+ L +G FG ++ G L +E+ VK + + + + L E L+ L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 582 QHRNLVKLLGCCLEE-DENMLIYEFMPNKSLDYF-----IFDESRKQLLDWKKRFDIILG 635
H+N++ +L C+E+ + ++Y +M +L F + + + Q L ++ + +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-VF-------GGEEILA 687
IA G+ YLH + +IH+D+ A N ++DE++ +I+D +R +F G E
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ +M+ E ++ +S+ SDV+SFGV+L E++T
Sbjct: 183 VK--------WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 529 NFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRL-----STTSGQGIEELKNEVLLIAKLQ 582
N+ LGQG FG VY G+E+AVK++ S + + + L+ E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 583 HRNLVKLLGCCLEEDENML--IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL-----G 635
H +V+ GC + E L E MP S+ + QL + + +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSI--------KDQLKSYGALTENVTRKYTRQ 114
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-----VFGGEEILAITK 690
I GV YLH + I+HRD+K +NIL D N ++ DFG ++ G + ++T
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT- 170
Query: 691 RVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
GT +MSPE + K+D++S G ++E++T K
Sbjct: 171 ---GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-18
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 29/226 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-----------------IAVKRLSTTSGQGIE- 569
+ KLG+G FG V+ + ++ +AVK L + +
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 570 ELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD-ESRKQLLDWKK 628
+ E+ ++++L+ N+++LL C+ D +I E+M N L+ F+ E ++
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 629 RF-------DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
+ IA G+ YL S L +HRDL N L+ + +I+DFG +R
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ I R V +MS E L G F+T SDV++FGV L EI+T
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 55/202 (27%), Positives = 105/202 (51%), Gaps = 10/202 (4%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHR 584
NF K+G+G F VY+ L + + +A+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-FDESRKQLLDWKKRFDIILGIARGVLYL 643
N++K L +E++E ++ E L I + + +K+L+ + + + + V ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703
H SR R++HRD+K +N+ + ++ D G R F + A +VGT YMSPE
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPER 177
Query: 704 ALDGVFSTKSDVFSFGVILLEI 725
+ ++ KSD++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 536 LGQGGFGPV------YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GK+ +++ KRL SG+ + L+ E+L K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+ L+ M L Y I++ + L + ++ I G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTA-RVFGGEEILAITKRVVGTYGYMSPEYALDGV 708
I++RD+K N+LLD++ N R+SD G A + G+ IT+R GT GYM+PE +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR-AGTNGYMAPEILKEEP 170
Query: 709 FSTKSDVFSFGVILLEIITGK 729
+S D F+ G + E++ G+
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 6e-18
Identities = 58/217 (26%), Positives = 116/217 (53%), Gaps = 17/217 (7%)
Query: 519 ELSTLLAATD---NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNE 574
+L T+++ D ++ K+GQG G V+ ++ GQE+A+K+++ E + NE
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE 66
Query: 575 VLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 634
+L++ +L++ N+V L L DE ++ E++ SL D + +D + +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCR 122
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--V 692
+ + +LH + ++IHRD+K+ N+LL + +++DFG E+ +KR +
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ----SKRSTM 175
Query: 693 VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
VGT +M+PE + K D++S G++ +E++ G+
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 7e-18
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 43/217 (19%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLIAKLQHR 584
KLG+G + VYK + G+ +A+K++ +E K+ E+ L+ +L+H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGE---RKEAKDGINFTALREIKLLQELKHP 62
Query: 585 NLVKLLGCCLEEDENMLIYEFMP--------NKSLDYFIFDESRKQLLDWKKRFDIILGI 636
N++ LL + L++EFM +KS+ D K +L
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVL--------TPADIKS---YMLMT 111
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG--GEEILAITKRVVG 694
RG+ YLH I+HRDLK +N+L+ +++DFG AR FG + +T +VV
Sbjct: 112 LRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK---MTHQVV- 164
Query: 695 TYGYMSPEYALDGV--FSTKSDVFSFGVILLEIITGK 729
T Y +PE L G + D++S G I E++
Sbjct: 165 TRWYRAPEL-LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-18
Identities = 76/289 (26%), Positives = 125/289 (43%), Gaps = 40/289 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK---LSNGQ---EIAVKRL-STTSGQGIEELKNEVLLIAK 580
+N S LG G FG V + LS ++AVK L T E L +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 581 L-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
L H N+V LLG C ++I E+ L F+ R+ L + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG----- 694
+ +L + IHRDL A N+LL +I DFG AR +I+ + VV
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARL 205
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT--GKKNTRIFNDDDSSNLIKYAWELWS 752
+M+PE + V++ +SDV+S+G++L EI + + D LIK + +
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265
Query: 753 DNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801
A + M +C ++ L+ RP+ +V ++
Sbjct: 266 PEHAPAEIYDIM-KTCWDADPLK---------------RPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 9e-18
Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 43/217 (19%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRL-----STTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LGQG FG VY + G+E+A K++ S + + + L+ E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 590 LGCCLEEDENML--IYEFMPNKSLD-----YFIFDES-----RKQLLDWKKRFDIILGIA 637
GC + E L E+MP S+ Y ES +Q+L+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE------------ 117
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-----VFGGEEILAITKRV 692
G+ YLH + I+HRD+K +NIL D N ++ DFG ++ G I ++T
Sbjct: 118 -GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT--- 170
Query: 693 VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
GT +MSPE + K+DV+S G ++E++T K
Sbjct: 171 -GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 57/202 (28%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLV 587
F+ ++G+G FG VYKG + +E+ A+K + + IE+++ E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+ G L+ + +I E++ S D + L+ I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
R IHRD+KA+N+LL E+ + +++DFG A +I T VGT +M+PE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 708 VFSTKSDVFSFGVILLEIITGK 729
+ K+D++S G+ +E+ G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 56/202 (27%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLV 587
F+ ++G+G FG V+KG + Q++ A+K + + IE+++ E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
K G L+ + +I E++ S D R D + ++ I +G+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
+ IHRD+KA+N+LL E+ + +++DFG A +I T VGT +M+PE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176
Query: 708 VFSTKSDVFSFGVILLEIITGK 729
+ +K+D++S G+ +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 33/209 (15%)
Query: 536 LGQGGFGPVYKG--KLSNGQEIAVKRLSTTSGQGIEELKN---EVLLIAKLQHRNLVKLL 590
+G G FG V G KL +EI V + +G ++ ++ E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL------GIARGVLYLH 644
G + M++ E+M N SLD F+ RK +F +I GIA G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL----RKH----DGQFTVIQLVGMLRGIASGMKYL- 122
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG------Y 698
S + +HRDL A NIL++ + ++SDFG +RV + A T R G +
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRW 175
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+PE F++ SDV+S+G+++ E+++
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 69/207 (33%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 536 LGQGGFGPVY------KGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GKL +++ KRL +G E E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 590 LGCCLEEDENM-LIYEFMPNKSLDYFIF--DESRKQLLDWKKRF---DIILGIARGVLYL 643
+ ++ L+ M L Y I+ DE + + F II G+ +L
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLE----HL 113
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA-RVFGGEEILAITKRVVGTYGYMSPE 702
HQ RII+RDLK N+LLD N RISD G A + G+ TK GT G+M+PE
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---KTKGYAGTPGFMAPE 167
Query: 703 YALDGVFSTKSDVFSFGVILLEIITGK 729
+ D F+ GV L E+I +
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 67/219 (30%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 529 NFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRL-----STTSGQGIEELKNEVLLIAKLQ 582
N+ LG+G FG VY G+E+AVK++ S + + + L+ E+ L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 583 HRNLVKLLGCCLEEDENML--IYEFMPNKSLDYFIFDESRKQL-----LDWKKRFDIILG 635
H +V+ GC + +E L E+MP S+ + QL L
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI--------KDQLKAYGALTENVTRRYTRQ 114
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-----VFGGEEILAITK 690
I +GV YLH + I+HRD+K +NIL D N ++ DFG ++ G I K
Sbjct: 115 ILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI----K 167
Query: 691 RVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
V GT +MSPE + K+DV+S ++E++T K
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 70/221 (31%), Positives = 111/221 (50%), Gaps = 42/221 (19%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTS---GQGIEELKNEVLLIAKLQHR 584
F N++G+G +G VY+ + + EI A+K++ + G I L+ E+ L+ L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 585 NLVKLL---------------GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKR 629
N+V+L C E+D L+ MP F ES+ +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDN-MPTP------FSESQVKC------ 112
Query: 630 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689
++L + RG+ YLH++ IIHRDLK SN+LL +K +I+DFG AR + G +T
Sbjct: 113 --LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMT 166
Query: 690 KRVVGTYGYMSPEYALDGVFSTKS-DVFSFGVILLEIITGK 729
+VV T Y +PE L T + D+++ G IL E++ K
Sbjct: 167 PKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 526 ATDNFSTSNKLGQGGFGPVY--------KGKLSNGQEIAVKRL-STTSGQGIEELKNEVL 576
D LG+G FG V K K + ++AVK L S + + + +L +E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 577 LIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIF-------------DESRKQ 622
++ + +H+N++ LLG C ++ +I E+ +L ++ + ++
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 623 LLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682
L +K +ARG+ YL + + IHRDL A N+L+ E +I+DFG AR
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192
Query: 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ T +M+PE D +++ +SDV+SFGV+L EI T
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 28/217 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQH-R 584
D+ +LG+G +G V K + + G +AVKR+ +T + Q + L ++ + +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIAR 638
V G E + + E M + SLD F K++ D I + I +
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVK 114
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV-VGTYG 697
+ YLH S+L +IHRD+K SN+L++ ++ DFG + G + ++ K + G
Sbjct: 115 ALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKP 168
Query: 698 YMSPEYALDGV-----FSTKSDVFSFGVILLEIITGK 729
YM+PE ++ + KSDV+S G+ ++E+ TG+
Sbjct: 169 YMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 528 DNFSTSNKLGQGGFGPVY--------KGKLSNGQEIAVKRLS-TTSGQGIEELKNEVLLI 578
D + LG+G FG V K K +AVK L + + + +L +E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 579 AKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----------FDESR--KQLL 624
+ +H+N++ LLG C ++ +I E+ +L ++ +D +R + +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+K +ARG+ YL + + IHRDL A N+L+ E +I+DFG AR +
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
T +M+PE D V++ +SDV+SFGV++ EI T
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 65/202 (32%), Positives = 108/202 (53%), Gaps = 20/202 (9%)
Query: 536 LGQGGFGPVYKGK-LSNGQEI----AVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG G FG VYKG + +G+ + A+K L TS + +E+ +E ++A + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 590 LGCCLEEDENMLIYEFMPNKSL-DYFIFDESR---KQLLDWKKRFDIILGIARGVLYLHQ 645
LG CL L+ + MP L DY ++ R + LL+W + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLEE 127
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
+R++HRDL A N+L+ + +I+DFG AR+ +E +M+ E L
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 706 DGVFSTKSDVFSFGVILLEIIT 727
F+ +SDV+S+GV + E++T
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 536 LGQGGFGPVYKGKLSNG---QEIAVKRLSTTSGQGIE-ELKNEVLLIAKL-QHRNLVKLL 590
+G+G FG V K ++ + A+KR+ + + + E+ ++ KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 591 GCCLEEDENMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRFDIILGIA 637
G C L E+ P+ +L D+ F S L ++ +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG 697
RG+ YL Q + IHRDL A NIL+ E +I+DFG +R G+E+ K+ +G
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGRLP 186
Query: 698 --YMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+M+ E V++T SDV+S+GV+L EI++
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--EVLLIAKLQ---HRNLVK 588
++G G +G VYK + +G +A+K + + + L EV L+ +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 589 LLGCCL-----EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
L+ C E + L++E + Y D+ L + D++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703
H + I+HRDLK NIL+ +++DFG AR++ + +A+T VV T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVV-TLWYRAPEV 178
Query: 704 ALDGVFSTKSDVFSFGVILLEIITGK 729
L ++T D++S G I E+ K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 536 LGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEE-LKNEVLLIAKLQHRNLVKLLG 591
LG GGFG V K+ S + A+K + G +E + +E ++ + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 592 CCLEEDEN---MLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQ 645
+D+ ML+ E+ L + D R ++ RF ++L YLH
Sbjct: 60 -RTFKDKKYIYMLM-EYCLGGELWTILRD--RGLFDEYTARFYIACVVLAFE----YLH- 110
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
II+RDLK N+LLD ++ DFG A+ + T GT Y++PE L
Sbjct: 111 --NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIIL 165
Query: 706 DGVFSTKSDVFSFGVILLEIITGK 729
+ + D +S G++L E++TG+
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIE-ELKNEVLLIAKLQHRNLVKLLG 591
N++G G G VYK G+ A+K + + ++ E+ ++ + H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 592 CCLEEDENMLIYEFMPNKSLD-YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
E ++ EFM SL+ I DE + L D ++ I+ GIA YLH R
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADE--QFLADVARQ--ILSGIA----YLH---RRH 188
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT----KRVVGTYGYMSPEY--- 703
I+HRD+K SN+L++ N +I+DFG +R ILA T VGT YMSPE
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSR------ILAQTMDPCNSSVGTIAYMSPERINT 242
Query: 704 -----ALDGVFSTKSDVFSFGVILLEIITGK 729
A DG D++S GV +LE G+
Sbjct: 243 DLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-17
Identities = 57/196 (29%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 535 KLGQGGFGPV-YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
K+G+G G V + G+++AVK++ Q E L NEV+++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
L DE ++ EF+ +L D ++ ++ + L + R + YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 654 RDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKS 713
RD+K+ +ILL ++SDFG E + K +VGT +M+PE + T+
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 714 DVFSFGVILLEIITGK 729
D++S G++++E+I G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 56/203 (27%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 530 FSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
++ K+GQG G VY ++ GQE+A+K+++ E + NE+L++ + ++ N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
L L DE ++ E++ SL D + +D + + + + +LH +
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN-- 134
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMSPEYALD 706
++IHRD+K+ NILL + +++DFG E+ +KR +VGT +M+PE
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRSTMVGTPYWMAPEVVTR 189
Query: 707 GVFSTKSDVFSFGVILLEIITGK 729
+ K D++S G++ +E++ G+
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN----EVLLIAKLQ 582
+ + +G+G +G V K + + G+ +A+K+ + E++K EV ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLR 58
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H N+V L + L++E++ L+ E+ L I + + + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
H IIHRD+K NIL+ E ++ DFG AR +T V T Y +PE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE 171
Query: 703 YAL-DGVFSTKSDVFSFGVILLEIITG 728
+ D + DV++ G I+ E++ G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 23/274 (8%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLST---TSGQGIEELKNEVLLIAKLQHR 584
NF K+G+G F VY+ L +G +A+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYL 643
N++K +E++E ++ E L I + +K+L+ K + + + + ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703
H SR R++HRD+K +N+ + ++ D G R F + A +VGT YMSPE
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPER 177
Query: 704 ALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763
+ ++ KSD++S G +L E+ + + D L+S K +E D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM--AALQSPFYGDK---------MNLYSLCKKIEQCDYP 226
Query: 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTV 797
S SE LR Q+ +C+ RP ++ V
Sbjct: 227 PLPSDHYSEELR--QLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 9e-17
Identities = 56/203 (27%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 530 FSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
++ K+GQG G VY ++ GQE+A+++++ E + NE+L++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
L L DE ++ E++ SL D + +D + + + + +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMSPEYALD 706
++IHRD+K+ NILL + +++DFG E+ +KR +VGT +M+PE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRSTMVGTPYWMAPEVVTR 190
Query: 707 GVFSTKSDVFSFGVILLEIITGK 729
+ K D++S G++ +E+I G+
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 536 LGQGGFGPVYKGK-LSNGQEI----AVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKL 589
LG G FG V+KG + G I A+K + SG Q +E+ + +L + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
LG C L+ + P SL + + LD ++ + + IA+G+ YL +
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVF 709
R++HR+L A NILL +I+DFG A + ++ +M+ E L G +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 710 STKSDVFSFGVILLEIIT 727
+ +SDV+S+GV + E+++
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 32/211 (15%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQG---IEELKNEVLLIAKLQHRNLVKLLG 591
+ +G +G V+ K S G A+K + ++++ E ++++ Q +VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 592 CCLEEDENM-LIYEFMPN---KSL--DYFIFDESRKQLLDWKKRF--DIILGIARGVLYL 643
+ +N+ L+ E++P SL + DE D + + +I+L + YL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVARIYIAEIVLALE----YL 109
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV-FGGEEILAI-----TKRVVGTYG 697
H IIHRDLK NIL+D + +++DFG ++V +I KR+VGT
Sbjct: 110 HS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 698 YMSPEYALDGVFSTKSDVFSFGVILLEIITG 728
Y++PE L S D +S G IL E + G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 535 KLGQGGFGPVYKGKLSN---GQEIAVKRL--STTSGQGIEELK-NEVLLIAKLQHRNLVK 588
+G+G +G VYK K N G+E A+K+ GI + E+ L+ +L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFD---------ESRKQLLDWKKRFDIILGIARG 639
L+ LE + +Y DY D ++++ + ++ I G
Sbjct: 67 LVEVFLE-HADKSVYLL-----FDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 640 VLYLHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTARVFGGE-EILAITKRVVG 694
V YLH + ++HRDLK +NIL+ E+ +I D G AR+F + LA VV
Sbjct: 121 VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 695 TYGYMSPEYALDGVFSTKS-DVFSFGVILLEIIT 727
T Y +PE L TK+ D+++ G I E++T
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 49/230 (21%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQH 583
D F ++G+G +G VYK + + G+ +A+K++ + G I ++ E+ ++ +L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD----------ESR------------- 620
RN+V L ++ + + +F +K Y +F+ ES
Sbjct: 66 RNIVNLKEIVTDKQDAL---DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 621 KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
KQLL+ G+ Y H+ + L HRD+K SNILL+ K +++DFG AR++
Sbjct: 123 KQLLE-------------GLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 681 GGEEILAITKRVVGTYGYMSPEYAL-DGVFSTKSDVFSFGVILLEIITGK 729
EE T +V+ T Y PE L + + DV+S G IL E+ T K
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 2e-16
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 530 FSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLV 587
F +G G +G VYKG+ + GQ A+K + T G EE+K E+ ++ K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIA 66
Query: 588 KLLGCCLE------EDENMLIYEFMPNKSLDYFIFDESRKQLL-DWKKRFDIILGIARGV 640
G ++ +D+ L+ EF S+ I + L +W I I RG+
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMS 700
+LHQ ++IHRD+K N+LL E ++ DFG + + + +GT +M+
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMA 179
Query: 701 PEYAL-----DGVFSTKSDVFSFGVILLEIITG 728
PE D + KSD++S G+ +E+ G
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 536 LGQGGFGPVY--------KGKLSNGQEIAVKRLST-TSGQGIEELKNEVLLIAKL-QHRN 585
LG+G FG V K K + +AVK L + + + +L +E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----------FDESR--KQLLDWKKRFDI 632
++ LLG C ++ ++ E+ +L ++ FD + ++ L +K
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV 692
+ARG+ YL + + IHRDL A N+L+ E +I+DFG AR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 693 VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+M+PE D V++ +SDV+SFGV+L EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 530 FSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEE---LKNEVLLIAKLQHRN 585
F ++GQGG+G V+ K + EI A+KR+ + + E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 586 LVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
LVKLL ++DE + L E++P D+ + L + RF + V LH
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH 118
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYA 704
L IHRDLK N L+D + +++DFG ++ I+ VVG+ YM+PE
Sbjct: 119 ---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVL 170
Query: 705 LDGVFSTKSDVFSFGVILLEIITG 728
+ D +S G +L E + G
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 57/203 (28%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 535 KLGQGGFGPVYKG--KLSNGQ-EIAVKRLSTTSGQGI-EELKNEVLLIAKLQHRNLVKLL 590
+LG G FG V KG K+ Q ++A+K L + + + +E+ E ++ +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
G C E + ML+ E L+ F+ +K + +++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY--GYMSPEYALDGV 708
+HRDL A N+LL + +ISDFG ++ G ++ R G + + +PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECINFRK 174
Query: 709 FSTKSDVFSFGVILLEIIT-GKK 730
FS++SDV+S+G+ + E + G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 39/210 (18%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
+LG G FG VYK + G A K + T S + +E+ E+ ++A H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESR-----------KQLLDWKKRFDIILGIARGVLY 642
E+ ++ EF ++D + + R KQ L+ + Y
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE-------------ALNY 118
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMS 700
LH++ +IIHRDLKA NIL + +++DFG + + I +R +GT +M+
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMA 171
Query: 701 PEYAL-----DGVFSTKSDVFSFGVILLEI 725
PE + D + K+DV+S G+ L+E+
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 535 KLGQGGFGPVYKG--KLSNGQEI--AVKRLSTTSGQGIEEL-KNEVLLIAKLQHRNLVKL 589
+G+G FG VY+G ++I AVK + + E E ++ + H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+G E+ ++ E P L ++ + K LD ++ + YL
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVF 709
R +HRD+ A N+L+ ++ DFG +R E +K + +M+PE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINFRRF 185
Query: 710 STKSDVFSFGVILLEIIT-GKK 730
++ SDV+ FGV + EI+ G K
Sbjct: 186 TSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 6e-16
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 45/218 (20%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN------EVLLIAKLQHRNLVK 588
+G G +G V G+++A+K++S ++L + E+ L+ L+H N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNV----FDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 589 LLGCCLEEDENMLIYEFMPNKSLD----YFIFD----------ESRKQLLDWKKRFDIIL 634
LL ++L P D Y + + +S + L D ++ +
Sbjct: 64 LL--------DILR----PPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY-FLY 110
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL--AITKRV 692
I RG+ YLH +IHRDLK SNIL++ + +I DFG AR +E +T+ V
Sbjct: 111 QILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 693 VGTYGYMSPEYALDGVFSTKS-DVFSFGVILLEIITGK 729
V T Y +PE L TK+ D++S G I E++T K
Sbjct: 168 V-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
DNF K+G+G G V + S+G+ +AVK++ Q E L NEV+++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
V++ L DE ++ EF+ +L D ++ ++ + L + + + LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD 706
+IHRD+K+ +ILL ++SDFG E + K +VGT +M+PE
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISR 190
Query: 707 GVFSTKSDVFSFGVILLEIITGK 729
+ + D++S G++++E++ G+
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 73/275 (26%), Positives = 133/275 (48%), Gaps = 41/275 (14%)
Query: 535 KLGQGGFG-PVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLG 591
K+G+G FG + +G++ +K ++ + S + EE + EV +++ ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 592 CCLEEDENM-LIYEFMPNKSLDYFIFDE-----SRKQLLDWKKRFDIILGIARGVLYLHQ 645
EE+ N+ ++ ++ L I + Q+LDW + I + ++H
Sbjct: 67 S-FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVHD 119
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
+I+HRD+K+ NI L + ++ DFG ARV LA T +GT Y+SPE
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICE 174
Query: 706 DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS-DNKALEIVDSSM 764
+ ++ KSD+++ G +L E+ T +K+A+E + N L+I+ S
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT----------------LKHAFEAGNMKNLVLKIIRGSY 218
Query: 765 AN-SCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798
S S LR + L R DRPS+++++
Sbjct: 219 PPVSSHYSYDLRNLVSQLFKRNPR--DRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 21/199 (10%)
Query: 535 KLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL----QHRNLVKL 589
++G+G FG V+ G+L ++ +AVK T +LK + L A++ H N+V+L
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLP---PDLKAKFLQEARILKQYSHPNIVRL 58
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+G C ++ ++ E + + D+ F + L K+ ++ A G+ YL
Sbjct: 59 IGVCTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH-- 114
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT----YGYMSPEYAL 705
IHRDL A N L+ EK +ISDFG +R EE + G + +PE
Sbjct: 115 -CIHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 706 DGVFSTKSDVFSFGVILLE 724
G +S++SDV+SFG++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-16
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 535 KLGQGGFGPVYKGK-LSNGQE-IAVKRLST-TSGQGIE-ELKNEVLLIAKLQ---HRNLV 587
++G+G +G V+K + L NG +A+KR+ T +G+ EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 588 KLLGCCL-----EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
+L C E + L++E + Y D+ + + + D++ + RG+ +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
LH R++HRDLK NIL+ +++DFG AR++ + VV T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPE 179
Query: 703 YALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD 739
L ++T D++S G I E+ K R +D D
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 51/204 (25%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
++F ++G G +G VYK + ++ G+ A+K + G+ ++ E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLD--YFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
V G L D+ + EF SL Y + + + + R + +G+ YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYA 704
+ +HRD+K +NILL + + +++DFG + +A K +GT +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVA 178
Query: 705 L---DGVFSTKSDVFSFGVILLEI 725
G ++ D+++ G+ +E+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-16
Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 536 LGQGGFGPV------YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GK+ +++ KR+ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-------FDESRKQLLDWKKRFDIILGIARGVLY 642
+D L+ M L + I F+E R + I G+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE--------ICCGLED 117
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA-RVFGGEEILAITKRVVGTYGYMSP 701
LHQ+ RI++RDLK NILLD+ + RISD G A V G+ I K VGT GYM+P
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI----KGRVGTVGYMAP 170
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGK 729
E + ++ D ++ G +L E+I G+
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKN---EVLLIAKLQHRNLVKLLG 591
+G G +G V + G+++A+K+LS Q K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 592 C-----CLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
LE+ +++ L+ M L+ + ++L D +F ++ I RG+ Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLM-GADLNNIV---KCQKLSDDHIQF-LVYQILRGLKYIHS 136
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
IIHRDLK SNI ++E +I DFG AR E +T V T Y +PE L
Sbjct: 137 ---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVA-TRWYRAPEIML 188
Query: 706 DGVFSTKS-DVFSFGVILLEIITGK 729
+ + ++ D++S G I+ E++TGK
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 13/213 (6%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLS--TTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
+G+G +G V + ++G++ +K+L+ S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 593 CLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
ED + ++ F L Y E + +LL + + + IA + YLH+ I
Sbjct: 68 WEGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HI 123
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFST 711
+HRDLK N+ L ++ D G ARV + +A T ++GT YMSPE + ++
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNY 181
Query: 712 KSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744
KSDV++ G + E+ T K FN D ++L+
Sbjct: 182 KSDVWALGCCVYEMATLK---HAFNAKDMNSLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 533 SNKLGQGGFGPVYKGK-LSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQHRNLVK 588
K+GQG FG V+K + Q +A+K++ + G I L+ E+ ++ L+H N+V
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN 75
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFD---ESRKQLLDWKK-RFD------IILGIAR 638
L+ C + K Y +F+ LL K +F ++ +
Sbjct: 76 LIEIC-----RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA---ITKRVVGT 695
G+ Y+H R +I+HRD+KA+NIL+ + +++DFG AR F + T RVV T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 696 YGYMSPEYAL-DGVFSTKSDVFSFGVILLEIIT 727
Y PE L + + D++ G I+ E+ T
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 31/208 (14%)
Query: 536 LGQGGFGPV------YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GK+ +++ KR+ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-------FDESRKQLLDWKKRFDIILGIARGVLY 642
+D L+ M L + I FDE R + I G+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE--------ITCGLED 117
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA-RVFGGEEILAITKRVVGTYGYMSP 701
LH R RI++RDLK NILLD+ + RISD G A + GE I + VGT GYM+P
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI----RGRVGTVGYMAP 170
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGK 729
E + ++ D + G ++ E+I GK
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 35/216 (16%)
Query: 535 KLGQGGFGPVYKG------KLSNGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNL 586
+LGQG FG VY+G K +AVK ++ ++ + IE L NE ++ ++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHV 71
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIF-------DESRKQLLDWKKRFDIILGIARG 639
V+LLG + +++ E M + L ++ + + ++ + IA G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--------GGEEILAITKR 691
+ YL+ + +HRDL A N ++ +I DFG R GG+ +L +
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186
Query: 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+M+PE DGVF+T SD++SFGV+L EI +
Sbjct: 187 ------WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 41/225 (18%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKR-LSTTSGQGIEELK-NEVLLIAKLQHR 584
D + K+G+G +G VYK + + G+ +A+K+ +GI E+ L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 585 N-LVKLLGCCLEEDENMLIYEFMPNKSLDYFIF---DESRKQLLDWKKR----------- 629
+V+LL +E E K Y +F D K+ +D R
Sbjct: 61 IYIVRLL--DVEHVEEK------NGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTI 112
Query: 630 ----FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEE 684
+ ++ G+A + H + ++HRDLK N+L+D +K +I+D G R F
Sbjct: 113 KSFMYQLLKGVA----HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIP 164
Query: 685 ILAITKRVVGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEIITG 728
+ + T +V T Y +PE L +ST D++S G I E+
Sbjct: 165 VKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 57/198 (28%), Positives = 108/198 (54%), Gaps = 14/198 (7%)
Query: 535 KLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
K+G+G G V + +G+++AVK + Q E L NEV+++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
L +E ++ EF+ +L I ++R L+ ++ + + + + YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALTD-IVSQTR---LNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 654 RDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMSPEYALDGVFST 711
RD+K+ +ILL ++SDFG F + + KR +VGT +M+PE + T
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 712 KSDVFSFGVILLEIITGK 729
+ D++S G++++E++ G+
Sbjct: 197 EVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 54/195 (27%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 535 KLGQGGFGPVYKGKLSNGQEI-AVKRLSTTS-GQGIEELK-NEVLLIAKLQHRNLVKLLG 591
K+G+G +G V+K K EI A+KR+ +G+ E+ L+ +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
+ + L++E+ YF +S +D + + + +G+ + H +
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG-VFS 710
+HRDLK N+L+++ +++DFG AR F G + + VV T Y P+ ++S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 178
Query: 711 TKSDVFSFGVILLEI 725
T D++S G I E+
Sbjct: 179 TSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 536 LGQGGFGPVYKG---KLSNGQEIAVKRLST-TSGQGIEELKNEVLLIAKL-QHRNLVKLL 590
+G+G FG V + K A+K L S + E+ ++ KL H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 591 GCCLEEDENMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRFDIILGIA 637
G C + E+ P +L D+ F + L ++ +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG 697
G+ YL S + IHRDL A N+L+ E + +I+DFG +R GEE+ K+ +G
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--VKKTMGRLP 181
Query: 698 --YMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+M+ E V++TKSDV+SFGV+L EI++
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG G G VYK L + +AVK + T Q +++ +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYIIGFYG 66
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
E+ + EFM SLD ++ + + +L I + + +G+ YL L+I
Sbjct: 67 AFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKI 116
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFST 711
+HRD+K SN+L++ + ++ DFG + + + +I K VGT YM+PE +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 712 KSDVFSFGVILLEIITGK 729
SDV+S G+ +E+ G+
Sbjct: 173 HSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 55/215 (25%)
Query: 538 QGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE 596
+G FG VY K S G A+K L + +IAK Q N+ E
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSD------------MIAKNQVTNV-------KAE 46
Query: 597 DENMLIYEFMPNKSLDYFIFD-----------------ESRKQLL-----DWKKRFDIIL 634
M+I P + Y+ F S + L DW K++ I
Sbjct: 47 RAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IA 104
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ GV LHQ IIHRD+K N+L+D+ + +++DFG +R G K+ VG
Sbjct: 105 EVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GL----ENKKFVG 155
Query: 695 TYGYMSPEYALDGVFSTK-SDVFSFGVILLEIITG 728
T Y++PE + GV K SD +S G ++ E + G
Sbjct: 156 TPDYLAPE-TILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 49/203 (24%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--EVLLIAKLQ-HRNLVKL 589
K+G+G F V K + G+ A+K + + +E++ N E+ + +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 590 LGCCLEEDEN--MLIYEFMPNKSLDYFIFD--ESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+ + L++E M D +++ + RK+ L K+ + + + + ++H+
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
+ I HRD+K NIL+ + +++DFG+ R + + T Y +PE L
Sbjct: 119 NG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE---YISTRWYRAPECLL 171
Query: 706 -DGVFSTKSDVFSFGVILLEIIT 727
DG + K D+++ G + EI++
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 536 LGQGGFGPVYKGKLS----NGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
+G G FG V +G+L +A+K L S + + + +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRK----QLLDWKKRFDIILGIARGVLYLHQD 646
G + M+I EFM N +LD F+ + QL+ ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG------MLRGIAAGMKYL--- 122
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG---TYGYMSPEY 703
S + +HRDL A NIL++ + ++SDFG +R + +G + +PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 704 ALDGVFSTKSDVFSFGVILLEIIT 727
F++ SDV+S+G+++ E+++
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 536 LGQGGFGP--VYKGKLSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
+G+G FG + + S+ Q+ A+K + S +E+ + E +L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRK-----QLLDWKKRFDIILGIARGVLYLHQDS 647
+ ++ E+ L I + K +L W + + GV ++H+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK- 119
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
R++HRD+K+ NI L + ++ DFG+AR+ A T VGT Y+ PE +
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENM 175
Query: 708 VFSTKSDVFSFGVILLEIITGK 729
++ KSD++S G IL E+ T K
Sbjct: 176 PYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLL 577
+LS L F +G G +G VYKG+ + GQ A+K + T + EE+K E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINM 65
Query: 578 IAKL-QHRNLVKLLGCCLE------EDENMLIYEFMPNKSLDYFIFDESRKQLL-DWKKR 629
+ K HRN+ G ++ +D+ L+ EF S+ + + L DW
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125
Query: 630 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689
I I RG+ +LH ++IHRD+K N+LL E ++ DFG + + +
Sbjct: 126 --ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRR 178
Query: 690 KRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITG 728
+GT +M+PE D + +SD++S G+ +E+ G
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 534 NKLGQGGFGPVYKG--KLSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
+KLG+G + VYKG KL++ +A+K RL G ++ EV L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
E L++E++ +K L ++ D + K F + + RG+ Y H R
Sbjct: 70 HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RR 123
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT-KRVVGTYGYMSPEYALDGV 708
+++HRDLK N+L++E+ +++DFG AR + I T V T Y P+ L
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 709 -FSTKSDVFSFGVILLEIITGK 729
+ST+ D++ G I E+ TG+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 93/348 (26%), Positives = 137/348 (39%), Gaps = 110/348 (31%)
Query: 536 LGQGGFGPVYK------GKLSNGQEIAVKRL---STTSGQG--IEELKNEVLLIAKLQHR 584
LG+G FG V + K ++ + +AVK L +T S + ELK +LI H
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK---ILIHIGHHL 71
Query: 585 NLVKLLGCCLE-EDENMLIYE-----------------FMPNK----SLDYFIFDESRKQ 622
N+V LLG C + M+I E F P + E +KQ
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131
Query: 623 LLD-------------------------------WKKRF---DII---LGIARGVLYLHQ 645
LD +K+ D+I +ARG+ +L
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL-- 189
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTAR--------VFGGEEILAITKRVVGTYG 697
SR + IHRDL A NILL E +I DFG AR V G+ L +
Sbjct: 190 ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK-------- 240
Query: 698 YMSPEYALDGVFSTKSDVFSFGVILLEIIT--GKKNTRIFNDDDSSNLIKYAWELWSDNK 755
+M+PE D V++T+SDV+SFGV+L EI + + D++ +K + +
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEY 300
Query: 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
A + S M L C + DRP+ S +V +L +
Sbjct: 301 ATPEIYSIM----------------LDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 535 KLGQGGFGPVYKGKLSN-GQEIAVKR-LSTTSGQGIEELK-NEVLLIAKLQHRNLVKLLG 591
+G+G +G V K K GQ +A+K+ L + + ++++ E+ ++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
+ L++EF+ + LD E LD + + I RG+ + H + I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN---I 121
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVGTYGYMSPEYAL-DGV 708
IHRD+K NIL+ + ++ DFG AR GE + V T Y +PE + D
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE----VYTDYVATRWYRAPELLVGDTK 177
Query: 709 FSTKSDVFSFGVILLEIITG 728
+ D+++ G ++ E++TG
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 25/202 (12%)
Query: 535 KLGQGGFGPVYKG--KLSNGQE-IAVKRLSTTSGQGIEELKNEVLLIAK----LQHRNLV 587
+LG G FG V KG K+ ++ +AVK L + LK+E+L A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+++G C E + ML+ E L+ F+ + K + + K +++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTE-KNITELVHQVSMGMKYLEETN 115
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG-----YMSPE 702
+HRDL A N+LL + +ISDFG ++ G +E K T+G + +PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPE 168
Query: 703 YALDGVFSTKSDVFSFGVILLE 724
FS+KSDV+SFGV++ E
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 44/179 (24%), Positives = 79/179 (44%), Gaps = 33/179 (18%)
Query: 574 EVLLIAKLQHRNLVKLLGCCLEEDENMLIYE-----FMPNKSLDYFIFDESRKQLLDWKK 628
E +L+ + H +++++ + L+ +P+ S D + + R + L +
Sbjct: 107 EAMLLQNVNHPSVIRMK--------DTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV------FGG 682
I I G+ YLH RIIHRD+K NI +++ I D G A+ F G
Sbjct: 159 ALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215
Query: 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS 741
+ GT +PE +++K+D++S G++L E++ IF D S+
Sbjct: 216 ---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST--IFEDPPST 263
|
Length = 357 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 51/228 (22%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-----TTSGQGIEELKNEVLLIAKL 581
+ + +G+G +G V G ++A+K++S T + + E+K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 582 QHRNLVKLLGCCLEED-ENM----LIYEFMP-------------NKSLDYFIFDESRKQL 623
+H N++ +L E+ ++ E M N + YF++ Q+
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY-----QI 115
Query: 624 LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683
L RG+ Y+H + ++HRDLK SN+LL+ + +I DFG AR+ E
Sbjct: 116 L-------------RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159
Query: 684 EILAIT-KRVVGTYGYMSPEYALDGVFSTKS-DVFSFGVILLEIITGK 729
V T Y +PE L+ TK+ D++S G IL E+++ +
Sbjct: 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 2e-14
Identities = 68/219 (31%), Positives = 106/219 (48%), Gaps = 44/219 (20%)
Query: 534 NKLGQGGFGPVYKG-KLSNGQEIAVKRL-----STTSGQGIEELKNEVLLIAKL-QHRNL 586
KLG+G +G V+K + +A+K++ + T Q E++ + +L H N+
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ---RTFREIMFLQELGDHPNI 69
Query: 587 VKLLGCCLEEDENM----LIYEFMPNKSLDYFIFDES------RKQLL-DWKKRFDIILG 635
VKLL + + EN L++E+M E+ R +L D KR+ I+
Sbjct: 70 VKLLN--VIKAENDKDIYLVFEYM-----------ETDLHAVIRANILEDVHKRY-IMYQ 115
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF----GGEEILAITKR 691
+ + + Y+H S +IHRDLK SNILL+ +++DFG AR E +T
Sbjct: 116 LLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD- 171
Query: 692 VVGTYGYMSPEYALDGVFSTKS-DVFSFGVILLEIITGK 729
V T Y +PE L TK D++S G IL E++ GK
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 70/224 (31%), Positives = 105/224 (46%), Gaps = 40/224 (17%)
Query: 536 LGQGGFGPVYK-GKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC-- 592
+G+GGFG VY K G+ A+K L + I+ + E L + + +LV C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 593 --CLE-----EDENMLIYEFMPNKSLDYF-----IFDESRKQLLDWKKRF---DIILGIA 637
C+ D+ I + M L Y +F E+ + RF +IILG+
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-------EMRFYAAEIILGLE 111
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG 697
H +R +++RDLK +NILLDE + RISD G A F ++ A VGT+G
Sbjct: 112 ------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHG 160
Query: 698 YMSPEYALDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDS 740
YM+PE GV + + +D FS G +L +++ G R D
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 536 LGQGGFGPV------YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GK+ +++ KR+ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-------FDESRKQLLDWKKRFDIILGIARGVLY 642
+D L+ M L + I FDE R I A
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA-----------IFYAAELCCG 114
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA-RVFGGEEILAITKRVVGTYGYMSP 701
L R RI++RDLK NILLD++ + RISD G A ++ GE + + VGT GYM+P
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV----RGRVGTVGYMAP 170
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGKKNTR 733
E + ++ D + G ++ E+I G+ R
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 49/231 (21%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRL--------STTSGQGIEE------LKNEVLLI 578
LG+G +G V K G+ +A+K++ T Q + E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------I 632
+++H N++ L+ +E D L+ + M K+++D K R I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQVKCI 124
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI------- 685
+L I G+ LH+ +HRDL +NI ++ K +I+DFG AR +G
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 686 ------LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGK 729
+T +VV T Y +PE + + D++S G I E++TGK
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 28/212 (13%)
Query: 536 LGQGGFGPVYKGKLSNG---QEIAVKRLSTTSGQGI-EELKNEVLLIAKL-QHRNLVKLL 590
+G+G FG V K ++ + A+KR+ + + + E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 591 GCCLEEDENMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRFDIILGIA 637
G C L E+ P+ +L D+ F S L ++ +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG 697
RG+ YL S+ + IHRDL A NIL+ E +I+DFG +R G+E+ K+ +G
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGRLP 174
Query: 698 --YMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+M+ E V++T SDV+S+GV+L EI++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 536 LGQGGFGPV------YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG+GGFG V GK+ + + KR+ G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+D L+ M L + I++ + + F I G+ LH+++
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-YAAEILCGLEDLHREN-- 122
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTA-RVFGGEEILAITKRVVGTYGYMSPEYALDGV 708
++RDLK NILLD+ + RISD G A ++ GE I + VGT GYM+PE +
Sbjct: 123 -TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI----RGRVGTVGYMAPEVLNNQR 177
Query: 709 FSTKSDVFSFGVILLEIITGKKNTR 733
++ D + G ++ E+I G+ R
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 51/203 (25%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 529 NFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
++ ++G G +G VYK L G+ AVK + G ++ E+ ++ + +H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLD--YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
G L ++ + E+ SL Y + + + + R + +G+ YLH
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHS 124
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
++ HRD+K +NILL + + +++DFG A +A K +GT +M+PE A
Sbjct: 125 KGKM---HRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAA 179
Query: 706 ---DGVFSTKSDVFSFGVILLEI 725
+G ++ D+++ G+ +E+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL----STT--SGQGIEELK 572
T+ T+ + +G G FG V + GQ +A+K++ ST + + ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 573 NEVLLIAKLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESR---KQLLDWKK 628
L+ L+H N++ L + E++ + E + D SR KQ + +
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQY-- 112
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688
+ I RG+ Y+H ++HRDLK SNIL++E + +I DFG AR+ + +
Sbjct: 113 ---FLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ----M 162
Query: 689 TKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGK 729
T V Y Y +PE L + + D++S G I E++ GK
Sbjct: 163 TGYVSTRY-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL------STTSGQGIEELKNEVLLIAKL 581
D+F ++LG G G V K + I ++L Q I EL+ ++ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF-DIILG----- 635
+V G + E + E M SLD Q+L KR + ILG
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKEAKRIPEEILGKVSIA 111
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ RG+ YL + + +I+HRD+K SNIL++ + ++ DFG + G+ I ++ VGT
Sbjct: 112 VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 165
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
YMSPE +S +SD++S G+ L+E+ G+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 536 LGQGGFGPVYK-GKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC-- 592
+G+GGFG VY K G+ A+K L + I+ + E L + + +LV C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 593 --CLE-----EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKK-RF---DIILGIARGVL 641
C+ D+ I + M L Y + S+ + K+ RF +IILG+
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLE---- 111
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
H +R +++RDLK +NILLDE + RISD G A F ++ A VGT+GYM+P
Sbjct: 112 --HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 164
Query: 702 EYALDGV-FSTKSDVFSFGVILLEIITGKKNTR 733
E G + + +D FS G +L +++ G R
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 51/239 (21%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTT----SGQGIEELKNEVLLIAKLQ 582
D+F +G+G FG V+ + + ++ A+K L + Q I ++ E ++A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59
Query: 583 HRNLVKLLGCCLEEDENM-LIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGI 636
+VKL +++E++ L+ E+MP L +F E + + + I
Sbjct: 60 SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY-----I 107
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA------------------- 677
A VL L +L IHRD+K NIL+D + +++DFG
Sbjct: 108 AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 678 --RVFGGEEILAITKR------VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG 728
R +R VGT Y++PE + + D +S GVIL E++ G
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHR 584
D++ KLG+G + VYKGK NG+ +A+K RL G ++ E L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLL-DWKKRFDIILGIARGVLYL 643
N+V L ++ L++E++ Y D+ L + K F + + RG+ Y+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLF--LFQLLRGLSYI 119
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT-KRVVGTYGYMSPE 702
HQ I+HRDLK N+L+ + +++DFG AR + + + T V T Y P+
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPD 173
Query: 703 YALDGV-FSTKSDVFSFGVILLEIITG 728
L +ST D++ G I +E+I G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 536 LGQGGFGPVYKG--KLSNGQEIAVK----RLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
LG G FG + +G KL + +E+ V R + Q L E L + + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRL 71
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQ--LLDWKKRFDIILGIARGVLYLHQDS 647
G + M++ E+M N +LD F+ RK L + ++ G+A G+ YL S
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGLASGMKYL---S 124
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
+ +H+ L A +L++ + +IS F + E I T + +PE
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT-TMSGKSPVLWAAPEAIQYH 183
Query: 708 VFSTKSDVFSFGVILLEIIT 727
FS+ SDV+SFG+++ E+++
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTT----SGQGIEELKNEVLLIAKLQ 582
D+F LG G FG V + + A+K LS Q +E + NE ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD----------I 632
H LV L G ++ L+ E++P L F RK RF +
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSHLRK-----SGRFPEPVARFYAAQV 110
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV 692
+L + YLH L I++RDLK N+LLD +I+DFG A+ G T +
Sbjct: 111 VLALE----YLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTL 158
Query: 693 VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG 728
GT Y++PE L + D ++ G+++ E++ G
Sbjct: 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 534 NKLGQGGFGPVYKG--KLSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589
KLG+G + V+KG KL+ +A+K RL G ++ EV L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+ L++E++ +K L ++ D + K F + I RG+ Y H R
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RR 123
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL-DGV 708
+++HRDLK N+L++E+ +++DFG AR + VV T Y P+ L
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181
Query: 709 FSTKSDVFSFGVILLEIITGK 729
+ST+ D++ G I E+ +G+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 4e-13
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIE-ELKNEVLLIAKLQHRNLVKLLGCC 593
K+G+G +G VYK K +G++ L G GI E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 594 LEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY-----LHQD 646
L + L++++ + F + K KK + G+ + +LY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 647 SRLRIIHRDLKASNILL----DEKMNPRISDFGTARVFGGE-EILAITKRVVGTYGYMSP 701
++HRDLK +NIL+ E+ +I+D G AR+F + LA VV T+ Y +P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 702 EYALDGVFSTKS-DVFSFGVILLEIITGK 729
E L TK+ D+++ G I E++T +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL------STTSGQGIEELKNEVLLIAKL 581
D+F ++LG G G V+K I ++L Q I EL+ ++ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR--KQLLDWKKRFDIILGIARG 639
+V G + E + E M SLD + R +Q+L + + + +G
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKG 115
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
+ YL + + +I+HRD+K SNIL++ + ++ DFG + G+ I ++ VGT YM
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYM 169
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITGK 729
SPE +S +SD++S G+ L+E+ G+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 40/196 (20%)
Query: 552 GQEIAVKRLS------TTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605
GQ +A+K+LS T + + EL L+ + H+N++ LL F
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIGLLNV------------F 84
Query: 606 MPNKSLDYF--------IFDESRKQ----LLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
P KSL+ F + D + Q LD ++ ++ + G+ +LH IIH
Sbjct: 85 TPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIH 141
Query: 654 RDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKS 713
RDLK SNI++ +I DFG AR G +T VV Y Y +PE L +
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVILGMGYKENV 198
Query: 714 DVFSFGVILLEIITGK 729
D++S G I+ E+I G
Sbjct: 199 DIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-13
Identities = 65/235 (27%), Positives = 95/235 (40%), Gaps = 59/235 (25%)
Query: 535 KLGQGGFGPVYKG-KLSNGQEIAVKR----LSTTSGQGIEELKNEVLLIAK----LQHRN 585
+G+GG G VY + +A+K+ LS LK L AK L H
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-----ENPLLKKRFLREAKIAADLIHPG 63
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLD--WKKR-------------- 629
+V + C + D +Y MP +I + K LL W+K
Sbjct: 64 IVPVYSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 630 -FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE---- 684
I I + Y+H S+ ++HRDLK NILL I D+G A EE
Sbjct: 115 FLSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171
Query: 685 ------------ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ I ++VGT YM+PE L S +D+++ GVIL +++T
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 67/245 (27%), Positives = 110/245 (44%), Gaps = 32/245 (13%)
Query: 536 LGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNE--VLLIAKLQHRNLVKL 589
LG+G FG V +L +G+ AVK L +E E +L +A+ H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARGVLYLH 644
C D + EF+ L + I FDE+R + + I +++LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFLH 113
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL--AITKRVVGTYGYMSPE 702
II+RDLK N+LLD + + +++DFG + E I T GT Y++PE
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPE 166
Query: 703 YALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI---KYAWELWSDNKALEI 759
+ ++ D ++ GV+L E++ G N+DD I + + W A++I
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDI 226
Query: 760 VDSSM 764
+ + M
Sbjct: 227 LKAFM 231
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIE-ELKNEVLLIAKLQHRNLVKLLGCC 593
K+G+G +G VYK K +G++ L G GI E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 594 LEEDENM--LIYEFMPNKSLDYFIF---DESRKQLLDWKKRF--DIILGIARGVLYLHQD 646
L + L++++ + F ++ K+ + + ++ I G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 647 SRLRIIHRDLKASNILL----DEKMNPRISDFGTARVFGGE-EILAITKRVVGTYGYMSP 701
++HRDLK +NIL+ E+ +I+D G AR+F + LA VV T+ Y +P
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 702 EYALDGVFSTKS-DVFSFGVILLEIITGK 729
E L TK+ D+++ G I E++T +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 534 NKLGQGGFGPVYKGKLS-NGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
+KLG+G + V+KG+ +A+K RL G ++ EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
E L++E++ + Y ++ L+ + + RG+ Y H + +
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV-F 709
I+HRDLK N+L++EK +++DFG AR + VV T Y P+ L +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 710 STKSDVFSFGVILLEIITGK 729
ST D++ G IL E+ TG+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 44/132 (33%), Positives = 71/132 (53%), Gaps = 21/132 (15%)
Query: 604 EFMPNKSLDYFIFDESRKQLLDWKKRF-DIILG-----IARGVLYLHQDSRLRIIHRDLK 657
E M SLD Q+L R + ILG + RG+ YL + + +I+HRD+K
Sbjct: 79 EHMDGGSLD---------QVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVK 127
Query: 658 ASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFS 717
SNIL++ + ++ DFG + G+ I ++ VGT YMSPE ++ +SD++S
Sbjct: 128 PSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 718 FGVILLEIITGK 729
G+ L+E+ G+
Sbjct: 184 LGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 522 TLLAATDNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKN---EVLL 577
T+ + + + +G G +G V G +AVK+LS Q I K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRL 69
Query: 578 IAKLQHRNLVKLL-----GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDI 632
+ ++H N++ LL LEE ++ + + L+ + ++L D +F +
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-L 125
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV 692
I I RG+ Y+H IIHRDLK SN+ ++E +I DFG AR +E+
Sbjct: 126 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 177
Query: 693 VGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEIITGK 729
V T Y +PE L+ + ++ D++S G I+ E++TG+
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 67/227 (29%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 520 LSTLLAATDNFSTSNKLGQGGFGPVYK-GKLSNGQEIAVKRLSTTSGQGIEELKNEVLLI 578
L +L TD + +G+G +G VYK +G AVK L S EE++ E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 579 AKL-QHRNLVKLLGCCLEEDENM-----LIYEFMPNKSLDYFIFDESRKQLLDWKKRFD- 631
L H N+VK G + D+ + L+ E S+ + K LL +R D
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127
Query: 632 -----IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686
I+ G G+ +LH + RIIHRD+K +NILL + ++ DFG + +
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 687 AITKRVVGTYGYMSPEY-----ALDGVFSTKSDVFSFGVILLEIITG 728
T VGT +M+PE D + + DV+S G+ +E+ G
Sbjct: 185 RNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 48/211 (22%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQH 583
D+ +G G FG V+ + + A+K ++ + + + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 584 RNLVKLLGCCLEEDENML--IYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIAR 638
+++L E D+ L + E++P L F + + + + F +I+ +
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCALE- 115
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
YLH I++RDLK NILLD++ + +++DFG A+ ++ T + GT Y
Sbjct: 116 ---YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEY 164
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
++PE + D ++ G+++ E++ G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 535 KLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIE-ELKNEVLLIAKLQHRNLVKLLGC 592
KLG+G + VYKG NGQ +A+K +S + +G+ E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
++ ++E+M Y I + L + R + + RG+ Y+H I+
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRL-FMFQLLRGLAYIH---GQHIL 125
Query: 653 HRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT-KRVVGTYGYMSPEYALDGV-FS 710
HRDLK N+L+ +++DFG AR + I + T V T Y P+ L +S
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182
Query: 711 TKSDVFSFGVILLEIITGK 729
+ D++ G I +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 51/217 (23%)
Query: 535 KLGQGGFGPVYKGKLS-NGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
KLG+G + VYKG+ GQ +A+K RL G ++ E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKR-----------FDIILGIARGV 640
+ L++E++ D KQ +D F ++ RG+
Sbjct: 71 IIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGL 116
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV-------- 692
Y HQ R++HRDLK N+L+ E+ +++DFG AR K V
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR----------AKSVPSKTYSNE 163
Query: 693 VGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEIITG 728
V T Y P+ L +ST D++ G I E+ TG
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIA---VKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKL 589
+++G G FG V G+ G A VK L ++ + EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYLHQDS 647
LG C+E +L+ EF P L ++ +K + +A G+L+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYA--- 704
IH DL N L ++ +I D+G A E+ +++PE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 705 ----LDGVFSTKSDVFSFGVILLEIIT 727
L + KS+++S GV + E+ T
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 46/217 (21%)
Query: 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKN--EVLLIAKLQHRNLVKLLGC 592
+G+G +G V K S +++A+K+++ I+ + E+ L+ L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 593 CLEEDENM-----LIYEFM---------PNKSL-----DYFIFDESRKQLLDWKKRFDII 633
++YE M +++L YF++ QLL
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY-----QLL--------- 118
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
RG+ Y+H + ++HRDLK SN+LL+ + +I DFG AR E+ +T+ VV
Sbjct: 119 ----RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV 170
Query: 694 GTYGYMSPEYALDGVFSTKS-DVFSFGVILLEIITGK 729
T Y +PE L+ T + DV+S G I E++ K
Sbjct: 171 -TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 70/237 (29%), Positives = 105/237 (44%), Gaps = 58/237 (24%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLL---IAKLQHR--NLVKL 589
+G G G VYK + G +AVK++ T + EE K +L+ + H +VK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENK-RILMDLDVVLKSHDCPYIVKC 79
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLD-WKKRF-----DIILG-----IAR 638
G I + D FI E LD KR + ILG I +
Sbjct: 80 YGY--------FITDS------DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK-RVVGTYG 697
+ YL + +IHRD+K SNILLD N ++ DFG + G + + K R G
Sbjct: 126 ALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRSAGCAA 179
Query: 698 YMSPEYALD-----GVFSTKSDVFSFGVILLEIITGK---KN--------TRIFNDD 738
YM+PE +D + ++DV+S G+ L+E+ TG+ KN T+I ++
Sbjct: 180 YMAPE-RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 536 LGQGGFGPVY-----KGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVK 588
LGQG FG V+ G + GQ A+K L +T + K E ++A++ H +VK
Sbjct: 4 LGQGSFGKVFLVRKITGPDA-GQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
L E + LI +F+ L F K+++ ++ D+ +A L L
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEE--DVKFYLAELALALDHLHS 116
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK--RVVGTYGYMSPEYALD 706
L II+RDLK NILLDE+ + +++DFG ++ E I K GT YM+PE
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 707 GVFSTKSDVFSFGVILLEIITG 728
+ +D +SFGV++ E++TG
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKL 589
LG+G FG V +L E+ AVK L +E E VL +A +H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQL 61
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVL 641
C +D + E++ L + I FDE R RF +I+LG+
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA-------RFYAAEIVLGL----Q 110
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL--AITKRVVGTYGYM 699
+LH+ II+RDLK N+LLD + + +I+DFG + E IL T GT Y+
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK----EGILGGVTTSTFCGTPDYI 163
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+PE + D ++ GV+L E++ G+ ++D+ I
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 536 LGQGGFGPVYKGKLS-NGQEIAVKRLS---TTSGQGIE--ELKNEVLLIAKLQHRNLVKL 589
LG+G FG V+ +L Q A+K L +E ++ VL +A +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61
Query: 590 LGCCLEEDENML-IYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARGVLYL 643
C + EN+ + E++ L + I FD R +II G+ +L
Sbjct: 62 Y-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY----AAEIICGLQ----FL 112
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL--AITKRVVGTYGYMSP 701
H I++RDLK NILLD + +I+DFG + E +L A T GT Y++P
Sbjct: 113 HSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPDYIAP 165
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGK 729
E L ++T D +SFGV+L E++ G+
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 536 LGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGI--EELKNEVLLIAKLQHRNLVKLLGC 592
+G G +G V G+++A+K+LS I + E+ L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 593 CLEE---DENMLIYEFMPNKSLDY-----FIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
DE Y MP D E + Q L + + G+ Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL--------VYQMLCGLKYIH 134
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYA 704
IIHRDLK N+ ++E +I DFG AR E +T VV T Y +PE
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVV-TRWYRAPEVI 186
Query: 705 LDGVFSTKS-DVFSFGVILLEIITGK 729
L+ + ++ D++S G I+ E++TGK
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKR-LSTTSGQGIEELK-NEVLLIAKLQHRNLVKLLG 591
K+G+G +G V+K + GQ +A+K+ + + I+++ E+ ++ +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRK--QLLDWKKRFDIILGIARGVLYLHQDSRL 649
+ + L++E+ D+ + +E K + + II + V + H+
Sbjct: 68 VFRRKRKLHLVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK---H 119
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL-DGV 708
IHRD+K NIL+ ++ ++ DFG AR+ G T V T Y +PE + D
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTD-YVATRWYRAPELLVGDTQ 177
Query: 709 FSTKSDVFSFGVILLEIITG 728
+ DV++ G + E++TG
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 30/227 (13%)
Query: 536 LGQGGFGPV---YKGKLSNGQEIAVKRLSTTSGQGIEELKN--EVLLIAKLQHRNLVKLL 590
+G G +G V Y +L Q++AVK+LS I + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 591 -----GCCLEE-DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
+E +E L+ M L+ + ++L D +F +I + RG+ Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLM-GADLNNIV---KCQKLSDEHVQF-LIYQLLRGLKYIH 135
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYA 704
IIHRDLK SN+ ++E RI DFG AR E V T Y +PE
Sbjct: 136 SAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIM 187
Query: 705 LDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750
L+ + ++ D++S G I+ E++ GK +F +D + +K E+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKA---LFPGNDYIDQLKRIMEV 231
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 53/219 (24%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLI-----AKLQHRNLVKL- 589
LG+G FG V +L T I+ LK +V+L + R ++ L
Sbjct: 3 LGKGSFGKVMLAELKG----------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALA 52
Query: 590 --------LGCCLEEDENML-IYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DI 632
L C + E++ + E++ L + I FDE+R RF +I
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA-------RFYAAEI 105
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK-- 690
I G+ +LH+ II+RDLK N+LLD+ + +I+DFG + E + K
Sbjct: 106 ICGLQ----FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK----ENMNGEGKAS 154
Query: 691 RVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
GT Y++PE ++ D +SFGV+L E++ G+
Sbjct: 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 536 LGQGGFGPV-YKGKLSNGQEIAVKRLST--TSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
+G G +G V G ++A+K+L S + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 593 CLEEDENM-------LIYEFMPN---KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
D ++ L+ FM K + + E R Q L ++ + +G+ Y
Sbjct: 83 -FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ--------MLKGLKY 133
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
+H IIHRDLK N+ ++E +I DFG AR E +T VV T Y +PE
Sbjct: 134 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVV-TRWYRAPE 185
Query: 703 YALDGVFSTKS-DVFSFGVILLEIITGK 729
L+ + T++ D++S G I+ E++TGK
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 31/209 (14%)
Query: 536 LGQGGFGPVYKGKLSN---------GQEIAVKRLSTTSGQGI-EELKNEVLLIAKLQHRN 585
LGQG F +YKG L GQE++V S L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
LVKL G C+ DEN+++ E++ LD F+ E L WK D+ +A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 646 DSRLRIIHRDLKASNILL-----DEKMNP--RISDFGTARVFGGEEILAITKRVVGTYGY 698
+++H ++ NIL+ +E P ++SD G E V +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIPW 170
Query: 699 MSPEYALDGVFSTKS--DVFSFGVILLEI 725
++PE +G S D +SFG LLEI
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 534 NKLGQGGFGPVYKGKLS-NGQEIAVK--RLSTTSGQGIEELK-NEVLLIAKLQHR----N 585
++LG+G +G VYK G +A+K RL ++E K N++++ + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSPY 60
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+V G E + E+M SLD + + I + +G+ +L +
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY-- 703
+ IIHRD+K +N+L++ ++ DFG + G + ++ K +G YM+PE
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIK 174
Query: 704 ----ALDGVFSTKSDVFSFGVILLEIITGK 729
+ ++ +SDV+S G+ +LE+ G+
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 536 LGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLL---- 590
LG G G V+ S+ + +AVK++ T Q ++ E+ +I +L H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 591 --GCCLEEDENML-----IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
G L ED L +Y D E + + F L RG+ Y+
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQL--LRGLKYI 130
Query: 644 HQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEEILA--ITKRVVGTYGYMS 700
H + ++HRDLK +N+ ++ E + +I DFG AR+ +++ +V + Y S
Sbjct: 131 HSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRS 186
Query: 701 PEYALDGVFSTKS-DVFSFGVILLEIITGK 729
P L TK+ D+++ G I E++TGK
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
I RG+ YLH I+HRD+K N+L++ +I DFG ARV +E +T+ VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 696 YGYMSPEYALDGV--FSTKSDVFSFGVILLEIITGK 729
Y Y +PE L G +++ D++S G I E++ +
Sbjct: 169 Y-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 76/268 (28%), Positives = 107/268 (39%), Gaps = 87/268 (32%)
Query: 536 LGQGGFGPVYKG------KLSNGQEIAVKRL---STTSGQG--IEELKNEVLLIAKLQHR 584
LG G FG V + K S+ +AVK L +T S + ELK +LI H
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELK---ILIHIGNHL 71
Query: 585 NLVKLLGCCLEEDEN-MLIYEFMPNKSLDYFI------FDESRKQLLDWKKRFDIILGIA 637
N+V LLG C + + M+I EF +L F+ F R++ + RF ++ +
Sbjct: 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131
Query: 638 RG-------------------------------------------VLYLHQDSR------ 648
R + Y Q +R
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA 191
Query: 649 -LRIIHRDLKASNILLDEKMNPRISDFGTAR--------VFGGEEILAITKRVVGTYGYM 699
+ IHRDL A NILL E +I DFG AR V G L + +M
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK--------WM 243
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIIT 727
+PE D V++T+SDV+SFGV+L EI +
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 74/284 (26%), Positives = 115/284 (40%), Gaps = 88/284 (30%)
Query: 528 DNFSTSNKLGQGGFGPVYK------GKLSNGQEIAVKRL-STTSGQGIEELKNEVLLIAK 580
DN LG G FG V + GK N +AVK L ++ E L +E+ +++
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 581 L-QHRNLVKLLG--------------CCL--------EEDENMLIY----EFMPNKSLDY 613
L QH+N+V LLG CC ++ E L + + S DY
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157
Query: 614 --------FIFDES-------------------------RKQLLD----WKKRFDIILG- 635
+I +S K D W D +L
Sbjct: 158 KNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRF 217
Query: 636 ---IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV 692
+A+G+ +L + IHRD+ A N+LL + +I DFG AR +I+ + V
Sbjct: 218 SSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYV 269
Query: 693 VGTYG-----YMSPEYALDGVFSTKSDVFSFGVILLEIITGKKN 731
V +M+PE D V++ +SDV+S+G++L EI + K+
Sbjct: 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 6e-11
Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 24/188 (12%)
Query: 550 SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609
+ + KR+ S I+ L+NE+L + +L H N++K+ E +M +
Sbjct: 190 PKCERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKIEEILRSEA-----NTYMITQ 243
Query: 610 SLDY----FIFDESRKQLLDWKKR------FDIILGIARGVLYLHQDSRLRIIHRDLKAS 659
D+ F++DE+ DWK R I+ + V Y+H ++IHRD+K
Sbjct: 244 KYDFDLYSFMYDEA----FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLE 296
Query: 660 NILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFG 719
NI L+ + DFGTA F E A VGT SPE + +D++S G
Sbjct: 297 NIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCG 355
Query: 720 VILLEIIT 727
+ILL++++
Sbjct: 356 LILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 536 LGQGGFGPV----YKGKLSNGQEIAVKRLS---TTSGQGIEELKNE--VLLIA-KLQHRN 585
LG+G FG V YK G+ A+K L + +E L E + A +H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFI----FDESRKQLLDWKKRFDIILGIARGVL 641
LV L C ED + E+ L I F E R ++LG+
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY----AACVVLGLQ---- 115
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV---FGGEEILAITKRVVGTYGY 698
YLH++ +I++RDLK N+LLD + +I+DFG + FG T GT +
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-----TSTFCGTPEF 167
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEIITG 728
++PE + ++ D + GV++ E++ G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 536 LGQGGFGPVYKGKLS-NGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG+G FG V +L G+ AVK L +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 592 CCLEEDENML-IYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQDS 647
C + E++ + EF+ L + I D+ R L ++ F +I+ G+ +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCGLQ----FLHSKG 116
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTAR--VFGGEEILAITKRVVGTYGYMSPEYAL 705
II+RDLK N++LD + +I+DFG + VFG GT Y++PE
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR----ASTFCGTPDYIAPEILQ 169
Query: 706 DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
++ D +SFGV+L E++ G+ F+ DD L +
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSP---FHGDDEDELFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 38/230 (16%)
Query: 514 DVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLST--TSGQGIEEL 571
D TF T+L N QG Y L + +A+K+LS + +
Sbjct: 17 DSTF----TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRA 70
Query: 572 KNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF--------IFDESRKQL 623
E++L+ + H+N++ LL F P KSL+ F + D + Q+
Sbjct: 71 YRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQV 118
Query: 624 ----LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
LD ++ ++ + G+ +LH IIHRDLK SNI++ +I DFG AR
Sbjct: 119 IQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175
Query: 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
G +T VV Y Y +PE L + D++S G I+ E+I G
Sbjct: 176 AGTS--FMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 535 KLGQGGFGPVYKGKLSNG---QEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLL 590
++G G FG V G++++G ++ VK L ++ Q + E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLL--DWKKRFDIILGIARGVLYLHQDSR 648
G C E +L+ EF P L ++ + +L+ D + IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV 708
IH DL N LL + +I D+G + E+ ++ +++PE +D V
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL-VDEV 177
Query: 709 F--------STKSDVFSFGVILLEI 725
+ +S+V+S GV + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 40/100 (40%), Positives = 56/100 (56%), Gaps = 19/100 (19%)
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR--------VFGGEEILA 687
+A+G+ +L SR + IHRDL A NILL E +I DFG AR V G+ L
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ +M+PE D V++ +SDV+SFGV+L EI +
Sbjct: 245 LK--------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-10
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 48/205 (23%)
Query: 552 GQEIAVKRLSTTSGQGIEE---LKNEVLLIAKLQHRNLVKLL--GCCLEEDENMLIYEFM 606
G E+A+K L T + + + + E L A+L H N+V LL G ++E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR--------------II 652
P ++L +++L A G L + RL I+
Sbjct: 62 PGRTL---------REVLA-----------ADGALPAGETGRLMLQVLDALACAHNQGIV 101
Query: 653 HRDLKASNILL---DEKMNPRISDFGTARVFGG-----EEILAITKRVVGTYGYMSPEYA 704
HRDLK NI++ + + ++ DFG + G L T V+GT Y +PE
Sbjct: 102 HRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
Query: 705 LDGVFSTKSDVFSFGVILLEIITGK 729
+ SD++++G+I LE +TG+
Sbjct: 162 RGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKNEVLLIAK----LQHRN--LVK 588
LG+G FG V + E+ A+K L I++ E ++ K L + L +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQ 65
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYLHQD 646
L C D + E++ L Y I +Q+ +K+ + IA G+ +LH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTAR--VFGGEEILAITKRVVGTYGYMSPEYA 704
II+RDLK N++LD + + +I+DFG + +FGG T+ GT Y++PE
Sbjct: 121 G---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFCGTPDYIAPEII 173
Query: 705 LDGVFSTKSDVFSFGVILLEIITGK 729
+ D ++FGV+L E++ G+
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 59/189 (31%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 552 GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611
G +AVK+LS +N+ AK +R LV LL C ++ L+ F P KSL
Sbjct: 46 GINVAVKKLS-------RPFQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSL 95
Query: 612 DYF--------IFDESRKQL----LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKAS 659
+ F + D + Q+ LD ++ ++ + G+ +LH IIHRDLK S
Sbjct: 96 EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 152
Query: 660 NILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFG 719
NI++ +I DFG AR +T VV Y Y +PE L + D++S G
Sbjct: 153 NIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVG 209
Query: 720 VILLEIITG 728
I+ E++ G
Sbjct: 210 CIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 49/225 (21%)
Query: 528 DNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLS------TTSGQGIEELKNEVLLIAK 580
+ +G G +G V +G+++A+K++ T + + + ELK ++
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRH 60
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD---YFIFD----------ESRKQLLDWK 627
+H N++ + P + Y + D S + L +
Sbjct: 61 FKHDNIIAIRDI------------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEH 108
Query: 628 KRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687
R+ + + RG+ Y+H + +IHRDLK SN+L++E RI DFG AR
Sbjct: 109 IRY-FLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-- 162
Query: 688 ITKRV----VGTYGYMSPE--YALDGVFSTKSDVFSFGVILLEII 726
K V T Y +PE +L ++T D++S G I E++
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQ--EIAVKRLSTTS---GQGIEELKNEVLLIAKLQ 582
++F+ LG G FG V N +A+KR + + ++ + +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI---ARG 639
H V L G +E L+ EF+ ++F F L KRF +G A+
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTF-------LRRNKRFPNDVGCFYAAQI 140
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
VL L I++RDLK N+LLD+ +++DFG A+V + T + GT Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYI 195
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITG 728
+PE L+ +D ++ G+ + EI+ G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 39/115 (33%), Positives = 55/115 (47%), Gaps = 14/115 (12%)
Query: 616 FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
F ES ++ IA VL L +L II+RD+K NILLD + + ++DFG
Sbjct: 102 FTESEVRVY-----------IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFG 150
Query: 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDGV--FSTKSDVFSFGVILLEIITG 728
++ F EE GT YM+PE G D +S GV+ E++TG
Sbjct: 151 LSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 38/230 (16%)
Query: 514 DVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLST--TSGQGIEEL 571
D TF T+L N QG Y L + +A+K+LS + +
Sbjct: 10 DSTF----TVLKRYQNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRA 63
Query: 572 KNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF--------IFDESRKQL 623
E++L+ + H+N++ LL F P KSL+ F + D + Q+
Sbjct: 64 YRELVLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQV 111
Query: 624 ----LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
LD ++ ++ + G+ +LH IIHRDLK SNI++ +I DFG AR
Sbjct: 112 IQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168
Query: 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
G +T VV Y Y +PE L + D++S G I+ E++ K
Sbjct: 169 AGTS--FMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 529 NFSTSNKLGQGGFGPVYKGK---LSNGQEIAVKRLSTTSGQGI------EELKNEVLLIA 579
+ +LGQG +G V + S + +A+K+++ + I ELK LL
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELK---LLRH 57
Query: 580 KLQHRNLVKLLGCCLEEDEN---MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
H+N+ L + N + +YE + L I S + L D + I I
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTDAHFQS-FIYQI 114
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVG 694
G+ Y+H + ++HRDLK N+L++ +I DFG AR F E V
Sbjct: 115 LCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 695 TYGYMSPEYALDGVFSTKS-DVFSFGVILLEIITGK 729
T Y +PE L TK+ DV+S G IL E++ K
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 35/209 (16%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEV----LLIAKLQHRNLVKLL 590
+G+G FG V K ++G+ AVK L + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFD-----------ESRKQLLDWKKRFDIILGIARG 639
Y F L YF+ D + + + + RF IA
Sbjct: 63 ------------YSFQTADKL-YFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASA 108
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
+ YLH L II+RDLK NILLD + + ++DFG + G E T GT Y+
Sbjct: 109 LGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYL 163
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITG 728
+PE + D + G +L E++ G
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-09
Identities = 44/156 (28%), Positives = 83/156 (53%), Gaps = 2/156 (1%)
Query: 572 KNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD 631
++E+ +A H +VK +D+ +LI E+ L+ I + K+ L +++ ++
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-KQRLKEHLPFQE-YE 170
Query: 632 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691
+ L + VL L + +++HRDLK++NI L ++ DFG ++ + L +
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
GT Y++PE +S K+D++S GVIL E++T
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 62/239 (25%), Positives = 100/239 (41%), Gaps = 42/239 (17%)
Query: 504 TKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLST 562
K K D + ++LS +F LG G FG V K G+ A+K L
Sbjct: 1 MKAAYMFTKPDTSSWKLS-------DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK 53
Query: 563 TS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDES 619
+ ++ + E ++ +L H +V ++ +E+ + EF+ L F
Sbjct: 54 REILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL----FTHL 109
Query: 620 RKQLLDWKKRF----------DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669
RK RF +++L YLH II+RDLK N+LLD K +
Sbjct: 110 RK-----AGRFPNDVAKFYHAELVLAFE----YLHS---KDIIYRDLKPENLLLDNKGHV 157
Query: 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG 728
+++DFG A+ ++ T + GT Y++PE D ++ GV+L E I G
Sbjct: 158 KVTDFGFAK-----KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 64/248 (25%), Positives = 113/248 (45%), Gaps = 32/248 (12%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEEL-----KNEVLLIAKLQHRNLVKL 589
LG+G FG V +L E+ A+K L +++ + +L +A +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARGVLYLH 644
C +D + E++ L + I FDE R RF + +++LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS-------RF-YAAEVTLALMFLH 113
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL--AITKRVVGTYGYMSPE 702
+ +I+RDLK NILLD + + +++DFG + E IL T GT Y++PE
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFGMCK----EGILNGVTTTTFCGTPDYIAPE 166
Query: 703 YALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKY---AWELWSDNKALEI 759
+ + D ++ GV++ E++ G+ N+DD I + + +W +A+ I
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSI 226
Query: 760 VDSSMANS 767
+ + M +
Sbjct: 227 LKAFMTKN 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 30/225 (13%)
Query: 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKN---- 573
++ L +++ +G+G FG V + + Q++ A+K LS E +K
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSK-----FEMIKRSDSA 88
Query: 574 ---EVLLIAKLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFI--FDESRKQLLDWK 627
E I + V L C ++D+ + ++ E+MP L + +D K W
Sbjct: 89 FFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WA 144
Query: 628 KRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687
K + A VL L + +IHRD+K N+LLD+ + +++DFGT E +
Sbjct: 145 KFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMV 198
Query: 688 ITKRVVGTYGYMSPEY----ALDGVFSTKSDVFSFGVILLEIITG 728
VGT Y+SPE DG + + D +S GV L E++ G
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 30/211 (14%)
Query: 536 LGQGGFGPVYKGKLSN----GQ----EIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
LGQG F ++KG G+ E+ +K L + E ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY-LHQD 646
G C+ DE++++ E++ SLD ++ + WK L +A+ + + LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHFL 116
Query: 647 SRLRIIHRDLKASNILL-----DEKMNP---RISDFGTARVFGGEEILAITKRVVGTYGY 698
+ H ++ A N+LL + NP ++SD G + +EIL +R+ +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PW 170
Query: 699 MSPEYALDG-VFSTKSDVFSFGVILLEIITG 728
+ PE + S +D +SFG L EI +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKN----EVLLIAKLQ 582
+ F +G+G +G V K + +EI A+K+ + EE+K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLK 58
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
N+V+L + L++E++ L+ + +E + K R I + + + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVR-SYIYQLIKAIHW 115
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
H++ I+HRD+K N+L+ ++ DFG AR E A V T Y SPE
Sbjct: 116 CHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPE 171
Query: 703 YALDGVFSTKSDVFSFGVILLEIITGK 729
L + D++S G IL E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 536 LGQGGFGPV-YKGKLSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
LG G G V ++S+G+ AVK + S + EV + ++VK
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK---- 95
Query: 593 CLEE----DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL----- 643
C E+ D M LDY + R+++ K G+L++
Sbjct: 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 644 --HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
H S+ +IHRD+K++NILL ++ DFG ++++ + + GT Y++P
Sbjct: 156 VHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGKK 730
E +S K+D+FS GV+L E++T K+
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 42/231 (18%)
Query: 519 ELSTLLAATDNFSTSNKLGQGGFGPVY--KGKLSNGQEIAVKRLSTTSGQGIEELK---- 572
+++ L ++F +G+G FG V + K S Q A+K LS E +K
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSK-QVYAMKLLSK-----FEMIKRSDS 87
Query: 573 ----NEVLLIAKLQHRNLVKLLGCCLEEDENML--IYEFMPNKSL-----DYFIFDESRK 621
E ++A +V+L +D+ L + E+MP L +Y I +
Sbjct: 88 AFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE---- 141
Query: 622 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
W + + A VL L + IHRD+K N+LLD+ + +++DFGT +
Sbjct: 142 ---KWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKM 192
Query: 682 GEEILAITKRVVGTYGYMSPEYAL----DGVFSTKSDVFSFGVILLEIITG 728
+ VGT Y+SPE DG + + D +S GV L E++ G
Sbjct: 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYL 643
L +L C D + E++ L Y I +Q+ +K+ + IA G+ +L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL--AITKRVVGTYGYMSP 701
H II+RDLK N++LD + + +I+DFG + E + TK GT Y++P
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDYIAP 170
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE 749
E + D ++FGV+L E++ G+ F +D L + E
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAP---FEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 27/218 (12%)
Query: 525 AATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAK-LQ 582
+ ++ N +G G FG VY+ + +++A+K++ + KN LLI K L
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLN 117
Query: 583 HRNLVKL-----LGCCLEEDENM---LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 634
H N++ L C + ++N+ ++ EF+P Y L
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTAR-VFGGEEILA-ITKR 691
+ R + Y+H I HRDLK N+L+D + ++ DFG+A+ + G+ ++ I R
Sbjct: 178 QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 692 VVGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEIITG 728
Y +PE L ++T D++S G I+ E+I G
Sbjct: 235 F-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 45/226 (19%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
D+F +G+G FG V K+ + + I A+K L+ K E+L A+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN----------KWEMLKRAET----- 45
Query: 587 VKLLGCCLEEDENMLI-----------YEFMPNKSL----DYFIFDESRKQLLDWKKRFD 631
C E+ N+L+ Y F L DY++ + L ++ R
Sbjct: 46 -----ACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP 100
Query: 632 IILG---IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688
+ IA VL +H +L +HRD+K N+LLD + R++DFG+ + +
Sbjct: 101 EDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ- 159
Query: 689 TKRVVGTYGYMSPEY--ALD---GVFSTKSDVFSFGVILLEIITGK 729
+ VGT Y+SPE A++ G + + D +S GV + E++ G+
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 30/210 (14%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
+ K K +AVK+ L + S + ++ L+ E++ +LQH N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 594 LEEDENMLIYEFMPNKSLDYFI---FDESRKQLLDWKKRFDIILGIARGVL----YLHQD 646
+ + E ++ M S + + F E +L I I + VL Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA--------IAFILKDVLNALDYIHS- 119
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAI---TKRVVGTYGYMSP 701
IHR +KAS+ILL +S + G+ + K V ++SP
Sbjct: 120 --KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 702 EY---ALDGVFSTKSDVFSFGVILLEIITG 728
E L G ++ KSD++S G+ E+ G
Sbjct: 178 EVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 536 LGQGGFGPVYKGKL----SNGQEIAVKRLS----TTSGQGIEELKNEVLLIAKLQHRNLV 587
LG+GG+G V++ + G+ A+K L + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLH 644
L+ + LI E++ L F+ E ++ F +I L + +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALE----HLH 117
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR--VFGGEEILAITKRVVGTYGYMSPE 702
Q II+RDLK NILLD + + +++DFG + + G +T GT YM+PE
Sbjct: 118 Q---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT----VTHTFCGTIEYMAPE 170
Query: 703 YALDGVFSTKSDVFSFGVILLEIITG 728
+ D +S G ++ +++TG
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 527 TDNFSTSNKLGQGGFGPVYK-GKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HR 584
+D + +G+G +G V+K NG + AVK L EE++ E ++ L H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHP 75
Query: 585 NLVKLLGCCLEEDEN-----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------II 633
N+VK G ++D L+ E S+ + K L +R + I+
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAYIL 130
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
G+ +LH + + IHRD+K +NILL + ++ DFG + + T V
Sbjct: 131 HEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--V 185
Query: 694 GTYGYMSPEY-----ALDGVFSTKSDVFSFGVILLEIITG 728
GT +M+PE LD + + DV+S G+ +E+ G
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 35/209 (16%)
Query: 536 LGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEV----LLIAKLQHRNLVKLL 590
+G+G FG V K S+G AVK L + +E + + +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFD-----------ESRKQLLDWKKRFDIILGIARG 639
Y F + L YF+ D + + L+ + RF +A
Sbjct: 63 ------------YSFQTAEKL-YFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASA 108
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
+ YLH L II+RDLK NILLD + + ++DFG + G E T GT Y+
Sbjct: 109 IGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYL 163
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITG 728
+PE + D + G +L E++ G
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 25/180 (13%)
Query: 564 SGQGIEELKNEVLLIAKLQHRNLVKLLGC-------CLEEDENMLIYEFMPNKSLDYFIF 616
+ G + E+ ++ + HR ++ L+ C+ MP D F +
Sbjct: 126 AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCM----------VMPKYKCDLFTY 175
Query: 617 DESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676
+ R L ++ I + + YLH IIHRD+K NI LDE N + DFG
Sbjct: 176 VD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA 231
Query: 677 ARVFGGEEILAITKRVVGTYGYMSPEY-ALDGVFSTKSDVFSFGVILLEIITGKKNTRIF 735
A GT SPE ALD + K+D++S G++L E+ KN +F
Sbjct: 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSV--KNVTLF 288
|
Length = 392 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-08
Identities = 26/79 (32%), Positives = 38/79 (48%), Gaps = 8/79 (10%)
Query: 346 GFIKLERMKLPDTSVAANVDMNLGLKACEEKCL-SNCSCVAYASASAETNRGIGCLMYH- 403
F++L KLP S +L + C KCL SNCSC ++ N GCL++
Sbjct: 5 CFVRLPNTKLPGFSRIVISVASL--EECASKCLNSNCSCRSFTY----NNGTKGCLLWSE 58
Query: 404 GDLNDTRKYTNAGQDLFVR 422
L D R + + G DL+ +
Sbjct: 59 SSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNEVLLIAKLQHR 584
+F+ LG+G FG V + E+ A+K L +E E ++A
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 585 NLVKLLGCCLEE-DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVL 641
+ L C + D + E++ L Y I +Q+ +K+ + I+ G+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAVFYAAEISVGLF 115
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
+LH+ II+RDLK N++LD + + +I+DFG + + + T+ GT Y++P
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAP 170
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE 749
E + D +++GV+L E++ G+ F+ +D L + E
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPP---FDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 19/100 (19%)
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR--------VFGGEEILA 687
+ARG+ +L + +HRDL A N+LL + +I DFG AR V G L
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ +M+PE D +++T SDV+S+G++L EI +
Sbjct: 303 VK--------WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 24/230 (10%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQE----IAVKRLSTTS----GQGIEELKNEVLLIAK 580
NF LG G +G V+ + +G + A+K L + + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 581 LQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
++ + L + D + LI +++ L F R++ K ++ +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERF----KEQEVQIYSGEI 114
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR---VVGTY 696
VL L +L II+RD+K NILLD + ++DFG ++ F +E +R GT
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE----VERAYSFCGTI 170
Query: 697 GYMSPEYAL--DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744
YM+P+ DG D +S GV++ E++TG + + +S I
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 72/338 (21%), Positives = 137/338 (40%), Gaps = 68/338 (20%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI----AVKRLSTTSGQGIEELKNEVLLIAKLQH 583
+F + +G+G FG V + +I +K+ + + + + E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 584 RNLVKLLGCCLEEDENMLIYEFMP--------NKSLDYFIFDESRKQLLDWKKRFDIILG 635
+ +L ++D L+ E+ P N+ D FDE Q
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMAQFY----------- 107
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT-ARVFGGEEILAITKRVVG 694
+A VL +H ++ +HRD+K N+L+D + +++DFG+ AR+ + + + K VG
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS--KLPVG 165
Query: 695 TYGYMSPEY--ALDG----VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS------- 741
T Y++PE ++G + + D +S GVI E+I G F++ S+
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG---RSPFHEGTSAKTYNNIM 222
Query: 742 ---NLIKYAWELWSDNKALEIVDSSMANSC--LASEALRCIQVGLLCVQDRTTDRPSMST 796
+K+ + + L+++ S + L E L C P S
Sbjct: 223 NFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCC--------------HPFFSK 268
Query: 797 VVFMLSNETFVPSPKQPTFSVRRTEIDTDNSSSGIKSS 834
+ + +N P PT +++ DT N K+S
Sbjct: 269 IDW--NNIRNSLPPFVPTL---KSDDDTSNFDEPEKNS 301
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 8e-08
Identities = 60/250 (24%), Positives = 104/250 (41%), Gaps = 64/250 (25%)
Query: 528 DNFSTSNKLGQGGFGPV-YKGKLSNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKLQ 582
D+F + +G+G FG V K G A+K+L + Q + ++ E ++A+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59
Query: 583 HRNLVKLLGCCLEEDENM-LIYEFMPNKSL-------DYFIFDESRKQLLDWKKRFDIIL 634
+ +VKL +++ + LI E++P + D F +E+R
Sbjct: 60 NPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR-------------F 105
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG------------------- 675
IA +L + +L IHRD+K N+LLD K + ++SDFG
Sbjct: 106 YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165
Query: 676 ---------TARVFGGEEILAITKR--------VVGTYGYMSPEYALDGVFSTKSDVFSF 718
++ + KR VGT Y++PE L ++ + D +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225
Query: 719 GVILLEIITG 728
GVI+ E++ G
Sbjct: 226 GVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 60/234 (25%), Positives = 104/234 (44%), Gaps = 23/234 (9%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN---EVLLIAKLQHRNLVKLLG 591
LG+G FG V + ++G+ A+K L +E+ + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
+D + E++ L F SR+++ + I + YLH +I
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFST 711
++RDLK N++LD+ + +I+DFG + G A K GT Y++PE D +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 712 KSDVFSFGVILLEIITGKKNTRIFNDDDSSNL--------IKYAWELWSDNKAL 757
D + GV++ E++ G+ F + D L IK+ L +D K+L
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP---FYNQDHEKLFELILMEDIKFPRTLSADAKSL 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+A+G+ +L + IHRDL A NILL +I DFG AR + +
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+M+PE + V++ +SDV+S+G++L EI +
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 37/97 (38%), Positives = 50/97 (51%), Gaps = 10/97 (10%)
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT-KRVVGTY 696
R + Y+H + + HRDLK NIL + +I DFG ARV + AI V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 697 GYMSPEYALDGVFSTKS----DVFSFGVILLEIITGK 729
Y +PE L G F +K D++S G I E++TGK
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 47/227 (20%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
D+F +G+G FG V K+ N ++ A+K L+ K E+L A+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN----------KWEMLKRAET----- 45
Query: 587 VKLLGCCLEEDENMLI-----------YEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIIL 634
C E+ ++L+ Y F +L Y + D LL +F+ L
Sbjct: 46 -----ACFREERDVLVNGDRRWITNLHYAFQDENNL-YLVMDYYVGGDLLTLLSKFEDRL 99
Query: 635 G-------IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687
+A VL + +L +HRD+K N+LLD+ + R++DFG+ + +
Sbjct: 100 PEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159
Query: 688 ITKRVVGTYGYMSPEY--ALD---GVFSTKSDVFSFGVILLEIITGK 729
+ VGT Y+SPE A++ G + + D +S GV + E++ G+
Sbjct: 160 -SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 59/284 (20%), Positives = 123/284 (43%), Gaps = 57/284 (20%)
Query: 544 VYKGKLSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600
+YKG N +E+ ++ I+ +NE+ + ++ N++K+ G ++ +++
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 601 ----LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRD 655
LI E+ L + E + L +K + D+ + +G+ L++ ++ +++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKN 148
Query: 656 LKASNILLDEKMNPRISDFGTARVFGG-EEILAITK-RVVGTYGYMSPEYALDGVFST-- 711
L + + L+ E +I + G E+IL+ + V Y S + D +FS
Sbjct: 149 LTSVSFLVTENYKLKI-------ICHGLEKILSSPPFKNVNFMVYFSYKMLND-IFSEYT 200
Query: 712 -KSDVFSFGVILLEIITGK---KN---TRIFNDDDSSNLIKYAWELWSDNKA-LEIVDSS 763
K D++S GV+L EI TGK +N I++ +I L LEI
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD-----LIINKNNSLKLPLDCPLEI--KC 253
Query: 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFV 807
+ +C + ++++ RP++ +++ LS F
Sbjct: 254 IVEACTSHDSIK---------------RPNIKEILYNLSLYKFY 282
|
Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 48/211 (22%), Positives = 89/211 (42%), Gaps = 31/211 (14%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIA---VKRLSTTSGQGIEE--LKN-EVLLIAKLQHRNLVK 588
++G G FG V ++ +A VK L + + L+ + I LQH N+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI--LQHPNILQ 59
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL-------GIARGVL 641
LG C+E +L++E+ L ++ E W +R +L IA GV
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVT 113
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
++H + +H DL N L + ++ D+G E+ + +++P
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 702 EYAL---DGVFSTK----SDVFSFGVILLEI 725
E G+ + + S+V++ GV L E+
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-07
Identities = 18/88 (20%), Positives = 29/88 (32%), Gaps = 15/88 (17%)
Query: 339 STCQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSN---CSCVAYASASAETNR 395
C+ + +K+ T C +C N SC A+ A A
Sbjct: 3 EFCKSAGTTLIKIALKIKTTKANT-------ADECANRCEKNGLPFSCKAFVFAKARK-- 53
Query: 396 GIGCLMYH-GDLNDTRKYTNAGQDLFVR 422
CL + ++ RK + G DL+
Sbjct: 54 --QCLWFPFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEV----LLIAKLQHRNLVKLL 590
+G+G FG V K +G+ AVK L +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
++ + +F+ L F + + + + RF IA + YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARF-YAAEIASALGYLHS---IN 116
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFS 710
I++RDLK NILLD + + ++DFG + G T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 711 TKSDVFSFGVILLEIITG 728
D + G +L E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKNEVLLIAKLQH----RNLVKLL 590
+G+G FG VY+ + + + I A+K LS K E++ ++ H RN+ L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS----------KKEIVAKKEVAHTIGERNI---L 47
Query: 591 GCCLEEDENMLI---YEFMPNKSLDYFIFDESRKQLLDW----KKRFD---IILGIARGV 640
L ++ ++ + F + L Y + D L W + RF IA V
Sbjct: 48 VRTLLDESPFIVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELV 106
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMS 700
L L + I++RDLK NILLD + + DFG ++ + T GT Y++
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLA 164
Query: 701 PEYALDGVFSTKS-DVFSFGVILLEIITG 728
PE LD TK D +S GV++ E+ G
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 2/90 (2%)
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
+L L +L I++RD+K NILLD + + ++DFG ++ F EE T GT YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYM 173
Query: 700 SPEYALDGVFSTKS-DVFSFGVILLEIITG 728
+PE K+ D +S G+++ E++TG
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 19/100 (19%)
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR--------VFGGEEILA 687
+A G+ +L + +HRDL A N+L+ E +I DFG AR + G L
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ +M+PE + +++T SDV+SFG++L EI T
Sbjct: 305 LK--------WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 56/220 (25%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAK------------LQ- 582
LG+G FG V I V+ +T ++ LK EV+ IAK LQ
Sbjct: 3 LGKGTFGKV----------ILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQN 51
Query: 583 --HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF------IFDESRKQLLDWKKRF---D 631
H L L D + E+ L +F +F E R RF +
Sbjct: 52 TRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRA-------RFYGAE 103
Query: 632 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL--AIT 689
I+ + YLH +++RDLK N++LD+ + +I+DFG + E I A
Sbjct: 104 IVSALG----YLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATM 152
Query: 690 KRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
K GT Y++PE D + D + GV++ E++ G+
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 4e-07
Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 46/238 (19%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEE-----LKNEVLLIAKLQ 582
+ + K+G G FG V+ K QE + S +G++E L EV ++ +L+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELK 70
Query: 583 HRNLVKLLGCCLEEDENML--IYEFMPNKSLD------YFIFDESRKQLLDWKKRFDIIL 634
H+N+V+ + L + L + EF L Y +F + + + DI
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-----VDITR 125
Query: 635 GIARGVLYLHQ----DSRLRIIHRDLKASNILLD-------------EKMNPR----ISD 673
+ + Y H + R++HRDLK NI L +N R I D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 674 FGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV--FSTKSDVFSFGVILLEIITGK 729
FG ++ G I ++ VGT Y SPE L + KSD+++ G I+ E+ +GK
Sbjct: 186 FGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 50/212 (23%), Positives = 96/212 (45%), Gaps = 13/212 (6%)
Query: 536 LGQGGFGPVYKGKLSNGQEI----AVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLL 590
+G+G + V +L + I VK+ + I+ ++ E + + H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
C E + E++ L + + + +++L + RF I+ + YLH+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARF-YSAEISLALNYLHERG--- 116
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFS 710
II+RDLK N+LLD + + +++D+G + G T GT Y++PE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 711 TKSDVFSFGVILLEIITGKKNTRIFNDDDSSN 742
D ++ GV++ E++ G+ I D+ +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 50/220 (22%), Positives = 97/220 (44%), Gaps = 13/220 (5%)
Query: 536 LGQGGFGPVYKGKLSNGQEI----AVKRLSTTSGQGIEELKNEVLLIAKLQHRN-LVKLL 590
+G+G + V +L +I VK+ + I+ ++ E + + LV L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
C L+ E++ L + + + +++L + RF I + +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARF-YAAEICIALNFLHERG--- 116
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFS 710
II+RDLK N+LLD + +++D+G + G T GT Y++PE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 711 TKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750
D ++ GV++ E++ G+ I D+ N Y +++
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 51/193 (26%), Positives = 80/193 (41%), Gaps = 46/193 (23%)
Query: 574 EVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDI- 632
E ++ + H ++++L G LI +P D + + L K+ I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCY-------LAAKRNIAIC 182
Query: 633 -ILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA---------R 678
IL I R VL YLH++ RIIHRD+KA NI ++ + + DFG A +
Sbjct: 183 DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239
Query: 679 VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDD 738
+G GT +PE + D++S G++L E+ T + +F D
Sbjct: 240 YYGW----------AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS--LFEKD 287
Query: 739 ------DSSNLIK 745
DS IK
Sbjct: 288 GLDGDCDSDRQIK 300
|
Length = 391 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 45/226 (19%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
++F +G+G FG V KL N ++ A+K L+ K E+L A+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN----------KWEMLKRAET----- 45
Query: 587 VKLLGCCLEEDENMLI-----------YEFMPNKSL----DYFIFDESRKQLLDWKKRFD 631
C E+ ++L+ Y F +L DY++ + L ++ R
Sbjct: 46 -----ACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP 100
Query: 632 IILG---IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688
+ +A V+ + +L +HRD+K NIL+D + R++DFG+ E+
Sbjct: 101 EDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQ 159
Query: 689 TKRVVGTYGYMSPEY--ALD---GVFSTKSDVFSFGVILLEIITGK 729
+ VGT Y+SPE A++ G + + D +S GV + E++ G+
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 601 LIYEFMPNKSLDYFI--FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658
++ E+MP L + +D K W + + A VL L + IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIHSMGFIHRDVKP 170
Query: 659 SNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY----ALDGVFSTKSD 714
N+LLD+ + +++DFGT E ++ VGT Y+SPE DG + + D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECD 229
Query: 715 VFSFGVILLEIITGK------------------KNTRIFNDD-----DSSNLI 744
+S GV L E++ G KN+ F DD ++ NLI
Sbjct: 230 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLL--------------IAKL 581
LG+G FG V I VK +T ++ LK EV++ +
Sbjct: 3 LGKGTFGKV----------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL 641
+H L L D + E+ L F SR+++ + I +
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALD 109
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
YLH + +++RDLK N++LD+ + +I+DFG + G + A K GT Y++P
Sbjct: 110 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 165
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGK 729
E D + D + GV++ E++ G+
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLSTTSGQGIEELKNEV----LLIAKLQHRNLVKLL 590
+G+G FG V + ++ AVK L + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
D+ + +++ L Y + + + L+ + RF IA + YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARF-YAAEIASALGYLHS---LN 116
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFS 710
I++RDLK NILLD + + ++DFG + E T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 711 TKSDVFSFGVILLEIITG 728
D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 32/149 (21%), Positives = 61/149 (40%), Gaps = 19/149 (12%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV--KLLGC 592
L G VY + + +K + + + EV ++ L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLAS 61
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYLHQDSRLR 650
+ + L+ E++ ++LD + +E ++ + + L +A+ LHQ L
Sbjct: 62 GESDGWSYLLMEWIEGETLD-EVSEEEKEDIAE-------QLAELLAK----LHQLPLLV 109
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARV 679
+ H DL NIL+D+ I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 48/202 (23%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 536 LGQGGFGPVYKGKLSNGQEI----AVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
+G+G FG V + + + Q I +++ S + E ++A++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 592 CCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
++ L+ F+ L + + FD SR + A + L
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFY-----------TAELLCALENL 109
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD 706
+ +I+RDLK NILLD + + + DFG ++ ++ T GT Y++PE L
Sbjct: 110 HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLG 167
Query: 707 GVFSTKSDVFSFGVILLEIITG 728
++ D ++ GV+L E++TG
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 61/255 (23%), Positives = 98/255 (38%), Gaps = 65/255 (25%)
Query: 528 DNFSTSNKLGQGGFGPV-YKGKLSNGQEIAVKRLSTTSGQGIEEL---KNEVLLIAKLQH 583
++F T +G+G FG V K G+ A+K L + ++L K E ++A+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGIAR 638
+V L + LI EF+P L Y F E RF +A
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-------VTRF----YMAE 109
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA-------------RVFGGEEI 685
VL + +L IHRD+K NIL+D + ++SDFG + ++ G+
Sbjct: 110 CVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169
Query: 686 ----------------LAITKR----------------VVGTYGYMSPEYALDGVFSTKS 713
L ++ + VGT Y++PE L + +
Sbjct: 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 714 DVFSFGVILLEIITG 728
D +S G I+ E + G
Sbjct: 230 DWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 5e-06
Identities = 39/164 (23%), Positives = 68/164 (41%), Gaps = 25/164 (15%)
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILGI 636
+ N +KL ++LI +++ + L FD LL + + II +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FD-----LLKKEGKLSEAEVKKIIRQL 118
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTARVFGGEEILAITKRVVGT 695
+ LH + IIH D+K N+L D + + D+G ++ G GT
Sbjct: 119 VEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GT 169
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD 739
Y SPE + D ++ GV+ E++TGK + D++
Sbjct: 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 536 LGQGGFGPVYKGKLSNGQEI----AVKRLSTTSGQGIEELKNE--VLLIAKLQHRNLVKL 589
+G+G + V +L + I +K+ + I+ ++ E V A H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-NHPFLVGL 61
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQD 646
C E + EF+ L + + + +++L + RF +I L + +LH+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALN----FLHER 115
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA--ITKRVVGTYGYMSPEYA 704
II+RDLK N+LLD + + +++D+G + E I T GT Y++PE
Sbjct: 116 G---IIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 705 LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSN 742
+ D ++ GV++ E++ G+ I D+ +
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 27/94 (28%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
I + YLH +++RD+K N++LD+ + +I+DFG + + A K GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
Y++PE D + D + GV++ E++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 19/157 (12%)
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
L++++ H +L + G C+ EN+++ EF+ + LD + E + + WK + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--ITVAQQL 126
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNIL-----LDEKMNP--RISDFGTARVFGGEEILAIT 689
A + YL + ++H ++ A NIL L E +P ++SD G L+
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV-----SFTALSRE 178
Query: 690 KRVVGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEI 725
+R V +++PE G ST +D +SFG LLEI
Sbjct: 179 ER-VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 43/238 (18%)
Query: 528 DNFSTSNKLGQGGFGPV-YKGKLSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQH 583
++F + +G+G FG V K G A+K L + + ++ E ++ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
+VK+ ++ LI EF+P + + + L + + +F IA VL +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQF----YIAETVLAI 114
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFG-------------------------TAR 678
+L IHRD+K N+LLD K + ++SDFG T +
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 679 VFGGEEILAITKR--------VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG 728
+ KR VGT Y++PE + ++ D +S GVI+ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-05
Identities = 47/179 (26%), Positives = 73/179 (40%), Gaps = 36/179 (20%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTSGQGIEELKNEVLL----- 577
D+F KLG+G FG VYK L N + +K+ +T G +E NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 578 -IAKLQHRNLVKLLGCCLEEDENMLI---------YEFMPNKSLDY----FIFDESRKQL 623
A + L + +EDE L+ + M +K Y ++ + +
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 624 LDWKKRFDIILGIARGVLY----LHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTA 677
++ II I R +L+ LH I+HRD+K NI+ E +I D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 59/238 (24%), Positives = 97/238 (40%), Gaps = 43/238 (18%)
Query: 528 DNFSTSNKLGQGGFGPV-YKGKLSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQH 583
D+F + +G+G FG V K G A+K L + + ++ E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
+VK+ ++ LI EF+P D + L + +F IA VL +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQF----YIAETVLAI 114
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA----RVFGGEEILAIT---------- 689
+L IHRD+K N+LLD K + ++SDFG + E +T
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 690 ----KR---------------VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG 728
KR VGT Y++PE + ++ D +S GVI+ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 21/158 (13%)
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
++ ++ H+++V L G C+ + EN+++ EF+ LD F+ +S WK F + +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQL 114
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILL-----DEKMNP--RISDFGTARVFGGEEILAIT 689
A + YL +D L +H ++ NILL D + P ++SD G I ++
Sbjct: 115 ASALSYL-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-------ITVLS 164
Query: 690 KR-VVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEI 725
++ V +++PE D S +D +SFG L EI
Sbjct: 165 RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 20/102 (19%)
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG---------TARVFGG------EEIL 686
YLH I+HRDLK N+L+ + +++DFG T ++ G E L
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG 728
K+V GT Y++PE L + D ++ G+IL E + G
Sbjct: 173 --DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 2e-04
Identities = 17/39 (43%), Positives = 24/39 (61%), Gaps = 3/39 (7%)
Query: 802 SNETFVPSPKQPTFSVRRTEIDTDNSSSGIK---SSVNE 837
S T +P PKQP F V R+ +TD+SSS + +VN+
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQ 39
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 39/132 (29%), Positives = 56/132 (42%), Gaps = 32/132 (24%)
Query: 623 LLDW---------KKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNP- 669
LLDW + II + Y H + L ++H DLK NIL+ D ++P
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPV 275
Query: 670 ------------RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFS 717
RI D G +E + T +V T Y SPE L + +D++S
Sbjct: 276 TNRALPPDPCRVRICDLGGC----CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWS 330
Query: 718 FGVILLEIITGK 729
G I+ E+ TGK
Sbjct: 331 MGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 37/199 (18%)
Query: 552 GQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609
G + V+ L + + ++ L+NEV+L +H N++ +I FM
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 610 SLDYFI---FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK 666
S + + F E + L +I+ G RG+ YLHQ+ IHR++KAS+IL
Sbjct: 85 SANSLLKTYFPEGMSEALIG----NILFGALRGLNYLHQNG---YIHRNIKASHIL---- 133
Query: 667 MNPRISDFGTARVFGGEEILAITK-----RVVGTYG--------YMSPEYA---LDGVFS 710
IS G + G + ++ + +VV + ++SPE L G ++
Sbjct: 134 ----ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YN 188
Query: 711 TKSDVFSFGVILLEIITGK 729
KSD++S G+ E+ TG+
Sbjct: 189 VKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 64/257 (24%), Positives = 96/257 (37%), Gaps = 71/257 (27%)
Query: 530 FSTSNKLGQGGFGPV-YKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
F LG G FG V K+ A+K L K +VL ++ H VK
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLR----------KKDVLNRNQVAH---VK 49
Query: 589 LLGCCLEEDEN----MLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILG---IA 637
L E +N L Y F +L YF+ D LL + F +L IA
Sbjct: 50 AERDILAEADNEWVVKLYYSFQDKDNL-YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA 108
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG---------------- 681
L + ++ IHRD+K NIL+D + +++DFG F
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168
Query: 682 -----------------GEEILAITKR------------VVGTYGYMSPEYALDGVFSTK 712
G+ + + +R +VGT Y++PE L ++
Sbjct: 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228
Query: 713 SDVFSFGVILLEIITGK 729
D +S GVIL E++ G+
Sbjct: 229 CDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
Score = 36.5 bits (85), Expect = 0.002
Identities = 8/33 (24%), Positives = 13/33 (39%), Gaps = 1/33 (3%)
Query: 287 CDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKY 319
C C C +N + C+C PG+ +
Sbjct: 5 CASGNPCQNGGTC-VNTVGSYRCSCPPGYTGRN 36
|
Many of these proteins require calcium for their biological function and calcium-binding sites have been found to be located at the N-terminus of particular EGF-like domains; calcium-binding may be crucial for numerous protein-protein interactions. Six conserved core cysteines form three disulfide bridges as in non calcium-binding EGF domains, whose structures are very similar. EGF_CA can be found in tandem repeat arrangements. Length = 38 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 34/135 (25%), Positives = 53/135 (39%), Gaps = 41/135 (30%)
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF-----------GG-- 682
IA + ++ IHRD+K NIL+D + +++DFG F G
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 683 --------EEILAITKR--------------------VVGTYGYMSPEYALDGVFSTKSD 714
EE I + +VGT Y++PE L ++ D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226
Query: 715 VFSFGVILLEIITGK 729
+S GVIL E++ G+
Sbjct: 227 WWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 34/210 (16%)
Query: 496 SEREASISTKGNKEIRKV-DVTFFE--LSTLLAATDNFSTSNKLGQGGFGP---VYKGKL 549
E + + +KE RKV D F + L TL + +G G VY +
Sbjct: 10 READKREKREKDKEDRKVVDEVFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAET 69
Query: 550 SNGQEIAVK--RLSTTSGQGIEEL--------------KNEVLLIAKLQHRNLVKLLGCC 593
+G+ +AVK R ST+ + I + V A+ + RNL +
Sbjct: 70 GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG 129
Query: 594 ------LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+ N+L+ EF+ + L + +L + + ++ ++ R LY
Sbjct: 130 VRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMR-RLY----K 184
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTA 677
++H DL NIL+ + P I D A
Sbjct: 185 EAGLVHGDLSEYNILVHDG-EPYIIDVSQA 213
|
Length = 268 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 633 ILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688
+ +AR +L Y+H + IIHRD+K N+L++ + + DFG A G
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLE 724
+ GT +PE ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|214542 smart00179, EGF_CA, Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
Score = 36.1 bits (84), Expect = 0.002
Identities = 8/30 (26%), Positives = 11/30 (36%), Gaps = 1/30 (3%)
Query: 287 CDYYGHCGPNSNCNLNLTDGFECTCLPGFE 316
C C C +N + C C PG+
Sbjct: 5 CASGNPCQNGGTC-VNTVGSYRCECPPGYT 33
|
Length = 39 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 53/254 (20%), Positives = 93/254 (36%), Gaps = 65/254 (25%)
Query: 530 FSTSNKLGQGGFGPV-YKGKLSNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRN 585
F LG G FG V K+ A+K L + +K E ++A+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYF-----IFDESRKQLLDWKKRFDIILGIARGV 640
+V+L ++D + +++P + IF E + IA
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY-----------IAELT 111
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG------------------- 681
+ ++ IHRD+K NIL+D + +++DFG F
Sbjct: 112 CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 682 --------------GEEILAITKR------------VVGTYGYMSPEYALDGVFSTKSDV 715
G+ + + +R +VGT Y++PE L ++ D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 716 FSFGVILLEIITGK 729
+S GVIL E++ G+
Sbjct: 232 WSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 16/38 (42%), Positives = 26/38 (68%), Gaps = 3/38 (7%)
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
YLH+ IIHRDLK N+L+ + + +++DFG ++V
Sbjct: 119 YLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|238010 cd00053, EGF, Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
Score = 35.5 bits (82), Expect = 0.003
Identities = 8/30 (26%), Positives = 11/30 (36%), Gaps = 1/30 (3%)
Query: 287 CDYYGHCGPNSNCNLNLTDGFECTCLPGFE 316
C C C +N + C C PG+
Sbjct: 2 CAASNPCSNGGTC-VNTPGSYRCVCPPGYT 30
|
Length = 36 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 837 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.56 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.0 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.89 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.86 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.7 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.46 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.43 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.37 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.32 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.22 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.17 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.03 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.98 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.92 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.89 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.89 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.67 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.61 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.61 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.58 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.58 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.54 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.51 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.5 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.5 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.49 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.37 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.08 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.06 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.75 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.71 | |
| PLN02236 | 344 | choline kinase | 96.58 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.39 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.36 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.26 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.91 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.88 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.87 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.56 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.39 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.36 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.36 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.35 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-56 Score=485.64 Aligned_cols=289 Identities=45% Similarity=0.738 Sum_probs=258.4
Q ss_pred cceeecHHHHHHhhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeeccc
Q 003237 514 DVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593 (837)
Q Consensus 514 ~~~~~~~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 593 (837)
....|.+.++..||++|+..+.||+|+||.||+|.+++|..||||++.....+..++|.+|++++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999998765433156799999999999999999999999
Q ss_pred ccCC-ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeec
Q 003237 594 LEED-ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (837)
Q Consensus 594 ~~~~-~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 672 (837)
.+.+ +++||||||++|+|+++|+..... .++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999886554 78999999999999999999999998899999999999999999999999
Q ss_pred ccccceeccCccceeeeccc-cccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 003237 673 DFGTARVFGGEEILAITKRV-VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELW 751 (837)
Q Consensus 673 DFGla~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 751 (837)
|||+|+......... ... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+.........++.|++..+
T Consensus 220 DFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999997654311111 112 89999999999999999999999999999999999999988766555666999999999
Q ss_pred ccCccccccccccc-cccCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 752 SDNKALEIVDSSMA-NSCLA-SEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 752 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
.++.+.+++|+.+. ..+.. +++.++.++|++|++.+|++||+|.||+++|+.+.
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999987 55554 78899999999999999999999999999996543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=394.33 Aligned_cols=253 Identities=33% Similarity=0.495 Sum_probs=207.7
Q ss_pred cCCcccccCCeeEEEEEecCCcEEEEEEecCCCcc--CHHHHHHHHHHHHHhcCCCeeeeecccccCC-ccEEEEEecCC
Q 003237 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ--GIEELKNEVLLIAKLQHRNLVKLLGCCLEED-ENMLIYEFMPN 608 (837)
Q Consensus 532 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~ey~~~ 608 (837)
..+.||+|+||+||+|.++....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..+||||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34679999999999999975555999999754322 2569999999999999999999999999988 78999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-CeeecccccceeccCcccee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~DFGla~~~~~~~~~~ 687 (837)
|+|..+++.. ++..+++..+++++.|||+||.|||++.+ ||||||||+||||+.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999875 45679999999999999999999999874 99999999999999997 99999999998765432 2
Q ss_pred eeccccccCCccCccccc--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYAL--DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~--~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
......||+.|||||++. ..+|+.|+|||||||+||||+||+.||..... ...+..+...+....
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~------- 266 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPP------- 266 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCC-------
Confidence 223378999999999999 56999999999999999999999999974432 122222222222111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+......+..++.+||+.||+.||++.+++.+|+.+
T Consensus 267 --~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 267 --IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred --CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 1111334577888889999999999999999999865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=392.19 Aligned_cols=252 Identities=32% Similarity=0.497 Sum_probs=214.0
Q ss_pred cCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCCh
Q 003237 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 532 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
..+.||+|.||+||.|.++....||+|.++.. ....+.|.+|+++|.+|+|+|||+|+|+|..+...+||||||++|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 35799999999999999988889999999765 34567888999999999999999999999998899999999999999
Q ss_pred hhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeecc
Q 003237 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691 (837)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 691 (837)
.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+...++.+... ..
T Consensus 289 l~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~-~~ 363 (468)
T KOG0197|consen 289 LDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS-EG 363 (468)
T ss_pred HHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec-CC
Confidence 999976 34456889999999999999999999998 99999999999999999999999999996665555443 33
Q ss_pred ccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCH
Q 003237 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLA 770 (837)
Q Consensus 692 ~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 770 (837)
..-+..|.|||.+..+.|+.|||||||||+||||+| |+.|+..... .++.+.++...+-..+.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----------------~ev~~~le~GyRlp~P~ 427 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----------------EEVLELLERGYRLPRPE 427 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----------------HHHHHHHhccCcCCCCC
Confidence 556889999999999999999999999999999999 8888764432 12223333333333445
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 771 SEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 771 ~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
..+..+.+|+..||+.+|++|||.+.+...|+.+.
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 55667889999999999999999999999998653
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=402.52 Aligned_cols=256 Identities=30% Similarity=0.486 Sum_probs=219.2
Q ss_pred CCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
....+.||+|+||+||+|+.. +.+.||||.++..... ..++|++|++++..++|||||+|+|.|.+++..+||
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 344689999999999999753 3567999999876544 788999999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCC-----------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeee
Q 003237 603 YEFMPNKSLDYFIFDESR-----------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 671 (837)
+|||..|+|++||..... ...|+..+.+.||.|||.||+||-++. +|||||..+|+||.++..+||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEe
Confidence 999999999999963211 234888999999999999999999988 999999999999999999999
Q ss_pred cccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHH
Q 003237 672 SDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
+||||++.....++........-+.+|||||.|+.++||.+||||||||+|||+++ |+.|+....+++ +.+.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe~ 717 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIEC 717 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHHH
Confidence 99999999888887766555667889999999999999999999999999999998 888987554422 2233
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..++++.. +++....++..|++.||+.+|++||+++||-..|+..
T Consensus 718 i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 718 IRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 33444433 4555667799999999999999999999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=362.44 Aligned_cols=248 Identities=26% Similarity=0.372 Sum_probs=204.0
Q ss_pred cCCcccccCCeeEEEEEec-CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC-ccEEEEEecCC
Q 003237 532 TSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-ENMLIYEFMPN 608 (837)
Q Consensus 532 ~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~ey~~~ 608 (837)
..+.||+|..|+|||+.++ +++-+|+|.+... .....+++.+|++++.+.+||+||+++|.|.... ...|+||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 4579999999999999887 6788899999544 3455688999999999999999999999999988 49999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
|+|+.++... +.+++...-+|+.+|++||.|||+ .+ ||||||||+|||++..|++||+|||.++.+-+.
T Consensus 163 GSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 163 GSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 9999998654 347888889999999999999996 44 999999999999999999999999999877544
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
......||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..... ..............++ .|.+...
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv~~p------pP~lP~~ 305 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIVDEP------PPRLPEG 305 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHhcCC------CCCCCcc
Confidence 34558999999999999999999999999999999999999999976421 1122222221111111 1122221
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....++..++-.|++.||.+||+++|+++
T Consensus 306 ---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 ---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 24566889999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=363.20 Aligned_cols=200 Identities=31% Similarity=0.538 Sum_probs=180.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
..+|...+.||+|+||+||+|+++ ++.+||||.+.+. .....+.+..|+++|+.++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888899999999999999886 5899999999766 4556677889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC------CCeeecccccc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK------MNPRISDFGTA 677 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~------~~~ki~DFGla 677 (837)
|||++|+|.++|+..+ .++......++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999997654 4889999999999999999999998 9999999999999864 56899999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIF 735 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 735 (837)
+.+..... ....+|++-|||||+++...|+.|+|+||+|+||||+++|+.||+..
T Consensus 163 R~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 163 RFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99875533 34589999999999999999999999999999999999999999743
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=376.89 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=208.1
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
..|...+.||+|+|+.+|+++. ..|+.||+|++.+. .....+.+.+||++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999987 78999999999764 3345677889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
|+|++++|..++. +++.+++.+...++.||+.||.|||+++ |||||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999988885 4567999999999999999999999998 999999999999999999999999999998755
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
... ....|||+.|+|||++....++..+||||+||+||-||.|++||+...- - +....-+..+..
T Consensus 172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------k----ety~~Ik~~~Y~--- 236 (592)
T KOG0575|consen 172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV------K----ETYNKIKLNEYS--- 236 (592)
T ss_pred ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH------H----HHHHHHHhcCcc---
Confidence 433 3348999999999999999999999999999999999999999964211 1 111110111111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+.....+..+++..+++.+|.+|||+++|+.
T Consensus 237 ----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 ----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12223345678888999999999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=360.65 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=200.4
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCcc-------CHHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQ-------GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
+.|.+.+.||+|+||.|-+|.. ++|+.||||++++.... ....+.+|+++|++++|||||++++++..++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 5677889999999999999965 47999999999764211 223457999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC---CCeeeccccc
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK---MNPRISDFGT 676 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~ki~DFGl 676 (837)
|||||||++|+|.+++... +.+....-..++.|++.|+.|||+++ |+||||||+|||+..+ ..+||+|||+
T Consensus 252 YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence 9999999999999998654 34667777789999999999999998 9999999999999755 8899999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCC---CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVF---STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD 753 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 753 (837)
|+..+.. ..++..|||+.|.|||++.++.+ ..|+|+||+||+||-+++|.+||.....+. .+. +....
T Consensus 326 AK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~----eQI~~ 396 (475)
T KOG0615|consen 326 AKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK----EQILK 396 (475)
T ss_pred hhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH----HHHhc
Confidence 9987643 34566899999999999987643 348899999999999999999996433221 111 11111
Q ss_pred CccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 NKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
++... ....-.+-.++..+++-+++..||++|||++|+++
T Consensus 397 G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Ccccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11111 00112233466789999999999999999999974
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=338.21 Aligned_cols=258 Identities=23% Similarity=0.395 Sum_probs=207.2
Q ss_pred CCCcCCcccccCCeeEEEEE-ecCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeec-ccccCCc-cEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLG-CCLEEDE-NMLIY 603 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~-~~~~~~~-~~lV~ 603 (837)
.|.+.++||+|.||+|||+. +.+|..+|.|.++-. +.+..+....|+.+|++|+|||||++++ -+.+..+ ..|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46677899999999999995 568999999998744 4455677889999999999999999999 4555555 78999
Q ss_pred EecCCCChhhHhhh-cCCCCCCChhhHHHHHHHHHHHHHHHHhcCC-CceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 604 EFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYLHQDSR-LRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 604 ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||+..|+|..++.. ...++.++++..++++.|++.||.++|+.-+ ..|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999965 3445678999999999999999999998432 249999999999999999999999999999987
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
..... +...+|||.||+||.+.+.+|+.|+||||+||++|||..-+.||... ++......+ ..++...
T Consensus 180 s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI-~qgd~~~--- 247 (375)
T KOG0591|consen 180 SKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKI-EQGDYPP--- 247 (375)
T ss_pred chhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHH-HcCCCCC---
Confidence 65433 34579999999999999999999999999999999999999999632 333333222 1121111
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
+. ....+..+..++..|+..||+.||+...+++.+..
T Consensus 248 --~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 --LP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --Cc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 13345567788999999999999996555554443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=377.98 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=214.2
Q ss_pred CCcCCcccccCCeeEEEEEecC----CcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 530 FSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
..+.++||.|.||+||+|+++- ...||||.++.. .+....+|..|+.||.+++||||++|.|+.......+||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4456899999999999998862 357999999865 34567789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
||+||+|+.||.... ..+.+.+...++++||.||.||-+.+ +|||||.++|||++.+..+||+||||++.+.++.
T Consensus 711 yMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999997644 34899999999999999999999988 9999999999999999999999999999887654
Q ss_pred ceee-eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 685 ILAI-TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 685 ~~~~-~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.... +....-+..|.|||.+...+|+.++|||||||++||.++ |.+|+-...+ .++...++.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----------------QdVIkaIe~ 849 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----------------QDVIKAIEQ 849 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----------------HHHHHHHHh
Confidence 2222 222344679999999999999999999999999999887 9999854332 222333333
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..+-..+++....|.+++++|||+|-.+||++.|++.+|.+.
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 344445667777899999999999999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=340.00 Aligned_cols=242 Identities=25% Similarity=0.353 Sum_probs=197.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
.++|++.++||+|+||+||.++.+ +++.+|+|.+++.. ....+..++|..+|.+++||.||+++..|++++..+||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357889999999999999999765 58889999997652 33567888999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
+||+.||.|..+|.+.. .+++....-.+..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++..-.
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999996543 4677777778899999999999998 99999999999999999999999999986433
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.. ..+...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||.... ...+........ ..
T Consensus 178 ~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k-~~----- 243 (357)
T KOG0598|consen 178 DG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK-LP----- 243 (357)
T ss_pred CC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc-CC-----
Confidence 22 23455899999999999999999999999999999999999999996422 222222222211 00
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCC
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRP 792 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 792 (837)
. .+.--..+...++...++.+|++|-
T Consensus 244 -~---~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 -L---PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -C---CCccCCHHHHHHHHHHhccCHHHhc
Confidence 0 0111123456777788999999995
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=386.91 Aligned_cols=258 Identities=31% Similarity=0.520 Sum_probs=214.7
Q ss_pred cCCCcCCcccccCCeeEEEEEecC--Cc----EEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN--GQ----EIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~--g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
...+..+.||+|+||.||+|+..+ |. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344567899999999999998753 43 4899999765 4567889999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcC----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 601 LIYEFMPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
|++|||++|+|..||.+.. +...|.....+.++.|||+|+.||++++ +|||||.++|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999997652 2346889999999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
|+.+...++........-+..|||||.+..+.|+.|+|||||||+|||++| |..||....+. ++.. .+...+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---~v~~---~~~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---EVLL---DVLEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---HHHH---HHHhCC-
Confidence 998777776665555566789999999999999999999999999999999 88888643321 1111 122222
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+| ..+......+.+|+..||+.+|++||++..+++.+..+
T Consensus 922 -------RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 922 -------RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred -------cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 11 12333455688999999999999999999999988765
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=350.26 Aligned_cols=264 Identities=27% Similarity=0.446 Sum_probs=221.3
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
....+.++||+|-||+|.++....+..||||+++..... ...+|.+|+++|.+++|||||+|+|+|..++..++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 445567899999999999999988899999999876544 4589999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|..|+...... .+.-...+.|+.|||.||+||.+.+ +|||||.++|||+|.++++||+|||+++-+...++.
T Consensus 618 EnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999754322 2456667789999999999999987 999999999999999999999999999988888887
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT--GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
....+...+..|||||.+..++|+.++|||+||+.+||+++ ...||....+ ++.++.+..++..+....++-
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~~l~--- 767 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQVVLS--- 767 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcceecc---
Confidence 77777888999999999999999999999999999999864 7778865433 334455555555443333221
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+.-....+.++++.||..+-++||+.+++...|...
T Consensus 768 ---~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 ---RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1222344678999999999999999999999988653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=356.48 Aligned_cols=259 Identities=28% Similarity=0.438 Sum_probs=203.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.+.+.+.+.||+|.||+||+|++. ..||||+++... .+..+.|++|+..+++.+|.||+-+.|+|..... .||+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 345566789999999999999985 479999997653 4467899999999999999999999999988777 99999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
+|++.+|+.+||... ..++..+.++||.|||+||.|||.++ |||||||..||+|.+++.+||+||||+..-..-.
T Consensus 468 wCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred hccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 999999999998765 34888999999999999999999998 9999999999999999999999999987543221
Q ss_pred ceeeeccccccCCccCcccccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALD---GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
-.......-|...|||||+++. .+|+..+||||||+|+|||++|..||..... .+++- +...+.. ..|
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqIif----mVGrG~l--~pd 613 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQIIF----MVGRGYL--MPD 613 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hheEE----Eeccccc--Ccc
Confidence 1111122457779999999974 4799999999999999999999999972211 11110 0011100 011
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
... .......++.++...||..+|++||...+|+.+|+.+.
T Consensus 614 ~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 614 LSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred chh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 100 11122345778888999999999999999999887653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=326.51 Aligned_cols=264 Identities=20% Similarity=0.307 Sum_probs=201.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
+.|+...++|+|+||.|||++.+ +|+.||||++.... +.-.+-..+|+++|++++|+|+|.|+.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35667789999999999999887 59999999986542 2234456799999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|++.--|++.-.. ..-++.+...+++.|+++|+.|+|+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9998766555322 223778888899999999999999998 9999999999999999999999999999886321
Q ss_pred ceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH--------HHHHhccCc
Q 003237 685 ILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKY--------AWELWSDNK 755 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~ 755 (837)
. .. ...+.|..|+|||.+.+ ..|...+|||++||++.||++|.+-+....+-+...++.. ...++....
T Consensus 156 d-~Y-TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 D-NY-TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred c-hh-hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 1 11 23677999999999988 6899999999999999999999987755444332222211 112222211
Q ss_pred c-ccccccccc-----cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 756 A-LEIVDSSMA-----NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 756 ~-~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. ..+.-|... +..-+.....+++++..|++.||.+|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 111111111 1111222345789999999999999999999873
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=357.55 Aligned_cols=260 Identities=29% Similarity=0.437 Sum_probs=202.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEe------cCCcEEEEEEecCCCc-cCHHHHHHHHHHHHHh-cCCCeeeeecccccCC-
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED- 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~- 597 (837)
.++|.+.++||+|+||.||+|.. .++..||||++..... ...+.+.+|++++.++ +||||++++++|....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788899999999999999964 2356899999965432 3346788999999999 8999999999887654
Q ss_pred ccEEEEEecCCCChhhHhhhcCC---------------------------------------------------------
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESR--------------------------------------------------------- 620 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~--------------------------------------------------------- 620 (837)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864211
Q ss_pred --CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccccccCCc
Q 003237 621 --KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698 (837)
Q Consensus 621 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y 698 (837)
...+++...+.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134778888999999999999999987 999999999999999999999999999865433222222334567889
Q ss_pred cCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHH
Q 003237 699 MSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCI 777 (837)
Q Consensus 699 ~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 777 (837)
+|||++.+..++.++|||||||++|||++ |+.|+...... ..+. .....+.... . +......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~----~~~~~~~~~~-----~----~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFC----QRLKDGTRMR-----A----PENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHH----HHHhcCCCCC-----C----CCCCCHHHH
Confidence 99999999999999999999999999997 99998643221 1111 1111111111 1 111234578
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 778 QVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 778 ~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+++.+|++.+|++||||.||+++|+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=338.68 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=201.6
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCC--ccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED--ENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~ey 605 (837)
++...+.||+|.||.||++... +|...|||.+........+.+.+|+++|.+++|||||+++|...... .+.+.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4566789999999999999876 48999999987654333677899999999999999999999855544 58899999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC-CCCeeecccccceeccC-c
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVFGG-E 683 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~DFGla~~~~~-~ 683 (837)
+++|+|.+++..... .++.........||++||.|||+++ ||||||||+||||+. ++.+||+|||+++.... .
T Consensus 98 ~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred cCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999976543 4899999999999999999999988 999999999999999 79999999999987664 1
Q ss_pred cceeeeccccccCCccCcccccCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
..........||+.|||||++..+. ...++|||||||++.||+||++|+... .....+...........
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P----- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP----- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC-----
Confidence 1122233478999999999999643 345999999999999999999998643 11112222222222111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
..+........+++..|++.+|++|||++++++..
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 12223344567899999999999999999999754
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=340.04 Aligned_cols=265 Identities=23% Similarity=0.347 Sum_probs=201.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 601 (837)
.+.|+.+++||+|.||.||||+. .+|+.||+|+++... .....-..+||.+|++|+|||||+|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35577778999999999999965 579999999997654 34455667999999999999999999999887 57899
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|+|||++ +|.-++... .-.++..++..++.|++.||+|+|..+ |+|||||.+|||||.+|.+||+|||||+...
T Consensus 196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999988 565555432 234888999999999999999999998 9999999999999999999999999999887
Q ss_pred CccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH-----HHhccCc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAW-----ELWSDNK 755 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~ 755 (837)
.......+. .+-|..|.|||.+.+. .|+.++|+||.||||.||+.|++.+....+-++.+.+-... ..|...+
T Consensus 270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 665554554 4569999999999975 79999999999999999999999886544322222111100 0111011
Q ss_pred cc--ccccc------ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 756 AL--EIVDS------SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 756 ~~--~~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+. ..+.+ .+.+. ........+.++-.+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11 11111 11111 1111234567777888999999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=344.47 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=205.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHH--HHHHHHHHHhc-CCCeeeeecccccCC-ccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEEL--KNEVLLIAKLQ-HRNLVKLLGCCLEED-ENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~--~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~l 601 (837)
.++|.+.++||.|.||.||+|+- ..|..||||++++.-. ..++. .+|++.|++|+ |||||+|..++.+.+ ..++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 46788889999999999999965 4789999999976532 24444 47999999999 999999999999988 8999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|||||+. +|..++.+. ...++...+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+||||||...
T Consensus 88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 9999976 787777655 567999999999999999999999998 9999999999999999999999999999876
Q ss_pred CccceeeeccccccCCccCccccc-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccc-
Q 003237 682 GEEILAITKRVVGTYGYMSPEYAL-DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI- 759 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~- 759 (837)
..... ...+.|..|+|||++. .+-|+.+.|+|++|||++||.+-++-|....+ .+++.+.. +++..+.....
T Consensus 162 SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc-~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 162 SKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKIC-EVLGTPDKDSWP 235 (538)
T ss_pred cCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHH-HHhCCCccccch
Confidence 54322 2367899999999986 56899999999999999999998887754322 22333322 22222111111
Q ss_pred --------c---ccccc----cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 760 --------V---DSSMA----NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 760 --------~---d~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
+ -+... ....+....++++++.+|++.||.+|||++|.+++
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1 11111 11122255678899999999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=312.20 Aligned_cols=281 Identities=24% Similarity=0.368 Sum_probs=214.7
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCcc--CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQ--GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|...++||+|.||.||+|+. .+|+.||||+++..... -.....+|++.|+.++|+||+.|+++|-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3567778999999999999975 47999999999765322 23456789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
||+. +|+..+.+. ...++-.+...++.++++||+|||.+. |+||||||.|+|+++++.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9986 788888654 346888888999999999999999998 9999999999999999999999999999987654
Q ss_pred ceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc------cc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK------AL 757 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~ 757 (837)
..... .+.|..|.|||.+.+. .|+..+|+||.|||+.||+-|.+-+.... +.+++... ...+..+. +.
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s--DidQL~~I-f~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS--DIDQLSKI-FRALGTPTPDQWPEMT 230 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc--hHHHHHHH-HHHcCCCCcccCcccc
Confidence 33222 3678999999999874 69999999999999999999887654322 22333322 22222111 11
Q ss_pred cccc--------cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCcccccc
Q 003237 758 EIVD--------SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVPSPKQPTFSVRRT 820 (837)
Q Consensus 758 ~~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~~~~p~~p~~~~~~~ 820 (837)
.+.| ..............+++++..++..||.+|+|++|++++= -....|.|..|.-.....
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~lp~p~ 300 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSKLPIPS 300 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhhCcCCc
Confidence 1111 1111223344556678999999999999999999998753 234466666665554443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=353.66 Aligned_cols=259 Identities=29% Similarity=0.428 Sum_probs=205.6
Q ss_pred CCCcCCcccccCCeeEEEEEecC--C--cE-EEEEEecC---CCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSN--G--QE-IAVKRLST---TSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~--g--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
+..+.++||+|+||+||+|++.- + .. ||||..+. .......+|.+|+++|++++|||||+++|++......+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34456899999999999998753 2 23 89999874 23556789999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+|||+|+||+|+++|..... .++..+++.++.+.|.||+|||+++ +|||||.++|+|++.+..+||+||||++..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999975433 5899999999999999999999998 999999999999999999999999998764
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
. .+........-+..|+|||.+..+.|+.++|||||||++||+++ |..|+..... ......+...+....
T Consensus 313 ~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------~~v~~kI~~~~~r~~- 383 (474)
T KOG0194|consen 313 S--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------YEVKAKIVKNGYRMP- 383 (474)
T ss_pred c--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH------HHHHHHHHhcCccCC-
Confidence 3 11111112346789999999999999999999999999999999 7888864322 111111112111111
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCC
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVPS 809 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~~~~ 809 (837)
.+......+..++..|++.+|++||+|.+|.+.|+.+.....
T Consensus 384 --------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 384 --------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 122233455677779999999999999999999987644433
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=341.38 Aligned_cols=264 Identities=28% Similarity=0.440 Sum_probs=204.4
Q ss_pred cCCCcCCcccccCCeeEEEEEecC-----------------CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeee
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN-----------------GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKL 589 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l 589 (837)
++|.+.++||+|+||.||++.+++ +..||+|.+.... .....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788999999999999997532 3469999987543 3345678999999999999999999
Q ss_pred ecccccCCccEEEEEecCCCChhhHhhhcC----------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceee
Q 003237 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDES----------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653 (837)
Q Consensus 590 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 653 (837)
++++.+.+..++||||+++|+|.+++.... ....+++...+.++.||++||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1234788899999999999999999987 999
Q ss_pred CCCCCCcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhC--CCC
Q 003237 654 RDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG--KKN 731 (837)
Q Consensus 654 ~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG--~~p 731 (837)
|||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999876544333333345567899999999999999999999999999999874 455
Q ss_pred CCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 732 TRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 732 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
+.... .......+............. ..++.....+.+++.+|++.+|++||||.+|+++|++
T Consensus 242 ~~~~~---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELT---DEQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCC---HHHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 54322 222233232222211111000 0111223457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=389.86 Aligned_cols=261 Identities=27% Similarity=0.473 Sum_probs=215.3
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
..+...+.||+|+||.||+|+. .++..||||++...... ...|++++++++|||||+++++|.++...++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567778999999999999987 47899999998644322 235688999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|.+++.. ++|..+.+++.|||+||+|||+.+..+|+||||||+||+++.++.+++. ||........
T Consensus 766 ~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 99999999842 7899999999999999999997766779999999999999999888875 6655432211
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
....++..|+|||++.+..++.|+|||||||++|||++|+.|++.... ....+..|+............+|+.+..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 123678899999999999999999999999999999999999854322 3345667776666555566667776643
Q ss_pred --ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 767 --SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 767 --~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
....++..++.+++.+|++.+|++||||+||+++|+++..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3455677888999999999999999999999999987533
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=327.50 Aligned_cols=261 Identities=22% Similarity=0.338 Sum_probs=205.8
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+.|++.+.||.|..++||+|.. +.++.||||++.-. .....+.+++|+..|..++||||++++..|..+...++||+|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 5688889999999999999965 56899999999754 334478999999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
|.+|++.+.+...-.. -+++..+..|++++++||.|||+++ .||||||+.||||+.+|.+||+|||.+..+.....
T Consensus 106 Ma~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999765433 3888889999999999999999998 99999999999999999999999998765533221
Q ss_pred e-eee-ccccccCCccCcccccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 686 L-AIT-KRVVGTYGYMSPEYALD--GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 686 ~-~~~-~~~~gt~~y~APE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
. ... ....||+.|||||+++. ..|+.|+||||||+...||.+|..||..... .+.....+. +......-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLq-n~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQ-NDPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhc-CCCCCccc
Confidence 1 111 55789999999999654 3699999999999999999999999975432 111111111 11111111
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+..+........+.+++-.|++.||.+|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11222222233346778899999999999999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=339.10 Aligned_cols=271 Identities=25% Similarity=0.342 Sum_probs=213.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 601 (837)
..+|...+.||+|+|++|++|+.. .++++|||++.+. .+...+.+..|-.+|.+| .||.|++|+..|+++...|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 356888899999999999999654 6899999998654 233456677899999999 79999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|+||+++|+|.++|...+ .++..-....+.+|+.||+|||+.+ ||||||||+|||||+|+++||+|||.|+.+.
T Consensus 152 vLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999997653 4788778889999999999999998 9999999999999999999999999999886
Q ss_pred Cccce---------ee--eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 682 GEEIL---------AI--TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 682 ~~~~~---------~~--~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
..... .. ...++||..|.+||++.....+..+|+|+|||+||+|+.|++||....+ ..+...
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqk---- 298 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQK---- 298 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHH----
Confidence 43222 11 1348899999999999999999999999999999999999999974332 111111
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hc-----cCCCCCCCCCCCcccccc
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LS-----NETFVPSPKQPTFSVRRT 820 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~--L~-----~~~~~~~p~~p~~~~~~~ 820 (837)
+++ ++-.+ ++.....+.+++.+-+..||.+|+|.+|+-+. ++ ++....-|+.-.|.....
T Consensus 299 -----I~~-l~y~f----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p~~~ 365 (604)
T KOG0592|consen 299 -----IQA-LDYEF----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYKPATS 365 (604)
T ss_pred -----HHH-hcccC----CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCCCccc
Confidence 111 11122 22223446677778889999999999998763 23 334445555555544433
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=352.15 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=202.6
Q ss_pred cCCCcCCcccccCCeeEEEEEe------cCCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 599 (837)
++|++.++||+|+||.||+|+. .++..||||+++... ....+.+.+|++++..+ +||||++++++|.+++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688889999999999999963 246689999986442 33456788999999999 899999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCC-----------------------------------------------------------
Q 003237 600 MLIYEFMPNKSLDYFIFDESR----------------------------------------------------------- 620 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~----------------------------------------------------------- 620 (837)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999864221
Q ss_pred -------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 621 -------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 621 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 124788899999999999999999987 9999999999999999999999999998765433222
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......++..|+|||++.+..++.++|||||||++|||++ |..|+...... ...... ...+....
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~----~~~~~~~~-------- 337 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKM----IKEGYRML-------- 337 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHH----HHhCccCC--------
Confidence 2222345678999999999999999999999999999998 88887533211 111111 11111000
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.+.....++.+++.+|++.+|++||+|+||+++|++
T Consensus 338 -~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 -SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 011112357799999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=350.58 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=202.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDE 598 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 598 (837)
.++|++.+.||+|+||.||+++.. ++..||||+++... ....+.+.+|+++++.+ +|+|||+++++|.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 356888999999999999998642 34579999996543 23345688999999999 89999999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcCC----------------------------------------------------------
Q 003237 599 NMLIYEFMPNKSLDYFIFDESR---------------------------------------------------------- 620 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~---------------------------------------------------------- 620 (837)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999854210
Q ss_pred ---------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeecc
Q 003237 621 ---------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691 (837)
Q Consensus 621 ---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 691 (837)
...+++....+++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124778889999999999999999987 99999999999999999999999999986543322222222
Q ss_pred ccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCH
Q 003237 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLA 770 (837)
Q Consensus 692 ~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 770 (837)
..++..|+|||++.+..++.++|||||||++|||++ |+.||....... .... ....+. .... +.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~~~-----~~~~----~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKRGY-----QMSR----PD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHccc-----CccC----CC
Confidence 345678999999999999999999999999999997 999986432211 1111 111110 0000 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 771 SEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 771 ~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.....+.+++.+|++.+|++|||+.+|+++|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1124577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=341.59 Aligned_cols=239 Identities=28% Similarity=0.466 Sum_probs=195.5
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCChh
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 612 (837)
.+-||.|+.|.||+|+++ ++.||||+++... ..+|+-|++|+|+||+.+.|+|.....++||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 468999999999999996 6899999985322 35888999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccc
Q 003237 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV 692 (837)
Q Consensus 613 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 692 (837)
..|... ..+.-.....+..+||.||.|||.+. |||||||.-||||..+-.+||+|||-++..... .....+
T Consensus 201 ~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 201 EVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 999543 34667778899999999999999987 999999999999999999999999999876543 222348
Q ss_pred cccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHH
Q 003237 693 VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASE 772 (837)
Q Consensus 693 ~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 772 (837)
+||..|||||++.+.+.++|+|||||||||||||||..||....... .++.+ ..+...+ ..+...
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwGV--GsNsL~L-------pvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWGV--GSNSLHL-------PVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEec--cCCcccc-------cCcccC
Confidence 99999999999999999999999999999999999999985322110 00000 1111121 123333
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 773 ALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 773 ~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
..-+.-++.+||+..|.+||++.+++..|+=
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 3445677889999999999999999999963
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.14 Aligned_cols=245 Identities=20% Similarity=0.336 Sum_probs=196.7
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEEecCCCccC---HHHHHHHHHHHHHhcCCCeeeeeccccc----CCccEEEEEec
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQG---IEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENMLIYEFM 606 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ey~ 606 (837)
..||+|++|.||+|.+ +|+.||||+++...... .+.+.+|+.+|.+++|||||++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 58999999997653333 4678899999999999999999999876 34578999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
++|+|.+++... ..+++...+.++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999998643 3588999999999999999999985 5 7899999999999999999999999998654322
Q ss_pred eeeeccccccCCccCcccccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALD--GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+... ....+.. ..
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~---i~~~~~~-----~~ 242 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDL---IINKNNS-----LK 242 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHH---HHhcCCC-----CC
Confidence 12467889999999976 6899999999999999999999999964321 111111 1111110 01
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
+ +......+.+++.+||+.||++||||+||++.|+...
T Consensus 243 ~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 L----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred C----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1 1122345778999999999999999999999998653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=339.20 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=206.9
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
..|..-++||+|+.|.||.+.. ..++.||||++........+-+.+|+.+|+..+|+|||++++.+..+++.+.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 3566668999999999999954 578999999997766666677889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|.+.+... .+++.++..|++++++||+|||.++ |+|||||.+||||+.++.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 999999988433 4889999999999999999999998 99999999999999999999999999998776554
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......||+.|||||++....|.+|+||||||++++||+-|.+||-.. +-+...+.+...+ ..++
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE------~PlrAlyLIa~ng-~P~l------- 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE------NPLRALYLIATNG-TPKL------- 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC------ChHHHHHHHhhcC-CCCc-------
Confidence 234589999999999999999999999999999999999999998531 1111111111111 1111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.........+.++..+||+.||++||+++|+++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 122333456778999999999999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.85 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=202.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC----Cc-cCHHHHHHHHHHHHHhc-CCCeeeeecccccCCcc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT----SG-QGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~ 599 (837)
.+.|.+.+.||+|.||+|++|... ++..||||.+.+. .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 467888999999999999999664 6899999977553 12 23556778999999999 99999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC-CCeeecccccce
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTAR 678 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~DFGla~ 678 (837)
++||||+.+|+|.+++... ..+.+.....++.|++.|++|||+.+ |+||||||+|||++.+ +++||+|||++.
T Consensus 96 ~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999763 34677888999999999999999998 9999999999999999 999999999999
Q ss_pred ecc-CccceeeeccccccCCccCcccccCCC-CC-CcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 679 VFG-GEEILAITKRVVGTYGYMSPEYALDGV-FS-TKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 679 ~~~-~~~~~~~~~~~~gt~~y~APE~~~~~~-~s-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
... .+ ...+..+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.. +.......... +
T Consensus 170 ~~~~~~---~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~ki~~-~- 238 (370)
T KOG0583|consen 170 ISPGED---GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYRKIRK-G- 238 (370)
T ss_pred ccCCCC---CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHHHHhc-C-
Confidence 873 22 2344589999999999999987 86 7899999999999999999999741 11111111111 1
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv 798 (837)
++ .+..... ...+..++.+|++.+|.+|+|+.+++
T Consensus 239 --~~---~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 --EF---KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred --Cc---cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 00 0111111 45678999999999999999999998
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=331.23 Aligned_cols=257 Identities=31% Similarity=0.544 Sum_probs=205.6
Q ss_pred cCCCcCCcccccCCeeEEEEEecC------CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|++.+.||+|+||.||+|.... ...||+|.+.... .....++.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778999999999999997643 2579999986443 233567889999999999999999999999888999
Q ss_pred EEEEecCCCChhhHhhhcCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC
Q 003237 601 LIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~ 667 (837)
++|||+++++|.+++..... ...+++...+.++.|+++||.|||+.+ |+|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 145788899999999999999999987 99999999999999999
Q ss_pred CeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHH
Q 003237 668 NPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKY 746 (837)
Q Consensus 668 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 746 (837)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+..... ..+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIE- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH-
Confidence 999999999987654433333334556788999999999999999999999999999998 9999854322 11111
Q ss_pred HHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 747 AWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 747 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
....+... ..+.....++.+++.+|++.+|.+||+++||++.|++
T Consensus 238 ---~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 ---MIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 1122234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=331.50 Aligned_cols=249 Identities=33% Similarity=0.539 Sum_probs=194.3
Q ss_pred CCcccccCCeeEEEEEec-----CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 533 SNKLGQGGFGPVYKGKLS-----NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.+.||.|.||.||+|++. .+..|+||.++... ....+++.+|++.+.+++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999886 35789999996542 334788999999999999999999999999888899999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|.++|... ....+++..+..|+.||++||.|||+.+ |+|+||+++||++++++.+||+|||++.........
T Consensus 84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999765 2345899999999999999999999987 999999999999999999999999999887443333
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
...........|+|||.+....++.++||||||+++|||++ |+.|+... .... ..... .++....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~---~~~~~-~~~~~~~------- 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEE---IIEKL-KQGQRLP------- 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHH---HHHHH-HTTEETT-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc---cccc---ccccc-cccccce-------
Confidence 33444567789999999999999999999999999999999 67886432 1111 11122 2221111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
.+......+..++..||+.+|++||+|.++++.|
T Consensus 226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111234577899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=308.60 Aligned_cols=197 Identities=27% Similarity=0.401 Sum_probs=176.7
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.+..- ...+...+|..+|+.+.||++++|++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46777899999999999999876 588899999976532 23456678999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|.|..+|.... .++.....-+|.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999996543 3788888889999999999999998 999999999999999999999999999987643
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIF 735 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 735 (837)
+-..|||+.|+|||.+..+.|..++|.|+|||++|||+.|..||...
T Consensus 198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 34589999999999999999999999999999999999999999643
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=323.41 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=205.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.++|++.+.||+|+||.||+|...+++.||||.++... ...+++.+|++++.+++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35678889999999999999998888899999986543 34678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986543 345799999999999999999999987 999999999999999999999999999876532211
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
. ......+..|+|||++.+..++.++||||||++++||++ |+.|+.... ...+.... ......
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~----~~~~~~-------- 223 (261)
T cd05068 160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQV----DQGYRM-------- 223 (261)
T ss_pred c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH----HcCCCC--------
Confidence 1 111223457999999999999999999999999999999 888875321 11111111 111000
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
..+......+.+++.+|++.+|++||+|+++++.|+.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111223567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=344.37 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=203.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhc-CCCeeeeecccccCCc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDE 598 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 598 (837)
.++|.+.++||+|+||.||+|+.. .+..||||++..... ...+.+.+|++++.++. ||||++++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888899999999999999753 234799999965432 33467889999999996 9999999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcCC----------------------------------------------------------
Q 003237 599 NMLIYEFMPNKSLDYFIFDESR---------------------------------------------------------- 620 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~---------------------------------------------------------- 620 (837)
.+|||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864210
Q ss_pred -----------------------------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC
Q 003237 621 -----------------------------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE 665 (837)
Q Consensus 621 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~ 665 (837)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124778888999999999999999987 999999999999999
Q ss_pred CCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHH
Q 003237 666 KMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLI 744 (837)
Q Consensus 666 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~ 744 (837)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... ...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHH
Confidence 99999999999987643322222223456778999999999999999999999999999997 888875322111 111
Q ss_pred HHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 745 KYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 745 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
. ....+... ..+......+.+++.+|++.+|++||++.+|+++|+.+
T Consensus 351 ~----~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 N----KIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred H----HHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1 11111000 01112234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=326.86 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=201.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec----CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46778899999999999999763 35689999987643 23345788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999986532 35889999999999999999999987 99999999999999999999999998765432
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
... .......++..|+|||.+.+..++.++|||||||++||+++ |+.|+..... ...... . ..+...
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~---~-~~~~~~---- 227 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKA---V-EDGFRL---- 227 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHH---H-HCCCCC----
Confidence 211 11112345678999999999999999999999999999875 9999853321 111111 1 111100
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. +......+.+++..|++.+|++||+++++.+.|++.
T Consensus 228 -~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -PA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01 112234577899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=323.84 Aligned_cols=254 Identities=29% Similarity=0.454 Sum_probs=205.1
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++.+++|+||+++++.+...+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5678889999999999999998888899999986432 346788999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++.... ...+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999986542 335788899999999999999999987 9999999999999999999999999998765432211
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....++..|+|||++....++.++|||||||++|||++ |+.|+.... ......... ..... + ...
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~----~~~~~----~-~~~ 227 (261)
T cd05072 161 -REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSALQ----RGYRM----P-RME 227 (261)
T ss_pred -cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC---HHHHHHHHH----cCCCC----C-CCC
Confidence 122345678999999998999999999999999999998 999885321 111111111 11000 0 011
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.....+.+++.+|++.+|++||+|++++++|++
T Consensus 228 ----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 ----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=322.43 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=202.1
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|++.+.||+|+||.||+++..++..+|+|.+... ....+++.+|++++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 356778899999999999999988889999988543 3345788999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+|+|.+++.... ..+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999886432 34789999999999999999999987 9999999999999999999999999988654332221
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+.... ........ ..... ...+.
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i---~~~~~---~~~~~--- 224 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMI---SRGFR---LYRPK--- 224 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH---HCCCC---CCCCC---
Confidence 112345568999999998899999999999999999999 888885322 11122211 11111 01111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.....+.+++.+|++.+|++||+|++++++|.
T Consensus 225 ----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 ----LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12245789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=327.23 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=203.1
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 598 (837)
++++|++.+.||+|+||.||+|... .+..||||++.... .....++.+|+.++..++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999999753 35679999986432 2334568899999999999999999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcCC-------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeee
Q 003237 599 NMLIYEFMPNKSLDYFIFDESR-------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 671 (837)
.++||||+++++|.+++..... ...+++..++.++.|+++||.|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 234678889999999999999999987 999999999999999999999
Q ss_pred cccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHH
Q 003237 672 SDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+..... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~---- 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRF---- 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----
Confidence 99999986554333222222345778999999999999999999999999999999 6788753211 111111
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
........ . +......+.+++.+|++.+|++|||+.|++++|+.
T Consensus 234 ~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 1 11123457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=326.57 Aligned_cols=257 Identities=27% Similarity=0.468 Sum_probs=205.3
Q ss_pred cCCCcCCcccccCCeeEEEEEecC------CcEEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|.+.+.||+|+||.||+|+..+ +..||||.++..... ..+.+.+|++++.+++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999997643 478999998765433 4578899999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcC-----------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 601 LIYEFMPNKSLDYFIFDES-----------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
+||||+++++|.+++.... ....+++.....++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986432 2245788899999999999999999987 9999999999999999999
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 748 (837)
||+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |+.|+..... .......
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~- 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECI- 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH-
Confidence 9999999986543332222233456788999999999999999999999999999998 9999753221 1111111
Q ss_pred HHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 749 ELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 749 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
..+.... .+......+.+++..|++.+|++||++.||++.|++
T Consensus 238 ---~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 ---TQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111111 111223457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=330.83 Aligned_cols=246 Identities=23% Similarity=0.388 Sum_probs=204.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+. ..+.++.+.+|++++++++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777789999999999999765 6889999999654 34457788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+.+ +|..+|.+.. .++++....|+.++++||.|||+.. |+|||+||.||||+..+.+|++|||+|+.+....
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 9999996543 4889999999999999999999987 9999999999999999999999999999876532
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
.....+.||+.|||||.+.+.+|+..+|.||+|||+||+++|++||-.. .+...+..+..+ +..
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d--------~v~ 218 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKD--------PVK 218 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcC--------CCC
Confidence 2344589999999999999999999999999999999999999998421 112222222111 111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+......+..+...-++.||..|.|-.+++.
T Consensus 219 ---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 ---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 12234456778888889999999999999875
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=324.83 Aligned_cols=256 Identities=31% Similarity=0.485 Sum_probs=209.4
Q ss_pred hhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+..+|++.++||+|+||.||+|...++..+|+|.+.........++.+|+.++..++|+||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999888999999999776655677899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++.... ...+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999997643 345799999999999999999999987 99999999999999999999999999987643322
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. .....++..|+|||.+.+..++.++||||||+++++|++ |+.|+.... ......... . + .
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~---~-~---------~ 221 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQIT---A-G---------Y 221 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHH---h-C---------C
Confidence 1 112345678999999998999999999999999999998 888885322 111111111 1 0 0
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
....+......+.+++.+|++.+|++|||++++++.|++
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 001112233457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=325.44 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=198.5
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
|...+.||+|+||.||++... +++.||||.+.... ......+.+|++++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 566789999999999999764 78999999986432 22344678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++|+|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999988876432 235789999999999999999999987 99999999999999999999999999987543221
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......... .......... .
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~-~--------- 221 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKED-Q--------- 221 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhcc-c---------
Confidence 12357899999999999999999999999999999999999999743321111 1111111000 0
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~eVv~ 799 (837)
..........+.+++.+|++.+|++||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111122345778999999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=328.79 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=206.8
Q ss_pred CCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
+|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|++++.+++|+||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4677789999999999999742 3456899998765555567889999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcC-------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 603 YEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 99999999999986432 1234889999999999999999999988 9999999999999999999
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 748 (837)
||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .....
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~--- 236 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIE--- 236 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---
Confidence 9999999986654333222333456788999999999999999999999999999999 9998753221 11111
Q ss_pred HHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 749 ELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 749 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
....+..... .......+.+++.+|++.+|++||+|++|+++|+.+
T Consensus 237 -~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 237 -CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred -HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111111 111234578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.47 Aligned_cols=256 Identities=30% Similarity=0.492 Sum_probs=202.5
Q ss_pred CCCcCCcccccCCeeEEEEEe-----cCCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
.|++.++||+|+||.||+|+. ..+..+|+|.+.... ......+.+|++++++++||||+++++++..+...++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 466778999999999999974 246789999986432 33446788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC
Q 003237 603 YEFMPNKSLDYFIFDESR--------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN 668 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 668 (837)
|||+++++|.+++..... ...+++...+.++.|++.||.|||+.+ |+|+||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCc
Confidence 999999999999853221 235788899999999999999999987 999999999999999999
Q ss_pred eeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHH
Q 003237 669 PRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYA 747 (837)
Q Consensus 669 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 747 (837)
+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..|+..... ..+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~-- 237 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE-- 237 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH--
Confidence 99999999987644333222333456778999999998899999999999999999998 8888753211 11111
Q ss_pred HHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 748 WELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 748 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
......... .... ....+.+++.+|++.+|++||++.+|.++|+.
T Consensus 238 --~~~~~~~~~-----~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 --MVRKRQLLP-----CSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcCCcCC-----CCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111 1111 22457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=316.88 Aligned_cols=245 Identities=21% Similarity=0.377 Sum_probs=205.3
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.+|++.+.||+|.||+|-++.. ..|+.||||.+++. +.+.+-.+++|+++|..|+||||+.++.+|...+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3577788999999999999965 68999999999765 4556667889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||..+|.|.+++.+. ..|+..+...+++||..|+.|+|.+. ++|||||.+|||||.++++||+||||+.++..+
T Consensus 133 EYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999654 45899999999999999999999987 999999999999999999999999999887655
Q ss_pred cceeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
... ..+||.+.|.+||++.+.+| .+.+|-||+||+||-|+.|..||+... .-..++++ ..+...
T Consensus 207 kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQI-s~GaYr----- 271 (668)
T KOG0611|consen 207 KFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQI-SRGAYR----- 271 (668)
T ss_pred cHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHh-hccccc-----
Confidence 433 34899999999999999998 578999999999999999999997432 11122211 111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.++......-++.||+..+|++|-|+.+|..
T Consensus 272 ------EP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 272 ------EPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ------CCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 1122234567888999999999999999975
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.55 Aligned_cols=247 Identities=24% Similarity=0.383 Sum_probs=206.1
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.|+..+.||+|.||.||||... .++.||+|.+.-. .....+++++|+.+|.+++|+||.++++.+..+...+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4666789999999999999764 6889999999754 3456788999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
.+|++.+.|.. ...+++....-|+++++.||.|||.+. .+|||||+.|||+.++|.+|++|||.+..+......
T Consensus 94 ~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 94 GGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred cCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999998843 334577777788999999999999998 999999999999999999999999999887665544
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
. ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+..... -++.-++......
T Consensus 168 r--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~PP 229 (467)
T KOG0201|consen 168 R--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAPP 229 (467)
T ss_pred c--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCCC
Confidence 3 558999999999999988999999999999999999999999864332 2222333222222
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.........+.+++..|++.+|++||++.++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 222234445788999999999999999999975
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=335.20 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=208.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.-|.+++.||+|+-|.|-+|++. +|+.+|||++.+.. ......+.+|+.+|+.+.||||++|++++.+..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34677899999999999999875 79999999997652 223456789999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|.|.+++... ..+...+..+++.||+.|+.|+|..+ |+||||||+|+|||.+.++||+|||+|.+-.++
T Consensus 92 Eyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999998654 45888999999999999999999998 999999999999999999999999999875544
Q ss_pred cceeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.. ...-||.++|.|||++++.+| ..++||||.|||||.||+|+.||+ ++....|...+. .+ ..+
T Consensus 166 kl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~----~G-~f~---- 230 (786)
T KOG0588|consen 166 KL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQ----RG-VFE---- 230 (786)
T ss_pred cc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHH----cC-ccc----
Confidence 32 334799999999999999998 568999999999999999999996 222222222211 11 111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCCCCCCC
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETFVPSP 810 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~~~~~p 810 (837)
.+..-..++.+++.+|+..||+.|-|++||.+ .|.+-..++.+
T Consensus 231 -----MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 231 -----MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred -----CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 11122345668888999999999999999997 45554444444
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=297.97 Aligned_cols=264 Identities=24% Similarity=0.292 Sum_probs=212.9
Q ss_pred hhcCCCcCCcccccCCeeEEEEE-ecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc-----c
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE-----N 599 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-----~ 599 (837)
..++|.+.++||+|+|+.||+++ +.++..+|+|++.....++.+..++|++..++++||||+++++++..+.. .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34678899999999999999997 45788999999987777888999999999999999999999999876544 7
Q ss_pred EEEEEecCCCChhhHhhhcCCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 600 MLIYEFMPNKSLDYFIFDESRK-QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
+|+++|...|+|.+.+.....+ ..+++.+.+.|+.+|++||.+||+.. ++++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999765544 47999999999999999999999987 479999999999999999999999999987
Q ss_pred eccCcc-----cee--eeccccccCCccCcccccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 003237 679 VFGGEE-----ILA--ITKRVVGTYGYMSPEYALD---GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 679 ~~~~~~-----~~~--~~~~~~gt~~y~APE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 748 (837)
...-.. ... .......|..|+|||.+.- ..+++++|||||||+||+|+.|..||+.....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---------- 247 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---------- 247 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc----------
Confidence 643211 000 0112356889999998863 45799999999999999999999999743221
Q ss_pred HHhccCc-cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 749 ELWSDNK-ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 749 ~~~~~~~-~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+. ...+....+.-.-.....+.+.+++.+|++.||.+||++.+++..+..+
T Consensus 248 ----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 ----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111 1223333332222223566789999999999999999999999988754
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=336.57 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=202.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccC-C
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE-D 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 597 (837)
.++|.+.++||+|+||.||+|... +++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357888999999999999999642 35789999986543 22345677899999999 799999999988654 4
Q ss_pred ccEEEEEecCCCChhhHhhhcCC---------------------------------------------------------
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESR--------------------------------------------------------- 620 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~--------------------------------------------------------- 620 (837)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998854221
Q ss_pred -CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccccccCCcc
Q 003237 621 -KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699 (837)
Q Consensus 621 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ 699 (837)
...++|..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125789999999999999999999987 9999999999999999999999999998764333222223345677899
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHH
Q 003237 700 SPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQ 778 (837)
Q Consensus 700 APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 778 (837)
|||++.+..++.++|||||||+++||++ |+.|+......+ .+.. ......... .+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~~~~---------~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR----RLKEGTRMR---------APEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH----HHhccCCCC---------CCccCCHHHHH
Confidence 9999999999999999999999999998 999885422111 1111 111111110 11122345789
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 779 VGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 779 l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
++.+|++.+|++||++.||+++|+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.58 Aligned_cols=256 Identities=28% Similarity=0.442 Sum_probs=203.9
Q ss_pred cCCCcCCcccccCCeeEEEEEecC----CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.+.||+|+||.||+|.+.. ...||||.+.... .....++.+|+.++.+++|+||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468888999999999999998742 3579999986543 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999986532 35889999999999999999999987 99999999999999999999999999988753
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
...........++..|+|||.+.+..++.++||||||++++||++ |..|+..... ..+.... .......
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~--- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV----EDGYRLP--- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCCCCC---
Confidence 222222222345678999999999999999999999999999998 9988743221 1111111 1110000
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+......+.+++.+|++.+|++||+|++|+++|+.+
T Consensus 229 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112234578999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.35 Aligned_cols=255 Identities=25% Similarity=0.445 Sum_probs=200.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCc----EEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
.+|+..+.||+|+||.||+|++. ++. .||||.++... ....+++.+|+.++..++||||++++++|... ...+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888899999999999999864 333 38999986543 34456788999999999999999999999764 5789
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|+||+++|+|.+++.... ..+++...+.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999986532 34788999999999999999999987 9999999999999999999999999998765
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
.............+..|+|||++.+..++.++|||||||++|||++ |+.|++.... ..+. .....+... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~--~ 231 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEIS----SILEKGERL--P 231 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHhCCCCC--C
Confidence 4333222222345678999999999999999999999999999998 9999853211 1111 111111100 0
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+......+.+++.+|++.+|.+||++.+|+..|...
T Consensus 232 -------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 232 -------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred -------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111223577899999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.85 Aligned_cols=259 Identities=28% Similarity=0.471 Sum_probs=206.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|.+.+.||+|+||+||++... ++..+|+|.+........+.+.+|++++.+++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46778899999999999999742 345689999876655556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcC----------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeee
Q 003237 602 IYEFMPNKSLDYFIFDES----------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 671 (837)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 2234899999999999999999999987 999999999999999999999
Q ss_pred cccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHH
Q 003237 672 SDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.|+..... ..... ..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~---~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIE---CI 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---HH
Confidence 99999986644332222233445778999999999999999999999999999998 8888753321 11111 11
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
..+.... .... ....+.+++.+|++.+|.+|||+.+|++.|+++.
T Consensus 236 -~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 -TQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred -HcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111111 1111 2235789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=326.89 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=199.7
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
..++|++.++||+|+||.||+++.+ +|..+|+|++++.. ....+.++.|-.+|...++|+||+|+..|++.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999765 68999999998763 3345677889999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||++||++..+|.. ...|+.......+.+++-||.-||+.+ ||||||||+|+|||..|++||+||||+..+.
T Consensus 219 iMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999954 356888888889999999999999998 9999999999999999999999999986432
Q ss_pred Cc----------------------ccee-----------------------eeccccccCCccCcccccCCCCCCcccHH
Q 003237 682 GE----------------------EILA-----------------------ITKRVVGTYGYMSPEYALDGVFSTKSDVF 716 (837)
Q Consensus 682 ~~----------------------~~~~-----------------------~~~~~~gt~~y~APE~~~~~~~s~k~DV~ 716 (837)
.. +... .....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 0000 00135799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCcc-hHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC--
Q 003237 717 SFGVILLEIITGKKNTRIFNDDDSS-NLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPS-- 793 (837)
Q Consensus 717 S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-- 793 (837)
|+|||+||||.|-+||......+.. .++.|-. .+..+ .......+..++|.+|+. ||++|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-~l~fP-------------~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-TLKFP-------------EEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-hccCC-------------CcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 9999999999999999654332221 1122211 11100 011112456678888888 9999975
Q ss_pred -HHHHHH
Q 003237 794 -MSTVVF 799 (837)
Q Consensus 794 -m~eVv~ 799 (837)
++||-+
T Consensus 438 G~~EIK~ 444 (550)
T KOG0605|consen 438 GAEEIKK 444 (550)
T ss_pred cHHHHhc
Confidence 556543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.17 Aligned_cols=198 Identities=26% Similarity=0.397 Sum_probs=173.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++.+++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 57888999999999999999876 68889999986542 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 85 MDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999998643 34788889999999999999999853 39999999999999999999999999987654321
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRI 734 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 734 (837)
.....|+..|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2335689999999999999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=332.46 Aligned_cols=251 Identities=28% Similarity=0.417 Sum_probs=209.1
Q ss_pred CCcCCcccccCCeeEEEEEecC-CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 530 FSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
..+.++||.|.||.||.|.++. .-.||||.++.+ ....++|..|..+|+.++|||+|+|+|+|..+...|||+|||..
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 4456899999999999998864 668999999654 45688999999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|.++|.+-.+ ..++-...+.++.||+.||.||..++ +|||||.++|+|+.++..+||+||||++++..+.+...
T Consensus 348 GNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 348 GNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred ccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 999999976543 44666777889999999999999988 99999999999999999999999999999887654432
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
. ...-+..|.|||-+....|+.|+|||+|||+||||.| |..||.... + ..+ .++++...+-+
T Consensus 424 A-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------l-SqV---------Y~LLEkgyRM~ 486 (1157)
T KOG4278|consen 424 A-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------L-SQV---------YGLLEKGYRMD 486 (1157)
T ss_pred c-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------H-HHH---------HHHHhcccccc
Confidence 2 2445779999999999999999999999999999998 777874321 1 112 23333333333
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.+......+.++++.||+.+|.+||++.|+-+.++
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 44455567899999999999999999999988775
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.31 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=202.9
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
+|++.++||+|+||.||+|... .++.||+|.+... ....+++.+|++++.+++|+||+++++++......++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4667789999999999999765 5889999998643 3446788999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++.... ...+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||++..........
T Consensus 86 ~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 86 YGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999986533 345799999999999999999999987 9999999999999999999999999998765432211
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......+..|+|||.+.+..++.++|||||||++|||++ |..|+.... ...+.. .. ... ...
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---~~~~~~---~~-~~~-----~~~---- 224 (263)
T cd05052 162 -HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYE---LL-EKG-----YRM---- 224 (263)
T ss_pred -cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH---HH-HCC-----CCC----
Confidence 112234568999999999999999999999999999998 888875321 111111 11 111 001
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..+......+.+++.+|++.+|++||+|.+++++|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112234577899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=335.61 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=201.0
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++..++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5788899999999999999876 58899999986542 2345678889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++++|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 82 YVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 99999999998543 35788889999999999999999988 99999999999999999999999999986543
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... .+....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~---~~~~---~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENLK---YWKE---TLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHHH---hccc---cccCCC
Confidence 22346789999999999999999999999999999999999999864321 11111111 0000 000000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
...........+.+++.+|++.+|++||+++++++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000001223457788899999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.26 Aligned_cols=251 Identities=25% Similarity=0.438 Sum_probs=201.6
Q ss_pred CCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+|.+.+.||+|+||.||+|+..++..+|||.+... ....+++.+|+.++.+++||||+++++++.+....++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46677899999999999998877778999998643 33457789999999999999999999999988889999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
++|.+++.... ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~- 157 (256)
T cd05113 84 GCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS- 157 (256)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee-
Confidence 99999986532 25899999999999999999999987 9999999999999999999999999998764432211
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
.....++..|+|||++.+..++.++|||||||++|||++ |+.|+..... ...... ... +... .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~---~~~-~~~~---------~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEK---VSQ-GLRL---------Y 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHH---Hhc-CCCC---------C
Confidence 112335678999999998899999999999999999998 9988853321 111111 111 1100 0
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
........+.+++.+|++.+|++||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112356789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.40 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=201.6
Q ss_pred CCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
.|.+.++||+|+||.||+|+.. .+..||||+++..... ..+.+.+|+.++..++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556689999999999999763 2578999999754322 24568899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcC-------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC
Q 003237 602 IYEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN 668 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 668 (837)
++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1234788889999999999999999987 999999999999999999
Q ss_pred eeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHH
Q 003237 669 PRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYA 747 (837)
Q Consensus 669 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 747 (837)
+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..|+..... ..+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~-- 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIE-- 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH--
Confidence 99999999887654433333334456789999999998999999999999999999998 7777753211 11111
Q ss_pred HHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 748 WELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 748 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.. ...... ..+.+....+..++..|++.+|++||+|++|++.|+.
T Consensus 238 -~i-~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 -MI-RNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HH-HcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 111111 1112233457799999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=298.10 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=204.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|.||.||.|+.+ ++-.||+|++.+. ..+...++.+|+++-..|+||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 57889999999999999999765 6778999998654 2334578899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||.++|+|...|.+... ..++......++.|+|.||.|+|..+ +|||||||+|+|++.++..||+|||-+.....
T Consensus 102 Eya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~- 176 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 176 (281)
T ss_pred EecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence 99999999999975433 34677777889999999999999988 99999999999999999999999999876432
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
...+..+||..|.+||...+..++.++|+|++|++.||++.|.+||+.... ......+. ..++.+|
T Consensus 177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~etYkrI~-------k~~~~~p- 242 (281)
T KOG0580|consen 177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---SETYKRIR-------KVDLKFP- 242 (281)
T ss_pred ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---HHHHHHHH-------HccccCC-
Confidence 223458999999999999999999999999999999999999999974432 11221111 1122222
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..-...+.+++..|+..+|.+|.+..||+.
T Consensus 243 ------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 243 ------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 222345678999999999999999999975
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.49 Aligned_cols=248 Identities=27% Similarity=0.388 Sum_probs=195.5
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCCh
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 68899999876442 33456789999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeecc
Q 003237 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691 (837)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 691 (837)
.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998543 235789999999999999999999987 99999999999999999999999999876543211111111
Q ss_pred ccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCH
Q 003237 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLA 770 (837)
Q Consensus 692 ~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 770 (837)
...+..|+|||.+.++.++.++||||||+++|||++ |..|+..... .... ...... .....+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~~----~~~~~~---------~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQTR----EAIEQG---------VRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHHH----HHHHcC---------CCCCCcc
Confidence 223457999999999999999999999999999998 8888753221 1111 111110 0011111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 771 SEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 771 ~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.....+.+++.+|++.+|++|||+.+|.++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=315.61 Aligned_cols=264 Identities=24% Similarity=0.325 Sum_probs=200.7
Q ss_pred CCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHh--cCCCeeeeecccccCC----ccEEEE
Q 003237 530 FSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL--QHRNLVKLLGCCLEED----ENMLIY 603 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~~----~~~lV~ 603 (837)
.+..++||+|+||.||||.+. ++.||||++.. +..+.|++|-++.... +|+||++++++-.... +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 344579999999999999996 59999999964 4456788888887764 7999999999877665 789999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc------CCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD------SRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
||.++|+|.++|.. ..++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||||
T Consensus 288 ~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999999954 4689999999999999999999975 3567999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCC-CCC-----CcccHHHHHHHHHHHHhCCCCCCCCCCCCc-----------
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDG-VFS-----TKSDVFSFGVILLEIITGKKNTRIFNDDDS----------- 740 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s-----~k~DV~S~Gvvl~elltG~~p~~~~~~~~~----------- 740 (837)
..+........+...+||.+|||||++.+. .+. .+.||||+|.|||||++.-.-.......+.
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 998876655556668999999999998764 233 368999999999999996544321100000
Q ss_pred chHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 741 SNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 741 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
..+-..-..++++.....+.+. .....-+..+++.+-.||+.||+-|-|+.=|.+.+.++.
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~----W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDA----WRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhh----hhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 0011111111111111111111 111234566788999999999999999999998887653
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=319.22 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=200.4
Q ss_pred CCcCCcccccCCeeEEEEEecC----CcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc-----
Q 003237 530 FSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE----- 598 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 598 (837)
|.+.+.||+|+||.||+|++.. +..||||+++... ....+++.+|++.+..++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998742 3679999986532 2345678999999999999999999998876554
Q ss_pred -cEEEEEecCCCChhhHhhhcC---CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccc
Q 003237 599 -NMLIYEFMPNKSLDYFIFDES---RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (837)
Q Consensus 599 -~~lV~ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DF 674 (837)
.++|+||+++++|..++.... ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999986532 2346889999999999999999999987 999999999999999999999999
Q ss_pred ccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhcc
Q 003237 675 GTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSD 753 (837)
Q Consensus 675 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 753 (837)
|+++................+..|+|||.+.+..++.++||||||+++|||++ |..|+.... ...+.... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~----~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYL----RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----Hc
Confidence 99987654433222222345678999999988899999999999999999999 888875322 11121111 11
Q ss_pred CccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 754 NKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 754 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+.... .+......+.+++.+|++.+|++||++.||++.|+++
T Consensus 231 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 1112334678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=321.99 Aligned_cols=264 Identities=27% Similarity=0.418 Sum_probs=207.0
Q ss_pred cCCCcCCcccccCCeeEEEEEecC-----------------CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeee
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN-----------------GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKL 589 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l 589 (837)
.+|++.++||+|+||.||+++... +..||+|++.... ....+++.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 568889999999999999997642 2458999987543 3345678899999999999999999
Q ss_pred ecccccCCccEEEEEecCCCChhhHhhhcC--------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcE
Q 003237 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDES--------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNI 661 (837)
Q Consensus 590 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 661 (837)
++++..+...++|+||+++++|..++.... ....+++..++.++.|++.||.|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 999999999999999999999999986543 1235889999999999999999999987 99999999999
Q ss_pred EEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCCCC
Q 003237 662 LLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT--GKKNTRIFNDDD 739 (837)
Q Consensus 662 ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt--G~~p~~~~~~~~ 739 (837)
+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--- 238 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--- 238 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC---
Confidence 999999999999999987654433333334556789999999998899999999999999999998 566664322
Q ss_pred cchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 740 SSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 740 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.......+...+.......... .+.....++.+++.+|++.+|++||||.||++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1222232322222211111111 111223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=347.50 Aligned_cols=252 Identities=18% Similarity=0.219 Sum_probs=201.8
Q ss_pred CCCcCCcccccCCeeEEEEEec-C-CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-N-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|++++..++|||||++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3777889999999999999654 3 6788999875555455567788999999999999999999999999999999999
Q ss_pred CCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 607 PNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 607 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
++|+|.+++.+. .....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988653 23345788899999999999999999987 99999999999999999999999999987654333
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.|+..... . ........ +... +
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~---~~~~~~~~-~~~~----~--- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---R---EIMQQVLY-GKYD----P--- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHh-CCCC----C---
Confidence 2233446799999999999999999999999999999999999999853211 1 11111111 1100 0
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+......+.+++..|++.+|++||++.+++.
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11112245778999999999999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.94 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=201.5
Q ss_pred CCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
+|++.+.||+|+||.||+|+.. ....+|+|.+.... ....+.+.+|+.++..++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667889999999999999753 23578888886543 2345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcC---------------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 003237 602 IYEFMPNKSLDYFIFDES---------------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 660 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 660 (837)
|+||+++++|.+++.... ....+++...+.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985421 1134788999999999999999999987 9999999999
Q ss_pred EEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 003237 661 ILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDD 739 (837)
Q Consensus 661 Ill~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 739 (837)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 9999999999999999986543322222223456778999999998899999999999999999998 988875322
Q ss_pred cchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 740 SSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 740 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
...+.... .... ....+......+.+++.+|++.+|++||++++|++.|++.
T Consensus 235 ~~~~~~~~----~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 235 PERLFNLL----KTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred HHHHHHHH----hCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11111111 1110 0011111234577999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.64 Aligned_cols=262 Identities=20% Similarity=0.280 Sum_probs=199.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|++.+.||+|+||.||+++.. +++.+|||++.... ....+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999886 57899999986542 2345677899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|++++.+..+... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9999877655422 235788899999999999999999987 9999999999999999999999999998764322
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH------------hc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL------------WS 752 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------------~~ 752 (837)
.. ......++..|+|||++.+..++.++|||||||++|||++|+.||......+ .+.. .... ..
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID--QLFT-IQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHhhCCCCHHHHHhhhc
Confidence 11 1223568999999999999999999999999999999999999986432211 1111 1110 00
Q ss_pred cCcccccccccccc------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 753 DNKALEIVDSSMAN------SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 753 ~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.........+.... .........+.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000010000 001112345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=343.58 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=215.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCC-cEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecc-cccC------C
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNG-QEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGC-CLEE------D 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~-~~~~------~ 597 (837)
..++++.+.|.+|||+.||.+....+ ..+|+|++-..++..++.+++|+++|++|+ |+|||.+++. .... -
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34567788999999999999988765 999999998778888999999999999997 9999999993 2221 2
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
+.+|.||||.+|.|-+++....... |++.++++|+.++++|+.+||... +||||||||-+||||+.++..||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 5689999999999999997655444 999999999999999999999975 78999999999999999999999999998
Q ss_pred eeccCccce-----eeec--cccccCCccCcccc---cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 003237 678 RVFGGEEIL-----AITK--RVVGTYGYMSPEYA---LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYA 747 (837)
Q Consensus 678 ~~~~~~~~~-----~~~~--~~~gt~~y~APE~~---~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 747 (837)
...-..... .... ...-|+.|+|||++ .+.++++|+|||+|||+||-|+....||+..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s------------ 261 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES------------ 261 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC------------
Confidence 753222110 0001 12458899999987 5778999999999999999999999999632
Q ss_pred HHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC--CCCCCCCCC
Q 003237 748 WELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE--TFVPSPKQP 813 (837)
Q Consensus 748 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~--~~~~~p~~p 813 (837)
....+++....-...+....++..||..||+.+|.+||++.||+..+..+ +++|.+..+
T Consensus 262 -------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 262 -------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred -------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 12344444433333456778899999999999999999999999988776 445555544
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=321.06 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=201.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEecC------CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
+++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.++.+++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678888999999999999998753 5678999886443 33345788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC---Ceeec
Q 003237 600 MLIYEFMPNKSLDYFIFDESR----KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM---NPRIS 672 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ki~ 672 (837)
++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ ++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865432 235889999999999999999999987 99999999999998654 59999
Q ss_pred ccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHh
Q 003237 673 DFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELW 751 (837)
Q Consensus 673 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 751 (837)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~~---~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFV---T 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---H
Confidence 9999987643332222222334568999999999999999999999999999997 8888853221 1111111 1
Q ss_pred ccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 752 SDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 752 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.... ...+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 236 ~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 0111122346778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.23 Aligned_cols=263 Identities=26% Similarity=0.424 Sum_probs=201.6
Q ss_pred cCCCcCCcccccCCeeEEEEEecC---------------CcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN---------------GQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLG 591 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~---------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~ 591 (837)
++|++.++||+|+||.||++.... ...||+|.++.. .......+.+|++++.+++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987542 234899998654 2334567889999999999999999999
Q ss_pred ccccCCccEEEEEecCCCChhhHhhhcCC---------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEE
Q 003237 592 CCLEEDENMLIYEFMPNKSLDYFIFDESR---------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 662 (837)
Q Consensus 592 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIl 662 (837)
++......++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854321 124688899999999999999999987 999999999999
Q ss_pred EcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCCCCc
Q 003237 663 LDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT--GKKNTRIFNDDDS 740 (837)
Q Consensus 663 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt--G~~p~~~~~~~~~ 740 (837)
++.++.+||+|||++................++..|+|||++.++.++.++|||||||+++||++ |..|+.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 99999999999999986543332222233445778999999999999999999999999999998 4556543221
Q ss_pred chHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 741 SNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 741 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.................... ..+......+.+++.+|++.+|++||+|++|+++|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 12222222222111110000 011112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=330.94 Aligned_cols=244 Identities=23% Similarity=0.286 Sum_probs=197.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46778899999999999999876 58899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999998653 34678888889999999999999988 999999999999999999999999999876432
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
. ....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..... ... ..+.. .
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~---~~i-~~~~~------~ 233 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIY---EKI-LAGRL------K 233 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHH---HHH-hcCCc------C
Confidence 2 23578999999999999999999999999999999999999985321 11111 111 11110 0
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~eVv~ 799 (837)
+... ....+.+++..|++.||.+||+ +++++.
T Consensus 234 ~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 FPNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 1234678999999999999997 677763
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.89 Aligned_cols=263 Identities=24% Similarity=0.412 Sum_probs=200.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-----CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-----NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 600 (837)
++|.+.+.||+|+||.||++..+ ++..||+|++........+.+.+|++++.+++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46777899999999999999742 5789999999766656667899999999999999999999987543 4578
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+|+||+++++|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998643 234899999999999999999999987 999999999999999999999999999876
Q ss_pred cCcccee-eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCC--------c-chHHHHHHHH
Q 003237 681 GGEEILA-ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD--------S-SNLIKYAWEL 750 (837)
Q Consensus 681 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~--------~-~~l~~~~~~~ 750 (837)
....... ......++..|+|||++.+..++.++|||||||+++||++|..+.......- . ..+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE- 237 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH-
Confidence 4332211 1111233456999999999899999999999999999999877643211100 0 000000001
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+...............+.+++.+|++.+|++||||.||++.|+.+
T Consensus 238 --------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 --------LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred --------HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111000011112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=320.90 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=199.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCc----EEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|.+.+.||+|+||+||+|... +++ .+++|.+..... ....++..|+.++.+++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35677899999999999999864 344 477887754322 33467788898999999999999999875 455789
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
++||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999986532 35899999999999999999999987 9999999999999999999999999998765
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
............++..|+|||++.++.++.++||||||+++|||++ |+.|+..... ..+. .....+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVP----DLLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHCCCcCC--
Confidence 4332222333567789999999999999999999999999999998 9988853221 1111 1111111111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
.+. .+ ...+.+++.+|++.+|++|||+.|+++.|.....
T Consensus 232 ~~~---~~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQ---IC----TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCC---CC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111 11 2346778899999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.70 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=205.3
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCC-CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCC
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 597 (837)
..++|++.+.||+|+||.||++... ....+|+|.+... ......++.+|++++.++ +|+||+++++++..+.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456888899999999999999764 2367999998654 233446688999999999 7999999999999999
Q ss_pred ccEEEEEecCCCChhhHhhhc-------------CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDE-------------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 664 (837)
..+++|||+++|+|..++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 12345889999999999999999999987 99999999999999
Q ss_pred CCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchH
Q 003237 665 EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNL 743 (837)
Q Consensus 665 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 743 (837)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ..+
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~ 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EEL 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---HHH
Confidence 999999999999987654433222333345678999999999999999999999999999998 8888753211 111
Q ss_pred HHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 744 IKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 744 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
. .....+... ..+......+.+++.+|++.+|++||||.||++.|+++
T Consensus 244 ~----~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 F----KLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred H----HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1 111111110 11122234678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=316.17 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=200.2
Q ss_pred CCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+|++.+.||+|+||.||++..+++..+|+|.+.... ...+.+.+|++++.+++|+||+++++++......++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 466788999999999999988877889999986432 3446788999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 99999986432 25889999999999999999999988 9999999999999999999999999998654322111
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ...... . ... ... .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~---~-~~~-----~~~----~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVES---V-SAG-----YRL----Y 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHH---H-HcC-----CcC----C
Confidence 111223457999999999999999999999999999999 7888853321 111111 1 111 000 1
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.+......+.+++.+|++.+|++||||.||+++|.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 11112346789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=323.24 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=197.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|++.++||+|+||.||+|... +++.||+|.++... ......+.+|++++.+++||||+++++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999875 68899999986442 23345678999999999999999999999998899999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++ +|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 888887543 234788889999999999999999987 99999999999999999999999999986543221
Q ss_pred eeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc-----------
Q 003237 686 LAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD----------- 753 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------- 753 (837)
......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ............
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK---EELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHHhhcccc
Confidence 1123467899999998875 56899999999999999999999998543211 111111111110
Q ss_pred -Ccccccccccccccc----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 -NKALEIVDSSMANSC----LASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 -~~~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
........+...... .......+.+++.+|++.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000111111110000 0011235678999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.40 Aligned_cols=241 Identities=23% Similarity=0.362 Sum_probs=200.2
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 600 (837)
.-++|...++||+|.||+|+++.++ +++.+|||.+++. .....+..+.|.+++.... ||.|+.|+.+|++.++.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3467889999999999999999886 5788999999876 3456778889999998885 999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||+.||++..+. ....++.....-++..|+.||.|||+++ ||+||||.+|||||.+|++||+||||++..
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999954443 2245788888889999999999999998 999999999999999999999999999864
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
-.. ...++.++||+.|||||++.+..|+.++|.|||||+|||||.|..||....+++ ++
T Consensus 519 m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------------------~F 577 (694)
T KOG0694|consen 519 MGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------------------VF 577 (694)
T ss_pred CCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------HH
Confidence 322 235677999999999999999999999999999999999999999996432211 11
Q ss_pred cccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003237 761 DSSMAN--SCLASEALRCIQVGLLCVQDRTTDRPSM 794 (837)
Q Consensus 761 d~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 794 (837)
|..+.. .++.-...+.+.++.+.+..+|++|.-+
T Consensus 578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111111 1333344567788889999999999877
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=323.11 Aligned_cols=245 Identities=20% Similarity=0.266 Sum_probs=198.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999876 68899999986432 233456889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999998643 34788889999999999999999988 999999999999999999999999999865432
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+..... ..+.. .... +.. .
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~---~i~~-~~~------~ 216 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGIYE---KILA-GKL------E 216 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHh-CCc------C
Confidence 1235689999999999999999999999999999999999999864221 11111 1111 100 0
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPS-----MSTVVFM 800 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~eVv~~ 800 (837)
+ +......+.+++.+|++.||.+||+ ++++++.
T Consensus 217 ~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 F----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred C----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1 1111335678999999999999995 8887753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=318.07 Aligned_cols=255 Identities=28% Similarity=0.450 Sum_probs=197.0
Q ss_pred CcCCcccccCCeeEEEEEecCC-c--EEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccC------Ccc
Q 003237 531 STSNKLGQGGFGPVYKGKLSNG-Q--EIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------DEN 599 (837)
Q Consensus 531 ~~~~~LG~G~fG~Vy~~~~~~g-~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~ 599 (837)
.+.++||+|+||.||+|+.... . .+|+|.++.. .....+.+.+|++++..++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568999999999999987643 2 5899988643 234456788999999999999999999987542 246
Q ss_pred EEEEEecCCCChhhHhhhc---CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 600 MLIYEFMPNKSLDYFIFDE---SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
++++||+++|+|..++... .....+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999987432 12345889999999999999999999987 99999999999999999999999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ...+... ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~----~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYDY----LRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH----HHcCC
Confidence 987654332222222345678999999999999999999999999999999 788875321 1111111 11111
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
... ........+.+++.+|++.+|++||||.+|++.|+.+
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 0111233577999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=325.63 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=206.6
Q ss_pred hcCCCcCCcccccCCeeEEEEEec--------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccC
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE 596 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 596 (837)
.++|.+.+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356778899999999999999641 24579999986432 34457789999999999 799999999999999
Q ss_pred CccEEEEEecCCCChhhHhhhcCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 663 (837)
...++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999975321 235788899999999999999999987 9999999999999
Q ss_pred cCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003237 664 DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSN 742 (837)
Q Consensus 664 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 742 (837)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 9999999999999987754433323333456678999999999999999999999999999998 777764321
Q ss_pred HHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 003237 743 LIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVP 808 (837)
Q Consensus 743 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~~~ 808 (837)
........ ....... .+......+.+++.+|++.+|++||+|.||++.|+++..+.
T Consensus 245 ~~~~~~~~-~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 245 VEELFKLL-KEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHHHH-HcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11111111 1111110 11122345778999999999999999999999998765543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.43 Aligned_cols=253 Identities=28% Similarity=0.479 Sum_probs=201.8
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|++.++||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++.+++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4678889999999999999998888899999986543 34567899999999999999999999875 456899999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999986532 234789999999999999999999987 9999999999999999999999999998764432211
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....++..|+|||.+.+..++.++||||||++++||++ |+.|+.... ...... .... .. ..
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~---~~~~-~~---------~~ 222 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLE---QVER-GY---------RM 222 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHH---HHHc-CC---------CC
Confidence 112335668999999988899999999999999999999 888885321 111111 1111 10 00
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
..+......+.+++.+|++.+|++||||.+++++|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=321.57 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=192.5
Q ss_pred CCCcCCcccccCCeeEEEEEec--CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHh---cCCCeeeeeccccc-----C
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS--NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKL---QHRNLVKLLGCCLE-----E 596 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~ 596 (837)
+|++.+.||+|+||.||+|+.. ++..||||+++... ......+.+|+.++..+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888899999999999999763 46889999986432 22234566787777766 69999999998852 3
Q ss_pred CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
...++||||++ ++|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 45789999997 58888885432 234789999999999999999999988 99999999999999999999999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC--
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN-- 754 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 754 (837)
++..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .............
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~~~~~ 230 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGE 230 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCCh
Confidence 9875433 1223456899999999999999999999999999999999999998643221 1111111111000
Q ss_pred -ccc-------cccccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 755 -KAL-------EIVDSSMA---NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 755 -~~~-------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... ..+.+... .....+....+.+++.+|++.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000 0001112245678999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.35 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=203.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec--------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 597 (837)
.+|.+.+.||+|+||.||++... .+..||+|.+.... ....+++.+|++++.++ +|+||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35788899999999999999642 12368999886432 33457889999999999 7999999999999999
Q ss_pred ccEEEEEecCCCChhhHhhhcC-------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 664 (837)
..++++||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1234788999999999999999999987 99999999999999
Q ss_pred CCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchH
Q 003237 665 EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNL 743 (837)
Q Consensus 665 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 743 (837)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------V 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------H
Confidence 999999999999987654322222222344567999999999999999999999999999998 788874321 1
Q ss_pred HHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 003237 744 IKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFV 807 (837)
Q Consensus 744 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~~ 807 (837)
....... ....... .+......+.+++.+|++.+|++||+|.|+++.|+.+...
T Consensus 243 ~~~~~~~-~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 243 EELFKLL-KEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHHHHH-HcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 1111111 1111111 1112234577999999999999999999999999877533
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=335.61 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=201.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhc-CCCeeeeecccccCCc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDE 598 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 598 (837)
.++|.+.++||+|+||.||+|++. .+..||||+++.... ...+.+.+|++++.++. |||||+++++|.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345777899999999999999863 346899999975432 23457889999999997 9999999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcC-----------------------------------------------------------
Q 003237 599 NMLIYEFMPNKSLDYFIFDES----------------------------------------------------------- 619 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~----------------------------------------------------------- 619 (837)
.++|+||+++|+|.++++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999996432
Q ss_pred ------------------------------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE
Q 003237 620 ------------------------------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (837)
Q Consensus 620 ------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 663 (837)
....+++...+.++.||++||.|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1124677888899999999999999887 9999999999999
Q ss_pred cCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003237 664 DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSN 742 (837)
Q Consensus 664 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 742 (837)
++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.|+......+ .
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--~ 350 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--Q 350 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--H
Confidence 9999999999999986543221111122356788999999999999999999999999999998 888875322110 1
Q ss_pred HHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 743 LIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 743 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+ ......+... ..+......+.+++..|++.+|++||+|++|++.|++.
T Consensus 351 ~----~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 F----YNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred H----HHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 1111111100 01111234577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=319.92 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=202.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|...++||+|+||.||++... ++..+|+|.+........+.+.+|++++..++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35667789999999999999642 356789999876666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCC------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 602 IYEFMPNKSLDYFIFDESR------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
|+||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 134789999999999999999999987 9999999999999999999
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 748 (837)
||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+..... .....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~--- 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIE--- 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHH---
Confidence 9999999986543332222223345678999999999999999999999999999998 8888743221 11111
Q ss_pred HHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 749 ELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 749 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.. ..+.... .+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 236 ~~-~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CI-TQGRELE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HH-HcCccCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11 1111000 01112234679999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=320.67 Aligned_cols=261 Identities=25% Similarity=0.412 Sum_probs=203.1
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 598 (837)
..++|++.++||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567889999999999999999653 24579999886443 2234467889999999999999999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcCC-------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeee
Q 003237 599 NMLIYEFMPNKSLDYFIFDESR-------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 671 (837)
.++||||+++|+|.+++..... ...+.+.....++.||+.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 234567788899999999999999987 999999999999999999999
Q ss_pred cccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHH
Q 003237 672 SDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.|+..... ..... ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~---~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLK---FV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---HH
Confidence 99999986543332222222345678999999999999999999999999999998 7778753211 11111 11
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
.. +.... .+......+.+++.+|++.+|++||||.++++.|+...
T Consensus 235 ~~-~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MD-GGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred Hc-CCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11 11111 11112346889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.00 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=208.2
Q ss_pred CCcccccCCeeEEEEEe-cCC----cEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 533 SNKLGQGGFGPVYKGKL-SNG----QEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~-~~g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.++||+|+||+||||.+ +.| -+||||++... ..+...++.+|+-+|.+++||||+||+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 57999999999999965 344 46899988665 4456789999999999999999999999998765 88999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
+.|+|.+++... +..+--+..+.+..|||+||.|||.+. +|||||.++||||.+-..+||+|||+++.+..+...
T Consensus 780 P~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 780 PLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred ccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 999999999753 345778889999999999999999887 999999999999999999999999999999877666
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.......-.+.|||-|.+....|+.++|||||||.+||++| |..|++....++. .+++....+
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------~dlle~geR 918 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------PDLLEKGER 918 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------hHHHhcccc
Confidence 55555667889999999999999999999999999999998 8889865433222 222222222
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
-..++.....+..++++||..|+..||+++++...+..
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 33455566778999999999999999999999876643
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=319.65 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=205.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEecC-----CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeeccccc-CCcc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLE-EDEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~ 599 (837)
.++|.+.+.||+|+||.||+|.... +..|++|++.... ....+.+.+|+.++.+++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999998765 6889999886542 3345678899999999999999999998776 4678
Q ss_pred EEEEEecCCCChhhHhhhcCCC-----CCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccc
Q 003237 600 MLIYEFMPNKSLDYFIFDESRK-----QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DF 674 (837)
++++||+++++|.+++...... ..+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654322 46889999999999999999999987 999999999999999999999999
Q ss_pred ccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhcc
Q 003237 675 GTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSD 753 (837)
Q Consensus 675 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 753 (837)
|+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+.... ...+..+.. ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~---~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID---PFEMAAYLK---DG 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC---HHHHHHHHH---cC
Confidence 99987654433322333456778999999998899999999999999999999 999985321 112221111 11
Q ss_pred CccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 754 NKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 754 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
... .. .......+.+++.+|++.+|++|||+.+|+++|+.+
T Consensus 236 ~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 236 YRL------AQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCC------CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000 00 111224578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=320.40 Aligned_cols=266 Identities=27% Similarity=0.380 Sum_probs=200.6
Q ss_pred CcCCcccccCCeeEEEEEe-----cCCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccEEE
Q 003237 531 STSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLI 602 (837)
Q Consensus 531 ~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV 602 (837)
...+.||+|+||+||++.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7778999999999988643 357889999986543 23456788999999999999999999988654 357899
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|.+++... .+++..+..++.|+++||.|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999998542 3899999999999999999999987 99999999999999999999999999987654
Q ss_pred ccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 683 EEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 683 ~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.... .......++..|+|||.+.+..++.++||||||++++||++|+.|+....... .................+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhh
Confidence 3221 11122345667999999998899999999999999999999999975432110 000100000000111111222
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.......+......+.+++..|++.+|++||||++|+++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 2221112222345688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=327.09 Aligned_cols=199 Identities=26% Similarity=0.397 Sum_probs=172.8
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|++.++||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367889999999999999999876 57889999886542 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++++|.+++... ..+++.....++.|+++||.|||+.+ +|+|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999998643 34788888999999999999999753 39999999999999999999999999987653221
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRI 734 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 734 (837)
.....++..|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2235689999999999998999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=345.67 Aligned_cols=256 Identities=23% Similarity=0.290 Sum_probs=202.2
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC-----
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED----- 597 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 597 (837)
..++|.+.+.||+|+||+||+++.. +|+.||||++... .......+.+|+.++..++|+||+++...+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 4568999999999999999999754 7899999998654 2334567788999999999999999988765432
Q ss_pred ---ccEEEEEecCCCChhhHhhhcC-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecc
Q 003237 598 ---ENMLIYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673 (837)
Q Consensus 598 ---~~~lV~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 673 (837)
..++||||+++|+|.+++.... ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 2579999999999999986532 2346888899999999999999999987 99999999999999999999999
Q ss_pred cccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc
Q 003237 674 FGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD 753 (837)
Q Consensus 674 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 753 (837)
||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..........
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~- 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLA- 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhc-
Confidence 999987654332233344679999999999999999999999999999999999999985321 1111111111
Q ss_pred CccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 754 NKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 754 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
+.. + .+ +......+.+++..|++.+|++||++.+++..
T Consensus 260 ~~~----~-~~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRY----D-PL----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC----C-CC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 110 0 01 11223457789999999999999999999763
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.04 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=201.1
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|.+.++||+|+||.||+|+..+...||+|++.... ...+++.+|++++.+++|+||+++++.+. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 4688889999999999999988777789999996432 34567899999999999999999999874 456799999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+|+|.+++.... ...+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 999999986432 335789999999999999999999987 999999999999999999999999999876543221
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......++..|+|||+..+..++.++||||||+++|||++ |+.|+..... ..... .... .. ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~---~~~~-~~---------~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD---QVER-GY---------RM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHH---HHhc-CC---------CC
Confidence 1122345678999999998999999999999999999999 7778753211 11111 1111 00 00
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
....+....+.+++.+|++.+|++||++++++++|+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1112234567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.60 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=191.6
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+|+..++||+|+||.||+++.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++......++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556789999999999999875 68999999986543 233567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.... ...+.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999986432 3456777889999999999999987 99999999999999999999999999987643211
Q ss_pred eeeccccccCCccCcccccC-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALD-----GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
......|+..|+|||++.. ...+.++|||||||++|||++|+.||......+ ............ .
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~-~----- 293 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMSQ-P----- 293 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhccC-C-----
Confidence 1223578999999998753 234568999999999999999999987322211 111111110000 0
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
..........+.+++.+||+.+|++||++.||++.
T Consensus 294 ----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 ----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111223457889999999999999999999874
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=318.51 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=204.4
Q ss_pred cCCCcCCcccccCCeeEEEEEecC------CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|.+.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.++..++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 567888999999999999997642 3689999986543 233457889999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCC-------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecc
Q 003237 601 LIYEFMPNKSLDYFIFDESR-------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 673 (837)
+||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence 99999999999999865322 234788999999999999999999987 99999999999999999999999
Q ss_pred cccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhc
Q 003237 674 FGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWS 752 (837)
Q Consensus 674 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 752 (837)
||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+.... ........ .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~~~----~ 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---NEEVLKFV----I 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC---HHHHHHHH----h
Confidence 999987654433222233456789999999998899999999999999999998 888875321 11222211 1
Q ss_pred cCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 753 DNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 753 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.+..... +......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 236 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111111 11123467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.94 Aligned_cols=253 Identities=29% Similarity=0.456 Sum_probs=202.8
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
+.|++.++||+|+||.||+|..++++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++ ..+..+++|||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCC
Confidence 5678889999999999999998889999999986543 3457889999999999999999999986 4557899999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 84 NGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999886543 345789999999999999999999987 9999999999999999999999999998765332211
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....++..|+|||++....++.++||||||++++||++ |+.|+..... ....... ......
T Consensus 160 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~~~~--------- 222 (260)
T cd05067 160 -REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNL----ERGYRM--------- 222 (260)
T ss_pred -ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHH----HcCCCC---------
Confidence 122345678999999998899999999999999999999 9999853221 1111111 111000
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
........++.+++.+|++.+|++||++++++.+|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111123458899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=319.19 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=196.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467888999999999999999876 688999999865432 234567789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|++ ++|.+++... ...++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 5777776432 234788888999999999999999988 9999999999999999999999999987543221
Q ss_pred ceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc------
Q 003237 685 ILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL------ 757 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------ 757 (837)
. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....+ ..................
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence 1 1223567899999998875 4589999999999999999999999964322 111111111111110000
Q ss_pred --ccccc-ccc--cccCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 --EIVDS-SMA--NSCLA-------SEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 --~~~d~-~l~--~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...++ ... ..... .....+.+++..|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 000 00000 01234678999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.14 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=202.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCc----EEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|+..++||+|+||+||+|+.. +++ .||+|.++.. .....+++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 46778899999999999999753 444 4899998654 33345678899999999999999999999875 45789
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
++||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999998653 235889999999999999999999987 9999999999999999999999999998765
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
............++..|+|||.+.+..++.++|||||||++|||++ |+.|+.... ...+.... ..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~----~~~~~~~-- 231 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPDLL----EKGERLP-- 231 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH----HCCCcCC--
Confidence 4332222222344678999999999999999999999999999998 888875322 11111111 1111110
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVP 808 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~~~ 808 (837)
.+......+.+++.+|++.+|++||++.++++.|+.....|
T Consensus 232 -------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 232 -------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 01112345778999999999999999999999998765554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.80 Aligned_cols=241 Identities=20% Similarity=0.264 Sum_probs=193.2
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 609 (837)
+.||+|+||.||+++.. +|+.+|||++.... ......+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999775 68899999987532 233456778999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeee
Q 003237 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689 (837)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 689 (837)
+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 999888643 35789999999999999999999988 9999999999999999999999999987532211 112
Q ss_pred ccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccC
Q 003237 690 KRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCL 769 (837)
Q Consensus 690 ~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 769 (837)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. .... +. ..+ +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~---~~~~-~~------~~~----p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFE---LILM-EE------IRF----P 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHH---HHHc-CC------CCC----C
Confidence 33579999999999999999999999999999999999999985321 111111 1111 10 011 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 770 ASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 770 ~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
......+.+++.+|++.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 12234577899999999999999 7998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=325.16 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=210.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc-cEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE-NMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lV~ 603 (837)
++|...+++|+|+||.++..+++ ++..+++|.+.-.. ....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46788899999999999999775 57889999986542 3344567889999999999999999999999998 89999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
+|++||+|.+.|.+.. ...++.+....++.||+.|+.|||+.. |+|||||+.||+++.+..+||+|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997765 566889999999999999999999777 999999999999999999999999999998876
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
. .....+.||+.||.||.+.+.+|..|+|||||||++|||.+-+++|...+. ..|+.. .... .+.
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~k---i~~~-----~~~-- 224 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELILK---INRG-----LYS-- 224 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHHH---Hhhc-----cCC--
Confidence 5 234558999999999999999999999999999999999999999864332 222221 1111 111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
..+.....++..++..|++.+|+.||++.+++.+
T Consensus 225 ---Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 ---PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1233445567889999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.98 Aligned_cols=241 Identities=20% Similarity=0.237 Sum_probs=191.3
Q ss_pred ccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCCh
Q 003237 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 536 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
||+|+||.||+++.. +++.||+|++... .......+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 5789999998643 233456778899999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeecc
Q 003237 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691 (837)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 691 (837)
.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 9998643 34788999999999999999999988 9999999999999999999999999988643222 12234
Q ss_pred ccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHH
Q 003237 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLAS 771 (837)
Q Consensus 692 ~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 771 (837)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ .. .+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~-------~~----~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEP-------LR----FPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCC-------CC----CCCc
Confidence 678999999999999999999999999999999999999985321 111111111110 00 1111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 772 EALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 772 ~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
....+.+++.+|++.+|++||++.++.+.|
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 224567889999999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.02 Aligned_cols=258 Identities=28% Similarity=0.466 Sum_probs=202.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ....+++.+|+.++.+++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888899999999999999763 46789999986543 33456788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCC-------------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 003237 600 MLIYEFMPNKSLDYFIFDESR-------------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 660 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 660 (837)
++|+||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999864321 124778889999999999999999987 9999999999
Q ss_pred EEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 003237 661 ILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDD 739 (837)
Q Consensus 661 Ill~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 739 (837)
|+++.++.+||+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..|+.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999886543322211222344667999999998999999999999999999998 8777742211
Q ss_pred cchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 740 SSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 740 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
. .... ....+.... .+......+.+++.+|++.+|++|||+.||++.|++
T Consensus 239 -~---~~~~-~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -E---EVIY-YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -H---HHHH-HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 1111 111111111 111223567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.01 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=203.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 599 (837)
++|.+.+.||+|+||.||+++.. .+..||||+++... ....+.+.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56888899999999999999641 35579999986543 23346788999999999 799999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++||||+++|+|.+++.... ...+++.++..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999986533 234899999999999999999999987 99999999999999999999999999986
Q ss_pred ccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
..............++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... ..... ....+...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~----~~~~~~~~- 263 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYK----LIKEGYRM- 263 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHH----HHHcCCcC-
Confidence 644322222222345778999999999999999999999999999998 99887532211 11111 11111100
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
..+......+.+++.+|++.+|++|||+.||++.|++
T Consensus 264 --------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 264 --------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0111123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.16 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=199.2
Q ss_pred cCCCcCCcccccCCeeEEEEEecC-Cc--EEEEEEecCC-CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQ--EIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999998753 33 4788888642 233456788999999999 799999999999999999999
Q ss_pred EEecCCCChhhHhhhcC-------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 603 YEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
+||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986432 1134788999999999999999999987 9999999999999999999
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 748 (837)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |+.|+..... ..+..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~~~--- 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AELYE--- 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH---
Confidence 99999998643211 11111233557999999999899999999999999999997 9999853221 11111
Q ss_pred HHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 749 ELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 749 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
.. ..+ .....+......+.+++.+|++.+|.+||++++|++.|++...
T Consensus 230 ~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 230 KL-PQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HH-hcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 111 0000111122457789999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.00 Aligned_cols=246 Identities=27% Similarity=0.446 Sum_probs=194.4
Q ss_pred cccccCCeeEEEEEe---cCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCC
Q 003237 535 KLGQGGFGPVYKGKL---SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 609 (837)
.||+|+||.||+|.+ .++..+|+|+++... ....+++.+|+.++..++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999965 357889999986443 234567889999999999999999999875 45678999999999
Q ss_pred ChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee-
Q 003237 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI- 688 (837)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~- 688 (837)
+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||.||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999998543 34789999999999999999999987 99999999999999999999999999987654332211
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
.....++..|+|||.+....++.++|||||||++|||++ |+.|+..... ..+... ...+....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~----i~~~~~~~--------- 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQM----IESGERME--------- 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHCCCCCC---------
Confidence 122334578999999988889999999999999999998 9999864321 111111 11111111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.+......+.+++.+|++.+|++||+|++|+++|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111223457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=323.61 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=202.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec--------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 597 (837)
++|.+.+.||+|+||.||++... ....+|+|.+.... .....++.+|++++.++ +|+||+++++++....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888899999999999999752 23569999987542 33456788899999999 7999999999999999
Q ss_pred ccEEEEEecCCCChhhHhhhcCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 664 (837)
..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999965321 235889999999999999999999987 99999999999999
Q ss_pred CCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchH
Q 003237 665 EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNL 743 (837)
Q Consensus 665 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 743 (837)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+.... ...+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---~~~~ 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEEL 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHH
Confidence 999999999999876543222222222334568999999999999999999999999999998 888874321 1111
Q ss_pred HHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 744 IKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 744 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. ........+ .+......+.+++.+|++.+|++||+|.+|++.|+.+
T Consensus 252 ~~----~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 252 FK----LLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HH----HHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11 111111111 1112234677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.47 Aligned_cols=256 Identities=26% Similarity=0.451 Sum_probs=201.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CC---cEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NG---QEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|+..+.||+|+||.||+|++. ++ ..+|+|++.... ....+++.+|++++.+++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777899999999999999875 23 368999986542 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|..++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999986432 35889999999999999999999987 99999999999999999999999999987643
Q ss_pred ccceeee-ccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 683 EEILAIT-KRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 683 ~~~~~~~-~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
....... .....+..|+|||++.+..++.++|||||||++|||++ |+.|+..... ..+.... ......
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i----~~~~~~--- 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAI----NDGFRL--- 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHH----hcCCCC---
Confidence 3221111 11223457999999998899999999999999999997 9999853321 1111111 111000
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+ ...+....+.+++.+|++.+|++||+|.+|++.|+++
T Consensus 230 -~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 -P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 1111234578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=328.88 Aligned_cols=261 Identities=21% Similarity=0.326 Sum_probs=193.1
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC-----ccE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----ENM 600 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 600 (837)
+|++.++||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677899999999999999865 6899999998643 2233456889999999999999999999876432 468
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||+. ++|..++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 6888887533 34889999999999999999999988 999999999999999999999999999865
Q ss_pred cCccc-eeeeccccccCCccCcccccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc-----
Q 003237 681 GGEEI-LAITKRVVGTYGYMSPEYALD--GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS----- 752 (837)
Q Consensus 681 ~~~~~-~~~~~~~~gt~~y~APE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----- 752 (837)
..... ........++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...........
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV---HQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCCHH
Confidence 32211 111233578999999999876 67899999999999999999999998543211 11111111100
Q ss_pred ------cCccccccc---cccccc---cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 753 ------DNKALEIVD---SSMANS---CLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 753 ------~~~~~~~~d---~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.....+.+. +..... ........+.+++.+|++.+|++|||++||++
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000 000000 00011234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=310.44 Aligned_cols=260 Identities=22% Similarity=0.371 Sum_probs=206.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.++||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999865 6899999987542 2233456889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcC-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 604 EFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
||+++++|.+++.... ....++......++.||++||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345788899999999999999999987 99999999999999999999999999887653
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ......... .... .+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~-~~~~-----~~ 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKI-EQCD-----YP 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHH-hcCC-----CC
Confidence 321 11234678899999999988899999999999999999999999743211 111111111 1100 01
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
.. ........+.+++.+|++.+|++||++.+|++.|++.+
T Consensus 227 ~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 PL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11 11223355788999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=328.19 Aligned_cols=258 Identities=19% Similarity=0.220 Sum_probs=193.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
++|++.++||+|+||.||++... +++.||+|.... ..+.+|++++++++|||||++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 57899999999999999999764 688999997532 34678999999999999999999999999999999998
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
. ++|..++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 166 K-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred C-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 6 6787777543 34789999999999999999999987 99999999999999999999999999975432111
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCC----cchHHHHHHHHhccC--------
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD----SSNLIKYAWELWSDN-------- 754 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~----~~~l~~~~~~~~~~~-------- 754 (837)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+-.....+ ...............
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 11223579999999999999999999999999999999999998764322111 011111111110000
Q ss_pred --cccccc---------cccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 755 --KALEIV---------DSSMAN--SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 755 --~~~~~~---------d~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...+.. .+.... .........+..++.+|++.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 000000 000122346778999999999999999999984
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=315.36 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=202.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-----------------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeee
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-----------------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKL 589 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l 589 (837)
++|++.++||+|+||.||++... +...+|+|++.... .....++.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998532 23468999986542 3345678999999999999999999
Q ss_pred ecccccCCccEEEEEecCCCChhhHhhhcCC--------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcE
Q 003237 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESR--------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNI 661 (837)
Q Consensus 590 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 661 (837)
++++...+..++||||+++++|.+++..... ...+++.....++.||+.||.|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 124778889999999999999999987 99999999999
Q ss_pred EEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCCCC
Q 003237 662 LLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT--GKKNTRIFNDDD 739 (837)
Q Consensus 662 ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt--G~~p~~~~~~~~ 739 (837)
|++.++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++ |..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 999999999999999986644332222223345678999999988899999999999999999998 6677653222
Q ss_pred cchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 740 SSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 740 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.................... + .+......+.+++.+|++.+|++||+|.+|++.|++
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 -EQVIENTGEFFRDQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -HHHHHHHHHHHhhccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11122111111111111111 0 011122567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=313.60 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=199.8
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--------------cCHHHHHHHHHHHHHhcCCCeeeee
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--------------QGIEELKNEVLLIAKLQHRNLVKLL 590 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv~l~ 590 (837)
..++|++.+.||+|.||.|-+|... +++.||||++.+... ..++.+.+|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4578999999999999999999765 689999999865311 1246788999999999999999999
Q ss_pred cccccC--CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC
Q 003237 591 GCCLEE--DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN 668 (837)
Q Consensus 591 ~~~~~~--~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 668 (837)
.+..+. +..|||+|||..|.+...- .....++..+..++++++..||+|||.++ ||||||||+|+||+++++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 998765 4679999999999875432 22233899999999999999999999998 999999999999999999
Q ss_pred eeecccccceeccCc---cceeeeccccccCCccCcccccCCC----CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 003237 669 PRISDFGTARVFGGE---EILAITKRVVGTYGYMSPEYALDGV----FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS 741 (837)
Q Consensus 669 ~ki~DFGla~~~~~~---~~~~~~~~~~gt~~y~APE~~~~~~----~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~ 741 (837)
+||+|||.+..+... ..........||+.|+|||...++. .+.+.||||+||.||.|+.|+-||-...
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----- 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----- 323 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-----
Confidence 999999999876221 1112223478999999999998743 3568999999999999999999984211
Q ss_pred hHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 742 NLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 742 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
...... .++...+.-...+++..++..++++++++||+.|-+..+|....
T Consensus 324 -~~~l~~---------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 -ELELFD---------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -HHHHHH---------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111111 12222222222334556778999999999999999999997655
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=308.95 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=196.8
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCChh
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 612 (837)
++||+|+||.||+|...++..+|+|.+..... .....+.+|++++.+++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988899999999865532 23446889999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccc
Q 003237 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV 692 (837)
Q Consensus 613 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 692 (837)
+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 9885432 34789999999999999999999987 999999999999999999999999998764332211 11122
Q ss_pred cccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHH
Q 003237 693 VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLAS 771 (837)
Q Consensus 693 ~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 771 (837)
.++..|+|||++.+..++.++||||||+++||+++ |..|+..... ..... .. ...... ..+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~~---~~-~~~~~~---------~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQARE---QV-EKGYRM---------SCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHHH---HH-HcCCCC---------CCCCC
Confidence 34567999999998999999999999999999998 8888853211 11111 11 111100 11112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 772 EALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 772 ~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
....+.+++.+|++.+|++||++.+|++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2346789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=309.74 Aligned_cols=258 Identities=23% Similarity=0.376 Sum_probs=207.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||+|... +|+.+|+|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999886 7899999988632 2233567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 604 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
||+++++|..++... .....+++..+..++.++++||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988653 23345889999999999999999999987 99999999999999999999999999886543
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.... .....++..|+|||.+.+..++.++|||||||+++||++|+.|+.... ..+....... ..+..
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~-~~~~~------ 225 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKI-EKCDY------ 225 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhh-hcCCC------
Confidence 2211 122457889999999998899999999999999999999999975322 1111111111 11111
Q ss_pred ccccccCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 763 SMANSCLA-SEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 763 ~l~~~~~~-~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
...+. .....+.+++.+|++.+|++|||+.+|+++|+++
T Consensus 226 ---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 ---PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11111 2334677899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=328.51 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=205.8
Q ss_pred cCCCcCCcccccCCeeEEEEEecC--CcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN--GQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|++++..++||||+++++++.++...++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999997643 368999998643 223456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999998643 34788899999999999999999988 99999999999999999999999999987543
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ...... +..
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~---~~~i~~-~~~------ 245 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLI---YQKILE-GII------ 245 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HHH---HHHHhc-CCC------
Confidence 2 1235789999999999998999999999999999999999999863211 111 111111 110
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH--hccC-------CCCCCCCCCCccc
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVFM--LSNE-------TFVPSPKQPTFSV 817 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~~--L~~~-------~~~~~p~~p~~~~ 817 (837)
.+... ....+.+++.+|++.+|++|+ +++++++. +++. ..++.|..|.+..
T Consensus 246 ~~p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 246 YFPKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred CCCCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 01111 123467889999999999995 89998764 2221 3445666666543
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.63 Aligned_cols=259 Identities=28% Similarity=0.426 Sum_probs=199.1
Q ss_pred cCCCcCCcccccCCeeEEEEEe------cCCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccC-Cc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE-DE 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~~ 598 (837)
++|.+.++||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5788899999999999999963 357889999997543 23345688999999999 689999999988654 45
Q ss_pred cEEEEEecCCCChhhHhhhcCC----------------------------------------------------------
Q 003237 599 NMLIYEFMPNKSLDYFIFDESR---------------------------------------------------------- 620 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~---------------------------------------------------------- 620 (837)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 6899999999999999864210
Q ss_pred ------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccccc
Q 003237 621 ------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694 (837)
Q Consensus 621 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~g 694 (837)
...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 124678888999999999999999987 99999999999999999999999999986543322222222345
Q ss_pred cCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHH
Q 003237 695 TYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEA 773 (837)
Q Consensus 695 t~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 773 (837)
+..|+|||.+.+..++.++||||||++++||++ |..|+...... ..+.. ....+..... .... .
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~----~~~~~~~~~~-----~~~~----~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCR----RLKEGTRMRA-----PDYT----T 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHH----HHhccCCCCC-----CCCC----C
Confidence 678999999999999999999999999999997 88887532211 11111 1111111110 0111 2
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 774 LRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 774 ~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..+.+++..|++.+|++|||+.||++.|+.+
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.89 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=192.5
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.|+..+.||+|+||+||+|+.. +++.+|||++.... ....+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4777899999999999999764 68899999996532 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999998643 34788888889999999999999987 9999999999999999999999999976432100
Q ss_pred c---------------------------------------------eeeeccccccCCccCcccccCCCCCCcccHHHHH
Q 003237 685 I---------------------------------------------LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFG 719 (837)
Q Consensus 685 ~---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~G 719 (837)
. ........||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHH--cccCCCCCCCCHHHH
Q 003237 720 VILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLL--CVQDRTTDRPSMSTV 797 (837)
Q Consensus 720 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPtm~eV 797 (837)
|++|||++|+.||......+ .. ...........+. + ..... ..+.+++.+ |...+|..||++++|
T Consensus 236 ~il~elltG~~Pf~~~~~~~---~~---~~i~~~~~~~~~~-~--~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE---TQ---LKVINWENTLHIP-P--QVKLS----PEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH---HH---HHHHccccccCCC-C--CCCCC----HHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999996432111 11 1111101001100 0 00112 234445544 677788889999999
Q ss_pred HH
Q 003237 798 VF 799 (837)
Q Consensus 798 v~ 799 (837)
+.
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=309.86 Aligned_cols=253 Identities=29% Similarity=0.461 Sum_probs=200.4
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|.+.++||+|+||.||++....+..+|+|++.... ...+.+.+|++++.+++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577788999999999999998877789999886433 34567889999999999999999999875 456889999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999986532 335789999999999999999999987 9999999999999999999999999998764332211
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....... ..... .
T Consensus 160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~-----~---- 222 (260)
T cd05069 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQV----ERGYR-----M---- 222 (260)
T ss_pred -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCC-----C----
Confidence 112345678999999998999999999999999999999 8888753211 1111111 11100 0
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
..+......+.+++.+|++.+|++||++++|+++|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111223457889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=322.13 Aligned_cols=241 Identities=20% Similarity=0.268 Sum_probs=192.5
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 609 (837)
+.||+|+||.||+++.. +|..||+|.+... .......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999865 6899999998653 2234456778999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeee
Q 003237 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689 (837)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 689 (837)
+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 998888543 35789999999999999999999987 99999999999999999999999999875322211 12
Q ss_pred ccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccC
Q 003237 690 KRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCL 769 (837)
Q Consensus 690 ~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 769 (837)
....|++.|+|||++.+..++.++|||||||++|||++|+.|+..... .... ...... . ..+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~---~~~~~~-~------~~~p~--- 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLF---ELILME-E------IRFPR--- 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHH---HHHhcC-C------CCCCC---
Confidence 235789999999999999999999999999999999999999853221 1111 111111 0 01111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 770 ASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 770 ~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
.....+.+++.+|++.+|++|| ++.++++
T Consensus 217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 -TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1223567889999999999998 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.84 Aligned_cols=277 Identities=25% Similarity=0.306 Sum_probs=202.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc-C-HHHHHHHHHHHHHhcCCCeeeeeccccc--CCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ-G-IEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV 602 (837)
++|+..++|++|.||.||+|+.+ +++.||+|+++..... + .-.-.+||.+|.+++|||||.+-.+..- -+..+||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 56777899999999999999875 6889999999754322 1 1233689999999999999999887654 3468999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
||||+. +|...+.... +.+...+...++.|+++|+.|||... |+|||||++|+|+...|.+||+|||||+..+.
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999987 7888886554 45778888889999999999999988 99999999999999999999999999998876
Q ss_pred ccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc---Ccc--
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD---NKA-- 756 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~-- 756 (837)
... .. ...+.|..|.|||.+.+. .|+...|+||+|||+.||+++++-|....+-+ ++..... .+.- ...
T Consensus 230 p~k-~~-T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~-llGtPte~iwpg 304 (419)
T KOG0663|consen 230 PLK-PY-TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFK-LLGTPSEAIWPG 304 (419)
T ss_pred Ccc-cC-cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHH-HhCCCccccCCC
Confidence 522 22 236779999999999875 69999999999999999999998875443322 2222211 1110 000
Q ss_pred ---cccc---------ccccccccCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCcc
Q 003237 757 ---LEIV---------DSSMANSCLAS-EALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVPSPKQPTFS 816 (837)
Q Consensus 757 ---~~~~---------d~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~~~~p~~p~~~ 816 (837)
...+ ...+...+... ....-.++.-..+..||.+|-|++|.++.= -..+.|.|..|.+.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~-~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE-YFRETPLPIDPSMF 376 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc-ccccCCCCCChhhc
Confidence 0001 11122222221 223445666778889999999999876421 12455555554444
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=310.18 Aligned_cols=255 Identities=29% Similarity=0.456 Sum_probs=205.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.++|.+.++||+|+||.||+|..+++..+|||.+... ....+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4678888999999999999999888889999998643 345678999999999999999999999998888999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999986532 235899999999999999999999987 999999999999999999999999999876542211
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
. ......+..|+|||.+.+..++.++||||||++++||++ |+.|+.... ....... ...... .
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~---~~~~~~------~--- 223 (261)
T cd05034 160 A-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQ---VERGYR------M--- 223 (261)
T ss_pred h-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH---HHcCCC------C---
Confidence 1 112234568999999999899999999999999999998 999885321 1111111 111000 0
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
..+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011113457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.83 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=192.4
Q ss_pred CcccccCCeeEEEEEecC---CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCC
Q 003237 534 NKLGQGGFGPVYKGKLSN---GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 609 (837)
+.||+|+||.||+|...+ +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999997643 4579999986543 233457888999999999999999999999988999999999999
Q ss_pred ChhhHhhhcCC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 610 SLDYFIFDESR--KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 610 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+|.+++..... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999865322 234567788889999999999999987 9999999999999999999999999997654333222
Q ss_pred eeccccccCCccCcccccCC-------CCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDG-------VFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~-------~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
......++..|+|||++.+. .++.++||||||+++|||++ |+.|+...... ...... ..+....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTYT----VREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHHH----hhcccCCC
Confidence 22334567889999988642 35889999999999999996 99998543221 111111 11111222
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.++.+... ....+.+++..|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222211 1224567778898 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=322.42 Aligned_cols=242 Identities=21% Similarity=0.271 Sum_probs=193.8
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 609 (837)
+.||+|+||.||++... +++.||||++.+. .......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 6899999999754 2234567788999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeee
Q 003237 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689 (837)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 689 (837)
+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 998888543 35889999999999999999999987 9999999999999999999999999987533221 112
Q ss_pred ccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccC
Q 003237 690 KRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCL 769 (837)
Q Consensus 690 ~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 769 (837)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ....... +..+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~---~~~~~~~-------~~~~p~--- 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKL---FELILME-------DIKFPR--- 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHH---HHHhccC-------CccCCC---
Confidence 335789999999999999999999999999999999999999853211 111 1111110 001111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003237 770 ASEALRCIQVGLLCVQDRTTDRP-----SMSTVVFM 800 (837)
Q Consensus 770 ~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~~ 800 (837)
.....+.+++.+|++.+|++|| ++.|+++.
T Consensus 217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 -TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1223567888999999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=308.33 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=201.9
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|+..+.||+|++|.||+++.. +++.+++|.+... .....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999875 6889999998643 234567788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998754 2346889999999999999999999987 99999999999999999999999999987654322
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
. .....++..|+|||++.+..++.++||||||++++||++|+.|+.... ...... .... +...
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~---~~~~-~~~~-------- 219 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALIL---KIIR-GVFP-------- 219 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HHHc-CCCC--------
Confidence 1 223467889999999999999999999999999999999999986332 111111 1111 1000
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.........+.+++.+|++.+|++||+|.++++.
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111223457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=320.32 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=202.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec--------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 597 (837)
++|.+.++||+|+||.||+++.. ....+|+|.++... .....++.+|++++.++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999642 24578999886542 33456788999999999 5999999999999888
Q ss_pred ccEEEEEecCCCChhhHhhhcC-------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 664 (837)
..++||||+++|+|.+++.... ....+++.++..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 8999999999999999996532 1245889999999999999999999987 99999999999999
Q ss_pred CCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchH
Q 003237 665 EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNL 743 (837)
Q Consensus 665 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 743 (837)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 999999999999987653322222222334567999999999999999999999999999999 8888743211 111
Q ss_pred HHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 744 IKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 744 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
... ...+.... .+......+.+++.+|++.+|++|||+.++++.|+++
T Consensus 246 ~~~----~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 246 FKL----LREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHH----HHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111 11111111 1112233577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=308.83 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=203.2
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|++.+.||+|+||.||+|... |+.||||.+..... ..+++.+|+.++.+++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46778899999999999999875 78999999965543 56788999999999999999999999999899999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999865432 35899999999999999999999988 99999999999999999999999999987632211
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
....+..|+|||.+....++.++||||||++++||++ |+.|+..... ..+.... .......
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~-------- 219 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHV----EKGYRME-------- 219 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----hcCCCCC--------
Confidence 2334668999999998899999999999999999997 9888753211 1111111 1110101
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+......+.+++.+|++.+|++||++++|+++|+++
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 -APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1111234577899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=308.54 Aligned_cols=267 Identities=25% Similarity=0.326 Sum_probs=199.1
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecC--CCccCHHHHHHHHHHHHHhcCCCeeeeeccccc-----CC
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLST--TSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE-----ED 597 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~~ 597 (837)
....|...+.||+|+||.|..+... +|+.||||++.. ......++..+|+++|+.++|+||+.+++.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999775 789999999973 344456778899999999999999999999876 23
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..++|+|+| ..+|...+... +.|+.....-++.||++||.|+|+.+ |+||||||+|+|++.+..+||+|||||
T Consensus 100 DvYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 569999999 55787777432 34788888889999999999999998 999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH------
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL------ 750 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------ 750 (837)
+...........+..+.|..|.|||++.. ..|+.+.||||.|||+.||++|+.-|.....-++..++......
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98764322233344678999999998865 57999999999999999999999988654332222222111100
Q ss_pred --hccCcccccccccc---c---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 751 --WSDNKALEIVDSSM---A---NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 751 --~~~~~~~~~~d~~l---~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...++....+.... . ....+......+++..+|+..||.+|+|++|.++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 01011111111000 0 0001112234678888999999999999999975
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.48 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=200.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.+.||+|+||+||+++.. +++.||||++.... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36788899999999999999876 68999999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998654 45788999999999999999999987 999999999999999999999999999866433
Q ss_pred c---------------------------ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 003237 684 E---------------------------ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFN 736 (837)
Q Consensus 684 ~---------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~ 736 (837)
. .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011223568999999999999999999999999999999999999986432
Q ss_pred CCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 003237 737 DDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPS-MSTVVFM 800 (837)
Q Consensus 737 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-m~eVv~~ 800 (837)
. ...............+ +. .......+.+++..|++ +|.+||+ ++++++.
T Consensus 235 ~------~~~~~~i~~~~~~~~~--p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 L------QETYNKIINWKESLRF--PP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H------HHHHHHHhccCCcccC--CC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 1111111110000000 00 00023456788889997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=310.92 Aligned_cols=259 Identities=22% Similarity=0.364 Sum_probs=205.3
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||++.. .++..+|||.+.... ....+++.+|+.++..++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999986 478999999886432 233467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 604 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
||+++++|.+++... .....+++.....++.||++||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 23456899999999999999999999987 99999999999999999999999999876543
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.... .....++..|+|||++.+..++.++||||||+++|||++|..|+..... ......... .....+
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~------~~~~~~ 226 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI------EQCDYP 226 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhh------hcCCCC
Confidence 3211 1235688899999999999999999999999999999999999853211 111111111 111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+. .......+.+++.+|++.+|++||||.+|++++++.
T Consensus 227 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111 112334577899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=308.20 Aligned_cols=250 Identities=34% Similarity=0.526 Sum_probs=202.9
Q ss_pred CcccccCCeeEEEEEecC----CcEEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
++||+|+||.||+++... +..+|+|.+...... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998764 788999999765433 367889999999999999999999999998899999999999
Q ss_pred CChhhHhhhcCC------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 609 KSLDYFIFDESR------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 609 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
++|.+++..... ...+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999876421 256899999999999999999999987 99999999999999999999999999987765
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
...........++..|+|||.+....++.++||||+|++++||++ |+.|+..... ..+... ... +...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~---~~~-~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEY---LRK-GYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH---HHc-CCCC----
Confidence 432222334567889999999998899999999999999999999 5888864311 111111 111 1110
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
..+......+.+++.+|++.+|++|||+.|+++.|+
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=308.77 Aligned_cols=247 Identities=24% Similarity=0.422 Sum_probs=193.5
Q ss_pred cccccCCeeEEEEEec---CCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCC
Q 003237 535 KLGQGGFGPVYKGKLS---NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 610 (837)
.||+|+||.||+|.+. .+..||+|.+..... ...+++.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 355799999865532 33467899999999999999999999885 457899999999999
Q ss_pred hhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee-e
Q 003237 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI-T 689 (837)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~-~ 689 (837)
|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++........... .
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99988642 345889999999999999999999987 99999999999999999999999999986543322111 1
Q ss_pred ccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 690 KRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 690 ~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .... .....+.. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~~~~~---------~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVM----SFIEQGKR---------LDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHH----HHHHCCCC---------CCC
Confidence 11233578999999988889999999999999999996 9999853321 1111 11111111 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
+......+.+++..|++.+|++||++.+|.+.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 22234567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=323.64 Aligned_cols=201 Identities=24% Similarity=0.373 Sum_probs=173.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||+||++... +++.+|||++.+.. ......+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36788899999999999999765 58899999996532 223456788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999998643 35889999999999999999999988 999999999999999999999999998764321
Q ss_pred cce---------------------------------eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCC
Q 003237 684 EIL---------------------------------AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKK 730 (837)
Q Consensus 684 ~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~ 730 (837)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 003237 731 NTRI 734 (837)
Q Consensus 731 p~~~ 734 (837)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9953
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.25 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=192.8
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 5789999998754 223445677899988877 799999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 9998887543 34789999999999999999999987 9999999999999999999999999987532211 11
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCC--cchHHHHHHHHhccCcccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD--SSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....... ......+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 233578999999999999999999999999999999999999996432211 11111222221111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCC------HHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPS------MSTVV 798 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt------m~eVv 798 (837)
..+......+.+++.+|++.||++||+ +.+++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 260 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHh
Confidence 011222345678999999999999998 46664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.45 Aligned_cols=270 Identities=26% Similarity=0.396 Sum_probs=203.1
Q ss_pred CCCcCCcccccCCeeEEEEEec-----CCcEEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeeccccc--CCccE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-----NGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENM 600 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 600 (837)
.|...+.||+|+||.||++++. .+..+|||.+...... ..+.+.+|+++++.++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 5666789999999999999864 3678999999755432 46789999999999999999999999877 55789
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999999986533 24899999999999999999999987 999999999999999999999999999877
Q ss_pred cCccc-eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 681 GGEEI-LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 681 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
..... ........++..|+|||.+.+..++.++||||||++++||++|+.|+......... ...............+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLEL 238 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHHH
Confidence 53322 11122234456799999999889999999999999999999999887532221100 00000000000000011
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+........+......+.+++.+|++.+|++||||.||+++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=317.57 Aligned_cols=240 Identities=23% Similarity=0.333 Sum_probs=188.1
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|.+++..+ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 57889999986532 23344556677777654 799999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|..++... ..++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 9999888543 34788888999999999999999987 9999999999999999999999999998643322 12
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ..... .+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~---~i~~~-------~~~~---- 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFD---SILND-------RPHF---- 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHcC-------CCCC----
Confidence 2346789999999999999999999999999999999999999864321 11111 11110 0111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMS-TVV 798 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~-eVv 798 (837)
+......+.+++.+|++.+|++||++. ++.
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111223466888999999999999986 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=321.02 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=194.4
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||.||+++.. +++.||||.+++. .....+.+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999875 6889999999753 223345678899999998 699999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 9998887543 35899999999999999999999988 9999999999999999999999999987432111 11
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCC--cchHHHHHHHHhccCcccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD--SSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....||..|+|||++.+..++.++|||||||++|||++|+.||+.....+ ......+.......... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC
Confidence 233678999999999999999999999999999999999999997433221 11112222222111111 1111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPS------MSTVVF 799 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt------m~eVv~ 799 (837)
.....+.+++.+|++.||.+||+ ++++++
T Consensus 227 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 ----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12335778999999999999997 677763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=313.35 Aligned_cols=250 Identities=25% Similarity=0.325 Sum_probs=198.5
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
|++.++||+|+||+||++... +++.||||++.... ......+.+|++++++++|+||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 667789999999999999865 68899999986532 22334577899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++|+|..++.... ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 82 MNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999998886532 235889999999999999999999987 99999999999999999999999999987543221
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ............ .
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~----------~ 221 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKED----------Q 221 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhc----------c
Confidence 123468999999999999999999999999999999999999986432211 111111111000 0
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
...+......+.+++..|++.||++|| +++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 111222344577899999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.19 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=196.5
Q ss_pred CCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+|+..++||+|+||.||+|.. .+++.+|+|.+... .....+++.+|++++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567788999999999999976 46889999998654 2334467889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999996552 3577888899999999999999987 9999999999999999999999999998654321
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcch-HHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSN-LIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+.......... ..... ....... .+.+.
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~ 221 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-QCIVDED-----PPVLP 221 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-HHHhccC-----CCCCC
Confidence 223578999999999999999999999999999999999999986533222111 11111 1111110 01111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.......+.+++.+|++.+|++||+++|+++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 ---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11122357789999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=325.18 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=195.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888899999999999999875 68999999996431 233456788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999998653 34888999999999999999999988 999999999999999999999999998765321
Q ss_pred ccee------------------------------------eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh
Q 003237 684 EILA------------------------------------ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727 (837)
Q Consensus 684 ~~~~------------------------------------~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt 727 (837)
.... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 003237 728 GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPS---MSTVVF 799 (837)
Q Consensus 728 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---m~eVv~ 799 (837)
|+.||..... ...............+.. .. .....+.+++..|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~------~~~~~~i~~~~~~~~~~~-----~~--~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNP------QETYRKIINWKETLQFPD-----EV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCH------HHHHHHHHcCCCccCCCC-----CC--CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999863221 111111111111111100 00 112245567777886 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=323.43 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=198.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.+.||+|+||+||+++.. +++.+|||+++... ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36788899999999999999775 68899999997542 234566889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++... ...+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998653 235888999999999999999999988 999999999999999999999999999876543
Q ss_pred cceeeeccccccCCccCccccc------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 684 EILAITKRVVGTYGYMSPEYAL------DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~------~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence 322 223357899999999987 45678999999999999999999999853221 11111111111111
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...+ .......+..++..|++ +|++||++.++++
T Consensus 229 ~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1110 01122346677788997 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.38 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=197.7
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCc--EEEEEEecCC-CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ--EIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.+.||+|+||.||+|... ++. .+|+|++... .....+++.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46778899999999999999865 454 4578877543 233456788999999999 899999999999999999999
Q ss_pred EEecCCCChhhHhhhcCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 603 YEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
+||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999965321 235789999999999999999999987 9999999999999999999
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 748 (837)
||+|||+++..... ........+..|+|||++.+..++.++|||||||+++||++ |..|+..... .....
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~--- 234 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE--- 234 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHH---
Confidence 99999998642211 11111234567999999988889999999999999999998 9998853221 11111
Q ss_pred HHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 749 ELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 749 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. ..+...+ .+......+.+++.+|++.+|++||++++++++|+.+
T Consensus 235 ~~-~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 KL-PQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HH-hcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 1110000 0111223567899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=309.17 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=199.0
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34566666779999999999999865 57889999987666566678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC-CCCeeecccccceeccC
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVFGG 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~DFGla~~~~~ 682 (837)
||+++++|.+++.........++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999875422212277888889999999999999987 999999999999986 67999999999876543
Q ss_pred ccceeeeccccccCCccCcccccCCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGV--FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~--~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
... ......++..|+|||++.... ++.++||||||++++||++|+.|+....... ...+......
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~-------- 228 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK-------- 228 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc--------
Confidence 221 112245788999999987644 7899999999999999999999985322111 1111100000
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.....+......+.+++.+|++.+|++||||.||++
T Consensus 229 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ---IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 001112222345778899999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.66 Aligned_cols=248 Identities=28% Similarity=0.407 Sum_probs=197.6
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCChh
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 612 (837)
++||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999998877999999998655333 4567899999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccc
Q 003237 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV 692 (837)
Q Consensus 613 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 692 (837)
+++.... ..+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9986532 34788899999999999999999987 999999999999999999999999999865432221111222
Q ss_pred cccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHH
Q 003237 693 VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLAS 771 (837)
Q Consensus 693 ~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 771 (837)
..+..|+|||.+.++.++.++||||||++++||++ |..|+..... ...... ..... ....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~~~----~~~~~---------~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTRER----IESGY---------RMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHHHH----HhcCC---------CCCCCcc
Confidence 34567999999998999999999999999999999 7877743321 111111 11110 0011112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 772 EALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 772 ~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
....+.+++.+|++.+|++|||+.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=321.20 Aligned_cols=241 Identities=23% Similarity=0.310 Sum_probs=192.0
Q ss_pred CcccccCCeeEEEEEe----cCCcEEEEEEecCC----CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 534 NKLGQGGFGPVYKGKL----SNGQEIAVKRLSTT----SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++||+|+||.||+++. ..++.||||.+... .......+.+|++++..++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 35789999998643 123345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++... ..+.+.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999988543 34677888889999999999999988 99999999999999999999999999875432221
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .. .+
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~-~~------~~- 219 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKG-KL------NL- 219 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcC-CC------CC-
Confidence 12335789999999999999999999999999999999999999863221 1111111111 00 01
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
+......+.+++.+|++.+|++|| ++.++++
T Consensus 220 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 ---PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ---CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111224567899999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=311.59 Aligned_cols=246 Identities=26% Similarity=0.333 Sum_probs=194.3
Q ss_pred ccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCCh
Q 003237 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 536 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
||+|+||+||++... +++.+|||.+.... ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999765 68899999986432 22345677899999999999999999999999999999999999999
Q ss_pred hhHhhhcC-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeec
Q 003237 612 DYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK 690 (837)
Q Consensus 612 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 690 (837)
..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 98875432 3345889999999999999999999987 999999999999999999999999999866443221 22
Q ss_pred cccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCH
Q 003237 691 RVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLA 770 (837)
Q Consensus 691 ~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 770 (837)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||........ ........ +.... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~---------~~~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRI---------LNDSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhh---------cccCC--CCcc
Confidence 35789999999999999999999999999999999999999864322111 00111111 00000 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 771 SEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 771 ~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
.....+.+++..|++.+|++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2334577899999999999999 7777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=311.73 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=199.3
Q ss_pred CCCcCCcccccCCeeEEEEEecC-C---cEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSN-G---QEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.|.+.+.||+|+||.||+|.+.. + ..||||.+... .....++|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 36677899999999999998753 3 36999998654 3344578999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998643 235789999999999999999999987 999999999999999999999999998765433
Q ss_pred cceee-ecccc--ccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 684 EILAI-TKRVV--GTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 684 ~~~~~-~~~~~--gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
..... ..... .+..|+|||.+.+..++.++|||||||+++|+++ |+.|+..... ........ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~---~~~~~--- 230 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIE---QDYRL--- 230 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHH---cCCcC---
Confidence 22111 11111 2357999999999999999999999999999886 9998853221 11111111 10000
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. +.+....+.+++..|++.+|.+||+|.+|+++|++.
T Consensus 231 ---~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 ---PP----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 111234567899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.95 Aligned_cols=243 Identities=21% Similarity=0.325 Sum_probs=191.7
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||+||+++.. +++.+|||++++.. ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 57899999997542 23345678899999888 599999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|..++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 9998887543 34889999999999999999999987 9999999999999999999999999987532211 11
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........................ .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~---- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RI---- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CC----
Confidence 23467899999999999999999999999999999999999999754433222222222222111110 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSM 794 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm 794 (837)
+......+.+++.+|++.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11122346789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=321.67 Aligned_cols=251 Identities=21% Similarity=0.287 Sum_probs=195.3
Q ss_pred CCCcCCcccccCCeeEEEEEe----cCCcEEEEEEecCC----CccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCcc
Q 003237 529 NFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTT----SGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~ 599 (837)
+|++.++||+|+||.||+++. .+++.||+|++.+. .....+.+..|++++..++ |+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 367789999999999999975 35789999998643 1223456788999999995 99999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++||||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999998643 34788999999999999999999987 99999999999999999999999999986
Q ss_pred ccCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
....... ......||..|+|||++.+. .++.++|||||||++|||++|+.|+.......... ........
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~------ 225 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK------ 225 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc------
Confidence 5332211 12235789999999999875 47899999999999999999999986433222111 11111111
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
.++.+... ....+.+++.+|++.||++|| +++++++
T Consensus 226 -~~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 -CDPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -CCCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11111111 223467889999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.55 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=188.8
Q ss_pred CcccccCCeeEEEEEecC---CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCC
Q 003237 534 NKLGQGGFGPVYKGKLSN---GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 609 (837)
+.||+|+||.||+|+... ...+|+|.+.... ......+.+|+++++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3568888875432 233457889999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 610 SLDYFIFDESR--KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 610 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+|.+++..... ....++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 233567788899999999999999987 9999999999999999999999999987543332222
Q ss_pred eeccccccCCccCcccccC-------CCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 688 ITKRVVGTYGYMSPEYALD-------GVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~-------~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
......++..|+|||++.. ..++.++|||||||++|||++ |+.|+..... ..... .... .....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~---~~~~-~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQVLK---QVVR-EQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHH---HHhh-ccCccC
Confidence 2223345678999998743 356889999999999999999 7777753221 11111 1111 111222
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.++.+... ....+.+++..|+ .+|++|||+++|+++|.
T Consensus 231 ~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22222222 2234456777787 59999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.61 Aligned_cols=249 Identities=29% Similarity=0.433 Sum_probs=196.1
Q ss_pred CcccccCCeeEEEEEecC----CcEEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|++++.++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999875543 24567889999999999999999999875 5568999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
++|.+++.... .+++..+..++.|++.||.|||..+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999996543 5789999999999999999999987 99999999999999999999999999987644322111
Q ss_pred -eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 689 -TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 689 -~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+..... ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCcCC--------
Confidence 111223467999999999999999999999999999998 9999854321 22222221 111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
.+......+.+++.+|++.+|++||++.+|+++|+++.
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11112245779999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.04 Aligned_cols=254 Identities=20% Similarity=0.353 Sum_probs=199.7
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
++|++.+.||+|+||.||+|+. .+++.+|+|++........+.+.+|+.++.+++||||+++++.+..++..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688899999999999999986 468899999997655555667889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++... ..+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 999999988543 34788999999999999999999987 99999999999999999999999999986643211
Q ss_pred eeeccccccCCccCccccc---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYAL---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
......++..|+|||.+. ...++.++|||||||+++||++|+.|+......+.. .. . ... ....+.
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~----~-~~~---~~~~~~ 230 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FL----M-SKS---NFQPPK 230 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--ee----e-ecC---CCCCCC
Confidence 112346788999999884 445788999999999999999999997432211000 00 0 000 000011
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
... .......+.+++.+|++.+|++||++++|++.|
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Ccc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 110 111234677899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=307.99 Aligned_cols=249 Identities=30% Similarity=0.435 Sum_probs=198.6
Q ss_pred CcccccCCeeEEEEEecC--C--cEEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLSN--G--QEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
++||+|++|.||+|.+.. + ..||||.+..... ...+.+.+|++++.+++|+||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998643 3 3689999976655 556788999999999999999999999988 888999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc-ee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI-LA 687 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~-~~ 687 (837)
++|.+++..... ..+++.....++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999876432 46899999999999999999999987 99999999999999999999999999987654321 11
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......++..|+|||++.+..++.++||||||++++||++ |+.|+..... ....... ........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~---~~~~~~~~-------- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKI---DKEGERLE-------- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---HhcCCcCC--------
Confidence 2223456789999999999999999999999999999999 9999853211 1111111 11110000
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11122346778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.44 Aligned_cols=253 Identities=28% Similarity=0.447 Sum_probs=201.9
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|.+.++||+|+||.||++...++..+|+|.+... ....+.+.+|++++++++|+||+++.+++.+ ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 567888999999999999999877888999988643 2345678899999999999999999999877 67899999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 84 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999986532 345788999999999999999999987 9999999999999999999999999998764332211
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....++..|+|||++....++.++||||||++++|+++ |+.|+..... ..+.... .......
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~----~~~~~~~-------- 223 (260)
T cd05073 160 -REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRAL----ERGYRMP-------- 223 (260)
T ss_pred -ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----hCCCCCC--------
Confidence 112345678999999998899999999999999999999 8888853211 1111111 1111100
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
........+.+++.+|++.+|++||++.+|.++|+.
T Consensus 224 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 -RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111223457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=309.92 Aligned_cols=251 Identities=34% Similarity=0.528 Sum_probs=197.3
Q ss_pred CcccccCCeeEEEEEecC-------CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 534 NKLGQGGFGPVYKGKLSN-------GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+.||+|+||.||+|+..+ +..+|||.+.... .....++.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999997642 2579999886543 23466788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcC----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-----Ceeeccccc
Q 003237 606 MPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-----NPRISDFGT 676 (837)
Q Consensus 606 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~ki~DFGl 676 (837)
+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 2234788999999999999999999987 99999999999999877 899999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
++...............++..|+|||++.++.++.++|||||||++|||++ |+.|+..... ....... ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHH----hcCC
Confidence 986644332222223345678999999999999999999999999999998 9988853211 1111111 1111
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.. .........+.+++.+|++.+|++||+|++|+++|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0111223457789999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=309.49 Aligned_cols=249 Identities=28% Similarity=0.426 Sum_probs=193.1
Q ss_pred CcccccCCeeEEEEEecC-Cc--EEEEEEecCC-CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLSN-GQ--EIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||.||+|++.+ +. .+|+|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998753 43 4688888643 234456788999999999 799999999999999999999999999
Q ss_pred CChhhHhhhcC-------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccc
Q 003237 609 KSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (837)
Q Consensus 609 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFG 675 (837)
|+|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1234789999999999999999999987 9999999999999999999999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccC
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDN 754 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 754 (837)
++...... ........+..|+|||++....++.++||||||++++||++ |+.|+..... .... ... ..+
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~---~~~-~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELY---EKL-PQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHH---HHH-hCC
Confidence 98632211 11111234567999999988899999999999999999997 9999853211 1111 111 111
Q ss_pred ccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 755 KALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 755 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
...+ ........+.+++.+|++.+|.+|||+.++++.|+++
T Consensus 228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1111 1111223577999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.47 Aligned_cols=250 Identities=26% Similarity=0.478 Sum_probs=200.2
Q ss_pred CCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+|++.+.||+|+||.||++...++..+|+|.+... .....++.+|++++.+++||||+++++++......++|+||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 56677899999999999998877889999998643 23456789999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~- 157 (256)
T cd05112 84 GCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS- 157 (256)
T ss_pred CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc-
Confidence 99999886432 34789999999999999999999987 9999999999999999999999999998654332211
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
.....++..|+|||.+.++.++.++||||||+++|||++ |+.|+..... ..... .. ..+ .....+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~---~~-~~~--~~~~~~~~--- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVE---TI-NAG--FRLYKPRL--- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHH---HH-hCC--CCCCCCCC---
Confidence 112334678999999998999999999999999999998 8888753211 11111 11 111 01111111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
....+.+++.+|++.+|++||||.+|+++|
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 234678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=328.37 Aligned_cols=260 Identities=21% Similarity=0.305 Sum_probs=195.3
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC-----ccE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----ENM 600 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 600 (837)
+|++.++||+|+||.||++... +++.||||++... .....+.+.+|++++..++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 3677899999999999999864 7899999998643 2234567889999999999999999999998776 789
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+|+||+. ++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 577777643 235889999999999999999999988 999999999999999999999999999875
Q ss_pred cCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc-
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE- 758 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~- 758 (837)
....... .....++..|+|||++.+. .++.++|||||||+++||++|+.||...... .....+..........+
T Consensus 154 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI---QQLDLITDLLGTPSLEAM 229 (372)
T ss_pred ccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCCCHHHH
Confidence 4332211 1224578899999998874 5799999999999999999999998643221 11111111111100000
Q ss_pred ---------cc-----cc-ccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 ---------IV-----DS-SMA--NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 ---------~~-----d~-~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+ .+ ... ..........+.+++.+|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00 00 000 0011112345778999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=309.16 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=200.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-C---CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-N---GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
.+|.+.+.||+|+||.||+|+.. + +..+|+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46777899999999999999764 2 3479999986542 23356788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|.+++.... ..+++.+.+.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999986432 35789999999999999999999987 99999999999999999999999999987654
Q ss_pred ccceee-eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 683 EEILAI-TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 683 ~~~~~~-~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
...... .....++..|+|||++.+..++.++||||||++++|+++ |+.|+..... ........ ++. ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~----~~~--~~- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIE----EGY--RL- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHh----CCC--cC-
Confidence 322111 112233568999999999899999999999999999887 9999853221 11111111 110 00
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+ ........+.+++.+|++.+|++||+|.+|++.|+.+
T Consensus 229 -~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0111234567899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.11 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=197.9
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccc-cCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL-EEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~ey~ 606 (837)
++|.+.+.||+|+||.||++... |..+|+|.++.. ...+.+.+|+.++++++|+||+++++++. +++..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46778899999999999999875 788999998643 23567889999999999999999999764 455689999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999986533 335789999999999999999999987 9999999999999999999999999988643321
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.....+..|+|||++.+..++.++||||||+++|||++ |+.|+.... ...+.... ..+....
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~----~~~~~~~------- 219 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRV----EKGYKMD------- 219 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----hcCCCCC-------
Confidence 12344568999999998899999999999999999998 888875321 11111111 1111111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
........+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112234577899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=313.69 Aligned_cols=262 Identities=25% Similarity=0.409 Sum_probs=200.9
Q ss_pred CCCcCCcccccCCeeEEEEEe-----cCCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENM 600 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 600 (837)
.|.+.+.||+|+||.||+++. .++..||+|.++... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467788999999999999974 357889999986543 33456789999999999999999999998775 4678
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 9999999999999985432 35799999999999999999999987 999999999999999999999999999876
Q ss_pred cCccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--------CcchHHHHHHHHh
Q 003237 681 GGEEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDD--------DSSNLIKYAWELW 751 (837)
Q Consensus 681 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~--------~~~~l~~~~~~~~ 751 (837)
...... .......++..|+|||++.+..++.++||||||++++||++++.|....... .............
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 433221 1222345677899999999889999999999999999999987664221100 0000001111111
Q ss_pred ccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 752 SDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 752 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..+... .........+.+++.+|++.+|++|||+++|++.|+.+
T Consensus 240 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111110 01112335688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=310.61 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=197.1
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecccccC------
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE------ 596 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~------ 596 (837)
.+++.|+..+.||+|+||.||+|... +++.+|+|++... .....++.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888899999999999999875 5888999998644 34456788999999998 699999999998753
Q ss_pred CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
...++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999998653 2345889999999999999999999987 99999999999999999999999999
Q ss_pred ceeccCccceeeeccccccCCccCccccc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELW 751 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 751 (837)
+....... .......|+..|+|||++. ...++.++|||||||++|||++|+.|+...... ... ....
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~-~~~~ 229 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RAL-FLIP 229 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHH-HHHh
Confidence 98654321 1123356889999999986 346888999999999999999999998532211 110 1111
Q ss_pred ccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 752 SDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 752 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. ...... .......+.+++.+|++.+|.+|||+.+|++
T Consensus 230 ~~-~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RN-PAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cC-CCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 10 001111 1112235778999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.08 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=192.5
Q ss_pred ccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCCh
Q 003237 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 536 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
||+|+||.||+++.. +|+.+|+|++.... ......+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 68999999986432 12234556799999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeecc
Q 003237 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691 (837)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 691 (837)
..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 98886543 234789999999999999999999987 99999999999999999999999999987643321 123
Q ss_pred ccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHH
Q 003237 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLAS 771 (837)
Q Consensus 692 ~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 771 (837)
..++..|+|||++.+..++.++|||||||++|||++|+.|+........ ........... . +.. ... .
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~-~----~~~-~~~----~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLED-E----VKF-EHQ----N 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhcc-c----ccc-ccc----c
Confidence 5688999999999999999999999999999999999999864322111 11111111110 0 000 001 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 772 EALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 772 ~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
....+.+++..|++.+|++||+++|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 233467899999999999999998766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.28 Aligned_cols=240 Identities=20% Similarity=0.347 Sum_probs=187.3
Q ss_pred CcccccCCeeEEEEEecC-------------CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 534 NKLGQGGFGPVYKGKLSN-------------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
+.||+|+||.||+|+... ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2258889886555455567888999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC-------eeecc
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN-------PRISD 673 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~-------~ki~D 673 (837)
+||||+++++|+.++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999887543 235889999999999999999999987 999999999999987664 89999
Q ss_pred cccceeccCccceeeeccccccCCccCccccc-CCCCCCcccHHHHHHHHHHHH-hCCCCCCCCCCCCcchHHHHHHHHh
Q 003237 674 FGTARVFGGEEILAITKRVVGTYGYMSPEYAL-DGVFSTKSDVFSFGVILLEII-TGKKNTRIFNDDDSSNLIKYAWELW 751 (837)
Q Consensus 674 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~k~DV~S~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~ 751 (837)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+......+ . ....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~----~~~~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---K----ERFY 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---H----HHHH
Confidence 9998754322 1245778899999887 467899999999999999998 5777764321110 0 0111
Q ss_pred ccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 752 SDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 752 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.. . .... ......+.+++.+|++.+|++||++.++++.|+
T Consensus 223 ~~-~-~~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EG-Q-CMLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hc-C-ccCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 10 0 0000 111245778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.04 Aligned_cols=261 Identities=22% Similarity=0.308 Sum_probs=198.7
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|++.++||+|+||.||++... ++..+|+|.+.... .....++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36788899999999999999875 57889999886542 23345688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++... ..+++.....++.||++||.|||+.. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999998643 34788889999999999999999742 39999999999999999999999999987543221
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc----------
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK---------- 755 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------- 755 (837)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+...... ..............
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccccC
Confidence 22356889999999998888999999999999999999999998532211 11111000000000
Q ss_pred ----------ccccccccccc---cc-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 756 ----------ALEIVDSSMAN---SC-LASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 756 ----------~~~~~d~~l~~---~~-~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
..+..+..... .. .......+.+++.+|++.+|++|||+.+|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 00 00123357899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=301.05 Aligned_cols=263 Identities=24% Similarity=0.327 Sum_probs=198.2
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc--CHHHHHHHHHHHHHhcCCC-eeeeecccccCC------c
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ--GIEELKNEVLLIAKLQHRN-LVKLLGCCLEED------E 598 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~------~ 598 (837)
.|...++||+|+||+||+|+.. +|+.||+|+++..... ......+|+.++.+++|+| ||+|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3455678999999999999765 7899999999765332 3345679999999999999 999999998877 6
Q ss_pred cEEEEEecCCCChhhHhhhcCCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRK-QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
.+||+||++. +|..++...... ..++-..+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 7899999865 788888654322 34566788899999999999999998 999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC--
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN-- 754 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 754 (837)
+...-.... .....+|..|.|||++.+. .|+...||||+|||+.||++++.-|....+ .+....+.+....+
T Consensus 168 ra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 168 RAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCCc
Confidence 966532211 2236789999999999986 799999999999999999998887754433 22223333332221
Q ss_pred -cc---ccccccc--ccccc-----C---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 755 -KA---LEIVDSS--MANSC-----L---ASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 755 -~~---~~~~d~~--l~~~~-----~---~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.. ..+.+-. ..... . +.......+++.+|++.+|.+|.|++.++.+
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11 1111111 11111 0 0011356789999999999999999999875
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=325.71 Aligned_cols=253 Identities=21% Similarity=0.265 Sum_probs=197.8
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
..++|++.++||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|++++..++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467888999999999999999875 6889999998643 22334567889999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++|+|..++... .++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988542 3677778889999999999999987 9999999999999999999999999998764
Q ss_pred CccceeeeccccccCCccCcccccCC----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDG----VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..............
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~ 266 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSL 266 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcC
Confidence 33211 12335799999999998753 478999999999999999999999863221 11111111111111
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTD--RPSMSTVVF 799 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPtm~eVv~ 799 (837)
...+ .......+.+++..|++.+|++ ||+++|++.
T Consensus 267 ~~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 TFPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 1100 1112345678889999999987 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.58 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=200.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46788899999999999999764 68899999997665555678889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999999853 24788999999999999999999987 999999999999999999999999998765432211
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||...... . ........+. .. +
T Consensus 173 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~----~~~~~~~~~~-~~-----~-- 236 (296)
T cd06654 173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--R----ALYLIATNGT-PE-----L-- 236 (296)
T ss_pred --cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--H----hHHHHhcCCC-CC-----C--
Confidence 12246788999999999988999999999999999999999998532211 1 1111111110 00 0
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+......+.+++.+|++.+|++|||+.+|++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 011122245778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=306.68 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=189.9
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc-----cEEEE
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE-----NMLIY 603 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-----~~lV~ 603 (837)
|...+++|.|+||.||+|++. +++.||||++-...+. -.+|+++|++++|||||+|+.++....+ ..|||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 455689999999999999876 4789999998654332 2469999999999999999998865332 35899
Q ss_pred EecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC-CCeeecccccceecc
Q 003237 604 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARVFG 681 (837)
Q Consensus 604 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~DFGla~~~~ 681 (837)
|||+. +|...+... ..+..++.....-+..||++||.|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 777777642 22334555566668999999999999987 9999999999999965 999999999999886
Q ss_pred CccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc---
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL--- 757 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--- 757 (837)
..+.. ....-+..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.... ...++...+. ++.-+...
T Consensus 178 ~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s--~~dQL~eIik-~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 178 KGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS--SVDQLVEIIK-VLGTPTREDIK 251 (364)
T ss_pred cCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC--HHHHHHHHHH-HhCCCCHHHHh
Confidence 55432 124557899999999875 79999999999999999999998875422 2333443332 22211111
Q ss_pred -------cccccccccc-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 -------EIVDSSMANS-----CLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 -------~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+.-.+.+... .......+.++++.++++.+|.+|.++.|++.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111111111 12223356788999999999999999999974
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=342.18 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=200.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.++||+|+||.||+|+.. +++.||||++..... ...+++.+|++++.+++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999875 589999999965422 23457889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcC--------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccc
Q 003237 604 EFMPNKSLDYFIFDES--------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFG 675 (837)
||+++++|.+++.... ....+++...+.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1223567788899999999999999987 9999999999999999999999999
Q ss_pred cceeccCccc----------------eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCC
Q 003237 676 TARVFGGEEI----------------LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD 739 (837)
Q Consensus 676 la~~~~~~~~----------------~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~ 739 (837)
+++....... ........||+.|+|||++.+..++.++|||||||+++||++|+.|+......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9987621110 00111246899999999999999999999999999999999999998642111
Q ss_pred cchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccC
Q 003237 740 SSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRP-SMSTVVFMLSNE 804 (837)
Q Consensus 740 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-tm~eVv~~L~~~ 804 (837)
... .. ... .++... ....+....+.+++.+|++.+|++|| +++++.+.|+..
T Consensus 238 --ki~-~~------~~i---~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 --KIS-YR------DVI---LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred --hhh-hh------hhc---cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 00 000 000000 00011223467899999999999995 677777777653
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.43 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=209.5
Q ss_pred CCCcCCcccccCCeeEEEEEecC---C--cEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSN---G--QEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~---g--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
.....+.||+|-||.||+|...+ | -.||||..+.+ .....+.|..|..+|++++|||||+|+|+|.+ ...+||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34456789999999999997642 3 35889988764 45567889999999999999999999999964 478999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
||.++-|.|..+|... +..|+......++.||..||+|||+.. +|||||..+|||+...-.+|++||||++.+..
T Consensus 469 mEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 9999999999999654 345888888899999999999999987 99999999999999999999999999999887
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
+.+... +....+..|||||.+.-.+|+.++|||-|||.+||++. |..||....+. ++.-.++
T Consensus 544 ~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~~iE 606 (974)
T KOG4257|consen 544 DAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIGHIE 606 (974)
T ss_pred cchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEEEec
Confidence 665543 35677889999999999999999999999999999886 99998654332 2222233
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..-+-.+++.....+..++.+||+.+|.+||...++...|+.+
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 3333334555666788999999999999999999998877543
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.79 Aligned_cols=239 Identities=23% Similarity=0.348 Sum_probs=185.9
Q ss_pred cccccCCeeEEEEEecC-------------------------CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeee
Q 003237 535 KLGQGGFGPVYKGKLSN-------------------------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL 589 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 589 (837)
+||+|+||.||+|.+.. ...||+|.+.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13588998865544445678889999999999999999
Q ss_pred ecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC--
Q 003237 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-- 667 (837)
Q Consensus 590 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-- 667 (837)
++++.+....++||||+++|+|..++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888543 235788999999999999999999987 99999999999998654
Q ss_pred -----CeeecccccceeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHH-hCCCCCCCCCCCCc
Q 003237 668 -----NPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEII-TGKKNTRIFNDDDS 740 (837)
Q Consensus 668 -----~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~ell-tG~~p~~~~~~~~~ 740 (837)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......+
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3799999987643221 11346788999998876 56899999999999999995 6888885432211
Q ss_pred chHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 741 SNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 741 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
..... ... ..+... ....+.+++.+|++.+|++||+|.+|++.|+
T Consensus 230 --~~~~~----~~~-------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 --KERFY----EKK-------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHH----Hhc-------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111 100 001111 1135778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=326.21 Aligned_cols=262 Identities=17% Similarity=0.220 Sum_probs=195.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
...|.+.+.||+|+||.||++... .++.||||.... ..+.+|++++++++|+|||++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457888899999999999999876 478899996422 3457899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+. ++|..++... ...+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 6888877543 235899999999999999999999987 99999999999999999999999999987644322
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-C----cchHHHHHHHHhcc-Cccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDD-D----SSNLIKYAWELWSD-NKALEI 759 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~-~----~~~l~~~~~~~~~~-~~~~~~ 759 (837)
........||..|+|||++.+..++.++|||||||+||||++|..++-..... . ...+...+...... ......
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 22223457999999999999999999999999999999999988765322111 1 11122222111000 000000
Q ss_pred ccccc------------ccccC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 760 VDSSM------------ANSCL-------ASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 760 ~d~~l------------~~~~~-------~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
....+ ..... ......+.+++.+|++.||.+|||+.||++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 00000 0111246789999999999999999999864
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=319.90 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=190.7
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHH---HHhcCCCeeeeecccccCCccEEE
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLI---AKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
|.+.+.||+|+||.||++... +++.||||+++... ....+.+.+|++++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456789999999999999875 68999999996532 23345666776665 456799999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|..++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999888743 35899999999999999999999987 99999999999999999999999999875322
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .... ....... .
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~---~~i~~~~-------~ 218 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVF---DSIVNDE-------V 218 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhCC-------C
Confidence 11 122346789999999999999999999999999999999999999863221 1111 1111110 0
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
.. +......+.+++.+|++.+|.+|| ++.++++
T Consensus 219 ~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RY----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01 111234567899999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=328.44 Aligned_cols=200 Identities=24% Similarity=0.366 Sum_probs=170.5
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
+|++.++||+|+||.||+++.. +++.||||.+.+.. ....+.+.+|++++.+++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5788899999999999999765 58899999986432 2335668899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++|+|.+++... ..++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999998643 34778888889999999999999988 9999999999999999999999999975331000
Q ss_pred -----------------------------------------ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHH
Q 003237 685 -----------------------------------------ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILL 723 (837)
Q Consensus 685 -----------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ 723 (837)
.........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000011247999999999999999999999999999999
Q ss_pred HHHhCCCCCCC
Q 003237 724 EIITGKKNTRI 734 (837)
Q Consensus 724 elltG~~p~~~ 734 (837)
||++|+.||..
T Consensus 236 ell~G~~Pf~~ 246 (376)
T cd05598 236 EMLVGQPPFLA 246 (376)
T ss_pred ehhhCCCCCCC
Confidence 99999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=322.11 Aligned_cols=241 Identities=20% Similarity=0.271 Sum_probs=191.8
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 609 (837)
+.||+|+||.||+++.. +++.||+|.+... .......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 6889999998653 2233456778999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
+|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 998887543 358899999999999999999997 56 99999999999999999999999999875432211 1
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. .... .. ..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~---~i~~-~~------~~~p~~- 218 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE---LILM-EE------IRFPRT- 218 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHH---HHhc-CC------CCCCCC-
Confidence 2235789999999999999999999999999999999999999853221 11111 1110 00 011111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
....+.+++.+|++.||++|| ++.++++
T Consensus 219 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 219 ---LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ---CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 223467888999999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.00 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=205.9
Q ss_pred cCCcccccCCeeEEEEEec--CCc--EEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 532 TSNKLGQGGFGPVYKGKLS--NGQ--EIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 532 ~~~~LG~G~fG~Vy~~~~~--~g~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
..++||+|.||.|++|.+. +|. .||||.++..... ....|.+|+.+|.+|+|+|+|+|+|+..+ ....||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3579999999999999775 454 5799999766443 67899999999999999999999999877 7889999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc-c
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE-I 685 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~-~ 685 (837)
+.|+|.+.|++ ..+..+-......++.|||.||.||.++. +|||||..+|+||-..-.+||+||||.+-++..+ .
T Consensus 193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999988 34455677778899999999999999988 9999999999999999999999999999887544 4
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
..+.....-+..|.|||.+....|+.++|||+|||.+|||+| |..|+-.... -.+.+.+|..-
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~qIL~~iD~~e 332 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQILKNIDAGE 332 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HHHHHhccccc
Confidence 444555566889999999999999999999999999999998 6667643211 12333444333
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
.-.-+....++++++++.||..+|++|||+..+.+.+
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2334555677899999999999999999999997443
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=318.85 Aligned_cols=241 Identities=21% Similarity=0.344 Sum_probs=191.4
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
++||+|+||.||+|+.. +++.||||++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 5789999998653 223445677899998876 799999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
++|..++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 9999888543 34788889999999999999999988 99999999999999999999999999875432221 1
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ...... .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~---~i~~~~----~~---~---- 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFE---SILHDD----VL---Y---- 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHH---HHHcCC----CC---C----
Confidence 2335789999999999999999999999999999999999999964321 11111 111111 00 0
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRP-------SMSTVVF 799 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RP-------tm~eVv~ 799 (837)
+......+.+++..|++.+|++|| ++.++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 111123567888999999999999 7888864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=323.61 Aligned_cols=262 Identities=19% Similarity=0.218 Sum_probs=198.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEec---CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
..+|.+.++||+|+||.||++... .+..||||.+... +.+.+|++++.+++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357888999999999999999753 3578999988543 24568999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
|++. ++|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 57777773 2345899999999999999999999987 999999999999999999999999999876544
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc------
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL------ 757 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------ 757 (837)
..........||..|+|||++....++.++|||||||++|||++|+.|+..............+..........
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33323334679999999999999999999999999999999999999986543322211111111111100000
Q ss_pred -cc------cccccccccC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 758 -EI------VDSSMANSCL-------ASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 758 -~~------~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.+ .......... ......+..++.+|++.+|++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000 0112356678899999999999999999864
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.77 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=199.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-----ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|.+.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++.+++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999764 68999999886432 1234568889999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988543 34788888999999999999999987 9999999999999999999999999998654
Q ss_pred Cccceee-eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEILAI-TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.|+..... . ............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~-~~~~~~~~~~~~---- 225 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-----M-AAIFKIATQPTN---- 225 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-----H-HHHHHHhccCCC----
Confidence 3221111 1234577899999999999999999999999999999999999853211 1 111111111111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.. .+......+.+++..|++.+|++|||+.++++.
T Consensus 226 -~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -PQ----LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CC----CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11 111223356789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.07 Aligned_cols=241 Identities=23% Similarity=0.314 Sum_probs=190.6
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCC-CeeeeecccccCCccEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHR-NLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~ 603 (837)
+|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 3677899999999999999876 5788999998653 233456778899999999764 6888999998889999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999888543 34788899999999999999999987 999999999999999999999999998753221
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.. ......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+... ... .. ..
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~---i~~-~~------~~ 219 (324)
T cd05587 155 GK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQS---IME-HN------VS 219 (324)
T ss_pred CC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH---HHc-CC------CC
Confidence 11 12235789999999999999999999999999999999999999863221 111111 111 00 01
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSM 794 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 794 (837)
+ +......+.+++.+|++.+|++||+.
T Consensus 220 ~----~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 Y----PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1 11122356788999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=302.75 Aligned_cols=249 Identities=23% Similarity=0.392 Sum_probs=201.4
Q ss_pred cCCCcCCcccccCCeeEEEEEecC-CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
++|+..++||+|+||.||+|.... ++.+++|.+..... .+++.+|++++++++|+||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999998864 78999999865432 678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++... ...+++.....++.|+++||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998543 345899999999999999999999987 99999999999999999999999999887654321
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......++..|+|||++.+..++.++||||||++++||++|+.|+........ .... .. ...+.+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~~~~-~~-----~~~~~~~- 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------IFMI-PN-----KPPPTLS- 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------hhhh-cc-----CCCCCCC-
Confidence 12234578899999999999999999999999999999999999864322110 0000 00 0000010
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+......+.+++.+|++.+|++|||+.||++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11122345788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=316.87 Aligned_cols=240 Identities=23% Similarity=0.335 Sum_probs=189.4
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||+||+|+.. +++.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999876 57899999987542 23345566788888764 899999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence 9999988543 34788899999999999999999987 99999999999999999999999999875322211 1
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+. .. .+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~----~~------~~~~~~-- 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIR----MD------NPCYPR-- 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hC------CCCCCc--
Confidence 2235789999999999999999999999999999999999999864221 11111111 00 011111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMS-TVV 798 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~-eVv 798 (837)
.....+.+++.+|++.+|++||++. ++.
T Consensus 218 --~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 218 --WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1223467889999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=325.50 Aligned_cols=255 Identities=20% Similarity=0.252 Sum_probs=196.2
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
...++|++.+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.++..++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34567899999999999999999876 5789999998642 2233456788999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||+++|+|.+++... .++......++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999988532 3678888899999999999999987 999999999999999999999999999876
Q ss_pred cCccceeeeccccccCCccCcccccCC----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDG----VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 756 (837)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .............
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~ 265 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNS 265 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCcc
Confidence 43221 112346799999999998754 378999999999999999999999963221 1111111111111
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 003237 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTT--DRPSMSTVVFM 800 (837)
Q Consensus 757 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~--~RPtm~eVv~~ 800 (837)
..+. . .......+.+++..|++.+|. .||++.|+++.
T Consensus 266 ~~~p-----~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 LNFP-----E--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCC-----C--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1110 0 111123456777788875554 38999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=317.97 Aligned_cols=236 Identities=24% Similarity=0.353 Sum_probs=188.3
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||.||+++.. +++.||||++.+. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 5889999998653 223456677888888877 699999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~ 152 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T 152 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence 9999888543 34788999999999999999999987 99999999999999999999999999875432211 1
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ...... ... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~---~~~i~~-~~~---~---~---- 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDL---FEAILN-DEV---V---Y---- 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHH---HHHHhc-CCC---C---C----
Confidence 2335789999999999999999999999999999999999999864221 111 111111 110 0 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSM 794 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm 794 (837)
+......+.+++.+|++.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11122356789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=307.62 Aligned_cols=252 Identities=29% Similarity=0.462 Sum_probs=197.1
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCH--HHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGI--EELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
|++.+.||+|+||+||+++.. +++.+|+|.+........ ....+|+.++.+++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999876 467899999976643322 23456999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++. ....+++..+..++.||++||.+||+.+ |+|+||||+||++++++.++|+|||.+...... .
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--N 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST--T
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--c
Confidence 9999999997 2345799999999999999999999987 999999999999999999999999999864211 1
Q ss_pred eeeccccccCCccCccccc-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYAL-DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~-~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.......++..|+|||++. +..++.++||||+|+++++|++|+.|+..... .+........... ........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKILKR----PLPSSSQQ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHHHHT----HHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---hhhhhhhhhcccc----cccccccc
Confidence 2233467889999999998 88899999999999999999999999864311 1111111111000 00000000
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.......+.+++..|++.+|++||+|.++++
T Consensus 226 ---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 ---SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001157889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.14 Aligned_cols=238 Identities=26% Similarity=0.285 Sum_probs=190.1
Q ss_pred CcccccCCeeEEEEEe----cCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 534 NKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
+.||+|+||.||+++. .+|+.+|+|++.... ......+..|++++.+++||||+++++++.++...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 358899999986532 2234566789999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+|+|.+++... ..+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 99999988543 35889999999999999999999988 99999999999999999999999999886543321
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
......|+..|+|||.+.+..++.++|||||||++|||++|+.|+..... .... ...... .. .+
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~---~~i~~~-~~------~~--- 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETM---TMILKA-KL------GM--- 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHH---HHHHcC-CC------CC---
Confidence 12235789999999999998999999999999999999999999863211 1111 111111 00 01
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPSMST 796 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~e 796 (837)
+......+.+++.+|++.||++||++.+
T Consensus 218 -p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 -PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1112234678889999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.78 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=193.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.++||+|+||+||+++.. +++.||||++.+.. ....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36788899999999999999765 68899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998643 34788888889999999999999988 999999999999999999999999999643211
Q ss_pred cce---------------------------------------------eeeccccccCCccCcccccCCCCCCcccHHHH
Q 003237 684 EIL---------------------------------------------AITKRVVGTYGYMSPEYALDGVFSTKSDVFSF 718 (837)
Q Consensus 684 ~~~---------------------------------------------~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~ 718 (837)
... .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 00012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCC---CCHH
Q 003237 719 GVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDR---PSMS 795 (837)
Q Consensus 719 Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ptm~ 795 (837)
||++|||++|+.||..... ..... ..........+.+ . ......+.+++.+|++ +|.+| |++.
T Consensus 235 Gvil~elltG~~Pf~~~~~---~~~~~---~i~~~~~~~~~p~-----~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS---HETYR---KIINWRETLYFPD-----D--IHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCH---HHHHH---HHHccCCccCCCC-----C--CCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999853221 11111 1111111111100 0 0112345677778887 66654 6999
Q ss_pred HHHHH
Q 003237 796 TVVFM 800 (837)
Q Consensus 796 eVv~~ 800 (837)
|+++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.01 Aligned_cols=261 Identities=22% Similarity=0.349 Sum_probs=195.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|.+.++||+|+||.||+|+.. +++.||+|.++... ......+.+|++++.+++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46788899999999999999875 67889999986543 23345677899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++ +|..++... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 777777543 235788889999999999999999987 99999999999999999999999999976543221
Q ss_pred eeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc---c----
Q 003237 686 LAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA---L---- 757 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~---- 757 (837)
......++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+ .............. .
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED---ELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHhhhcc
Confidence 1122467889999998865 468999999999999999999999986432211 11111111110000 0
Q ss_pred --ccccccccc-------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 --EIVDSSMAN-------SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 --~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+..+..... .........+.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 000111234678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.09 Aligned_cols=238 Identities=24% Similarity=0.429 Sum_probs=188.4
Q ss_pred CcccccCCeeEEEEEecCCc-----------EEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 534 NKLGQGGFGPVYKGKLSNGQ-----------EIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999886433 5788877544333 6788999999999999999999999988 778999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-------Ceeecccc
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-------NPRISDFG 675 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-------~~ki~DFG 675 (837)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999865432 5789999999999999999999987 99999999999999888 79999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccCC--CCCCcccHHHHHHHHHHHHhC-CCCCCCCCCCCcchHHHHHHHHhc
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDG--VFSTKSDVFSFGVILLEIITG-KKNTRIFNDDDSSNLIKYAWELWS 752 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~k~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~ 752 (837)
++..... .....++..|+|||++... .++.++||||||++++||++| ..|+......+ .... ..
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~----~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERF----YQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHH----Hh
Confidence 9886543 1224566789999999876 789999999999999999994 66664332111 0000 00
Q ss_pred cCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 753 DNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 753 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.... + +......+.+++.+|++.+|.+|||+.+|++.|+
T Consensus 221 ~~~~-------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHR-------L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCC-------C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 0 0001156789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.52 Aligned_cols=237 Identities=22% Similarity=0.270 Sum_probs=185.7
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHH-HHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVL-LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||+||+|+.. +|+.||||++.... .....++..|.. ++..++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999875 68999999986432 122344455544 55778999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|..++... ..+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 9999888543 35788888899999999999999987 9999999999999999999999999987532211 12
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~-------~~~~~-- 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------TAEMYDNILNKP-------LRLKP-- 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC------HHHHHHHHHcCC-------CCCCC--
Confidence 234578999999999999999999999999999999999999985321 111111111110 01111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMS 795 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~ 795 (837)
.....+.+++.+|++.+|++||++.
T Consensus 218 --~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 --NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1234577899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=329.21 Aligned_cols=259 Identities=20% Similarity=0.317 Sum_probs=189.8
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccC--------C
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--------D 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~ 597 (837)
.++|.+.++||+|+||.||+|... +++.||||++.... ....+|+.+++.++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467899999999999999999875 68899999985432 2345799999999999999998876432 1
Q ss_pred ccEEEEEecCCCChhhHhhh-cCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-Ceeecccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFG 675 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~DFG 675 (837)
..++||||+++ +|..++.. ......+++.....++.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999986 66666543 223456889999999999999999999988 99999999999999664 79999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN 754 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 754 (837)
+++.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.... ......
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~-~~~~~p 290 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS--VDQLVRII-QVLGTP 290 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHH-HHhCCC
Confidence 9986543221 1235678999999998764 699999999999999999999999864321 11111111 111110
Q ss_pred cc----------ccc-----cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 755 KA----------LEI-----VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 755 ~~----------~~~-----~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. .++ ....+...++.....++.+++.+|++.+|.+|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00 000 0000111111122346789999999999999999999984
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.11 Aligned_cols=241 Identities=23% Similarity=0.320 Sum_probs=191.2
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
+|.+.+.||+|+||.||+|+.. +++.+|||.+.+.. ....+.+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3677889999999999999876 57899999987542 22344567788888877 5899999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999888543 34788999999999999999999987 999999999999999999999999999754322
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.... .. ...
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i---~~-~~~------- 218 (323)
T cd05616 155 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSI---ME-HNV------- 218 (323)
T ss_pred CC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHH---Hh-CCC-------
Confidence 11 12346789999999999999999999999999999999999999864221 1111111 11 100
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSM 794 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 794 (837)
..+......+..++.+|++.+|++|++.
T Consensus 219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111223456789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=302.97 Aligned_cols=254 Identities=19% Similarity=0.319 Sum_probs=189.0
Q ss_pred CcccccCCeeEEEEEecCCc---EEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCC
Q 003237 534 NKLGQGGFGPVYKGKLSNGQ---EIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 609 (837)
+.||+|+||.||+|...++. .+++|.+.... ....+.+.+|+.++..++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999764433 45677665433 334578899999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 610 SLDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 610 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
+|.+++..... ....++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999875422 234566777889999999999999987 99999999999999999999999999864322222122
Q ss_pred eccccccCCccCcccccC-------CCCCCcccHHHHHHHHHHHHhC-CCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 689 TKRVVGTYGYMSPEYALD-------GVFSTKSDVFSFGVILLEIITG-KKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~-------~~~s~k~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
.....++..|+|||++.. ..++.++||||||+++|||+++ +.|+..... .. ...... .+....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~---~~~~~~-~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---RE---VLNHVI-KDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HH---HHHHHH-hhcccccC
Confidence 233567889999998753 2457899999999999999974 556643211 11 111111 12223334
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
++.+...+. ..+.+++..|+ .+|++||+|++|+++|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 444433222 34567778899 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.70 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=205.1
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788889999999999999986 478999999997655555677889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999998853 34788899999999999999999987 999999999999999999999999998865433211
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ +. .....+ .+.+
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~----~~~~~~------~~~~-- 235 (297)
T cd06656 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY----LIATNG------TPEL-- 235 (297)
T ss_pred --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee----eeccCC------CCCC--
Confidence 1234678899999999999999999999999999999999999853221110 00 000000 0000
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCCCCC
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETFVP 808 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~~~~ 808 (837)
..+......+.+++.+|++.+|++||++++|++ .++..++.+
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 011112244678899999999999999999987 554444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.79 Aligned_cols=250 Identities=29% Similarity=0.425 Sum_probs=190.9
Q ss_pred CcccccCCeeEEEEEec----CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeeccccc-CCccEEEEEecC
Q 003237 534 NKLGQGGFGPVYKGKLS----NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE-EDENMLIYEFMP 607 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~ey~~ 607 (837)
+.||+|+||.||+|... +...+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999763 2457999998543 23445678899999999999999999998764 456789999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999986432 33677888899999999999999987 9999999999999999999999999998654322111
Q ss_pred --eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCC-CCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 688 --ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKK-NTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 688 --~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
......++..|+|||.+.+..++.++||||||+++|||++|.. |+... ....+.. ........ ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~---~~~~~~~~------~~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITV---YLLQGRRL------LQ 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHH---HHhcCCCC------CC
Confidence 1122345778999999998899999999999999999999654 44321 1111111 11111100 00
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. .....+.+++..|++.+|++||++.+|++.|++.
T Consensus 224 ~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 224 PE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11 1123577999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.37 Aligned_cols=255 Identities=26% Similarity=0.435 Sum_probs=200.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCc----EEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
.+|.+.+.||+|+||.||+|... +|. .+|+|.+..... ....++.+|+.++.+++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45777899999999999999864 333 589998865532 345678899999999999999999999987 78899
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|+||+++|+|.+++.... ..+++.....++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999986532 34889999999999999999999977 9999999999999999999999999998765
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
............++..|+|||.+....++.++||||||++++|+++ |+.|+..... ..+.. .. ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~---~~-~~~~~~--- 230 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPD---LL-EKGERL--- 230 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHH---HH-hCCCCC---
Confidence 4332221122234568999999988899999999999999999999 9999864321 11111 11 111110
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..+......+.+++..|+..+|.+||++.++++.|+..
T Consensus 231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01111223567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=315.58 Aligned_cols=193 Identities=20% Similarity=0.320 Sum_probs=164.4
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
....+|.+.+.||+|+||.||+|+.. ++..||+|..... ....|+.++.+++|+||+++++++..+...++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34568999999999999999999876 5678999975432 2346999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+. ++|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 5787777543 345899999999999999999999987 999999999999999999999999999754322
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNT 732 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~ 732 (837)
. ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 112356899999999999999999999999999999999976654
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=312.80 Aligned_cols=240 Identities=23% Similarity=0.311 Sum_probs=189.2
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||.||+|+.. +|+.||||.++... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999876 68899999986532 23345667788888765 899999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|..++... ..+++.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 9999888543 34788888999999999999999987 9999999999999999999999999987532211 11
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ...+..... .. .+.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~~~~----~~------~~~~~~~- 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFESIR----VD------TPHYPRW- 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHH----hC------CCCCCCC-
Confidence 234678999999999999999999999999999999999999985321 111111111 00 0111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMS-TVV 798 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~-eVv 798 (837)
....+.+++.+|++.||++||++. ++.
T Consensus 219 ---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 223467888999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=307.70 Aligned_cols=263 Identities=26% Similarity=0.357 Sum_probs=196.3
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|++.+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3677889999999999999875 68999999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
++ ++|..++........+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 98 688888765444456899999999999999999999987 99999999999999999999999999986543221
Q ss_pred eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh-------cc----
Q 003237 686 LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELW-------SD---- 753 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-------~~---- 753 (837)
......++..|+|||++.+. .++.++||||||++++||++|+.|+...... ..+........ ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcchhh
Confidence 11224568899999988754 5789999999999999999999998632211 11111100000 00
Q ss_pred Ccccccccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 NKALEIVDSSMAN---SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 ~~~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
......++..... ........++.+++.+|++.||++|||+.+|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 000012245678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.07 Aligned_cols=246 Identities=24% Similarity=0.405 Sum_probs=197.3
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++......++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455678999999999999765 57889999986443 3345678899999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++.. ..+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 86 ~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 86 GGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 9999988743 35788999999999999999999987 99999999999999999999999999976543221
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
......++..|+|||++.+..++.++||||||++++||++|+.|+....... ... ..... ..+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~----~~~~~-----~~~~~--- 221 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLF----LIPKN-----SPPTL--- 221 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHh----hhhcC-----CCCCC---
Confidence 1122457889999999999999999999999999999999999975322111 000 00000 01111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.......+.+++.+|++.+|++||+|.+|++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 -EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12233457799999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.29 Aligned_cols=240 Identities=21% Similarity=0.270 Sum_probs=186.7
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHH-HHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVL-LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||+||+++.. +|+.+|||++.+.. .....++..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999765 68999999986531 223345555554 46778999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 9998887543 35788999999999999999999987 9999999999999999999999999987532211 11
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ............ . .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~------~~~~~~~~~~~~-~------~~---- 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD------VAEMYDNILHKP-L------VL---- 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC------HHHHHHHHHcCC-c------cC----
Confidence 233578999999999999999999999999999999999999985321 111111111110 0 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMSTVV 798 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv 798 (837)
.+.....+.+++..|++.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 111234567889999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=307.80 Aligned_cols=240 Identities=22% Similarity=0.374 Sum_probs=188.1
Q ss_pred CcccccCCeeEEEEEecC--------CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 534 NKLGQGGFGPVYKGKLSN--------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.++..++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997642 234888888655445567788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC--------eeecccccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN--------PRISDFGTA 677 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~ki~DFGla 677 (837)
+++|+|..++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999986543 35789999999999999999999987 999999999999987765 589999988
Q ss_pred eeccCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCC-CCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGK-KNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+..... ..... ....
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---~~~~~----~~~~-- 220 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---QKKLQ----FYED-- 220 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---HHHHH----HHHc--
Confidence 654322 224578899999999874 5899999999999999999995 44432111 00000 0000
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.. ..+......+.+++.+|++.+|++|||++++++.|+
T Consensus 221 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 RH---------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cc---------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 111112245789999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.52 Aligned_cols=241 Identities=23% Similarity=0.316 Sum_probs=192.3
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||+||+++.. +++.||||.+++. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999876 5789999998753 223455677899999888 699999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T 152 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence 9999888543 34889999999999999999999987 99999999999999999999999999875322211 1
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. .... ... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~---~i~~-~~~------~~---- 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQ---SILE-DEV------RY---- 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHH---HHHc-CCC------CC----
Confidence 2235689999999999999999999999999999999999999853221 11111 1111 100 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSM-----STVVF 799 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm-----~eVv~ 799 (837)
+......+.+++.+|++.||++||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11123456789999999999999999 88865
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.12 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=197.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCc----EEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|+..+.||+|+||.||+|+.. ++. .+|+|.+..... ....++.+|+.++..++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677889999999999999764 444 478888865432 2344788999999999999999999998654 5679
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
++||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998643 234788899999999999999999987 9999999999999999999999999998765
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ...+... ...+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~----~~~~~~~~-- 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDL----LEKGERLP-- 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH----HHCCCCCC--
Confidence 3322222222345678999999999999999999999999999997 888875321 1111111 11111100
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
. .......+.+++..|+..+|++||+|++|++.|+.+
T Consensus 232 ~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 Q-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 111224577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=319.41 Aligned_cols=258 Identities=21% Similarity=0.261 Sum_probs=198.1
Q ss_pred HHHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC
Q 003237 522 TLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED 597 (837)
Q Consensus 522 ~l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 597 (837)
++....++|++.+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.++..++||||+++++.+.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445678999999999999999999876 5789999998642 2233456788999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..++||||+++|+|..++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 999999999999999988542 3677888889999999999999988 999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCC----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDG----VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD 753 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 753 (837)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...........
T Consensus 190 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~ 262 (371)
T cd05622 190 MKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMNH 262 (371)
T ss_pred eEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC------HHHHHHHHHcC
Confidence 876433211 12346799999999998754 37899999999999999999999986321 11111222211
Q ss_pred CccccccccccccccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003237 754 NKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTD--RPSMSTVVFM 800 (837)
Q Consensus 754 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPtm~eVv~~ 800 (837)
.....+.+ .......+.+++..|++.+|.+ ||+++++++.
T Consensus 263 ~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 KNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11111111 1112344667888899844433 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=304.36 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=198.9
Q ss_pred CCCcCCcccccCCeeEEEEEecC--CcEEEEEEecCC----------CccCHHHHHHHHHHHHH-hcCCCeeeeeccccc
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSN--GQEIAVKRLSTT----------SGQGIEELKNEVLLIAK-LQHRNLVKLLGCCLE 595 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~ 595 (837)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999998764 678999987532 12234557778888875 789999999999999
Q ss_pred CCccEEEEEecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccc
Q 003237 596 EDENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (837)
Q Consensus 596 ~~~~~lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DF 674 (837)
++..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.. +|+|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887542 23345888999999999999999999632 3999999999999999999999999
Q ss_pred ccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC
Q 003237 675 GTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN 754 (837)
Q Consensus 675 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 754 (837)
|++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... .......... .
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~~~~-~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKIVE-A 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHHHhh-c
Confidence 9998765433 2233568889999999999899999999999999999999999975321 1111111111 1
Q ss_pred ccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 755 KALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 755 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
... +.... .....+.+++.+|++.+|++||+|.||..+|+
T Consensus 229 ~~~----~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE----PLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC----cCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 110 10000 12245778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.99 Aligned_cols=256 Identities=28% Similarity=0.409 Sum_probs=197.9
Q ss_pred CCcCCcccccCCeeEEEEEec----CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC------
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 597 (837)
|.+.+.||+|+||.||+|.+. .++.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999763 3688999998654 2334667889999999999999999999886543
Q ss_pred ccEEEEEecCCCChhhHhhhcC---CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDES---RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DF 674 (837)
..++++||+++|+|..++.... ....+++.....++.||+.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875432 1224788889999999999999999987 999999999999999999999999
Q ss_pred ccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhcc
Q 003237 675 GTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSD 753 (837)
Q Consensus 675 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 753 (837)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.|+.... ...+..+.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~---~~~~~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE---NSEIYNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC---HHHHHHHHH---cC
Confidence 99987654332222222345678999999999999999999999999999999 888875321 111221111 11
Q ss_pred CccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 754 NKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 754 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
... . ........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 232 ~~~-~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRL-K---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcC-C---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 0 0112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=326.28 Aligned_cols=200 Identities=24% Similarity=0.372 Sum_probs=170.3
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.|+..++||+|+||.||+|+.. +++.+|||++.+.. ....+.+.+|++++.+++|+|||++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4778899999999999999765 68899999986532 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++|+|.+++... ..++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999988643 34778888889999999999999988 9999999999999999999999999975331100
Q ss_pred ---------------------------------------------ceeeeccccccCCccCcccccCCCCCCcccHHHHH
Q 003237 685 ---------------------------------------------ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFG 719 (837)
Q Consensus 685 ---------------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~G 719 (837)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001224689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 003237 720 VILLEIITGKKNTRI 734 (837)
Q Consensus 720 vvl~elltG~~p~~~ 734 (837)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=306.49 Aligned_cols=256 Identities=28% Similarity=0.405 Sum_probs=200.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|+..+.||+|+||.||+|+.. +.+.+++|.+...... ..+++.+|++++.+++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46777889999999999999864 2467899988654333 4567899999999999999999999999989999
Q ss_pred EEEEecCCCChhhHhhhcCCC------CCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccc
Q 003237 601 LIYEFMPNKSLDYFIFDESRK------QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DF 674 (837)
+||||+++++|.+++...... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654322 25899999999999999999999988 999999999999999999999999
Q ss_pred ccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhcc
Q 003237 675 GTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSD 753 (837)
Q Consensus 675 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 753 (837)
|+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..|+..... ...... . ..
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~---~-~~ 233 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR---L-QA 233 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH---H-Hc
Confidence 998754322211 1222355678999999998889999999999999999999 7778743211 111111 1 11
Q ss_pred CccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 754 NKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 754 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
+..... . .......+.+++.+|++.+|++||++.|++++|+
T Consensus 234 ~~~~~~----~----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELP----V----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCC----C----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111100 0 1112246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=304.87 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=200.1
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+|+..+.||.|+||.||+|+.. +++.+|+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777889999999999999875 68899999986543 344567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 999999998543 5889999999999999999999987 99999999999999999999999999987654321
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......++..|+|||++.+..++.++||||||+++|||++|+.|+..... .... ... .... .+.+..
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~---~~~-~~~~-----~~~~~~ 220 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVL---FLI-PKNN-----PPSLEG 220 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHH---HHh-hhcC-----CCCCcc
Confidence 12235678899999999998999999999999999999999999864321 1111 111 1111 111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. .....+.+++..|++.+|++|||++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 02335678899999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=304.92 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=200.2
Q ss_pred cCCCcCCcccccCCeeEEEEEecC----CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|.+.++||+|+||.||+|...+ ...||||...... ....+.+.+|+.++.+++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778999999999999997643 2468999886554 3455688999999999999999999998865 567899
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999986432 34899999999999999999999987 99999999999999999999999999987654
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
..... .....++..|+|||.+....++.++||||||++++|+++ |+.||..... ...... . ..+....
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~---~-~~~~~~~--- 228 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGR---I-ENGERLP--- 228 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHH---H-HcCCcCC---
Confidence 42221 112334568999999988899999999999999999986 9999853322 111111 1 1111110
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
. +......+.+++.+|+..+|++|||+.++++.|+++.
T Consensus 229 --~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 229 --M----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred --C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1122345778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=306.27 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=201.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|++.+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++..++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45677789999999999999765 68899999876543 34457889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|..++... ..+++.....++.+++.||.|||+.. +|+|+||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 9999999887542 35789999999999999999999742 3999999999999999999999999998754322
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCC-----cchHHHHHHHHhccCcccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD-----SSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~~ 760 (837)
......++..|+|||++.+..++.++|||||||+++||++|+.|+....... ...+...........
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 1223578999999999988899999999999999999999999987543211 111112111111110
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
.+.+. .......+.+++.+|++.+|++|||+.||+++.
T Consensus 230 ~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 01110 111234577899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=312.75 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=207.6
Q ss_pred hcCCCcCCcccccCCeeEEEEEecC-CcEEEEEEecCCCcc---CHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQ---GIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 601 (837)
.+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4568888999999999999998774 999999999765432 4568899999999998 9999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC----CCCeeecccccc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE----KMNPRISDFGTA 677 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~ki~DFGla 677 (837)
|||++.+|.|.+.+... . ++......++.||+.++.|||+.+ |+||||||+|+|+.. ++.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999765 2 889999999999999999999987 999999999999963 357999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
...... ......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... .. ..++.
T Consensus 187 ~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i-~~~~~- 255 (382)
T KOG0032|consen 187 KFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AI-LRGDF- 255 (382)
T ss_pred eEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HH-HcCCC-
Confidence 987762 23456899999999999999999999999999999999999999997543322111 11 11111
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
......-......+.+++..|+..||..|+|+.++++.
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11112222334556788999999999999999999983
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=305.45 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=198.7
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++.+++|+||+++++.+......++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777899999999999999876 6899999988653 2333567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|..++........+++..+..++.||++||.|||+.. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 99999998865433446899999999999999999999742 39999999999999999999999999987653221
Q ss_pred eeeccccccCCccCcccccCC------CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDG------VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~------~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.|+..... ............ ..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~-~~----- 226 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLSAIVD-GD----- 226 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHHHHhh-cC-----
Confidence 2234578899999998654 358899999999999999999999853211 111111111110 00
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....+......+..++.+|++.+|++||++++++.
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 ----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 01122223455778999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=306.62 Aligned_cols=260 Identities=24% Similarity=0.341 Sum_probs=191.2
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHh---cCCCeeeeecccccC-----C
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKL---QHRNLVKLLGCCLEE-----D 597 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~-----~ 597 (837)
+|++.+.||+|+||+||+|... +++.||+|.++... ......+.+|+.++..+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777899999999999999775 68899999986532 12234556777777666 699999999987642 3
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..++||||+++ +|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 46899999985 7888775432 234789999999999999999999988 999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc--
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK-- 755 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-- 755 (837)
+....... .....++..|+|||++.+..++.++|||||||+++||++|+.|+...... ..+.. .........
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--~~~~~-~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGK-IFDLIGLPPED 229 (288)
T ss_pred ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--HHHHH-HHHHhCCCChh
Confidence 86543221 12356788999999999999999999999999999999999988532211 11111 111111000
Q ss_pred -cc-------ccccccc---ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 756 -AL-------EIVDSSM---ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 756 -~~-------~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. ..+.+.. .....++....+.+++.+|++.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0000000 00111122345679999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=305.99 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=197.3
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++..++|+||+++++++..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566789999999999999876 4778899998766555677889999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
++|..++... ...+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 9998887642 235899999999999999999999987 9999999999999999999999999987653221 11
Q ss_pred eccccccCCccCccccc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 689 TKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.....++..|+|||++. +..++.++|||||||++|||++|+.|+..... ........... ...+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~-~~~~~~-- 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-PPTLAQ-- 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhcC-CCCCCC--
Confidence 22356889999999984 34578899999999999999999999853221 11111111110 001110
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
+......+.+++.+|++.+|++||++.++++.
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 -----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122457789999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.99 Aligned_cols=273 Identities=24% Similarity=0.331 Sum_probs=203.1
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc-----CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ-----GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
+|+..+.||+|+||.||+|... +++.||||++...... ....+..|++++.+++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677789999999999999875 6899999999754322 234567899999999999999999999998899999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+ +++|..++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999986533 35899999999999999999999988 99999999999999999999999999987654
Q ss_pred ccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC-------
Q 003237 683 EEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN------- 754 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------- 754 (837)
.... .....++..|+|||.+.+ ..++.++|||||||+++||++|..++....+ ..............
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD---IDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc---HHHHHHHHHHcCCCchhhhhh
Confidence 3211 122346778999998865 4679999999999999999999777653221 11111111111000
Q ss_pred --ccccccccccccc-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCCCCCCCCC
Q 003237 755 --KALEIVDSSMANS-----CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNETFVPSPKQ 812 (837)
Q Consensus 755 --~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~--L~~~~~~~~p~~ 812 (837)
............. ........+.+++.+|++.+|++|||++||++. +++......|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~~~ 296 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQ 296 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCCCC
Confidence 0000000000000 112224567899999999999999999999985 655443333433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=299.29 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=202.4
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|+..+.||+|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4777899999999999999764 6889999987643 334556788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986543 345789999999999999999999987 99999999999999999999999999987644332
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
......++..|+|||.+.+..++.++||||||++++||++|+.|+.... .......... +.....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~-~~~~~~------ 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN------PLNLVVKIVQ-GNYTPV------ 221 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHc-CCCCCC------
Confidence 1233568899999999998889999999999999999999999985321 1111111111 111110
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
.......+.+++.+|++.+|++||++.++++.+
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112234577899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=299.63 Aligned_cols=250 Identities=35% Similarity=0.539 Sum_probs=199.5
Q ss_pred CcCCcccccCCeeEEEEEecC-----CcEEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 531 STSNKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 531 ~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++.+.||+|+||.||+++... +..||+|.+...... ..+.+..|++++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456899999999999998763 378999999655433 56789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999865332 12799999999999999999999987 9999999999999999999999999998776543
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
..... ...++..|+|||.+.+..++.++||||+|++++||++ |+.|+... ....+.. .... .....
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~~---~~~~-~~~~~----- 224 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVLE---YLKK-GYRLP----- 224 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHH---HHhc-CCCCC-----
Confidence 22211 2336789999999988889999999999999999998 77776531 1111111 1111 11111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
........+.+++.+|++.+|++|||+.|++++|
T Consensus 225 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 ----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111234577899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=300.70 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=196.5
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|.+.+.||+|+||.||++.. .++.+|+|.+.... ..+.+.+|+.++.+++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4577889999999999999975 57889999986432 346788999999999999999999998654 5799999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999986543 235789999999999999999999987 9999999999999999999999999987643221
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....+..|+|||.+.+..++.++||||||++++||++ |+.|+..... ..+. .....+....
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~~~~~~~-------- 217 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVK----ECVEKGYRME-------- 217 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHH----HHHhCCCCCC--------
Confidence 12334568999999998999999999999999999998 8888753221 1111 1111111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
........+.+++.+|++.+|++||++++|++.|+.
T Consensus 218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111223457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.86 Aligned_cols=198 Identities=28% Similarity=0.445 Sum_probs=159.9
Q ss_pred CCcccccCCeeEEEEEec---CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeeccccc--CCccEEEEEecC
Q 003237 533 SNKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENMLIYEFMP 607 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ey~~ 607 (837)
.++||+|+||.||+|+.. +++.+|+|.+.... ....+.+|++++.+++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999986432 23457889999999999999999998854 345689999987
Q ss_pred CCChhhHhhhcC------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE----cCCCCeeecccccc
Q 003237 608 NKSLDYFIFDES------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTA 677 (837)
Q Consensus 608 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~ki~DFGla 677 (837)
+ +|..++.... ....+++.....++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 7766664221 1234788889999999999999999988 9999999999999 46678999999999
Q ss_pred eeccCccc-eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 003237 678 RVFGGEEI-LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFN 736 (837)
Q Consensus 678 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~ 736 (837)
+....... ........+|+.|+|||++.+. .++.++||||+||+++||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643321 1122346789999999999874 58999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=301.05 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=199.7
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+|++.++||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++.+++|+||+++++.+.++...++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3667889999999999999775 6889999998643 2344567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++... ....++......++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999888543 2345788889999999999999999987 99999999999999999999999999986643221
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......++..|+|||++.+..++.++||||||+++++|++|+.|+.... ......... .+.... +
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~~-----~-- 220 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS------WKNLILKVC-QGSYKP-----L-- 220 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC------HHHHHHHHh-cCCCCC-----C--
Confidence 1223568889999999999899999999999999999999999985321 111111111 111111 1
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
+......+.+++.+|++.+|++||++.+|+..
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122346788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=304.85 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=195.5
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
|+..+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++.+++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 555688999999999999775 68899999986542 22334577899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998886543 235899999999999999999999987 99999999999999999999999999976543211
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.....|+..|+|||++.+..++.++||||||++++||++|+.||........ ............ ..
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~------~~-- 223 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE------EV-- 223 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc------cc--
Confidence 1235689999999999999999999999999999999999999864321111 111111111100 00
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~eVv~ 799 (837)
........+.+++..|++.+|++||+ +.+++.
T Consensus 224 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 --YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11112234678899999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.13 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=199.8
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.|+..++||+|+||.||+|... ++..||+|.+.... ......+.+|+.++.+++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666789999999999999875 58899999986543 344567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999998843 24788888999999999999999987 99999999999999999999999999987644321
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......++..|+|||++.+..++.++|||||||++|||++|+.|+...... .... .+......
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~-------------~~~~~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVLF-------------LIPKNNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHhh-------------hhhcCCCC
Confidence 122245788999999999889999999999999999999999998532211 0000 00000111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.........+.+++..|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233345567899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=297.73 Aligned_cols=267 Identities=22% Similarity=0.308 Sum_probs=200.1
Q ss_pred hhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHH--hcCCCeeeeecccccCC----cc
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAK--LQHRNLVKLLGCCLEED----EN 599 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~ 599 (837)
...+..+.+.||+|.||+||+|.++ |+.||||++...+ ++...+|.++.+. |+|+||+.+++.-..+. +.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3456777899999999999999996 8999999996543 3456778887776 59999999998865544 46
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHh-----cCCCceeeCCCCCCcEEEcCCCCeeeccc
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-----DSRLRIIHRDLKASNILLDEKMNPRISDF 674 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivH~Dlkp~NIll~~~~~~ki~DF 674 (837)
+||++|.++|+|.++|.. ..++....++++..+|.||+|||- ++++.|.|||||++|||+..++.+.|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 899999999999999954 458999999999999999999995 47788999999999999999999999999
Q ss_pred ccceeccCc--cceeeeccccccCCccCcccccCC----CCC--CcccHHHHHHHHHHHHhC----------CCCCCCCC
Q 003237 675 GTARVFGGE--EILAITKRVVGTYGYMSPEYALDG----VFS--TKSDVFSFGVILLEIITG----------KKNTRIFN 736 (837)
Q Consensus 675 Gla~~~~~~--~~~~~~~~~~gt~~y~APE~~~~~----~~s--~k~DV~S~Gvvl~elltG----------~~p~~~~~ 736 (837)
|||-..... .........+||..|||||++-.. .|. ..+||||||.|+||+... +.||...-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999876543 222233456899999999988543 122 259999999999999752 23333222
Q ss_pred CCCcchHHHHHHHHhccCcccccccccc-ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 737 DDDSSNLIKYAWELWSDNKALEIVDSSM-ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 737 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
+.++.. +-.++++-..+ +.|.+ ......+.+..+.+++..||..+|.-|-|+--+-+.|.++..
T Consensus 441 p~DPs~--eeMrkVVCv~~----~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSDPSF--EEMRKVVCVQK----LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCH--HHHhcceeecc----cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 222110 00111111111 11222 123455677888999999999999999999999888877654
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=312.52 Aligned_cols=237 Identities=22% Similarity=0.279 Sum_probs=185.1
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHH-HHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVL-LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
++||+|+||.||+++.. +++.+|+|++.+.. .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 68899999986432 122344555554 57888999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
++|..++... ..+.......++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 9998887542 34677888889999999999999987 9999999999999999999999999987532221 12
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ........... . + ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~-~--------~--~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHK-P--------L--QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcC-C--------C--CC
Confidence 234678999999999999999999999999999999999999985321 11111111111 0 0 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMS 795 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~ 795 (837)
+......+.+++.+|++.+|.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 122334577899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=308.23 Aligned_cols=264 Identities=22% Similarity=0.348 Sum_probs=207.8
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++|+||+++++++..+...++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3588889999999999999975 478999999987655555678889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|..++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999998853 24789999999999999999999987 999999999999999999999999998865433221
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....++..|+|||.+.+..++.++|||||||++|||++|+.|+...... .......... ...+.
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~------~~~~~~~~~~-~~~~~------ 236 (296)
T cd06655 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNG-TPELQ------ 236 (296)
T ss_pred --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC-CcccC------
Confidence 12346788999999999999999999999999999999999998543211 1111111100 00000
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCCCCCCCCCCC
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETFVPSPKQPT 814 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~~~~~p~~p~ 814 (837)
.+......+.+++.+|++.+|++||++.+|++ .++...++..++.-.
T Consensus 237 -~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~~~~~ 285 (296)
T cd06655 237 -NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLI 285 (296)
T ss_pred -CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccccCCccc
Confidence 01111234668899999999999999999985 455545554444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.67 Aligned_cols=244 Identities=27% Similarity=0.439 Sum_probs=198.5
Q ss_pred cccccCCeeEEEEEecC-CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCChhh
Q 003237 535 KLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDY 613 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~ 613 (837)
+||+|.||+||.|+..+ ...+|||.+........+.+.+|+.+-++++|+|||+++|.+.++...-|.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999998764 45789999988777777888999999999999999999999999998899999999999999
Q ss_pred HhhhcCCCCCC--ChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-CCCCeeecccccceeccCccceeeec
Q 003237 614 FIFDESRKQLL--DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEEILAITK 690 (837)
Q Consensus 614 ~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~DFGla~~~~~~~~~~~~~ 690 (837)
+|... -.++ ++.+.--..+||++||.|||++. |||||||-.|||++ -.|.+||+|||-++.+.. ....+.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 88532 1223 44555567899999999999998 99999999999997 578999999999987643 334456
Q ss_pred cccccCCccCcccccCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 691 RVVGTYGYMSPEYALDG--VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 691 ~~~gt~~y~APE~~~~~--~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.+-||..|||||++-.+ .|..++|||||||.+.||.||++||-...+... .++.-+-. ......
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmy------KvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMY------KVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcce------ecCCCC
Confidence 68899999999999766 489999999999999999999999964433111 11111110 112234
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+.+-..++..++++|+.++|.+||+++++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 5566678889999999999999999999985
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=301.23 Aligned_cols=249 Identities=26% Similarity=0.453 Sum_probs=197.0
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc---------CHHHHHHHHHHHHHhcCCCeeeeecccccCCc
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ---------GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 598 (837)
+|.+.+.||+|+||.||+|... +++.+|+|.+...... ..+.+.+|+.++.+++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999764 5889999988654221 12567889999999999999999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.++|+||+++++|..++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999998543 34788888999999999999999987 9999999999999999999999999998
Q ss_pred eccCccce----eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC
Q 003237 679 VFGGEEIL----AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN 754 (837)
Q Consensus 679 ~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 754 (837)
........ .......++..|+|||.+.+..++.++||||||++++||++|+.|+..... . .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~-~~~~~~~--- 225 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-----L-QAIFKIG--- 225 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-----H-HHHHHHh---
Confidence 76532111 111124578899999999999999999999999999999999999863211 1 1111110
Q ss_pred ccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 755 KALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 755 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....+.+ +......+.+++.+|++.+|++||++.||++
T Consensus 226 ---~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ---ENASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---ccCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111111 1222345778889999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=301.52 Aligned_cols=251 Identities=28% Similarity=0.437 Sum_probs=197.7
Q ss_pred CCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCc------cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
+|...+.||+|+||+||+|...+++.+|||.+..... ...+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3667889999999999999888899999998864321 1235678899999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998543 34788888999999999999999987 99999999999999999999999999876532
Q ss_pred cc----ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 683 EE----ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 683 ~~----~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
.. .........++..|+|||++.+..++.++||||||++++||++|+.|+..... ..... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~-~~~~~~~--- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LAAMF-YIGAHRG--- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----HHHHH-HhhhccC---
Confidence 11 11112235688899999999998999999999999999999999999853221 11100 0000000
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+.+. ......+..++.+|++.+|++||++.+|++
T Consensus 226 -~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -LMPRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011111 122345788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.79 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=198.7
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC-ccEEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-ENMLIYE 604 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~e 604 (837)
+|++.+.||+|++|.||+++.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+...+ ..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3777899999999999999865 57889999986432 334567889999999999999999998876444 5689999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++++|.+++.... ...+++.++..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999986532 345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. ......+++.|+|||++.+..++.++||||||++++||++|+.|+.... .......... +...
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~-~~~~------- 220 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIE-GKLP------- 220 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHh-cCCC-------
Confidence 1 1223567889999999999999999999999999999999999985321 1111111111 1110
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1112233467899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.95 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=195.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|.+.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++.+++|+||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46788899999999999999875 58899999986442 23345677899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
++ ++|..++... ...+++.....++.||++||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 98 5888887543 234788899999999999999999987 99999999999999999999999999876432221
Q ss_pred eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc---Cccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD---NKALEIVD 761 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d 761 (837)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ............. .....++.
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCChhhchhhhc
Confidence 11224568899999988754 578999999999999999999999864321 1111111111110 00000000
Q ss_pred ---------ccccccc----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 762 ---------SSMANSC----LASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 762 ---------~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+...... .......+.+++.+|++.||.+|||++||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 0111234678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=304.80 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=200.0
Q ss_pred HHHHHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecccc---
Q 003237 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCL--- 594 (837)
Q Consensus 520 ~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~--- 594 (837)
++.+..+.++|++.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455567789999999999999999999775 57899999885432 2346788899999999 6999999999874
Q ss_pred --cCCccEEEEEecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeee
Q 003237 595 --EEDENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (837)
Q Consensus 595 --~~~~~~lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 671 (837)
.+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345679999999999999987642 23345788889999999999999999987 999999999999999999999
Q ss_pred cccccceeccCccceeeeccccccCCccCcccccC-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 003237 672 SDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD-----GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKY 746 (837)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 746 (837)
+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+...... ..+.
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--~~~~-- 239 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--RALF-- 239 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--HHHh--
Confidence 99999987643221 1223468899999998853 45789999999999999999999998532210 0000
Q ss_pred HHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 747 AWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 747 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.. .........++. .....+.+++.+|++.+|++|||+.||++.
T Consensus 240 --~~-~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 --KI-PRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --hc-cccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00 000001111111 112357789999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.47 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=196.3
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
|+..+.||+|+||.||++... +++.+|||.+.... ....+.+.+|+.++.+++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 556789999999999999775 68899999986542 22234577899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999886433 234788999999999999999999987 99999999999999999999999999876543221
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||......... .......... .....
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~------~~~~~ 225 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEV------QEEYS 225 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhh------hhhcC
Confidence 12246899999999999999999999999999999999999999643221110 1111110000 00011
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~eVv~ 799 (837)
. .....+.+++..|++.+|++||| ++|+++
T Consensus 226 ~----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 E----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred c----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1 12234678899999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=306.28 Aligned_cols=261 Identities=23% Similarity=0.368 Sum_probs=197.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|++.++||+|+||.||+|... +++.+|+|++..... ...+.+.+|++++..++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36778899999999999999886 588999998865422 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++++|..+.... ..+++..+..++.||++||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998876432 23899999999999999999999987 9999999999999999999999999988754332
Q ss_pred ceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc--Ccccccc-
Q 003237 685 ILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD--NKALEIV- 760 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~- 760 (837)
. ......++..|+|||++.+ ..++.++||||||++++||++|+.|+..... ............. .......
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD---IDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHHHhCCCchhhHHHhc
Confidence 1 1122457889999999875 4578899999999999999999988853221 1111111100000 0000000
Q ss_pred ---------cccccc-----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 ---------DSSMAN-----SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 ---------d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+.... .........+.+++.+|++.+|++||+|.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000 001122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=315.62 Aligned_cols=259 Identities=22% Similarity=0.262 Sum_probs=192.8
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC------
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 597 (837)
.++|++.+.||+|+||.||++... +|..||||++... .......+.+|+.++..++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468999999999999999999765 6899999998643 2234567789999999999999999999886543
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..++||||++++ |...+.. .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~-l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDAN-LCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCcC-HHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 468999999864 5555422 3678888899999999999999988 999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH---------
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAW--------- 748 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------- 748 (837)
+...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.....
T Consensus 171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI--DQWNKVIEQLGTPSAEF 245 (359)
T ss_pred cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCcHHH
Confidence 7643221 122356889999999999999999999999999999999999998643211 11100000
Q ss_pred ---------HHhccC-c-----cccccccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 749 ---------ELWSDN-K-----ALEIVDSSMA---NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 749 ---------~~~~~~-~-----~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...... . ..+....... ..........+.+++.+|++.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 0 0000000000 0001112345778999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.50 Aligned_cols=200 Identities=24% Similarity=0.346 Sum_probs=170.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||+++.. +++.||||.+.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999875 5889999998642 2234456889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++... ...++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998542 234788888999999999999999988 999999999999999999999999998765432
Q ss_pred cceeeeccccccCCccCcccccC-----CCCCCcccHHHHHHHHHHHHhCCCCCC
Q 003237 684 EILAITKRVVGTYGYMSPEYALD-----GVFSTKSDVFSFGVILLEIITGKKNTR 733 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~ 733 (837)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 221 1122468999999999873 457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=329.93 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=190.5
Q ss_pred HHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCC------CeeeeecccccC
Q 003237 524 LAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR------NLVKLLGCCLEE 596 (837)
Q Consensus 524 ~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~~~~~~~ 596 (837)
...+++|.+.++||+|+||+||+|... .++.||||+++... ...+++..|++++.+++|. +|+++++++..+
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 345678999999999999999999875 57889999996432 2345567788888887654 588888888765
Q ss_pred -CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEEcCCC-------
Q 003237 597 -DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKM------- 667 (837)
Q Consensus 597 -~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NIll~~~~------- 667 (837)
.+.++|||++ +++|.+++... ..+++..+..++.||+.||.|||++ + ||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 4678999987 66787877543 3588999999999999999999974 6 99999999999998765
Q ss_pred ---------CeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 003237 668 ---------NPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDD 738 (837)
Q Consensus 668 ---------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~ 738 (837)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 4999999987643221 22367899999999999999999999999999999999999999653321
Q ss_pred CcchHHHHHH-----------------HHhcc-Cccccccccc----ccc-c--cCHHHHHHHHHHHHHcccCCCCCCCC
Q 003237 739 DSSNLIKYAW-----------------ELWSD-NKALEIVDSS----MAN-S--CLASEALRCIQVGLLCVQDRTTDRPS 793 (837)
Q Consensus 739 ~~~~l~~~~~-----------------~~~~~-~~~~~~~d~~----l~~-~--~~~~~~~~l~~l~~~Cl~~~P~~RPt 793 (837)
+...++.... .++.. +......++. +.. . ....+...+++++..||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 1111110000 00000 0000000000 000 0 00011245779999999999999999
Q ss_pred HHHHHH
Q 003237 794 MSTVVF 799 (837)
Q Consensus 794 m~eVv~ 799 (837)
++|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999986
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.67 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=198.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+.|++.++||+|+||.||+|+.. ++..+++|.+........+.+.+|+++++.++|+||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56788899999999999999876 58899999997766666778899999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|..++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 9999988875432 34889999999999999999999987 9999999999999999999999999987543221
Q ss_pred eeeccccccCCccCccccc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 687 AITKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.......++..|+|||++. ...++.++|||||||++|||++|+.|+..... ........... .
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~-~----- 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-P----- 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC-C-----
Confidence 1112345788999999985 34578899999999999999999999853221 11111111110 0
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+.+. .+......+.+++.+|++.+|++||++.+|++
T Consensus 233 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 11112235678999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=287.08 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=196.6
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++.|++-+.||+|.|+.||+... ++|+.+|+|.+... ...+.+++.+|+++.+.++|||||+|.....+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677778999999999999955 47999999987543 3447788999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC---CCCeeecccccceec
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTARVF 680 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~DFGla~~~ 680 (837)
|+|.+++|-.-|... ...++...-..++||+++|.|+|.++ |||||+||+|++|-. .--+|++|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999997666433 34666677788999999999999998 999999999999953 345899999999988
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
+... ......||++|||||++...+|+..+|||+.|||||-|+.|..||... +...+...+. .+.. + +
T Consensus 164 ~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~---~~~rlye~I~----~g~y-d-~ 231 (355)
T KOG0033|consen 164 NDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYEQIK----AGAY-D-Y 231 (355)
T ss_pred CCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHh----cccc-C-C
Confidence 7332 233478999999999999999999999999999999999999998531 2222222211 1110 0 1
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv 798 (837)
++.. -..-......++.+|+..||.+|.|+.|.+
T Consensus 232 ~~~~----w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 232 PSPE----WDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CCcc----cCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 1100 111123456788899999999999998875
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=311.21 Aligned_cols=255 Identities=19% Similarity=0.255 Sum_probs=193.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.+.||+|+||.||+++.. +++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999876 5788999998642 2223455788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999996532 34788888899999999999999987 999999999999999999999999999876543
Q ss_pred cceeeeccccccCCccCcccccC-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALD-----GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
... ......|++.|+|||++.+ +.++.++|||||||++|||++|+.||.... ................
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~ 228 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHEERFQ 228 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC------HHHHHHHHHcCCCccc
Confidence 221 1223578999999999875 568899999999999999999999985321 1111111111111111
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTD--RPSMSTVVFM 800 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPtm~eVv~~ 800 (837)
+.+.. . +....+.+++.+|++.++++ |++++++++.
T Consensus 229 -~p~~~-~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 -FPSHI-T----DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -CCCcc-c----cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 01111 1 11234566777777655443 5688888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.84 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=198.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++.+++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999876 58999999886432 2234567899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|++++.|..++... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999888776432 34899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH----------Hhcc
Q 003237 685 ILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE----------LWSD 753 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~----------~~~~ 753 (837)
.. .....++..|+|||.+.+ ..++.++||||||++++||++|+.|+......+ .+...... .+..
T Consensus 155 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 155 DD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred cc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhccc
Confidence 11 122456789999999876 568999999999999999999999986432211 11111100 0000
Q ss_pred Ccc-ccccccccccccC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 NKA-LEIVDSSMANSCL-----ASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 ~~~-~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... .....+......+ ......+.+++.+|++.+|++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 0000011100001 112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=307.50 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=196.8
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
|.....||+|+||.||++... ++..||||++........+.+.+|+.++..++|+||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333468999999999999875 6889999998665555567788999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
++|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++........ .
T Consensus 104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 174 (292)
T cd06658 104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K 174 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence 999998743 24788999999999999999999987 99999999999999999999999999876533221 1
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+..... ........ ..+.+.+..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~---------~~~~~~~~~-- 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIR---------DNLPPRVKD-- 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH---------hcCCCcccc--
Confidence 1234678899999999988999999999999999999999999853211 11111110 011111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.......+..++.+|++.+|++|||++++++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11122346678889999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=311.95 Aligned_cols=240 Identities=23% Similarity=0.333 Sum_probs=190.2
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEE
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 604 (837)
|+..+.||+|+||.||++... +++.||||++.+.. ....+.+..|.+++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 566789999999999999765 68899999987532 233456778999998886 5778889999988889999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999888543 34889999999999999999999987 9999999999999999999999999987543221
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. ......||..|+|||++.+..++.++|||||||++|||++|+.|+..... ..+... ... ...
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~---i~~-~~~-------- 218 (323)
T cd05615 156 V--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQS---IME-HNV-------- 218 (323)
T ss_pred c--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH---HHh-CCC--------
Confidence 1 12335689999999999999999999999999999999999999864321 111111 111 000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSM 794 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 794 (837)
..+......+.+++.+|++.+|.+|++.
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111123456789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=317.05 Aligned_cols=261 Identities=22% Similarity=0.249 Sum_probs=194.5
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC-----
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED----- 597 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 597 (837)
..++|.+.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999765 58899999986532 233467788999999999999999999876432
Q ss_pred -ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 598 -ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 598 -~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
..++||||+++ +|...+.. .+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999976 45555532 3788888899999999999999987 99999999999999999999999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH-------
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE------- 749 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~------- 749 (837)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...... ..+......
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCPE 240 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence 98654321 122356899999999999999999999999999999999999998643211 001100000
Q ss_pred -----------Hhcc-Cccccccccc-----c---ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 750 -----------LWSD-NKALEIVDSS-----M---ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 750 -----------~~~~-~~~~~~~d~~-----l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.... .....+..+. + ...........+.+++.+|++.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0000000000 0 000111123467899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=283.34 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=196.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC----ccC----HHHHHHHHHHHHHhc-CCCeeeeecccccCC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS----GQG----IEELKNEVLLIAKLQ-HRNLVKLLGCCLEED 597 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~----~~~----~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 597 (837)
+.|...+.||.|..+.|-+..++ +|.+.|+|++.... ... .+.-..|+.+|+++. ||+|++|.++++...
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45677789999999999998665 68899999985431 111 234567999999985 999999999999999
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
-.++|+|.|+.|.|.++|... -.++++...+|+.|+.+|++|||..+ ||||||||+|||+|++.++||+|||++
T Consensus 97 F~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 999999999999999999543 35889999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccC------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALD------GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELW 751 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 751 (837)
+.+...+.. ...|||++|+|||.+.. ..|+..+|.|+.|||+|-|+.|.+||-.. .++. ...+.
T Consensus 171 ~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-----kQml--MLR~I 240 (411)
T KOG0599|consen 171 CQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-----KQML--MLRMI 240 (411)
T ss_pred eccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-----HHHH--HHHHH
Confidence 988766433 34899999999999863 35888999999999999999999998310 0000 00111
Q ss_pred ccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 752 SDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 752 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
-+++.. .....=.+......+++.+|++.||.+|-|++|+++
T Consensus 241 meGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 241 MEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred Hhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 111110 000011123345678999999999999999999974
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=315.81 Aligned_cols=195 Identities=25% Similarity=0.385 Sum_probs=168.4
Q ss_pred CCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-C-----CCeeeeecccccCCccEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-H-----RNLVKLLGCCLEEDENML 601 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~~l 601 (837)
+|++.+.||+|.||.|.|+.. .+++.||||++++. ..-..+...|+++|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788899999999999999965 47999999999654 344566778999999997 4 389999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC--CCCeeeccccccee
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--KMNPRISDFGTARV 679 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~ki~DFGla~~ 679 (837)
|+|.+.. +|.++|....- ..++......|+.||+.||.+||+.+ |||+||||+||||.+ ...+||+|||.+..
T Consensus 266 VfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 9998855 89999976543 34889999999999999999999987 999999999999974 34799999999987
Q ss_pred ccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRI 734 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 734 (837)
....-. ....+..|+|||++.+.+|+.+.|+||||||+.||++|.+-|..
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 654433 25567899999999999999999999999999999999776643
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.19 Aligned_cols=247 Identities=27% Similarity=0.402 Sum_probs=198.2
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-----ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
+|+..+.||+|+||.||+|... ++..|++|.+.... .+..+.+.+|+.++..++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666789999999999999876 78999999886543 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
+||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998543 34789999999999999999999987 99999999999999999999999999887644
Q ss_pred ccceeeeccccccCCccCcccccCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.. ......++..|+|||.+.... ++.++|+||||++++||++|+.|+..... ..............
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~---- 221 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELP---- 221 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCC----
Confidence 32 123356888999999988776 89999999999999999999999864321 11111111101110
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+......+.+++.+|++.+|.+||++.++++
T Consensus 222 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 -----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 011112345678899999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=301.71 Aligned_cols=252 Identities=21% Similarity=0.364 Sum_probs=197.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
++|.+.++||+|+||.||+|+.. +++.+|+|.++.........+.+|+.++..++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777789999999999999765 68899999987655555567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++... ..+++.+...++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 999999988543 35789999999999999999999987 9999999999999999999999999987654321
Q ss_pred eeeccccccCCccCccccc---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYAL---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.......|+..|+|||++. ...++.++|||||||++|||++|+.|+....... .+. .... .. ...+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~----~~~~-~~---~~~~~ 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALF----LMTK-SN---FQPPK 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHH----hhhc-cC---CCCCc
Confidence 1123356889999999874 4568899999999999999999999974322110 000 0000 00 00011
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... .......+.+++.+|++.+|++||++++|++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 100 0011234678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.79 Aligned_cols=199 Identities=20% Similarity=0.292 Sum_probs=164.3
Q ss_pred cCCccccc--CCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 532 TSNKLGQG--GFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 532 ~~~~LG~G--~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+.++||+| +|++||+++.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78999999764 78999999986542 233456778999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc-
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI- 685 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~- 685 (837)
++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 234789999999999999999999987 99999999999999999999999986544321110
Q ss_pred ----eeeeccccccCCccCcccccC--CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 003237 686 ----LAITKRVVGTYGYMSPEYALD--GVFSTKSDVFSFGVILLEIITGKKNTRI 734 (837)
Q Consensus 686 ----~~~~~~~~gt~~y~APE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~ 734 (837)
........++..|+|||++.+ ..++.++|||||||+++||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 001122356778999999976 4689999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=311.67 Aligned_cols=241 Identities=22% Similarity=0.276 Sum_probs=185.7
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHH-HHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVL-LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||+||+++.. +++.+|+|++.... ......+..|.. ++..++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999876 57889999986432 122334444444 56778999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
++|..++... ..+.......++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 9999988643 34667777889999999999999988 9999999999999999999999999987543221 12
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... ...... . .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~---~i~~~~--~-----~~---- 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYD---NILNKP--L-----QL---- 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHH---HHHhCC--c-----CC----
Confidence 2346799999999999999999999999999999999999999853221 11111 111110 0 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.......+.+++.+|++.+|.+||++.+.+.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 1112235678889999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.85 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=202.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|++++.+++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56888899999999999999875 57889999997665556788999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++... ...++......++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999988543 235789999999999999999999987 99999999999999999999999999876543211
Q ss_pred eeeccccccCCccCcccccCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDG---VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~---~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
......++..|+|||.+.+. .++.++||||||++++||++|+.|+...... .... .... . .+..+.
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--~~~~----~~~~-~---~~~~~~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--RALF----LISK-S---NFPPPK 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHH----HHHh-c---cCCCcc
Confidence 11235678899999999877 8899999999999999999999998532211 0011 0000 0 000001
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+. ........+.+++.+|++.+|.+|||+.+|+.
T Consensus 226 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 12223456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.80 Aligned_cols=262 Identities=26% Similarity=0.355 Sum_probs=202.1
Q ss_pred ecHHHHHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeeccccc
Q 003237 518 FELSTLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE 595 (837)
Q Consensus 518 ~~~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 595 (837)
+.+.++..++++|++.+.||+|+||.||++... +++.+|+|.+.... ...+++.+|+.++.++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445556667889999999999999999999874 68899999985432 2346778899999999 79999999999875
Q ss_pred CC-----ccEEEEEecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 596 ED-----ENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 596 ~~-----~~~lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
.+ ..++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 578999999999999988642 22345889999999999999999999987 9999999999999999999
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG-----VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 744 (837)
||+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.|+..... ...+
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~- 242 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTL- 242 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHH-
Confidence 99999998865432211 1234678899999988643 368999999999999999999999853221 1111
Q ss_pred HHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 745 KYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 745 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..... .....+.+ .......+.+++.+|++.+|++||++.|+++
T Consensus 243 ---~~~~~-~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 ---FKIPR-NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---HHHhc-CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 11111111 1122345789999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=316.88 Aligned_cols=201 Identities=25% Similarity=0.382 Sum_probs=172.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|+..+.||+|+||.||+++.. +++.||||++... .......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 35778899999999999999875 6889999998643 2234567888999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++... ..++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998643 34788889999999999999999988 999999999999999999999999998754321
Q ss_pred cce---------------------------------eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCC
Q 003237 684 EIL---------------------------------AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKK 730 (837)
Q Consensus 684 ~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~ 730 (837)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113478999999999999999999999999999999999999
Q ss_pred CCCC
Q 003237 731 NTRI 734 (837)
Q Consensus 731 p~~~ 734 (837)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.87 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=203.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888899999999999999864 67899999986542 33567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++........+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976444346889999999999999999999987 99999999999999999999999999876654322
Q ss_pred e--eeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 686 L--AITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 686 ~--~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
. .......++..|+|||.+... .++.++||||||++++||++|+.|+...... ..... ..... .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~----~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLML----TLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHH----HhcCC------CC
Confidence 1 122334688899999998877 7899999999999999999999998643221 11111 11110 01
Q ss_pred cccccc-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSC-LASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+.... .......+.+++..|++.+|++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111 0122345778999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.02 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=190.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-----ccCHHHHHHHHHHHHHhcCCCeeeeecccccC--Ccc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 599 (837)
.+|+..+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36788899999999999999765 58899999886432 12345678899999999999999999988653 456
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++++||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999998643 24788889999999999999999887 99999999999999999999999999876
Q ss_pred ccCccc-eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 680 FGGEEI-LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 680 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.|+..... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~---- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQP---- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCC----
Confidence 542211 1111234578899999999998999999999999999999999999853211 11111111111
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+.+ +......+..+ +.|+..+|++||+|+||++
T Consensus 226 -~~~~~----~~~~~~~~~~l-i~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TNPQL----PSHISEHARDF-LGCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCC----chhcCHHHHHH-HHHhcCChhhCcCHHHHhc
Confidence 01111 11111223333 4788899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.88 Aligned_cols=249 Identities=23% Similarity=0.371 Sum_probs=199.7
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|+..+.||+|+||.||+++.. +|+.+|+|++... .....+++.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4677899999999999999765 6889999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999886432 234788999999999999999999987 99999999999999999999999999987644321
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
. .....++..|+|||++.+..++.++|||||||+++||++|+.|+.... ........... ...
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~-~~~-------- 219 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRG-SYP-------- 219 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcC-CCC--------
Confidence 1 123457889999999999999999999999999999999999985321 11111111111 100
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+......+.+++.+|++.+|++||+|.+|++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 011222345778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=300.49 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=200.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.++|++.++||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888899999999999999875 6889999998766555667889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|..++.... ..+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999886432 35889999999999999999999988 99999999999999999999999999876533211
Q ss_pred eeeeccccccCCccCccccc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 686 LAITKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
......++..|+|||.+. ...++.++||||||+++|||++|+.|+..... ......... ...
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~---- 225 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP------MRVLLKILK-SEP---- 225 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH------HHHHHHHhc-CCC----
Confidence 122346888999999875 34578899999999999999999999853311 111111111 100
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+.+. .+......+.+++..|++.+|.+||++.+|++
T Consensus 226 -~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 -PTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred -CCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 0010 01112235678899999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=313.07 Aligned_cols=260 Identities=22% Similarity=0.275 Sum_probs=194.4
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccC------
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------ 596 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 596 (837)
..++|.+.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999765 5889999998653 233456778899999999999999999987543
Q ss_pred CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
...++||||+++ +|...+.. .+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 246899999976 56665532 3778888999999999999999987 99999999999999999999999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc----
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS---- 752 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---- 752 (837)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 246 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCP 246 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence 98654322 122356899999999999999999999999999999999999998643211 11111100000
Q ss_pred ---------------c-Cccc-----ccccccc---ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 753 ---------------D-NKAL-----EIVDSSM---ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 753 ---------------~-~~~~-----~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
. .... .+..... ...........+.+++.+|++.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0000 0000000 000111123467789999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.20 Aligned_cols=197 Identities=28% Similarity=0.435 Sum_probs=158.8
Q ss_pred CCcccccCCeeEEEEEec---CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeeccccc--CCccEEEEEecC
Q 003237 533 SNKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENMLIYEFMP 607 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ey~~ 607 (837)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++.+++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999865 35789999986432 23467889999999999999999998854 456789999988
Q ss_pred CCChhhHhhhc------CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE----cCCCCeeecccccc
Q 003237 608 NKSLDYFIFDE------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTA 677 (837)
Q Consensus 608 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~ki~DFGla 677 (837)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 6 666665321 12234788889999999999999999987 9999999999999 56779999999999
Q ss_pred eeccCccce-eeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 003237 678 RVFGGEEIL-AITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIF 735 (837)
Q Consensus 678 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 735 (837)
+........ .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543211 11233568899999999876 45899999999999999999999998644
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=313.50 Aligned_cols=258 Identities=26% Similarity=0.337 Sum_probs=192.3
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccC------
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------ 596 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 596 (837)
..++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999764 68899999986532 22345677899999999999999999988643
Q ss_pred CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
...++++|++ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3458999987 7788777632 34889999999999999999999988 99999999999999999999999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...............
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~ 236 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY---IDQLKRIMEVVGTPS 236 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHhCCCC
Confidence 9865432 123568999999999877 5789999999999999999999999853221 111111111110000
Q ss_pred -----------ccccccc--ccccc----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 756 -----------ALEIVDS--SMANS----CLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 756 -----------~~~~~d~--~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....+.. ..... ........+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00000 00001124678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=332.90 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=197.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 601 (837)
.++|.+.++||+|+||+||+++.. .+..+|+|.+... .......+..|+.++.+++|||||++++++... ...+|
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 457888999999999999999875 5778899988643 223456788999999999999999999988543 45789
Q ss_pred EEEecCCCChhhHhhhcC-CCCCCChhhHHHHHHHHHHHHHHHHhcCC----CceeeCCCCCCcEEEcC-----------
Q 003237 602 IYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSR----LRIIHRDLKASNILLDE----------- 665 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~Dlkp~NIll~~----------- 665 (837)
||||+++|+|..+|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 999999999999986532 23458999999999999999999998542 34999999999999964
Q ss_pred ------CCCeeecccccceeccCccceeeeccccccCCccCcccccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 003237 666 ------KMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD--GVFSTKSDVFSFGVILLEIITGKKNTRIFND 737 (837)
Q Consensus 666 ------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~ 737 (837)
...+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.....
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3358999999998764322 1233578999999999864 4589999999999999999999999853221
Q ss_pred CCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHhcc
Q 003237 738 DDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV--FMLSN 803 (837)
Q Consensus 738 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv--~~L~~ 803 (837)
.......+.... .+. .......+.+++..||+.+|.+||++.|++ ..+..
T Consensus 249 -----~~qli~~lk~~p--------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 249 -----FSQLISELKRGP--------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred -----HHHHHHHHhcCC--------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 111111111110 000 011134577899999999999999999998 44543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.63 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=201.2
Q ss_pred CCCcCCcccccCCeeEEEEEecC-CcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
+|+..+.||.|.-|+||++++.+ +..+|+|++.+.. .....+.+.|-+||+.++||.+.+|++.++.+...+||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45567899999999999999875 5889999997653 3445667789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc-
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE- 683 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~- 683 (837)
||+||+|+..++.+. .+.++.....-.+..|+-||+|||-.| ||.|||||+||||.++|++.|+||.|+..+...
T Consensus 158 yCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999998886554 456788888889999999999999988 999999999999999999999999987544110
Q ss_pred --------------------------------cc---------------------eeeeccccccCCccCcccccCCCCC
Q 003237 684 --------------------------------EI---------------------LAITKRVVGTYGYMSPEYALDGVFS 710 (837)
Q Consensus 684 --------------------------------~~---------------------~~~~~~~~gt~~y~APE~~~~~~~s 710 (837)
.. .......+||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 00 0111236799999999999999999
Q ss_pred CcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCC
Q 003237 711 TKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTD 790 (837)
Q Consensus 711 ~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~ 790 (837)
.++|.|+|||++|||+.|+.||......+. +.. ++-..+.-...+..+..+.++|..-+.+||++
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~N-------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LRN-------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhh--HHH-------------HhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 999999999999999999999975543222 111 22111211112233456778999999999999
Q ss_pred CCC----HHHHHH
Q 003237 791 RPS----MSTVVF 799 (837)
Q Consensus 791 RPt----m~eVv~ 799 (837)
|-- +.||-+
T Consensus 379 Rlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 379 RLGSKRGAAEIKR 391 (459)
T ss_pred hhccccchHHhhc
Confidence 998 778754
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.59 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=196.5
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---c-------CHHHHHHHHHHHHHhcCCCeeeeecccccCC
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---Q-------GIEELKNEVLLIAKLQHRNLVKLLGCCLEED 597 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 597 (837)
+|...+.||+|+||.||+|... +++.+|+|.++.... . ..+.+.+|++++.+++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3666789999999999999764 689999998753211 0 1346788999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998654 35788899999999999999999987 999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGV--FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
+...............++..|+|||.+.... ++.++||||||++++|+++|+.|+.... .. ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~-~~~~~~~~~~- 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-----AI-AAMFKLGNKR- 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-----hH-HHHHHhhccc-
Confidence 8654322111122356788999999987755 8999999999999999999999984211 11 1111111111
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
....+.... .......+.+++..|++.+|++||+|++|++.
T Consensus 229 ~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111111 11223467788999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=307.68 Aligned_cols=201 Identities=22% Similarity=0.314 Sum_probs=170.7
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.++||+|+||.||+++.. +++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36788899999999999999876 4778999998642 1223445788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++.... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999996532 34788888999999999999999988 999999999999999999999999998765332
Q ss_pred cceeeeccccccCCccCccccc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 003237 684 EILAITKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGKKNTRI 734 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 734 (837)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 21 1123357899999999986 34689999999999999999999999853
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=299.29 Aligned_cols=260 Identities=24% Similarity=0.341 Sum_probs=211.7
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
-|.+.+.||+|.|+.|-++++- +|..||||++.+.. ......+.+|++.|+.++|||||+|+.+.......|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 4666789999999999999764 79999999997653 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE-cCCCCeeecccccceeccCcc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL-DEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~ki~DFGla~~~~~~~ 684 (837)
-++|+|.++|..... -+.+....+++.||+.||.|+|+.+ +|||||||+||.+ .+-|-+||+|||++..+...+
T Consensus 99 GD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999965433 3788888899999999999999998 9999999999866 567889999999998877654
Q ss_pred ceeeeccccccCCccCcccccCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFS-TKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.. ...+|...|-|||++.+..|+ +++||||+|||||-|++|+.||...++.+. +.-++|-.
T Consensus 174 kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCK 235 (864)
T KOG4717|consen 174 KL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCK 235 (864)
T ss_pred hh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhccc
Confidence 43 347999999999999999985 689999999999999999999975544332 12223322
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCCCCCCCCCC
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETFVPSPKQP 813 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~~~~~p~~p 813 (837)
. ..+.....+|.++|..|++.||++|.+.++|+. .|+....-++-..|
T Consensus 236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iP 285 (864)
T KOG4717|consen 236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIP 285 (864)
T ss_pred c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCc
Confidence 1 134445678899999999999999999999984 45554433333333
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.04 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=199.7
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeeccccc--CCccEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENMLIY 603 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ 603 (837)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+++.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3677889999999999999764 6889999998643 23345678889999999999999999998764 34568999
Q ss_pred EecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcC--CCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 604 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDS--RLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 604 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
||+++++|.+++... .....+++...+.++.||++||.|||..+ ..+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 22356899999999999999999999432 334999999999999999999999999999876
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
...... .....++..|+|||.+.+..++.++||||||+++++|++|+.|+.... ...+... ...+..
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~----~~~~~~---- 227 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASK----IKEGKF---- 227 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHH----HhcCCC----
Confidence 543321 223468899999999999899999999999999999999999986432 1111111 111111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
...+......+.+++.+|++.+|++||+|.+|++.
T Consensus 228 -----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11222334567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=296.79 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=193.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-----ccCHHHHHHHHHHHHHhcCCCeeeeecccccC--Ccc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 599 (837)
++|++.+.||+|+||.||+|... ++..||||.+.... ....+.+.+|++++.+++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46788899999999999999875 58899999885321 12345778899999999999999999988764 356
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++||||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 7999999999999988543 24788888999999999999999988 99999999999999999999999999886
Q ss_pred ccCccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 680 FGGEEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 680 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... .... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~~~-~~~~~~~~---- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-----AMAA-IFKIATQP---- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-----hHHH-HHHHhcCC----
Confidence 5432111 11223468889999999998889999999999999999999999985321 1111 11111110
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.....+......+..++..|+. +|++||+++||++
T Consensus 226 -----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0111233334456677788884 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=296.63 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=200.8
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+|+..+.||+|+||.||++... +++.+|+|++.... ....+++.+|++++++++||||+++++.+......++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5667789999999999999876 68899999987653 344567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
++++|.+++.... ..++......++.|+++||.|||+ .+ ++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999986542 457888889999999999999999 66 99999999999999999999999999876532211
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
....++..|+|||.+.+..++.++||||||+++++|++|+.|+...... ............... . +.+.
T Consensus 157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-~-----~~~~ 225 (265)
T cd06605 157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP-P-----PRLP 225 (265)
T ss_pred ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC-C-----CCCC
Confidence 1256788999999999999999999999999999999999998643221 111222222111111 0 0111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. .....+.+++..|++.+|++|||+.+++.
T Consensus 226 ~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 SG---KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 00 13345778999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=299.64 Aligned_cols=261 Identities=21% Similarity=0.328 Sum_probs=194.1
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|+..+.||+|+||.||+|+.. +|+.+|+|++.... ......+.+|++++.+++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677789999999999999875 68899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++ +|..++... ...+++.....++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 974 777776532 234899999999999999999999987 99999999999999999999999999986543211
Q ss_pred eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc------ccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK------ALE 758 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~ 758 (837)
......++..|+|||++.+. .++.++|||||||+++||++|+.|+....+ ................ ...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHHhhh
Confidence 11224568899999998765 479999999999999999999998643221 1111111111111000 000
Q ss_pred ccccc----cc-----cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 IVDSS----MA-----NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 ~~d~~----l~-----~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+.. .. ..........+.+++.+|++.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 00 0011112346678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=294.09 Aligned_cols=251 Identities=27% Similarity=0.357 Sum_probs=204.5
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+|++.+.||+|++|.||+++.. +++.++||++..... ...+.+.+|++.+.+++|+||+++++++......++|+||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5778899999999999999887 589999999876543 44678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
++++|.+++... ..++...+..++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 999999998653 458899999999999999999999 77 99999999999999999999999999987654332
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.|+..........+.. .... ... +.
T Consensus 156 ~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~~-~~~-----~~-- 222 (264)
T cd06623 156 QC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---AICD-GPP-----PS-- 222 (264)
T ss_pred cc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH---HHhc-CCC-----CC--
Confidence 21 23467889999999999999999999999999999999999986443211111111 1111 101 11
Q ss_pred cccCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 766 NSCLAS-EALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 766 ~~~~~~-~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.+.. ....+.+++..|++.+|++||++.++++.
T Consensus 223 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 --LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 33567889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=304.90 Aligned_cols=267 Identities=23% Similarity=0.329 Sum_probs=195.9
Q ss_pred CCCcCCcccccCCeeEEEEEec---CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENM 600 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 600 (837)
+|++.++||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677789999999999999875 47899999997632 33446778899999999999999999999988 7789
Q ss_pred EEEEecCCCChhhHhhhcC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC----CCCeeeccc
Q 003237 601 LIYEFMPNKSLDYFIFDES--RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE----KMNPRISDF 674 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~ki~DF 674 (837)
+||||+++ +|..++.... ....++......++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 5656554322 1235788889999999999999999988 999999999999999 999999999
Q ss_pred ccceeccCccc-eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcch------HHHH
Q 003237 675 GTARVFGGEEI-LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSN------LIKY 746 (837)
Q Consensus 675 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~------l~~~ 746 (837)
|+++....... ........++..|+|||.+.+. .++.++||||||++++||++|+.|+.......... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122335678899999988764 58999999999999999999999987544332100 0001
Q ss_pred HHHHhccC------------ccccccc---------cccccccCH--HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 747 AWELWSDN------------KALEIVD---------SSMANSCLA--SEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 747 ~~~~~~~~------------~~~~~~d---------~~l~~~~~~--~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+...+... ......+ ..+...... .....+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111100 0000000 000000000 22346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=297.43 Aligned_cols=260 Identities=25% Similarity=0.305 Sum_probs=199.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 603 (837)
++|+..+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999875 588999999865432 3456789999999999999999999988654 3578999
Q ss_pred EecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 604 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
||+++++|.+++... .....++......++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887542 23345788889999999999999999987 99999999999999999999999999875432
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ............ .....+.+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~- 230 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVN-MPNPELKD- 230 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhc-CCchhhcc-
Confidence 21 123457889999999999999999999999999999999999987543211 111111111111 11111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.... .......+.+++.+|++.+|.+||||.||++
T Consensus 231 ~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 EPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1100 0112356789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=304.39 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=198.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|+..+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|++++..++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36778899999999999999876 489999999875432 24567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+.+++|.+++... ....+++.....++.||++||.|||..+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988643 2346889999999999999999999987 999999999999999999999999998754321
Q ss_pred cce---------------------------eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 003237 684 EIL---------------------------AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFN 736 (837)
Q Consensus 684 ~~~---------------------------~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~ 736 (837)
... .......|+..|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01112467889999999999999999999999999999999999986332
Q ss_pred CCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 003237 737 DDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPS----MSTVVF 799 (837)
Q Consensus 737 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt----m~eVv~ 799 (837)
.. ..+ .... +....-.........+.+++.+|++.+|++||| ++|++.
T Consensus 237 ~~--~~~----~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD--ETF----SNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH--HHH----HHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 111 1111 111100011113456889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.07 Aligned_cols=261 Identities=20% Similarity=0.307 Sum_probs=199.3
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|++.++||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5788899999999999999876 5889999988643 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
++++.+..++.. ...+++.....++.||++||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 998777665532 234789999999999999999999987 99999999999999999999999999987654432
Q ss_pred eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc-----------
Q 003237 686 LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD----------- 753 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------- 753 (837)
. ......++..|+|||++.+. .++.++||||||++++||++|+.|+...... .........+..
T Consensus 156 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 156 S-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred c-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhccc
Confidence 1 12235678899999999888 8899999999999999999999988643211 111111111000
Q ss_pred -Cccc--cccccc----cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 -NKAL--EIVDSS----MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 -~~~~--~~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.... +..+.. .....+......+.+++.+|++.+|++||+|++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 000000 000111112466889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=294.37 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=198.1
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|+..+.||+|+||.||++... +++.+|||.+... .....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4677889999999999999764 6889999998654 233456788999999999999999999999888899999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC-CCeeecccccceeccCcc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARVFGGEE 684 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~DFGla~~~~~~~ 684 (837)
+++++|.+++.... ...+++..+..++.++++||.|||+.+ |+|+||||+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999996532 345789999999999999999999987 9999999999999855 458999999998765432
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. .....++..|+|||.+.+..++.++||||||+++++|++|+.|+..... ..... .... .....+
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~---~~~~-~~~~~~----- 221 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVL---KIMS-GTFAPI----- 221 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHH---HHHh-cCCCCC-----
Confidence 1 1224678899999999988899999999999999999999999853221 11111 1111 000111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.......+.+++..|++.+|++|||+.|+++
T Consensus 222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112345779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=300.39 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=198.0
Q ss_pred HHHHHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeeccccc--
Q 003237 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE-- 595 (837)
Q Consensus 520 ~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~-- 595 (837)
+.++..+.+.|++.+.||+|+||.||+|... +++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3444456678899999999999999999874 68899999885442 3446788899999998 69999999999863
Q ss_pred ----CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeee
Q 003237 596 ----EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (837)
Q Consensus 596 ----~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 671 (837)
....+++|||+++|+|.+++.... ...+++..+..++.||++||.|||+.+ |+|+||||+||++++++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 346789999999999999886532 334778888899999999999999987 999999999999999999999
Q ss_pred cccccceeccCccceeeeccccccCCccCccccc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 003237 672 SDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKY 746 (837)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 746 (837)
+|||++........ ......++..|+|||.+. ...++.++|||||||++|||++|+.|+........
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------ 234 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------ 234 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------
Confidence 99999876532211 122356888999999886 34688899999999999999999999853221100
Q ss_pred HHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 747 AWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 747 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.... .....+.+. .......+.+++.+|++.+|.+||++.|+++
T Consensus 235 ~~~~------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 LFLI------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhhH------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 000011111 1112345788999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=295.44 Aligned_cols=253 Identities=25% Similarity=0.439 Sum_probs=199.0
Q ss_pred CCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCc------cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
+|+..+.||+|+||.||+++. .+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999976 4689999999864321 134678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-Ceeecccccceec
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVF 680 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~DFGla~~~ 680 (837)
|+||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998643 35788999999999999999999987 99999999999998776 5999999998776
Q ss_pred cCccce--eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 681 GGEEIL--AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 681 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
...... .......++..|+|||.+.+..++.++||||+|++++||++|+.|+....... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~----- 226 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIASA----- 226 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhcc-----
Confidence 433111 11223467889999999988899999999999999999999999985332211 11111111000
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
......+......+.+++.+|++.+|++||++.++++
T Consensus 227 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011122233456778999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=301.10 Aligned_cols=245 Identities=23% Similarity=0.342 Sum_probs=196.1
Q ss_pred cCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCC
Q 003237 532 TSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (837)
Q Consensus 532 ~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 610 (837)
....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3458999999999999765 689999999876555556778899999999999999999999999999999999999999
Q ss_pred hhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeec
Q 003237 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK 690 (837)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 690 (837)
|..++.. ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++........ ...
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 175 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK 175 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence 9987743 34789999999999999999999987 99999999999999999999999999875543221 122
Q ss_pred cccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCH
Q 003237 691 RVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLA 770 (837)
Q Consensus 691 ~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 770 (837)
...++..|+|||++.+..++.++|||||||+++||++|+.|+..... ...... . ....... .. ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~---~-~~~~~~~-----~~--~~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKR---L-RDSPPPK-----LK--NAH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH---H-hccCCCC-----cc--ccC
Confidence 35688999999999998999999999999999999999999853221 111111 1 1110000 00 001
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 771 SEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 771 ~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.....+.+++.+|++.+|++||++++|++
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 11234678899999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=297.66 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=199.8
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999875 68999999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+ +++|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886543 45899999999999999999999987 99999999999999999999999999987654321
Q ss_pred eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc---------
Q 003237 686 LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK--------- 755 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------- 755 (837)
. ......++..|+|||.+.+. .++.++||||+|++++||++|+.++....+ ...............
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 R-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred C-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence 1 12235688899999998754 468999999999999999999777643221 111111111111100
Q ss_pred ---ccccccccc----ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 756 ---ALEIVDSSM----ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 756 ---~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
...+..+.. ......+....+.+++.+|++.+|++|||+++++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 000111223677899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=298.06 Aligned_cols=255 Identities=24% Similarity=0.380 Sum_probs=199.0
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecccccCC-----
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED----- 597 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~----- 597 (837)
.++++|++.+.||+|+||.||+|... +++.+++|.+.... ...+++.+|+.++.++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999875 57889999986543 3457789999999999 6999999999997654
Q ss_pred -ccEEEEEecCCCChhhHhhhcC-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccc
Q 003237 598 -ENMLIYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (837)
Q Consensus 598 -~~~lV~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFG 675 (837)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ |+|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 3799999999999999886532 2346889999999999999999999987 9999999999999999999999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccC-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALD-----GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
++........ ......++..|+|||.+.. ..++.++|||||||+++||++|+.|+..... ... ....
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~----~~~~ 230 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRA----LFKI 230 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHH----HHHh
Confidence 9876543221 1223567889999998753 3478899999999999999999999853211 111 1111
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. ... +.+. ........+.+++.+|++.||++|||+.||++
T Consensus 231 ~~-~~~-----~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PR-NPP-----PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hc-cCC-----CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 000 0110 11123356779999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=299.74 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=194.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|+..+.||+|++|.||+|+.. +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999876 688999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++ +|.+++.... ..+++.....++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 8988876433 25788999999999999999999987 99999999999999999999999999875432211
Q ss_pred eeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc-------
Q 003237 686 LAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL------- 757 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------- 757 (837)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ..................
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhh
Confidence 1 112346788999999875 4589999999999999999999999853321 111111111111100000
Q ss_pred --c-------ccc-ccccccc-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 --E-------IVD-SSMANSC-LASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 --~-------~~d-~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+ ... ..+.... .......+.+++.+|++.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000 0000000 0011245678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=298.88 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=191.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHH-HHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLL-IAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|++.+.||+|+||.||+++.. +|+.||+|++.... .....++..|+.+ ++.++||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36778899999999999999875 68999999986542 2234455566665 555689999999999999999999999
Q ss_pred ecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 605 FMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 605 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
|++ ++|..++... .....+++.....++.||+.||.|||++. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 6787777542 23356899999999999999999999862 3999999999999999999999999998865432
Q ss_pred cceeeeccccccCCccCcccccC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALD----GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
.. .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+..... . . ........ +.
T Consensus 158 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~--~-~~~~~~~~-~~---- 224 (283)
T cd06617 158 VA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--P--F-QQLKQVVE-EP---- 224 (283)
T ss_pred cc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--C--H-HHHHHHHh-cC----
Confidence 11 122457889999998865 4568899999999999999999999853211 1 0 11111111 00
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+.+.. ......+.+++..|++.+|++||++.+|++
T Consensus 225 -~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 -SPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011110 012245778999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=299.08 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=200.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
++|.+.+.||+|+||.||++... ++..||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999754 68899999986554455677889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999853 24788899999999999999999987 999999999999999999999999998765433221
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....++..|+|||.+....++.++||||||+++||+++|+.||......... . .....+. +..
T Consensus 172 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~----~~~~~~~------~~~-- 235 (293)
T cd06647 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIATNGT------PEL-- 235 (293)
T ss_pred --cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--e----ehhcCCC------CCC--
Confidence 12346788999999999888999999999999999999999998643221110 0 0000000 000
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.........+.+++..|++.+|++||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111123456789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=295.44 Aligned_cols=247 Identities=24% Similarity=0.416 Sum_probs=197.1
Q ss_pred CCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCC-CccCHHHHHHHHHHHHHhc---CCCeeeeecccccCCccEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.|+..+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778999999999999986 46899999998654 3345677889999999997 999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++.. ..+++.....++.|+++||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988743 25889999999999999999999987 999999999999999999999999999876543
Q ss_pred cceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.. ......|+..|+|||.+.++ .++.++||||||+++|||++|+.|+..... ..... .... ...+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~------~~~~~-~~~~-----~~~~ 220 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA------FRAMM-LIPK-----SKPP 220 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh------hhhhh-cccc-----CCCC
Confidence 31 12234688899999998754 578999999999999999999999863221 11110 0000 0111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+... .....+.+++.+|++.+|++||++.+++.
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111 12345778999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=296.33 Aligned_cols=246 Identities=24% Similarity=0.430 Sum_probs=197.4
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
|+..+.||+|+||.||+|... ++..+|||.+.... ....+.+.+|+.++.+++|+||+++++++.++...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 566789999999999999764 68899999886432 2345678899999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|..++.. ..+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06641 86 GGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh-
Confidence 9999988843 34789999999999999999999987 999999999999999999999999998866433211
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
.....++..|+|||.+.+..++.++|||||||+++||++|+.|+..... . ...... ..... +.+..
T Consensus 158 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~---~~~~~~-~~~~~-----~~~~~- 223 (277)
T cd06641 158 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---M---KVLFLI-PKNNP-----PTLEG- 223 (277)
T ss_pred -hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---H---HHHHHH-hcCCC-----CCCCc-
Confidence 1224678899999999988899999999999999999999999853211 1 111111 11110 11111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.....+.+++.+|++.+|++||+|.++++.
T Consensus 224 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 ---NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 223456789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=288.89 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=203.6
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLIY 603 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 603 (837)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3666789999999999999886 688999999865542 4567889999999999999999999999888 7889999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986543 6899999999999999999999987 999999999999999999999999999877654
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
..........++..|+|||.+....++.++||||||+++++|++|+.|+.... ................
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~------ 223 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPP------ 223 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCc------
Confidence 32111233568889999999998889999999999999999999999986443 1111111111101111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+......+.+++.+|++.+|++||++.++++
T Consensus 224 ---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 ---EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 112222456789999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=293.60 Aligned_cols=252 Identities=25% Similarity=0.439 Sum_probs=199.2
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc--CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ--GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|...+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677899999999999999865 6889999998765442 567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++... ..+++..+..++.++++||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998643 34788899999999999999999988 99999999999999999999999999987654322
Q ss_pred eee--eccccccCCccCcccccCCC---CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 686 LAI--TKRVVGTYGYMSPEYALDGV---FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 686 ~~~--~~~~~gt~~y~APE~~~~~~---~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
... .....++..|+|||++.+.. ++.++||||||++++|+++|+.||..... .. ........ +.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~---~~~~~~~~-~~----- 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EF---QIMFHVGA-GH----- 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hH---HHHHHHhc-CC-----
Confidence 111 12346788999999998776 89999999999999999999999864321 11 11111100 00
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+.+... ......+.+++.+|++.+|++||++.|++.
T Consensus 224 ~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111110 011334668899999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=297.10 Aligned_cols=261 Identities=23% Similarity=0.354 Sum_probs=194.6
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|+..+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3677889999999999999875 68899999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+. ++|..++.... ...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 58888875533 345889999999999999999999987 99999999999999999999999999876543211
Q ss_pred eeeeccccccCCccCcccccCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc---------
Q 003237 686 LAITKRVVGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK--------- 755 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------- 755 (837)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+..... ...+............
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCChhhhhhhhHH
Confidence 112235678899999887654 68899999999999999999999853221 1111111111100000
Q ss_pred ------cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 756 ------ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 756 ------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
........+. .........+.+++.+|++.||++||||+++++
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 000111234678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=296.45 Aligned_cols=262 Identities=24% Similarity=0.381 Sum_probs=198.2
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+|+..++||+|++|.||+|+.. +|..||||.+..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4777899999999999999886 688999999875432 23567788999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++ +|.+++........+++..+..++.||++||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888765544456899999999999999999999987 99999999999999999999999999976533211
Q ss_pred eeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc---cc-----
Q 003237 687 AITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK---AL----- 757 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~----- 757 (837)
......++..|+|||.+.+. .++.++||||||++++||++|+.|+...... .............. ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE---DQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhhHHHHhcC
Confidence 11224567889999988664 5789999999999999999999998643221 11111111110000 00
Q ss_pred ccccccc-------ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 EIVDSSM-------ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 ~~~d~~l-------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+.... .....+.....+.+++.+|++.+|.+||++++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 00111122355779999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=300.70 Aligned_cols=257 Identities=18% Similarity=0.244 Sum_probs=199.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||++... .++.||+|.+.... ....+.+.+|++++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36778899999999999999875 57899999986543 233557789999999999999999999999998999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++... ..+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999998543 34788888999999999999999987 999999999999999999999999998742111
Q ss_pred cc-------------eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 684 EI-------------LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 684 ~~-------------~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
.. ........++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ...+.. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~~---~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFG---QV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HH
Confidence 00 001112457889999999999899999999999999999999999985221 111111 11
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. + ....+.... .....+.+++.+|++.+|++||++.++.++|+..
T Consensus 229 ~~-~---~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 229 IS-D---DIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred Hh-c---ccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 11 0 001111111 1223467899999999999999987777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=311.03 Aligned_cols=243 Identities=26% Similarity=0.396 Sum_probs=191.9
Q ss_pred CCcccccCCeeEEEEEec-CCcEEE---EEEec-CCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc--cEEEEEe
Q 003237 533 SNKLGQGGFGPVYKGKLS-NGQEIA---VKRLS-TTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE--NMLIYEF 605 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~-~g~~va---vK~l~-~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~lV~ey 605 (837)
..+||+|+|-+||||... +|-+|| ||.-. ...+...+.|..|+++|+.|+|+|||+++..+.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 468999999999999765 577776 22211 1234556889999999999999999999999988766 6789999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-CCCCeeecccccceeccCcc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~DFGla~~~~~~~ 684 (837)
|..|+|..++.+-. .++.+....+++||++||.|||++. +||||||||-.||+|+ ..|.+||+|+|||.......
T Consensus 125 ~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999986543 3778899999999999999999987 6899999999999998 46899999999999876443
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
.+.+.|||.|||||+.. ..|++.+|||||||.++||+|+..||..-.. ..++.+.+........+..+-|
T Consensus 201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~kV~d--- 270 (632)
T KOG0584|consen 201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALSKVKD--- 270 (632)
T ss_pred ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhhccCC---
Confidence 23379999999999765 8999999999999999999999999864322 2223332222211111222222
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.++.++|-+|+.. .++|||+.|+++
T Consensus 271 ---------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 ---------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 2456888999999 999999999985
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.92 Aligned_cols=240 Identities=21% Similarity=0.256 Sum_probs=183.4
Q ss_pred ccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHh---cCCCeeeeecccccCCccEEEEEecCC
Q 003237 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL---QHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 536 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
||+|+||+||+|+.. +++.||||++.+.. ......+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 58999999986432 12233455677777665 699999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|..++... ..+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~ 152 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T 152 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence 9999888543 34788999999999999999999988 99999999999999999999999999875432221 1
Q ss_pred eccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||..... ......... +.. .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~-~~~------~~~~~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAF-GKV------RFPKN 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHc-CCC------CCCCc
Confidence 2346789999999998765 489999999999999999999999853211 111111111 110 01110
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPS----MSTVVF 799 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPt----m~eVv~ 799 (837)
.....+.+++.+|++.+|++||+ +.++++
T Consensus 220 ---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 ---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11234668889999999999984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.98 Aligned_cols=248 Identities=28% Similarity=0.454 Sum_probs=201.6
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+||+++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 667789999999999999886 6889999999766555667899999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
++|.+++.... ..+++..+..++.|++.||.|||..+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999886532 45899999999999999999999977 99999999999999999999999999887654332
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+..... ...... . .......+..+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~---~-~~~~~~~~~~~------ 220 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFK---I-ATNGPPGLRNP------ 220 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch---HHHHHH---H-HhcCCCCcCcc------
Confidence 2335678899999999988899999999999999999999999863321 111111 1 00111111110
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..-...+.+++..|++.+|++|||+.||++
T Consensus 221 -~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 -EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001345788999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.58 Aligned_cols=245 Identities=22% Similarity=0.377 Sum_probs=203.9
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
|.+.++||+|+||.|||+.++ .|+.+|||++... ..++++..|+.+|++.+.|++|+++|.+......++|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556789999999999999776 6999999998543 4678999999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+..+.+.. +++.|...++..++...++||+|||... -||||||+.||||+-+|.+||+|||.|..+... ...
T Consensus 113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAK 185 (502)
T KOG0574|consen 113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAK 185 (502)
T ss_pred CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HHh
Confidence 999999854 4567999999999999999999999876 799999999999999999999999999876432 233
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc--ccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD--SSMAN 766 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d--~~l~~ 766 (837)
...+.||+.|||||++..-.|+.++||||+|+...||.-|++|+.....-. ..-.+. |...-
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------------AIFMIPT~PPPTF 249 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------------AIFMIPTKPPPTF 249 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------------eeEeccCCCCCCC
Confidence 445889999999999999999999999999999999999999985332210 000111 11111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..++.=..++-+++..|+-.+|++|-|+.++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 123333567789999999999999999998875
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=302.96 Aligned_cols=252 Identities=26% Similarity=0.352 Sum_probs=202.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecC--CCccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLST--TSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 603 (837)
...|++.++||+||.+.||++...+.+.+|+|++.. .+.+....|.+|+.+|.+++ |.+||+|++|-..++..||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 356788899999999999999988888999998754 35667888999999999996 999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
|| ..-+|..+|..... ....| .+..+..|++.++.++|+++ |||.||||.|+|+-. |.+||+|||.|..+..+
T Consensus 440 E~-Gd~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 EC-GDIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ec-ccccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 98 45588888865433 33456 55668899999999999998 999999999999965 68999999999998887
Q ss_pred cceeeeccccccCCccCcccccCCC-----------CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGV-----------FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS 752 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~-----------~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 752 (837)
.........+||+.||+||.+.... .+.++||||+|||||+|+.|+.||.... + .|
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n--~~------ 579 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N--QI------ 579 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H--HH------
Confidence 7766667789999999999986432 5678999999999999999999995321 1 11
Q ss_pred cCccccccccccccccCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 753 DNKALEIVDSSMANSCLA-SEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 753 ~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.++..+.||.-.-+++. .+-.++++++..|++.||++|||..++++
T Consensus 580 -aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 -AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 12344555532211111 11122889999999999999999999986
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=298.47 Aligned_cols=261 Identities=24% Similarity=0.312 Sum_probs=196.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV 602 (837)
++|+..+.||+|+||.||+|+.. +++.+|+|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999876 588999999864422 2234567899999999999999999998877 788999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++ +|.+++.... ..+++.....++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 8888875432 35899999999999999999999987 99999999999999999999999999987654
Q ss_pred ccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc--------
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD-------- 753 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-------- 753 (837)
... ......++..|+|||.+.+. .++.++|+||||++++||++|+.|+...... .........+..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI---DQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchHHHHH
Confidence 321 11224568899999998764 4689999999999999999999998643221 111111111000
Q ss_pred ---------CccccccccccccccCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 ---------NKALEIVDSSMANSCLAS-EALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 ---------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..........+...+... ....+.+++..|++.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000001111111111111 2445678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.75 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=194.4
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++++|.+.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+.++..++|+||+++++++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4567888999999999999999764 688999999865432 33346788999999999999999999999988999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+. ++|..++... ...+.+.....++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 6776666432 234678888889999999999999987 999999999999999999999999998764322
Q ss_pred cceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC--------
Q 003237 684 EILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN-------- 754 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 754 (837)
... .....++..|+|||++.+. .++.++||||||++++||++|+.|+...... ..............
T Consensus 157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhh
Confidence 111 1224568899999998764 5889999999999999999999998643221 11111111110000
Q ss_pred ----cc-cccccccccccc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 755 ----KA-LEIVDSSMANSC-----LASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 755 ----~~-~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. .+.......... ...+...+.+++.+|++.+|.+||||+|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 000000000000 0011345678899999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.19 Aligned_cols=246 Identities=27% Similarity=0.432 Sum_probs=193.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
+.|...+.||+|+||.||+|+.. +++.||+|.+..... ...+++.+|++++..++||||+++++++.+....++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777899999999999999875 689999999864432 23356889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||++ |+|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 5666665432 235899999999999999999999987 999999999999999999999999998765432
Q ss_pred cceeeeccccccCCccCccccc---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYAL---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
....++..|+|||++. ...++.++||||||+++|||++|+.|+..... .......... ..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~~~-~~---- 231 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-DS---- 231 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHhcC-CC----
Confidence 2246788999999884 45689999999999999999999999753211 1111111110 00
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
+.+ ........+.+++.+|++.+|++||+|.+|+..
T Consensus 232 -~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 -PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011 011223457889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.56 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=201.9
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++.|+..+.||+|+||.||+|... ++..+++|.+..... ..+.+.+|++++.+++|+||+++++.+......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566788899999999999999886 688999999975543 56778899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999996543 36899999999999999999999977 9999999999999999999999999987554322
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ..... .... .......+
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~---~~~~~---~~~~-~~~~~~~~--- 238 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALF---LITT-KGIPPLKN--- 238 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHh-cCCCCCcc---
Confidence 1 11224577899999999988999999999999999999999999853211 11111 1101 11111000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.......+.+++.+|++.+|.+||++.+|++
T Consensus 239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 ----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112245778999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.03 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=194.7
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
|++.+.||+|++|.||+|... +|..||+|++.... ....+.+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456789999999999999875 79999999986543 223457889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
+ ++|.+++..... ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 689888854332 35899999999999999999999987 999999999999999999999999999765322111
Q ss_pred eeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc--------cc
Q 003237 687 AITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK--------AL 757 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------~~ 757 (837)
.....++..|+|||++.+. .++.++||||||+++|||++|+.|+..... ...+............ ..
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE--IDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhhhhhhch
Confidence 1123467889999988764 579999999999999999999999854321 1111111111000000 00
Q ss_pred cc---ccc---ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 EI---VDS---SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 ~~---~d~---~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+. +.. .............+.+++.+|++.+|++|||++||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 000 0000011112246779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.94 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=196.5
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccEEEEE
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLIYE 604 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e 604 (837)
|++.++||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++.+++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456789999999999999876 58899999997653 33446788999999999999999999999887 78999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++ +|..++.... ..+++..+..++.||++||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 8888875432 35889999999999999999999987 9999999999999999999999999998765433
Q ss_pred ceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc------cc
Q 003237 685 ILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK------AL 757 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~ 757 (837)
.. ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+..... ............... ..
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE---LEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCchhhccccc
Confidence 21 1122456788999998765 4689999999999999999999999864322 111111111111000 00
Q ss_pred c-----------ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 E-----------IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 ~-----------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. .....+.......+...+.+++.+|++.+|++||++++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00000111111112456789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=295.26 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=197.3
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
|...++||+|++|.||++... +++.+++|++........+.+.+|+.++..++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 344579999999999999864 6889999998655555566788999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999998865 24788999999999999999999987 99999999999999999999999998875543211 1
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+.... . ......... ... +.+..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~---~---~~~~~~~~~-~~~-----~~~~~-- 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP---P---LQAMKRIRD-NLP-----PKLKN-- 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC---H---HHHHHHHHh-cCC-----CCCcc--
Confidence 123468889999999998899999999999999999999999975321 1 111111111 100 11110
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.......+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1112246789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.13 Aligned_cols=247 Identities=25% Similarity=0.304 Sum_probs=199.4
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
+|++.+.||+|+||.||++... +++.+|+|.+.+.. ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677889999999999999876 58999999986542 2346788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+.+++|.+++... ..++......++.||++||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998543 35788999999999999999999987 9999999999999999999999999988765432
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
......++..|+|||.+.+..++.++||||||+++|+|++|+.|+......... ........ .. +
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~--~~----~-- 219 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAKQET--AD----V-- 219 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HHHHHhcc--cc----c--
Confidence 122356788999999999888999999999999999999999998644322111 11111110 00 0
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSM--STVV 798 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm--~eVv 798 (837)
..+......+.+++.+|++.+|.+||++ +|++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 --LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111223567899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.14 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=198.6
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|+..+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4667789999999999999876 58899999986432 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-CeeecccccceeccCcc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGGEE 684 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~DFGla~~~~~~~ 684 (837)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ |+|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999986533 235789999999999999999999987 99999999999999885 46999999988765332
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. ......|+..|+|||++.+..++.++||||||++++||++|+.|+.... .......... +....
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~~------ 221 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ-GYFAP------ 221 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-ccCCC------
Confidence 1 1122457889999999998899999999999999999999999985321 1122211111 11111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
........+.+++.+|++.+|++|||+.||++.
T Consensus 222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111223457789999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=297.08 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=193.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCc-----
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDE----- 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~----- 598 (837)
++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++..++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36788899999999999999875 68999999876442 223467888999999995 6999999999877665
Q ss_pred cEEEEEecCCCChhhHhhhcCC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC-CCCeeecccc
Q 003237 599 NMLIYEFMPNKSLDYFIFDESR--KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFG 675 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~DFG 675 (837)
.++||||+++ +|..++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78888765332 345899999999999999999999987 999999999999998 8999999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN 754 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 754 (837)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|+.|+..... ...+.... ......
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~-~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE--LQQLLHIF-KLLGTP 231 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHH-HHhCCC
Confidence 98865332111 112346788999998865 4579999999999999999999998853221 11111111 111000
Q ss_pred ccc------cccc----cc----cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 755 KAL------EIVD----SS----MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 755 ~~~------~~~d----~~----l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... ...+ +. ......+.....+.+++.+|++.+|.+||+++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0000 00 000001122355788999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=305.50 Aligned_cols=267 Identities=20% Similarity=0.309 Sum_probs=197.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC-----cc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----EN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~ 599 (837)
+++|++.++||+|+||.||+|+.. +|+.||||.+... .......+.+|+.++.+++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467899999999999999999764 6899999998643 2234566788999999999999999998876543 46
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++|+||+++ +|...+.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999975 77666632 35889999999999999999999987 99999999999999999999999999987
Q ss_pred ccCcccee-eeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc--
Q 003237 680 FGGEEILA-ITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK-- 755 (837)
Q Consensus 680 ~~~~~~~~-~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-- 755 (837)
........ ......++..|+|||.+.+ ..++.++|||||||+++||++|+.|+..... ...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---LHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCCHH
Confidence 54322111 1123467889999998765 5689999999999999999999999853211 111111111111110
Q ss_pred -ccccccccc-------c--c-----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccC
Q 003237 756 -ALEIVDSSM-------A--N-----SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNE 804 (837)
Q Consensus 756 -~~~~~d~~l-------~--~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~--L~~~ 804 (837)
...+.+... . . ...+.....+.+++.+|++.+|++|||+.|+++. ++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000010000 0 0 0011123557899999999999999999999985 6554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=307.17 Aligned_cols=203 Identities=30% Similarity=0.467 Sum_probs=176.1
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC------ccEE
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ENML 601 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~l 601 (837)
+...+.||+|+||.||+|+.+ .|+.||||.+++.. ....+...+|+++|++++|+|||++++.-.+.. ..++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445679999999999999864 79999999997653 334566778999999999999999999865543 5689
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc--C--CCCeeecccccc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--E--KMNPRISDFGTA 677 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~--~--~~~~ki~DFGla 677 (837)
|||||.+|+|...|.+..+..-|+..+.+.++.+++.||.|||+++ |+||||||.||++- + ....||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988888778999999999999999999999888 99999999999983 3 345899999999
Q ss_pred eeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDD 738 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~ 738 (837)
+.+..+. ......||..|++||++.. +.|+..+|.|||||++||..||..||......
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9887654 3344889999999999984 89999999999999999999999999876554
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=295.63 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=192.1
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|...++||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999875 58999999986542 234567889999999996 99999999999998899999999
Q ss_pred cCCCChhhHhhh--cCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 606 MPNKSLDYFIFD--ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 606 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
+.. +|..+... ......+++.....++.++++||+|||+.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 875 44443221 112345889999999999999999999752 3999999999999999999999999998765432
Q ss_pred cceeeeccccccCCccCcccccCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDG---VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~---~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
.. .....++..|+|||.+.+. .++.++|||||||+++||++|+.|+.... .............
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~------ 227 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD------ 227 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC------
Confidence 21 1224578899999999876 68999999999999999999999986432 1111111111110
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+.+...........+.+++.+|++.+|++|||+++|++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111111223446789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=288.92 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=201.5
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|++.++||+|+||.||+++.. +++.+|+|.+.... .....++.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999764 68899999986532 23455778899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcC-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 606 MPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 606 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
+++++|..++.+.. ....+++.....++.|++.||.|||+.+ ++|+||+|.||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999986532 2345889999999999999999999987 999999999999999999999999999876543
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
......++..|+|||.+.+..++.++|+||||++++||++|+.|+..... ..+... ......
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~----~~~~~~-------- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYK----VQRGKY-------- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HhcCCC--------
Confidence 12234578899999999999999999999999999999999999864321 111111 111111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
..........+..++..|++.+|++||++.++++.
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 -PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11122344568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=297.65 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=195.0
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
|...+.||+|+||.||+++.. ++..+|+|++..... .....+.+|++++++++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566789999999999999865 688999999864422 2345788899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++ +|.+.+... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 975 776666432 234899999999999999999999987 999999999999999999999999998754322
Q ss_pred eeeeccccccCCccCccccc---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYAL---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
....++..|+|||++. .+.++.++|||||||+++||++|+.|+..... . ........... +
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~---~~~~~~~~~~~------~ 242 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---M---SALYHIAQNES------P 242 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---H---HHHHHHHhccC------C
Confidence 2346788999999974 45789999999999999999999999753211 1 11111111110 0
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFV 807 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~~ 807 (837)
.. ........+.+++.+|++.+|.+||++.+|++.+-.....
T Consensus 243 ~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 243 TL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 00 0111233577899999999999999999999866544333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=293.22 Aligned_cols=243 Identities=24% Similarity=0.336 Sum_probs=197.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36778899999999999999875 68999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++... ..++...+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998654 35788999999999999999999987 999999999999999999999999999876543
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.....+++.|+|||.+.+...+.++||||||++++||++|+.|+.... ...... ... .+.. .
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~---~~~-~~~~------~ 216 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYE---KIL-EGKV------R 216 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HHh-cCCc------c
Confidence 233568899999999998889999999999999999999999985322 111111 111 1110 1
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVV 798 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv 798 (837)
+ +......+.+++.+|++.+|.+|| +++|++
T Consensus 217 ~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 F----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred C----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1 111234577899999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.77 Aligned_cols=263 Identities=24% Similarity=0.356 Sum_probs=195.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCC--ccE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED--ENM 600 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~--~~~ 600 (837)
.++|++.+.||+|+||.||+|... +++.+|||++... .......+.+|+.++.++ +|+||+++++++...+ ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888899999999999999875 5889999988542 233445677899999999 9999999999886543 579
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||++ ++|..++... .+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999998 4888877432 5789999999999999999999987 999999999999999999999999999866
Q ss_pred cCccce---eeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh-----
Q 003237 681 GGEEIL---AITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELW----- 751 (837)
Q Consensus 681 ~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----- 751 (837)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......+ .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~ 234 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN---QLEKIIEVIGPPSA 234 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCH
Confidence 433211 12223567889999998765 567899999999999999999999985432211 111100000
Q ss_pred ------ccCcccccccccc------ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 752 ------SDNKALEIVDSSM------ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 752 ------~~~~~~~~~d~~l------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.......+++... ...........+.+++.+|++.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000001111000 000011123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=301.08 Aligned_cols=259 Identities=24% Similarity=0.300 Sum_probs=194.8
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccC------
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------ 596 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 596 (837)
..++|+..+.||+|+||.||+++.. +++.||||.+... .....+.+.+|++++.+++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467999999999999999999865 6899999998643 223345677899999999999999999987643
Q ss_pred CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
...++||||+.+ +|...+... ++......++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 246899999965 777766422 788888899999999999999987 99999999999999999999999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc----
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS---- 752 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---- 752 (837)
++....... .....++..|+|||.+.+..++.++|||||||++++|++|+.||...... .........+.
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 238 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI---DQWNKIIEQLGTPSD 238 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence 987643321 22245788999999999999999999999999999999999998533210 00000000000
Q ss_pred ---------------cCc------ccccccccc----ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 753 ---------------DNK------ALEIVDSSM----ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 753 ---------------~~~------~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... ..+++...+ ...........+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 001111100 00001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.43 Aligned_cols=265 Identities=24% Similarity=0.352 Sum_probs=197.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC-----c
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----E 598 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~ 598 (837)
.++|.+.+.||+|+||.||+++.. ++..||||.+... .......+.+|+.++..++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888899999999999999764 6899999998653 2334456778999999999999999999886543 4
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.++|+||+. ++|..++... ..+++.....++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 699999996 6787777532 35889999999999999999999987 9999999999999999999999999998
Q ss_pred eccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc----
Q 003237 679 VFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD---- 753 (837)
Q Consensus 679 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---- 753 (837)
...... .......++..|+|||.+.+ ..++.++|||||||+++||++|+.|+..... .............
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY---VHQLKLITELLGSPSEE 231 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCChH
Confidence 764332 11223457889999998875 4689999999999999999999999854321 1111111111110
Q ss_pred -------Ccccccc-------ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccC
Q 003237 754 -------NKALEIV-------DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNE 804 (837)
Q Consensus 754 -------~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~--L~~~ 804 (837)
......+ +.... .........+.+++.+|++.+|++|||++++++. ++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000 00000 0011234567899999999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.13 Aligned_cols=270 Identities=26% Similarity=0.327 Sum_probs=211.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
+.|..-++||+|+||+||-.+.. +|..+|.|++.+. ..++..-..+|-.+|.+++.+.||.|-..+.+.+..+||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56777789999999999999765 6899999988654 3445566788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
..|+||+|+.+|..... +.++....+-.+.+|+-||++||+.. ||.|||||+|||||+.|+++|+|+|||..+...
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999977654 45888888889999999999999988 999999999999999999999999999987765
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
+.. ....||.+|||||++.++.|+...|.||+||+||||+.|+.||....+... .+-+|.+
T Consensus 341 ~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------------~eEvdrr 401 (591)
T KOG0986|consen 341 KPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------------REEVDRR 401 (591)
T ss_pred Ccc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------------HHHHHHH
Confidence 432 224899999999999999999999999999999999999999964322111 1112221
Q ss_pred c---ccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHH----------HHhcc-CCCCCCCCCCCcccccc
Q 003237 764 M---ANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVV----------FMLSN-ETFVPSPKQPTFSVRRT 820 (837)
Q Consensus 764 l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv----------~~L~~-~~~~~~p~~p~~~~~~~ 820 (837)
. ...++.....++..+...-++.||++|. .+++|- ++|+. -.+.|.-|.|.--.+.+
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakD 477 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKD 477 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhh
Confidence 1 1223344444555555567788998885 445554 34443 35566666666555544
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=297.00 Aligned_cols=263 Identities=21% Similarity=0.316 Sum_probs=191.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc------
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE------ 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------ 598 (837)
++|+..++||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888899999999999999875 68999999886432 2223456789999999999999999999876543
Q ss_pred --cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 599 --NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 599 --~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
.++||||+.+ +|...+... ...+++.+...++.||++||.|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4999999975 777776432 235789999999999999999999987 99999999999999999999999999
Q ss_pred ceeccCccce--eeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc
Q 003237 677 ARVFGGEEIL--AITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD 753 (837)
Q Consensus 677 a~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 753 (837)
+......... .......++..|+|||.+.+. .++.++||||||++++||++|+.|+..... .............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~---~~~~~~~~~~~~~ 242 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE---QHQLTLISQLCGS 242 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCC
Confidence 9866432211 111224567889999988764 478999999999999999999998853321 1111111111110
Q ss_pred --------Ccccccccc-cccccc---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 --------NKALEIVDS-SMANSC---------LASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 --------~~~~~~~d~-~l~~~~---------~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....+..+. .+.... ...+...+.+++.+|++.+|++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000000 000000 0011234678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=297.19 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=193.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 601 (837)
.++|++.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999875 689999999864322 2233566899999999999999999998755 45799
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+.+ +|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 7877775432 45899999999999999999999988 9999999999999999999999999998765
Q ss_pred CccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc--cc-
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK--AL- 757 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--~~- 757 (837)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ............... ..
T Consensus 160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE---IEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChhhch
Confidence 43211 112345778999999875 5689999999999999999999999863221 111211111111000 00
Q ss_pred --------cc--ccccccccc---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 --------EI--VDSSMANSC---LASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 --------~~--~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. +........ .......+.+++.+|++.||++|||++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 000000000 0011345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=294.92 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=195.3
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC----
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED---- 597 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 597 (837)
...++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578899999999999999999886 58899999986542 223456778999999999999999999987655
Q ss_pred ------ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeee
Q 003237 598 ------ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (837)
Q Consensus 598 ------~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 671 (837)
..++|+||+++ +|...+... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 67899999987 666665432 335899999999999999999999987 999999999999999999999
Q ss_pred cccccceeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 672 SDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
+|||++......... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.|+..... ..........
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRL 233 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH
Confidence 999999876433211 1112345778999998865 4578999999999999999999999863221 1111111111
Q ss_pred hccCcc---ccc--------ccc------ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 751 WSDNKA---LEI--------VDS------SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 751 ~~~~~~---~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...... ..+ .+. ...... ......+.+++..|++.+|.+||++++|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111100 000 000 000000 011345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=322.46 Aligned_cols=258 Identities=29% Similarity=0.430 Sum_probs=206.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec----C----CcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS----N----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~----~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 597 (837)
++..+.+.||+|.||.|++|... . ...||||.++... ....+.+..|+++|..+ +|+||+.++|+|....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455679999999999999753 1 4579999997653 34667899999999999 5999999999999988
Q ss_pred ccEEEEEecCCCChhhHhhhcC------C-----C--CCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDES------R-----K--QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 664 (837)
..++|.||+..|+|..+|.... . . ..+.....+.++.|||.|++||++.. +|||||.++|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999997654 0 0 23888999999999999999999987 99999999999999
Q ss_pred CCCCeeecccccceeccCccceeee-ccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003237 665 EKMNPRISDFGTARVFGGEEILAIT-KRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSN 742 (837)
Q Consensus 665 ~~~~~ki~DFGla~~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 742 (837)
++..+||+|||+++........... ....-+..|||||.+....|+.|+|||||||+||||+| |..|+..... ...
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~~ 530 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TEE 530 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HHH
Confidence 9999999999999977665544322 11124667999999999999999999999999999998 7778743110 111
Q ss_pred HHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 743 LIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 743 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
+ .+.+.++...+ .+.....++..++..||+.+|++||+..++++.|+.
T Consensus 531 l----~~~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 531 L----LEFLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred H----HHHHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 1 22333333322 222234567799999999999999999999999987
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=284.96 Aligned_cols=265 Identities=24% Similarity=0.323 Sum_probs=216.8
Q ss_pred HHHHHHhhcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecc
Q 003237 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGC 592 (837)
Q Consensus 520 ~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~ 592 (837)
..++....+++.....+-+|.||.||+|.+. +.+.|-||.++... +-....+..|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4556666678888889999999999999554 34567788876542 3345567789999999999999999999
Q ss_pred cccC-CccEEEEEecCCCChhhHhh-----hcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC
Q 003237 593 CLEE-DENMLIYEFMPNKSLDYFIF-----DESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK 666 (837)
Q Consensus 593 ~~~~-~~~~lV~ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~ 666 (837)
+.+. ...+.+|.++.-|+|+.||. +....+.++-.+...++.|++.|++|||.++ +||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8765 45788999999999999997 5555566788888899999999999999998 9999999999999999
Q ss_pred CCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHH
Q 003237 667 MNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIK 745 (837)
Q Consensus 667 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~ 745 (837)
.++||+|=.|++.+-..++.........+..||+||.+.+..|+.++|||||||+||||+| |+.|+......+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------ 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------ 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence 9999999999998888888777777778889999999999999999999999999999998 888875332211
Q ss_pred HHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 746 YAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 746 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
....+....+-..+.....++..++.-||...|++||+.+|++.-|+.
T Consensus 507 ----------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 507 ----------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ----------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 111122222222344456778999999999999999999999998864
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.58 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=201.4
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcE-EEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-IAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~-vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+.|+++..||.|+||.||++..++... .|.|.+.......++.+.-|++||...+||+||+|++.|..++..+|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 446667889999999999998775444 4678887777888899999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
.||-.+..+.... ..|...++.-+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.+..... ..
T Consensus 112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 9999999887654 35889999999999999999999998 99999999999999999999999999865432 12
Q ss_pred eeeccccccCCccCccccc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 687 AITKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.....+.||+.|||||+++ ..+|+.++||||||+.|.||..+.+|-.... ..+....+ .......++.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMRVllKi-aKSePPTLlq 257 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKI-AKSEPPTLLQ 257 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHHHHHHH-hhcCCCcccC
Confidence 2234588999999999886 4589999999999999999999999864321 12222111 1111111221
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+..=...+.++...|+..||..||+++++++
T Consensus 258 -------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 -------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1222344667888999999999999999875
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=299.69 Aligned_cols=243 Identities=28% Similarity=0.448 Sum_probs=193.1
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc---CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ---GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
|+..+.||.|+||.||-++.. +.+.||||++...-.+ ....+..|++.|.+++|||+|.+.|++..+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 555678999999999999764 6889999999765333 356788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
|-| +-.++|.- -++++-..++..|..+.+.||+|||+++ .||||||+.||||++.|.+||+|||.|....+.
T Consensus 108 ClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 108 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred Hhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 966 33444421 1345778888899999999999999998 999999999999999999999999999875443
Q ss_pred eeeeccccccCCccCccccc---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYAL---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
..++||+.|||||++. .+.|+-|+||||+|+...||.-.++|.-.. +.......+-..+ -|
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAMSALYHIAQNe------sP 243 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNE------SP 243 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHHHHHHHHHhcC------CC
Confidence 3478999999999996 468999999999999999999999997422 1122111111111 11
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+. ..+=...+++++-.|++.-|.+|||.++++.
T Consensus 244 tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 111 2334566789999999999999999988753
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.76 Aligned_cols=247 Identities=24% Similarity=0.317 Sum_probs=196.2
Q ss_pred ccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCCh
Q 003237 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 536 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
||+|+||.||+++.. +|+.+++|.+..... ...+.+.+|++++.+++|+||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999886 489999999865432 3456788999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc------
Q 003237 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI------ 685 (837)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~------ 685 (837)
.+++.... .+++..+..++.||++||.|||+.+ |+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99986533 5889999999999999999999987 99999999999999999999999999876533211
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
........++..|+|||.+.....+.++||||||++++||++|+.|+..... . ........ +.. . ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~---~~~~~~~~-~~~-~-----~~ 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---E---EIFQNILN-GKI-E-----WP 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHhc-CCc-C-----CC
Confidence 0112235678899999999988899999999999999999999999853321 1 11111111 100 0 00
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
... .....+.+++..|++.+|++|||+.+|.+.|+.
T Consensus 222 ~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 222 EDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred ccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 000 013457789999999999999999888887764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=291.30 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=197.8
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456689999999999999875 688999999865432 24567888999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++ +|..++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 86 8877775432 45899999999999999999999988 99999999999999999999999999987755431
Q ss_pred eeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc---cccccc-
Q 003237 687 AITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK---ALEIVD- 761 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d- 761 (837)
......++..|+|||.+.+. .++.++||||||+++++|++|+.|+..... ............... ...+.+
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE---IDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCchHhcccchhh
Confidence 11224577889999998876 789999999999999999999998854322 111111111111100 000000
Q ss_pred ----------cc--cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 762 ----------SS--MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 762 ----------~~--l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. ............+.+++..|++.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 000111223457889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=289.16 Aligned_cols=242 Identities=26% Similarity=0.322 Sum_probs=185.7
Q ss_pred cccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHH---hcCCCeeeeecccccCCccEEEEEecC
Q 003237 535 KLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAK---LQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~---l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
.||+|+||.||++... +++.+|+|.+.+... .....+.+|..++.. .+|+||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 588999998865421 122334445444443 369999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++... ..+++.....++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999888543 35899999999999999999999988 9999999999999999999999999987654321
Q ss_pred eeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||.......... ...... .....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~------~~~~~--- 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTL------TVNVE--- 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhh------cCCcC---
Confidence 123468999999998864 568999999999999999999999986433222111 111100 01111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVFM 800 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~~ 800 (837)
.+......+.+++..|++.+|++|| +++++++.
T Consensus 218 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 -LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1222334677889999999999999 69999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=290.78 Aligned_cols=257 Identities=20% Similarity=0.304 Sum_probs=191.2
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhc-CCCeeeeecccccC--CccEEEEE
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEE--DENMLIYE 604 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~e 604 (837)
|.+.++||+|+||.||+|+.. +++.+|+|+++... ........+|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456789999999999999865 68899999986542 222234457888999885 99999999999887 78899999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 4777777543 245899999999999999999999987 999999999999999 999999999998764332
Q ss_pred ceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc----------
Q 003237 685 ILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD---------- 753 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---------- 753 (837)
.. ....++..|+|||.+.. ..++.++|||||||+++||++|+.|+..... .............
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhc
Confidence 11 12457889999997654 5678999999999999999999999854322 1112221111110
Q ss_pred -Ccccccccccccc----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 -NKALEIVDSSMAN----SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 -~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
........+.... .........+.+++.+|++.+|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000100000000 001123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=287.28 Aligned_cols=242 Identities=23% Similarity=0.288 Sum_probs=193.2
Q ss_pred ccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCCh
Q 003237 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 536 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999876 48899999986542 23446788999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeecc
Q 003237 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691 (837)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 691 (837)
.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 9998643 34788999999999999999999987 9999999999999999999999999998765432 1223
Q ss_pred ccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHH
Q 003237 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLAS 771 (837)
Q Consensus 692 ~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 771 (837)
..++..|+|||.+.+..++.++|+||||+++|||++|+.|+.....+ ............ .....+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~---------~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGN---------GKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccC---------CCCCCCcc
Confidence 46788999999998888999999999999999999999998654321 111111111100 01111111
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003237 772 EALRCIQVGLLCVQDRTTDRPS-----MSTVVF 799 (837)
Q Consensus 772 ~~~~l~~l~~~Cl~~~P~~RPt-----m~eVv~ 799 (837)
....+.+++..|++.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2456789999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=299.75 Aligned_cols=245 Identities=25% Similarity=0.365 Sum_probs=202.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
...|.+.+.||+|.|++|.+|++. .+..||||.+.+.. ......+.+|+++|..++|||||+++.+.......++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456888899999999999999775 69999999997653 234456889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||..+|.+.+++....+ +.......+..|+.+|++|||+++ |+|||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999976544 344667778999999999999998 999999999999999999999999999987643
Q ss_pred cceeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
. .....+|++.|.|||++.+..| .+++|+||+|++||-|++|..||+... +.++-++
T Consensus 209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-------------------lk~Lr~r 266 (596)
T KOG0586|consen 209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-------------------LKELRPR 266 (596)
T ss_pred c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-------------------cccccch
Confidence 3 3345899999999999999876 679999999999999999999996321 1222222
Q ss_pred ccccccC--HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCL--ASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~--~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+.+.+. .--..+|-+++.+.+-.+|.+|++++++.+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 2222221 112345678888999999999999999975
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=288.78 Aligned_cols=260 Identities=24% Similarity=0.303 Sum_probs=194.3
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEec
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
|.+.+.||+|+||+||+|+.. +++.|+||++..... .......+|+..+.+++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456789999999999999886 578899999865432 22334457999999999 999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
+++|.+++.... ...+++..+..++.|++++|.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889988876543 245899999999999999999999987 99999999999999999999999999986643221
Q ss_pred eeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc-------------
Q 003237 687 AITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS------------- 752 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~------------- 752 (837)
.....++..|+|||++.. ..++.++||||||++++||++|+.|+......+. .........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ---LYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH---HHHHHHhcCCCChhhhhhHhhh
Confidence 122457889999998854 4579999999999999999999988854322110 100000000
Q ss_pred cCccccccccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 753 DNKALEIVDSSMA---NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 753 ~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.......+..... ..........+.+++.+|++.+|++|||++|++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000 00011113568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=284.70 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=202.7
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|.+.+.||+|+||.||++... +++.+|+|++..... ...+++.+|++++++++|+|++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677789999999999999875 688999999865432 4567788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcC-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 606 MPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 606 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986532 2356899999999999999999999987 9999999999999999999999999998765443
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
.......+++.|+|||.+.+..++.++||||+|+++++|++|+.|+.... .......... .... .+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~-----~~ 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILK-GQYP-----PI 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhc-CCCC-----CC
Confidence 12233567889999999999899999999999999999999999985332 1111111111 1111 11
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+......+.+++.+|++.+|++|||+.++++
T Consensus 224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=300.49 Aligned_cols=263 Identities=20% Similarity=0.323 Sum_probs=196.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeeccccc----CCcc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~ 599 (837)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999765 68999999987542 2345677889999999999999999998764 3457
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++|+||+. ++|..++... ..+++.....++.||++||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999996 5888887432 34899999999999999999999987 99999999999999999999999999986
Q ss_pred ccCccce--eeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc----
Q 003237 680 FGGEEIL--AITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS---- 752 (837)
Q Consensus 680 ~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---- 752 (837)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~---~~~~~~~~~~g~~~~ 233 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV---HQLKLILSVLGSPSE 233 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH---HHHHHHHHHhCCChh
Confidence 5432211 11123468889999999866 46899999999999999999999998532211 11111111100
Q ss_pred -------cCccccccccc-cc-----cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 753 -------DNKALEIVDSS-MA-----NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 753 -------~~~~~~~~d~~-l~-----~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...+.+.++.. .. ..........+.+++..|++.+|++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00011111000 00 0011123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=290.61 Aligned_cols=262 Identities=22% Similarity=0.324 Sum_probs=192.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|++.+.||+|.+|.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46788899999999999999875 68899999986432 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC-CCCeeecccccceeccCc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVFGGE 683 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~DFGla~~~~~~ 683 (837)
|++ ++|..++.... ...+++.....++.||+.||.|||+.+ |+|+||+|+||+++. +..+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 47777764322 223577788889999999999999987 999999999999985 567999999999765432
Q ss_pred cceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc--c----
Q 003237 684 EILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK--A---- 756 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--~---- 756 (837)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.|+..... .............+. .
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE---IDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChhhcccc
Confidence 11 1122456789999998876 4578999999999999999999999864221 111111111111000 0
Q ss_pred ---cc---cc---ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 757 ---LE---IV---DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 757 ---~~---~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. .. .+.............+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00 000000011122345788999999999999999999986
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=295.45 Aligned_cols=260 Identities=20% Similarity=0.276 Sum_probs=190.6
Q ss_pred Cccccc--CCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQG--GFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G--~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
..||+| +||+||+++.. +|+.||||.+.... ....+.+.+|+.++..++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 466776 89999999875 79999999986432 23346788999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce--
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL-- 686 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~-- 686 (837)
++|.+++.... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999886543 234788888899999999999999987 999999999999999999999999865433211100
Q ss_pred ---eeeccccccCCccCcccccCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH------------
Q 003237 687 ---AITKRVVGTYGYMSPEYALDG--VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE------------ 749 (837)
Q Consensus 687 ---~~~~~~~gt~~y~APE~~~~~--~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~------------ 749 (837)
.......++..|+|||++.+. .++.++|||||||+++||++|+.|+...... ..+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccc
Confidence 001112345679999999764 4789999999999999999999998643211 000000000
Q ss_pred ----Hh----------------ccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 750 ----LW----------------SDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 750 ----~~----------------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. .......+.+..+...........+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 000000111111112222334567889999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=292.72 Aligned_cols=252 Identities=22% Similarity=0.368 Sum_probs=191.3
Q ss_pred cCCCcCCcccccCCeeEEEEEecC-CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|++.+.||+|+||.||+|+... ++.||||.++... .....++..|+.++.+.. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567788999999999999998874 8999999997543 233456667887777775 9999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++ +|..++.... ..+++..+..++.||++||.|||+.. +|+||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9854 6766654422 36889999999999999999999742 39999999999999999999999999987654322
Q ss_pred ceeeeccccccCCccCcccccCCC----CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGV----FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~----~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
.. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+...... ........... ...
T Consensus 170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~-- 238 (296)
T cd06618 170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPS-- 238 (296)
T ss_pred cc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCC--
Confidence 11 1235678999999987654 889999999999999999999998532110 11111111111 000
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
+... ......+.+++.+|++.+|++||++.++++.
T Consensus 239 ---~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ---LPPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---CCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0123457889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=283.58 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=199.6
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+|++.+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++.+++|+|++++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3677889999999999999775 578999999976543 3557889999999999999999999999999899999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988543 45899999999999999999999987 99999999999999999999999999987654332
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
. .....++..|+|||...+..++.++||||+|++++||++|+.|+..... ... ...... ... +.+
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~-~~~~~~-~~~-----~~~- 219 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAA-LFRIVQ-DDH-----PPL- 219 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHH-HHHHhc-cCC-----CCC-
Confidence 1 1234678899999999888899999999999999999999999853221 111 111110 000 011
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+......+..++.+|++.+|++||++.+++.
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112345678999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=315.46 Aligned_cols=267 Identities=24% Similarity=0.317 Sum_probs=185.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEecC--CcEEEEE------------------EecCCCccCHHHHHHHHHHHHHhcCCCe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSN--GQEIAVK------------------RLSTTSGQGIEELKNEVLLIAKLQHRNL 586 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~nI 586 (837)
.++|.+.++||+|+||+||++.++. +...++| ++. ........+.+|++++.+++|+||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999987542 2222222 111 112234567899999999999999
Q ss_pred eeeecccccCCccEEEEEecCCCChhhHhhhcCC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc
Q 003237 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR--KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (837)
Q Consensus 587 v~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 664 (837)
|++++++...+..++|+|++.. +|..++..... ...........++.||+.||.|||+.+ ||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999999999999999999864 66666643221 112334556789999999999999987 99999999999999
Q ss_pred CCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCCCCCcchH
Q 003237 665 EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKN-TRIFNDDDSSNL 743 (837)
Q Consensus 665 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p-~~~~~~~~~~~l 743 (837)
.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.+ +..........+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999987653322 112235789999999999999999999999999999999998854 332221111222
Q ss_pred HHHHHHHhc-cC-------cccccccccccc---ccCHH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 744 IKYAWELWS-DN-------KALEIVDSSMAN---SCLAS------EALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 744 ~~~~~~~~~-~~-------~~~~~~d~~l~~---~~~~~------~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
......... .+ +..+.++..... ..... ....+..++.+|++.||++|||+.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 221111100 00 000011000000 00000 1123556788999999999999999986
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=287.45 Aligned_cols=244 Identities=29% Similarity=0.368 Sum_probs=190.6
Q ss_pred ccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCCh
Q 003237 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 536 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
||+|+||+||++... +|+.+|+|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999765 68899999986432 22345567899999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeecc
Q 003237 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691 (837)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 691 (837)
.+++..... ..+++..+..++.|+++||.|||+.+ |+|+||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 999865432 35789999999999999999999987 9999999999999999999999999987654321 1122
Q ss_pred ccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHH
Q 003237 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLAS 771 (837)
Q Consensus 692 ~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 771 (837)
..++..|+|||++.+..++.++||||||++++||++|+.|+........... .... ... .....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~-----~~~-----~~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE---LKRR-----TLE-----MAVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH---HHhc-----ccc-----ccccCCcc
Confidence 4577899999999988899999999999999999999999864332111110 0000 000 00011112
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 772 EALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 772 ~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
....+.+++.+|++.+|++|| ++.+++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 234577899999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=297.75 Aligned_cols=268 Identities=24% Similarity=0.314 Sum_probs=202.1
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC-----ccE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----ENM 600 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 600 (837)
+|.+.+.||+|+||.||+|+.. +++.+|||++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777899999999999999875 48999999987643 344567889999999999999999999998775 779
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||+++ +|..++... ..+++..+..++.||++||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 788877543 26899999999999999999999987 999999999999999999999999999876
Q ss_pred cCccc-eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc-----
Q 003237 681 GGEEI-LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD----- 753 (837)
Q Consensus 681 ~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----- 753 (837)
..... ........++..|+|||.+.+. .++.++||||||+++++|++|+.||...... ............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCChhH
Confidence 54321 0112234578899999999888 8999999999999999999999998543321 111111111000
Q ss_pred ------Ccccccccc---cc---ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCCC
Q 003237 754 ------NKALEIVDS---SM---ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNETF 806 (837)
Q Consensus 754 ------~~~~~~~d~---~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~--L~~~~~ 806 (837)
....+.+.. .. ...........+.+++.+|++.+|++||++.++++. +++...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000 00 000011123457889999999999999999999973 655433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=291.67 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=193.9
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCChh
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 612 (837)
.+||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999875 68999999986555455667889999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccc
Q 003237 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV 692 (837)
Q Consensus 613 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 692 (837)
+++.. ..+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 88743 24788999999999999999999987 99999999999999999999999999876543221 11234
Q ss_pred cccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHH
Q 003237 693 VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASE 772 (837)
Q Consensus 693 ~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 772 (837)
.++..|+|||.+.+..++.++||||||++++||++|+.|+..... .......... +.+.+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~---------~~~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDN---------LPPKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhh---------CCcccCC--cccC
Confidence 678899999999888899999999999999999999999853211 1111111110 0111100 0111
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 773 ALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 773 ~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...+.+++.+|++.+|.+||++.+|++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 234668889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=283.11 Aligned_cols=244 Identities=21% Similarity=0.263 Sum_probs=187.3
Q ss_pred hhcCCCcCCcc--cccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEE
Q 003237 526 ATDNFSTSNKL--GQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 526 at~~~~~~~~L--G~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 601 (837)
..++|++.+.+ |+|+||.||++... ++..+|+|.+....... .|+.....+ +|+||+++++.+...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34566666766 99999999999865 67889999986432211 122222222 69999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-Ceeecccccceec
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVF 680 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~DFGla~~~ 680 (837)
||||+++++|.+++.... .+++.....++.||++||.|||+.+ |+||||||+||+++.++ .++|+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999985432 6899999999999999999999988 99999999999999998 9999999998865
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
... ....++..|+|||++.+..++.++||||||++++||++|+.|+....... .....+.... .....
T Consensus 161 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---~~~~~-- 228 (267)
T PHA03390 161 GTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ---QKKLP-- 228 (267)
T ss_pred CCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh---cccCC--
Confidence 432 12467889999999999999999999999999999999999987332211 1111111111 00000
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPS-MSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-m~eVv~ 799 (837)
........+.+++..|++.+|.+||+ ++++++
T Consensus 229 -------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 -------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11123345778899999999999996 688863
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=289.89 Aligned_cols=260 Identities=19% Similarity=0.222 Sum_probs=190.9
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCC
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 610 (837)
.+.+|.|+++.||+++. +++.||||++... .....+.+.+|++++..++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34556666666666655 6899999998754 34456789999999999999999999999999999999999999999
Q ss_pred hhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc-----
Q 003237 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI----- 685 (837)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~----- 685 (837)
|.+++..... ..+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999865432 34788888899999999999999987 99999999999999999999999999875532211
Q ss_pred eeeeccccccCCccCcccccCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh----ccC-----
Q 003237 686 LAITKRVVGTYGYMSPEYALDG--VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELW----SDN----- 754 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~--~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----~~~----- 754 (837)
........++..|+|||++... .++.++|||||||+++||++|+.||..... ...+........ ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCccccccCchhhh
Confidence 1111234567789999998763 588999999999999999999999864321 111111110000 000
Q ss_pred --cccc----ccccc----cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 755 --KALE----IVDSS----MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 755 --~~~~----~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.... ..++. ............+.+++.+|++.+|++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 00000 001112223456788999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=299.05 Aligned_cols=263 Identities=21% Similarity=0.315 Sum_probs=193.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC------
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 597 (837)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++.+++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468888999999999999999864 68999999986532 223456789999999999999999999987543
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..++|+||+.. +|..++ ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999874 666554 124788999999999999999999987 999999999999999999999999998
Q ss_pred eeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC--
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN-- 754 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 754 (837)
+..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||..... ..............
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGP 236 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence 764322 122456888999999876 4689999999999999999999999864221 11111111110000
Q ss_pred ---------ccccccc--cc-ccccc---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCCC
Q 003237 755 ---------KALEIVD--SS-MANSC---LASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETF 806 (837)
Q Consensus 755 ---------~~~~~~d--~~-l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~~ 806 (837)
.....+. +. ..... .+.....+.+++.+|++.+|++||++++|+. .++..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000000 00 00000 0112245779999999999999999999994 4666544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=287.70 Aligned_cols=260 Identities=17% Similarity=0.188 Sum_probs=179.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCC----cEEEEEEecCCCccCHH-----------HHHHHHHHHHHhcCCCeeeeec
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNG----QEIAVKRLSTTSGQGIE-----------ELKNEVLLIAKLQHRNLVKLLG 591 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g----~~vavK~l~~~~~~~~~-----------~~~~E~~~l~~l~H~nIv~l~~ 591 (837)
.++|.+.++||+|+||.||+|...++ ..+|+|........... ....+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35788899999999999999987643 45566653322211111 1122333455568999999999
Q ss_pred ccccCC----ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC
Q 003237 592 CCLEED----ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667 (837)
Q Consensus 592 ~~~~~~----~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~ 667 (837)
++.... ..++++|++.. ++.+.+... ...++.....++.|+++||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 766544 23567776543 454444322 22467778899999999999999987 99999999999999999
Q ss_pred CeeecccccceeccCccce-----eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 003237 668 NPRISDFGTARVFGGEEIL-----AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSN 742 (837)
Q Consensus 668 ~~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~ 742 (837)
.++|+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||....... .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~ 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence 9999999999876422111 11123468999999999999999999999999999999999999997542211 1
Q ss_pred HHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 743 LIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 743 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
+......-+ ...+....+.- ......+.+++..|++.+|++||++.++++.|+
T Consensus 242 ~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDF----IKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHH----HHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111111000 00000010000 011245778889999999999999999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=315.08 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=187.6
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccC------
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------ 596 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 596 (837)
+-..+|+..+.||+|+||.|||++.+ ||+.+|||+|.-. +......+.+|++++.+|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34467888899999999999999877 8999999999755 334456788999999999999999997643210
Q ss_pred --------------------------------------------------------------------------------
Q 003237 597 -------------------------------------------------------------------------------- 596 (837)
Q Consensus 597 -------------------------------------------------------------------------------- 596 (837)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHH
Q 003237 597 ---------------------------------DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643 (837)
Q Consensus 597 ---------------------------------~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL 643 (837)
...||-||||+.-+|++++.+..... .-...++++++|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 01256788888888887775543221 3456678999999999999
Q ss_pred HhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc----C------------ccceeeeccccccCCccCcccccCC
Q 003237 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG----G------------EEILAITKRVVGTYGYMSPEYALDG 707 (837)
Q Consensus 644 H~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~APE~~~~~ 707 (837)
|+++ ||||||||.||+||++..+||+|||+|.... . ...........||..|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9998 9999999999999999999999999998721 0 0111123347899999999999765
Q ss_pred ---CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH--HHhccCccccccccccccccCHHHHHHHHHHHHH
Q 003237 708 ---VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAW--ELWSDNKALEIVDSSMANSCLASEALRCIQVGLL 782 (837)
Q Consensus 708 ---~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 782 (837)
+|+.|+|+||+|||++||+. ||... .+.+. .-++.+.+..- ..+..++...-.+++.|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--------MERa~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS--------MERASILTNLRKGSIPEP------ADFFDPEHPEEASLIRW 853 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCch--------HHHHHHHHhcccCCCCCC------cccccccchHHHHHHHH
Confidence 49999999999999999987 34321 11111 11122222111 11233334445689999
Q ss_pred cccCCCCCCCCHHHHHH
Q 003237 783 CVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 783 Cl~~~P~~RPtm~eVv~ 799 (837)
+++.||.+|||+.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999864
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=283.83 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=193.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC-----CccCHHHHHHHHHHHHHhcCCCeeeeecccccC--Ccc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-----SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 599 (837)
.+|.+.+.||+|+||.||+|+.. ++..+|+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36788899999999999999865 6899999987532 123346788999999999999999999998764 346
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++|+||+++++|.+++... ..+++.....++.||++||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999988543 24788889999999999999999987 99999999999999999999999999986
Q ss_pred ccCccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 680 FGGEEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 680 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
....... .......++..|+|||++.+..++.++|||||||+++||++|+.|+..... . .........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~-~~~~~~~~~~---- 225 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----M-AAIFKIATQP---- 225 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----H-HHHHHHHcCC----
Confidence 5321110 111234678899999999988899999999999999999999999853211 1 1111111111
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.....+......+.+++..|++ +|..||+..+++.
T Consensus 226 -----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 -----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111222333457788889999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=290.22 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=192.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccCC------
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 597 (837)
.++|++.++||+|+||.||+|+.. +++.+|||++..... .....+.+|++++.+++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888999999999999999875 688999999864422 22346778999999999999999999876543
Q ss_pred --ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccc
Q 003237 598 --ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (837)
Q Consensus 598 --~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFG 675 (837)
..++|+||+.. +|...+... ...+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999875 566665432 235899999999999999999999987 9999999999999999999999999
Q ss_pred cceeccCcccee---------eeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHH
Q 003237 676 TARVFGGEEILA---------ITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745 (837)
Q Consensus 676 la~~~~~~~~~~---------~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~ 745 (837)
+++......... ......++..|+|||.+.+. .++.++|||||||+++||++|+.|+...... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~---~~~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI---DQLH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH---HHHH
Confidence 998654322111 11123567889999988654 5899999999999999999999998533221 1111
Q ss_pred HHHHHhccC---------ccccc--------cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 746 YAWELWSDN---------KALEI--------VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 746 ~~~~~~~~~---------~~~~~--------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
......... .+... ..+.+.. ........+.+++.+|++.+|++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111100 00000 0000000 00112245789999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=285.51 Aligned_cols=260 Identities=25% Similarity=0.342 Sum_probs=192.8
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHh---cCCCeeeeecccccCCc-----
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKL---QHRNLVKLLGCCLEEDE----- 598 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~----- 598 (837)
|++.+.||+|+||.||+|+.. +++.+|+|++..... .....+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456789999999999999886 489999999964322 2234566788877766 59999999999988776
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.+++|||+++ +|.+++..... ..+++..+..++.||++||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999985 78888755332 34899999999999999999999987 9999999999999999999999999998
Q ss_pred eccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc--
Q 003237 679 VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA-- 756 (837)
Q Consensus 679 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-- 756 (837)
........ ....++..|+|||.+.+..++.++||||||++++||++|+.|+...... ..+.............
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHhc
Confidence 76433211 1234688999999999999999999999999999999998887643221 1111111111000000
Q ss_pred -------ccccccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 757 -------LEIVDSSMA---NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 757 -------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
......... .....+....+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 1111223356778999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=283.76 Aligned_cols=245 Identities=22% Similarity=0.259 Sum_probs=188.7
Q ss_pred CcccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHH-HHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLI-AKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.||+|+||.||+|+.. +++.||||.+.+... .....+..|..++ ...+|+||+++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999775 588999999865421 1223344555444 445899999999999999999999999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
++|..++... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999998543 34788889999999999999999987 99999999999999999999999999876433
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+..... ..... .. ...... ... ..
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~---~~-~~~~~~--~~~----~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFD---NI-LSRRIN--WPE----EV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HH-HhcccC--CCC----cc
Confidence 1234678899999999988899999999999999999999999853221 11111 11 001000 000 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.......+.+++.+|++.+|++||++.++.+.|+-
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 11223457899999999999999998888777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=286.48 Aligned_cols=254 Identities=21% Similarity=0.278 Sum_probs=197.5
Q ss_pred CCcCCcccccCCeeEEEEEe----cCCcEEEEEEecCCC----ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccE
Q 003237 530 FSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 600 (837)
|++.+.||+|+||.||+++. .++..+|||.+++.. ....+.+.+|++++.++ +|+||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 66678999999999999974 357889999986432 22345678899999999 5999999999998888999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||+++++|..++... ..+++.....++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 999999999999988543 34788889999999999999999987 999999999999999999999999998875
Q ss_pred cCccceeeeccccccCCccCcccccCCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGV--FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
...... ......++..|+|||.+.+.. .+.++||||||++++||++|+.|+...... .............
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~----- 227 (288)
T cd05583 156 LAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKS----- 227 (288)
T ss_pred cccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHcc-----
Confidence 433211 112346788999999987765 788999999999999999999998532211 1111111111111
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.+.. +......+.+++.+|++.+|++|||+.+|.+.|+.
T Consensus 228 --~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 --KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0111 11122356788999999999999999999988865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=289.71 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=192.1
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.|+..+.||+|+||.||+|+.. ++..+|+|.+... .....+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666789999999999999875 5788999998643 22234567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+. |+|.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 997 5777766432 234788999999999999999999987 999999999999999999999999998765432
Q ss_pred ceeeeccccccCCccCccccc---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYAL---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
....++..|+|||.+. ...++.++|||||||+++||++|+.|+...... ....... ....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~~----- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-QNES----- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHh-hcCC-----
Confidence 2245788999999975 356888999999999999999999997432110 0011110 0100
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
+.. ........+.+++.+|++.+|++||++.+|+...-
T Consensus 232 ~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 111 11123345678999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=290.57 Aligned_cols=268 Identities=22% Similarity=0.321 Sum_probs=196.9
Q ss_pred HHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC---
Q 003237 524 LAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED--- 597 (837)
Q Consensus 524 ~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--- 597 (837)
....++|++.+.||+|+||.||++... ++..||||++.... ....+.+.+|++++.+++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999754 68999999985432 223456789999999999999999999887654
Q ss_pred ---ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccc
Q 003237 598 ---ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (837)
Q Consensus 598 ---~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DF 674 (837)
..++||||+ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 348999998 6788877742 34789999999999999999999987 999999999999999999999999
Q ss_pred ccceeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH-----
Q 003237 675 GTARVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAW----- 748 (837)
Q Consensus 675 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~----- 748 (837)
|++...... .....++..|+|||.+.+ ..++.++||||||+++++|++|+.|+..... ...+.....
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~ 235 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH--LDQLMEIMKVTGTP 235 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCC
Confidence 999865432 122457889999999876 4588999999999999999999999863221 001111000
Q ss_pred -----HHhccCccccccc--cccc----cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHhccCCC
Q 003237 749 -----ELWSDNKALEIVD--SSMA----NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV--FMLSNETF 806 (837)
Q Consensus 749 -----~~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv--~~L~~~~~ 806 (837)
...........+. +... ..........+.+++.+|++.+|++|||+.+++ ..++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0000000000000 0000 000111223577999999999999999999998 45555433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=283.64 Aligned_cols=241 Identities=26% Similarity=0.343 Sum_probs=185.0
Q ss_pred cccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHH---HHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 535 KLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLL---IAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~---l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
.||+|+||.||++... +++.||+|.+.+... .....+..|..+ +....||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 588999999865421 122233444443 444579999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988853 245899999999999999999999987 9999999999999999999999999987654321
Q ss_pred eeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....|+..|+|||.+.++ .++.++||||+|++++||++|+.|+............ .... .....+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~------~~~~~~~~ 220 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL------TMAVELPD 220 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhh------ccCCCCCC
Confidence 1234689999999998754 6899999999999999999999998643221111110 0000 00111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
.....+.+++.+|++.+|.+|| ++.++++
T Consensus 221 ----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1234677888999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=281.48 Aligned_cols=249 Identities=27% Similarity=0.369 Sum_probs=193.0
Q ss_pred CCCcCCcccccCCeeEEEEEecC-CcEEEEEEecCC-----CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTT-----SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++.+++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778999999999999997653 445556655432 122334567899999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 603 YEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||+++. ..+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988652 23456899999999999999999999987 999999999999975 569999999998764
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.... ......++..|+|||.+.+..++.++|+||||+++++|++|+.|+... ........... +. .
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~------~~~~~~~~~~~-~~-----~ 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ------NFLSVVLRIVE-GP-----T 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHHc-CC-----C
Confidence 3322 122356788999999998888999999999999999999999998521 11111111111 10 1
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+. .+......+.+++.+|++.+|++||++.++++
T Consensus 223 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 12233456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=296.24 Aligned_cols=266 Identities=21% Similarity=0.304 Sum_probs=193.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccC----------
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE---------- 596 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~---------- 596 (837)
.+|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888899999999999999775 6889999998766556677889999999999999999999876654
Q ss_pred ----CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-CCCCeee
Q 003237 597 ----DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRI 671 (837)
Q Consensus 597 ----~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki 671 (837)
...++|+||++ ++|..++.. ..+++.....++.||++||.|||+.+ |+||||||+||+++ ++..+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 24689999997 588877742 24788999999999999999999987 99999999999998 4567899
Q ss_pred cccccceeccCccce-eeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 003237 672 SDFGTARVFGGEEIL-AITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE 749 (837)
Q Consensus 672 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 749 (837)
+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+. .......
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~~ 234 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILES 234 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHh
Confidence 999999865432111 11122357889999998765 5688999999999999999999999864322110 0000000
Q ss_pred Hhc--cCccccc---ccccc-----cc-----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhcc
Q 003237 750 LWS--DNKALEI---VDSSM-----AN-----SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSN 803 (837)
Q Consensus 750 ~~~--~~~~~~~---~d~~l-----~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~ 803 (837)
... ....... +...+ .. ........++.+++..|++.+|++|||+.+|+. .++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 000 0000000 00000 00 001112245778999999999999999999984 4543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=286.65 Aligned_cols=249 Identities=28% Similarity=0.364 Sum_probs=199.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 602 (837)
++|.+.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|++++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788899999999999999875 6899999998653 2233467889999999998 99999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999998643 25899999999999999999999987 99999999999999999999999999987654
Q ss_pred ccce------------------eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 003237 683 EEIL------------------AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744 (837)
Q Consensus 683 ~~~~------------------~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 744 (837)
.... .......++..|+|||.+....++.++||||||++++|+++|+.|+..... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHH
Confidence 3211 112234578899999999988899999999999999999999999864321 1111
Q ss_pred HHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 003237 745 KYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSM----STVVF 799 (837)
Q Consensus 745 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm----~eVv~ 799 (837)
. .... .....+......+.+++..|++.+|++||++ +++++
T Consensus 232 ~---~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 Q---KILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H---HHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1 1110 0001111223457899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=283.15 Aligned_cols=259 Identities=26% Similarity=0.353 Sum_probs=196.4
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
|+..+.||+|.||.||+|+.. +++.+|+|.+.... ....+.+..|++++++++|+||+++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999876 58999999987653 334567888999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
+ ++|.+++.... ..+++..+..++.|+++||.|||+.+ |+|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999986542 35889999999999999999999987 99999999999999999999999999987643321
Q ss_pred eeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc---------c
Q 003237 687 AITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK---------A 756 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~ 756 (837)
......++..|+|||.+.+. .++.++|||||||+++||++|+.|+..... ............... .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE---IDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHHHhCCCcHHHHHhhccc
Confidence 11223456789999998876 889999999999999999999988854221 111111111111000 0
Q ss_pred ---cccccc---ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 757 ---LEIVDS---SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 757 ---~~~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...+.. .......+.....+.+++..|++.+|++||++.+|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 0000001111356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=284.98 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=193.2
Q ss_pred CCCcCCcccccCCeeEEEEEe----cCCcEEEEEEecCCC----ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCcc
Q 003237 529 NFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 599 (837)
+|++.+.||+|+||.||+++. .+|..||+|++.... ....+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366788999999999999976 368899999986532 22346778899999999 599999999999988889
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++||||+++++|.+++... ..+++.....++.||++||.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998643 34778888889999999999999987 99999999999999999999999999987
Q ss_pred ccCccceeeeccccccCCccCcccccCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALDG--VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
....... ......++..|+|||.+... .++.++||||||++++||++|+.|+..... ...............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~--- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSE--- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhhccC---
Confidence 6433221 12235688899999998753 478899999999999999999999863221 111122222111111
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
+. .+......+..++.+|++.+|++|| ++++++.
T Consensus 229 ----~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ----PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00 1111224567899999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=294.42 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=195.5
Q ss_pred HHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeeccccc-CCc
Q 003237 523 LLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE-EDE 598 (837)
Q Consensus 523 l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 598 (837)
+...+++|++.+.||+|+||.||++... ++..||||++.+. .....+.+.+|++++.+++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456788999999999999999999765 7899999988543 22345678899999999999999999998865 456
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.++|+||+. ++|..++.. ..+.+.....++.||++||.|||+.+ |+|+||+|+||++++++.+||+|||++.
T Consensus 85 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehhc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999984 588877743 24677888889999999999999987 9999999999999999999999999987
Q ss_pred eccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc-----
Q 003237 679 VFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS----- 752 (837)
Q Consensus 679 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----- 752 (837)
..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.|+..... ............
T Consensus 157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~---~~~~~~~~~~~~~~~~~ 228 (328)
T cd07856 157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH---VNQFSIITDLLGTPPDD 228 (328)
T ss_pred ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHH
Confidence 54321 122456788999998866 5689999999999999999999999854321 111111111100
Q ss_pred ------cCccccccccc-cccccCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 753 ------DNKALEIVDSS-MANSCLA-----SEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 753 ------~~~~~~~~d~~-l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.....+++... .....+. .....+.+++.+|++.+|++|||+.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00111111000 0001111 123567899999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=292.53 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=193.4
Q ss_pred cCCC-cCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccC--------------HHHHHHHHHHHHHhcCCCeeeeec
Q 003237 528 DNFS-TSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQG--------------IEELKNEVLLIAKLQHRNLVKLLG 591 (837)
Q Consensus 528 ~~~~-~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~~ 591 (837)
++|. +.+.||+|+||+||+|... +++.||||.+....... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3467999999999999865 68999999986442211 124678999999999999999999
Q ss_pred ccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeee
Q 003237 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (837)
Q Consensus 592 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 671 (837)
++..++..++||||++ ++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 588888753 234788999999999999999999987 999999999999999999999
Q ss_pred cccccceeccCccc------------eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 003237 672 SDFGTARVFGGEEI------------LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDD 738 (837)
Q Consensus 672 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~ 738 (837)
+|||++........ ........++..|+|||++.+. .++.++||||||++++||++|+.|+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~- 239 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE- 239 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 99999987652111 0111123467889999998764 478999999999999999999999864322
Q ss_pred CcchHHHHHHHHhccCccc---cc--------ccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 739 DSSNLIKYAWELWSDNKAL---EI--------VDSSMAN---SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 739 ~~~~l~~~~~~~~~~~~~~---~~--------~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
......+.......... .. ....... .........+.+++..|++.+|++||+++||+.
T Consensus 240 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 --IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred --HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11222222211111000 00 0000000 001112345779999999999999999999986
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=287.35 Aligned_cols=244 Identities=27% Similarity=0.433 Sum_probs=189.7
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
|...++||+|+||+||+|+.. +++.|++|++..... ...+.+.+|+++++.++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999875 688999999864322 2335678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 4676666432 235889999999999999999999987 99999999999999999999999999864322
Q ss_pred eeeeccccccCCccCccccc---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYAL---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.....++..|+|||++. ...++.++|||||||+++||++|+.|+..... ........... ...
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~-~~~---- 239 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQND-SPT---- 239 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC-CCC----
Confidence 12356788999999984 45688999999999999999999999753211 11111111111 000
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
. ........+.+++.+|++.+|.+||++.+++..
T Consensus 240 -~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 -L---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011112346789999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=295.19 Aligned_cols=265 Identities=23% Similarity=0.304 Sum_probs=195.2
Q ss_pred HHHHHHhhcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccC
Q 003237 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE 596 (837)
Q Consensus 520 ~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 596 (837)
..++...+++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++.+++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345667789999999999999999999975 478999999986532 22345678899999999999999999987643
Q ss_pred ------CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCee
Q 003237 597 ------DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670 (837)
Q Consensus 597 ------~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 670 (837)
...+++++++ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 2356777776 7788877642 24789999999999999999999987 99999999999999999999
Q ss_pred ecccccceeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 003237 671 ISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE 749 (837)
Q Consensus 671 i~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 749 (837)
|+|||+++..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.|+...... ..+......
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~ 233 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRL 233 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHH
Confidence 9999998764322 123467889999998876 56899999999999999999999998532211 111111100
Q ss_pred Hhc-cCcccc------------cccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 750 LWS-DNKALE------------IVDSSMAN---SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 750 ~~~-~~~~~~------------~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... ...... .+...... .........+.+++..|++.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000 000000 00000000 000012345779999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=268.14 Aligned_cols=285 Identities=24% Similarity=0.322 Sum_probs=200.7
Q ss_pred cCCCcCCcccccCCeeEEEEEec---C--CcEEEEEEecCCC-ccC-HHHHHHHHHHHHHhcCCCeeeeeccccc-CCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS---N--GQEIAVKRLSTTS-GQG-IEELKNEVLLIAKLQHRNLVKLLGCCLE-EDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~---~--g~~vavK~l~~~~-~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~ 599 (837)
..|+...+||+|.||.||+|.-. + ...+|||+++... ..+ ....-+|+.+++.++||||+.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46788899999999999999543 2 2368999986442 122 2345689999999999999999999988 6677
Q ss_pred EEEEEecCCCChhhHhh--hcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC----CCeeecc
Q 003237 600 MLIYEFMPNKSLDYFIF--DESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK----MNPRISD 673 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~ki~D 673 (837)
+|++||.+. +|...|+ .....+.++-.....|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 899999887 5555553 2233356788888899999999999999988 9999999999999877 9999999
Q ss_pred cccceeccCccc-eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCC----cc--hHHH
Q 003237 674 FGTARVFGGEEI-LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDD----SS--NLIK 745 (837)
Q Consensus 674 FGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~----~~--~l~~ 745 (837)
||+++++...-. ......++.|..|.|||.+.+. .|+.+.|||+.|||+.||++-++-|...+..- .. +-+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999998865422 2233457789999999999885 68999999999999999999887765432211 11 1112
Q ss_pred HHHHHhccCc---c---cccccc-cc----c-cccCHH-----------HHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 746 YAWELWSDNK---A---LEIVDS-SM----A-NSCLAS-----------EALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 746 ~~~~~~~~~~---~---~~~~d~-~l----~-~~~~~~-----------~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.+.+++.-+. . ....+. .+ . ...+.- ......++...+++.||.+|-|+++.++-.
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~- 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP- 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-
Confidence 2222222111 0 000000 00 0 000000 001256788889999999999999876532
Q ss_pred cCCCCCCCCCCCccc
Q 003237 803 NETFVPSPKQPTFSV 817 (837)
Q Consensus 803 ~~~~~~~p~~p~~~~ 817 (837)
--...+.||.|....
T Consensus 339 yF~~d~lpp~pt~~~ 353 (438)
T KOG0666|consen 339 YFTEDPLPPLPTSDN 353 (438)
T ss_pred ccccCCCCCCcccce
Confidence 124556666665543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=272.67 Aligned_cols=199 Identities=24% Similarity=0.332 Sum_probs=173.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|+..++||+|.||+|-+++-+ .++.+|+|++++... .....-..|-++|+..+||.+..|...++..+..++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 57888899999999999999765 689999999987632 33344567999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||..+|.|..+|.+ ...++.....-....|+.||.|||+.+ ||.||||.+|.|||.+|++||+||||++.--
T Consensus 248 eyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 248 EYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--
Confidence 99999999888854 345666666668889999999999988 9999999999999999999999999998522
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRI 734 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 734 (837)
..-..++..|||+.|+|||++....|..++|.|.+||++|||++|+.||..
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 123456779999999999999999999999999999999999999999853
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=291.16 Aligned_cols=261 Identities=23% Similarity=0.294 Sum_probs=188.6
Q ss_pred CCCcCCcccccCCeeEEEEEec-C--CcEEEEEEecCCC--ccCHHHHHHHHHHHHHh-cCCCeeeeecccccC----Cc
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-N--GQEIAVKRLSTTS--GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE----DE 598 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~ 598 (837)
+|++.+.||+|+||.||+++.. . +..+|||++.... ....+.+.+|++++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667789999999999999875 3 7789999986432 22346678899999999 599999999875432 34
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.++++||+. ++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 588888743 345889999999999999999999988 9999999999999999999999999998
Q ss_pred eccCccce--eeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc---
Q 003237 679 VFGGEEIL--AITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS--- 752 (837)
Q Consensus 679 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--- 752 (837)
........ .......|+..|+|||++.+ ..++.++|||||||++++|++|+.|+..... ............
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY---VDQLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH---HHHHHHHHHHhCCCC
Confidence 65432211 11223568899999998766 4689999999999999999999999864321 111111111000
Q ss_pred --------cCccccc---ccccc---ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 753 --------DNKALEI---VDSSM---ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 753 --------~~~~~~~---~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....... ..... ...........+.+++.+|++.+|++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00000 00000111346779999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=319.61 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=197.9
Q ss_pred hhcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
.+-++....+||.|.||.||-|.. ++|...|||-++-. .........+|+.++..++|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 345677788999999999999965 46888999977533 344567788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
||||++|+|.+.+.... ..++.....+..|++.|+.|||+++ ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999986543 2445555567899999999999998 99999999999999999999999999998765
Q ss_pred cc--ceeeeccccccCCccCcccccCCC---CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 683 EE--ILAITKRVVGTYGYMSPEYALDGV---FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 683 ~~--~~~~~~~~~gt~~y~APE~~~~~~---~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
.. .........||+-|||||++.+.. ..-+.||||+|||++||+||++|+.....+ -.+.+ .+..++..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy---~V~~gh~P 1460 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMY---HVAAGHKP 1460 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHh---HHhccCCC
Confidence 42 111123468999999999997643 567899999999999999999998654321 11111 11122222
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.+ +..-..+-.+++-.|++.||+.|.++.|+++.
T Consensus 1461 q~---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 QI---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CC---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 21 22233344578889999999999999877654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=292.20 Aligned_cols=258 Identities=25% Similarity=0.350 Sum_probs=194.4
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc----
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE---- 598 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---- 598 (837)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999876 5789999998643 22234567789999999999999999998876654
Q ss_pred --cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 599 --NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 599 --~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 79999998 5689888753 34899999999999999999999987 99999999999999999999999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc--
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD-- 753 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-- 753 (837)
+...... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.|+..... .............
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~ 236 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVGTPD 236 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCC
Confidence 9865432 223467889999999865 3678999999999999999999999853221 1111111111100
Q ss_pred ---------Cccccccccc---cccc---cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 ---------NKALEIVDSS---MANS---CLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 ---------~~~~~~~d~~---l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.....++... .... ........+.+++.+|++.+|++|||+.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000 0000 00112456889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=262.15 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=198.6
Q ss_pred CCcccccCCeeEEEEE-ecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEecCCCC
Q 003237 533 SNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~~gs 610 (837)
.+.||+|+|+.|--+. +.+|.++|||++.+........+.+|++++.+.+ |+||++|+.+|+++...|||||-|.+|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3689999999998884 5689999999998887788889999999999996 9999999999999999999999999999
Q ss_pred hhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC---CeeecccccceeccCc--cc
Q 003237 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM---NPRISDFGTARVFGGE--EI 685 (837)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ki~DFGla~~~~~~--~~ 685 (837)
|..+|++. +.+++.+..++..+||.||.|||.++ |.||||||+|||-.... -+||+||.|....... -.
T Consensus 163 lLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 99999654 45888999999999999999999998 99999999999997543 4899999887654321 11
Q ss_pred e---eeeccccccCCccCccccc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 686 L---AITKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 686 ~---~~~~~~~gt~~y~APE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
. ...-..+|+..|||||++. ...|+.+.|.||+|||||-|++|-.||......+-. |..++.-
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG---------WdrGe~C 307 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG---------WDRGEVC 307 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC---------ccCCCcc
Confidence 1 1112357888999999873 246899999999999999999999999765432211 1111111
Q ss_pred c-----cccccccc--ccCHHH----HHHHHHHHHHcccCCCCCCCCHHHHHH-----HhccCCCCCCCC
Q 003237 758 E-----IVDSSMAN--SCLASE----ALRCIQVGLLCVQDRTTDRPSMSTVVF-----MLSNETFVPSPK 811 (837)
Q Consensus 758 ~-----~~d~~l~~--~~~~~~----~~~l~~l~~~Cl~~~P~~RPtm~eVv~-----~L~~~~~~~~p~ 811 (837)
+ ++...-.+ +++.++ ..+..+++..-+..+|.+|-++.+|+. +...+.++|.|+
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~ 377 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQ 377 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCc
Confidence 0 01110011 122222 233445666666789999999999976 334445555554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=269.65 Aligned_cols=236 Identities=26% Similarity=0.328 Sum_probs=190.7
Q ss_pred ccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCCh
Q 003237 536 LGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 536 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
||+|+||.||++... +++.+|+|.+..... ...+.+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 588999999865432 2456788999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeecc
Q 003237 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691 (837)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 691 (837)
.+++.... .+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 99986432 4789999999999999999999987 9999999999999999999999999998764432 11233
Q ss_pred ccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHH
Q 003237 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLAS 771 (837)
Q Consensus 692 ~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 771 (837)
..++..|+|||.+.+...+.++|+||||++++||++|+.|+..... ...... ... .. . ..+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~---~~~-~~------~----~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEK---ILK-DP------L----RFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHH---Hhc-CC------C----CCCCC
Confidence 5678899999999988899999999999999999999999853321 111111 111 00 0 01111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHH
Q 003237 772 EALRCIQVGLLCVQDRTTDRPSMST 796 (837)
Q Consensus 772 ~~~~l~~l~~~Cl~~~P~~RPtm~e 796 (837)
....+.+++.+|+..+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1345778999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=265.67 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=189.2
Q ss_pred CCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEecCCC
Q 003237 533 SNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~g 609 (837)
...||.|+||+|+|-.++ .|+.+|||+++... ..+.+++..|.+...+- +.||||+++|.+..+...++.||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 468999999999999775 69999999998654 35667788888877665 589999999999999999999999965
Q ss_pred ChhhHhhh--cCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 610 SLDYFIFD--ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 610 sL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+|+.+-.. ..++..+++.-.-.|....++||.||.... .|||||+||+||||+..|.+||+|||.+..+...-.
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA-- 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA-- 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence 45443221 122234666666677888899999998764 599999999999999999999999999876543321
Q ss_pred eeccccccCCccCcccccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALD--GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.....|-..|||||.+.. ..|+.++||||+|+.|+|+.||+.|+....+ +.+.+..+.. ++...+..+
T Consensus 224 -kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~-gdpp~l~~~--- 293 (361)
T KOG1006|consen 224 -KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI-GDPPILLFD--- 293 (361)
T ss_pred -hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc-CCCCeecCc---
Confidence 123567889999999964 3589999999999999999999999975432 2222222222 222221111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.........+++++-.|+-.|..+||...++.+
T Consensus 294 -~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 -KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111234556889999999999999999999865
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=267.88 Aligned_cols=221 Identities=20% Similarity=0.146 Sum_probs=175.0
Q ss_pred cCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCChhhHhhh
Q 003237 539 GGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD 617 (837)
Q Consensus 539 G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~ 617 (837)
|.||.||++... +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999775 68899999996542 234555666666799999999999999999999999999999998864
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccccccCC
Q 003237 618 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG 697 (837)
Q Consensus 618 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~ 697 (837)
. ..+++.....++.|+++||.|||+.+ |+||||||+||+++.++.++++|||++....... ....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 3 24889999999999999999999987 9999999999999999999999999876554321 12345678
Q ss_pred ccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHH
Q 003237 698 YMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCI 777 (837)
Q Consensus 698 y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 777 (837)
|+|||.+....++.++||||+|++++||++|+.|+....... ... .... .+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~-----~~~~----~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH-----TTLN----IPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc-----cccC----CcccCCHHHH
Confidence 999999988889999999999999999999998764211100 000 0000 1111234577
Q ss_pred HHHHHcccCCCCCCCCHHH
Q 003237 778 QVGLLCVQDRTTDRPSMST 796 (837)
Q Consensus 778 ~l~~~Cl~~~P~~RPtm~e 796 (837)
+++.+|++.||++||++.+
T Consensus 207 ~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 207 SLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHccCCHHHhcCCCc
Confidence 8999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=306.18 Aligned_cols=145 Identities=24% Similarity=0.399 Sum_probs=129.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.++||+|+||.||+|... +++.||||+++... ......+..|+.++..++|+||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999876 68999999986542 223467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
||+.+++|..++... ..+++...+.++.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998643 34788889999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=257.03 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=187.4
Q ss_pred cCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEecCC
Q 003237 532 TSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 532 ~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
....||.|..|.|++.+.. .|..+|||.+.... ....+++...+.++..-+ +|.||+.+|+|.......+.||.|.-
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 3468999999999999876 58899999997653 345566677777776665 89999999999999999999998854
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
.++.++... ++++++.-.=++...+.+||.||.+++ +|+|||+||+|||+|+.|++|++|||++..+-+...
T Consensus 176 -C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--- 247 (391)
T KOG0983|consen 176 -CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--- 247 (391)
T ss_pred -HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc---
Confidence 344444332 234666666678889999999999876 699999999999999999999999999977654322
Q ss_pred eccccccCCccCcccccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALD---GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.+...|-+.|||||.+-- ..|+.++||||||+.|+||.||+.||.....+ ...+. .+..++ .|.+.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~lt----kvln~e------PP~L~ 316 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLT----KVLNEE------PPLLP 316 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHH----HHHhcC------CCCCC
Confidence 233578899999999853 46899999999999999999999999643221 11111 122211 12332
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
++. .....++++...|++.|+.+||...++++
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 221 14456788999999999999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=271.04 Aligned_cols=239 Identities=25% Similarity=0.344 Sum_probs=188.0
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
+|....+||+|+||+|.+|.-+ +.+.+|||++++.. ....+--+.|-++|... +-|.+++|..+++.-+..++||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 5777889999999999999765 46778999997652 23344456788888776 4689999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+.+|+|-.++.+-.+ +.+....-.|..||-||-+||+++ ||.||||..|||||.+|++||+|||+++.---+
T Consensus 430 EyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999999866543 556667778999999999999998 999999999999999999999999999853222
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
...++..+||+.|+|||++...+|...+|.|||||+||||+.|+.||+...++ .+... +.+..
T Consensus 504 --~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~a------------I~ehn 566 (683)
T KOG0696|consen 504 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQA------------IMEHN 566 (683)
T ss_pred --CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH------------HHHcc
Confidence 23456789999999999999999999999999999999999999999754332 12211 11111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCC
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRP 792 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 792 (837)
. .++...+.+.+.+...-+..+|.+|.
T Consensus 567 v--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 V--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred C--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 1 13333344455555566777888873
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=285.67 Aligned_cols=240 Identities=22% Similarity=0.249 Sum_probs=191.3
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.++.|.....+|.|+|+.|-++... +++..+||++.+.. .+..+|+.++... +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567888888999999999999765 68899999996552 2335677666666 6999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE-cCCCCeeecccccceeccC
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL-DEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~ki~DFGla~~~~~ 682 (837)
|.+.++-|.+.+.... .....+..|+.+|+.|+.|||.++ +|||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998887775332 222677789999999999999988 9999999999999 5999999999999998765
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
. ....+-|..|.|||++....|++++|+||||++||+|++|+.|+..-..+ .++. .....
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~----~~i~~--------- 528 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH----TRIQM--------- 528 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH----HhhcC---------
Confidence 4 22256788999999999999999999999999999999999998643322 1111 11111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+.+...-+....+++.+|+|.||.+||+|.++..
T Consensus 529 ---~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 529 ---PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1111223345668888999999999999999964
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=278.91 Aligned_cols=194 Identities=29% Similarity=0.470 Sum_probs=168.6
Q ss_pred CCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCC
Q 003237 533 SNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 609 (837)
.+.||.|.||+||-|+++ +|+.||||.+.+. ......++++|+.+|++++||.||.|.-.|+..+..+.|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 479999999999999875 7999999998764 3345688999999999999999999999999999999999999776
Q ss_pred ChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC---CCCeeecccccceeccCccce
Q 003237 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~DFGla~~~~~~~~~ 686 (837)
-|+-.|... +..|+.....-++.||+.||.|||.++ |+|+||||+||||.. -.++||+|||+|+.+++...
T Consensus 649 MLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMILSSE--KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 565555332 234777777778999999999999998 999999999999964 35799999999999887644
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRI 734 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 734 (837)
.+.+.||+.|+|||+++++.|+..-|+||.|||+|--++|..||..
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 3458999999999999999999999999999999999999999963
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=263.32 Aligned_cols=238 Identities=28% Similarity=0.356 Sum_probs=192.2
Q ss_pred CCeeEEEEEec-CCcEEEEEEecCCCccC-HHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCChhhHhhh
Q 003237 540 GFGPVYKGKLS-NGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD 617 (837)
Q Consensus 540 ~fG~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~ 617 (837)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999886 48999999997665444 68899999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccccccCC
Q 003237 618 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG 697 (837)
Q Consensus 618 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~ 697 (837)
... +++..+..++.++++++.|||+.+ |+|+||+|+||+++.++.++|+|||++....... ......++..
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 332 788999999999999999999987 9999999999999999999999999998765432 2233567889
Q ss_pred ccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHH
Q 003237 698 YMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCI 777 (837)
Q Consensus 698 y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 777 (837)
|++||.+....++.++||||||++++||++|+.|+.... +........ ........ .........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~----~~~~~~~~-------~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKI----GKPKPPFP-------PPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHH----hccCCCCc-------cccccCCHHHH
Confidence 999999998889999999999999999999999985421 111111111 11110000 00000234678
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 003237 778 QVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 778 ~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 8999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-31 Score=271.82 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=192.9
Q ss_pred cCCCcCCcccccCCeeEEEEE-ecCCcEEEEEEecCCCc-------cCHHHHHHHHHHHHHhcCCCeeeeeccccc-CCc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSG-------QGIEELKNEVLLIAKLQHRNLVKLLGCCLE-EDE 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 598 (837)
++|-+.++||+|+|++|||+. +...+-||||+-..... ...+...+|.++-+.|.||.||++++++.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 456667899999999999995 45677889997532211 123456689999999999999999999874 456
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc---CCCCeeecccc
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFG 675 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~DFG 675 (837)
.+-|.|||++.+|+-+|.. .+.++.++...|+.||+.||.||.+.. +||||.||||.||||. .-|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 7899999999999999853 456899999999999999999999875 6899999999999995 45789999999
Q ss_pred cceeccCccc-----eeeeccccccCCccCcccccCC----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 003237 676 TARVFGGEEI-----LAITKRVVGTYGYMSPEYALDG----VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKY 746 (837)
Q Consensus 676 la~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~----~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 746 (837)
|++++..+.+ ...++...||..|++||.+.-+ +++.|+||||+|||+|..+.|++||+.... ...++.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILq- 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQ- 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHh-
Confidence 9999876533 3456678899999999998643 589999999999999999999999964322 111111
Q ss_pred HHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003237 747 AWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798 (837)
Q Consensus 747 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv 798 (837)
...+...-+-.+. ..+....+...++.+|++..-++|-...++.
T Consensus 696 ------eNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 ------ENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ------hhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111111000000 0111123456788899999999997666553
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=293.67 Aligned_cols=284 Identities=19% Similarity=0.241 Sum_probs=213.0
Q ss_pred HHHHHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeeccccc
Q 003237 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE 595 (837)
Q Consensus 520 ~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 595 (837)
..++....++|.+.++||+|+||.|..++++ +++.+|+|++++- .......|+.|-.+|..-+.+-|+.|...|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3445556688999999999999999999886 5788899999762 34456788999999999999999999999999
Q ss_pred CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccc
Q 003237 596 EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (837)
Q Consensus 596 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFG 675 (837)
+.+.|||||||+||+|-.++.... .++..-..-++..|+-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999885543 4677777778889999999999988 9999999999999999999999999
Q ss_pred cceeccCccceeeeccccccCCccCccccc----C-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYAL----D-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
.+-.+..+. .......+|||.|++||++. + +.|...+|.||+||++|||+.|..||.. ..++.--..+
T Consensus 221 sClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KI 293 (1317)
T KOG0612|consen 221 SCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKI 293 (1317)
T ss_pred hHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHH
Confidence 988776443 23455679999999999996 2 5799999999999999999999999853 1233222222
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH--Hh-----ccCCCCCCCCCCCcccccc
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPS---MSTVVF--ML-----SNETFVPSPKQPTFSVRRT 820 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---m~eVv~--~L-----~~~~~~~~p~~p~~~~~~~ 820 (837)
.+......+.+. .+-+.....+|..-+ -+|+.|-. ++++-. ++ .++++...|-.|..+...+
T Consensus 294 m~hk~~l~FP~~-------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~D 365 (1317)
T KOG0612|consen 294 MNHKESLSFPDE-------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDD 365 (1317)
T ss_pred hchhhhcCCCcc-------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCc
Confidence 222222222211 111223334443333 25677776 888764 23 3446666666777765554
Q ss_pred cccc
Q 003237 821 EIDT 824 (837)
Q Consensus 821 ~~~~ 824 (837)
.++.
T Consensus 366 TsnF 369 (1317)
T KOG0612|consen 366 TSNF 369 (1317)
T ss_pred cccc
Confidence 4433
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=292.51 Aligned_cols=259 Identities=22% Similarity=0.271 Sum_probs=167.4
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-C----CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecc------cc
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-N----GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC------CL 594 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~ 594 (837)
..++|++.++||+|+||.||+|++. + +..||||++..... .+....| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999875 4 68999999854321 1111111 1122223333333222 23
Q ss_pred cCCccEEEEEecCCCChhhHhhhcCCC-----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 003237 595 EEDENMLIYEFMPNKSLDYFIFDESRK-----------------QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 657 (837)
Q Consensus 595 ~~~~~~lV~ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 657 (837)
.+...+|||||+++++|.+++...... ..........++.||++||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999988643210 01112334578999999999999987 9999999
Q ss_pred CCcEEEcC-CCCeeecccccceeccCccceeeeccccccCCccCcccccCC----------------------CCCCccc
Q 003237 658 ASNILLDE-KMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG----------------------VFSTKSD 714 (837)
Q Consensus 658 p~NIll~~-~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~s~k~D 714 (837)
|+|||++. ++.+||+|||+++.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57999999999986543221 122346789999999965422 2445679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc----cccccccccccc----c--CHHHHHHHHHHHHHcc
Q 003237 715 VFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK----ALEIVDSSMANS----C--LASEALRCIQVGLLCV 784 (837)
Q Consensus 715 V~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----~~~~~d~~l~~~----~--~~~~~~~l~~l~~~Cl 784 (837)
||||||+||||+++..+.+. .+......+...+. ....+.+....+ + .........+++.+|+
T Consensus 362 VwSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999997765421 11111111110000 001111110000 0 0001123457999999
Q ss_pred cCCCCCCCCHHHHHH
Q 003237 785 QDRTTDRPSMSTVVF 799 (837)
Q Consensus 785 ~~~P~~RPtm~eVv~ 799 (837)
+.||++|||++|+++
T Consensus 435 ~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 435 RFKGRQRISAKAALA 449 (566)
T ss_pred cCCcccCCCHHHHhC
Confidence 999999999999986
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=255.44 Aligned_cols=258 Identities=22% Similarity=0.250 Sum_probs=195.7
Q ss_pred hhcCCCcC-CcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccC----Cc
Q 003237 526 ATDNFSTS-NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEE----DE 598 (837)
Q Consensus 526 at~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~----~~ 598 (837)
.+++|.+. ++||-|-.|+|.....+ +++.+|+|++... ...++|+++--... |||||.+++++... ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35566654 57999999999999775 7899999999543 34578888877764 99999999998653 34
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc---CCCCeeecccc
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFG 675 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~DFG 675 (837)
.++|||.|+||.|...+.+.. .+.+++++.-.|+.||+.|+.|||+.+ |.||||||+|+|.. .|..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 579999999999999987654 456899999999999999999999998 99999999999996 45679999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
+|+..... ......+-|+.|.|||++...+|+...|+||+||++|-|++|-+||-...... + ..+.
T Consensus 210 FAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---i--------spgM 275 (400)
T KOG0604|consen 210 FAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---I--------SPGM 275 (400)
T ss_pred cccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---C--------ChhH
Confidence 99975532 22334788999999999999999999999999999999999999985332211 0 0010
Q ss_pred cccccccccccccCHHH----HHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCCCCC
Q 003237 756 ALEIVDSSMANSCLASE----ALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETFVP 808 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~----~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~~~~ 808 (837)
...+.... -+++.+| ++...+++...+..+|.+|-|+.+++. .+.+...+|
T Consensus 276 k~rI~~gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 276 KRRIRTGQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred HhHhhccC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 01110000 0122222 234557788888999999999999985 444444443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=251.87 Aligned_cols=279 Identities=21% Similarity=0.307 Sum_probs=210.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|.+.++||+|+|++|..+++. +.+.+|+|++++. ....++-++.|..+..+. +||.+|-|..+++.+...++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 46788899999999999999886 5678899998764 345566778888888877 699999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
.||+++|+|--++.+ +..|+.+...-....|.-||.|||+.+ ||.||||..|||||.+|++|++|+|+++.--.
T Consensus 330 ieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999666543 334677777778889999999999998 99999999999999999999999999985322
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCC-cchHHHHHHHHhccCccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD-SSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d 761 (837)
+ -..++..+||+.|+|||++++..|...+|.|++||+++||+.|+.||+....+. ..+...+..++..+..+.
T Consensus 404 ~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---- 477 (593)
T KOG0695|consen 404 P--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---- 477 (593)
T ss_pred C--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc----
Confidence 2 234567999999999999999999999999999999999999999999876443 334445554443322211
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCC------HHHH----------HHHhccCCCCCCCCCCCccccccccccC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPS------MSTV----------VFMLSNETFVPSPKQPTFSVRRTEIDTD 825 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt------m~eV----------v~~L~~~~~~~~p~~p~~~~~~~~~~~~ 825 (837)
.+.....+...+...-+..||.+|.. .+++ -.+|++ +++-.|=+|.....+.+...+
T Consensus 478 ------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq-k~v~ppf~p~i~~d~~l~~fd 550 (593)
T KOG0695|consen 478 ------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ-KQVLPPFQPQITDDYGLDNFD 550 (593)
T ss_pred ------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh-cccCCCCCCccccccCccccc
Confidence 12222234456666677888887742 2232 134444 344445566666555443333
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=279.54 Aligned_cols=259 Identities=19% Similarity=0.267 Sum_probs=177.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-----------------cCCcEEEEEEecCCCccCHHH--------------HHHHH
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-----------------SNGQEIAVKRLSTTSGQGIEE--------------LKNEV 575 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E~ 575 (837)
.++|++.++||+|+||.||+|.+ ..++.||||++........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 235689999986543222222 33477
Q ss_pred HHHHHhcCCCe-----eeeeccccc--------CCccEEEEEecCCCChhhHhhhcCC---------------------C
Q 003237 576 LLIAKLQHRNL-----VKLLGCCLE--------EDENMLIYEFMPNKSLDYFIFDESR---------------------K 621 (837)
Q Consensus 576 ~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lV~ey~~~gsL~~~l~~~~~---------------------~ 621 (837)
.++.+++|.++ ++++++|.. ....+|||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888877654 677887753 3467999999999999999864211 1
Q ss_pred CCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCc
Q 003237 622 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701 (837)
Q Consensus 622 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 701 (837)
..++|..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++........ ......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 23567788899999999999999987 999999999999999999999999999765432211 11123447899999
Q ss_pred ccccCCCC----------------------CCcccHHHHHHHHHHHHhCCC-CCCCCCCCC------cchHHHHHHHHhc
Q 003237 702 EYALDGVF----------------------STKSDVFSFGVILLEIITGKK-NTRIFNDDD------SSNLIKYAWELWS 752 (837)
Q Consensus 702 E~~~~~~~----------------------s~k~DV~S~Gvvl~elltG~~-p~~~~~~~~------~~~l~~~~~~~~~ 752 (837)
|.+..... ..+.||||+||+++||++|.. |+....... ...+..| ....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--Hhhc
Confidence 98864321 235799999999999999875 553211100 0001111 1111
Q ss_pred cCccccccccccccccCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 003237 753 DNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRT---TDRPSMSTVVF 799 (837)
Q Consensus 753 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPtm~eVv~ 799 (837)
... .+- ...........+++.+++..+| .+|+|++|+++
T Consensus 458 ~~~----~~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQK----YDF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccC----CCc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 110 000 0111122345677778887655 78999999975
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=279.48 Aligned_cols=260 Identities=24% Similarity=0.387 Sum_probs=207.2
Q ss_pred cHHHHHHhhcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeeccccc-
Q 003237 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE- 595 (837)
Q Consensus 519 ~~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~- 595 (837)
.++.+...++.|++.+.||+|.+|.||+++. ++++..|||++... ....+++..|.++++.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3445555678889999999999999999975 47888999988544 44557788899999988 59999999999864
Q ss_pred ----CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeee
Q 003237 596 ----EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (837)
Q Consensus 596 ----~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 671 (837)
++..+||||||.+|+..+++.... ...+.|..+.-|+..++.||.+||... ++|||||-.||||+.++.+|+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 467899999999999999997765 566899999999999999999999987 999999999999999999999
Q ss_pred cccccceeccCccceeeeccccccCCccCcccccCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 003237 672 SDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG-----VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKY 746 (837)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 746 (837)
.|||++..+... ........||+.|||||++... .|+..+|+||+|++..||--|.+|+-.... ...
T Consensus 165 vDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP------mra 236 (953)
T KOG0587|consen 165 VDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP------MRA 236 (953)
T ss_pred eeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch------hhh
Confidence 999999876432 2233457899999999999753 478899999999999999999999743221 111
Q ss_pred HHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 747 AWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 747 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.....+. ..|.+ ..+..=..++.+++..|+..|-+.||++.++++
T Consensus 237 LF~IpRN------PPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 LFLIPRN------PPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hccCCCC------CCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111111 11111 123344567889999999999999999998874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=280.36 Aligned_cols=245 Identities=25% Similarity=0.348 Sum_probs=184.5
Q ss_pred CCcCCcccccCCee-EEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEecC
Q 003237 530 FSTSNKLGQGGFGP-VYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 530 ~~~~~~LG~G~fG~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
|...+.+|.|.-|+ ||+|... |++||||++-.. ..+-..+|+..|+.-+ ||||||+++.-.+....||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34456789999885 7999984 899999998533 2345678999999884 9999999988888888999999996
Q ss_pred CCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC-----CCCeeecccccceecc
Q 003237 608 NKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-----KMNPRISDFGTARVFG 681 (837)
Q Consensus 608 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~ki~DFGla~~~~ 681 (837)
. +|++++... .......-...+.++.|+++||++||+.+ ||||||||.||||+. ...++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 899998653 11111111344678899999999999977 999999999999975 3579999999999887
Q ss_pred Cccc-eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 682 GEEI-LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG-KKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 682 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
.+.. ........||.+|+|||++....-+.++||||+|||+|+.++| ++||+..- .+.+.-......+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~-------~R~~NIl~~~~~L~~- 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-------ERQANILTGNYTLVH- 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH-------HhhhhhhcCccceee-
Confidence 5532 3334567899999999999999889999999999999999986 89996321 111111111111111
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv 798 (837)
+. . ..+. +..++|.+|++.+|..||++.+|+
T Consensus 735 L~----~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 LE----P--LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ec----c--CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11 0 1111 567889999999999999999996
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=260.26 Aligned_cols=268 Identities=19% Similarity=0.246 Sum_probs=200.7
Q ss_pred eecHHHHHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcC--C----Ceeee
Q 003237 517 FFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH--R----NLVKL 589 (837)
Q Consensus 517 ~~~~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~----nIv~l 589 (837)
+|...+.. +++|.+..++|+|.||.|-+.... .+..||||+++.. ....+..+-|+++++++.+ | -+|.+
T Consensus 80 v~~~gD~l--~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 80 VYQVGDIL--TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEEecccc--ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 34444433 678999999999999999999654 4789999999543 3344566779999999942 3 37888
Q ss_pred ecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC----
Q 003237 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---- 665 (837)
Q Consensus 590 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---- 665 (837)
.+++.-.++.+||+|.+ +-++.++|.... -.+++...+..++.|++++++|||+.. ++|-||||+|||+..
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYF 231 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceE
Confidence 89999999999999987 447888886532 345778899999999999999999987 999999999999831
Q ss_pred ----------------CCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCC
Q 003237 666 ----------------KMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729 (837)
Q Consensus 666 ----------------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~ 729 (837)
+..+||+|||.|..-.... +.++.|..|.|||++.+..++..+||||+||||.|+.+|.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 3468999999998754433 3477899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHHHH----------------HHHHhccCcc-----------ccccccc----cccccCHHHHHHHHH
Q 003237 730 KNTRIFNDDDSSNLIKY----------------AWELWSDNKA-----------LEIVDSS----MANSCLASEALRCIQ 778 (837)
Q Consensus 730 ~p~~~~~~~~~~~l~~~----------------~~~~~~~~~~-----------~~~~d~~----l~~~~~~~~~~~l~~ 778 (837)
.-|..-. +.++|... +.+.+..+.+ ..+.++. ..-.....+..+|++
T Consensus 307 ~LFqtHe--n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 307 TLFQTHE--NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred eecccCC--cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 8764322 22222211 1111111100 0111110 011234456778999
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 003237 779 VGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 779 l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
++..++..||.+|+|+.|+++
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHccCccccccHHHHhc
Confidence 999999999999999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=226.26 Aligned_cols=195 Identities=26% Similarity=0.448 Sum_probs=162.7
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
|.-.++||+|.||+||||+.. +++.||+|+++-. ++.......+|+-+++.++|+|||++++....+....+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 444679999999999999875 5788999998754 2333456789999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
.. +|..+... -...++......++.|+++||.++|+++ +.||||||.|.|++.+|++|++|||+++-++-.-.-
T Consensus 84 dq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 84 DQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 65 56555422 2345788888899999999999999998 999999999999999999999999999987654211
Q ss_pred eeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCC
Q 003237 687 AITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNT 732 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~ 732 (837)
-+....|..|.+|.++.+. .|+...|+||-|||+.|+....+|.
T Consensus 158 --ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred --eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 2235678999999999875 5899999999999999998765554
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=222.52 Aligned_cols=110 Identities=48% Similarity=1.140 Sum_probs=105.6
Q ss_pred EecCCCCCccccCccCceeeeeeEEEEEeCCCeeEEEeeccCCceeEEEEEcccccEEEEEEecCCCceEEEEeccCCCC
Q 003237 208 WRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERC 287 (837)
Q Consensus 208 w~sg~w~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~rl~Ld~~G~l~~~~w~~~~~~W~~~~~~p~~~C 287 (837)
||+|||||..|+|+|++.....+.+.|+.+++|+|++|...+.+.++|++||.+|++++|.|++..++|.+.|.+|.|+|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 89999999999999999988999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCCccccCCCCCCcccccCCCCCcCC
Q 003237 288 DYYGHCGPNSNCNLNLTDGFECTCLPGFEPKY 319 (837)
Q Consensus 288 ~~~g~CG~~g~C~~~~~~~~~C~C~~gf~~~~ 319 (837)
|+|+.||+||+|+.+.. +.|+||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~--~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNS--PKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCC--CceECCCCcCCCc
Confidence 99999999999987654 8999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=262.54 Aligned_cols=207 Identities=22% Similarity=0.360 Sum_probs=173.2
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.-|..++.||-|+||+|.++.. ++...+|+|.|++.+ ......++.|-.||...+.+-||+|+..|.+.+..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4577788999999999999954 456678999998764 334566788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC-
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG- 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~- 682 (837)
+|++||++-.+|.+.+ .+.+....-.+..+..|+++.|..+ +|||||||.|||||.+|++||+||||+.-+.-
T Consensus 709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999886543 4667766677888999999999988 99999999999999999999999999865420
Q ss_pred --ccce-------------------------------------eeeccccccCCccCcccccCCCCCCcccHHHHHHHHH
Q 003237 683 --EEIL-------------------------------------AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILL 723 (837)
Q Consensus 683 --~~~~-------------------------------------~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ 723 (837)
..+. ......+||+.|+|||++....|+..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0000 0112357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCc
Q 003237 724 EIITGKKNTRIFNDDDS 740 (837)
Q Consensus 724 elltG~~p~~~~~~~~~ 740 (837)
||+.|+.||......+.
T Consensus 863 em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHhhCCCCccCCCCCcc
Confidence 99999999976554443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=265.59 Aligned_cols=246 Identities=23% Similarity=0.283 Sum_probs=195.8
Q ss_pred CCcCCcccccCCeeEEEEEecCCc-EEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 530 FSTSNKLGQGGFGPVYKGKLSNGQ-EIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~~g~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+.....||-|+||.|-+...+... .+|+|.+++. +....+.+..|-.+|...+.|.||+|+-.+.+....|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 334568999999999999876433 4888888764 334456788899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
|-+|.|-..|.+.. .++.....-++..+++|++|||+++ ||.|||||+|.|||.+|-+||.|||+|+.++...
T Consensus 502 ClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 502 CLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred hcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 99999999986543 3666666678889999999999998 9999999999999999999999999999887553
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.+-.++||+.|.|||++.++..+.++|.||+|++++||++|++||.....-...+++-.....+ +
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------~------- 639 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------E------- 639 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------h-------
Confidence 2345899999999999999999999999999999999999999997654433333332111111 1
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~eVv~ 799 (837)
++..-.....+++..-+..+|.+|.- +.++-+
T Consensus 640 --~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 640 --FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred --cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 12222334557777777889999976 555543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-30 Score=248.22 Aligned_cols=261 Identities=23% Similarity=0.389 Sum_probs=185.3
Q ss_pred CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC--------c
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED--------E 598 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--------~ 598 (837)
|+-..+||+|.||+||+|+.+ +|+.||+|++-... ...-....+|+++|..++|+|++.++..|.... .
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444579999999999999775 57788998764321 112234568999999999999999999986532 3
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.+||+.+|+. +|.-.|.+. ...++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 6899999987 566666443 234778888899999999999999987 9999999999999999999999999998
Q ss_pred eccCccce--eeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH-----HH
Q 003237 679 VFGGEEIL--AITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAW-----EL 750 (837)
Q Consensus 679 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~~ 750 (837)
.+...... ..-...+.|..|.+||.+.+. .|+++.|||.-|||+.||+++.+-+....+.....++.... +.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 76533211 112234568999999999875 69999999999999999999987665433222222222111 11
Q ss_pred hccCcccc----------------ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 751 WSDNKALE----------------IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 751 ~~~~~~~~----------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
|.+-.-.. .+..++......+ ..++++-..+..||.+||++++++.
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~---~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDD---EALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCCh---hHHHHHHHHhccCcccCcchHhhhc
Confidence 11111011 1111111111111 3566777788999999999999863
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=246.64 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=190.1
Q ss_pred CcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC-----ccEEE
Q 003237 531 STSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-----ENMLI 602 (837)
Q Consensus 531 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV 602 (837)
+..+.||-|+||.||..+.+ +|+.||+|++... .-...+.+.+|+++|.-++|.|++..++...... +.+.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34579999999999999875 7999999998543 2234567889999999999999999998876543 45778
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
+|.|.. +|+..|.. .+.++-....-++.||++||.|||+.+ |+||||||.|.|++.+..+||+|||+++....
T Consensus 136 TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 888754 66666632 345777777788999999999999988 99999999999999999999999999998776
Q ss_pred ccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc---------
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS--------- 752 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--------- 752 (837)
++...++. ...|..|.|||.+++. .|+.+.||||.|||+.||+..+.-|.....-+..+++ .+++.
T Consensus 209 d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI---tdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 209 RDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI---IDLLGTPSQEAMKY 284 (449)
T ss_pred hhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH---HHHhCCCcHHHHHH
Confidence 66555544 4568899999999985 6999999999999999999988777544332222222 11111
Q ss_pred --cCccccccccc--------ccc-ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 753 --DNKALEIVDSS--------MAN-SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 753 --~~~~~~~~d~~--------l~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
++....++... +.. ..+...-.+.+.+.+.++..+|..|.+..+.+..+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111111111 100 00111122344556677889999999988887655
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-29 Score=225.21 Aligned_cols=111 Identities=41% Similarity=0.709 Sum_probs=79.3
Q ss_pred CCeEEEecCCCCCCCCC--CceEEEeeccceEEEecCCCcceeeec-ccccCCCCceEEEEecCCCEEEEecCCCceeee
Q 003237 69 QLTLLWVANRNNPINDT--SGVLSVNIQGNLVLHERNQSTVPVWQA-NISEASAGNTVAQLLDTGNLVLVRNDTGETLWQ 145 (837)
Q Consensus 69 ~~t~vW~Anr~~p~~~~--~~~l~~~~~G~L~l~~~~~~~~~~Wst-~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWq 145 (837)
++||||+|||+.|+.+. ..+|.|+.||+|+|.+ +.+.++|+| ++...+..+..|+|+|+|||||++ ..+.+|||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~--~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d-~~~~~lW~ 77 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYD--SNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYD-SSGNVLWQ 77 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEE--TTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEE-TTSEEEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEc--CCCCEEEEecccCCccccCeEEEEeCCCCEEEEe-ecceEEEe
Confidence 47999999999999653 4889999999999995 445679999 433222246789999999999995 68899999
Q ss_pred cccCCccccccCCcccccccCCCcceeeecCCCCCCC
Q 003237 146 SFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPG 182 (837)
Q Consensus 146 SFd~PtDtlLpg~~l~~~~~tg~~~~l~Sw~s~~dps 182 (837)
||||||||+||+|+|+.+..+|.+..++||++.+|||
T Consensus 78 Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 78 SFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp STTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred ecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999999988888778899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=230.23 Aligned_cols=202 Identities=27% Similarity=0.377 Sum_probs=164.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC-CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
+.......||+|++|.|-+-++. +|+.+|+|++... ..+..++...|+.+..+. .+|.+|.++|...++...++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 34445678999999999988764 7999999999754 345566777888877665 69999999999999999999999
Q ss_pred ecCCCChhhHhhh-cCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 605 FMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 605 y~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
.|+- +|+.+-.+ -.....+++.-.=+|+..|.+||.|||++- .+||||+||+|||++.+|++||+|||.+..+.+.
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9965 56555432 233445777777789999999999999974 5999999999999999999999999999877543
Q ss_pred cceeeeccccccCCccCcccccC----CCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 003237 684 EILAITKRVVGTYGYMSPEYALD----GVFSTKSDVFSFGVILLEIITGKKNTRIF 735 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~----~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 735 (837)
-.. +...|-..|||||.+.. ..|+.|+||||+|+.+.||.+++.|++..
T Consensus 203 iAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 203 IAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 221 11457789999998853 36899999999999999999999999744
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=233.66 Aligned_cols=211 Identities=36% Similarity=0.588 Sum_probs=183.1
Q ss_pred ccccCCeeEEEEEecC-CcEEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCChhh
Q 003237 536 LGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDY 613 (837)
Q Consensus 536 LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~ 613 (837)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|++.+..++|++|+++++++......++++||+++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 899999998755332 35778999999999999999999999999899999999999999999
Q ss_pred HhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC-CCCeeecccccceeccCccceeeeccc
Q 003237 614 FIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVFGGEEILAITKRV 692 (837)
Q Consensus 614 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~DFGla~~~~~~~~~~~~~~~ 692 (837)
++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. +..++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 986532 35789999999999999999999987 999999999999999 89999999999987654321 12234
Q ss_pred cccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHH
Q 003237 693 VGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLAS 771 (837)
Q Consensus 693 ~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 771 (837)
.+...|++||.+... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577899999999887 889999999999999998
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003237 772 EALRCIQVGLLCVQDRTTDRPSMSTVVFML 801 (837)
Q Consensus 772 ~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L 801 (837)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4577899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=227.30 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=190.5
Q ss_pred hcCCCcCCcccccCCeeEEEEE-ecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccCC--ccEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEED--ENMLI 602 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lV 602 (837)
.++|++.+++|+|.|++||.|. ..+.+.++||.++.. ..+.+.+|+++|..+. ||||++|++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678889999999999999996 457889999999643 3467899999999998 999999999998765 45799
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC-CCCeeecccccceecc
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVFG 681 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~DFGla~~~~ 681 (837)
+||+++.+....- +.++-..+...+.++++||.|+|+.+ |+|||+||.|+++|. .-.++|+|+|||....
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876543 23566667778999999999999998 999999999999995 5579999999998776
Q ss_pred CccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc--
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE-- 758 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-- 758 (837)
....... ...+..|.-||.+..- .|+..-|+|||||+|.+|+..+.||-... +...++++.+.-+.. ..+..
T Consensus 185 p~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLGt-~el~~Yl 259 (338)
T KOG0668|consen 185 PGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLGT-DELYAYL 259 (338)
T ss_pred CCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhCh-HHHHHHH
Confidence 5433221 2345678899998864 58899999999999999999999985433 344556655432211 11000
Q ss_pred -----cccccccc----------------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 -----IVDSSMAN----------------SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 -----~~d~~l~~----------------~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+|+.... +-..-...+.++++-.-+..|-++|||++|.+.
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 12222111 000001134566666778899999999999863
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=253.87 Aligned_cols=194 Identities=26% Similarity=0.393 Sum_probs=166.0
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--------cCHHHHHHHHHHHHHhc---CCCeeeeecccccC
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--------QGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEE 596 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~ 596 (837)
.|...+.||+|+||.|+.+.++ +...|+||.+.+..- ..+-.+-.|+.+|..++ |+||++++++|++.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 5788899999999999999886 466789998865421 11223456999999998 99999999999999
Q ss_pred CccEEEEEec-CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccc
Q 003237 597 DENMLIYEFM-PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (837)
Q Consensus 597 ~~~~lV~ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFG 675 (837)
+.++|+||-- ++-+|.++|. .++.+++.+..-|.+||+.|+++||+++ |||||||-+||.++.+|-+||+|||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 9999999975 4557888874 3455888899999999999999999998 9999999999999999999999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCC
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNT 732 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~ 732 (837)
.+.+....... .++||..|.|||++.+.+| ...-|||++|++||-++....||
T Consensus 716 saa~~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 716 SAAYTKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred chhhhcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99887765543 3789999999999999887 45689999999999999988886
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=228.91 Aligned_cols=198 Identities=32% Similarity=0.467 Sum_probs=171.2
Q ss_pred CCcCCcccccCCeeEEEEEecC-CcEEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 530 FSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
|...+.||+|++|.||++.... ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556899999999999998875 889999999765544 57788999999999999999999999998899999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++..... .+++.....++.+++.+|.+||..+ ++|+||+|.||+++.++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999999865332 1788999999999999999999987 99999999999999999999999999987654320 0
Q ss_pred eeccccccCCccCcccc-cCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 003237 688 ITKRVVGTYGYMSPEYA-LDGVFSTKSDVFSFGVILLEIITGKKNTR 733 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~-~~~~~s~k~DV~S~Gvvl~elltG~~p~~ 733 (837)
......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 12235677889999998 66778889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=231.67 Aligned_cols=273 Identities=23% Similarity=0.263 Sum_probs=196.7
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC------c
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------E 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~ 598 (837)
.+|...+.+|.|.- .|-.+.. -.+++||+|++... .....+...+|..++..++|+||++++.++.... +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35556678888888 5555533 36899999987543 2344567789999999999999999999987543 4
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.++|||||.. +|...++. .++.+....|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 6899999965 67776652 3677888899999999999999988 9999999999999999999999999998
Q ss_pred eccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcc----------------h
Q 003237 679 VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS----------------N 742 (837)
Q Consensus 679 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~----------------~ 742 (837)
.-... -..+....|..|.|||++.+..+.+.+||||+||++.||++|+.-|.....-+.. +
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 65433 2334467889999999999999999999999999999999999876532110000 0
Q ss_pred HHHHHHHHhcc-C-----cccccc-ccccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhc---cCCCCC
Q 003237 743 LIKYAWELWSD-N-----KALEIV-DSSMA--NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLS---NETFVP 808 (837)
Q Consensus 743 l~~~~~~~~~~-~-----~~~~~~-d~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~---~~~~~~ 808 (837)
+...++.+... + ...+++ |.... .+.+......+..++.+|+-.+|++|-++++++. -++ ...+++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ 323 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVE 323 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccccc
Confidence 11111111110 0 001111 11110 0112233455678889999999999999999986 344 456666
Q ss_pred CCCCC
Q 003237 809 SPKQP 813 (837)
Q Consensus 809 ~p~~p 813 (837)
.|+.+
T Consensus 324 ap~pe 328 (369)
T KOG0665|consen 324 APPPE 328 (369)
T ss_pred CCCCc
Confidence 66666
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=205.02 Aligned_cols=115 Identities=43% Similarity=0.733 Sum_probs=100.2
Q ss_pred CccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEecCCCccee
Q 003237 30 QPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPV 109 (837)
Q Consensus 30 ~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~~ 109 (837)
++|++|++|+|++|.|++|||.+......+.+|||.+++ +++||.||++.| ....+.|.|+.||+|+|.+ .++.++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~--~~g~~v 77 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYD--GSGTVV 77 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEc--CCCcEE
Confidence 578899999999999999999997765589999999987 899999999998 4566789999999999995 455789
Q ss_pred eecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCC
Q 003237 110 WQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHP 150 (837)
Q Consensus 110 Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~P 150 (837)
|+|+++. +....+|+|+|+|||||++ ..+.+||||||||
T Consensus 78 W~S~~~~-~~~~~~~~L~ddGnlvl~~-~~~~~~W~Sf~~P 116 (116)
T cd00028 78 WSSNTTR-VNGNYVLVLLDDGNLVLYD-SDGNFLWQSFDYP 116 (116)
T ss_pred EEecccC-CCCceEEEEeCCCCEEEEC-CCCCEEEcCCCCC
Confidence 9999764 3556789999999999984 4589999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-25 Score=232.35 Aligned_cols=131 Identities=25% Similarity=0.373 Sum_probs=107.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-----C---CCeeeeeccccc---
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-----H---RNLVKLLGCCLE--- 595 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~~~~~~--- 595 (837)
.+|.+.++||-|.|++||++... +.+-||+|+.+. .....+....||++|++++ | ..||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 57888999999999999999654 678899999854 3444566788999999994 3 369999999975
Q ss_pred -CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE
Q 003237 596 -EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (837)
Q Consensus 596 -~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 663 (837)
+.+.+||+|++.. +|..+|.... .+-++.....+|++||+.||.|||.++ +|||-||||+||||
T Consensus 157 NG~HVCMVfEvLGd-nLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGD-NLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhhh-HHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4578999999855 5556664432 234788888999999999999999988 69999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-26 Score=241.49 Aligned_cols=203 Identities=22% Similarity=0.281 Sum_probs=170.9
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhc------CCCeeeeecccccCCc
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ------HRNLVKLLGCCLEEDE 598 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~~~~~~~~~ 598 (837)
.-.+|.+....|+|-|++|.+|... -|+.||||+|.... .-.+.=..|+++|.+|+ --|.++|+-.|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 3467888889999999999999765 48899999997652 22233457999999996 2489999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC-CCeeecccccc
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTA 677 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~DFGla 677 (837)
.|||+|-+. -+|.+.|...++.--|.......++.|+.-||..|...+ |+|.||||.|||+++. ..+||||||.|
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 999999764 488999988777777888999999999999999999988 9999999999999864 56899999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFND 737 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~ 737 (837)
......+... ...+..|.|||++.+.+|+...|+||.||.||||.||+..|....+
T Consensus 585 ~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 585 SFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 8876554322 3445689999999999999999999999999999999988765443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=218.68 Aligned_cols=253 Identities=21% Similarity=0.355 Sum_probs=185.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecc-cccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGC-CLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~-~~~~~~~~lV~e 604 (837)
+.|.+.+.||+|.||.+-+++++ ..+.+++|.+... ....++|.+|...--.| .|.||+.-++. |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 56888899999999999999887 5678999988543 34568899998866666 49999987765 556677889999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE-c-CCCCeeecccccceeccC
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL-D-EKMNPRISDFGTARVFGG 682 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll-~-~~~~~ki~DFGla~~~~~ 682 (837)
|++.|+|..-+...+ +.+....+++.|+++||.|+|+++ +||||||.+|||| + +...+||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999998885533 556667789999999999999998 9999999999999 3 344799999999886542
Q ss_pred ccceeeeccccccCCccCcccccCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDG-----VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
. .....-+..|.|||..... ...+.+|||.||++++.++||+.|+......+.. . |-+..|..+...
T Consensus 176 t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~-Y--~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 176 T-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP-Y--WEWEQWLKRKNP 247 (378)
T ss_pred e-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch-H--HHHHHHhcccCc
Confidence 2 2234456789999977532 2467899999999999999999999743332221 2 222333333333
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
.+.+ . + ......+.++-.+-+..+|++|-...++.++..
T Consensus 248 ~~P~--~---F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 248 ALPK--K---F-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cCch--h---h-cccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 2211 1 1 112334556666778899999966666665543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-26 Score=248.13 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=198.6
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.++|+..+.+|.|.||.|||++.. .++..|||.++-.......-+++|+-+++..+|+|||.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888899999999999999765 6889999999877777778888999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+.+|+|++.-+- ..++++.++....+...+||.|||+.+ -+|||||-.|||+++.+.+|++|||.+..+.. .
T Consensus 94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--t 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--T 165 (829)
T ss_pred cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--h
Confidence 999999887653 345788888888999999999999998 79999999999999999999999999876542 2
Q ss_pred eeeeccccccCCccCccccc---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYAL---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
....+.+.||+.|||||+.. .+.|..++|||+.|+...|+---+.|...... .. +..+.. ....++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr-~l~LmT----kS~~qp 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MR-ALFLMT----KSGFQP 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HH-HHHHhh----ccCCCC
Confidence 23345588999999999874 56799999999999999999877766432111 11 111111 111111
Q ss_pred -ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 -SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 -~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+... ..-...+-+++..|+-.+|++|||++.+++
T Consensus 235 p~lkDk--~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccCC--ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111 111234557888899999999999987653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-25 Score=267.91 Aligned_cols=196 Identities=18% Similarity=0.206 Sum_probs=138.8
Q ss_pred HhcC-CCeeeeecccc-------cCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCce
Q 003237 580 KLQH-RNLVKLLGCCL-------EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651 (837)
Q Consensus 580 ~l~H-~nIv~l~~~~~-------~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 651 (837)
.++| +||++++++|. +....++++||+ +++|.++|... ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 58888888772 234567778887 55999999643 245899999999999999999999988 9
Q ss_pred eeCCCCCCcEEEcC-------------------CCCeeecccccceeccCccc--------------eeeeccccccCCc
Q 003237 652 IHRDLKASNILLDE-------------------KMNPRISDFGTARVFGGEEI--------------LAITKRVVGTYGY 698 (837)
Q Consensus 652 vH~Dlkp~NIll~~-------------------~~~~ki~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 698 (837)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 45677777777764321000 0001124578889
Q ss_pred cCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHH
Q 003237 699 MSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQ 778 (837)
Q Consensus 699 ~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 778 (837)
||||++.+..++.++|||||||+||||++|..|+... ......... ..+.+.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~~~--------~~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMSSLRH--------RVLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHHHH--------hhcChhh-----hhcCHHHHH
Confidence 9999999999999999999999999999988875311 001110000 0111111 111233567
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 003237 779 VGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 779 l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
++.+|++.+|.+||+|.||++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 788999999999999999975
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=193.47 Aligned_cols=113 Identities=41% Similarity=0.724 Sum_probs=97.6
Q ss_pred CccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEecCCCccee
Q 003237 30 QPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPV 109 (837)
Q Consensus 30 ~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~~ 109 (837)
+.|++|++|+|++|.|++|||.+... ..+.+|||++.+ +++||.|||+.|+.++ +.|.|+.||+|+|.+ +.+.++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~--~~g~~v 76 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYD--GDGRVV 76 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEe--CCCCEE
Confidence 56889999999999999999999654 688999999987 8999999999998654 789999999999995 445789
Q ss_pred eecccccCCCCceEEEEecCCCEEEEecCCCceeeecccC
Q 003237 110 WQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDH 149 (837)
Q Consensus 110 Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~ 149 (837)
|+|++. .+.+..+|+|+|+|||||+ +..+++|||||||
T Consensus 77 W~S~t~-~~~~~~~~~L~ddGnlvl~-~~~~~~~W~Sf~~ 114 (114)
T smart00108 77 WSSNTT-GANGNYVLVLLDDGNLVIY-DSDGNFLWQSFDY 114 (114)
T ss_pred EEeccc-CCCCceEEEEeCCCCEEEE-CCCCCEEeCCCCC
Confidence 999975 3445678999999999998 4567899999997
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-24 Score=223.00 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=193.7
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEec----CCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCcc
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~ 599 (837)
...+.|...++||+|.|++||++++. ..+.||+|.+...+ ....+.+|+++|..+. +.||+++.+++..++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34567888999999999999999764 35689999986543 3456889999999996 99999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-CCCCeeecccccce
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTAR 678 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~DFGla~ 678 (837)
.+|+||+++-...++... ++.......+..+++||.++|..+ ||||||||+|+|.+ ..+.-.|.|||||.
T Consensus 111 ~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 999999999998888743 567788889999999999999998 99999999999998 45678999999997
Q ss_pred eccCc-------c------ce-----------------------------eeeccccccCCccCcccccC-CCCCCcccH
Q 003237 679 VFGGE-------E------IL-----------------------------AITKRVVGTYGYMSPEYALD-GVFSTKSDV 715 (837)
Q Consensus 679 ~~~~~-------~------~~-----------------------------~~~~~~~gt~~y~APE~~~~-~~~s~k~DV 715 (837)
..... . .. ...-...||+||.|||++.. ..-+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 21000 0 00 00012469999999999875 467899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH---------hccCc--ccc------c---------cc--cccccc
Q 003237 716 FSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL---------WSDNK--ALE------I---------VD--SSMANS 767 (837)
Q Consensus 716 ~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~---------~~~~~--~~~------~---------~d--~~l~~~ 767 (837)
||.|||++.+++++.||-...++ ...+...+... ...+. +.+ + ++ +.....
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeccceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999998654332 22222221100 00111 000 0 00 000000
Q ss_pred --------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 768 --------CLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 768 --------~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
........++++.-+|+..||.+|-|+++.++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00111236788999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.7e-23 Score=202.36 Aligned_cols=166 Identities=17% Similarity=0.167 Sum_probs=123.8
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
|+|.+++... ...+++..+..++.||++||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888888643 345899999999999999999999875 999999999999999 99988754321
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
..|++.|+|||++.+..++.++|||||||++|||++|+.|+..... ................ +... ..
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~------~~~~-~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPADD------PRDR-SN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccCC------cccc-cc
Confidence 3688999999999999999999999999999999999999853221 1111111111111000 0000 00
Q ss_pred CHHHH--HHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 769 LASEA--LRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 769 ~~~~~--~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
..... ..+.+++.+|++.+|++||++.|+++.+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11111 258899999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=218.42 Aligned_cols=175 Identities=20% Similarity=0.224 Sum_probs=133.9
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEec--CCcEEEEEEecCCC-----ccCHHHHHHHHHHHHHhcCCCeee-eecccccC
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKLS--NGQEIAVKRLSTTS-----GQGIEELKNEVLLIAKLQHRNLVK-LLGCCLEE 596 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~ 596 (837)
...++|.+.+.||+|+||+||+|.+. +++.+|||++.... ....+.+.+|+++|.+++|+|+++ ++.+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34578999999999999999999764 57788999875331 123456899999999999999985 4432
Q ss_pred CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCC-CCCcEEEcCCCCeeecccc
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL-KASNILLDEKMNPRISDFG 675 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~ki~DFG 675 (837)
...+|||||+++++|... . . . . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~-~--~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R-P--H---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C-c--c---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999632 1 1 0 1 1457889999999999987 999999 9999999999999999999
Q ss_pred cceeccCccceee------eccccccCCccCcccccCCC------CCCcccHH
Q 003237 676 TARVFGGEEILAI------TKRVVGTYGYMSPEYALDGV------FSTKSDVF 716 (837)
Q Consensus 676 la~~~~~~~~~~~------~~~~~gt~~y~APE~~~~~~------~s~k~DV~ 716 (837)
+++.+........ -....++..|+|||.+.... .+...|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9998754432111 12467888999999886432 33446665
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-22 Score=198.98 Aligned_cols=244 Identities=21% Similarity=0.348 Sum_probs=188.8
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCC
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 610 (837)
..+|.+...|+.|+|++. |..+++|++... .....+.|..|.-.|+.+.||||+.++|.|....+..++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 458899999999999997 555666766432 23334678889999999999999999999999999999999999999
Q ss_pred hhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeec--ccccceeccCccceee
Q 003237 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS--DFGTARVFGGEEILAI 688 (837)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~--DFGla~~~~~~~~~~~ 688 (837)
|...|++... -..+..+..+++.+||+|++|||+..+. |.-.-|.+..|++|++.+++|+ |--++..
T Consensus 274 lynvlhe~t~-vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsfq--------- 342 (448)
T KOG0195|consen 274 LYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------- 342 (448)
T ss_pred HHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeeee---------
Confidence 9999987543 3567788899999999999999998732 4455789999999999998874 2222111
Q ss_pred eccccccCCccCcccccCCCCC---CcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 689 TKRVVGTYGYMSPEYALDGVFS---TKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s---~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.....-.+.||+||.+..++-+ .++|+|||++++|||.|...||.....-+-. +.+.-..++
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglr 407 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLR 407 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhcccc
Confidence 1113346789999999877643 4799999999999999999999644332211 111122344
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
...++.....+.+++.-|+.+||.+||..+.|+-+||+
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 45566666678899999999999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-19 Score=197.17 Aligned_cols=261 Identities=29% Similarity=0.397 Sum_probs=195.5
Q ss_pred CCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCcc---CHHHHHHHHHHHHHhcCC-CeeeeecccccCCccEEEEEe
Q 003237 530 FSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ---GIEELKNEVLLIAKLQHR-NLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~ey 605 (837)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999886 88899998765332 367889999999999988 799999999766677999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-CeeecccccceeccCcc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGGEE 684 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~DFGla~~~~~~~ 684 (837)
+.++++..++........+.......++.|++.++.|+|..+ ++|||+||+||+++... .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643321125788889999999999999999998 99999999999999988 79999999998665443
Q ss_pred cee----eeccccccCCccCcccccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-CcchHHHHHHHHhccCcc
Q 003237 685 ILA----ITKRVVGTYGYMSPEYALD---GVFSTKSDVFSFGVILLEIITGKKNTRIFNDD-DSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 685 ~~~----~~~~~~gt~~y~APE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~ 756 (837)
... ......++..|+|||.+.+ ..++...|+||+|++++++++|..|+...... ...............
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 221 2345789999999999988 57899999999999999999999996543321 011111111111110
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 757 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000001000001223456678888999999999999987763
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.5e-20 Score=199.29 Aligned_cols=259 Identities=22% Similarity=0.261 Sum_probs=188.0
Q ss_pred CCCcCCcccccCCeeEEEEEecCC--cEEEEEEecCCCccCHHHHHHHHHHHHHhcC----CCeeeeeccc-ccCCccEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSNG--QEIAVKRLSTTSGQGIEELKNEVLLIAKLQH----RNLVKLLGCC-LEEDENML 601 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~l 601 (837)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999987543 4788888765433333377889999999873 5888888888 46777899
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC-----CCeeeccccc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-----MNPRISDFGT 676 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~ki~DFGl 676 (837)
||+.+ +.+|.++..... ...++-.+.+.|+.|++.+|.+||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99875 668888764443 456899999999999999999999998 9999999999999854 4689999999
Q ss_pred ce--eccCcc----ceee--eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 003237 677 AR--VFGGEE----ILAI--TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 677 a~--~~~~~~----~~~~--~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 748 (837)
++ ...... .... ....+||..|+++....+...+.+.|+||++.++.|++.|..|+..............
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~-- 251 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK-- 251 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH--
Confidence 98 321111 1111 1235699999999999999999999999999999999999999854332221111110
Q ss_pred HHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 749 ELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 749 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. ......+ .....+.+ +.++...+-..+..++|....+...|+..
T Consensus 252 -~~----~~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 252 -DP----RKLLTDR--FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred -Hh----hhhcccc--ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 00 0001110 11122232 33444444457889999999999887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-20 Score=216.68 Aligned_cols=253 Identities=17% Similarity=0.222 Sum_probs=185.5
Q ss_pred CCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCC-ccCHHHHHHHHHHHH--HhcCCCeeeeecccccCCccEEEEEe
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS-GQGIEELKNEVLLIA--KLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~--~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++...+.||.+.|=+|.+|+.++|. |+||++-+.. ...++.|.++++-++ .++|||.+++.-.-......+||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566789999999999999998887 8899876554 456666766555444 45899999998887777777899898
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc--
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE-- 683 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~-- 683 (837)
+.+ +|++.| ..++.+...+..-|+.|++.||..+|..+ |+|+|||.+||||+.-.-+.|+||...+...-.
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 766 666666 34567778888889999999999999998 999999999999999999999999987654321
Q ss_pred ---cceeeeccccccCCccCcccccCC----------C-CCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 003237 684 ---EILAITKRVVGTYGYMSPEYALDG----------V-FSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 684 ---~~~~~~~~~~gt~~y~APE~~~~~----------~-~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 748 (837)
++.........-.+|+|||.+... . .+++.||||+||++.||++ |+++|+. .+|..+-.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhc
Confidence 122222223344589999988542 2 6789999999999999998 5666642 22332221
Q ss_pred H-HhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 749 E-LWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 749 ~-~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
. ....+.+.+.+. -..+..+++.|+|.||++|-+++++++--++...
T Consensus 250 ~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred cCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 1 001111111110 1135689999999999999999999998766543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=218.35 Aligned_cols=252 Identities=24% Similarity=0.270 Sum_probs=185.4
Q ss_pred CCcccccCCeeEEEEEec-CCcEEEEEEec----CC-C-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 533 SNKLGQGGFGPVYKGKLS-NGQEIAVKRLS----TT-S-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~----~~-~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.+.+|.|++|.|+..... .....+.|... .. . .+....+..|+.+-..++|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 578999999988777543 33334444322 11 1 11112255677777888999999999888887777777999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
++. +|..++... ..+...++..++.|+..|+.|||..+ |.|||||++|++++.++.+||+|||.+..+.....
T Consensus 403 ~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred ccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999 999888543 24677788889999999999999998 99999999999999999999999999987754433
Q ss_pred e--eeeccccccCCccCcccccCCCCCC-cccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 686 L--AITKRVVGTYGYMSPEYALDGVFST-KSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 686 ~--~~~~~~~gt~~y~APE~~~~~~~s~-k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
. ......+|...|+|||.+....|.+ ..||||.|+++..|++|+.|+......+... .............
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~-- 548 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFE-- 548 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccccccc--
Confidence 3 4455678999999999999999976 5899999999999999999987654443321 0000000000000
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
-..........+...++.++++.+|.+|-||++|++
T Consensus 549 -~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 -GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 001112233455678888999999999999999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=179.22 Aligned_cols=140 Identities=18% Similarity=0.171 Sum_probs=108.2
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCcc--C-------HHH-----------------HHHHHHHHHHhcCCCe
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ--G-------IEE-----------------LKNEVLLIAKLQHRNL 586 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~nI 586 (837)
...||+|+||.||+|...+|+.||||+++..... . ... ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999654211 1 112 2349999999988776
Q ss_pred eeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHH-HhcCCCceeeCCCCCCcEEEcC
Q 003237 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL-HQDSRLRIIHRDLKASNILLDE 665 (837)
Q Consensus 587 v~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlkp~NIll~~ 665 (837)
.....+. ....+|||||+++++|...... ...++......++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433221 2234899999999877654322 23478888999999999999999 5766 99999999999998
Q ss_pred CCCeeecccccceecc
Q 003237 666 KMNPRISDFGTARVFG 681 (837)
Q Consensus 666 ~~~~ki~DFGla~~~~ 681 (837)
++.++|+|||++....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9e-20 Score=184.70 Aligned_cols=172 Identities=15% Similarity=0.168 Sum_probs=134.1
Q ss_pred hhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHH---H------HHHHHHHHHHhcCCCeeeeecccccC
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIE---E------LKNEVLLIAKLQHRNLVKLLGCCLEE 596 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~---~------~~~E~~~l~~l~H~nIv~l~~~~~~~ 596 (837)
..++|...++||+|+||.||+... ++..+|||.++.......+ . +.+|++.+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999766 5778999999754332222 2 67899999999999999998886543
Q ss_pred --------CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC
Q 003237 597 --------DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN 668 (837)
Q Consensus 597 --------~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 668 (837)
...+|||||++|.+|.++.. ++. ....+|+.+|..||+.+ ++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 34789999999999977631 121 34669999999999988 99999999999999988
Q ss_pred eeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh
Q 003237 669 PRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727 (837)
Q Consensus 669 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt 727 (837)
++|+|||.......+... ..++....|..++|+|+||+.+..+..
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999988754322111 113445567789999999999876543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-19 Score=198.08 Aligned_cols=216 Identities=22% Similarity=0.339 Sum_probs=163.7
Q ss_pred HHHhcCCCeeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 003237 578 IAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 657 (837)
Q Consensus 578 l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 657 (837)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...++|.....++++|++||.|||+.. . ..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 35678999999999999999999999999999999999763 345899999999999999999999865 1 2999999
Q ss_pred CCcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCC-------CCCcccHHHHHHHHHHHHhCCC
Q 003237 658 ASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV-------FSTKSDVFSFGVILLEIITGKK 730 (837)
Q Consensus 658 p~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-------~s~k~DV~S~Gvvl~elltG~~ 730 (837)
+.|+++|..+.+||+|||+.................-...|.|||.+.... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999988764311111122233456899999997642 4678999999999999999999
Q ss_pred CCCCCCCCCc-chHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 731 NTRIFNDDDS-SNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 731 p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
||+....... ..++.++.. .....+.|.+.... +....+..++..||.++|++||++++|-..++..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9976443332 223333222 11122222222111 2223688899999999999999999999988764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=174.21 Aligned_cols=141 Identities=21% Similarity=0.249 Sum_probs=110.8
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCcc---------------------C-----HHHHHHHHHHHHHhcCCCe
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ---------------------G-----IEELKNEVLLIAKLQHRNL 586 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~nI 586 (837)
...||+|+||.||+|+..+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754211 0 1223578999999999987
Q ss_pred eeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEEcC
Q 003237 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDE 665 (837)
Q Consensus 587 v~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~ 665 (837)
.....+... ..+|||||++++++....... ..++......++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544433322 358999999998654432221 236677888999999999999999 77 99999999999999
Q ss_pred CCCeeecccccceeccC
Q 003237 666 KMNPRISDFGTARVFGG 682 (837)
Q Consensus 666 ~~~~ki~DFGla~~~~~ 682 (837)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=175.44 Aligned_cols=202 Identities=22% Similarity=0.314 Sum_probs=167.2
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
-+|.+.++||+|+||+.+.|+. -++++||||.-...+ ..-++..|.+..+.|. .++|...+.|-.++.+..||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 4788999999999999999964 479999999864433 3357788999999886 68999999999999999999998
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC-----CCeeecccccceec
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-----MNPRISDFGTARVF 680 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~ki~DFGla~~~ 680 (837)
+ +-+|+++..--. ..++.++..-+|.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+..
T Consensus 106 L-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 7 567777653222 23788999999999999999999998 9999999999999643 35889999999977
Q ss_pred cCccce-----eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 003237 681 GGEEIL-----AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFND 737 (837)
Q Consensus 681 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~ 737 (837)
.+.... ...+..-||..||+--...+..-+.+.|.=|+|-++.+.|-|..|+.....
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 544322 122346799999999988999999999999999999999999999975543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-18 Score=166.61 Aligned_cols=205 Identities=23% Similarity=0.315 Sum_probs=164.8
Q ss_pred hcCCCcCCcccccCCeeEEEEE-ecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcC-CCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH-RNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 604 (837)
...|.+.++||.|+||.+|.|. +.+|++||||.-+.... ..++..|.++...++| ..|..+..+..+.....|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3578889999999999999995 46899999998755433 2467789999999986 677778888888889999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC---CCCeeecccccceecc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTARVFG 681 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~DFGla~~~~ 681 (837)
.+ +.+|++...--. ..++.++.+-++-|++.-++|+|.++ +|||||||+|+|..- ...+.++|||||+...
T Consensus 92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 86 667877653222 23778888999999999999999998 999999999999963 3468899999999765
Q ss_pred Cccc-----eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCC
Q 003237 682 GEEI-----LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD 739 (837)
Q Consensus 682 ~~~~-----~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~ 739 (837)
+... ....+...||..|.+--...+...+.+.|.=|+|.+|.++.-|..|+.......
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 3221 112234578999998887777888999999999999999999999997554433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=164.95 Aligned_cols=184 Identities=17% Similarity=0.125 Sum_probs=138.7
Q ss_pred cCCcccccCCeeEEEEEecCCcEEEEEEecCCCccC----HHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEec
Q 003237 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQG----IEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 532 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+...|++|+||+||.+.- .+.+++.+.+....... ...+.+|+++|.++. |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997765 67888888775443211 125789999999995 5889999886 4569999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCC-CCCcEEEcCCCCeeecccccceeccCccc
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL-KASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
.+.+|...+.. ....++.|++++|.++|..+ |+|||| ||.|||+++++.++|+|||++........
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99998654311 11347789999999999998 999999 79999999999999999999986543321
Q ss_pred e----e-------eeccccccCCccCcccccCC-CCC-CcccHHHHHHHHHHHHhCCCCCC
Q 003237 686 L----A-------ITKRVVGTYGYMSPEYALDG-VFS-TKSDVFSFGVILLEIITGKKNTR 733 (837)
Q Consensus 686 ~----~-------~~~~~~gt~~y~APE~~~~~-~~s-~k~DV~S~Gvvl~elltG~~p~~ 733 (837)
. . .......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0 01123467788888754432 333 56788999999999999998753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=165.96 Aligned_cols=135 Identities=19% Similarity=0.273 Sum_probs=105.7
Q ss_pred cCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHh-----cCCCeeeeecccccCC---c-cEEE
Q 003237 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-----QHRNLVKLLGCCLEED---E-NMLI 602 (837)
Q Consensus 532 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~-~~lV 602 (837)
..++||+|+||.||. ++.....+||++........+.+.+|++++..+ +||||++++|++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 457999999999996 443333479988765445567899999999999 5799999999998764 2 2378
Q ss_pred EEe--cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHH-HHHHhcCCCceeeCCCCCCcEEEcC----CCCeeecccc
Q 003237 603 YEF--MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV-LYLHQDSRLRIIHRDLKASNILLDE----KMNPRISDFG 675 (837)
Q Consensus 603 ~ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~ki~DFG 675 (837)
+|| +.+++|.+++.+. .++.. ..++.+++.++ .|||+++ |+||||||+|||++. +..++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5589999999542 24444 35678888887 9999998 999999999999974 3479999955
Q ss_pred cc
Q 003237 676 TA 677 (837)
Q Consensus 676 la 677 (837)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3e-17 Score=193.67 Aligned_cols=197 Identities=21% Similarity=0.250 Sum_probs=158.4
Q ss_pred hhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc---CCCeeeeecccccCCccEEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV 602 (837)
..+.|.+.+.||+|+||+||+|+..+|+.||+|.-+...... |.--.+++.+|+ -+-|+.+.....-.+..+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 456788889999999999999999889999999876654432 111222333333 24456666666677888999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-------CCCCeeecccc
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-------EKMNPRISDFG 675 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-------~~~~~ki~DFG 675 (837)
+||.+.|+|.+++. ..+.++|...+.++.|+++-+++||..+ |||+||||+|.||. ....++|+|||
T Consensus 773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999986 4557899999999999999999999998 99999999999994 24568999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCC
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKN 731 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p 731 (837)
-+-.+..-......+..++|-.+-.+|+..+.+++..+|.|.|+-+++-||.|+.-
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 98755322222334557889999999999999999999999999999999999853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.4e-18 Score=188.77 Aligned_cols=186 Identities=28% Similarity=0.341 Sum_probs=152.1
Q ss_pred cccccCCeeEEEEE----ecCCcEEEEEEecCCCcc--CHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEecC
Q 003237 535 KLGQGGFGPVYKGK----LSNGQEIAVKRLSTTSGQ--GIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~----~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
.+|+|.||.|++.. .+.|..+|+|.+++.... .......|..++..++ ||.+|++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999763 235778899988765321 1124556888889987 9999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+|.|...+... ...+..........++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 99998777443 23445555556677888999999988 99999999999999999999999999986533221
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRI 734 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 734 (837)
.+||..|||||++. ....++|.||||++++||++|..||..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 38999999999988 678899999999999999999999863
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.9e-17 Score=168.63 Aligned_cols=230 Identities=20% Similarity=0.266 Sum_probs=147.1
Q ss_pred cCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcC----------CCeeeeecccc---
Q 003237 532 TSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQH----------RNLVKLLGCCL--- 594 (837)
Q Consensus 532 ~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H----------~nIv~l~~~~~--- 594 (837)
..+.||.|+++.||.+++. +++++|||..... .....+++++|...+..+.+ -.++..++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3578999999999999886 5899999986533 23346677777766555332 12222222111
Q ss_pred ------cCC--------ccEEEEEecCCCChhhHhh---hcCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCC
Q 003237 595 ------EED--------ENMLIYEFMPNKSLDYFIF---DESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL 656 (837)
Q Consensus 595 ------~~~--------~~~lV~ey~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl 656 (837)
... ..+++|+-+ .++|..++. .... ...+....++.+..|+++.+++||+.+ ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 111 235677766 567777753 2221 223556677788899999999999998 999999
Q ss_pred CCCcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccC--------CCCCCcccHHHHHHHHHHHHhC
Q 003237 657 KASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD--------GVFSTKSDVFSFGVILLEIITG 728 (837)
Q Consensus 657 kp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~k~DV~S~Gvvl~elltG 728 (837)
+|+|++++++|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999987764432111 234578999997744 2578999999999999999999
Q ss_pred CCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCC
Q 003237 729 KKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDR 791 (837)
Q Consensus 729 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R 791 (837)
+.|++.......... .-..+. +-.+.+..++...++.+|.+|
T Consensus 247 ~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999975433222111 112344 445567788889999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=160.41 Aligned_cols=134 Identities=20% Similarity=0.311 Sum_probs=113.1
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEEecCCCcc--------CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ--------GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+.||+|++|.||+|.. .|..++||+....... ....+.+|++++..++|++|.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6788999986543211 124577899999999999998887777777888999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
+++++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988532 12 77889999999999999988 99999999999999 78899999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.8e-16 Score=158.21 Aligned_cols=146 Identities=19% Similarity=0.189 Sum_probs=113.5
Q ss_pred HHHHHhhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCcc----------------------CHHHHHHHHHHH
Q 003237 521 STLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ----------------------GIEELKNEVLLI 578 (837)
Q Consensus 521 ~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~E~~~l 578 (837)
.++......|.+.+.||+|+||.||++..++|+.||||++...... ....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 4455555557788999999999999999888999999987543210 012356789999
Q ss_pred HHhcCCC--eeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCC
Q 003237 579 AKLQHRN--LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL 656 (837)
Q Consensus 579 ~~l~H~n--Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl 656 (837)
..+.|++ +.+.++ ....++||||+++++|...... .....++.++++++.++|+.+ |+|+||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 9998874 444443 2355899999999998765320 234568899999999999987 999999
Q ss_pred CCCcEEEcCCCCeeecccccceeccC
Q 003237 657 KASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 657 kp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
||+||++++++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.7e-16 Score=161.26 Aligned_cols=152 Identities=20% Similarity=0.201 Sum_probs=114.9
Q ss_pred HHHHHHhhcCCCcCCcccccCCeeEEEEE--ecCCcEEEEEEecCCCcc------------------------CHHHHHH
Q 003237 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGK--LSNGQEIAVKRLSTTSGQ------------------------GIEELKN 573 (837)
Q Consensus 520 ~~~l~~at~~~~~~~~LG~G~fG~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~ 573 (837)
+..+..-...|.+.+.||+|+||.||+|. ..+|+.||||.++..... ....+..
T Consensus 20 ~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 20 LYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred HHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 34444444568888999999999999998 568999999998643210 0123568
Q ss_pred HHHHHHHhcCCC--eeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCce
Q 003237 574 EVLLIAKLQHRN--LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651 (837)
Q Consensus 574 E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 651 (837)
|++.+.++.|.. +.+++++ ...+|||||+++.+|....... ..+.......++.||+.+|.+||+.+ .|
T Consensus 100 E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~i 170 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--EL 170 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CE
Confidence 999999997633 3344432 2458999999998886654221 23455566789999999999999876 39
Q ss_pred eeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 652 IHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 652 vH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
+||||||+||+++ ++.++|+|||++....
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999999 8899999999987544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.4e-16 Score=161.81 Aligned_cols=196 Identities=18% Similarity=0.223 Sum_probs=131.3
Q ss_pred cCCCeeeeecccccC---------------------------CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHH
Q 003237 582 QHRNLVKLLGCCLEE---------------------------DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 634 (837)
Q Consensus 582 ~H~nIv~l~~~~~~~---------------------------~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 634 (837)
+|||||++.++|.+. ...++||.-++. +|+.++.... .+...+.-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 599999999988651 224677766544 6777775432 45666677999
Q ss_pred HHHHHHHHHHhcCCCceeeCCCCCCcEEEc--CCC--CeeecccccceeccCc----cceeeeccccccCCccCcccccC
Q 003237 635 GIARGVLYLHQDSRLRIIHRDLKASNILLD--EKM--NPRISDFGTARVFGGE----EILAITKRVVGTYGYMSPEYALD 706 (837)
Q Consensus 635 ~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~--~~~--~~ki~DFGla~~~~~~----~~~~~~~~~~gt~~y~APE~~~~ 706 (837)
|+++|+.|||.++ |.|||+|++||||. +|. .+.|+|||.+--.... .+....-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999993 343 4789999986533221 11111112356778999998864
Q ss_pred CC--C----CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHH
Q 003237 707 GV--F----STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVG 780 (837)
Q Consensus 707 ~~--~----s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 780 (837)
.+ . -.|+|.|+.|-+.||+++...||....+ ..+.. ....+---|.+...+++ .+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---m~L~~--------r~Yqe~qLPalp~~vpp----~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---MLLDT--------RTYQESQLPALPSRVPP----VARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch---heech--------hhhhhhhCCCCcccCCh----HHHHHH
Confidence 32 1 3589999999999999999999854111 00000 01111111233333443 356788
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 003237 781 LLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 781 ~~Cl~~~P~~RPtm~eVv~~ 800 (837)
..-++.||.+||+..-..-.
T Consensus 491 ~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHHhcCCccccCCccHHHhH
Confidence 88899999999987654433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.7e-16 Score=155.75 Aligned_cols=130 Identities=23% Similarity=0.364 Sum_probs=106.6
Q ss_pred cccccCCeeEEEEEecCCcEEEEEEecCCCc-c-------CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG-Q-------GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.||+|+||.||+|.. ++..+++|....... . ..+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 578899998643321 1 1356778999999999887666555566677789999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++++|.+.+..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999888743210 68999999999999987 99999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.6e-16 Score=178.82 Aligned_cols=136 Identities=18% Similarity=0.289 Sum_probs=111.0
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEE-ecCCCc-------cCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR-LSTTSG-------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~-l~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
..|...++||+|+||+||+|.+.+.. +++|+ +.+... ...+.+.+|++++.+++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34556789999999999999876443 44443 222111 1235678999999999999999888887777788
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++||||+++++|.+++. ....++.+++++|.|||+.+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998874 34678999999999999988 9999999999999 678999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-16 Score=173.22 Aligned_cols=124 Identities=30% Similarity=0.444 Sum_probs=108.7
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..++.|+++...+|.++|.+.......++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 457899999999999999876666678888999999999999999 44 899999999999999999999999998
Q ss_pred eeccCcc----ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh
Q 003237 678 RVFGGEE----ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727 (837)
Q Consensus 678 ~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt 727 (837)
....... .........||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7765443 2233345789999999999999999999999999999999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=145.12 Aligned_cols=137 Identities=21% Similarity=0.248 Sum_probs=98.3
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCcc--CHHH----------------------HHHHHHHHHHhcCCC--e
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ--GIEE----------------------LKNEVLLIAKLQHRN--L 586 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--I 586 (837)
.+.||+|+||.||+|...+++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999998653211 1111 134666666665432 3
Q ss_pred eeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEEcC
Q 003237 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDE 665 (837)
Q Consensus 587 v~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~ 665 (837)
.+++++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 246899999999654322111110 11 5567899999999999998 66 99999999999999
Q ss_pred CCCeeecccccceecc
Q 003237 666 KMNPRISDFGTARVFG 681 (837)
Q Consensus 666 ~~~~ki~DFGla~~~~ 681 (837)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.1e-14 Score=136.64 Aligned_cols=134 Identities=23% Similarity=0.229 Sum_probs=114.6
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcC--CCeeeeecccccCCccEEEEEecCCCC
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH--RNLVKLLGCCLEEDENMLIYEFMPNKS 610 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~ey~~~gs 610 (837)
.+.||+|.++.||+++..+ ..++||....... ...+.+|+.++..++| .++.+++.+....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4689999999999999864 7899999865433 5678899999999987 589999998888888999999999987
Q ss_pred hhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
+..+ +......++.+++++|.+||.....+++|+|++|.||++++.+.++++|||.++.
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7543 4556677899999999999987655699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.9e-15 Score=120.87 Aligned_cols=66 Identities=53% Similarity=0.990 Sum_probs=56.7
Q ss_pred cCCCccEEEEecccCCCCccccccccccCHHHHHHHhhhcCcceeeecccccccCCeeeEEeccCcccc
Q 003237 341 CQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDT 409 (837)
Q Consensus 341 c~~~~~f~~~~~~~~p~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~~C~~~~~~l~~~ 409 (837)
|+.+|+|+++++|++|++... .++.++++++|++.||+||||+||+|.+ .. ++++|++|+++|.|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~-~~~~~~s~~~C~~~Cl~nCsC~Ayay~~-~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNA-IVDSSVSLEECEKACLSNCSCTAYAYSN-LS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcce-eeecCCCHHHHHhhcCCCCCEeeEEeec-cC-CCCEEEEEcCEeecC
Confidence 456799999999999999765 5556799999999999999999999964 22 678999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.5e-15 Score=169.04 Aligned_cols=165 Identities=25% Similarity=0.379 Sum_probs=117.7
Q ss_pred cCCCcCCcccccCCeeEEEEEecC-CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.+|+.++.|..|+||.||..+++. .+.+|+ ++++.. . -+++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~-l---ilRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-L---ILRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccc-h---hhhc---cccccCCccee-------------------
Confidence 578888999999999999998874 677888 443321 0 0011 22222334333
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc---
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE--- 683 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~--- 683 (837)
|+=...+... ..+. .+++.+++|||+-+ |+|||+||+|.+|+.-|++|++|||+++.....
T Consensus 136 --gDc~tllk~~---g~lP--------vdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLKNI---GPLP--------VDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhcccC---CCCc--------chhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 2222222111 1121 12378999999987 999999999999999999999999998754211
Q ss_pred ---------ccee-eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 003237 684 ---------EILA-ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIF 735 (837)
Q Consensus 684 ---------~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 735 (837)
+... ..+.++||+.|+|||++....|...+|.|++|+|+||.+-|+.||...
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 0111 123469999999999999999999999999999999999999998643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.1e-13 Score=140.50 Aligned_cols=134 Identities=19% Similarity=0.259 Sum_probs=104.2
Q ss_pred Cccc-ccCCeeEEEEEecCCcEEEEEEecCCC-------------ccCHHHHHHHHHHHHHhcCCCe--eeeecccccCC
Q 003237 534 NKLG-QGGFGPVYKGKLSNGQEIAVKRLSTTS-------------GQGIEELKNEVLLIAKLQHRNL--VKLLGCCLEED 597 (837)
Q Consensus 534 ~~LG-~G~fG~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~~ 597 (837)
..|| .|+.|+||+.... +..++||++.... ......+.+|++++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5788 8999999999885 7789998774311 1223567889999999998875 67777654332
Q ss_pred c----cEEEEEecCC-CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeec
Q 003237 598 E----NMLIYEFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (837)
Q Consensus 598 ~----~~lV~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 672 (837)
. .++|+|++++ .+|.+++.+. .++. ..+.+|+.+|.+||+.+ |+|+||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 6888887432 2332 24678999999999998 9999999999999998999999
Q ss_pred cccccee
Q 003237 673 DFGTARV 679 (837)
Q Consensus 673 DFGla~~ 679 (837)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.2e-14 Score=168.96 Aligned_cols=253 Identities=21% Similarity=0.253 Sum_probs=183.8
Q ss_pred CCCcCCcccccCCeeEEEEEecC--CcEEEEEEecCCC--ccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSN--GQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 46667889999999998886643 4456777665443 223344555777777776 999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHH-hcCCCceeeCCCCCCcEEEcCCC-Ceeecccccceecc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH-QDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFG 681 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlkp~NIll~~~~-~~ki~DFGla~~~~ 681 (837)
||..++++...+..... ...+-...-....|+..++.|+| ..+ +.|+||||+|.++++.+ ..+++|||+|....
T Consensus 101 ~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999888732211 12333444568899999999999 766 99999999999999999 99999999999877
Q ss_pred C-ccceeeeccccc-cCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 682 G-EEILAITKRVVG-TYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 682 ~-~~~~~~~~~~~g-t~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|.+........ ...
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------------~~~ 242 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------------YSS 242 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------cee
Confidence 6 444444555678 9999999999885 4577899999999999999999998755443311 111
Q ss_pred ccccccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 IVDSSMA--NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 ~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....... ......-.....++...++..+|..|.+.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1111000 0001111223456666777789999999888743
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.2e-12 Score=147.79 Aligned_cols=142 Identities=21% Similarity=0.240 Sum_probs=100.9
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCccCH----------------------------------------HHHH
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGI----------------------------------------EELK 572 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~ 572 (837)
.+.||.|++|.||+|++++|+.||||+.+....... -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999865421110 0234
Q ss_pred HHHHHHHHhc-----CCCeeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHH-HHHHHHhc
Q 003237 573 NEVLLIAKLQ-----HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR-GVLYLHQD 646 (837)
Q Consensus 573 ~E~~~l~~l~-----H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 646 (837)
+|++.+.+++ +++|.-..-+.......+|||||+++++|.+........ . .+..++..+++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence 4555555552 333332222222345679999999999998876432111 1 24457777666 46788887
Q ss_pred CCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 647 ~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
+ ++|+|+||.||+++.++.++++|||++..+..
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.6e-13 Score=111.21 Aligned_cols=71 Identities=23% Similarity=0.383 Sum_probs=62.2
Q ss_pred cCCCccEEEEecccCCCCccccccccccCHHHHHHHhhh---cCcceeeecccccccCCeeeEEeccCc-cccccccccC
Q 003237 341 CQKGEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLS---NCSCVAYASASAETNRGIGCLMYHGDL-NDTRKYTNAG 416 (837)
Q Consensus 341 c~~~~~f~~~~~~~~p~~~~~~~~~~~~~~~~C~~~Cl~---~CsC~a~~~~~~~~~~~~~C~~~~~~l-~~~~~~~~~g 416 (837)
|...++|+++.+|++|++.. +++++|++.|++ ||||+||+|.+ .+.+|.+|.++| .+++.+...|
T Consensus 5 ~~~~g~fl~~~~~klpd~~~-------~s~~eC~~~Cl~~~~nCsC~Aya~~~----~~~gC~~W~~~l~~d~~~~~~~g 73 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA-------NTADECANRCEKNGLPFSCKAFVFAK----ARKQCLWFPFNSMSGVRKEFSHG 73 (80)
T ss_pred eecCCeEEEeecccCCcccc-------cCHHHHHHHHhcCCCCCCceeeeccC----CCCCeEEecCcchhhHHhccCCC
Confidence 55668899999999998764 589999999999 99999999964 235899999999 9999988889
Q ss_pred cceeee
Q 003237 417 QDLFVR 422 (837)
Q Consensus 417 ~~~ylr 422 (837)
.++|+|
T Consensus 74 ~~Ly~r 79 (80)
T cd00129 74 FDLYEN 79 (80)
T ss_pred ceeEeE
Confidence 999997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.9e-12 Score=132.30 Aligned_cols=202 Identities=19% Similarity=0.238 Sum_probs=137.7
Q ss_pred HHHHHhcCCCeeeeecccccCC-----ccEEEEEecCCCChhhHhhhcCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCC
Q 003237 576 LLIAKLQHRNLVKLLGCCLEED-----ENMLIYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRL 649 (837)
Q Consensus 576 ~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 649 (837)
.-|-++.|.|||++..|+.+.. ...++.|||..|+|..+|.+... ...+......+++.||..||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 3455567999999999987643 45799999999999999976433 334666667789999999999999976 6
Q ss_pred ceeeCCCCCCcEEEcCCCCeeecccccceeccCc---cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHH
Q 003237 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGE---EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEII 726 (837)
Q Consensus 650 ~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~---~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ell 726 (837)
+|+|+++.-+-|++..++-+||.--.- ...... ..........+-++|.|||+=.....+.++|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 799999999999999998888743211 111100 0011122345678999999877777888999999999999998
Q ss_pred hCCCCCCCCCC-CCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 727 TGKKNTRIFND-DDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 727 tG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+..-...... ...+.-+ ..+...+...+. ...+..|++.+|..||+|.+++.
T Consensus 277 ilEiq~tnseS~~~~ee~i---------a~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENI---------ANVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhhhh---------hhheeeccCccc-----------cCcCcccccCCCCCCcchhhhhc
Confidence 87653211100 0000000 000001111111 24566899999999999999864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.4e-11 Score=119.59 Aligned_cols=130 Identities=21% Similarity=0.165 Sum_probs=98.4
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCee-eeecccccCCccEEEEEecCCCChh
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV-KLLGCCLEEDENMLIYEFMPNKSLD 612 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey~~~gsL~ 612 (837)
+.|+.|.++.||+++.. +..+++|....... ....+..|++++..+.+.+++ +++.+ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 57899999999999875 78899998754432 223567899999999766655 34443 234568999999998875
Q ss_pred hHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcC--CCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS--RLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 613 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
... .....++.+++++|..||... +..++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 011235788999999999976 33479999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=1e-11 Score=106.87 Aligned_cols=73 Identities=44% Similarity=0.899 Sum_probs=61.9
Q ss_pred ccEEEEecccCCCCccccccccccCHHHHHHHhhhcCcceeeecccccccCCeeeEEeccCccccccccccCcceeeech
Q 003237 345 EGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGDLNDTRKYTNAGQDLFVRAN 424 (837)
Q Consensus 345 ~~f~~~~~~~~p~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~~C~~~~~~l~~~~~~~~~g~~~ylr~~ 424 (837)
+.|+++.++++|+.... . .+.++++|++.||+||+|+||+|.+ ++++|++|.+++.+.+.....+..+|||++
T Consensus 12 ~~f~~~~~~~~~~~~~~--~-~~~s~~~C~~~Cl~nCsC~a~~~~~----~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 12 DGFLKLPDVKLPDNASA--I-TAISLEECREACLSNCSCTAYAYNN----GSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CEEEEeCCeeCCCchhh--h-ccCCHHHHHHHHhcCCCcceeeecC----CCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 68999999999987653 2 6789999999999999999999864 367999999999887765555678999974
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.8e-11 Score=136.08 Aligned_cols=248 Identities=21% Similarity=0.297 Sum_probs=174.1
Q ss_pred CCCcCCcccc--cCCeeEEEEEe---cCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccE
Q 003237 529 NFSTSNKLGQ--GGFGPVYKGKL---SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 529 ~~~~~~~LG~--G~fG~Vy~~~~---~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 600 (837)
.|...+.+|. |.+|.||.+.. .++..+|+|+-+.. .++....=.+|+....+++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556788999 99999999977 36788999984322 2222223346777777775 999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHH----HHHHHHhcCCCceeeCCCCCCcEEEcCC-CCeeecccc
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR----GVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFG 675 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~DFG 675 (837)
+-+|++. .+|..+.+... ..++-.....+..+..+ ||.++|... |+|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999987 67777765432 23445555666677777 999999988 9999999999999999 889999999
Q ss_pred cceeccCccceee---eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc
Q 003237 676 TARVFGGEEILAI---TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS 752 (837)
Q Consensus 676 la~~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 752 (837)
+...++....... ..+..+...|++||. ..+.++.+.|+|++|.+.+|..++-......-... |...+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCCC--------ccccc
Confidence 9998876543221 233467889999995 45678999999999999999998876543211000 00000
Q ss_pred cCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 753 DNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 753 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... + ..++-..-..++..+...+++.+|-.|++.+.+..
T Consensus 340 ~~~---i-----p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGY---I-----PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc---C-----chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 0 01111111123444778899999999998877653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.3e-11 Score=137.63 Aligned_cols=147 Identities=18% Similarity=0.187 Sum_probs=92.0
Q ss_pred cCCCcCCcccccCCeeEEEEEecC-CcEEEEEEecCCCccC----------------------------------HHH--
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQG----------------------------------IEE-- 570 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~----------------------------------~~~-- 570 (837)
..|+. +.||.|++|.||+|++++ |+.||||+++...... .+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 799999999999999987 9999999997542110 011
Q ss_pred ----HHHHHHHHHHhc----CCCeeeeeccccc-CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHH-HH
Q 003237 571 ----LKNEVLLIAKLQ----HRNLVKLLGCCLE-EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR-GV 640 (837)
Q Consensus 571 ----~~~E~~~l~~l~----H~nIv~l~~~~~~-~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL 640 (837)
+.+|+.-+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+...-.... .+ +..++...++ -+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d---~~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TD---MKLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CC---HHHHHHHHHHHHH
Confidence 233444444432 2232332222222 34678999999999997642111111 11 1122222222 12
Q ss_pred HHHHhcCCCceeeCCCCCCcEEEcCCC----CeeecccccceeccCc
Q 003237 641 LYLHQDSRLRIIHRDLKASNILLDEKM----NPRISDFGTARVFGGE 683 (837)
Q Consensus 641 ~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~ki~DFGla~~~~~~ 683 (837)
..++..+ ++|+|+||.||+++.++ .+++.|||+...+...
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 2334444 99999999999999888 9999999999877543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.3e-09 Score=112.14 Aligned_cols=142 Identities=17% Similarity=0.246 Sum_probs=109.7
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhcC--CCeeeeecccccCC---ccEEEEEecC
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQH--RNLVKLLGCCLEED---ENMLIYEFMP 607 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~---~~~lV~ey~~ 607 (837)
+.|+.|..+.||+++..+|..+++|....... .....+..|++++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887778999999765432 245678899999999976 34567777766543 5689999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS---------------------------------------- 647 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 647 (837)
+.++...+.. ..++...+..++.++++.|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765421 23566677778888888888888531
Q ss_pred -------------CCceeeCCCCCCcEEEcC--CCCeeeccccccee
Q 003237 648 -------------RLRIIHRDLKASNILLDE--KMNPRISDFGTARV 679 (837)
Q Consensus 648 -------------~~~ivH~Dlkp~NIll~~--~~~~ki~DFGla~~ 679 (837)
+..++|+|++|.||+++. +..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.6e-10 Score=125.84 Aligned_cols=246 Identities=20% Similarity=0.182 Sum_probs=172.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEec--CCcEEEEEEecCCCccCHHHH--HHHHHHHHHh-cCCCeeeeecccccCCccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS--NGQEIAVKRLSTTSGQGIEEL--KNEVLLIAKL-QHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~~~~~~~~--~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 601 (837)
+.+|.....||.|.|+.|++...+ ++..+++|.+.+.......++ ..|+-+...+ .|.++++....+..-.+.++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888899999999999998654 577889998866543332222 3466666666 49999999888888888889
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC-CCeeecccccceec
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARVF 680 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~DFGla~~~ 680 (837)
--||++++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 99999999987776 22345777888899999999999999887 9999999999999886 88899999998642
Q ss_pred cCccceeeeccccccCCcc--CcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 681 GGEEILAITKRVVGTYGYM--SPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~--APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
.-... .....-+++ +|+......+-.+.|++|||.-+.|.+++..-..... .|. .+..
T Consensus 418 ~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~-------~i~~ 477 (524)
T KOG0601|consen 418 AFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL-------TIRS 477 (524)
T ss_pred ceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce-------eeec
Confidence 21110 112222333 5666667788999999999999999999875432100 000 0000
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
-.-+.+.+ ....+..+...++..++..||.+.+...+.+-
T Consensus 478 ~~~p~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 478 GDTPNLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ccccCCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 00111111 11333445556788999999999888776653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.2e-09 Score=104.14 Aligned_cols=136 Identities=15% Similarity=0.146 Sum_probs=97.1
Q ss_pred CcccccCCeeEEEEEecC-------CcEEEEEEecCCC------------c---------cC-HHHHH----HHHHHHHH
Q 003237 534 NKLGQGGFGPVYKGKLSN-------GQEIAVKRLSTTS------------G---------QG-IEELK----NEVLLIAK 580 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~------------~---------~~-~~~~~----~E~~~l~~ 580 (837)
..||.|.-+.||.|.-.+ +..+|||..+... . .. .+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997543 4789999764210 0 00 12233 79999999
Q ss_pred hcC--CCeeeeecccccCCccEEEEEecCCCChhhH-hhhcCCCCCCChhhHHHHHHHHHHHHHHH-HhcCCCceeeCCC
Q 003237 581 LQH--RNLVKLLGCCLEEDENMLIYEFMPNKSLDYF-IFDESRKQLLDWKKRFDIILGIARGVLYL-HQDSRLRIIHRDL 656 (837)
Q Consensus 581 l~H--~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dl 656 (837)
+.. -++.+++++ ...+|||||+.+..+... +.+ ..++......+..+++.+|..| |..+ |||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 863 455566654 567899999987644222 211 1234445567789999999999 6766 999999
Q ss_pred CCCcEEEcCCCCeeecccccceecc
Q 003237 657 KASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 657 kp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
++.|||++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4679999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.4e-09 Score=100.86 Aligned_cols=131 Identities=23% Similarity=0.337 Sum_probs=102.4
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEE-ecCCCc--c-----CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKR-LSTTSG--Q-----GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~-l~~~~~--~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
..+++|+-+.+|.+.+. |.++++|. +++.-. . ..+...+|++++.+++--.|-..+-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999774 44455553 333211 1 123456899999999876666666667788889999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
+++..|.+.+... +..++..|-+-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888543 3567888888899999998 99999999999998775 99999999874
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.1e-08 Score=114.94 Aligned_cols=166 Identities=17% Similarity=0.230 Sum_probs=121.6
Q ss_pred ecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhh
Q 003237 549 LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKK 628 (837)
Q Consensus 549 ~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~ 628 (837)
..++.+|.|...+.......+...+-++.|+.++||||++++..+..+...|||+|-+.- |...+.+.. -..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l~------~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKELG------KEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHhH------HHH
Confidence 346888988888665554445677889999999999999999999999999999997633 334443221 223
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCC
Q 003237 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV 708 (837)
Q Consensus 629 ~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 708 (837)
..-.+.||+.||.|||+.+ .++|++|.-..|++++.|+-||++|.++.....-.. ..+....-..|..|+.+-...
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 3346789999999999776 499999999999999999999999998765332111 111122233466666432211
Q ss_pred CCCcccHHHHHHHHHHHHhC
Q 003237 709 FSTKSDVFSFGVILLEIITG 728 (837)
Q Consensus 709 ~s~k~DV~S~Gvvl~elltG 728 (837)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.2e-08 Score=97.20 Aligned_cols=142 Identities=25% Similarity=0.323 Sum_probs=106.5
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEE-ecCCC-------ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKR-LSTTS-------GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~-l~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
...|-+|+-+.|+++... |+...||. ..+.. .-..+..++|++++.+++--.|.-..-++.+.....|+||
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 468899999999999885 67666663 33321 1134567789999999986666555556677888899999
Q ss_pred ecCC-CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC---Ceeeccccccee
Q 003237 605 FMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM---NPRISDFGTARV 679 (837)
Q Consensus 605 y~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ki~DFGla~~ 679 (837)
|+++ .++.+++......+..+ .....++..|-+.+.-||..+ |||+||..+||+|..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 57888886544333222 222678899999999999998 99999999999997554 458999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.3e-08 Score=106.19 Aligned_cols=169 Identities=22% Similarity=0.322 Sum_probs=128.8
Q ss_pred CeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeeccccc----CCccEEEEEecCC-CChhhH
Q 003237 541 FGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENMLIYEFMPN-KSLDYF 614 (837)
Q Consensus 541 fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ey~~~-gsL~~~ 614 (837)
-.+.||+... +|..+++|+++-...+.......-+++.+++.|.|||++..++.. +...+|||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4578999765 899999999954433333333456888999999999999998873 3457899999986 567665
Q ss_pred hhhcC------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 615 IFDES------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 615 l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
-+... ......+...+.++.|+..||.++|+.| +.-+-|.|++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 1223567888999999999999999998 77799999999999999999999998877654
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCC
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKN 731 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p 731 (837)
+.... +. --.+-|.=.||.+++.|.||...
T Consensus 446 d~~~~----------------le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTEP----------------LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCcc----------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 43111 11 12367999999999999999754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.7e-07 Score=92.94 Aligned_cols=126 Identities=26% Similarity=0.341 Sum_probs=82.4
Q ss_pred eEEEEEecCCcEEEEEEecCCC--------------c-------c-----CHHHHHHHHHHHHHhcCC--Ceeeeecccc
Q 003237 543 PVYKGKLSNGQEIAVKRLSTTS--------------G-------Q-----GIEELKNEVLLIAKLQHR--NLVKLLGCCL 594 (837)
Q Consensus 543 ~Vy~~~~~~g~~vavK~l~~~~--------------~-------~-----~~~~~~~E~~~l~~l~H~--nIv~l~~~~~ 594 (837)
.||.|...+|..+|||..+... . . .....++|.+.|.++... ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999899999999764321 0 0 012456799999999765 45556544
Q ss_pred cCCccEEEEEecC--CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHH-HhcCCCceeeCCCCCCcEEEcCCCCeee
Q 003237 595 EEDENMLIYEFMP--NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL-HQDSRLRIIHRDLKASNILLDEKMNPRI 671 (837)
Q Consensus 595 ~~~~~~lV~ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlkp~NIll~~~~~~ki 671 (837)
...+|||||++ +..+..+. +.. ++......++.+++..+..+ |..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 35689999999 54454332 211 11334556778888866664 6666 9999999999999988 9999
Q ss_pred cccccceecc
Q 003237 672 SDFGTARVFG 681 (837)
Q Consensus 672 ~DFGla~~~~ 681 (837)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.4e-09 Score=121.61 Aligned_cols=204 Identities=20% Similarity=0.259 Sum_probs=143.7
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
..+.+.+.+-+-+|.++.++.+.-. .|...++|..... .....+....+-.++-..+||-+++...-+.-.....|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456777788899999999987543 2333333332211 11122233333333333456777766655556677899
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|++|..+++|...|+... .++.......+..+..+++|||... +.|+|++|.|++...++..+++|||.....+
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999998887654 2333333445566788999999876 8999999999999999999999998433221
Q ss_pred Cc-------------------------cce----eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 003237 682 GE-------------------------EIL----AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNT 732 (837)
Q Consensus 682 ~~-------------------------~~~----~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~ 732 (837)
.. ... .......+|+.|.|||...+......+|.|++|++++|.++|..|+
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 000 1122467899999999999999999999999999999999999998
Q ss_pred CCC
Q 003237 733 RIF 735 (837)
Q Consensus 733 ~~~ 735 (837)
...
T Consensus 1036 na~ 1038 (1205)
T KOG0606|consen 1036 NAE 1038 (1205)
T ss_pred CCc
Confidence 643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.6e-07 Score=97.21 Aligned_cols=141 Identities=18% Similarity=0.132 Sum_probs=99.6
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEEecCCCc-----------cCHHHHHHHHHHHHHhcCCCe--eeeeccccc-----
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG-----------QGIEELKNEVLLIAKLQHRNL--VKLLGCCLE----- 595 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~----- 595 (837)
+.+-+-....|.+..+ +|+.+.||+...... .....+.+|.+.+.++...+| .+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777766 578899997643221 111247789999999864333 344555433
Q ss_pred CCccEEEEEecCCC-ChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC-------CC
Q 003237 596 EDENMLIYEFMPNK-SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-------KM 667 (837)
Q Consensus 596 ~~~~~lV~ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-------~~ 667 (837)
....+||+|++++. +|.+++.+-. ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23468999999986 8888874321 123445667789999999999999998 999999999999975 56
Q ss_pred Ceeeccccccee
Q 003237 668 NPRISDFGTARV 679 (837)
Q Consensus 668 ~~ki~DFGla~~ 679 (837)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=8.1e-07 Score=101.16 Aligned_cols=146 Identities=17% Similarity=0.225 Sum_probs=96.8
Q ss_pred CCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCH------------------------------H---------
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGI------------------------------E--------- 569 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~------------------------------~--------- 569 (837)
.|+ .+.|+.++-|.||+|++++|+.||||+.+..-.... +
T Consensus 127 eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 444 368999999999999999999999998865421110 1
Q ss_pred -HHHHHHHHHHHhc-----CCCeeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHH-HHH
Q 003237 570 -ELKNEVLLIAKLQ-----HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG-VLY 642 (837)
Q Consensus 570 -~~~~E~~~l~~l~-----H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-L~y 642 (837)
.+.+|..-+.+++ .++|.-..-++.-.....|+|||++|-.+.+...-.. ...+- ..++..++++ +..
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~f~~q 280 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRAFLRQ 280 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHHHHHH
Confidence 1234555454442 3444333333444567899999999999888853222 12332 2344443333 222
Q ss_pred HHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 643 LH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
+-..+ ++|.|.+|.||+++.++.+.+.|||+...+...
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 22234 999999999999999999999999998876543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=6.8e-06 Score=87.78 Aligned_cols=194 Identities=13% Similarity=0.169 Sum_probs=126.7
Q ss_pred CcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeeccc------ccCC-ccEEE
Q 003237 531 STSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCC------LEED-ENMLI 602 (837)
Q Consensus 531 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~------~~~~-~~~lV 602 (837)
...+.||+|+-+.+|-.- +-..-+.|+..........+ .+..|... .||-+-.=+.+= -++. ..-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 346789999999999642 11122446665543332222 22233333 466433311111 1122 24577
Q ss_pred EEecCCCC-hhhHhhh---cCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 603 YEFMPNKS-LDYFIFD---ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 603 ~ey~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
|+.+++.. +..+... ...-+..+|...++.++.+|.+.+-||..+ .+-+|+.++|+|+.+++.+.+.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 77776642 2222221 222345789999999999999999999998 8899999999999999999998866555
Q ss_pred eccCccceeeeccccccCCccCcccccCC-----CCCCcccHHHHHHHHHHHHhC-CCCCCCC
Q 003237 679 VFGGEEILAITKRVVGTYGYMSPEYALDG-----VFSTKSDVFSFGVILLEIITG-KKNTRIF 735 (837)
Q Consensus 679 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~k~DV~S~Gvvl~elltG-~~p~~~~ 735 (837)
+..++.. ..-..|...|.+||.-.-+ .-+...|-|-+||++++++.| ++||...
T Consensus 166 i~~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 INANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eccCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 4422211 1124678899999965522 346789999999999999886 9998754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.8e-06 Score=88.12 Aligned_cols=136 Identities=21% Similarity=0.222 Sum_probs=95.5
Q ss_pred CCcCCcccccCCeeEEEEEecCCcEEEEEEecCCC----------------------ccCHHHHHHHHHHHHHhcCC--C
Q 003237 530 FSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS----------------------GQGIEELKNEVLLIAKLQHR--N 585 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----------------------~~~~~~~~~E~~~l~~l~H~--n 585 (837)
..++++||-|.-+.||.|..+.|.++|||.=+... .......++|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 44568999999999999999999999999532110 00123456799999998644 5
Q ss_pred eeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC
Q 003237 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE 665 (837)
Q Consensus 586 Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~ 665 (837)
|.+.+++ +...+||||+++-.|...- ++-...-.++..|+.-+.-+-..+ |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 5555543 4668999999997664332 122222234444444444444555 999999999999999
Q ss_pred CCCeeecccccceec
Q 003237 666 KMNPRISDFGTARVF 680 (837)
Q Consensus 666 ~~~~ki~DFGla~~~ 680 (837)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999876543
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.8e-06 Score=78.81 Aligned_cols=87 Identities=29% Similarity=0.472 Sum_probs=60.7
Q ss_pred EEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCcccccccCCCc
Q 003237 90 SVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLN 169 (837)
Q Consensus 90 ~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~tg~~ 169 (837)
.+..||+||+..... ..++|++|..........+.|.++|||||++ ..+.++|+| +|-
T Consensus 25 ~~q~dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~-~~g~~vW~S-----~t~--------------- 82 (114)
T smart00108 25 IMQNDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYD-GDGRVVWSS-----NTT--------------- 82 (114)
T ss_pred CCCCCEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEe-CCCCEEEEe-----ccc---------------
Confidence 345789999985332 5789999975443344678999999999984 457889987 110
Q ss_pred ceeeecCCCCCCCCcceEEEecCCCCCcceeec-CCeeEEecC
Q 003237 170 RYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYK-DDVKLWRAG 211 (837)
Q Consensus 170 ~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~-~~~~yw~sg 211 (837)
...|.+.+.|+.+|.. +++. ...+.|.|.
T Consensus 83 -----------~~~~~~~~~L~ddGnl--vl~~~~~~~~W~Sf 112 (114)
T smart00108 83 -----------GANGNYVLVLLDDGNL--VIYDSDGNFLWQSF 112 (114)
T ss_pred -----------CCCCceEEEEeCCCCE--EEECCCCCEEeCCC
Confidence 1345688999999984 4554 345778764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.5e-06 Score=85.69 Aligned_cols=107 Identities=24% Similarity=0.281 Sum_probs=83.3
Q ss_pred CHHHHHHHHHHHHHhcC--CCeeeeecccccCC----ccEEEEEecCCC-ChhhHhhhcCCCCCCChhhHHHHHHHHHHH
Q 003237 567 GIEELKNEVLLIAKLQH--RNLVKLLGCCLEED----ENMLIYEFMPNK-SLDYFIFDESRKQLLDWKKRFDIILGIARG 639 (837)
Q Consensus 567 ~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~----~~~lV~ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 639 (837)
......+|...+..+.. -.+.+.+++..... ..+||+|++++. +|.+++.+... ++...+..++.++++.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARL 130 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHH
Confidence 34567789998888863 33455666655432 347999999984 79888865322 4555677899999999
Q ss_pred HHHHHhcCCCceeeCCCCCCcEEEcCCC---Ceeeccccccee
Q 003237 640 VLYLHQDSRLRIIHRDLKASNILLDEKM---NPRISDFGTARV 679 (837)
Q Consensus 640 L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ki~DFGla~~ 679 (837)
+.-||..+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999998 99999999999999887 899999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.8e-06 Score=76.94 Aligned_cols=86 Identities=28% Similarity=0.451 Sum_probs=60.5
Q ss_pred Eee-ccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCcccccccCCCc
Q 003237 91 VNI-QGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLN 169 (837)
Q Consensus 91 ~~~-~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~tg~~ 169 (837)
... ||+||+..... ..++|++|..........+.|.++|||||+ +.++.++|+|=-
T Consensus 26 ~q~~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~-~~~g~~vW~S~~--------------------- 82 (116)
T cd00028 26 MQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIY-DGSGTVVWSSNT--------------------- 82 (116)
T ss_pred CCCCeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEE-cCCCcEEEEecc---------------------
Confidence 344 89999985322 578999997543345567899999999998 456789998720
Q ss_pred ceeeecCCCCCCCCcceEEEecCCCCCcceeecC-CeeEEecC
Q 003237 170 RYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKD-DVKLWRAG 211 (837)
Q Consensus 170 ~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~-~~~yw~sg 211 (837)
..+.+.+.+.|+.+|. +++++. ..+.|.|.
T Consensus 83 ----------~~~~~~~~~~L~ddGn--lvl~~~~~~~~W~Sf 113 (116)
T cd00028 83 ----------TRVNGNYVLVLLDDGN--LVLYDSDGNFLWQSF 113 (116)
T ss_pred ----------cCCCCceEEEEeCCCC--EEEECCCCCEEEcCC
Confidence 0024678899999998 455543 45678765
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.8e-07 Score=103.32 Aligned_cols=152 Identities=16% Similarity=0.308 Sum_probs=98.7
Q ss_pred HHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee-------eeccccccCCccCccccc
Q 003237 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA-------ITKRVVGTYGYMSPEYAL 705 (837)
Q Consensus 633 ~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~-------~~~~~~gt~~y~APE~~~ 705 (837)
+.+++.||.|+|... .+||++|.|++|.+++.+..||+.|+.+.......... ...-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999865 69999999999999999999999999876554311100 011123455899999999
Q ss_pred CCCCCCcccHHHHHHHHHHHHhCCCC-CCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcc
Q 003237 706 DGVFSTKSDVFSFGVILLEIITGKKN-TRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCV 784 (837)
Q Consensus 706 ~~~~s~k~DV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl 784 (837)
+..-+.++|+||+|+++|-+..|..+ +...... ..+...... .+... ......-..++.+=+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~~~~~-------~~~~~-~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSFSRNL-------LNAGA-FGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhhhhcc-------ccccc-ccccccCcHHHHHHHHHHh
Confidence 98889999999999999999954443 3322111 111111100 00000 0011222234555556678
Q ss_pred cCCCCCCCCHHHHHH
Q 003237 785 QDRTTDRPSMSTVVF 799 (837)
Q Consensus 785 ~~~P~~RPtm~eVv~ 799 (837)
..++.-||+|.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 899999998877753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.1e-05 Score=81.19 Aligned_cols=139 Identities=17% Similarity=0.190 Sum_probs=85.5
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCC--eeeeecccccCCccEEEEEecCCCC-
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN--LVKLLGCCLEEDENMLIYEFMPNKS- 610 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~ey~~~gs- 610 (837)
.+||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 58999999999984 25567788875432 3456789999999987443 3566777766777789999999974
Q ss_pred hhhHh---------------------hhcCCCCCCChhhHHHHH-H----------HHHH-HHHHHHhc-CCCceeeCCC
Q 003237 611 LDYFI---------------------FDESRKQLLDWKKRFDII-L----------GIAR-GVLYLHQD-SRLRIIHRDL 656 (837)
Q Consensus 611 L~~~l---------------------~~~~~~~~l~~~~~~~i~-~----------~ia~-gL~yLH~~-~~~~ivH~Dl 656 (837)
+...+ |.-.. .......+..-. . .+.+ ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 11000 001111100000 0 0111 12222211 2335789999
Q ss_pred CCCcEEEcCCCCeeeccccccee
Q 003237 657 KASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 657 kp~NIll~~~~~~ki~DFGla~~ 679 (837)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.2e-06 Score=70.45 Aligned_cols=73 Identities=34% Similarity=0.718 Sum_probs=56.0
Q ss_pred CccEEEEecccCCCCccccccccccCHHHHHHHhhh-cCcceeeecccccccCCeeeEEec-cCccccccccccCcceee
Q 003237 344 GEGFIKLERMKLPDTSVAANVDMNLGLKACEEKCLS-NCSCVAYASASAETNRGIGCLMYH-GDLNDTRKYTNAGQDLFV 421 (837)
Q Consensus 344 ~~~f~~~~~~~~p~~~~~~~~~~~~~~~~C~~~Cl~-~CsC~a~~~~~~~~~~~~~C~~~~-~~l~~~~~~~~~g~~~yl 421 (837)
...|++++++.+++.... .....++++|++.|++ +|+|.||.|.. ++.+|.+|. +.+.+.......+.++|.
T Consensus 3 ~~~f~~~~~~~l~~~~~~--~~~~~s~~~C~~~C~~~~~~C~s~~y~~----~~~~C~l~~~~~~~~~~~~~~~~~~~y~ 76 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRI--VISVASLEECASKCLNSNCSCRSFTYNN----GTKGCLLWSESSLGDARLFPSGGVDLYE 76 (78)
T ss_pred CceeEEecCccCCCCcce--eEcCCCHHHHHHHhCCCCCceEEEEEcC----CCCEEEEeeCCccccceecccCCceeEE
Confidence 356999999999965432 2356799999999999 99999999953 457999999 777777644555556665
Q ss_pred e
Q 003237 422 R 422 (837)
Q Consensus 422 r 422 (837)
|
T Consensus 77 ~ 77 (78)
T smart00473 77 K 77 (78)
T ss_pred e
Confidence 4
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.6e-05 Score=76.27 Aligned_cols=138 Identities=17% Similarity=0.158 Sum_probs=102.3
Q ss_pred ccccCCeeEEEEEecCCcEEEEEEecCC------CccCHHHHHHHHHHHHHhcCC--Ceeeeecccc-cC----CccEEE
Q 003237 536 LGQGGFGPVYKGKLSNGQEIAVKRLSTT------SGQGIEELKNEVLLIAKLQHR--NLVKLLGCCL-EE----DENMLI 602 (837)
Q Consensus 536 LG~G~fG~Vy~~~~~~g~~vavK~l~~~------~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~-~~----~~~~lV 602 (837)
-|+|+-+-|++-.+. |..+-+|+-... .+.+...|.+|...|.++... .+.+++ ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467888999998775 457899986421 144677899999999999643 344444 332 21 124799
Q ss_pred EEecCC-CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC--eeeccccccee
Q 003237 603 YEFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN--PRISDFGTARV 679 (837)
Q Consensus 603 ~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~ki~DFGla~~ 679 (837)
+|-+++ .+|.+++.+... ...+...+..++.+|++.+.-||..+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 588888744322 23566777889999999999999998 999999999999986666 99999987664
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.6e-05 Score=79.26 Aligned_cols=105 Identities=23% Similarity=0.243 Sum_probs=84.4
Q ss_pred HHHHHHHHHhcC-CCeeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCc
Q 003237 572 KNEVLLIAKLQH-RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650 (837)
Q Consensus 572 ~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 650 (837)
..|..+++.+++ +++.+++|+| ..++|.||.+.+++...-.....--..+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358889999986 6999999999 56899999998766422000011113589999999999999999999876666
Q ss_pred eeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 651 IIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 651 ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+...|++|+|+-+++++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.8e-05 Score=87.30 Aligned_cols=143 Identities=17% Similarity=0.220 Sum_probs=89.5
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCccC---------------------------HH----------HHHHHH
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQG---------------------------IE----------ELKNEV 575 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~---------------------------~~----------~~~~E~ 575 (837)
.+.||.-+.|.||+|++++|+.||||+-+..-... .+ .|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36899999999999999999999999875442211 00 133344
Q ss_pred HHHHHh----cCCCeee---eeccc-ccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcC
Q 003237 576 LLIAKL----QHRNLVK---LLGCC-LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647 (837)
Q Consensus 576 ~~l~~l----~H~nIv~---l~~~~-~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 647 (837)
+-..++ .|-++.. +=.++ .-...+.|+||||+|..+.+...-... .++-. +++..+.++... .--
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~---~i~~~l~~~~~~--qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPH---DILNKLVEAYLE--QIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHH---HHHHHHHHHHHH--HHH
Confidence 433333 3444111 11222 224578999999999988776432221 13333 344444443222 111
Q ss_pred CCceeeCCCCCCcEEEcC----CCCeeecccccceeccC
Q 003237 648 RLRIIHRDLKASNILLDE----KMNPRISDFGTARVFGG 682 (837)
Q Consensus 648 ~~~ivH~Dlkp~NIll~~----~~~~ki~DFGla~~~~~ 682 (837)
..+++|+|-+|.||+++. ++.+.+-|||+...+..
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 124999999999999983 67899999999886643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.1e-06 Score=98.31 Aligned_cols=186 Identities=18% Similarity=0.133 Sum_probs=133.2
Q ss_pred CCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCC-eeeeecccccCCccEEEEEecC
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN-LVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lV~ey~~ 607 (837)
.+...+-+++|++++++|.+-...+.+.++.+... ....-++++|.+++||| .++.++-+..++...++++++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 33344678899999999987544445556665332 44566899999999999 7788888888888899999998
Q ss_pred CC-ChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 608 NK-SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 608 ~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
.+ +-....... ...+...+...+.+.-++++++||+.- =+|+| ||+..+ ...|..||+....+.+..
T Consensus 318 ~~rs~~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 318 TGRSSALEMTVS--EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred CCccccccCChh--hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--
Confidence 87 211111000 001222233345556678899999853 48888 777766 678999999987765443
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNT 732 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~ 732 (837)
......+++.++|||+.....+..+.|+|+.|+-..++--|-.|-
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 234467899999999999999999999999999877877777664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.8e-05 Score=78.03 Aligned_cols=143 Identities=20% Similarity=0.215 Sum_probs=85.1
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCC--eeeeecccccC---CccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN--LVKLLGCCLEE---DENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~---~~~~lV~ey~~~ 608 (837)
+.|+.|..+.||+.+..+ ..+++|..... .....+..|..++..+.... +.+++.+.... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999877 69999997543 44567888999999886433 45666544322 235899999999
Q ss_pred CChhh----------------Hh---hhcC-CCCCCChhh---------HHHH------------HHHHHH-HHHHHHh-
Q 003237 609 KSLDY----------------FI---FDES-RKQLLDWKK---------RFDI------------ILGIAR-GVLYLHQ- 645 (837)
Q Consensus 609 gsL~~----------------~l---~~~~-~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~- 645 (837)
..+.. .+ +... ......+.. .... ...+.+ .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 98877 11 1110 101111110 0000 111222 2333332
Q ss_pred ---cCCCceeeCCCCCCcEEEc-CCCCeeeccccccee
Q 003237 646 ---DSRLRIIHRDLKASNILLD-EKMNPRISDFGTARV 679 (837)
Q Consensus 646 ---~~~~~ivH~Dlkp~NIll~-~~~~~ki~DFGla~~ 679 (837)
..+..++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 566668999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.89 E-value=5.9e-05 Score=75.74 Aligned_cols=137 Identities=15% Similarity=0.170 Sum_probs=89.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHH---------HHHHHHHHHhcCC---Ceeeeecccc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEEL---------KNEVLLIAKLQHR---NLVKLLGCCL 594 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~H~---nIv~l~~~~~ 594 (837)
.++|...+.+-......|.+-.. +|..+++|..+.......+.| .+++..+.+++.. ..+.++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 45666666777666666776666 478899998765433222222 2344545555322 2223222222
Q ss_pred -----cCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 595 -----EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 595 -----~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
-....+|+|||++|..|.++.. ++. .++..|++++.-||..+ ++|+|++|.|++++.++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 1234578999999988865531 111 25566778899999998 99999999999999654 9
Q ss_pred eeccccccee
Q 003237 670 RISDFGTARV 679 (837)
Q Consensus 670 ki~DFGla~~ 679 (837)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00012 Score=76.74 Aligned_cols=140 Identities=15% Similarity=0.152 Sum_probs=85.1
Q ss_pred cccccCC-eeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEecCCCChh
Q 003237 535 KLGQGGF-GPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612 (837)
Q Consensus 535 ~LG~G~f-G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 612 (837)
.|-.|.. ..||+.... +..+.||+..... ...+.+|++++..+. +--+.+++++...++..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4445555 789999765 4778888875432 345678999998885 444556777766666789999999998776
Q ss_pred hHh-------------------hhcCC-CCCCC--hhhHHHHHH--------------------HHHHHHHHHHh----c
Q 003237 613 YFI-------------------FDESR-KQLLD--WKKRFDIIL--------------------GIARGVLYLHQ----D 646 (837)
Q Consensus 613 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~ 646 (837)
... |.... ..... ...++.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11000 00000 001110000 01111122211 1
Q ss_pred CCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 647 ~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
..+.++|+|+.|.|||++++....|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23458999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00014 Score=73.71 Aligned_cols=151 Identities=20% Similarity=0.227 Sum_probs=94.7
Q ss_pred HHHHHHhhcCCCcCC---cccccCCeeEEEEEecCCcEEEEEEecCCCccC-------------------HH-----HHH
Q 003237 520 LSTLLAATDNFSTSN---KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQG-------------------IE-----ELK 572 (837)
Q Consensus 520 ~~~l~~at~~~~~~~---~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~-------------------~~-----~~~ 572 (837)
+..+.....+..+.. .|..|.-+.||+|.-.++..+|||+.+...... .+ -..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 344444444444444 456788889999988889999999885432111 11 123
Q ss_pred HHHHHHHHhc--CCCeeeeecccccCCccEEEEEecCCCCh-hhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCC
Q 003237 573 NEVLLIAKLQ--HRNLVKLLGCCLEEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649 (837)
Q Consensus 573 ~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 649 (837)
.|..-|.++. +-.+.+.+++. ...|||||+....+ .-.|.+. .+.......+..++++.+.-|-...
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 4566666653 33333444332 45799999976522 1111111 1222245556777778877776633
Q ss_pred ceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 650 ~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
++||+||..=|||+. ++.+.|+|+|.|....
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 399999999999999 8899999999887544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00036 Score=85.98 Aligned_cols=79 Identities=16% Similarity=0.386 Sum_probs=58.3
Q ss_pred CCcccccCCeeEEEEEecCC---cEEEEEEecCCC-ccCHHHHHHHHHHHHHhc-CCCe--eeeecccccC---CccEEE
Q 003237 533 SNKLGQGGFGPVYKGKLSNG---QEIAVKRLSTTS-GQGIEELKNEVLLIAKLQ-HRNL--VKLLGCCLEE---DENMLI 602 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nI--v~l~~~~~~~---~~~~lV 602 (837)
.++|+.|.+..+|+.+..++ ..+++|+..... ......+.+|++++..+. |.+| .+++.+|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 36789999999999887654 467777764332 223457889999999996 6665 7778887664 357899
Q ss_pred EEecCCCCh
Q 003237 603 YEFMPNKSL 611 (837)
Q Consensus 603 ~ey~~~gsL 611 (837)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00054 Score=62.33 Aligned_cols=100 Identities=26% Similarity=0.376 Sum_probs=66.2
Q ss_pred CeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEec-CCCCCCCCCCceEEEeeccceEEEecCCCcceeeeccc
Q 003237 36 DVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVA-NRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANI 114 (837)
Q Consensus 36 ~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~A-nr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~~Wst~~ 114 (837)
+.+.+.+|.+.|-|-..|+ |-|. +. ..+++|.. +...... ....+.|..||||||.+ ..+.++|++..
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~-~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d--~~~~~lW~Sf~ 80 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLY-DS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYD--SSGNVLWQSFD 80 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEE-ET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEE--TTSEEEEESTT
T ss_pred cccccccccccceECCCCe-----EEEE-cC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEe--ecceEEEeecC
Confidence 4566656999999988777 6664 32 25779999 4333322 45789999999999995 46789999842
Q ss_pred ccCCCCceEEEEec--CCCEEEEecCCCceeeecccCCc
Q 003237 115 SEASAGNTVAQLLD--TGNLVLVRNDTGETLWQSFDHPT 151 (837)
Q Consensus 115 ~~~~~~~~~a~lld--~GNlVl~~~~~~~~lWqSFd~Pt 151 (837)
....+...+++ .||++ + .....+.|.|=+.|+
T Consensus 81 ---~ptdt~L~~q~l~~~~~~-~-~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 ---YPTDTLLPGQKLGDGNVT-G-KNDSLTSWSSNTDPS 114 (114)
T ss_dssp ---SSS-EEEEEET--TSEEE-E-ESTSSEEEESS----
T ss_pred ---CCccEEEeccCcccCCCc-c-ccceEEeECCCCCCC
Confidence 22455677777 89998 5 334578898876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00052 Score=68.81 Aligned_cols=128 Identities=17% Similarity=0.270 Sum_probs=90.4
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCC----------------ccCHHHHHHHHHHHHHhc------CCCeeeee
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS----------------GQGIEELKNEVLLIAKLQ------HRNLVKLL 590 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~nIv~l~ 590 (837)
...||+|+.-.||. +++....+||++.... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999985 4556777888886554 223567777888777776 78899999
Q ss_pred cccccCCccEEEEEecCC------CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc
Q 003237 591 GCCLEEDENMLIYEFMPN------KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (837)
Q Consensus 591 ~~~~~~~~~~lV~ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 664 (837)
|+..+....-+|+|.+.+ .+|.+++.+. .++. . +...+-+-..||-.++ |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998743 2466666332 2343 2 3333334456666665 99999999999996
Q ss_pred CCC----Ceeecc
Q 003237 665 EKM----NPRISD 673 (837)
Q Consensus 665 ~~~----~~ki~D 673 (837)
... .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 332 456666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00035 Score=67.11 Aligned_cols=129 Identities=21% Similarity=0.279 Sum_probs=87.9
Q ss_pred cCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCCh
Q 003237 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 532 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
..+.|++|.+|.||+|.+. |..+|+|+-+.++ ....+..|+++|..++-.++-+=+..+ +..++.|||+.|-.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcch
Confidence 3578999999999999986 5588888865443 446788999999999866654322222 223455999999888
Q ss_pred hhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCC-CCcEEEcCCCCeeeccccccee
Q 003237 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK-ASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk-p~NIll~~~~~~ki~DFGla~~ 679 (837)
.+.-... + .+.+..+++.---|...+ |-|..|. |..++|..+..+.|+||..|..
T Consensus 100 ~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 6554211 1 123444555534444444 8899886 5555565666999999998873
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00057 Score=71.09 Aligned_cols=73 Identities=14% Similarity=0.266 Sum_probs=46.4
Q ss_pred CcccccCCe-eEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCC---CeeeeecccccCC---ccEEEEEec
Q 003237 534 NKLGQGGFG-PVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR---NLVKLLGCCLEED---ENMLIYEFM 606 (837)
Q Consensus 534 ~~LG~G~fG-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~~~~---~~~lV~ey~ 606 (837)
+.|+.|+.. .||+. +..+++|..+. ......+.+|++++..+... -+.++++.....+ ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777766 48875 24567776543 22345788999999888532 2334444433322 347899999
Q ss_pred CCCChh
Q 003237 607 PNKSLD 612 (837)
Q Consensus 607 ~~gsL~ 612 (837)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.001 Score=71.76 Aligned_cols=76 Identities=12% Similarity=0.108 Sum_probs=56.3
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcC---CCeeeeecccccC---CccEEEEEec
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH---RNLVKLLGCCLEE---DENMLIYEFM 606 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~~~~~~~---~~~~lV~ey~ 606 (837)
.+.||+|..+.||+....++ .+.+|..+. ......+..|.+.|+.+.- ..+.++++.|..+ +..+||||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 46899999999999987655 466676432 1123578899999998853 3677888777543 5579999999
Q ss_pred CCCCh
Q 003237 607 PNKSL 611 (837)
Q Consensus 607 ~~gsL 611 (837)
++.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00082 Score=66.82 Aligned_cols=125 Identities=25% Similarity=0.385 Sum_probs=89.8
Q ss_pred cCCCcCCcccccCC-eeEEEEEecCCcEEEEEEecC---CC--------c----------cCHHHHHHHHHHHHHhc---
Q 003237 528 DNFSTSNKLGQGGF-GPVYKGKLSNGQEIAVKRLST---TS--------G----------QGIEELKNEVLLIAKLQ--- 582 (837)
Q Consensus 528 ~~~~~~~~LG~G~f-G~Vy~~~~~~g~~vavK~l~~---~~--------~----------~~~~~~~~E~~~l~~l~--- 582 (837)
..++..+.||.|.- |.|||+++. |+.+|+|..+. .. . .....|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56777899999999 999999995 78999999321 00 0 11235778999999986
Q ss_pred CCCe--eeeecccccC------------------CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHH
Q 003237 583 HRNL--VKLLGCCLEE------------------DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642 (837)
Q Consensus 583 H~nI--v~l~~~~~~~------------------~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y 642 (837)
+.++ |+.+||..-. ..+.||.||++... ....+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 3456 8888886322 12357888776543 1122346677788889
Q ss_pred HHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 643 LH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999976 4588999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00068 Score=70.41 Aligned_cols=141 Identities=21% Similarity=0.266 Sum_probs=82.4
Q ss_pred CcccccCCeeEEEEEecC--CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCe-eeeecccccCCccEEEEEecCCCC
Q 003237 534 NKLGQGGFGPVYKGKLSN--GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-VKLLGCCLEEDENMLIYEFMPNKS 610 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ey~~~gs 610 (837)
+.|..|-...+|+....+ +..+++|........ .-...+|+.++..+...++ .++++.+. ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567888889999998764 678888876543222 1233578999998864344 34443322 248999999977
Q ss_pred hhhH-----------------hhhcCCC--------CCCC-hhhHHHHHH----------------------HHHHHHHH
Q 003237 611 LDYF-----------------IFDESRK--------QLLD-WKKRFDIIL----------------------GIARGVLY 642 (837)
Q Consensus 611 L~~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~gL~y 642 (837)
+... +|..... .... |.....+.. .+.+-+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 1111111 0111 211111110 11111111
Q ss_pred H----Hhc-CCCceeeCCCCCCcEEEcC-CCCeeeccccccee
Q 003237 643 L----HQD-SRLRIIHRDLKASNILLDE-KMNPRISDFGTARV 679 (837)
Q Consensus 643 L----H~~-~~~~ivH~Dlkp~NIll~~-~~~~ki~DFGla~~ 679 (837)
| ... .+..++|+|+.+.|||+++ +..+.++||..+..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1 111 2346999999999999998 57899999998753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0006 Score=71.91 Aligned_cols=139 Identities=17% Similarity=0.159 Sum_probs=79.8
Q ss_pred cccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCee-eeecccccCCccEEEEEecCCCChhh
Q 003237 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV-KLLGCCLEEDENMLIYEFMPNKSLDY 613 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey~~~gsL~~ 613 (837)
.+..|-...+|+.+. ++..+++|..........-...+|.+++..+....++ +++... ...+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 456788889999874 5678888876443222112357799999998644333 333332 2479999999876642
Q ss_pred H-----------------hhhcCC-CCCCChhhHH-HHHHH---------HHHHHHHHHhc-----CCCceeeCCCCCCc
Q 003237 614 F-----------------IFDESR-KQLLDWKKRF-DIILG---------IARGVLYLHQD-----SRLRIIHRDLKASN 660 (837)
Q Consensus 614 ~-----------------l~~~~~-~~~l~~~~~~-~i~~~---------ia~gL~yLH~~-----~~~~ivH~Dlkp~N 660 (837)
. ||.... ...++...++ ....+ +.+-+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111111 1112222111 11101 11112222111 12358999999999
Q ss_pred EEEcCCCCeeeccccccee
Q 003237 661 ILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 661 Ill~~~~~~ki~DFGla~~ 679 (837)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0023 Score=71.10 Aligned_cols=75 Identities=13% Similarity=0.222 Sum_probs=54.6
Q ss_pred CcccccCCeeEEEEEecCC-cEEEEEEecCC-----C--ccCHHHHHHHHHHHHHhc-C--CCeeeeecccccCCccEEE
Q 003237 534 NKLGQGGFGPVYKGKLSNG-QEIAVKRLSTT-----S--GQGIEELKNEVLLIAKLQ-H--RNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~lV 602 (837)
+.||.|.+..||+....+| +.++||.-... . +...+.+..|.+.|..+. + .++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998877 58999974311 1 234567778888888863 2 356666666 44668999
Q ss_pred EEecCCCC
Q 003237 603 YEFMPNKS 610 (837)
Q Consensus 603 ~ey~~~gs 610 (837)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.001 Score=71.70 Aligned_cols=143 Identities=17% Similarity=0.170 Sum_probs=88.2
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCC--eeeeeccc------ccCCccEEEEE
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN--LVKLLGCC------LEEDENMLIYE 604 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~------~~~~~~~lV~e 604 (837)
.+.|..|....+|+....+ ..+++|+... ...+++..|++++..+.+.+ +.+++... ...+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4577888888999987654 4788888754 23456778888888886433 44544321 12345579999
Q ss_pred ecCCCChhh----H----------hhhcCC--------CCCCChhhHH----------HHHHHHHHHHHHHHh----cCC
Q 003237 605 FMPNKSLDY----F----------IFDESR--------KQLLDWKKRF----------DIILGIARGVLYLHQ----DSR 648 (837)
Q Consensus 605 y~~~gsL~~----~----------l~~~~~--------~~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~ 648 (837)
|++|..+.. . +|.... .....|.... .....+.+.+.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 1 111100 0112332211 011123344555543 123
Q ss_pred CceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 649 LRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 649 ~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
..++|+|+.|.|||++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987788999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0024 Score=69.15 Aligned_cols=141 Identities=26% Similarity=0.336 Sum_probs=84.4
Q ss_pred CcccccCCeeEEEEEecC-------CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCee-eeecccccCCccEEEEEe
Q 003237 534 NKLGQGGFGPVYKGKLSN-------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV-KLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey 605 (837)
+.|..|-...+|+.+..+ ++.+++|+..... .......+|.+++..+....+. ++++++. ..+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456667777899988765 5788899875433 2334567898888888643333 4454443 2368999
Q ss_pred cCCCChhhH-----------------hhhcCCCC------CC--ChhhHHH--------------------------HHH
Q 003237 606 MPNKSLDYF-----------------IFDESRKQ------LL--DWKKRFD--------------------------IIL 634 (837)
Q Consensus 606 ~~~gsL~~~-----------------l~~~~~~~------~l--~~~~~~~--------------------------i~~ 634 (837)
++|..+... +|...... .. -|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 11111110 00 0111100 111
Q ss_pred HHHHHHHHHHh------cCCCceeeCCCCCCcEEEcCC----CCeeeccccccee
Q 003237 635 GIARGVLYLHQ------DSRLRIIHRDLKASNILLDEK----MNPRISDFGTARV 679 (837)
Q Consensus 635 ~ia~gL~yLH~------~~~~~ivH~Dlkp~NIll~~~----~~~ki~DFGla~~ 679 (837)
.+.+-+..|.. ..+..++|+|+.|.|||++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 244569999999999999985 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0028 Score=76.60 Aligned_cols=197 Identities=18% Similarity=0.177 Sum_probs=132.5
Q ss_pred HHHHHHHHHHHhcCCCeeeeecccccCCccE----EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHh
Q 003237 570 ELKNEVLLIAKLQHRNLVKLLGCCLEEDENM----LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645 (837)
Q Consensus 570 ~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~----lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 645 (837)
...-|++.+.++.|+|++.++.|-.+....- +..|++..-++...+... ...+....+.+..++.+||.|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHHH
Confidence 3445778888889999999998876654332 345777777776666432 346677777788999999999999
Q ss_pred cCCCceeeCCCCCC---cEEEcCCCCeeec--ccccceeccCccceeeeccccccCCccCcccccCCCCCCc--ccHHHH
Q 003237 646 DSRLRIIHRDLKAS---NILLDEKMNPRIS--DFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTK--SDVFSF 718 (837)
Q Consensus 646 ~~~~~ivH~Dlkp~---NIll~~~~~~ki~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k--~DV~S~ 718 (837)
.. ..|.-+..+ +...+.++...++ ||+.++....... ......+..+.|||......+..+ .|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHH
Confidence 75 555544444 4555666777777 9988876554322 112344567888888776665544 799999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003237 719 GVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798 (837)
Q Consensus 719 Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv 798 (837)
|..+..+..|..+..... .+..+++. ... . ........|...++++|+...+++
T Consensus 379 gll~~~~~~~~~i~~~~~------------------~~~~~l~~----~~~-~---~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA------------------VPVSLLDV----LST-S---ELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCccccccc------------------chhhhhcc----ccc-h---hhhhhhhhhcchhhhhccchhhhh
Confidence 999999999876532110 01111111 111 0 344566789999999999999998
Q ss_pred HHh
Q 003237 799 FML 801 (837)
Q Consensus 799 ~~L 801 (837)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.022 Score=62.20 Aligned_cols=143 Identities=17% Similarity=0.161 Sum_probs=79.7
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCC--eeeeecc------cccCCccEEEEE
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN--LVKLLGC------CLEEDENMLIYE 604 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~------~~~~~~~~lV~e 604 (837)
.+.|+.|....+|+.+..+| .+++|+... ...+.+..|+.++..|...+ +.+.+.. ....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677788889999987655 688888752 22344455666666664222 2333321 112345689999
Q ss_pred ecCCCChhh-----------H---hhhcCC--------CCCCCh-hhHHHH------------HHH-HHHHHHHHHhc--
Q 003237 605 FMPNKSLDY-----------F---IFDESR--------KQLLDW-KKRFDI------------ILG-IARGVLYLHQD-- 646 (837)
Q Consensus 605 y~~~gsL~~-----------~---l~~~~~--------~~~l~~-~~~~~i------------~~~-ia~gL~yLH~~-- 646 (837)
|++|..+.. . +|.... ...+.| .....- +.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999975421 1 111110 001112 221111 111 11122233211
Q ss_pred --CCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 647 --SRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 647 --~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
-+.+++|+|++|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 244699999999999999776668999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.034 Score=60.35 Aligned_cols=143 Identities=20% Similarity=0.196 Sum_probs=84.6
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCC--eeeeeccc------ccCCccEEEEE
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN--LVKLLGCC------LEEDENMLIYE 604 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~------~~~~~~~lV~e 604 (837)
.+.++.|.-..+|+....+| .+++|+.... ...+++..|++++..|.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677887889999876545 5778876442 12345667788888875322 34444322 12345689999
Q ss_pred ecCCCChhhH--------------hhhcCCC---------CCCChhhHHH------------HHHHHHHHHHHHHh----
Q 003237 605 FMPNKSLDYF--------------IFDESRK---------QLLDWKKRFD------------IILGIARGVLYLHQ---- 645 (837)
Q Consensus 605 y~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~~------------i~~~ia~gL~yLH~---- 645 (837)
|++|..+... +|..... ....|..... ....+.+.+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654210 1111000 0112221110 11123345555543
Q ss_pred cCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 646 ~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
..+..++|+|+++.||+++.+....|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234569999999999999998777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.014 Score=64.40 Aligned_cols=141 Identities=18% Similarity=0.250 Sum_probs=82.1
Q ss_pred CcccccCCeeEEEEEecC-----CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCee-eeecccccCCccEEEEEecC
Q 003237 534 NKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV-KLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey~~ 607 (837)
+.|-.|-.-.+|+....+ ++.+++|........... -.+|..++..+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 355567778899987542 367888887654433332 26799999988654444 455554322 5899998
Q ss_pred CCChhhH-----------------hhhcCC--CC-CCChhhHHHHHHH-----------------HHHHHHHH----Hh-
Q 003237 608 NKSLDYF-----------------IFDESR--KQ-LLDWKKRFDIILG-----------------IARGVLYL----HQ- 645 (837)
Q Consensus 608 ~gsL~~~-----------------l~~~~~--~~-~l~~~~~~~i~~~-----------------ia~gL~yL----H~- 645 (837)
+.+|... +|.... .. ..-|....++..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776422 111110 01 1112222222211 11112222 21
Q ss_pred cCCCceeeCCCCCCcEEEcC-CCCeeeccccccee
Q 003237 646 DSRLRIIHRDLKASNILLDE-KMNPRISDFGTARV 679 (837)
Q Consensus 646 ~~~~~ivH~Dlkp~NIll~~-~~~~ki~DFGla~~ 679 (837)
..+..++|+|+++.|||+++ +..+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 47899999998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.0048 Score=64.88 Aligned_cols=135 Identities=16% Similarity=0.163 Sum_probs=91.1
Q ss_pred CCCcCCcccccCCeeEEEEEecCCcEEEEEEecCC--------------------CccCH--HHHHHHHHHHHHhc-CCC
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--------------------SGQGI--EELKNEVLLIAKLQ-HRN 585 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--------------------~~~~~--~~~~~E~~~l~~l~-H~n 585 (837)
-+++.++||-|.-+.||.+-..+|++.++|.-+-. +...+ -...+|...|..+. |..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 46778999999999999999999999998842100 00011 12346888888885 322
Q ss_pred -eeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc
Q 003237 586 -LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (837)
Q Consensus 586 -Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 664 (837)
|.+.++ .+..++|||++.+-.|...- ...+..+. ...+..-+.-|..++ +||+|..--||+++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~l---y~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPTL---YDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeee------ecCChHHH---HHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 333333 34678999999887774432 12233333 333333455566666 99999999999999
Q ss_pred CCCCeeeccccccee
Q 003237 665 EKMNPRISDFGTARV 679 (837)
Q Consensus 665 ~~~~~ki~DFGla~~ 679 (837)
++..++++||--...
T Consensus 237 dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVS 251 (465)
T ss_pred cCCCEEEeechHhhc
Confidence 999999999975443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.029 Score=59.76 Aligned_cols=31 Identities=32% Similarity=0.578 Sum_probs=25.8
Q ss_pred CceeeCCCCCCcEEEcCCCC-eeeccccccee
Q 003237 649 LRIIHRDLKASNILLDEKMN-PRISDFGTARV 679 (837)
Q Consensus 649 ~~ivH~Dlkp~NIll~~~~~-~ki~DFGla~~ 679 (837)
..++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.0044 Score=51.39 Aligned_cols=50 Identities=12% Similarity=0.443 Sum_probs=36.4
Q ss_pred EecccCCCCccccccccccCHHHHHHHhhhcCcceeeecccccccCCeeeEEeccC
Q 003237 350 LERMKLPDTSVAANVDMNLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYHGD 405 (837)
Q Consensus 350 ~~~~~~p~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~~C~~~~~~ 405 (837)
+.++.++..+.. .. ...+.++|++.|+.+|+|.||.|.. +...|+++...
T Consensus 9 ~~~~~~~g~d~~-~~-~~~s~~~Cq~~C~~~~~C~afT~~~----~~~~C~lk~~~ 58 (73)
T cd01100 9 GSNVDFRGGDLS-TV-FASSAEQCQAACTADPGCLAFTYNT----KSKKCFLKSSE 58 (73)
T ss_pred cCCCccccCCcc-ee-ecCCHHHHHHHcCCCCCceEEEEEC----CCCeEEcccCC
Confidence 345666655443 22 2558999999999999999999963 34689888775
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.087 Score=56.70 Aligned_cols=145 Identities=16% Similarity=0.260 Sum_probs=83.6
Q ss_pred cccccCCeeEEEEEecCCcEEEEEEec-CCCccCHHHHHHHHHHHHHhcC--CCeeeeecccccCC--ccEEEEEecCCC
Q 003237 535 KLGQGGFGPVYKGKLSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQH--RNLVKLLGCCLEED--ENMLIYEFMPNK 609 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~~~~g~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~--~~~lV~ey~~~g 609 (837)
.+-.|.--.+|..... ++++++.+-. ...........+|.++|+.+.- .-+-+.++.|.++. ..+.||+|+++.
T Consensus 32 ~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 32 EISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred eccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 3333333344544443 7778887221 1223344566778888888753 23445667777776 569999999884
Q ss_pred ChhhHh----------h--------hc-----------------CCCCCCChhhHHHHHH--------HHHHHHHHHHhc
Q 003237 610 SLDYFI----------F--------DE-----------------SRKQLLDWKKRFDIIL--------GIARGVLYLHQD 646 (837)
Q Consensus 610 sL~~~l----------~--------~~-----------------~~~~~l~~~~~~~i~~--------~ia~gL~yLH~~ 646 (837)
.+...+ . .- ..++.-.|...+..+. ....-..+|+.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 322111 1 00 0011122222221111 122334555543
Q ss_pred -----CCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 647 -----SRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 647 -----~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
.+..++|+|+++.||+++.+.-+-|.||+++.+-
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2356999999999999998888999999998764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.059 Score=58.82 Aligned_cols=72 Identities=14% Similarity=0.235 Sum_probs=48.7
Q ss_pred cccccCCeeEEEEEecCC-cEEEEEEec----C---CCccCHHHHHHHHHHHHHhc--CCCee-eeecccccCCccEEEE
Q 003237 535 KLGQGGFGPVYKGKLSNG-QEIAVKRLS----T---TSGQGIEELKNEVLLIAKLQ--HRNLV-KLLGCCLEEDENMLIY 603 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~~~~g-~~vavK~l~----~---~~~~~~~~~~~E~~~l~~l~--H~nIv-~l~~~~~~~~~~~lV~ 603 (837)
.||.|....||++..++| +.|+||.-. . .-+...++..-|.+.|.... -|..| +++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998754 589999632 1 12334556667888887663 34334 44433 566678999
Q ss_pred EecCC
Q 003237 604 EFMPN 608 (837)
Q Consensus 604 ey~~~ 608 (837)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99965
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.041 Score=58.68 Aligned_cols=139 Identities=19% Similarity=0.254 Sum_probs=73.3
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc---CCCeeeeecccccCCccEEEEEecCCC
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEEDENMLIYEFMPNK 609 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~ey~~~g 609 (837)
.+.|+.|....+|+.+ .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 3578889999999988 568889999875 233456788988888884 345678888877777789999999877
Q ss_pred Ch--------hh---Hhhh-cCCC------------------CCCChhh-----HHHHHHH--------------HHHHH
Q 003237 610 SL--------DY---FIFD-ESRK------------------QLLDWKK-----RFDIILG--------------IARGV 640 (837)
Q Consensus 610 sL--------~~---~l~~-~~~~------------------~~l~~~~-----~~~i~~~--------------ia~gL 640 (837)
.. -. .||. .... -.-+|.+ |+....+ +.+.+
T Consensus 98 ~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~ 177 (288)
T PF03881_consen 98 SPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERL 177 (288)
T ss_dssp ---CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHH
Confidence 11 11 1232 1110 0123322 1111111 11111
Q ss_pred HH-HHhc-CCCceeeCCCCCCcEEEcCCCCeeecccc
Q 003237 641 LY-LHQD-SRLRIIHRDLKASNILLDEKMNPRISDFG 675 (837)
Q Consensus 641 ~y-LH~~-~~~~ivH~Dlkp~NIll~~~~~~ki~DFG 675 (837)
.. |+.. ..+.++|+||-+.|++.+.++.+.|.|=.
T Consensus 178 ~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 178 PSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 11 2222 24569999999999999999989998865
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.041 Score=60.77 Aligned_cols=74 Identities=15% Similarity=0.175 Sum_probs=50.9
Q ss_pred CCcccccCCeeEEEEEecC-CcEEEEEEec----C--CCccCHHHHHHHHHHHHHhc--CCCee-eeecccccCCccEEE
Q 003237 533 SNKLGQGGFGPVYKGKLSN-GQEIAVKRLS----T--TSGQGIEELKNEVLLIAKLQ--HRNLV-KLLGCCLEEDENMLI 602 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~----~--~~~~~~~~~~~E~~~l~~l~--H~nIv-~l~~~~~~~~~~~lV 602 (837)
.+.||.|.-..||++...+ ++.|+||.-. . .-+...++..-|.+.|+... -|..| +++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3588999999999999753 5689998532 1 12345667777888888764 35444 45433 56667889
Q ss_pred EEecCC
Q 003237 603 YEFMPN 608 (837)
Q Consensus 603 ~ey~~~ 608 (837)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.18 Score=56.15 Aligned_cols=73 Identities=11% Similarity=0.080 Sum_probs=50.7
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCC-----C--ccCHHHHHHHHHHHHHhc---CCCeeeeecccccCCccEEE
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT-----S--GQGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV 602 (837)
.+.||.|..-.||+.... +..++||+-... . +.....-..|++.|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 368899999999998864 567889975411 1 123444455677776664 246777888876 557889
Q ss_pred EEecCC
Q 003237 603 YEFMPN 608 (837)
Q Consensus 603 ~ey~~~ 608 (837)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.048 Score=55.58 Aligned_cols=30 Identities=30% Similarity=0.462 Sum_probs=21.6
Q ss_pred ceeeCCCCCCcEEE-cCCCCeeeccccccee
Q 003237 650 RIIHRDLKASNILL-DEKMNPRISDFGTARV 679 (837)
Q Consensus 650 ~ivH~Dlkp~NIll-~~~~~~ki~DFGla~~ 679 (837)
.+.|+|+.|.|||+ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47999999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.1 Score=57.27 Aligned_cols=141 Identities=18% Similarity=0.264 Sum_probs=79.6
Q ss_pred CcccccCCeeEEEEEecC----CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCee-eeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV-KLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey~~~ 608 (837)
+.|..|-.-.+|+....+ +..+++|.........+ .-.+|..++..+..-++. ++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 355557777889887543 23788888755433222 235789999998765554 455554222 58999987
Q ss_pred CChhhH-----------------hhhcCC---CCCCChhhHHHHHHH----------------------HHHHHHHH---
Q 003237 609 KSLDYF-----------------IFDESR---KQLLDWKKRFDIILG----------------------IARGVLYL--- 643 (837)
Q Consensus 609 gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~~----------------------ia~gL~yL--- 643 (837)
..|... +|.... ...--|....++..+ +.+-+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 111110 001112222111111 11111111
Q ss_pred H-h-cCCCceeeCCCCCCcEEEcC-CCCeeeccccccee
Q 003237 644 H-Q-DSRLRIIHRDLKASNILLDE-KMNPRISDFGTARV 679 (837)
Q Consensus 644 H-~-~~~~~ivH~Dlkp~NIll~~-~~~~ki~DFGla~~ 679 (837)
. . ..+.-++|+|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1 12234799999999999975 57899999998754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.035 Score=59.60 Aligned_cols=141 Identities=19% Similarity=0.210 Sum_probs=91.6
Q ss_pred cCCcccccCCeeEEEEEecCCcEEEEEEecCCC-----c----cCH-------------H----HHHHHHHHHHHhcCCC
Q 003237 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS-----G----QGI-------------E----ELKNEVLLIAKLQHRN 585 (837)
Q Consensus 532 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~-----~----~~~-------------~----~~~~E~~~l~~l~H~n 585 (837)
+...|..|.-+.||.++-.+|..+|||+.+... . .+. + -...|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345788899999999999999999999874320 0 010 1 1234666666665433
Q ss_pred eeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC
Q 003237 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE 665 (837)
Q Consensus 586 Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~ 665 (837)
|.-.--+. -...+|||+|+....... .......++.......-.+++.-|.-|-+.+ ++||.||.--|+|+-
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGrdgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGRDGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCcee--eecceEeeeeccCCCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence 22110000 013479999987432211 1112223556667778888888888888887 499999999999985
Q ss_pred CCCeeecccccceec
Q 003237 666 KMNPRISDFGTARVF 680 (837)
Q Consensus 666 ~~~~ki~DFGla~~~ 680 (837)
+|.+.|+|-+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 468899998876543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 837 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-54 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-24 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-21 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-19 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-18 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 416 bits (1072), Expect = e-140
Identities = 107/308 (34%), Positives = 158/308 (51%), Gaps = 19/308 (6%)
Query: 509 EIRKVDVTFFELSTLLAATDNFS------TSNKLGQGGFGPVYKGKLSNGQEIAVKRLST 562
E+ F L T+NF NK+G+GGFG VYKG + N +AVK+L+
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 563 ----TSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE 618
T+ + ++ E+ ++AK QH NLV+LLG + D+ L+Y +MPN SL +
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 619 SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
L W R I G A G+ +LH++ IHRD+K++NILLDE +ISDFG AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 679 VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDD 738
+T R+VGT YM+PE L G + KSD++SFGV+LLEIITG +
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 739 DSSNLIKYAWELWSDNKALE-IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTV 797
L+ E+ + K +E +D M ++ ++ V C+ ++ RP + V
Sbjct: 241 Q--LLLDIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 798 VFMLSNET 805
+L T
Sbjct: 298 QQLLQEMT 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 415 bits (1070), Expect = e-140
Identities = 123/311 (39%), Positives = 176/311 (56%), Gaps = 5/311 (1%)
Query: 501 SISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL 560
+ + + E+ + F L L A+DNFS N LG+GGFG VYKG+L++G +AVKRL
Sbjct: 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 561 STTSGQGIE-ELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDES 619
QG E + + EV +I+ HRNL++L G C+ E +L+Y +M N S+ + +
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 620 RKQL-LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
Q LDW KR I LG ARG+ YLH +IIHRD+KA+NILLDE+ + DFG A+
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 679 VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNT--RIFN 736
+ + +T V GT G+++PEY G S K+DVF +GV+LLE+ITG++
Sbjct: 183 LM-DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
Query: 737 DDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMST 796
+DD L+ + L + K +VD + + E + IQV LLC Q +RP MS
Sbjct: 242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 797 VVFMLSNETFV 807
VV ML +
Sbjct: 302 VVRMLEGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 374 bits (962), Expect = e-123
Identities = 103/312 (33%), Positives = 169/312 (54%), Gaps = 4/312 (1%)
Query: 491 SSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLS 550
S + + + + L L AT+NF +G G FG VYKG L
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 551 NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610
+G ++A+KR + S QGIEE + E+ ++ +H +LV L+G C E +E +LIY++M N +
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 611 LDYFIFDESRKQL-LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669
L ++ + + W++R +I +G ARG+ YLH + IIHRD+K+ NILLDE P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178
Query: 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+I+DFG ++ + ++ V GT GY+ PEY + G + KSDV+SFGV+L E++ +
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 730 KNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTT 789
+ NL ++A E ++ + +IVD ++A+ + + C+ +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 790 DRPSMSTVVFML 801
DRPSM V++ L
Sbjct: 299 DRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 1e-90
Identities = 65/308 (21%), Positives = 118/308 (38%), Gaps = 28/308 (9%)
Query: 518 FELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLL 577
L + +G FG V+K +L + +AVK Q + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 578 IAKLQHRNLVKLLGCCLE----EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 633
+ ++H N+++ +G + + LI F SL F+ + ++ W + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 634 LGIARGVLYLHQD-------SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686
+ARG+ YLH+D + I HRD+K+ N+LL + I+DFG A F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 687 AITKRVVGTYGYMSPEYALDGV-----FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS 741
T VGT YM+PE + + D+++ G++L E+ + D+
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 742 NLIKYAWELWSDNKALEIVDS-----SMANSCLASEALRCI-QVGLLCVQDRTTDRPSMS 795
+ + S E+V + + + + + C R S
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 796 TVVFMLSN 803
V ++
Sbjct: 308 CVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 5e-76
Identities = 64/334 (19%), Positives = 117/334 (35%), Gaps = 46/334 (13%)
Query: 518 FELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQG-IEELKNEVL 576
S DN +G+G +G VYKG L + + +AVK S + Q I E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK--NIY 59
Query: 577 LIAKLQHRNLVKLLGCCLEEDEN-----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD 631
+ ++H N+ + + + +L+ E+ PN SL ++ DW
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCR 115
Query: 632 IILGIARGVLYLHQD------SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685
+ + RG+ YLH + + I HRDL + N+L+ ISDFG + G +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 686 LAI------TKRVVGTYGYMSPEYALDGVFST--------KSDVFSFGVILLEIITGKKN 731
+ VGT YM+PE L+G + + D+++ G+I EI +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 732 TRIFNDDDSSNLIKYAWELWSDNKALEIVDS--------SMANSCLASEALRCIQVGLL- 782
+ + E+ + ++ + + +
Sbjct: 235 LFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 783 -CVQDRTTDRPSMSTVVFMLSN-ETFVPSPKQPT 814
C R + ++ K +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 5e-64
Identities = 62/198 (31%), Positives = 109/198 (55%), Gaps = 6/198 (3%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
K+G G FG V++ + +G ++AVK L + + E EV ++ +L+H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
+ ++ E++ SL + ++ LD ++R + +A+G+ YLH I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFST 711
+HR+LK+ N+L+D+K ++ DFG +R+ + +K GT +M+PE D +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNE 218
Query: 712 KSDVFSFGVILLEIITGK 729
KSDV+SFGVIL E+ T +
Sbjct: 219 KSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 4e-62
Identities = 71/288 (24%), Positives = 122/288 (42%), Gaps = 38/288 (13%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
+G+G FG V K K +++A+K++ S + E+ ++++ H N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 653
L + L+ E+ SL + L ++GV YLH +IH
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 654 RDLKASNILLDEKMN-PRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTK 712
RDLK N+LL +I DFGTA +I G+ +M+PE +S K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 713 SDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI---VDSSMAN--- 766
DVFS+G+IL E+IT + D+ + W + + + + + +
Sbjct: 184 CDVFSWGIILWEVITRR----KPFDEIGGPAFRIMWAV-HNGTRPPLIKNLPKPIESLMT 238
Query: 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN-ETFVPSPKQP 813
C + + + RPSM +V ++++ + P +P
Sbjct: 239 RCWSKDP---------------SQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-61
Identities = 72/208 (34%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRL----STTSGQGIEELKNEVLLIAKLQHRNLVKL 589
+G GGFG VY+ G E+AVK Q IE ++ E L A L+H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
G CL+E L+ EF L+ + + + + + IARG+ YLH ++ +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 650 RIIHRDLKASNILLDEKMNPR--------ISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
IIHRDLK+SNIL+ +K+ I+DFG AR + G Y +M+P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAP 183
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGK 729
E +FS SDV+S+GV+L E++TG+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-60
Identities = 70/289 (24%), Positives = 129/289 (44%), Gaps = 50/289 (17%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG-------IEELKNEVLLIAKLQHRN 585
++G+GGFG V+KG+ + + +A+K L +G +E + EV +++ L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+VKL G ++ EF+P L + + D++ + W + ++L IA G+ Y+
Sbjct: 85 IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQN 140
Query: 646 DSRLRIIHRDLKASNILLDEK-----MNPRISDFGTARVFGGEEILAITKRVVGTYGYMS 700
I+HRDL++ NI L + +++DFG ++ ++G + +M+
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMA 194
Query: 701 PE--YALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758
PE A + ++ K+D +SF +IL I+TG+ D+ S IK+ + +
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGE----GPFDEYSYGKIKFINMIREEGLRPT 250
Query: 759 I---VDSSMAN---SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801
I + N C + + RP S +V L
Sbjct: 251 IPEDCPPRLRNVIELCWSGDP---------------KKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 7e-60
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
KL + G ++KG+ G +I VK L S + + E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 592 CCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
C LI +MP SL + + + + D + L +ARG+ +LH L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLHTLEPL 133
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG-- 707
I L + ++++DE M RIS F + + +++PE AL
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE-ALQKKP 184
Query: 708 --VFSTKSDVFSFGVILLEIITGK 729
+D++SF V+L E++T +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 4e-59
Identities = 72/290 (24%), Positives = 109/290 (37%), Gaps = 50/290 (17%)
Query: 534 NKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
LG+G FG K G+ + +K L + EV ++ L+H N++K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
++ I E++ +L I + W +R IA G+ YLH + II
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 653 HRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR------------VVGTYGYMS 700
HRDL + N L+ E N ++DFG AR+ E+ R VVG +M+
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 701 PEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760
PE + K DVFSFG++L EII A + +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN----------------ADPDYLPRTMDFGL 234
Query: 761 DSS------MANSC---LASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801
+ +C +RC C D RPS + L
Sbjct: 235 NVRGFLDRYCPPNCPPSFFPITVRC------CDLDP-EKRPSFVKLEHWL 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 7e-57
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
++G G FG VYKGK ++AVK L + + Q ++ KNEV ++ K +H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 592 CCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
+ ++ ++ SL + + K + KK DI ARG+ YLH
Sbjct: 88 YSTAP--QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KS 140
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE---YALDG 707
IIHRDLK++NI L E +I DFG A +++ G+ +M+PE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 708 VFSTKSDVFSFGVILLEIITGK 729
+S +SDV++FG++L E++TG+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 8e-54
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
+G+G FG VY G+ E+A++ + + ++ K EV+ + +H N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651
C+ +I ++L + K +LD K I I +G+ YLH I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR---VVGTYGYMSPE------ 702
+H+DLK+ N+ D I+DFG + G + + G +++PE
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 703 ---YALDGVFSTKSDVFSFGVILLEIITGK 729
FS SDVF+ G I E+ +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-51
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNE--VLLIAKLQHRNLVKLLG 591
+G+G +G V++G G+ +AVK S+ + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 592 CCLEEDEN----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+ + LI + SL ++ + LD I+L IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 648 RLR-----IIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVGTYGYMS 700
I HRDLK+ NIL+ + I+D G A + ++ VGT YM+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 701 PE------YALDGVFSTKSDVFSFGVILLEIITGKKNTRIFND 737
PE + D+++FG++L E+ + I D
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-50
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 29/224 (12%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNE--VLLIAKLQHRNLVKLLG 591
++G+G +G V+ GK G+++AVK T E + ++H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 592 CCLEEDEN----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
++ + LI ++ N SL ++ + LD K + G+ +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 648 RLR-----IIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVGTYGYMS 700
I HRDLK+ NIL+ + I+D G A F E+ VGT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 701 PEYALDGV-------FSTKSDVFSFGVILLEIITGKKNTRIFND 737
PE LD +D++SFG+IL E+ + I +
Sbjct: 215 PE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 29/224 (12%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNE--VLLIAKLQHRNLVKLLG 591
+G+G FG V++GK G+E+AVK S+ + E + L+H N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 592 CCLEEDEN----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD- 646
+++ L+ ++ + SL ++ + + + + L A G+ +LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 647 ----SRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVGTYGYMS 700
+ I HRDLK+ NIL+ + I+D G A + I VGT YM+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 701 PEYALDGV-------FSTKSDVFSFGVILLEIITGKKNTRIFND 737
PE LD ++D+++ G++ EI I D
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-45
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 7/202 (3%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRN 585
++ ++G+G FG V+ G+L ++ +AVK T + E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+V+L+G C ++ ++ E + F+ + L K ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
IHRDL A N L+ EK +ISDFG +R A + +PE
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 706 DGVFSTKSDVFSFGVILLEIIT 727
G +S++SDV+SFG++L E +
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-44
Identities = 65/298 (21%), Positives = 123/298 (41%), Gaps = 36/298 (12%)
Query: 477 ERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKL 536
++ + ++ + + + + F + +L
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQ---------------QL 49
Query: 537 GQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
G+G FG V + + G+ +AVK+L ++ + + + + E+ ++ LQH N+VK G
Sbjct: 50 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 109
Query: 592 CCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
C LI E++P SL ++ + K+ +D K I +G+ YL
Sbjct: 110 VCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---GTK 164
Query: 650 RIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG-----YMSPEYA 704
R IHRDL NIL++ + +I DFG +V ++ V G + +PE
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPESL 220
Query: 705 LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762
+ FS SDV+SFGV+L E+ T + ++ + + +E++ +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 534 NKLGQGGFGPVYKGKLSNGQE----IAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
+G+G FG VY G+ + + A+K L T Q +E E LL+ L H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 589 LLGCCLEEDE-NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
L+G L + ++ +M + L FI R K L +ARG+ YL +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL---A 141
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY--GYMSPEYAL 705
+ +HRDL A N +LDE +++DFG AR E ++ + + + E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 706 DGVFSTKSDVFSFGVILLEIIT 727
F+TKSDV+SFGV+L E++T
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLT 223
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-44
Identities = 64/241 (26%), Positives = 112/241 (46%), Gaps = 21/241 (8%)
Query: 534 NKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
+LG+G FG V + + G+ +AVK+L ++ + + + + E+ ++ LQH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 589 LLGCCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
G C LI E++P SL ++ + K+ +D K I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG-----YMSP 701
R IHRDL NIL++ + +I DFG +V ++ V G + +P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAP 186
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761
E + FS SDV+SFGV+L E+ T + ++ + + +E++
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 762 S 762
+
Sbjct: 247 N 247
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 61/227 (26%), Positives = 91/227 (40%), Gaps = 25/227 (11%)
Query: 534 NKLGQGGFGPVYKGKLSN-----GQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLV 587
LG+G FG V G+ +AVK L + Q K E+ ++ L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 588 KLLGCCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
K GCC + L+ E++P SL ++ + + + I G+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG-----YMS 700
IHRDL A N+LLD +I DFG A+ V G + +
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYA 205
Query: 701 PEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKY 746
PE + F SDV+SFGV L E++T + I
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-43
Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 39/223 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-----IAVKRL-STTSGQGIEELKNEVLLIAKL 581
F LG G FG VYKG E +A+K L TS + +E+ +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILGIA 637
+ ++ +LLG CL LI + MP L ++ + + LL+W + IA
Sbjct: 75 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG 697
+G+ YL R++HRDL A N+L+ + +I+DFG A++ G EE Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 698 Y---------MSPEYALDGVFSTKSDVFSFGVILLEIIT-GKK 730
M+ E L +++ +SDV+S+GV + E++T G K
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 23/227 (10%)
Query: 534 NKLGQGGFGPVYKGKL-----SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLV 587
LG+G FG V + + G+++AVK L + G I +LK E+ ++ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 588 KLLGCCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
K G C E+ N LI EF+P+ SL ++ K ++ K++ + I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL-- 142
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG-----YMS 700
+ +HRDL A N+L++ + +I DFG + ++ V + +
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----TVKDDRDSPVFWYA 197
Query: 701 PEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKY 746
PE + F SDV+SFGV L E++T ++ +
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-43
Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 37/220 (16%)
Query: 534 NKLGQGGFGPVYKGKLSNGQE------IAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+LG+G FG V+ + N +AVK L S ++ + E L+ LQH+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYF------------IFDESRKQLLDWKKRFDIILG 635
+ G C E ++++E+M + L+ F ++ L + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV--------FGGEEILA 687
+A G++YL + L +HRDL N L+ + + +I DFG +R GG +L
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
I R +M PE L F+T+SDV+SFGV+L EI T
Sbjct: 224 I--R------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 534 NKLGQGGFGPVYKGKLSNG------QEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+LG+G FG V+ + N +AVK L + ++ + E L+ LQH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYF-------------IFDESRKQLLDWKKRFDIIL 634
K G C + D ++++E+M + L+ F K L + I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV--------FGGEEIL 686
IA G++YL + +HRDL N L+ + +I DFG +R GG +L
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
I R +M PE + F+T+SDV+SFGVIL EI T
Sbjct: 198 PI--R------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 534 NKLGQGGFGPVYKGKLSNG----QEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
+G+G FG VY G L + AVK L T + + E +++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 589 LLGCCLEEDEN-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
LLG CL + + +++ +M + L FI + K L +A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY--GYMSPEYAL 705
+ +HRDL A N +LDEK +++DFG AR +E ++ + +M+ E
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 706 DGVFSTKSDVFSFGVILLEIIT 727
F+TKSDV+SFGV+L E++T
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMT 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-43
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 534 NKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK 588
++LG+G FG V + + G +AVK+L + + + E+ ++ L +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 589 LLGCCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
G L+ E++P+ L F+ + + LD + I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG-----YMSP 701
R +HRDL A NIL++ + + +I+DFG A++ ++ VV G + +P
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199
Query: 702 EYALDGVFSTKSDVFSFGVILLEIIT 727
E D +FS +SDV+SFGV+L E+ T
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 5e-43
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 39/222 (17%)
Query: 534 NKLGQGGFGPVYKGKLSNG------QEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNL 586
+LG+ FG VYKG L Q +A+K L G EE ++E +L A+LQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYF-------------IFDESRKQLLDWKKRFDII 633
V LLG ++ +I+ + + L F D + K L+ ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--------GGEEI 685
IA G+ YL S ++H+DL N+L+ +K+N +ISD G R G +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
L I R +M+PE + G FS SD++S+GV+L E+ +
Sbjct: 192 LPI--R------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRN 585
+ + +LG G FG V GK ++A+K + + S +E E ++ L H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 80
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
LV+L G C ++ +I E+M N L ++ + ++ ++ + + YL
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL-- 136
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT---YGYMSPE 702
+ +HRDL A N L++++ ++SDFG +R +E VG+ + PE
Sbjct: 137 -ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPE 191
Query: 703 YALDGVFSTKSDVFSFGVILLEIIT 727
+ FS+KSD+++FGV++ EI +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-43
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRN 585
+ + +LG G FG V GK ++AVK + + S +E E + KL H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPK 64
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
LVK G C +E ++ E++ N L ++ S + L+ + ++ + G+ +L
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL-- 120
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT---YGYMSPE 702
+ IHRDL A N L+D + ++SDFG R ++ VGT + +PE
Sbjct: 121 -ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPE 175
Query: 703 YALDGVFSTKSDVFSFGVILLEIIT 727
+S+KSDV++FG+++ E+ +
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-43
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRN 585
+ ++G G FG V+ G N ++A+K + S E+ E ++ KL H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPK 64
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
LV+L G CLE+ L+ EFM + L ++ +++ L + + L + G+ YL
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL-- 120
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT---YGYMSPE 702
+IHRDL A N L+ E ++SDFG R ++ GT + SPE
Sbjct: 121 -EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPE 175
Query: 703 YALDGVFSTKSDVFSFGVILLEIIT 727
+S+KSDV+SFGV++ E+ +
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI--AVKRL--STTSGQGIEELKNEVLLIAKLQH 583
+ + +KLG G +G VY+G + AVK L T +EE E ++ +++H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKH 68
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
NLV+LLG C E +I EFM +L ++ E +Q + + I+ + YL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY--MSP 701
+ IHRDL A N L+ E +++DFG +R+ G+ T + +P
Sbjct: 128 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAP 181
Query: 702 EYALDGVFSTKSDVFSFGVILLEIIT 727
E FS KSDV++FGV+L EI T
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-42
Identities = 76/305 (24%), Positives = 137/305 (44%), Gaps = 38/305 (12%)
Query: 438 SNRARKRRLALIIVAIVLGVILLGLCFFFLRRRLATRIGERKRQRRRELLFLNSSTRFSE 497
+ RR A + I++ GL L+T ++ E L+ +
Sbjct: 10 HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELST---SLYKKAGSENLYFQGANTVHI 66
Query: 498 REASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNG----Q 553
++++ + + ++ V + L + +G+G FG VY G L +
Sbjct: 67 DLSALNPELVQAVQHVVIGPSSLIVHF--------NEVIGRGHFGCVYHGTLLDNDGKKI 118
Query: 554 EIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN-MLIYEFMPNKSL 611
AVK L T + + E +++ H N++ LLG CL + + +++ +M + L
Sbjct: 119 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178
Query: 612 DYFIFDESR----KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667
FI +E+ K L+ L +A+G+ +L + + +HRDL A N +LDEK
Sbjct: 179 RNFIRNETHNPTVKDLIG------FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKF 229
Query: 668 NPRISDFGTARVFGGEEILAITKRVVGTYG-----YMSPEYALDGVFSTKSDVFSFGVIL 722
+++DFG AR +E ++ + T +M+ E F+TKSDV+SFGV+L
Sbjct: 230 TVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 286
Query: 723 LEIIT 727
E++T
Sbjct: 287 WELMT 291
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE------IAVKRL-STTSGQGIEELKNEVLLIAK 580
+ + S +LGQG FG VY+G + +A+K + S + E NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF-------IFDESRKQLLDWKKRFDII 633
++V+LLG + ++I E M L + + + K +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR--------VFGGEEI 685
IA G+ YL + + +HRDL A N ++ E +I DFG R GG+ +
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
L + R +MSPE DGVF+T SDV+SFGV+L EI T
Sbjct: 202 LPV--R------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 534 NKLGQGGFGPVYKGKL----SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVK 588
+G G G V G+L +A+K L + + + + +E ++ + H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
L G M++ E+M N SLD F+ + + ++ G+ G+ YL S
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SD 169
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG------YMSPE 702
L +HRDL A N+L+D + ++SDFG +RV + A T G + +PE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPIRWTAPE 224
Query: 703 YALDGVFSTKSDVFSFGVILLEIIT 727
FS+ SDV+SFGV++ E++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 34/223 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNG----QEIAVKRL--STTSGQGIEELKNEVLLIAKL 581
F+ LG+G FG V + +L ++AVK L + IEE E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 582 QHRNLVKLLGCCLEEDEN------MLIYEFMPNKSLDYFIFD---ESRKQLLDWKKRFDI 632
H ++ KL+G L M+I FM + L F+ L +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV--------FGGEE 684
++ IA G+ YL S IHRDL A N +L E M ++DFG +R G
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
L + K +++ E D +++ SDV++FGV + EI+T
Sbjct: 200 KLPV-K-------WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE----IAVKRL--STTSGQGIEELKNEVLLIAKL 581
+ LG+G FG V +G L +AVK + +S + IEE +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 582 QHRNLVKLLGCCLEED-----ENMLIYEFMPNKSLDYFI---FDESRKQLLDWKKRFDII 633
H N+++LLG C+E + M+I FM L ++ E+ + + + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV--------FGGEEI 685
+ IA G+ YL S +HRDL A N +L + M ++DFG ++ G
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ + K +++ E D V+++KSDV++FGV + EI T
Sbjct: 211 MPV-K-------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+G+G FG V G G ++AVK + + + E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 588 KLLGCCLEEDEN-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+LLG +EE ++ E+M SL ++ + +L L + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG------YMS 700
+HRDL A N+L+ E ++SDFG + E + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTA 182
Query: 701 PEYALDGVFSTKSDVFSFGVILLEIIT 727
PE + FSTKSDV+SFG++L EI +
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-42
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+G+G FG V G G ++AVK + + + E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 588 KLLGCCLEEDEN-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+LLG +EE ++ E+M SL ++ R +L L + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT---YGYMSPEY 703
+HRDL A N+L+ E ++SDFG + + + +PE
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWTAPEA 357
Query: 704 ALDGVFSTKSDVFSFGVILLEIIT 727
+ FSTKSDV+SFG++L EI +
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYS 381
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+F +G GGFG V+K K +G+ +KR+ + E+ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 587 VKLLGCCLEEDENM----------------LIYEFMPNKSLDYFIFDESRKQLLDWKKRF 630
V GC D + + EF +L+ +I ++ R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 631 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK 690
++ I +GV Y+H ++I+RDLK SNI L + +I DFG +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--- 179
Query: 691 RVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKK 730
R GT YMSPE + + D+++ G+IL E++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 67/202 (33%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ +LG G FG V+ G + ++AVK L S + E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L +E +I E+M N SL F+ L K D+ IA G+ ++
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY--MSPEYAL 705
IHRDL+A+NIL+ + ++ +I+DFG AR+ E T R + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183
Query: 706 DGVFSTKSDVFSFGVILLEIIT 727
G F+ KSDV+SFG++L EI+T
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 33/222 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNG------QEIAVKRL-STTSGQGIEELKNEVLLIAK 580
N + LG G FG VY+G++S ++AVK L S Q + E L+I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI----FDESRKQLLDWKKRFDIILGI 636
H+N+V+ +G L+ ++ E M L F+ S+ L + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR---ISDFGTAR--------VFGGEEI 685
A G YL IHRD+ A N LL R I DFG AR GG +
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
L + + +M PE ++G+F++K+D +SFGV+L EI +
Sbjct: 207 LPV--K------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 12/221 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHR 584
+ + K+G+G FG K +G++ +K +S S + EE + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N+V+ E ++ ++ L I + + L + D + I + ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYA 704
+I+HRD+K+ NI L + ++ DFG ARV LA +GT Y+SPE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 705 LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+ ++ KSD+++ G +L E+ T K F NL+
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK---HAFEAGSMKNLVL 235
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-----IAVKRL-STTSGQGIEELKNEVLLIAKL 581
+ +G G FG VYKG L +A+K L + + + + E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL 641
H N+++L G + M+I E+M N +LD F+ + + ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG---- 697
YL + + +HRDL A NIL++ + ++SDFG +RV + T G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213
Query: 698 --YMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ +PE F++ SDV+SFG+++ E++T
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 30/209 (14%)
Query: 534 NKLGQGGFGPVYKGKLSNGQE-----IAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLV 587
LG G FG V+KG E + +K + SG Q + + + +L I L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILGIARGVLYL 643
+LLG C L+ +++P SL + + LL+W + IA+G+ YL
Sbjct: 79 RLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYL 131
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG-----Y 698
++HR+L A N+LL +++DFG A + ++ K+++ + +
Sbjct: 132 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-----KQLLYSEAKTPIKW 183
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEIIT 727
M+ E G ++ +SDV+S+GV + E++T
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKG--KLSNGQEI--AVKRL-STTSGQGIEELKNEVLLIAKLQ 582
+ +G+G FG V++G + A+K + TS E+ E L + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H ++VKL+G E +I E L F+ + RK LD ++ + Y
Sbjct: 75 HPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY--GYMS 700
L R +HRD+ A N+L+ ++ DFG +R K G +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY---YKASKGKLPIKWMA 185
Query: 701 PEYALDGVFSTKSDVFSFGVILLEIIT 727
PE F++ SDV+ FGV + EI+
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-41
Identities = 67/202 (33%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
++ KLG G FG V+ + ++AVK + S E E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLV 246
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
KL +E +I EFM SL F+ K D IA G+ ++
Sbjct: 247 KLHAVVTKE-PIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY--MSPEYAL 705
+ IHRDL+A+NIL+ + +I+DFG ARV E T R + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAIN 358
Query: 706 DGVFSTKSDVFSFGVILLEIIT 727
G F+ KSDV+SFG++L+EI+T
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 13/226 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHR 584
+++ +G G +G K + S+G+ + K + + + L +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 585 NLVKLLGCCLEEDENML--IYEFMPNKSLDYFIFDESRK-QLLDWKKRFDIILGIARGVL 641
N+V+ ++ L + E+ L I +++ Q LD + ++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 642 YLHQ--DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
H+ D ++HRDLK +N+ LD K N ++ DFG AR+ + A T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
SPE ++ KSD++S G +L E+ F L
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM---PPFTAFSQKELAG 226
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-41
Identities = 63/195 (32%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 534 NKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
+KLG G +G VY+G +AVK L + + +EE E ++ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 652
C E +I EFM +L ++ E +Q + + I+ + YL + I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 653 HRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTK 712
HR+L A N L+ E +++DFG +R+ G+ A + +PE FS K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399
Query: 713 SDVFSFGVILLEIIT 727
SDV++FGV+L EI T
Sbjct: 400 SDVWAFGVLLWEIAT 414
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 534 NKLGQGGFGPVYKGKLSNGQE---IAVKRL-STTSGQGIEELKNEVLLIAKL-QHRNLVK 588
+ +G+G FG V K ++ A+KR+ S + E+ ++ KL H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYF-------------IFDESRKQLLDWKKRFDIILG 635
LLG C L E+ P+ +L F S L ++
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ARG+ YL S+ + IHRDL A NIL+ E +I+DFG +R G+E+ V T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY-----VKKT 199
Query: 696 YG-----YMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
G +M+ E V++T SDV+S+GV+L EI++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 38/219 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-----IAVKRL-STTSGQGIEELKNEVLLIAKL 581
F LG G FG VYKG E +A+K L TS + +E+ +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILGIA 637
+ ++ +LLG CL LI + MP L ++ + + LL+W + IA
Sbjct: 75 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG 697
+G+ YL R++HRDL A N+L+ + +I+DFG A++ G EE Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 698 Y---------MSPEYALDGVFSTKSDVFSFGVILLEIIT 727
M+ E L +++ +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL--SNGQEI--AVKRL-STTSGQGIEELKNEVLLIAKLQ 582
++ + LG+G FG VY+G G++I AVK + E+ +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRK----QLLDWKKRFDIILGIAR 638
H ++VKL+G EE +I E P L +++ L+ + L I +
Sbjct: 72 HPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY------SLQICK 124
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK-----RVV 693
+ YL + +HRD+ NIL+ ++ DFG +R E+ + +
Sbjct: 125 AMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-- 179
Query: 694 GTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+MSPE F+T SDV+ F V + EI++
Sbjct: 180 ----WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-41
Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKG--KLSNGQEI--AVKRL---STTSGQGIEELKNEVLLIAK 580
+ KLG G FG V +G +G+ + AVK L + + +++ EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRK----QLLDWKKRFDIILGI 636
L HRNL++L G L ++ E P SL + L + + +
Sbjct: 78 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQV 130
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT- 695
A G+ YL R IHRDL A N+LL + +I DFG R + + +
Sbjct: 131 AEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRK 185
Query: 696 --YGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKK 730
+ + +PE FS SD + FGV L E+ T G++
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 535 KLGQGGFGPVYKGKLSNGQE---IAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
+LG G FG V +G ++ +A+K L T EE+ E ++ +L + +V+L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
G C E ML+ E L F+ +++ + +++ ++ G+ YL
Sbjct: 77 GVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY--GYMSPEYALDGV 708
+HRDL A N+LL + +ISDFG ++ G ++ T R G + + +PE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 189
Query: 709 FSTKSDVFSFGVILLEIIT 727
FS++SDV+S+GV + E ++
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 9e-41
Identities = 75/260 (28%), Positives = 115/260 (44%), Gaps = 50/260 (19%)
Query: 490 NSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKL 549
N + F+ + +SIS KE+ + ++T LG G FG VY+G++
Sbjct: 50 NPNYCFAGKTSSISDL--KEVPRKNITLIR---------------GLGHGAFGEVYEGQV 92
Query: 550 SNG------QEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602
S ++AVK L S Q + E L+I+K H+N+V+ +G L+ ++
Sbjct: 93 SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152
Query: 603 YEFMPNKSLDYFI----FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658
E M L F+ S+ L + IA G YL IHRD+ A
Sbjct: 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAA 209
Query: 659 SNILLDEKMNPR---ISDFGTAR--------VFGGEEILAITKRVVGTYGYMSPEYALDG 707
N LL R I DFG AR GG +L + + +M PE ++G
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV--K------WMPPEAFMEG 261
Query: 708 VFSTKSDVFSFGVILLEIIT 727
+F++K+D +SFGV+L EI +
Sbjct: 262 IFTSKTDTWSFGVLLWEIFS 281
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-40
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKG--KLSNGQEI--AVKRL-STTSGQGIEELKNEVLLIAKLQ 582
N S +G G FG V G KL + +EI A+K L + + + E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H N+++L G + M++ E+M N SLD F+ + ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT---YGYM 699
L S + +HRDL A NIL++ + ++SDFG RV + A T R G +
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWT 217
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIIT 727
SPE F++ SDV+S+G++L E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 535 KLGQGGFGPVYKGKLSNG---QEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKL 589
+LG G FG V KG + +AVK L +EL E ++ +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFIFDESR---KQLLDWKKRFDIILGIARGVLYLHQD 646
+G C E ML+ E L+ ++ K +++ + ++ G+ YL
Sbjct: 84 IGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYL--- 133
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG------YMS 700
+HRDL A N+LL + +ISDFG ++ +E + + +
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYA 188
Query: 701 PEYALDGVFSTKSDVFSFGVILLEIIT 727
PE FS+KSDV+SFGV++ E +
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQHRN 585
+F LG+GGFG V++ K + A+KR+ E++ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 586 LVKLLGCCLEEDE---------NMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDII 633
+V+ LE++ + +Y + ++L ++ + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV- 692
L IA V +LH ++HRDLK SNI ++ DFG +E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 693 ---------VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
VGT YMSPE +S K D+FS G+IL E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 34/244 (13%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
+F LGQG FG V K + + + A+K++ T + + + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFI---------FD--ESRKQLLDWKKRFDIIL 634
+V+ LE + + KS + +D S + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT----- 689
I + Y+H IIHRDLK NI +DE N +I DFG A+ +
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 690 -------KRVVGTYGYMSPE-YALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS 741
+GT Y++ E G ++ K D++S G+I E+I +
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FSTGMERV 235
Query: 742 NLIK 745
N++K
Sbjct: 236 NILK 239
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 51/217 (23%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRLSTTSGQGIEELKNEVLLIA 579
++ + LGQG F ++KG + E+ +K L E +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
KL H++LV G C+ DEN+L+ EF+ SLD ++ + K ++ + ++ +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPR--------ISDFGTARVFGGEEILAITKR 691
+ +L +IH ++ A NILL + + + +SD G + ++IL
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 692 VVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIIT 727
++ PE + + +D +SFG L EI +
Sbjct: 183 ------WVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 36/228 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRL-STTSGQGIEELKNEVLLI 578
D + LG+G FG V + +AVK L + + + +L +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 579 AKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSL-DY------------FIFDESRKQLL 624
+ +H+N++ LLG C ++ +I E+ +L +Y + + ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+K +ARG+ YL + + IHRDL A N+L+ E +I+DFG AR +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 685 ILAITKRVVGTYG-----YMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
T G +M+PE D V++ +SDV+SFGV++ EI T
Sbjct: 212 Y-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQH 583
NF K+G+G F VY+ L +G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--DIILG----IA 637
N++K +E++E ++ E L I K K+ + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTVWKYFVQLC 146
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG 697
+ ++H R++HRD+K +N+ + ++ D G R F + A + +VGT
Sbjct: 147 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 201
Query: 698 YMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
YMSPE + ++ KSD++S G +L E+ +
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 65/221 (29%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 534 NKLGQGGFGPVYKGKLSN------GQEIAVKRL-STTSGQGIEELKNEVLLIAKL-QHRN 585
LG+G FG V + + +AVK L + L +E+ ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 586 LVKLLGCCLEEDE-NMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRFD 631
+V LLG C + M+I EF +L Y ++ K L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 632 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691
+A+G+ +L + + IHRDL A NILL EK +I DFG AR +I
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDY 204
Query: 692 VVGTYG-----YMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
V +M+PE D V++ +SDV+SFGV+L EI +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 6e-40
Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 47/236 (19%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNG------QEIAVKRL-STTSGQGIEELKNEVLLIAK 580
N LG+G FG V K + +AVK L S + +L +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSL-DY--------------------FIFDES 619
+ H +++KL G C ++ +LI E+ SL + D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 620 RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR- 678
++ L I++G+ YL + ++++HRDL A NIL+ E +ISDFG +R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 679 -------VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
V + + + K +M+ E D +++T+SDV+SFGV+L EI+T
Sbjct: 200 VYEEDSYVKRSQGRIPV-K-------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-40
Identities = 67/291 (23%), Positives = 122/291 (41%), Gaps = 44/291 (15%)
Query: 473 TRIGERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATD---- 528
++ +R RR+ + SS+ + + +S D
Sbjct: 18 HKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWE 77
Query: 529 ----NFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRL-STTSGQGIEELKNEV 575
+ LG+G FG V + +AVK L + + + +L +E+
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 576 LLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSL-DY------------FIFDESRK 621
++ + +H+N++ LLG C ++ +I E+ +L +Y + + +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 622 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
+ + +K +ARG+ YL + + IHRDL A N+L+ E +I+DFG AR
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 682 GEEILAITKRVVGTYG-----YMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ T G +M+PE D V++ +SDV+SFGV++ EI T
Sbjct: 255 NIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 47/230 (20%)
Query: 534 NKLGQGGFGPVYKGKLSNG------QEIAVKRL-STTSGQGIEELKNEVLLIAKLQHRNL 586
+G+G FG V++ + +AVK L S + + E L+A+ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYF---------------------IFDESRKQLLD 625
VKLLG C L++E+M L+ F L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 626 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR------- 678
++ I +A G+ YL S + +HRDL N L+ E M +I+DFG +R
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 679 -VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
G + + I R +M PE ++T+SDV+++GV+L EI +
Sbjct: 230 YKADGNDAIPI--R------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 36/228 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE------IAVKRL-STTSGQGIEELKNEVLLIAK 580
+ S LG G FG V + + +AVK L + E L +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 581 L-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF---------------IFDESRKQLL 624
L H N+V LLG C ++I E+ L F E + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
D + +A+G+ +L + IHRDL A NILL +I DFG AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 685 ILAITKRVVGTYG-----YMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
VV +M+PE + V++ +SDV+S+G+ L E+ +
Sbjct: 200 N-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-39
Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 38/227 (16%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRL-STTSGQGIEELKNEVLLIAK 580
+N LG G FG V + ++AVK L ST E L +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 581 L-QHRNLVKLLGCCLEEDENMLIYEFMPNKSL-----------DYFIFDESRKQLLDWKK 628
L QH N+V LLG C ++I E+ L + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR--------VF 680
+A+G+ +L + IHRD+ A N+LL +I DFG AR +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
G L + K +M+PE D V++ +SDV+S+G++L EI +
Sbjct: 223 KGNARLPV-K-------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-39
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 534 NKLGQGGFGPVYKGKL--------SNGQEIAVKRL-STTSGQGIEELKNEVLLIAKL-QH 583
LG+G FG V + + ++AVK L S + + + +L +E+ ++ + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRF 630
+N++ LLG C ++ +I E+ +L +Y + + ++ L K
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 631 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK 690
+ARG+ YL + + IHRDL A N+L+ E +I+DFG AR +
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY----- 246
Query: 691 RVVGTYG-----YMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
T G +M+PE D +++ +SDV+SFGV+L EI T
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-39
Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
++ KLGQG FG V+ G + +A+K L + E E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 242
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L EE ++ E+M SL F + L + D+ IA G+ Y+
Sbjct: 243 QLYAVVSEE-PIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
R+ +HRDL+A+NIL+ E + +++DFG AR+ E A + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 708 VFSTKSDVFSFGVILLEIIT 727
F+ KSDV+SFG++L E+ T
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-39
Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
++ KLGQG FG V+ G + +A+K L + E E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 325
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L EE ++ E+M SL F + L + D+ IA G+ Y+
Sbjct: 326 QLYAVVSEEP-IYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
R+ +HRDL+A+NIL+ E + +++DFG AR+ E A + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 708 VFSTKSDVFSFGVILLEIIT 727
F+ KSDV+SFG++L E+ T
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-38
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 535 KLGQGGFGPVYKGKLSNGQE---IAVKRL-STTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
+LG G FG V +G ++ +A+K L T EE+ E ++ +L + +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
G C E ML+ E L F+ +++ + +++ ++ G+ YL
Sbjct: 403 GVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY--MSPEYALDGV 708
+HR+L A N+LL + +ISDFG ++ G ++ T R G + +PE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 515
Query: 709 FSTKSDVFSFGVILLEIIT 727
FS++SDV+S+GV + E ++
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 31/236 (13%)
Query: 516 TFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNE 574
+F+ ++ ++ KLG+GGF V + L +G A+KR+ Q EE + E
Sbjct: 17 LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76
Query: 575 VLLIAKLQHRNLVKLLGCCLEEDENM----LIYEFMPNKSLDYFIFDESRKQLLDWKKRF 630
+ H N+++L+ CL E L+ F +L I ++L D
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFL 131
Query: 631 D------IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV----- 679
++LGI RG+ +H HRDLK +NILL ++ P + D G+
Sbjct: 132 TEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188
Query: 680 FGGEEILAITKRV--VGTYGYMSPEYALDG----VFSTKSDVFSFGVILLEIITGK 729
G + L + T Y +PE V ++DV+S G +L ++ G+
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 8e-38
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 12/205 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKG--KLSNGQEI--AVKRL-STTSGQGIEELKNEVLLIAKLQ 582
+ +G+G FG V++G + A+K + TS E+ E L + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H ++VKL+G E +I E L F+ + RK LD ++ + Y
Sbjct: 450 HPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
L R +HRD+ A N+L+ ++ DFG +R +K + +M+PE
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 562
Query: 703 YALDGVFSTKSDVFSFGVILLEIIT 727
F++ SDV+ FGV + EI+
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILM 587
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 27/218 (12%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRNL 586
+S ++G GG V++ Q A+K L Q ++ +NE+ + KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 587 --VKLLGCCLEEDENMLIYEFM--PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
++L E + IY M N L+ ++ +K+ +D +R + V
Sbjct: 89 KIIRLYDY--EITDQY-IYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHT 142
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
+HQ I+H DLK +N L+ ++ DFG A + + VGT YM PE
Sbjct: 143 IHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 703 -----------YALDGVFSTKSDVFSFGVILLEIITGK 729
S KSDV+S G IL + GK
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 43/228 (18%)
Query: 534 NKLGQGGFGPVYKGKLSNGQE------IAVKRL-STTSGQGIEELKNEVLLIAKL-QHRN 585
LG G FG V + +AVK L E L +E+ ++ +L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSL-DY-------------------FIFDESRKQLLD 625
+V LLG C LI+E+ L +Y + +E +L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 626 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR-VFGGEE 684
++ +A+G+ +L +HRDL A N+L+ +I DFG AR +
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 685 ILAITK-----RVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+ + +M+PE +G+++ KSDV+S+G++L EI +
Sbjct: 228 YVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 27/218 (12%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRNL 586
+S ++G GG V++ Q A+K L Q ++ +NE+ + KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 587 --VKLLGCCLEEDENMLIYEFM--PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
++L E + IY M N L+ ++ +K+ +D +R + V
Sbjct: 70 KIIRLYDY--EITDQY-IYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHT 123
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
+HQ I+H DLK +N L+ ++ DFG A + + VGT YM PE
Sbjct: 124 IHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 703 -----------YALDGVFSTKSDVFSFGVILLEIITGK 729
S KSDV+S G IL + GK
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 57/249 (22%), Positives = 95/249 (38%), Gaps = 18/249 (7%)
Query: 487 LFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYK 546
L+ S + R +S +G + +F ++LG G +G V+K
Sbjct: 18 LYFQSMHQLQPRR--VSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFK 75
Query: 547 G-KLSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602
+G+ AVK + EV K+ QH V+L EE + +
Sbjct: 76 VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-WEEGGILYL 134
Query: 603 Y-EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNI 661
E SL E+ L + + + + +LH ++H D+K +NI
Sbjct: 135 QTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANI 188
Query: 662 LLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVI 721
L + ++ DFG G + G YM+PE L G + T +DVFS G+
Sbjct: 189 FLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLT 244
Query: 722 LLEIITGKK 730
+LE+ +
Sbjct: 245 ILEVACNME 253
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKLQHRNL 586
+S ++G GG V++ Q A+K L Q ++ +NE+ + KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 587 --VKLLGCCLEEDENMLIYEFM--PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
++L E + IY M N L+ ++ +K+ +D +R + V
Sbjct: 117 KIIRLYDY--EITDQY-IYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHT 170
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
+HQ I+H DLK +N L+ ++ DFG A + + VG YM PE
Sbjct: 171 IHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 703 -----------YALDGVFSTKSDVFSFGVILLEIITGK 729
S KSDV+S G IL + GK
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
++G+G F VYKG E+A + + + K E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 592 CCL---EEDENMLIY-EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+ + +++ E M + +L ++ R +++ K I +G+ +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 648 RLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD 706
IIHRDLK NI + + +I D G A + K V+GT +M+PE +
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE 204
Query: 707 GVFSTKSDVFSFGVILLEIITGK 729
DV++FG+ +LE+ T +
Sbjct: 205 KY-DESVDVYAFGMCMLEMATSE 226
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 24/219 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRN 585
+ S+ LGQG V++G+ G A+K + S + ++ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 586 LVKLLGCCLEEDENMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
+VKL EE EF P SL + + S L + ++ + G+ +
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 643 LHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
L + I+HR++K NI+ D + +++DFG AR +E + GT Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEY 181
Query: 699 MSPE--------YALDGVFSTKSDVFSFGVILLEIITGK 729
+ P+ + D++S GV TG
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 37/212 (17%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
LG+G +G VY G+ LSN IA+K + + + L E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 595 EEDENMLIYEFMPNKSLD--------YFIFDESR-----KQLLDWKKRFDIILGIARGVL 641
E + E +P SL +E KQ+L G+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-------------EGLK 136
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGGEEILAITKRVVGTYGYMS 700
YLH + +I+HRD+K N+L++ +ISDFGT++ G I T+ GT YM+
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMA 191
Query: 701 PE---YALDGVFSTKSDVFSFGVILLEIITGK 729
PE G + +D++S G ++E+ TGK
Sbjct: 192 PEIIDKGPRG-YGKAADIWSLGCTIIEMATGK 222
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-35
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 25/213 (11%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEV-LLIAKLQHRNLV 587
+F + LG G G + + + +++AVKR+ + EV LL +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 588 KLLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+ C E+D + E +Y E + + ++ G+ +LH
Sbjct: 82 RYF--CTEKDRQFQYIAIELCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 646 DSRLRIIHRDLKASNILLDEK-----MNPRISDFGTARVF-GGEEILAITKRVVGTYGYM 699
L I+HRDLK NIL+ + ISDFG + G + V GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 700 SPEYALDGVF----STKSDVFSFGVILLEIITG 728
+PE L + D+FS G + +I+
Sbjct: 194 APEM-LSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-35
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 24/219 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRN 585
+ S+ LGQG V++G+ G A+K + S + ++ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 586 LVKLLGCCLEEDENMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
+VKL EE EF P SL + + S L + ++ + G+ +
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 643 LHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
L + I+HR++K NI+ D + +++DFG AR +E + GT Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEY 181
Query: 699 MSPE--------YALDGVFSTKSDVFSFGVILLEIITGK 729
+ P+ + D++S GV TG
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 36/211 (17%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
++G+G FG V++ K G + AVK++ E++ A L +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGA 118
Query: 593 CLEEDENMLIYEFMPNKSL-----DYFIFDESR-----KQLLDWKKRFDIILGIARGVLY 642
E + E + SL E R Q L G+ Y
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL-------------EGLEY 165
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTARVFGGEEILAITKR---VVGTYGY 698
LH RI+H D+KA N+LL + + DFG A + + + GT +
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
M+PE + K D++S ++L ++ G
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
++ K+GQG G VY ++ GQE+A+++++ E + NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFI----FDESRKQLLDWKKRFDIILGIARGVL 641
+V L L DE ++ E++ SL + DE I + R L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE------------GQIAAVCRECL 126
Query: 642 ----YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
+LH + ++IHRD+K+ NILL + +++DFG F + +KR +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+M+PE + K D++S G++ +E+I G+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 60/254 (23%), Positives = 114/254 (44%), Gaps = 39/254 (15%)
Query: 490 NSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATD---NFSTSNKLGQGGFGPVYK 546
+++ + L ++ D + K+G+G G V
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKA------ALRMVVDQGDPRLLLDSYVKIGEGSTGIVCL 63
Query: 547 GK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605
+ +G+++AVK + Q E L NEV+++ QH N+V++ L +E ++ EF
Sbjct: 64 AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123
Query: 606 MPNKSLDYFI----FDESRKQLLDWKKRFDIILGIARGVL----YLHQDSRLRIIHRDLK 657
+ +L + +E + I + VL YLH +IHRD+K
Sbjct: 124 LQGGALTDIVSQVRLNE------------EQIATVCEAVLQALAYLHAQ---GVIHRDIK 168
Query: 658 ASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMSPEYALDGVFSTKSDV 715
+ +ILL ++SDFG F + + KR +VGT +M+PE +++T+ D+
Sbjct: 169 SDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDI 224
Query: 716 FSFGVILLEIITGK 729
+S G++++E++ G+
Sbjct: 225 WSLGIMVIEMVDGE 238
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
++ + KLG G +G V + E A+K + T S +L EV ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 584 RNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGI 636
N++KL E+ N L+ E L FDE + +F II +
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGEL----FDEIIH-----RMKFNEVDAAVIIKQV 145
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVV 693
GV YLH+ I+HRDLK N+LL ++ +I DFG + VF ++ + K +
Sbjct: 146 LSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERL 199
Query: 694 GTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
GT Y++PE L + K DV+S GVIL ++ G
Sbjct: 200 GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHRN 585
D+F ++LG G G V+K +G +A K + ++ E+ ++ +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--DIILGIARGVL-- 641
+V G + E + E M SLD Q+L R I+ ++ V+
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKKAGRIPEQILGKVSIAVIKG 143
Query: 642 --YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
YL + +I+HRD+K SNIL++ + ++ DFG + G+ I ++ VGT YM
Sbjct: 144 LTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYM 197
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITGK 729
SPE +S +SD++S G+ L+E+ G+
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-33
Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
+ ++ LG+G FG V K K QE AVK ++ + + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 584 RNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGI 636
N++KL E+ + ++ E L FDE K +KRF II +
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGEL----FDEIIK-----RKRFSEHDAARIIKQV 130
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVV 693
G+ Y+H+ I+HRDLK NILL ++ + +I DFG + F + K +
Sbjct: 131 FSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI 184
Query: 694 GTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG 728
GT Y++PE L G + K DV+S GVIL +++G
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 26/216 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSG-QGIEELKNEV-LLIAKLQHR 584
D+ +LG+G +G V K + + +GQ +AVKR+ T Q + L ++ + + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--DIILGIARGVL- 641
V G E + + E M + SLD F KQ++D + DI+ IA ++
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 642 ---YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK-RVVGTYG 697
+LH S+L +IHRD+K SN+L++ ++ DFG + G + + K G
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDDVAKDIDAGCKP 174
Query: 698 YMSPE----YALDGVFSTKSDVFSFGVILLEIITGK 729
YM+PE +S KSD++S G+ ++E+ +
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-32
Identities = 73/216 (33%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLST---TSGQGIEELKNEVLLIAKLQ 582
+D + LG+G FG V K GQE AVK +S E L EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 583 HRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILG 635
H N++KL E+ L+ E L FDE +KRF II
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGEL----FDEIIS-----RKRFSEVDAARIIRQ 134
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRV 692
+ G+ Y+H+ +I+HRDLK N+LL + N RI DFG + F + + K
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDK 188
Query: 693 VGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG 728
+GT Y++PE L G + K DV+S GVIL +++G
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 62/237 (26%), Positives = 116/237 (48%), Gaps = 18/237 (7%)
Query: 496 SEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQE 554
S + ++++K+D E S + F KLG+G +G VYK GQ
Sbjct: 1 SLETVQLRNPPRRQLKKLD----EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQI 56
Query: 555 IAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYF 614
+A+K++ ++E+ E+ ++ + ++VK G + + ++ E+ S+
Sbjct: 57 VAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI 114
Query: 615 IFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674
I R + L + I+ +G+ YLH R IHRD+KA NILL+ + + +++DF
Sbjct: 115 I--RLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADF 169
Query: 675 GTARVFGGEEILAITKR--VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
G G+ + KR V+GT +M+PE + ++ +D++S G+ +E+ GK
Sbjct: 170 G----VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHR 584
++ ++G+G +G V K +GQ +AVKR+ +T + ++L ++ ++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--DIILGIARGVL- 641
+V+ G E + + E M + S D F + +I+ I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 642 ---YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV-VGTYG 697
+L L+IIHRD+K SNILLD N ++ DFG + G+ + +I K G
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRP 190
Query: 698 YMSPE----YALDGVFSTKSDVFSFGVILLEIITGK 729
YM+PE A + +SDV+S G+ L E+ TG+
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 30/209 (14%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
+ ++ LG+G FG V K K QE AVK ++ + + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 584 RNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGI 636
N++KL E+ + ++ E L FDE K +KRF II +
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGEL----FDEIIK-----RKRFSEHDAARIIKQV 130
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVV 693
G+ Y+H+ I+HRDLK NILL ++ + +I DFG + F + K +
Sbjct: 131 FSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI 184
Query: 694 GTYGYMSPEYALDGVFSTKSDVFSFGVIL 722
GT Y++PE L G + K DV+S GVIL
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 58/207 (28%), Positives = 107/207 (51%), Gaps = 15/207 (7%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHR 584
+ F+ K+G+G FG V+KG + +A+K + + IE+++ E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
+ K G L++ + +I E++ S D LD + I+ I +G+ YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMSPE 702
+ + IHRD+KA+N+LL E +++DFG A G+ KR VGT +M+PE
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPE 189
Query: 703 YALDGVFSTKSDVFSFGVILLEIITGK 729
+ +K+D++S G+ +E+ G+
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
+ + +LG G FG VYK K G A K + T S + +E+ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL---- 641
+VKLLG + + ++ EF P ++D I E + L + I + R +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTE-----PQIQVVCRQMLEALN 131
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYM 699
+LH RIIHRDLKA N+L+ + + R++DFG + + + KR +GT +M
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWM 184
Query: 700 SPE-----YALDGVFSTKSDVFSFGVILLEIITGK 729
+PE D + K+D++S G+ L+E+ +
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG+GGF ++ + A K + E++ E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 592 CCLEEDENM-LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
E+++ + ++ E +SL + RK L + + R+ + I G YLH+
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHR--- 159
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV 708
R+IHRDLK N+ L+E + +I DFG A + + GT Y++PE
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 217
Query: 709 FSTKSDVFSFGVILLEIITGK 729
S + DV+S G I+ ++ GK
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHR 584
D F KLG G FG V+ + S+G E +K ++ Q +E+++ E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 585 NLVKLLGCCLEEDENM-LIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
N++K+ E+ NM ++ E L + + ++R + L +++ + + Y
Sbjct: 81 NIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 643 LHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
H ++H+DLK NIL +I DFG A +F +E GT YM
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYM 193
Query: 700 SPEYALDGVFSTKSDVFSFGVIL 722
+PE + K D++S GV++
Sbjct: 194 APE-VFKRDVTFKCDIWSAGVVM 215
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG+GGF ++ + A K + E++ E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 592 CCLEEDENM-LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
E+++ + ++ E +SL + RK L + + R+ + I G YLH R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLH---R 133
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV 708
R+IHRDLK N+ L+E + +I DFG A + + GT Y++PE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 191
Query: 709 FSTKSDVFSFGVILLEIITGK 729
S + DV+S G I+ ++ GK
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 30/208 (14%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
++ N +G+G +G V A K++ + ++ K E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 586 LVKLLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIA 637
+++L ED L+ E L F+ K+ F I+ +
Sbjct: 68 IIRLYETF--EDNTDIYLVMELCTGGEL----FERVVH-----KRVFRESDAARIMKDVL 116
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVG 694
V Y H+ L + HRDLK N L ++ DFG A F +++ + VG
Sbjct: 117 SAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVG 170
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVIL 722
T Y+SP+ L+G++ + D +S GV++
Sbjct: 171 TPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 62/272 (22%), Positives = 90/272 (33%), Gaps = 72/272 (26%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-TTSGQGIEELKNEVLLIAKLQHRN 585
+F +G+GGFG V++ K + A+KR+ E++ EV +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE--------------------------- 618
+V+ LE E D
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 619 ------------------SRKQLLDWKKR------------FDIILGIARGVLYLHQDSR 648
++ L DW R I + IA V +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK----------RVVGTYGY 698
++HRDLK SNI ++ DFG +E VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEIITGKK 730
MSPE +S K D+FS G+IL E++
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 49/239 (20%), Positives = 96/239 (40%), Gaps = 30/239 (12%)
Query: 506 GNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTS 564
++ A ++ ++G G G V+K + G IAVK++ +
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62
Query: 565 G-QGIEELKNEV-LLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQ 622
+ + + ++ +++ +V+ G + + + E M + K
Sbjct: 63 NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--------KL 113
Query: 623 LLDWKKRF--DIILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676
+ I+ + ++ YL + +IHRD+K SNILLDE+ ++ DFG
Sbjct: 114 KKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 677 ARVFGGEEILAITKRV-VGTYGYMSPE-----YALDGVFSTKSDVFSFGVILLEIITGK 729
+ G + K G YM+PE + ++DV+S G+ L+E+ TG+
Sbjct: 172 S----GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-31
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 19/215 (8%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHR 584
+ +LG GGFG V + G+++A+K+ E E+ ++ KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 585 NLVKLLGCCLEEDENM-------LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIA 637
N+V + + + L E+ L ++ L ++ I+
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ YLH+ RIIHRDLK NI+L +++ +I D G A+ E+ VG
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFVG 185
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
T Y++PE ++ D +SFG + E ITG
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 50/223 (22%), Positives = 90/223 (40%), Gaps = 35/223 (15%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGC 592
L +GGF VY+ + + +G+E A+KRL + + + EV + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 593 CLEEDENMLIYEFMPNKSLDYFIFDE-SRKQLLDW------KKRF------DIILGIARG 639
E ++ + E + QL+++ + I R
Sbjct: 95 ASIGKEES------DTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR-------- 691
V ++H+ + IIHRDLK N+LL + ++ DFG+A + + +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 692 --VVGTYGYMSPE---YALDGVFSTKSDVFSFGVILLEIITGK 729
T Y +PE + K D+++ G IL + +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRN 585
D++ +G G V +++A+KR++ Q ++EL E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD--IILGIARGVL-- 641
+V + +DE L+ + + S+ I + D I I R VL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 642 --YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG-TARVFGGEEILAITKR--VVGTY 696
YLH++ IHRD+KA NILL E + +I+DFG +A + G +I R VGT
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 697 GYMSPEYALDGV-FSTKSDVFSFGVILLEIITGK 729
+M+PE + K+D++SFG+ +E+ TG
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG---IEELKNEVLLIAKLQ 582
FS ++G G FG VY + + N + +A+K++S + Q +++ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H N ++ GC L E L+ E+ + D E K+ L + + G +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMS 700
LH +IHRD+KA NILL E ++ DFG + VGT +M+
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASI----MAPANSFVGTPYWMA 218
Query: 701 PE---YALDGVFSTKSDVFSFGVILLEIITGK 729
PE +G + K DV+S G+ +E+ K
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-30
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 41/226 (18%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-------------TTSGQGIEELK 572
+++ KLG G +G V K + E A+K + + EE+
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 573 NEVLLIAKLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF- 630
NE+ L+ L H N++KL E+ + L+ EF L F++ + + +F
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGEL----FEQ-----IINRHKFD 144
Query: 631 -----DIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGG 682
+I+ I G+ YLH+ I+HRD+K NILL + +N +I DFG + F
Sbjct: 145 ECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG 728
+ L + +GT Y++PE L ++ K DV+S GVI+ ++ G
Sbjct: 202 DYKL---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 49/228 (21%), Positives = 85/228 (37%), Gaps = 34/228 (14%)
Query: 527 TDNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKR--LSTTSGQGIEELKNEVLLIAKL-Q 582
T F K+G G FG V+K K +G A+KR + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 583 HRNLVKLLGCCLEEDENMLIY-EFMPNKSLDYFIFDESRKQLLDWKKRFD------IILG 635
H ++V+ ED++MLI E+ SL I + F ++L
Sbjct: 70 HSHVVRYFSAW-AEDDHMLIQNEYCNGGSLADAI-----SENYRIMSYFKEAELKDLLLQ 123
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV-------------FGG 682
+ RG+ Y+H ++H D+K SNI + P + G
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 683 EEILAITKRVVGTYGYMSPE-YALDGVFSTKSDVFSFGVILLEIITGK 729
++ + G +++ E + K+D+F+ + ++ +
Sbjct: 181 VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 55/231 (23%), Positives = 87/231 (37%), Gaps = 40/231 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEV-LLIAKLQHRNL 586
+ + LG G G V G+ +AVKR+ + E+ LL H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 587 VKLLGCCLEEDENM--LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARG 639
++ C E + + E N +L + DE+ K ++ ++ IA G
Sbjct: 72 IRYY--CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASG 127
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPR-------------ISDFGTARVFGGEE-- 684
V +LH L+IIHRDLK NIL+ ISDFG + +
Sbjct: 128 VAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 685 ILAITKRVVGTYGYMSPEYALDGVF-------STKSDVFSFGVILLEIITG 728
GT G+ +PE + + D+FS G + I++
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL--STTSGQGIEE-LKNEVLLIAKLQH 583
++F N LG+G F VY+ + + G E+A+K + G+ + ++NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 584 RNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILGI 636
++++L E+ + L+ E N + + + K F + I
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNR----VKPFSENEARHFMHQI 121
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY 696
G+LYLH I+HRDL SN+LL MN +I+DFG A T + GT
Sbjct: 122 ITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTP 176
Query: 697 GYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
Y+SPE A +SDV+S G + ++ G+
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-30
Identities = 36/250 (14%), Positives = 80/250 (32%), Gaps = 26/250 (10%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK------LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAK 580
+ + LG+G F VY+ N Q+ +K + + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI--FDESRKQLLDWKKRFDIILGIAR 638
+K L ++ ++L+ E +L I + + ++++ + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 639 GVLYLHQDSRLRIIHRDLKASNILL-----------DEKMNPRISDFGTARVFGGEEILA 687
+ +H IIH D+K N +L D + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK--KNTRIFNDDDSSNLIK 745
I T G+ E + ++ + D F + ++ G K + L +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
Query: 746 YAW--ELWSD 753
++W++
Sbjct: 301 RLPHLDMWNE 310
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-30
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK-----RLSTTSGQGIEELKNEVLLIAK 580
D + +G+G F V + GQ+ AVK + +++ G E+LK E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 581 LQHRNLVKLLGCCLEEDENM--LIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIA 637
L+H ++V+LL + M +++EFM L + + + I
Sbjct: 83 LKHPHIVELLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNP---RISDFGTARVFGGEEILAITKRVVG 694
+ Y H IIHRD+K +LL K N ++ FG A G + VG
Sbjct: 141 EALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVG 195
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVIL 722
T +M+PE + DV+ GVIL
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 7e-30
Identities = 31/290 (10%), Positives = 66/290 (22%), Gaps = 44/290 (15%)
Query: 475 IGERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSN 534
+R EL+ E A + + + S L
Sbjct: 10 FMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQ-NAETTVDSLLSQGERKLKLVE 68
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLL 590
L G V+ + + ++ A+K + S +E L A+L + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 591 GCC-----------------------LEEDENMLIYEFMPNKSLDYFIFDE------SRK 621
++ MP S+D + +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 622 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
+ + R L ++H N+ + + D G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 682 GEEILAITKRVVGTYGYMSPEYALDG--VFSTKSDVFSFGVILLEIITGK 729
Y E+ F+ + + G+ + +
Sbjct: 246 -----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-30
Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
D + +LG G FG V++ + G+ K ++T +KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 586 LVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLY 642
L+ L E+ M LI EF+ L FD + + + + + G+ +
Sbjct: 110 LINLHDAF-EDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKH 164
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPR--ISDFGTARVFGGEEILAITKRVVGTYGYMS 700
+H+ I+H D+K NI+ + K I DFG A +EI+ K T + +
Sbjct: 165 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAA 218
Query: 701 PEYALDGVFSTKSDVFSFGVIL 722
PE +D+++ GV+
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLG 240
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL--STTSGQGIEE-LKNEVLLIAKLQH 583
++F LG+G FG VY + + +A+K L + G+E L+ EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILGIA 637
N+++L G + LI E+ P ++ + E +K +FD I +A
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKL-----SKFDEQRTATYITELA 119
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR---VVG 694
+ Y H R+IHRD+K N+LL +I+DFG + + A + R + G
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCG 169
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
T Y+ PE + K D++S GV+ E + GK
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 527 TDNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
+DN+ +LG+G F V + + G E A K ++T S + ++L+ E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLY 642
N+V+L EE + L+++ + L F++ ++ I I + Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNP---RISDFGTARVFGGEEILAITKRVVGTYGYM 699
H I+HR+LK N+LL K +++DFG A E GT GY+
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYL 174
Query: 700 SPEYALDGVFSTKSDVFSFGVIL 722
SPE +S D+++ GVIL
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVIL 197
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
KLG GG VY + ++A+K + + ++ + EV ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 591 GCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 650
E+D L+ E++ +L +I L + I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 651 IIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFS 710
I+HRD+K NIL+D +I DFG A+ E L T V+GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 711 TKSDVFSFGVILLEIITGK 729
+D++S G++L E++ G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
S + LG G FG V+K + + G ++A K + T + EE+KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 588 KLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLH 644
+L E ++ L+ E++ L FD L + I G+ ++H
Sbjct: 150 QLYD-AFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRI--SDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
Q + I+H DLK NIL + +I DFG AR + E L K GT +++PE
Sbjct: 205 Q---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAPE 258
Query: 703 YALDGVFSTKSDVFSFGVIL 722
S +D++S GVI
Sbjct: 259 VVNYDFVSFPTDMWSVGVIA 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-29
Identities = 57/255 (22%), Positives = 105/255 (41%), Gaps = 15/255 (5%)
Query: 473 TRIGERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFST 532
ERKR+R ++ R +S +I K D++
Sbjct: 102 IPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDI 161
Query: 533 SNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
+LG G FG V++ + G A K + T E ++ E+ ++ L+H LV L
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221
Query: 592 CCLEEDENMLIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLHQDSRL 649
+++E ++IYEFM L F++ + + + + + +G+ ++H+
Sbjct: 222 AFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---N 274
Query: 650 RIIHRDLKASNILLDEKMNPRI--SDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
+H DLK NI+ K + + DFG ++ + K GT + +PE A
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGK 331
Query: 708 VFSTKSDVFSFGVIL 722
+D++S GV+
Sbjct: 332 PVGYYTDMWSVGVLS 346
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 527 TDNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
+DN+ +LG+G F V + + G E A K ++T S + ++L+ E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 584 RNLVKLLGCCLEEDENM--LIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGV 640
N+V+L ++E+ L+++ + L F++ ++ I I +
Sbjct: 88 PNIVRLHDSI--QEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESI 141
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNP---RISDFGTARVFGGEEILAITKRVVGTYG 697
Y H I+HR+LK N+LL K +++DFG A E GT G
Sbjct: 142 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPG 195
Query: 698 YMSPEYALDGVFSTKSDVFSFGVIL 722
Y+SPE +S D+++ GVIL
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 43/202 (21%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
+ + + LG+G FG V++ S+ + K + G +K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 586 LVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLY 642
++ L E E + +I+EF+ + F+ + L+ ++ + + + +
Sbjct: 63 ILHLHESF-ESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNP--RISDFGTARVFGGEEILAITKRVVGTYGYMS 700
LH I H D++ NI+ + + +I +FG AR + + + Y +
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYA 171
Query: 701 PEYALDGVFSTKSDVFSFGVIL 722
PE V ST +D++S G ++
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLV 193
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 42/214 (19%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
F LG G F V+ K G+ A+K + + L+NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD-----ESRKQLLDW---KKRF------D 631
+V L E Y + E L D + +
Sbjct: 68 IVTLEDIY--ESTTHY-----------YLVMQLVSGGE----LFDRILERGVYTEKDASL 110
Query: 632 IILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAI 688
+I + V YLH+ I+HRDLK N+L +E I+DFG +++ +
Sbjct: 111 VIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--- 164
Query: 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVIL 722
GT GY++PE +S D +S GVI
Sbjct: 165 -STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 28/214 (13%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGI---------EELKNEVL 576
+N+ LG+G V + +E AVK + T G E EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 577 LIAKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIIL 634
++ K+ H N+++L L+++ M L FD + K L K+ I+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMR 131
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ + LH+ L I+HRDLK NILLD+ MN +++DFG + E L + V G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCG 185
Query: 695 TYGYMSPE------YALDGVFSTKSDVFSFGVIL 722
T Y++PE + + D++S GVI+
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 37/233 (15%), Positives = 73/233 (31%), Gaps = 43/233 (18%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQH-------- 583
LGQ + G+ V T I+++K EVL + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 584 --------RNLVKLLGCC-----LEEDENMLI---YEFMPNKSLDYFIFDE------SRK 621
+LVK ++ +M + + P + F E S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 622 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681
+ L R + L + R + LH ++H L+ +I+LD++ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 682 GEEILAITKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGK 729
G ++ R + + + D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 52/231 (22%), Positives = 96/231 (41%), Gaps = 41/231 (17%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLS-----------------TTSGQGIEE 570
+++ L QG F + + + + A+K+ + ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 571 LKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL-DY----FIFDESRKQLLD 625
KNE+ +I +++ + G DE +IYE+M N S+ + F+ D++ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 626 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685
+ II + Y+H + I HRD+K SNIL+D+ ++SDFG + ++
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK- 206
Query: 686 LAITKRVVGTYGYMSPEYALDGVFSTK-------SDVFSFGVILLEIITGK 729
K GTY +M PE FS + D++S G+ L +
Sbjct: 207 ---IKGSRGTYEFMPPE-----FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 52/270 (19%), Positives = 89/270 (32%), Gaps = 59/270 (21%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK-----RLSTTSGQGIEELKNEVLLIAK 580
+ +GQG +G V A+K ++ + + +E +K EV L+ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 581 LQHRNLVKLLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRF-------- 630
L H N+ +L EDE L+ E L +
Sbjct: 85 LHHPNIARLYEVY--EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 631 -----------------------------DIILGIARGVLYLHQDSRLRIIHRDLKASNI 661
+I+ I + YLH I HRD+K N
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENF 199
Query: 662 LL--DEKMNPRISDFGTARVF--GGEEILAITKRVVGTYGYMSPE--YALDGVFSTKSDV 715
L ++ ++ DFG ++ F GT +++PE + + K D
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 716 FSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+S GV+L ++ G F + ++ I
Sbjct: 260 WSAGVLLHLLLMGA---VPFPGVNDADTIS 286
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKN--------EVLLIA 579
+ + K+G+G +G VYK K S G+ +A+KR+ ++ E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
+L H N+V L+ E L++EFM K L + + K L + + + RG
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRG 131
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
V + HQ RI+HRDLK N+L++ +++DFG AR F G + + T VV T Y
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYR 186
Query: 700 SPEYAL-DGVFSTKSDVFSFGVILLEIITGK 729
+P+ + +ST D++S G I E+ITGK
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-28
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 39/219 (17%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG--------IEELKNEVLL 577
+ + +G+G V + + G E AVK + T+ + E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 578 IAKL-QHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF----- 630
+ ++ H +++ L+ E M L+++ M L FD + K
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGEL----FDYLTE-----KVALSEKET 202
Query: 631 -DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689
I+ + V +LH I+HRDLK NILLD+ M R+SDFG + E L
Sbjct: 203 RSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--- 256
Query: 690 KRVVGTYGYMSPE------YALDGVFSTKSDVFSFGVIL 722
+ + GT GY++PE + + D+++ GVIL
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 9e-28
Identities = 36/241 (14%), Positives = 74/241 (30%), Gaps = 58/241 (24%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQ--------- 582
LGQ + G+ V T I+++K EVL + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 583 ----------------HRNLVKLLGCCLEEDENM----LIYEFMPNKSLDYF--IFDESR 620
+ ++++ E D + +Y M + + + S
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLD--ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 621 KQ-LLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
L R + L + R + LH ++H L+ +I+LD++ ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 680 FGGEEILAITKRVVGTYGYMSPEYALD-----------GVFSTKSDVFSFGVILLEIITG 728
G + G+ PE + + D ++ G+++ I
Sbjct: 256 DG------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 729 K 729
Sbjct: 310 D 310
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHR 584
F +G G +G VYKG+ + GQ A+K + T G EE+K E+ ++ K HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHR 81
Query: 585 NLVKLLGC------CLEEDENMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIA 637
N+ G +D+ L+ EF S+ D + ++ L + I I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEWIAYICREIL 139
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGT 695
RG+ +LHQ ++IHRD+K N+LL E ++ DFG + + + +R +GT
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGT 192
Query: 696 YGYMSPE-----YALDGVFSTKSDVFSFGVILLEIITGK 729
+M+PE D + KSD++S G+ +E+ G
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 67/217 (30%), Positives = 114/217 (52%), Gaps = 22/217 (10%)
Query: 524 LAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG-----IEELKNEVLL 577
++++ F KLG G + VYKG + G +A+K + S +G I E+ L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----L 56
Query: 578 IAKLQHRNLVKLLGCCLEEDENMLIYEFMPN--KSL--DYFIFDESRKQLLDWKKRFDII 633
+ +L+H N+V+L E++ L++EFM N K + + R L+ K F
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF--Q 114
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
+ +G+ + H++ +I+HRDLK N+L++++ ++ DFG AR F G + + VV
Sbjct: 115 WQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170
Query: 694 GTYGYMSPEYAL-DGVFSTKSDVFSFGVILLEIITGK 729
T Y +P+ + +ST D++S G IL E+ITGK
Sbjct: 171 -TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLST------TSGQGIEELKNEVLLIA 579
D + +LG G F V K + S G E A K + G EE++ EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 580 KLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIA 637
++ H N++ L E ++ LI E + L FD ++K+ L ++ I I
Sbjct: 71 QVLHHNVITLHDVY-ENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQIL 125
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNP----RISDFGTARVFGGEEILAITKRVV 693
GV YLH +I H DLK NI+L +K P ++ DFG A K +
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF 179
Query: 694 GTYGYMSPEYALDGVFSTKSDVFSFGVIL 722
GT +++PE ++D++S GVI
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
LG GG V+ + L + +++AVK L + E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 591 GCCLEEDENMLIY----EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
E + E++ +L + E + K+ ++I + + + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH-- 133
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI-LAITKRVVGTYGYMSPEYAL 705
+ IIHRD+K +NI++ ++ DFG AR + T V+GT Y+SPE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 706 DGVFSTKSDVFSFGVILLEIITGK 729
+SDV+S G +L E++TG+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT------SGQGIEELKNEVLLIA 579
D++ +LG G F V K + G+E A K + G EE++ EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 580 KLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIA 637
+++H N++ L E ++ LI E + L FD + K+ L + + I
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQIL 118
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNP----RISDFGTARVFGGEEILAITKRVV 693
GV YLH RI H DLK NI+L +K P ++ DFG A K +
Sbjct: 119 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF 172
Query: 694 GTYGYMSPEYALDGVFSTKSDVFSFGVIL 722
GT +++PE ++D++S GVI
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 42/223 (18%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLI 578
D + KLG+G +G VYK + +A+KR+ +E + EV L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------I 632
+LQHRN+++L LI+E+ + K+ +D
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSF 137
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR-----ISDFGTARVFGGEEILA 687
+ + GV + H R +HRDLK N+LL I DFG AR F G I
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193
Query: 688 ITKRVVGTYGYMSPEYAL-DGVFSTKSDVFSFGVILLEIITGK 729
T ++ T Y PE L +ST D++S I E++
Sbjct: 194 FTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTS------GQGIEELKNEVLLIA 579
D + +LG G F V K + S G E A K + G EE++ EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIAR 638
++ H N++ L + +LI E + L FD ++K+ L ++ I I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILD 126
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNP----RISDFGTARVFGGEEILAITKRVVG 694
GV YLH +I H DLK NI+L +K P ++ DFG A K + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFG 180
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVIL 722
T +++PE ++D++S GVI
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 33/216 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG-----IEELKNEVLLIAKL 581
+ + +KLG+G + VYKGK +A+K + +G I E+ L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKR-FD------IIL 634
+H N+V L E L++E++ D+ KQ LD + +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL----------DKDLKQYLDDCGNIINMHNVKLFLF 107
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ RG+ Y H+ +++HRDLK N+L++E+ +++DFG AR VV
Sbjct: 108 QLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV- 162
Query: 695 TYGYMSPEYAL-DGVFSTKSDVFSFGVILLEIITGK 729
T Y P+ L +ST+ D++ G I E+ TG+
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 55/211 (26%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKN--------EVLLIA 579
+ + K+G+G +G VYK + + G+ A+K++ +E+ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
+L+H N+VKL + +L++E + + L + + + L+ +L + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL--DVCEGGLESVTAKSFLLQLLNG 112
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
+ Y H R++HRDLK N+L++ + +I+DFG AR F G + T +V T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYR 167
Query: 700 SPEYAL-DGVFSTKSDVFSFGVILLEIITGK 729
+P+ + +ST D++S G I E++ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 48/233 (20%), Positives = 85/233 (36%), Gaps = 38/233 (16%)
Query: 520 LSTLLAATDNFSTSNKLGQG--GFGPVYKGK-LSNGQEIAVKR--LSTTSGQGIEELKNE 574
+S+ L + +G+G V + G+ + V+R L S + + L+ E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 575 VLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-------FDESRKQLLDWK 627
+ + H N+V + ++E ++ FM S I +E
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE--------- 127
Query: 628 KRFDIILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683
I I +GVL Y+H +HR +KAS+IL+ +S +
Sbjct: 128 ---LAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181
Query: 684 E-----ILAITKRVVGTYGYMSPE--YALDGVFSTKSDVFSFGVILLEIITGK 729
+ K V ++SPE + KSD++S G+ E+ G
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 51/213 (23%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLI 578
+ K+G+G +G V+K K + +A+KR+ +++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
+L+H+N+V+L + + L++EF + L + +S LD + + + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFLFQLLK 112
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
G+ + H ++HRDLK N+L++ ++++FG AR F G + + VV T Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWY 167
Query: 699 MSPEYAL-DGVFSTKSDVFSFGVILLEIITGKK 730
P+ ++ST D++S G I E+ +
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT------SGQGIEELKNEVLLIA 579
D + T +LG G F V K + S G + A K + G E+++ EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 580 KLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIA 637
++QH N++ L E ++ LI E + L FD + K+ L ++ + + I
Sbjct: 70 EIQHPNVITLHEVY-ENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQIL 124
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNP----RISDFGTARVFGGEEILAITKRVV 693
GV YLH L+I H DLK NI+L ++ P +I DFG A K +
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF 178
Query: 694 GTYGYMSPEYALDGVFSTKSDVFSFGVIL 722
GT +++PE ++D++S GVI
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-27
Identities = 59/242 (24%), Positives = 102/242 (42%), Gaps = 30/242 (12%)
Query: 499 EASISTKGNKEIRKVDVTFFELSTLLAA-TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIA 556
E ++S NK D+T + S A D + S LG G G V +++A
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 164
Query: 557 VKRLST--------TSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM-LIYEFMP 607
++ +S ++ E+ ++ KL H ++K+ + E+ ++ E M
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLELME 222
Query: 608 NKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK 666
L FD+ + L + V YLH+ IIHRDLK N+LL +
Sbjct: 223 GGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQ 275
Query: 667 MNP---RISDFGTARVFGGEEILAITKRVVGTYGYMSPE---YALDGVFSTKSDVFSFGV 720
+I+DFG +++ G ++ + + GT Y++PE ++ D +S GV
Sbjct: 276 EEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332
Query: 721 IL 722
IL
Sbjct: 333 IL 334
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 29/213 (13%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE--------LKNEVLL 577
D + S LG G G V +++A+K +S ++ E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 578 IAKLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILG 635
+ KL H ++K+ + E+ ++ E M L FD+ + L
Sbjct: 69 LKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ 122
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRV 692
+ V YLH IIHRDLK N+LL +E +I+DFG +++ G ++ + +
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTL 176
Query: 693 VGTYGYMSPE---YALDGVFSTKSDVFSFGVIL 722
GT Y++PE ++ D +S GVIL
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL--STTSGQGIEE-LKNEVLLIAKLQH 583
D+F LG+G FG VY + N +A+K L S +G+E L+ E+ + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 584 RNLVKLLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILG 635
N++++ D L+ EF P L + E +K RFD +
Sbjct: 74 PNILRMYNYF--HDRKRIYLMLEFAPRGEL----YKELQKH-----GRFDEQRSATFMEE 122
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+A + Y H ++IHRD+K N+L+ K +I+DFG + + + GT
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGT 175
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
Y+ PE K D++ GV+ E + G
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL----------STTSGQGIEELKNEVL 576
+ + +G+G +G V K + G+ +A+K+ + E+K
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA----MREIK---- 76
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
L+ +L+H NLV LL C ++ L++EF+ + LD E LD++ + I
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQI 133
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY 696
G+ + H IIHRD+K NIL+ + ++ DFG AR V T
Sbjct: 134 INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TR 188
Query: 697 GYMSPEYAL-DGVFSTKSDVFSFGVILLEIITGK 729
Y +PE + D + DV++ G ++ E+ G+
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 50/214 (23%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL----------STTSGQGIEELKNEVL 576
+ + K+G+G +G V+K + GQ +A+K+ + E++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA----LREIR---- 54
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
++ +L+H NLV LL + L++E+ + L + ++ + I
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQT 111
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY 696
+ V + H+ IHRD+K NIL+ + ++ DFG AR+ G V T
Sbjct: 112 LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TR 166
Query: 697 GYMSPEYAL-DGVFSTKSDVFSFGVILLEIITGK 729
Y SPE + D + DV++ G + E+++G
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 57/251 (22%), Positives = 101/251 (40%), Gaps = 43/251 (17%)
Query: 490 NSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK- 548
+ F + ++ V + + S A +D F ++LG+G VY+ K
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74
Query: 549 LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608
+ A+K L T + ++ E+ ++ +L H N++KL E +
Sbjct: 75 KGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF--ETPTEI------- 123
Query: 609 KSLDYFIFD-----ESRKQLLDW---KKRF------DIILGIARGVLYLHQDSRLRIIHR 654
+ + E L D K + D + I V YLH+ I+HR
Sbjct: 124 ----SLVLELVTGGE----LFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHR 172
Query: 655 DLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFST 711
DLK N+L +I+DFG +++ + ++ K V GT GY +PE +
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILRGCAYGP 229
Query: 712 KSDVFSFGVIL 722
+ D++S G+I
Sbjct: 230 EVDMWSVGIIT 240
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 42/216 (19%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH 583
T+ + +LG+G F V + + GQE A ++T S + ++L+ E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD-----ESRKQLLDW---KKRF----- 630
N+V+L +E Y IFD E L + ++ +
Sbjct: 70 PNIVRLHDSI--SEEGHH-----------YLIFDLVTGGE----LFEDIVAREYYSEADA 112
Query: 631 -DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP---RISDFGTARVFGGEEIL 686
I I VL+ HQ + ++HR+LK N+LL K+ +++DFG A GE+
Sbjct: 113 SHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-- 167
Query: 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVIL 722
GT GY+SPE + D+++ GVIL
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLI 578
+ + LG+G F VYK + + Q +A+K++ E K+ E+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 579 AKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
+L H N++ LL + L+++FM L+ I D S K + +L +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY--MLMTLQ 123
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
G+ YLHQ I+HRDLK +N+LLDE +++DFG A+ F G A T +VV T Y
Sbjct: 124 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWY 178
Query: 699 MSPEYALDG-VFSTKSDVFSFGVILLEIITGK 729
+PE ++ D+++ G IL E++
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 21/204 (10%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKL- 589
+G+GG G VY+ + + +A+K +S ++ ++ E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 590 -LGCCLEEDENMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
G E + L Y + L + + L + I+ I + H
Sbjct: 101 DFG----EIDGQL-YVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHA 152
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
HRD+K NIL+ + DFG A +E L VGT YM+PE
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 706 DGVFSTKSDVFSFGVILLEIITGK 729
+ + ++D+++ +L E +TG
Sbjct: 209 ESHATYRADIYALTCVLYECLTGS 232
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 42/228 (18%)
Query: 525 AATDNFSTS---------NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNE 574
+TD+FS + LG+G V L QE AVK + G + E
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 575 VLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--- 630
V ++ + Q HRN+++L+ EED L++E M S+ K ++ F
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHK-----RRHFNEL 111
Query: 631 ---DIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEE 684
++ +A + +LH I HRDLK NIL ++ +I DF
Sbjct: 112 EASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 685 ILAITKR-----VVGTYGYMSPE-----YALDGVFSTKSDVFSFGVIL 722
+ G+ YM+PE ++ + D++S GVIL
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 54/233 (23%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN--------EVLLI 578
+ K+GQG FG V+K + GQ++A+K++ +E K E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 579 AKLQHRNLVKLLGCCLEEDENM--------LIYEFMPN---KSLD--YFIFDESR----- 620
L+H N+V L+ C + L+++F + L F S
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 621 KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680
+ LL G+ Y+H++ +I+HRD+KA+N+L+ +++DFG AR F
Sbjct: 131 QMLL-------------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 681 G---GEEILAITKRVVGTYGYMSPEYAL-DGVFSTKSDVFSFGVILLEIITGK 729
+ T RVV T Y PE L + + D++ G I+ E+ T
Sbjct: 175 SLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHR-NLVKLL 590
+LG+G F V + S GQE A K L E+ +E+ ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 591 GCCLEEDENM-LIYEFMPNKSLDYFIFD---ESRKQLLDWKKRFDIILGIARGVLYLHQD 646
E + LI E+ + F +++ +I I GV YLHQ
Sbjct: 96 EVY-ENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ- 149
Query: 647 SRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703
I+H DLK NILL + +I DFG +R G L + ++GT Y++PE
Sbjct: 150 --NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL---REIMGTPEYLAPEI 204
Query: 704 ALDGVFSTKSDVFSFGVIL 722
+T +D+++ G+I
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 47/231 (20%), Positives = 84/231 (36%), Gaps = 60/231 (25%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK--------RLSTTSGQGIEELKNEVLLIA 579
+ST + LG G FG V+ +E+ VK + ++ E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI----------FDESRKQLLDWKKR 629
+++H N++K+ + N+ + F +D R
Sbjct: 85 RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFA-----FIDRHPR 126
Query: 630 FDIILG------IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683
D L + V YL IIHRD+K NI++ E ++ DFG+A
Sbjct: 127 LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 684 EILAITKRVVGTYGYMSPEYALDGVFSTKS------DVFSFGVILLEIITG 728
++ GT Y +PE V +++S GV L ++
Sbjct: 184 KLF---YTFCGTIEYCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-25
Identities = 43/205 (20%), Positives = 83/205 (40%), Gaps = 28/205 (13%)
Query: 535 KLGQGGFGPVYKGK--LSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHRNLVKLL- 590
+ GG G +Y NG+ + +K L + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 591 -GCCLEEDENMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+ + + Y E++ +SL S+ Q L + +L I + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMSPEYA 704
+ +++ DLK NI+L E+ ++ D G I + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--------RINSFGYLYGTPGFQAPEIV 249
Query: 705 LDGVFSTKSDVFSFGVILLEIITGK 729
G + +D+++ G L +
Sbjct: 250 RTGP-TVATDIYTVGRTLAALTLDL 273
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 57/221 (25%), Positives = 110/221 (49%), Gaps = 34/221 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK--LSNGQEIAVKRL----------STTSGQGIEELKNEV 575
+ ++G+G +G V+K + + G+ +A+KR+ +T I E+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST----IREVA--- 63
Query: 576 LL--IAKLQHRNLVKLLGCCLEEDEN-----MLIYEFMPNKSLDYFIFDESRKQLLDWKK 628
+L + +H N+V+L C + L++E + ++ L ++ D+ + + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTET 121
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688
D++ + RG+ +LH R++HRDLK NIL+ +++DFG AR++ + +A+
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MAL 176
Query: 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
T VV T Y +PE L ++T D++S G I E+ K
Sbjct: 177 TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 62/218 (28%), Positives = 110/218 (50%), Gaps = 22/218 (10%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN-----EVLLIA 579
AT + ++G G +G VYK + +G +A+K + +G G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 580 KLQ---HRNLVKLLGCCLEEDEN-----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD 631
+L+ H N+V+L+ C + L++E + ++ L ++ D++ L + D
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 632 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691
++ RG+ +LH + I+HRDLK NIL+ +++DFG AR++ + +A+T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPV 179
Query: 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
VV T Y +PE L ++T D++S G I E+ K
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 38/212 (17%)
Query: 527 TDNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
TD + +G G + + + E AVK + + EE++ +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIARG 639
++ L + ++ E M L D+ + +K F ++ I +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILR-----QKFFSEREASAVLFTITKT 128
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNP----RISDFGTARVFGGEEILAITKRVVGT 695
V YLH ++HRDLK SNIL ++ RI DFG A+ E L +T T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
Query: 696 YGYMSPEYALDGVFSTKS-----DVFSFGVIL 722
+++PE V + D++S GV+L
Sbjct: 184 ANFVAPE-----VLERQGYDAACDIWSLGVLL 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 65/254 (25%), Positives = 103/254 (40%), Gaps = 72/254 (28%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLS--------------------------TTSGQGI 568
+G+G +G V ++ A+K LS I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 569 EELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM--PNKSLDYFIFDESRK-QLLD 625
E++ E+ ++ KL H N+VKL E + PN+ Y +F+ + +++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL-------------VEVLDDPNEDHLYMVFELVNQGPVME 127
Query: 626 --WKKRF----------DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673
K D+I GI YLH +IIHRD+K SN+L+ E + +I+D
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 674 FGTARVFGGEEILAITKRVVGTYGYMSPE--YALDGVFS-TKSDVFSFGVILLEIITGKK 730
FG + F G + L VGT +M+PE +FS DV++ GV L + G
Sbjct: 181 FGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG-- 236
Query: 731 NTRI-FNDDDSSNL 743
+ F D+ L
Sbjct: 237 --QCPFMDERIMCL 248
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 53/235 (22%), Positives = 89/235 (37%), Gaps = 49/235 (20%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLS----TTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
LG+G +G V + AVK L G +K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 591 GCCLEEDENM--LIYEFMPNKSLDYFIF--------DESRK---QLLDWKKRFDIILGIA 637
E++ ++ E+ + ++ QL+D
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID------------ 120
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYG 697
G+ YLH I+H+D+K N+LL +IS G A + G+
Sbjct: 121 -GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 698 YMSPE-------YALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+ PE + G K D++S GV L I TG F D+ L +
Sbjct: 177 FQPPEIANGLDTF--SG---FKVDIWSAGVTLYNITTGLYP---FEGDNIYKLFE 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHRNLVKLLGCC 593
LG+G +G V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 594 LEEDENMLIYEFMPNKSL-DYFIF------DESRK---QLLDWKKRFDIILGIARGVLYL 643
E + L E+ L D ++++ QL+ GV+YL
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------------GVVYL 121
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703
H + I HRD+K N+LLDE+ N +ISDFG A VF + ++ GT Y++PE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 704 ALDGVFSTK------SDVFSFGVILLEIITG 728
+ + DV+S G++L ++ G
Sbjct: 178 ----LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 535 KLGQGGFGPVYKGK---LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
K+G+G +G VYK K + ++ A+K++ T G + + E+ L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACR-EIALLRELKHPNVISLQK 85
Query: 592 CCLEEDEN--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILGIARGVLYL 643
L + L++++ L + I + + ++ I G+ YL
Sbjct: 86 VFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPR----ISDFGTARVFG--GEEILAITKRVVGTYG 697
H + ++HRDLK +NIL+ + R I+D G AR+F + + + VV T+
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 698 YMSPEYALDG--VFSTKSDVFSFGVILLEIITGK 729
Y +PE L G ++ D+++ G I E++T +
Sbjct: 201 YRAPELLL-GARHYTKAIDIWAIGCIFAELLTSE 233
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 50/253 (19%), Positives = 101/253 (39%), Gaps = 40/253 (15%)
Query: 496 SEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI 555
+ + + + V + T ++ +G G FG V++ KL E+
Sbjct: 8 APLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV 67
Query: 556 AVKRLSTTSGQGIEELKN-EVLLIAKLQHRNLVKLLGCCLEEDENM------LIYEFMPN 608
A+K++ + KN E+ ++ ++H N+V L + L+ E++P
Sbjct: 68 AIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP- 121
Query: 609 KSLDYFIFDESRKQLLDWKKRFDIILG----------IARGVLYLHQDSRLRIIHRDLKA 658
E+ + + + + R + Y+H + I HRD+K
Sbjct: 122 ---------ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKP 169
Query: 659 SNILLDEKMNP-RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVF 716
N+LLD ++ DFG+A++ E + Y Y +PE ++T D++
Sbjct: 170 QNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYICSRY-YRAPELIFGATNYTTNIDIW 226
Query: 717 SFGVILLEIITGK 729
S G ++ E++ G+
Sbjct: 227 STGCVMAELMQGQ 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 46/229 (20%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHRNLVKLLGC 592
+G+G F V + + G+E+A+K + + + +++L EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 593 CLEEDENMLIYEFMPNKSL-DYFIF------DESRK---QLLDWKKRFDIILGIARGVLY 642
E LI E+ + DY + E+R Q++ V Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-------------AVQY 129
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
H + RI+HRDLKA N+LLD MN +I+DFG + F L G Y +PE
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPE 183
Query: 703 YALDGVFS------TKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+F + DV+S GVIL +++G F+ + L +
Sbjct: 184 -----LFQGKKYDGPEVDVWSLGVILYTLVSGSLP---FDGQNLKELRE 224
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHRNLVKLLGCC 593
LG+G +G V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 594 LEEDENMLIYEFMPNKSL-DYFIF------DESRK---QLLDWKKRFDIILGIARGVLYL 643
E + L E+ L D ++++ QL+ GV+YL
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------------GVVYL 121
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703
H + I HRD+K N+LLDE+ N +ISDFG A VF + ++ GT Y++PE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 704 ALDGVFSTK------SDVFSFGVILLEIITG 728
+ + DV+S G++L ++ G
Sbjct: 178 ----LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 32/205 (15%)
Query: 531 STSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVK 588
LG+G F K + Q AVK +S + E+ + + H N+VK
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70
Query: 589 LLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIARGV 640
L D+ L+ E + L F+ +K KK F I+ + V
Sbjct: 71 LHEVF--HDQLHTFLVMELLNGGEL----FERIKK-----KKHFSETEASYIMRKLVSAV 119
Query: 641 LYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVGTYG 697
++H + ++HRDLK N+L ++ + +I DFG AR+ + T T
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLH 174
Query: 698 YMSPEYALDGVFSTKSDVFSFGVIL 722
Y +PE + D++S GVIL
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVIL 199
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
++F LG+G F V + + +E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILG 635
VKL ++++ + N L +I FDE+ RF +I+
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAEIVSA 142
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ YLH IIHRDLK NILL+E M+ +I+DFGTA+V E A VGT
Sbjct: 143 LE----YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
Y+SPE + SD+++ G I+ +++ G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 73/243 (30%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG G FG V G+ G ++AVK R S + ++K E+ + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 592 CCLEEDENMLIYEFMPNKSLDYFI---------FD-----------ESRK---QLLDWKK 628
Y+ + + + + FD E+R+ Q+L
Sbjct: 77 -----------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS--- 122
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688
V Y H R ++HRDLK N+LLD MN +I+DFG + + E L
Sbjct: 123 ----------AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-- 167
Query: 689 TKRVVGTYGYMSPEYALDGVFS------TKSDVFSFGVILLEIITGKKNTRIFNDDDSSN 742
+ G+ Y +PE V S + D++S GVIL ++ G T F+D+
Sbjct: 168 -RTSCGSPNYAAPE-----VISGRLYAGPEVDIWSCGVILYALLCG---TLPFDDEHVPT 218
Query: 743 LIK 745
L K
Sbjct: 219 LFK 221
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 57/242 (23%), Positives = 97/242 (40%), Gaps = 72/242 (29%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG+G FG V Q++A+K R ++ E+ + L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 592 CCLEEDENMLIYEFMPNKSLDYFI--------FD-----------ESRK---QLLDWKKR 629
Y+ + + + FD E R+ Q++
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIIC---- 119
Query: 630 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689
+ Y H R +I+HRDLK N+LLD+ +N +I+DFG + + L
Sbjct: 120 ---------AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--- 164
Query: 690 KRVVGTYGYMSPEYALDGVFS------TKSDVFSFGVILLEIITGKKNTRIFNDDDSSNL 743
K G+ Y +PE V + + DV+S G++L ++ G F+D+ NL
Sbjct: 165 KTSCGSPNYAAPE-----VINGKLYAGPEVDVWSCGIVLYVMLVG---RLPFDDEFIPNL 216
Query: 744 IK 745
K
Sbjct: 217 FK 218
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 41/210 (19%)
Query: 532 TSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEV-LLIAKLQHRNLVKL 589
TS LG G G V + ++ A+K L + + EV L Q ++V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRI 120
Query: 590 LGCCLEEDENM------LIYEFMPNKSLDYFIFD--ESRKQLLDWKKRF------DIILG 635
+ E+ ++ E + L F + R + F +I+
Sbjct: 121 VDVY--ENLYAGRKCLLIVMECLDGGEL----FSRIQDRGD-----QAFTEREASEIMKS 169
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRV 692
I + YLH + I HRD+K N+L +++DFG A+ L
Sbjct: 170 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTP 223
Query: 693 VGTYGYMSPEYALDGVFSTKSDVFSFGVIL 722
T Y++PE + D++S GVI+
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 45/208 (21%), Positives = 82/208 (39%), Gaps = 38/208 (18%)
Query: 532 TSNKLGQGGFGPVYKG-KLSNGQEIAVKRLSTTSGQGIEELKNEV-LLIAKLQHRNLVKL 589
+ LG G G V + GQ+ A+K L + + + EV ++V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 590 LGCCLEEDENM------LIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIA 637
L E+ + +I E M L F +++ + F +I+ I
Sbjct: 88 LDVY--ENMHHGKRCLLIIMECMEGGEL----FSRIQER---GDQAFTEREAAEIMRDIG 138
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ +LH I HRD+K N+L ++ +++DFG A+ + +
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCY 191
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVIL 722
T Y++PE + D++S GVI+
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 31/221 (14%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQ 582
D F GQG FG V GK G +A+K++ + ++ ++ +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAVLH 77
Query: 583 HRNLVKLLGCCLEEDEN-------MLIYEFMP---NKSLDYFIFDESRKQLL--DWKKRF 630
H N+V+L E ++ E++P ++ + R+ K F
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY---RRQVAPPPILIKVF 134
Query: 631 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTARVFGGEEILAIT 689
+ + R + LH S + + HRD+K N+L++E ++ DFG+A+ E
Sbjct: 135 --LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN--V 189
Query: 690 KRVVGTYGYMSPEYALDGVFSTKS-DVFSFGVILLEIITGK 729
+ Y Y +PE T + D++S G I E++ G+
Sbjct: 190 AYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 41/223 (18%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKN-EVLLIAKLQHR 584
+++ + +G G FG VY+ KL +G+ +A+K++ + KN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 585 NLVKLLGCCLEEDENM------LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--- 635
N+V+L E L+ +++P E+ ++ R L
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP----------ETVYRVARHYSRAKQTLPVIY 157
Query: 636 -------IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTARVFGGEEILA 687
+ R + Y+H I HRD+K N+LLD ++ DFG+A+ E
Sbjct: 158 VKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN- 213
Query: 688 ITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGK 729
+ Y Y +PE +++ DV+S G +L E++ G+
Sbjct: 214 -VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 34/218 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VL-LIAK 580
++FS +G+GGFG VY + ++ ++ A+K L QG NE +L L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DI 632
+V + D+ I + M L Y + F E+ RF +I
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAAEI 301
Query: 633 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV 692
ILG+ ++H +++RDLK +NILLDE + RISD G A F ++
Sbjct: 302 ILGLE----HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHAS 350
Query: 693 VGTYGYMSPEYALDGVFSTKS-DVFSFGVILLEIITGK 729
VGT+GYM+PE GV S D FS G +L +++ G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 4e-22
Identities = 68/243 (27%), Positives = 102/243 (41%), Gaps = 73/243 (30%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG G FG V GK G ++AVK R S + +++ E+ + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 592 CCLEEDENMLIYEFMPNKSLDYFI---------FD-----------ESRK---QLLDWKK 628
Y+ + S + + FD ESR+ Q+L
Sbjct: 82 -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--- 127
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688
GV Y H R ++HRDLK N+LLD MN +I+DFG + + E L
Sbjct: 128 ----------GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-- 172
Query: 689 TKRVVGTYGYMSPEYALDGVFS------TKSDVFSFGVILLEIITGKKNTRIFNDDDSSN 742
+ G+ Y +PE V S + D++S GVIL ++ G T F+DD
Sbjct: 173 -RTSCGSPNYAAPE-----VISGRLYAGPEVDIWSSGVILYALLCG---TLPFDDDHVPT 223
Query: 743 LIK 745
L K
Sbjct: 224 LFK 226
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 45/221 (20%), Positives = 81/221 (36%), Gaps = 52/221 (23%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRL------STTSGQGIEELKNEVLLIAKLQHR--NL 586
LG GGFG VY G +S+ +A+K + + EV+L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFD--ESRKQLLDW---KKRFDIILG------ 635
++L ++ I + E + L D+ + L
Sbjct: 111 IRL-------------LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ V + H ++HRD+K NIL+D + ++ DFG+ + G
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDG 210
Query: 695 TYGYMSPEYALDGVFS------TKSDVFSFGVILLEIITGK 729
T Y PE + V+S G++L +++ G
Sbjct: 211 TRVYSPPE-----WIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 62/230 (26%), Positives = 92/230 (40%), Gaps = 49/230 (21%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHRNLVKLLGCC 593
+G G FG + + +AVK + G I+E ++ E++ L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE--RGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 594 LEEDENMLIYEFMPNKSL-DYFIF------DESRK---QLLDWKKRFDIILGIARGVLYL 643
L +I E+ L + DE+R QLL GV Y
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-------------GVSYC 132
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPR--ISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
H ++I HRDLK N LLD PR I DFG ++ K VGT Y++P
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAP 186
Query: 702 EYALDGVFSTK------SDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
E V + +DV+S GV L ++ G F D + +
Sbjct: 187 E-----VLLRQEYDGKIADVWSCGVTLYVMLVGAYP---FEDPEEPRDYR 228
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIE-ELKNEVLLIAKLQHR 584
D++ KLG+G + V++ ++N +++ VK L + I+ E+K +L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK---ILENLRGGP 91
Query: 585 NLVKLLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
N++ L + L++E + N + L D+ RF + I + + Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKALDY 145
Query: 643 LHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
H S I+HRD+K N+++D E R+ D+G A + + RV Y + P
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRY-FKGP 199
Query: 702 EYALDGVFSTKS-DVFSFGVILLEIITGKK 730
E +D S D++S G +L +I K+
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 43/222 (19%), Positives = 81/222 (36%), Gaps = 54/222 (24%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRL------STTSGQGIEELKNEV----LLIAKLQHR 584
LG+GGFG V+ G L++ ++A+K + + EV + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFI--FDESRKQLLDW---KKRFD------II 633
+++L ++ + + + L D+ K
Sbjct: 99 GVIRL-------------LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP-RISDFGTARVFGGEEILAITKRV 692
+ + + H ++HRD+K NIL+D + ++ DFG+ + E
Sbjct: 146 GQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDF 198
Query: 693 VGTYGYMSPEYALDGVFSTK------SDVFSFGVILLEIITG 728
GT Y PE S + V+S G++L +++ G
Sbjct: 199 DGTRVYSPPE-----WISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 8e-21
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
+ F LG+GGFG V ++ ++ A K+L +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGV 640
R +V L +D L+ M L + I+ + + + F +I G+
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE--- 300
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMS 700
LH R RI++RDLK NILLD+ + RISD G A + K VGT GYM+
Sbjct: 301 -DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMA 353
Query: 701 PEYALDGVFSTKS-DVFSFGVILLEIITGK 729
PE + T S D ++ G +L E+I G+
Sbjct: 354 PE-VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
D F LG+GGFG V+ ++ ++ A K+L+ +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI---------FDESRKQLLDWKKRF---D 631
R +V L + + L+ M + Y I F E R F
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTAQ 297
Query: 632 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR 691
I+ G+ +LHQ II+RDLK N+LLD+ N RISD G A + TK
Sbjct: 298 IVSGLE----HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKG 348
Query: 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
GT G+M+PE L + D F+ GV L E+I +
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 54/246 (21%), Positives = 91/246 (36%), Gaps = 34/246 (13%)
Query: 502 ISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLS 561
+ KG +R + + ++ + G +G V G S G +A+KR+
Sbjct: 2 MQAKGEAAMRDLIAELHAM------QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVF 55
Query: 562 TTSGQGIEELKNEVLLIAK-----------LQHRNLVKLLGCCL-EEDENM----LIYEF 605
T G + K H N++ L + E+ M L+ E
Sbjct: 56 NTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL 115
Query: 606 MPNKSLD-YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664
M D + + R + ++ + I G+ LH+ ++HRDL NILL
Sbjct: 116 MRT---DLAQVIHDQRIVISPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLA 168
Query: 665 EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKS-DVFSFGVILL 723
+ + I DF AR + T V Y +PE + TK D++S G ++
Sbjct: 169 DNNDITICDFNLAREDTADANK--THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225
Query: 724 EIITGK 729
E+ K
Sbjct: 226 EMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 6e-19
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 37/242 (15%)
Query: 503 STKGNKEIRKVDV--TFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKR 559
+K + + V+V + F + + +G G G V + +A+K+
Sbjct: 41 KSKVDNQFYSVEVGDSTFTV------LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK 94
Query: 560 LS-----TTSGQGI-EELKNEVLLIAKLQHRNLVKLL-----GCCLEEDENM-LIYEFMP 607
LS T + EL L+ + H+N++ LL LEE +++ L+ E M
Sbjct: 95 LSRPFQNQTHAKRAYRELV----LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD 150
Query: 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667
L I + +L + + ++ + G+ +LH IIHRDLK SNI++
Sbjct: 151 AN-LCQVI----QMELDHERMSY-LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDC 201
Query: 668 NPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+I DFG AR G ++ T VV T Y +PE L + D++S G I+ E++
Sbjct: 202 TLKILDFGLARTAGTSFMM--TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258
Query: 728 GK 729
K
Sbjct: 259 HK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-----TTSGQGI-EELKNEVLLIA 579
+ +G G G V + +A+K+LS T + EL L+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD-----YFIFD--ES------RKQLLDW 626
+ H+N++ LL N+ F P KSL+ Y + + ++ + +L
Sbjct: 80 CVNHKNIIGLL--------NV----FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 127
Query: 627 KKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686
+ + ++ + G+ +LH IIHRDLK SNI++ +I DFG AR G ++
Sbjct: 128 RMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
T VV T Y +PE L + D++S G I+ E+I G
Sbjct: 184 --TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 62/243 (25%), Positives = 110/243 (45%), Gaps = 38/243 (15%)
Query: 501 SISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKR 559
S+ K + V+ T +EL + + +G G +G V +G+++A+K+
Sbjct: 3 SLIRKKGFYKQDVNKTAWEL------PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK 56
Query: 560 LS-----TTSGQGI-EELKNEVLLIAKLQHRNLVKLL-----GCCLEEDENM-LIYEFMP 607
LS + EL L+ +QH N++ LL L + L+ FM
Sbjct: 57 LSRPFQSEIFAKRAYRELL----LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ 112
Query: 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667
L + + + K ++ ++ + +G+ Y+H ++HRDLK N+ ++E
Sbjct: 113 -TDLQKIM----GLKFSEEKIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDC 163
Query: 668 NPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKS-DVFSFGVILLEII 726
+I DFG AR E +T VV T Y +PE L + ++ D++S G I+ E++
Sbjct: 164 ELKILDFGLARHADAE----MTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
Query: 727 TGK 729
TGK
Sbjct: 219 TGK 221
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 4e-18
Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+A+G+ +L + + IHRDL A NILL EK +I DFG AR +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVILLEIIT 727
+M+PE D V++ +SDV+SFGV+L EI +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 34/157 (21%), Positives = 58/157 (36%), Gaps = 19/157 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRL-STTSGQGIEELKNEVLLIAK 580
D LG+G FG V + + + +AVK L + L +E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 581 L-QHRNLVKLLGCCLEEDE-NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
+ H N+V LLG C + M+I EF +L ++ KR + + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675
G + + I DLK + + S F
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 59/243 (24%), Positives = 113/243 (46%), Gaps = 35/243 (14%)
Query: 502 ISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL 560
++ V F++ ++ + +G+G +G V N +A+K++
Sbjct: 7 MAAAAAAGPEMVRGQVFDV------GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI 60
Query: 561 S----TTSGQGI-EELKNEVLLIAKLQHRNLVKLLGC----CLEEDENM-LIYEFMPNKS 610
S T Q E+K ++ + +H N++ + +E+ +++ ++ + M
Sbjct: 61 SPFEHQTYCQRTLREIK----ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TD 115
Query: 611 LDYFIFDESRKQLL-DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669
L + + Q L + + + I RG+ Y+H S ++HRDLK SN+LL+ +
Sbjct: 116 LYKLL----KTQHLSNDHICY-FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDL 167
Query: 670 RISDFGTARVFGGEEILA--ITKRVVGTYGYMSPEYALDGVFSTKS-DVFSFGVILLEII 726
+I DFG ARV + +T+ V T Y +PE L+ TKS D++S G IL E++
Sbjct: 168 KICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 727 TGK 729
+ +
Sbjct: 227 SNR 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 56/248 (22%), Positives = 97/248 (39%), Gaps = 59/248 (23%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKN-EVLLIAKLQHR 584
+ +S LG G FG V + +G+ A+K++ KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60
Query: 585 NLVKLLGCCLEEDENM--------------------------------------LIYEFM 606
N++KL+ + +I E++
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 607 P---NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663
P +K L FI S + + I + R V ++H L I HRD+K N+L+
Sbjct: 121 PDTLHKVLKSFI--RSGRSIPMNLISI-YIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 664 DEKMNP-RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV-FSTKSDVFSFGVI 721
+ K N ++ DFG+A+ E + + Y +PE L ++ D++S G +
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRF-YRAPELMLGATEYTPSIDLWSIGCV 231
Query: 722 LLEIITGK 729
E+I GK
Sbjct: 232 FGELILGK 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 56/236 (23%), Positives = 104/236 (44%), Gaps = 34/236 (14%)
Query: 513 VDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGI 568
+++ F+L + LG GG G V+ + +A+K++ S +
Sbjct: 2 MNIHGFDL------GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA 55
Query: 569 -EELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD-YFIFD--ES----- 619
E+K +I +L H N+VK+ + + Y + + E+
Sbjct: 56 LREIK----IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANV 111
Query: 620 --RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGT 676
+ LL+ R + + RG+ Y+H + ++HRDLK +N+ ++ E + +I DFG
Sbjct: 112 LEQGPLLEEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 677 ARVFGGE--EILAITKRVVGTYGYMSPEYALDGVFSTKS-DVFSFGVILLEIITGK 729
AR+ +++ +V T Y SP L TK+ D+++ G I E++TGK
Sbjct: 168 ARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 57/235 (24%), Positives = 104/235 (44%), Gaps = 39/235 (16%)
Query: 528 DNFSTSNKLGQGGFGPVYKG-KLSNGQEIAVKRLS----TTSGQGIEELKNEVLLIAKLQ 582
D+F +G+G FG V K + A+K ++ + + + E+ ++ L+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLE 73
Query: 583 HRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DII 633
H LV L +++E+M ++ + + L Y + F E + +++
Sbjct: 74 HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV-------KLFICELV 125
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
+ + YL RIIHRD+K NILLDE + I+DF A + E +
Sbjct: 126 MALD----YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMA 175
Query: 694 GTYGYMSPE--YALDGVFSTKS-DVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
GT YM+PE + G + + D +S GV E++ G+ R ++ S++ +
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR---RPYHIRSSTSSKE 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 32/223 (14%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL----STTSGQGI-EELKNEVLLIAK 580
+ +F + LG+G +G V G+ +A+K++ E+K ++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65
Query: 581 LQHRNLVKLLGC----CLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG 635
+H N++ + E + +I E M L I S + L D ++ I
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI---STQMLSDDHIQY-FIYQ 120
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRV--- 692
R V LH + +IHRDLK SN+L++ + ++ DFG AR+
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 693 -----VGTYGYMSPEYALDGVFSTKS-DVFSFGVILLEIITGK 729
V T Y +PE L +++ DV+S G IL E+ +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS-----TTSGQGI-EELKNEVLLIA 579
+ +G G +G V G ++A+K+L + EL+ L+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 580 KLQHRNLVKLLGCCL--EEDENM----LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 633
++H N++ LL E ++ L+ FM L + ++L + + +F ++
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQF-LV 134
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
+ +G+ Y+H IIHRDLK N+ ++E +I DFG AR E +T VV
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVV 187
Query: 694 GTYGYMSPEYALDGVFSTKS-DVFSFGVILLEIITGK 729
T Y +PE L+ + T++ D++S G I+ E+ITGK
Sbjct: 188 -TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 65/232 (28%), Positives = 111/232 (47%), Gaps = 37/232 (15%)
Query: 512 KVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL-----STTSG 565
+++ T +E+ + + + +G G +G V G +AVK+L S
Sbjct: 19 ELNKTIWEV------PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72
Query: 566 QGI-EELKNEVLLIAKLQHRNLVKLL-----GCCLEEDENM-LIYEFMPNKSLDYFIFDE 618
+ EL+ L+ ++H N++ LL LEE ++ L+ M L+ +
Sbjct: 73 KRTYRELR----LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--- 124
Query: 619 SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
++L D +F +I I RG+ Y+H IIHRDLK SN+ ++E +I DFG AR
Sbjct: 125 KCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180
Query: 679 VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKS-DVFSFGVILLEIITGK 729
E +T V T Y +PE L+ + ++ D++S G I+ E++TG+
Sbjct: 181 HTADE----MTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 48/242 (19%), Positives = 93/242 (38%), Gaps = 37/242 (15%)
Query: 508 KEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TT 563
++ + L + D+F +G+G F V K+ ++ A+K ++
Sbjct: 41 DFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML 100
Query: 564 SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFI------F 616
+ + E ++ R + +L +++ + L+ E+ L +
Sbjct: 101 KRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERI 159
Query: 617 DESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673
RF +I++ I +H+ L +HRD+K NILLD + R++D
Sbjct: 160 PAEMA-------RFYLAEIVMAID----SVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 674 FGTARVFGGEEILAITKRVVGTYGYMSPE-------YALDGVFSTKSDVFSFGVILLEII 726
FG+ + + VGT Y+SPE G + + D ++ GV E+
Sbjct: 206 FGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
Query: 727 TG 728
G
Sbjct: 265 YG 266
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 8e-16
Identities = 40/221 (18%), Positives = 83/221 (37%), Gaps = 23/221 (10%)
Query: 476 GERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNK 535
G + + S + + K + + D + +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIE------ELKNEVLLIAKLQHRNLVK 588
+G G +G V + + +A+K++ I+ E+ ++ +L H ++VK
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILNRLNHDHVVK 116
Query: 589 LLGCCLEED-ENM----LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
+L + +D E ++ E + L + + ++ + GV Y+
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT-LLYNLLVGVKYV 172
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
H S I+HRDLK +N L+++ + ++ DFG AR E
Sbjct: 173 H--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 42/207 (20%), Positives = 71/207 (34%), Gaps = 62/207 (29%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEV-LLIAKLQHRNLVKLLGC 592
LG G G V + ++ A+K L + + EV L Q ++V+++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 79
Query: 593 CLEEDENM------LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRF------DIILGIAR 638
E+ ++ E + L F R + F +I+ I
Sbjct: 80 Y--ENLYAGRKCLLIVMECLDGGEL----FSRIQDRGD-----QAFTEREASEIMKSIGE 128
Query: 639 GVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ YLH + I HRD+K N+L +++DFG A+ E
Sbjct: 129 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTG------EK 174
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVIL 722
Y D++S GVI+
Sbjct: 175 YD-------------KSCDMWSLGVIM 188
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 35/220 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
++F +G+G FG V KL N ++ A+K L+ + E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 584 RNLVKLLGCCLEEDENM-LIYEFMPNKSLDYFI------FDESRKQLLDWKKRF---DII 633
+ + L ++D N+ L+ ++ L + E RF +++
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-------RFYLAEMV 185
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
+ I +HQ L +HRD+K NIL+D + R++DFG+ + + V
Sbjct: 186 IAID----SVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAV 237
Query: 694 GTYGYMSPE-----YALDGVFSTKSDVFSFGVILLEIITG 728
GT Y+SPE G + + D +S GV + E++ G
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 52/230 (22%), Positives = 86/230 (37%), Gaps = 58/230 (25%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRL---STTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
KLG G F V+ K + N +A+K + + +E +KLL
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----------------IKLL 69
Query: 591 GCCLEEDENMLIYEFMPN--KSLDYFIFDESRKQ------------LLDWKKRF------ 630
+ D + K LD+F LL K++
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 631 -DIILGIAR----GVLYLHQDSRLRIIHRDLKASNILLDEKMNP------RISDFGTARV 679
+ I++ G+ Y+H R IIH D+K N+L++ +P +I+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC- 186
Query: 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+ E + T Y SPE L + +D++S ++ E+ITG
Sbjct: 187 WYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 61/263 (23%), Positives = 102/263 (38%), Gaps = 39/263 (14%)
Query: 479 KRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQ 538
K+Q E+ F + S + + K +V + FE LL G+
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLL------------GK 158
Query: 539 GGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
G FG V K A+K L + + E ++ +H L L
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218
Query: 595 EEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQD 646
D + E+ L + + F E R RF +I+ + YLH
Sbjct: 219 THDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAEIVSALD----YLH-- 265
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD 706
S +++RDLK N++LD+ + +I+DFG + + A K GT Y++PE D
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLED 323
Query: 707 GVFSTKSDVFSFGVILLEIITGK 729
+ D + GV++ E++ G+
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 32/250 (12%)
Query: 491 SSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLS 550
++ + SE+E S+ K + S A D F LG G FG V K
Sbjct: 5 AAKKGSEQE-SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 551 NGQEI-AVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606
A+K L + IE NE ++ + LVKL + ++ E++
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 607 PNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKA 658
+ + F E RF I+L YLH L +I+RDLK
Sbjct: 124 AGGEMFSHLRRIGRFSEPHA-------RFYAAQIVLTFE----YLHS---LDLIYRDLKP 169
Query: 659 SNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSF 718
N+L+D++ +++DFG A+ G T + GT ++PE L ++ D ++
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 719 GVILLEIITG 728
GV++ E+ G
Sbjct: 225 GVLIYEMAAG 234
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 52/266 (19%), Positives = 105/266 (39%), Gaps = 50/266 (18%)
Query: 506 GNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS--- 561
G + + + + DN+ + +G+G +G VY + + +A+K+++
Sbjct: 10 GRENLYFQGIKNVHV------PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF 63
Query: 562 --TTSGQGI-EELKNEVLLIAKLQHRNLVKLLGCCLEEDENM-----LIYEFMPNKSLDY 613
+ I E+ ++ +L+ +++L + +D ++ E L
Sbjct: 64 EDLIDCKRILREIT----ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKK 118
Query: 614 FIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673
++ L + + I+ + G ++H IIHRDLK +N LL++ + ++ D
Sbjct: 119 LF--KTPIFLTEEHIKT-ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCD 172
Query: 674 FGTARVFGGEEILAITKRV--------------------VGTYGYMSPEYALDGVFSTKS 713
FG AR E+ I + V T Y +PE L TKS
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232
Query: 714 -DVFSFGVILLEIITGKKNTRIFNDD 738
D++S G I E++ ++ +
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 20/201 (9%), Positives = 56/201 (27%), Gaps = 45/201 (22%)
Query: 535 KLGQGGFGPVYKG---KLSNGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVK 588
G ++ L +++A+ + ++E + L ++++ + +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
+L +++ E++ SL ++ + +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA--DTS---PSPVGAIRAMQSLAAAADAAH---R 147
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV 708
+ S + +S G V+ M
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA------ 179
Query: 709 FSTKSDVFSFGVILLEIITGK 729
+ + D+ G L ++ +
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 53/234 (22%), Positives = 100/234 (42%), Gaps = 30/234 (12%)
Query: 510 IRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSG 565
+ + T ++ L +++ +G+G FG V + + +++ A+K LS
Sbjct: 51 LSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 110
Query: 566 QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN----KSLDYFIFDESRK 621
E ++A +V+L ++ ++ E+MP + + E
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA 170
Query: 622 QLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678
RF +++L + +H + IHRD+K N+LLD+ + +++DFGT
Sbjct: 171 -------RFYTAEVVLALD----AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 679 VFGGEEILAITKRVVGTYGYMSPE----YALDGVFSTKSDVFSFGVILLEIITG 728
E ++ VGT Y+SPE DG + + D +S GV L E++ G
Sbjct: 217 KMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 6e-14
Identities = 29/201 (14%), Positives = 61/201 (30%), Gaps = 46/201 (22%)
Query: 524 LAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRL--------STTSGQGIEELKNEV 575
T+ K+G+G FG V++ + +A+K + + + + EE+ E+
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 576 LLIAKLQ---------HRNLVKLLGCCL-------------------EEDENMLIYEFMP 607
++ +L + L + N F
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 608 NKSLDYFIF-------DESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 660
++ F ++ R +L I+ + + LR HRDL N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 661 ILLDEKMNPRISDFGTARVFG 681
+LL + ++ +
Sbjct: 193 VLLKKTSLKKLHYTLNGKSST 213
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLSTTS----GQGIEELKNEVLLIAKLQ 582
+F LG G FG V+ + + A+K L Q +E +E L+++ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVT 64
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIIL 634
H ++++ G + + +I +++ L + F +F ++ L
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAAEVCL 117
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVG 694
+ YLH II+RDLK NILLD+ + +I+DFG A+ + +T + G
Sbjct: 118 ALE----YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCG 165
Query: 695 TYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG 728
T Y++PE ++ D +SFG+++ E++ G
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 59/245 (24%), Positives = 100/245 (40%), Gaps = 66/245 (26%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIE------ELKNEVLLIA 579
+ KLG+G +G V+K G+ +AVK++ + E+ +L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM---ILTE 64
Query: 580 KLQHRNLVKLLGCCLEEDEN--MLIYEFMP--------NKSLD-----YFIFDESRKQLL 624
H N+V LL +++ L++++M L+ Y ++ QL+
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY-----QLI 119
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
+ + YLH S ++HRD+K SNILL+ + + +++DFG +R F
Sbjct: 120 -------------KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 685 ILAITKRV-------------------VGTYGYMSPEYALDGVFSTKS-DVFSFGVILLE 724
+ + V T Y +PE L TK D++S G IL E
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223
Query: 725 IITGK 729
I+ GK
Sbjct: 224 ILCGK 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 54/242 (22%), Positives = 91/242 (37%), Gaps = 59/242 (24%)
Query: 536 LGQGGFGPVYKGK-LSNGQEIAVKRL---STTSGQGIEELK--------------NEVLL 577
+G+G FG V K Q +A+K + Q EE++ N + +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 578 IAKLQHRN---LV-KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR---KQLLDWKKRF 630
+ RN + +LL L YE + F R +L
Sbjct: 165 LENFTFRNHICMTFELLSMNL--------YELIKKNKFQGFSLPLVRKFAHSILQ----- 211
Query: 631 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP--RISDFGTARVFGGEEILAI 688
+ LH + RIIH DLK NILL ++ ++ DFG++ + + +
Sbjct: 212 --------CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVY-- 257
Query: 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAW 748
+ + Y +PE L + D++S G IL E++TG + +D + +
Sbjct: 258 --TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP---LLPGEDEGDQLACMI 312
Query: 749 EL 750
EL
Sbjct: 313 EL 314
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 7e-13
Identities = 72/249 (28%), Positives = 117/249 (46%), Gaps = 44/249 (17%)
Query: 496 SEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVY---KGKLSNG 552
S +E +I+ + K D + FEL +L GQG FG V+ K S+
Sbjct: 4 SIKEIAITHHVKEGHEKADPSQFELLKVL------------GQGSFGKVFLVKKISGSDA 51
Query: 553 QEI-AVKRLS--TTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609
+++ A+K L T + K E ++ ++ H +VKL E + LI +F+
Sbjct: 52 RQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG 111
Query: 610 SLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNI 661
L + F E +F ++ L + +LH L II+RDLK NI
Sbjct: 112 DLFTRLSKEVMFTEEDV-------KFYLAELALALD----HLHS---LGIIYRDLKPENI 157
Query: 662 LLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKS-DVFSFGV 720
LLDE+ + +++DFG ++ E A + GT YM+PE ++ T+S D +SFGV
Sbjct: 158 LLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE-VVNRRGHTQSADWWSFGV 214
Query: 721 ILLEIITGK 729
++ E++TG
Sbjct: 215 LMFEMLTGT 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 62/248 (25%), Positives = 103/248 (41%), Gaps = 43/248 (17%)
Query: 496 SEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI 555
E + G ++ + FE +L G+G FG V ++ ++
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVL------------GKGSFGKVMLARVKETGDL 50
Query: 556 -AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNK 609
AVK L +E E +L +A+ H L +L C D + EF+
Sbjct: 51 YAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLFCCFQTPDRLFFVMEFVNGG 109
Query: 610 SLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNI 661
L + I FDE+R RF +II + +LH II+RDLK N+
Sbjct: 110 DLMFHIQKSRRFDEARA-------RFYAAEIISALM----FLHD---KGIIYRDLKLDNV 155
Query: 662 LLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVI 721
LLD + + +++DFG + + T GT Y++PE + ++ D ++ GV+
Sbjct: 156 LLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEILQEMLYGPAVDWWAMGVL 213
Query: 722 LLEIITGK 729
L E++ G
Sbjct: 214 LYEMLCGH 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLLG 591
LG+G FG V + A+K L + + E ++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 592 CCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYL 643
D + E+ L + + F E R RF +I+ + YL
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RFYGAEIVSALE----YL 121
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL--AITKRVVGTYGYMSP 701
H +++RD+K N++LD+ + +I+DFG + E I A K GT Y++P
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAP 174
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGK 729
E D + D + GV++ E++ G+
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 44/245 (17%)
Query: 501 SISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVY---KGKLSNGQEI-A 556
S T N+ K+ FEL +L G+GG+G V+ K +N +I A
Sbjct: 2 SSETSVNRGPEKIRPECFELLRVL------------GKGGYGKVFQVRKVTGANTGKIFA 49
Query: 557 VKRLS----TTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLD 612
+K L + + K E ++ +++H +V L+ + LI E++ L
Sbjct: 50 MKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF 109
Query: 613 YFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664
+ F E F +I + + +LHQ II+RDLK NI+L+
Sbjct: 110 MQLEREGIFMEDTA-------CFYLAEISMALG----HLHQ---KGIIYRDLKPENIMLN 155
Query: 665 EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLE 724
+ + +++DFG + + + T GT YM+PE + + D +S G ++ +
Sbjct: 156 HQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213
Query: 725 IITGK 729
++TG
Sbjct: 214 MLTGA 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 55/247 (22%), Positives = 100/247 (40%), Gaps = 43/247 (17%)
Query: 497 EREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEI- 555
E+EA + + K + + F+L ++ G+G + V +L I
Sbjct: 33 EKEAMNTRESGKASSSLGLQDFDLLRVI------------GRGSYAKVLLVRLKKTDRIY 80
Query: 556 AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610
A++ + + I+ ++ E V A H LV L C E + E++
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGLHSCFQTESRLFFVIEYVNGGD 139
Query: 611 LDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNIL 662
L + + E RF +I L + YLH+ II+RDLK N+L
Sbjct: 140 LMFHMQRQRKLPEEHA-------RFYSAEISLALN----YLHE---RGIIYRDLKLDNVL 185
Query: 663 LDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVIL 722
LD + + +++D+G + T GT Y++PE + D ++ GV++
Sbjct: 186 LDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEILRGEDYGFSVDWWALGVLM 243
Query: 723 LEIITGK 729
E++ G+
Sbjct: 244 FEMMAGR 250
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 34/220 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH-RN 585
+ + K+G G FG +Y G ++ G+E+A+K + L E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDW-KKRFDI--ILGIARGVL- 641
+ + C E D N+++ E + SL+ L ++ ++F + +L +A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE---------DLFNFCSRKFSLKTVLLLADQMIS 116
Query: 642 ---YLHQDSRLRIIHRDLKASNILLDEKMNP---RISDFGTARVF----GGEEILAITKR 691
Y+H + IHRD+K N L+ I DFG A+ + + I +
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 692 -VVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGK 729
+ GT Y S G+ S + D+ S G +L+ G
Sbjct: 174 NLTGTARYASI-NTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 54/223 (24%), Positives = 85/223 (38%), Gaps = 54/223 (24%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELK--------------NEV 575
+ +G+G FG V K + +A+K Q E++ V
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 576 LLIAKLQHRN---LV-KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR---KQLLDWKK 628
L RN LV ++L L Y+ + N + + +R +Q+
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSYNL--------YDLLRNTNFRGVSLNLTRKFAQQMCT--- 168
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP--RISDFGTARVFGGEEIL 686
+L+L L IIH DLK NILL +I DFG++ G+ I
Sbjct: 169 ----------ALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIY 216
Query: 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+ + Y SPE L + D++S G IL+E+ TG+
Sbjct: 217 QY----IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 5e-12
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VLLIAKL 581
+F+ LG+G FG V + E+ AVK L +E E VL +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-G 399
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DII 633
+ L +L C D + E++ L Y I F E F +I
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAEIA 452
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR--VFGGEEILAITKR 691
+G+ +L II+RDLK N++LD + + +I+DFG + ++ G TK
Sbjct: 453 IGLF----FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKT 501
Query: 692 VVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
GT Y++PE + D ++FGV+L E++ G+
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 31/208 (14%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKL 589
+G+G + V +L I A+K + + I+ ++ E V A H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 75
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVL 641
C E + E++ L + + E RF +I L +
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAEISLALN---- 124
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
YLH+ II+RDLK N+LLD + + +++D+G + T GT Y++P
Sbjct: 125 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAP 179
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGK 729
E + D ++ GV++ E++ G+
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 31/207 (14%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKL 589
LG+G FG V+ + + A+K L +E E VL +A +H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHM 83
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVL 641
++ + E++ L Y I FD SR F +IILG+
Sbjct: 84 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-------TFYAAEIILGLQ---- 132
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
+LH I++RDLK NILLD+ + +I+DFG + + T GT Y++P
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAP 187
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITG 728
E L ++ D +SFGV+L E++ G
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 34/220 (15%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+ F K+G G FG +Y G + +E+A+K + + +L E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 587 V-KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDW-KKRFDI--ILGIARGVL- 641
+ + +E D N+L+ + + SL+ L ++ ++ + +L +A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLE---------DLFNFCSRKLSLKTVLMLADQMIN 114
Query: 642 ---YLHQDSRLRIIHRDLKASNILLDEKMNPR---ISDFGTARVF----GGEEILAITKR 691
++H S +HRD+K N L+ I DFG A+ + + I +
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 692 -VVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGK 729
+ GT Y S G+ S + D+ S G +L+ + G
Sbjct: 172 NLTGTARYASV-NTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 35/210 (16%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKL 589
LG+G FG V + E+ AVK L +E E VL + + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQL 86
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVL 641
C D + E++ L Y I F E F +I +G+
Sbjct: 87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAEIAIGLF---- 135
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL--AITKRVVGTYGYM 699
+L II+RDLK N++LD + + +I+DFG + E I TK GT Y+
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKTFCGTPDYI 188
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+PE + D ++FGV+L E++ G+
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-11
Identities = 21/123 (17%), Positives = 44/123 (35%), Gaps = 18/123 (14%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
D ++ + G + Y + N V +W + N +
Sbjct: 2 DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNLVLYDNN---------RAVWASGTNGKAS 50
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
VL + GNLV++ ++ +W +N + GN L N+V+ +++ +
Sbjct: 51 GC--VLKMQNDGNLVIYSGSR---AIWASNTN-RQNGNYYLILQRDRNVVI-YDNSNNAI 103
Query: 144 WQS 146
W +
Sbjct: 104 WAT 106
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 47/222 (21%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH-RN 585
++ ++G+G FG +++G L N Q++A+K S L++E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDW-KKRFDI--ILGIARGVL- 641
+ + E N+L+ + + SL+ LLD ++F + + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLE---------DLLDLCGRKFSVKTVAMAAKQMLA 117
Query: 642 ---YLHQDSRLRIIHRDLKASNILLDEKMNPR-----ISDFGTARVF----GGEEILAIT 689
+H+ S +++RD+K N L+ + + DFG + + + I
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 690 KR-VVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGK 729
K+ + GT YMS G S + D+ + G + + + G
Sbjct: 175 KKNLSGTARYMSI-NTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 62/260 (23%), Positives = 103/260 (39%), Gaps = 48/260 (18%)
Query: 490 NSSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVY---K 546
+ + + KV + FEL +L G G +G V+ K
Sbjct: 28 GGEQLLTVKHELRTANLTGHAEKVGIENFELLKVL------------GTGAYGKVFLVRK 75
Query: 547 GKLSNGQEI-AVKRLS----TTSGQGIEELKNE--VLLIAKLQHRNLVKLLGCCLEEDEN 599
+ ++ A+K L + E + E VL + Q LV L E +
Sbjct: 76 ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPFLVTLHYAFQTETKL 134
Query: 600 MLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRI 651
LI +++ L + F E + +I+L + +LH+ L I
Sbjct: 135 HLILDYINGGELFTHLSQRERFTEHEV-------QIYVGEIVLALE----HLHK---LGI 180
Query: 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFS- 710
I+RD+K NILLD + ++DFG ++ F +E GT YM+P+ G
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGH 239
Query: 711 TKS-DVFSFGVILLEIITGK 729
K+ D +S GV++ E++TG
Sbjct: 240 DKAVDWWSLGVLMYELLTGA 259
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 35/210 (16%)
Query: 536 LGQGGFGPVYKGKLSNGQEI-AVKRLS---TTSGQGIEELKNE--VLLIAKLQHRNLVKL 589
+G+G FG V + + AVK L + + + +E VLL ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN-VKHPFLVGL 104
Query: 590 LGCCLEEDENMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVL 641
D+ + +++ L Y + F E R RF +I +
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAAEIASALG---- 153
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL--AITKRVVGTYGYM 699
YLH L I++RDLK NILLD + + ++DFG + E I + T GT Y+
Sbjct: 154 YLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNSTTSTFCGTPEYL 206
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITGK 729
+PE + D + G +L E++ G
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 50/221 (22%), Positives = 86/221 (38%), Gaps = 36/221 (16%)
Query: 529 NFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH-RNL 586
NF K+G G FG + GK L + +A+K S +L E +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDW-KKRFDI--ILGIARGVL-- 641
++ N ++ E + SL+ L D + F + +L IA ++
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLE---------DLFDLCDRTFSLKTVLMIAIQLISR 117
Query: 642 --YLHQDSRLRIIHRDLKASNILLDEKMNPR-----ISDFGTARVF----GGEEILAITK 690
Y+H + +I+RD+K N L+ N I DF A+ + + I
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174
Query: 691 R-VVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGK 729
+ + GT YMS G S + D+ + G + + + G
Sbjct: 175 KSLTGTARYMSI-NTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 8e-11
Identities = 20/126 (15%), Positives = 41/126 (32%), Gaps = 19/126 (15%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
+ ++ + + G + Y N V W +N
Sbjct: 2 NLLTNGEGLYAGQSLDVEP--YHFIMQEDCNLVLYDHSTSV---------WASNTGILGK 50
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
+ GN V+++ +W ++ S GN V L + GN+V+ +D +
Sbjct: 51 KGC-KAVLQSDGNFVVYDAEGR--SLWASH-SVRGNGNYVLVLQEDGNVVIYGSD----I 102
Query: 144 WQSFDH 149
W + +
Sbjct: 103 WSTGTY 108
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-10
Identities = 23/124 (18%), Positives = 43/124 (34%), Gaps = 19/124 (15%)
Query: 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPI 82
++++S + G + Y L N V G W +N
Sbjct: 1 VNSLSSPNSLFTGHSLEVGPS-YRLIMQGDCNFVLYDSGKPV---------WASNTGGLG 50
Query: 83 NDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGET 142
+ L N GNLV+++++ +WQ + + V L N+V+ G
Sbjct: 51 SGCRLTLHNN--GNLVIYDQSNR--VIWQTKTN-GKEDHYVLVLQQDRNVVIY----GPV 101
Query: 143 LWQS 146
+W +
Sbjct: 102 VWAT 105
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 52/240 (21%), Positives = 76/240 (31%), Gaps = 74/240 (30%)
Query: 535 KLGQGGFGPVYKG--KLSNGQEIAVK--R---------------LSTTSGQGIEELKNEV 575
LG+G FG V + ++A+K R L + E V
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 576 LLIAKLQHRN---LV-KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR---KQLLDWKK 628
L+ + +LLG +EF+ + + R QL
Sbjct: 86 LMSDWFNFHGHMCIAFELLGKNT--------FEFLKENNFQPYPLPHVRHMAYQLC---- 133
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP------------------- 669
+ +LH ++ H DLK NIL
Sbjct: 134 ---------HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
R++DFG+A F E I V T Y PE L+ ++ DV+S G IL E G
Sbjct: 182 RVADFGSA-TFDHEHHTTI----VATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 46/229 (20%)
Query: 535 KLGQGGFGPVYKGKLSNGQEI------AVKRLSTTSGQGIEELK-----NEVLLIAKLQH 583
+GQGGFG +Y +++ + + VK + +G ELK + I K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 584 RNLVKLLG-----CCLEEDENMLIYEFMPNKSLDYFIFD---ESRKQLLDW-KKRFDI-- 632
+K LG D+N Y FM I D +++ + KRF
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFM--------IMDRFGSDLQKIYEANAKRFSRKT 153
Query: 633 ILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEKMNPRI--SDFGTARVF----GG 682
+L ++ +L Y+H+ +H D+KASN+LL+ K ++ D+G A +
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 683 EEILAITKRV-VGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGK 729
+ A KR GT + S + A +GV S + D+ G +++ +TG
Sbjct: 211 KAYAADPKRCHDGTIEFTSID-AHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 35/192 (18%), Positives = 75/192 (39%), Gaps = 33/192 (17%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIA---VKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLL 590
K+G GGFG +Y + ++ A VK +G L +E+ ++ ++ +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP----LFSELKFYQRVAKKDCIKKW 99
Query: 591 GCCLEEDE----NMLIYEFMPNKSLDY--FIFD---ESRKQLLDWKKRFDI--ILGIARG 639
+ D K Y + + +++ F +L +
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIR 159
Query: 640 VL----YLHQDSRLRIIHRDLKASNILLDEKMNPRI--SDFGTARVF----GGEEILAIT 689
+L Y+H++ +H D+KA+N+LL K ++ +D+G + + ++
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216
Query: 690 KRV-VGTYGYMS 700
++ GT + S
Sbjct: 217 RKGHNGTIEFTS 228
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 54/240 (22%), Positives = 83/240 (34%), Gaps = 74/240 (30%)
Query: 535 KLGQGGFGPVYKGK--LSNGQEIAVK--R---------------LSTTSGQGIEELKNEV 575
LG+G FG V + + G+ +AVK + L + V
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 576 LLIAKLQHRN---LV-KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR---KQLLDWKK 628
++ +H +V +LLG Y+F+ F D R Q+
Sbjct: 81 QMLEWFEHHGHICIVFELLGLST--------YDFIKENGFLPFRLDHIRKMAYQIC---- 128
Query: 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP------------------- 669
+ V +LH ++ H DLK NIL +
Sbjct: 129 ---------KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729
++ DFG+A + E T +V T Y +PE L +S DV+S G IL+E G
Sbjct: 177 KVVDFGSA-TYDDEHH--ST--LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 1e-09
Identities = 23/123 (18%), Positives = 40/123 (32%), Gaps = 20/123 (16%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
+ + Q + + + Y L + N VK G W +N +
Sbjct: 3 NVLLSGQTLHADHSLQAGA--YTLTIQNKCNLVKYQNGRQI---------WASNTDR--R 49
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
+ L++ GNLV+++ N + V + G L G V+ G L
Sbjct: 50 GSGCRLTLLSDGNLVIYDHNNNDV---WGSACWGDNGKYALVLQKDGRFVIY----GPVL 102
Query: 144 WQS 146
W
Sbjct: 103 WSL 105
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 53/244 (21%), Positives = 89/244 (36%), Gaps = 78/244 (31%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVK---RLSTTSGQGIEELK-------------NEVLL 577
K+G G FG V + + N + AVK + + E N V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101
Query: 578 IAKLQHRN---LV-KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESR---KQLLDWKKRF 630
K + + L+ + LG L YE + + + F ++ + ++L
Sbjct: 102 HGKFMYYDHMCLIFEPLGPSL--------YEIITRNNYNGFHIEDIKLYCIEIL------ 147
Query: 631 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP--------------------- 669
+ + YL ++ + H DLK NILLD+
Sbjct: 148 -------KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 670 ----RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEI 725
++ DFG A F + +I + T Y +PE L+ + SD++SFG +L E+
Sbjct: 198 STGIKLIDFGCA-TFKSDYHGSI----INTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252
Query: 726 ITGK 729
TG
Sbjct: 253 YTGS 256
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 35/204 (17%), Positives = 75/204 (36%), Gaps = 42/204 (20%)
Query: 529 NFSTSNKLGQGGFGPVYKGK---------LSNGQEIAVKRLSTTSGQGIEELK------- 572
+ + + G +Y+ Q+ ++K L G+ E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 573 -NEVLLIAKLQHRNLV---KLLGCCLEEDE-NMLIYEFMPNKSLDYFIFDESRKQLLDWK 627
+V KL L+ +G + +D+ L+ + +SL D S K +L +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSER 159
Query: 628 KRFDIILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEKMNPRI--SDFGTARVF- 680
+L +A +L +LH++ +H ++ A NI +D + ++ + +G A +
Sbjct: 160 ----SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 681 -GGEEIL---AITKRVVGTYGYMS 700
G+ + G ++S
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFIS 236
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 56/284 (19%), Positives = 94/284 (33%), Gaps = 100/284 (35%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
KLG G F V+ + + +A+K + ++ E +E+ +LL
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEI------------RLLKSV 90
Query: 594 LEEDENMLIYEFMPNKSLDYF------------IFDESRKQLLDWKKRFD---------- 631
D N E + + LD F +F+ LL W + +
Sbjct: 91 RNSDPNDPNREMVV-QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 632 -IILGIARGVLYLHQDSRLRIIHRDLKASNILL--------------------------- 663
II + +G+ YLH ++ RIIH D+K NILL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 664 ----------------------DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
EK+ +I+D G A + + + T Y S
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHF----TEDIQTRQYRSL 262
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGK------KNTRIFNDDD 739
E + ++T +D++S + E+ TG D+D
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED 306
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 6e-08
Identities = 23/123 (18%), Positives = 41/123 (33%), Gaps = 20/123 (16%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
+ + + + G+ + + R Y N V V W N
Sbjct: 2 NILYSGETLSPGEFLNNGR--YVFIMQEDCNLVLYDVDKPI---------WATNTGGLDR 50
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
+ + GNLV++ + P+W +N + GN V L N+V+ G
Sbjct: 51 RCHLSMQSD--GNLVVY--SPRNNPIWASN-TGGENGNYVCVLQKDRNVVIY----GTAR 101
Query: 144 WQS 146
W +
Sbjct: 102 WAT 104
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-06
Identities = 23/109 (21%), Positives = 37/109 (33%), Gaps = 18/109 (16%)
Query: 38 IVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNL 97
I+ +Y + N V +W N N + G L
Sbjct: 25 ILFGTHVYRFIMQTDCNLVLYDNN---------NPIWATNTGGLGNGCR--AVLQPDGVL 73
Query: 98 VLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146
V+ V VWQ+ ++ AG+ V L N+V+ G+ LW +
Sbjct: 74 VVI--TNENVTVWQSPVA-GKAGHYVLVLQPDRNVVI----YGDALWAT 115
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 6e-06
Identities = 21/128 (16%), Positives = 43/128 (33%), Gaps = 21/128 (16%)
Query: 19 ISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANR 78
I + + + Q + + + + L N V W +N
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTAKN--HQLVMQGDCNLVLYGGKY----------GWQSNT 49
Query: 79 NNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRND 138
+ N L +N +G L++ + +W + S + G V L D G V+
Sbjct: 50 HG--NGEHCFLRLNHKGELIIK--DDDFKTIWSSR-SSSKQGEYVLILQDDGFGVIY--- 101
Query: 139 TGETLWQS 146
G ++++
Sbjct: 102 -GPAIFET 108
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 8e-06
Identities = 48/338 (14%), Positives = 97/338 (28%), Gaps = 92/338 (27%)
Query: 471 LATRIGERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDVTFFEL-STLLAATDN 529
L + I +RQ + + E+ + N+ K +V+ + L A
Sbjct: 94 LMSPIKTEQRQPSMM------TRMYIEQRDRLYN-DNQVFAKYNVSRLQPYLKLRQALLE 146
Query: 530 FSTSNKL---GQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+ + G G G K + + +V L K+Q +
Sbjct: 147 LRPAKNVLIDGVLGSG---------------K--TW--------VALDVCLSYKVQCKMD 181
Query: 587 VKL----LGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
K+ L C + + + + L + D + D + + + L
Sbjct: 182 FKIFWLNLKNCNSPETVLEMLQ-----KL-LYQIDPNWTSRSDHSSNIKLRIHSIQAEL- 234
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE-EILAIT--KRVV-----G 694
RL + + + ++L N + F +IL T K+V
Sbjct: 235 ----RRL-LKSKPYENCLLVLLNVQNAKA-----WNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 695 TYGYMSPEYALDGVFSTKS-DVFS--FGV--------------ILLEIITGKKNTRIFND 737
T ++S ++ + + + L II +
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII-AES------I 337
Query: 738 DDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALR 775
D W+ + +K I++SS+ L R
Sbjct: 338 RDGLATWDN-WKHVNCDKLTTIIESSLNV--LEPAEYR 372
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 2e-05
Identities = 57/381 (14%), Positives = 102/381 (26%), Gaps = 129/381 (33%)
Query: 20 STSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVG---------IW------Y 64
ID I I D + + +++ V+++V +
Sbjct: 48 KEEIDHI-----IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102
Query: 65 NQISQLTLLWVANRNNPIND------------------TSGVLSVNIQGNLVLHERNQST 106
Q S +T +++ R+ ND +L + N+++
Sbjct: 103 RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID------ 156
Query: 107 VPVWQANISEASAGNTV--AQLLDTGNLVLVRNDTGETLWQSF---DHPTDTV--LPNMR 159
+G T + + + + + W + + P + L +
Sbjct: 157 --------GVLGSGKTWVALDVCLSYKVQCKMD--FKIFWLNLKNCNSPETVLEMLQKLL 206
Query: 160 FGWDKR-TGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDV---KLWRA----- 210
+ D T + + + K L + LL +V K W A
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC 266
Query: 211 ---------------GPWTGQRFSG-------TPEMTRTFIFNITYIDNQD---EVYLCD 245
T S TP+ ++ + QD EV +
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN 326
Query: 246 GLNDLSTIARMILNETGFLQRFTWNNRDR--RWIGYWTAPAERCDYYGHCGPNSNCNLNL 303
LS IA I RD W D + H NC+ L
Sbjct: 327 PRR-LSIIAESI--------------RDGLATW-----------DNWKH----VNCD-KL 355
Query: 304 TDGFECTCLPGFEPKYPKEWF 324
T E + L EP ++ F
Sbjct: 356 TTIIE-SSLNVLEPAEYRKMF 375
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 3e-05
Identities = 70/465 (15%), Positives = 139/465 (29%), Gaps = 133/465 (28%)
Query: 428 LAAEALNNSKSNRARKRRLALIIVAIVLG---------VILLGLCF-----FFLRRRLAT 473
+A + + K + ++ I + L +L L + + R ++
Sbjct: 166 VALDVCLSYK----VQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS 221
Query: 474 RIGERKRQRRRELLFLNSSTRFSE-----REASISTKGNKEIRKVDVTFFELS-TLLAAT 527
I R + EL L S + N + F LS +L T
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ-----NAKAWNA----FNLSCKILLTT 272
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNG--QEIAVKRLSTTSGQGIEELKNEVL--------L 577
++ L + S + L ++L EVL +
Sbjct: 273 RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI 332
Query: 578 IAKL-----------QHRNLVKL---LGCC---LEEDENMLIYEFMPNKSLDYFIFDESR 620
IA+ +H N KL + LE E +++ +F S
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD-------RLSVFPPSA 385
Query: 621 K---QLLD--W--KKRFDIILGIARGVLYLHQDSRLRIIHRDLKAS-----NILLDEKMN 668
LL W + D++ + +++ + ++ + K S +I L+ K+
Sbjct: 386 HIPTILLSLIWFDVIKSDVM-------VVVNKLHKYSLVEKQPKESTISIPSIYLELKVK 438
Query: 669 PRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVI---LLEI 725
E A+ + +V Y + D + D + + I L I
Sbjct: 439 L-------------ENEYALHRSIVDHYNIPK-TFDSDDLIPPYLDQYFYSHIGHHLKNI 484
Query: 726 ITGKKNT---RIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGL- 781
++ T +F D + + K I S A + S Q+
Sbjct: 485 EHPERMTLFRMVFLDFR-----------FLEQK---IRHDSTAWNASGSILNTLQQLKFY 530
Query: 782 ---LCVQDRTTDRPSMSTVVFMLSN-ETFVPSPKQPTFSVRRTEI 822
+C D +R +++ F+P ++ + T++
Sbjct: 531 KPYICDNDPKYER--------LVNAILDFLPKIEENLICSKYTDL 567
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 6e-05
Identities = 85/667 (12%), Positives = 177/667 (26%), Gaps = 205/667 (30%)
Query: 191 DLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDL 250
D+ P+ +L K+++ ++ T T + Q+E+
Sbjct: 37 DVQDMPKSILSKEEIDHIIMSK---------DAVSGTLRLFWTLLSKQEEMV-------- 79
Query: 251 STIARMILNETGFLQRF--TWNNRDRRWIGYWTAPAERCDYYGHCGPNSNCNLNLTDGFE 308
Q+F + +++ + P+ T +
Sbjct: 80 --------------QKFVEEVLRINYKFL--MSPIKTEQR-----QPSMM-----TRMYI 113
Query: 309 CTCLPGFE--PKYPKEWFLRDGSGGCKRKQGTSTCQKGEGFIKLERMKLPDTSVAANVDM 366
+ + K R + ++KL R L + A NV +
Sbjct: 114 EQRDRLYNDNQVFAKYNVSR-----------------LQPYLKL-RQALLELRPAKNVLI 155
Query: 367 NLGLKACEEKCLSNCSCVAYASASAETNRGIGCLMYH-------GDLNDTRKYTNAGQDL 419
+ G+ K + VA + + C M + N Q L
Sbjct: 156 D-GVLGSG-K-----TWVA---LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205
Query: 420 FVRA--NAAELAAEALN---NSKSNRARKRRL--------ALIIV-----AIVLGVILLG 461
+ N + + N S +A RRL L+++ A L
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265
Query: 462 LCFFFLRRRLATRIGERKRQRRRELLFLNSSTRFSEREASISTKGNKEIRKVDV----TF 517
C + L T TRF + +S I T
Sbjct: 266 -C-----KILLT-------------------TRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 518 FELSTLLAATDNFSTS---------NKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTSG 565
E+ +LL + N + L+ N + + +L+T
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE 360
Query: 566 QGIEELKNEVLLIAKLQHRNLV----------KLLG---CCLEEDENMLIYEFMPNKSLD 612
+ L+ + L LL + + + M++ + SL
Sbjct: 361 SSLNVLEPAEY---RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL- 416
Query: 613 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672
+ K + + I+ +LK + + ++ I
Sbjct: 417 ----------VEKQPKES---------TISIPS------IYLELKV-KLENEYALHRSIV 450
Query: 673 D-FGTARVFGGEEILAITKRVVGTY-----GYMSPEYALDGVFSTKSDVF-SFGVILLEI 725
D + + F ++ + + Y G+ + VF F + +I
Sbjct: 451 DHYNIPKTFDSDD---LIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKI 507
Query: 726 I--TGKKNTRIFNDDDSSNLIKYAWELWSDNKAL--EIVDS------SMANSCLASEALR 775
+ N + L Y DN +V++ + + + S+
Sbjct: 508 RHDSTAWNASGSILNTLQQLKFYK-PYICDNDPKYERLVNAILDFLPKIEENLICSKYTD 566
Query: 776 CIQVGLL 782
+++ L+
Sbjct: 567 LLRIALM 573
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 23/125 (18%), Positives = 44/125 (35%), Gaps = 23/125 (18%)
Query: 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNP 81
+ + Q + + + + L N V Y G W + N
Sbjct: 2 GTNYLLSGQTLDTEGHLKNGD--FDLVMQDDCNLV-LYNGNWQS-------------NTA 45
Query: 82 INDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGE 141
N L++ G LV+ N VW++ +++ GN A + G LV+ G
Sbjct: 46 NNGRDCKLTLTDYGELVIK--NGDGSTVWKSG-AQSVKGNYAAVVHPDGRLVVF----GP 98
Query: 142 TLWQS 146
++++
Sbjct: 99 SVFKI 103
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.3 bits (103), Expect = 9e-05
Identities = 38/280 (13%), Positives = 69/280 (24%), Gaps = 31/280 (11%)
Query: 20 STSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSV--KRYVGIWYNQISQLTLLWVAN 77
+ Q + G ++S + + L GN V +W Q +
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIPL 70
Query: 78 RNNPINDTSGVLSVNIQGNLVL--HERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLV 135
RN L+ +Q L + R + + S T L D GN+V
Sbjct: 71 RNKK-----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIV-- 123
Query: 136 RNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGF 195
LW + L + V G + L G
Sbjct: 124 -LVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVV---------YGAGASKLVFQGD 173
Query: 196 PQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTIAR 255
+ Y + G+ G N+ + V ++ A
Sbjct: 174 GNLVAYGPNGAATWNAGTQGK---GAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHAS-AV 229
Query: 256 MILNETGFL----QRFTWNNRDRRWIGYWTAPAERCDYYG 291
+ L G + ++ W + + +
Sbjct: 230 LRLQANGSIAILDEKPVWARFG--FQPTYRHIRKINPDQK 267
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 4e-04
Identities = 23/102 (22%), Positives = 30/102 (29%), Gaps = 18/102 (17%)
Query: 45 YALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQ 104
Y L + N V W N VL N G + +
Sbjct: 152 YRLSMETDCNLVLFDRDDRV---------WSTNTAGKGTGCRAVLQPN--GRMDV--LTN 198
Query: 105 STVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146
+ VW + S SAG V L NL + G LW +
Sbjct: 199 QNIAVWTSGNS-RSAGRYVFVLQPDRNLAIY----GGALWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 7e-04
Identities = 22/181 (12%), Positives = 45/181 (24%), Gaps = 35/181 (19%)
Query: 62 IWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGN 121
I + + + + + +S ++ NLVL + + VW +N + A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDV---RVWASNTA--GATG 57
Query: 122 TVAQLLDTGNLVLVRNDTGETLWQS-----------------------------FDHPTD 152
A L G LV++ W S
Sbjct: 58 CRAVLQSDGLLVILTAQN-TIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKG 116
Query: 153 TVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212
+V+ + + L + +L+ D ++W
Sbjct: 117 SVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNT 176
Query: 213 W 213
Sbjct: 177 A 177
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 7e-04
Identities = 18/123 (14%), Positives = 37/123 (30%), Gaps = 18/123 (14%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
+ + SQ + D + + Y+L N V +W + +
Sbjct: 7 NVLFSSQVMYDNAQLATRD--YSLVMRDDCNLVLTKGSKTNI-------VWESGTSG--R 55
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
+ + G L + + V+ +N G+ V L G V+ +
Sbjct: 56 GQHCFMRLGHSGELDIT--DDRLNTVFVSNTV-GQEGDYVLILQINGQAVVYGPA----V 108
Query: 144 WQS 146
W +
Sbjct: 109 WST 111
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 837 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.82 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.81 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.8 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.78 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.72 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.6 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.6 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.55 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.54 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.48 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.48 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.44 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.18 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.15 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.1 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.97 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.92 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.91 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.76 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.74 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.6 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.2 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.12 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.11 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.87 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.58 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.52 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.13 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.07 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.05 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.99 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.76 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.6 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.32 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.98 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.6 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.49 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.92 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 82.42 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.5 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.16 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=450.04 Aligned_cols=258 Identities=27% Similarity=0.451 Sum_probs=211.8
Q ss_pred CCcCCcccccCCeeEEEEEec------CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
+.+.++||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++.+++|||||+++|+|.+++..+||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445689999999999999863 4688999999754 334568899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 603 YEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
||||++|+|.++|..... ...++|..++.|+.|||+||.|||+++ ||||||||+||||++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence 999999999999965321 245899999999999999999999987 9999999999999999999
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 748 (837)
||+|||+++.....+.........||+.|||||++.++.|+.++|||||||+||||+| |+.||.... ...+...
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---~~~~~~~-- 259 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVVEM-- 259 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---HHHHHHH--
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---HHHHHHH--
Confidence 9999999998765554444556789999999999999999999999999999999998 899986432 1222222
Q ss_pred HHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 749 ELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 749 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
...+.... .+.+....+.+++.+||+.||++||||+||++.|+....
T Consensus 260 --i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 260 --IRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp --HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred --HHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 12222111 122223457899999999999999999999999986543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=455.51 Aligned_cols=260 Identities=27% Similarity=0.450 Sum_probs=206.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34566789999999999999864 478899999987776777889999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcC------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 602 IYEFMPNKSLDYFIFDES------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
|||||++|+|.++|+... ....++|.+++.|+.|||+||.|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997532 1246899999999999999999999987 9999999999999999999
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 748 (837)
||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ..+...+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCI- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHH-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHH-
Confidence 9999999998765554444455789999999999999999999999999999999999 8999864321 2222221
Q ss_pred HHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 749 ELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 749 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
..+.... ....+ ...+.+++.+||+.||++||||+||+++|+.+..
T Consensus 274 ---~~g~~~~-----~p~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 274 ---TQGRELE-----RPRAC----PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ---HHTCCCC-----CCTTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---HcCCCCC-----Ccccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1111111 11122 2457889999999999999999999999998744
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-53 Score=450.80 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=214.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|.+.++||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45677789999999999999864 478899999987766677889999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcC----------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeee
Q 003237 602 IYEFMPNKSLDYFIFDES----------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 671 (837)
|||||++|+|.++|.... ....++|.+++.++.|||+||.|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 2346999999999999999999999987 999999999999999999999
Q ss_pred cccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHH
Q 003237 672 SDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.... ...+...+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i--- 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECI--- 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHH---
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH---
Confidence 99999998766555444555679999999999999999999999999999999999 899986432 12222221
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..+.... .+......+.+++.+||+.||++||||+||+++|+++
T Consensus 244 -~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 244 -TQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp -HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1121111 1112234578999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=437.74 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=200.1
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+++.+.++||+|+||+||+|+++ ..||||+++.. .....++|.+|++++++++|||||+++++|.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 45667889999999999999875 36999998643 33456789999999999999999999999865 568999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
|++|+|.++|+... ..++|..++.|+.|||+||.|||+++ ||||||||+||||++++.+||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999996542 35899999999999999999999987 99999999999999999999999999987654443
Q ss_pred eeeeccccccCCccCcccccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALD---GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.......+||+.|||||++.+ ++|+.++|||||||+||||+||+.||..... ...+.. ....+. ..+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--~~~~~~----~~~~~~----~~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--RDQIIF----MVGRGY----ASP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHH----HHHTTC----CCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--HHHHHH----HHhcCC----CCC
Confidence 334455789999999999964 4699999999999999999999999964321 111111 111111 111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+. .........+.+++.+||+.||++||||+||++.|+.+
T Consensus 258 ~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 258 DLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred Ccc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 110 11112234577899999999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=434.99 Aligned_cols=266 Identities=28% Similarity=0.407 Sum_probs=214.8
Q ss_pred HHHHHhhcCCCcCCcccccCCeeEEEEEecC------CcEEEEEEecCCCc-cCHHHHHHHHHHHHHhcC-CCeeeeecc
Q 003237 521 STLLAATDNFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQH-RNLVKLLGC 592 (837)
Q Consensus 521 ~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H-~nIv~l~~~ 592 (837)
.+.+...++|++.++||+|+||+||+|++.. ++.||||++..... ...++|.+|+++|.+++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3333445788999999999999999998642 36799999976533 345679999999999975 899999999
Q ss_pred cccC-CccEEEEEecCCCChhhHhhhcCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCC
Q 003237 593 CLEE-DENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658 (837)
Q Consensus 593 ~~~~-~~~~lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 658 (837)
|.+. +..+||||||++|+|.++|..... +..++|..++.++.|||+||.|||+++ ||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence 9765 568999999999999999975321 345899999999999999999999988 99999999
Q ss_pred CcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 003237 659 SNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFND 737 (837)
Q Consensus 659 ~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~ 737 (837)
+||||++++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998766555555566789999999999999999999999999999999998 9999864322
Q ss_pred CCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 738 DDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 738 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
. ..+...+ ..+.... ....+ ..++.+++.+||+.||++||||+||++.|+.+
T Consensus 294 ~--~~~~~~i----~~g~~~~-----~p~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 294 D--EEFCRRL----KEGTRMR-----APDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp S--HHHHHHH----HHTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H--HHHHHHH----HcCCCCC-----CCccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1 1122221 2221111 11122 34577899999999999999999999999764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=420.81 Aligned_cols=267 Identities=21% Similarity=0.290 Sum_probs=200.5
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCC----ccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED----ENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV~ 603 (837)
++|.+.++||+|+||+||+|++ .|+.||||+++.... ....+..|+..+.+++|||||+++++|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3466778999999999999998 589999999964322 1222345666667889999999999998764 468999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc-----CCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-----SRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
|||++|+|.++|... .++|..+++++.|+|+||+|||++ ..++||||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999653 489999999999999999999987 23469999999999999999999999999998
Q ss_pred eccCcccee--eeccccccCCccCcccccCC------CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCc--------ch
Q 003237 679 VFGGEEILA--ITKRVVGTYGYMSPEYALDG------VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDS--------SN 742 (837)
Q Consensus 679 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~~------~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~--------~~ 742 (837)
......... .....+||+.|||||++.+. .++.++|||||||+||||+||+.|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 875443221 22346899999999999764 467899999999999999999887654322110 00
Q ss_pred HHHHHHHHhccCccccccccccccc-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 743 LIKYAWELWSDNKALEIVDSSMANS-CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 743 l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
........... ..+++.+... ...+....+.+++.+||+.||++||||.||+++|+++
T Consensus 237 ~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 01111111111 1122222222 2334556788999999999999999999999999865
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=419.94 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=206.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45788899999999999999875 69999999997665566677899999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|.+++... .+++.....++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 999999998642 4899999999999999999999998 99999999999999999999999999998754322
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||... ....+...+. . . ..+.+.
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~---~-~-----~~~~~~- 291 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIR---D-N-----LPPRLK- 291 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHH---H-S-----SCCCCS-
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHH---c-C-----CCCCCC-
Confidence 234478999999999999999999999999999999999999999532 1111221111 1 1 111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
........+.+++.+||+.||++|||++|+++
T Consensus 292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01112245778999999999999999999976
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=426.89 Aligned_cols=250 Identities=23% Similarity=0.383 Sum_probs=200.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|++.++||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57899999999999999999875 6999999999754 23346788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
||++|+|.++|.... ...+++.....++.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999996532 345788889999999999999999998 9999999999999999999999999998765322
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||.... ............ . +.+
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~-~-----~~~ 245 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGS-F-----PPV 245 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTC-C-----CCC
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCC-C-----CCC
Confidence 12334689999999999999999999999999999999999999996321 112222222111 1 011
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.... ...+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHY----SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122 235778999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=419.22 Aligned_cols=251 Identities=22% Similarity=0.250 Sum_probs=201.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+.|...++||+|+||+||+|+.. +|+.||||+++.... ..+|++++.+++|||||++++++.+++..+||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777789999999999999875 689999999975432 246999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-CeeecccccceeccCccc
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGGEEI 685 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~DFGla~~~~~~~~ 685 (837)
++|+|.++|... ..+++.....++.||+.||.|||+++ ||||||||+||||+.++ .+||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999654 35899999999999999999999988 99999999999999987 699999999998754322
Q ss_pred e---eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 686 L---AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 686 ~---~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ +...+ ........
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i---~~~~~~~~---- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKI---ASEPPPIR---- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHH---HHSCCGGG----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHH---HcCCCCch----
Confidence 1 12234689999999999999999999999999999999999999996443322 22111 11111100
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.+ +......+.+++.+||+.||++|||+.|+++.|..
T Consensus 277 ~~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 277 EI----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hc----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11 12223457789999999999999999999987754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=410.97 Aligned_cols=246 Identities=23% Similarity=0.369 Sum_probs=194.8
Q ss_pred CcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeeccccc----CCccEEEE
Q 003237 531 STSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENMLIY 603 (837)
Q Consensus 531 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 603 (837)
.+.++||+|+||+||+|... ++..||||++... .....+.|.+|++++++++|||||++++++.+ +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44568999999999999875 6889999999653 33345779999999999999999999999865 34578999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-CCCCeeecccccceeccC
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGG 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~DFGla~~~~~ 682 (837)
|||++|+|.+++... ..+++..+..++.||++||.|||+++ ++||||||||+||||+ +++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999653 35899999999999999999999976 3599999999999998 489999999999986443
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
. .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||..... ...+. .....+....
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~----~~i~~~~~~~---- 249 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIY----RRVTSGVKPA---- 249 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHH----HHHTTTCCCG----
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHH----HHHHcCCCCC----
Confidence 2 2234789999999998864 699999999999999999999999953211 11111 1111111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....... .++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111112 24678999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=417.43 Aligned_cols=247 Identities=25% Similarity=0.329 Sum_probs=207.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.++||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46888999999999999999875 6899999999653 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++... ..+++.....++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999654 34899999999999999999999998 999999999999999999999999999987655
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.........+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ...+.. ..... .. .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~---~i~~~-~~------~ 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFA---KIIKL-EY------D 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHT-CC------C
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HHHcC-CC------C
Confidence 44445556899999999999999999999999999999999999999995321 122221 11111 10 1
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTV 797 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eV 797 (837)
+.... ..++.+++.+|++.||++|||++|+
T Consensus 253 ~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 253 FPEKF----FPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp CCTTC----CHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred CCccc----CHHHHHHHHHHccCCHhHCcChHHH
Confidence 11122 2356789999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=420.85 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=207.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46888899999999999999875 69999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|.+++... .+++.....++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 999999998542 3899999999999999999999998 99999999999999999999999999998754322
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||... ....+...+. . . ..+.+..
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~---~-~-----~~~~~~~ 369 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIR---D-N-----LPPRLKN 369 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHH---H-S-----CCCCCSC
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHH---c-C-----CCCCCcc
Confidence 234578999999999999999999999999999999999999999532 1111221111 1 1 1111110
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.......+.+++.+||+.||++|||++|+++
T Consensus 370 --~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112235778999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=398.54 Aligned_cols=245 Identities=23% Similarity=0.362 Sum_probs=188.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 69999999997542 334567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+ +|+|.+++... ..+++.....++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 67998888653 35899999999999999999999998 999999999999999999999999999876543
Q ss_pred cceeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
. .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||... ....+...+ .. +..
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i---~~-~~~------ 229 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNI---SN-GVY------ 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH---HH-TCC------
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHH---Hc-CCC------
Confidence 2 2234789999999999998886 57999999999999999999999532 111122111 11 110
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+.... ...+.+++.+|++.||++|||++|+++
T Consensus 230 ~~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 TLPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111112 235678999999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=402.33 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=190.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc-------
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE------- 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------- 598 (837)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888899999999999999875 68999999997543 3345678999999999999999999999876443
Q ss_pred -----cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecc
Q 003237 599 -----NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673 (837)
Q Consensus 599 -----~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 673 (837)
.+|||||+++|+|.+++.........++...+.++.||++||.|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 5899999999999999976555455677778899999999999999998 99999999999999999999999
Q ss_pred cccceeccCcccee----------eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchH
Q 003237 674 FGTARVFGGEEILA----------ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNL 743 (837)
Q Consensus 674 FGla~~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l 743 (837)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 99999875432211 1223579999999999999999999999999999999996 65311 111
Q ss_pred HHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhcc
Q 003237 744 IKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSN 803 (837)
Q Consensus 744 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~ 803 (837)
....... ..... +. ........+..++.+|++.||++|||+.|+++ .+++
T Consensus 234 ~~~~~~~-~~~~~-----p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 234 VRTLTDV-RNLKF-----PP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHHH-HTTCC-----CH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHHHH-hcCCC-----CC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 1111111 11110 00 01122234567899999999999999999987 4543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=405.63 Aligned_cols=247 Identities=25% Similarity=0.280 Sum_probs=193.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec----CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|++.+.||+|+||+||+|+.. .++.||||++++.. ......+.+|+++|.+++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46888999999999999999762 47889999997542 2234468889999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++|+|.+++... ..+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999654 35899999999999999999999998 9999999999999999999999999998654
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ...+.. ..... ..
T Consensus 178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~---~i~~~-~~----- 243 (304)
T 3ubd_A 178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD---RKETMT---MILKA-KL----- 243 (304)
T ss_dssp ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHC-CC-----
T ss_pred CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC---HHHHHH---HHHcC-CC-----
Confidence 3322 2334789999999999999999999999999999999999999996321 112221 11111 10
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSM-----STVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm-----~eVv~ 799 (837)
.+.... ...+.+++.+||+.||++|||+ +|+++
T Consensus 244 -~~p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 -GMPQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -CCCCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111112 2357789999999999999984 56663
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=393.12 Aligned_cols=282 Identities=36% Similarity=0.621 Sum_probs=246.8
Q ss_pred HHHHHhhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 521 STLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 521 ~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
.++..++++|+..+.||+|+||.||+|++.+++.||||++........+.+.+|++++.+++||||+++++++.+.+..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34445678999999999999999999998889999999987766666788999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 601 LIYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
+||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999865432 235899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
..............||+.|+|||++.+..++.++||||||+++|||++|+.|+......+......+.......+....+
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 65433322333456899999999999999999999999999999999999999876666666677777766677777788
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
+++.+......+....+.+++.+|++.||++||||+||++.|+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 8888877788888899999999999999999999999999998753
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=383.89 Aligned_cols=236 Identities=17% Similarity=0.215 Sum_probs=184.6
Q ss_pred ccccccccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCC----CceEEEeec
Q 003237 19 ISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDT----SGVLSVNIQ 94 (837)
Q Consensus 19 ~~~~~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~----~~~l~~~~~ 94 (837)
++++.|+|++||+|++|++|||++|+|+||||.++ ++|| |+ |++ +||+|||++|+.++ +++|+|+.|
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~ 80 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFY 80 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEE
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCC
Confidence 46788999999999999999999999999999543 6677 77 777 99999999999875 789999999
Q ss_pred cceEEEecCCCcceeeecccccCC----CCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCcccccccCCCcc
Q 003237 95 GNLVLHERNQSTVPVWQANISEAS----AGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTGLNR 170 (837)
Q Consensus 95 G~L~l~~~~~~~~~~Wst~~~~~~----~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~tg~~~ 170 (837)
|+|+|.+.++.+.+||+|+++... ..+++|+|+|+|||||++ +.+|||| |||||||||||||.+.++|..
T Consensus 81 G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~---~~~lWqS--~ptdtlLpg~~~~~~l~~g~~- 154 (276)
T 3m7h_A 81 VQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD---SLALWNG--TPAIPLVPGAIDSLLLAPGSE- 154 (276)
T ss_dssp ESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE---EEEEEES--CTTSCCCCSCTTCEEECSSEE-
T ss_pred CcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC---CceeeCc--ccccccccccccccccccCcc-
Confidence 999994335667889999975321 345789999999999985 6899999 999999999999999988864
Q ss_pred eeeecCCCCCCCCcceEEEecCCCCCcceeecC-CeeEEecCCCCCccccCccCceeeeeeEEEEEeCCC-eeEEEeecc
Q 003237 171 YVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKD-DVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQD-EVYLCDGLN 248 (837)
Q Consensus 171 ~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~-~~~yw~sg~w~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 248 (837)
| ++.+||++|.|++.++++|. +++|+. ..+||++|+|++.. ..+.....-++.+.++++ .++++++..
T Consensus 155 -L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~----~~l~l~~dGnLvl~d~~~~~vWsS~t~~ 224 (276)
T 3m7h_A 155 -L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGA----VRAVFQGDGNLVVYGAGNAVLWHSHTGG 224 (276)
T ss_dssp -E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTC----CEEEECTTSCEEEECTTSCEEEECSCTT
T ss_pred -c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCcc----EEEEEcCCCeEEEEeCCCcEEEEecCCC
Confidence 5 67899999999999999995 566654 58999999997532 111111112334444433 455554432
Q ss_pred CCceeEEEEEcccccEEEEEEecCCCceEEEEeccC
Q 003237 249 DLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPA 284 (837)
Q Consensus 249 ~~s~~~rl~Ld~~G~l~~~~w~~~~~~W~~~~~~p~ 284 (837)
....|++|+.||++++|.| ...|..+|.+|+
T Consensus 225 --~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 225 --HASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp --CTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred --CCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 2358999999999999998 345766666554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=385.97 Aligned_cols=291 Identities=41% Similarity=0.682 Sum_probs=249.2
Q ss_pred ceeecHHHHHHhhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeeccc
Q 003237 515 VTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCC 593 (837)
Q Consensus 515 ~~~~~~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 593 (837)
...|.+.++..++++|++.+.||+|+||.||+|+..+++.||||++.... ......+.+|++++.+++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 45688899999999999999999999999999998889999999997543 22334789999999999999999999999
Q ss_pred ccCCccEEEEEecCCCChhhHhhhcC-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeec
Q 003237 594 LEEDENMLIYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (837)
Q Consensus 594 ~~~~~~~lV~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 672 (837)
......++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997643 33458999999999999999999999833349999999999999999999999
Q ss_pred ccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC--CCCCcchHHHHHHHH
Q 003237 673 DFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIF--NDDDSSNLIKYAWEL 750 (837)
Q Consensus 673 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~--~~~~~~~l~~~~~~~ 750 (837)
|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+... .......+..+....
T Consensus 177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999876543322 233456999999999999999999999999999999999999999632 223344566677667
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
........+.+..+.......+...+.+++.+|++.+|++||||+||+++|++...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 77777788888888888889999999999999999999999999999999987533
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=394.79 Aligned_cols=267 Identities=19% Similarity=0.305 Sum_probs=201.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeeccccc------CC
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLE------ED 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~ 597 (837)
.++|++.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999875 79999999996542 2334678899999999999999999998754 35
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..+||||||+ |+|.+++.. ...+++.....++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 6799999996 679888854 346899999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccc--eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC
Q 003237 678 RVFGGEEI--LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN 754 (837)
Q Consensus 678 ~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 754 (837)
+.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||..... ......+.......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence 87643321 2223457899999999998875 569999999999999999999999964321 12222222211111
Q ss_pred cccc-----------c---ccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhcc
Q 003237 755 KALE-----------I---VDSSMAN---SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSN 803 (837)
Q Consensus 755 ~~~~-----------~---~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~ 803 (837)
.... . +.+.... .........+.+++.+||+.||++|||++|+++ .+.+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 1000 0 0000000 000111245778999999999999999999986 4544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=381.33 Aligned_cols=199 Identities=24% Similarity=0.373 Sum_probs=170.6
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEec----CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCcc
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 599 (837)
...++|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|..+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999753 46789999986543 346788999999998 699999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC-CCeeecccccce
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTAR 678 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~DFGla~ 678 (837)
+|||||+++|+|.+++. .+++.+...++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999883 3789999999999999999999998 9999999999999877 799999999998
Q ss_pred eccCccce--------------------------eeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCC
Q 003237 679 VFGGEEIL--------------------------AITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKN 731 (837)
Q Consensus 679 ~~~~~~~~--------------------------~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p 731 (837)
........ ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432110 112235799999999999876 489999999999999999999999
Q ss_pred CCC
Q 003237 732 TRI 734 (837)
Q Consensus 732 ~~~ 734 (837)
|..
T Consensus 247 f~~ 249 (361)
T 4f9c_A 247 FYK 249 (361)
T ss_dssp SSC
T ss_pred CCC
Confidence 853
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=401.63 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=206.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|+.++|||||++++++.+....+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57889999999999999999875 69999999997766666678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC--CCeeecccccceeccCcc
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK--MNPRISDFGTARVFGGEE 684 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~ki~DFGla~~~~~~~ 684 (837)
++|+|.++|... ...+++.....++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 999999988543 235889999999999999999999998 9999999999999854 899999999999876543
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. ....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ..... ....... . +.+..
T Consensus 312 ~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~~---~i~~~~~--~-~~~~~ 379 (573)
T 3uto_A 312 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLR---NVKSCDW--N-MDDSA 379 (573)
T ss_dssp E---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH---HHHTTCC--C-CCSGG
T ss_pred c---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHH---HHHhCCC--C-CCccc
Confidence 2 2336899999999999999999999999999999999999999963221 11111 1111100 0 01111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... ....+.+++.+||+.||++|||+.|+++
T Consensus 380 ~~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FSG----ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1235678999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=361.25 Aligned_cols=284 Identities=36% Similarity=0.561 Sum_probs=232.5
Q ss_pred cceeecHHHHHHhhcCCCcC------CcccccCCeeEEEEEecCCcEEEEEEecCCC----ccCHHHHHHHHHHHHHhcC
Q 003237 514 DVTFFELSTLLAATDNFSTS------NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKLQH 583 (837)
Q Consensus 514 ~~~~~~~~~l~~at~~~~~~------~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H 583 (837)
+...|.+.++..++++|... ++||+|+||.||+|+. +++.||||++.... ....+.+.+|++++.+++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34568899999999999877 8999999999999987 58899999986532 2335678999999999999
Q ss_pred CCeeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE
Q 003237 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (837)
Q Consensus 584 ~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 663 (837)
|||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||.|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976555567899999999999999999999988 9999999999999
Q ss_pred cCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchH
Q 003237 664 DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNL 743 (837)
Q Consensus 664 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l 743 (837)
++++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.|+........ +
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence 9999999999999987655433333445679999999998764 589999999999999999999999875443322 2
Q ss_pred HHHHHHHhcc-CccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 744 IKYAWELWSD-NKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 744 ~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
..+....... ....+.+++.+. .........+.+++..|++.+|.+|||+++|++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2222222222 223344444442 345666778899999999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=394.98 Aligned_cols=248 Identities=26% Similarity=0.336 Sum_probs=198.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHH---HHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNE---VLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E---~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|++.++||+|+||+||+|+.. +|+.||||++.+.. ......+.+| +.++..++|||||++++++.+.+..+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67899999999999999999875 69999999996431 2233334444 55666678999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
|||||+++|+|..+|... ..+++.....++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999654 34899999999999999999999998 999999999999999999999999999987
Q ss_pred cCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
.... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||......+...+... .....
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---i~~~~----- 410 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMA----- 410 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---HHHCC-----
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hcCCC-----
Confidence 5432 334789999999999975 5799999999999999999999999964433222111111 11110
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 799 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~eVv~ 799 (837)
..+ +......+.+++.+|++.||++|++ ++||.+
T Consensus 411 --~~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 --VEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --CCC----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --CCC----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 011 1112345778999999999999998 677763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=367.59 Aligned_cols=266 Identities=27% Similarity=0.448 Sum_probs=202.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|++.++||+|+||.||+|+. .++.||||++.... ....+++.+|++++.+++||||+++++++.+....++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46788889999999999999987 58899999986543 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++|+|.+++........+++..++.++.||++||.|||+.+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999976443345899999999999999999999975 349999999999999999999999999998654322
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ......... .+
T Consensus 194 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~---~~~~~~~~~-----~~ 260 (309)
T 3p86_A 194 L--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVA---AVGFKCKRL-----EI 260 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHH---HHHHSCCCC-----CC
T ss_pred c--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHhcCCCC-----CC
Confidence 1 12346789999999999999999999999999999999999999864321 11111 111011111 11
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCC
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVPSPK 811 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~~~~p~ 811 (837)
+......+.+++.+|++.+|++|||+++|+++|+.+.....|+
T Consensus 261 ----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 261 ----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred ----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 1112235778999999999999999999999999874433333
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=374.36 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=210.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec--------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 597 (837)
++|.+.+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|++++.++ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 57888899999999999999752 35679999997553 33456789999999999 8999999999999999
Q ss_pred ccEEEEEecCCCChhhHhhhcCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 664 (837)
..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEEC
Confidence 99999999999999999976432 235789999999999999999999988 99999999999999
Q ss_pred CCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchH
Q 003237 665 EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNL 743 (837)
Q Consensus 665 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 743 (837)
.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+..... ..+
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~~~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EEL 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 999999999999997765443333344567889999999999999999999999999999999 9999864321 222
Q ss_pred HHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 744 IKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 744 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.... ..+... ..+......+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 315 ~~~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 315 FKLL----KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHHH----HTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH----hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2211 111111 11112234578899999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=363.53 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=209.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
++|.+.++||+|+||+||+|+.. +++.||+|++........+.+.+|++++.+++||||+++++++.++...++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46778899999999999999875 68999999997766667788999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999753 235899999999999999999999988 999999999999999999999999999876543221
Q ss_pred e------------eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC
Q 003237 687 A------------ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN 754 (837)
Q Consensus 687 ~------------~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 754 (837)
. ......||+.|+|||.+.+..++.++||||||+++|||++|..|+............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---------- 234 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---------- 234 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------
Confidence 1 011357999999999999999999999999999999999999987643322111000
Q ss_pred ccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 755 KALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 755 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
......+....... ...+.+++.+|++.||++|||+++|++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 235 NVRGFLDRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp CHHHHHHHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhccccccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00001111111111 23477899999999999999999999999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=368.66 Aligned_cols=268 Identities=23% Similarity=0.303 Sum_probs=208.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc----cEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE----NMLI 602 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----~~lV 602 (837)
.++|++.++||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357888899999999999999876 7999999996442 334456679999999999999999999987543 5999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc-------CCCceeeCCCCCCcEEEcCCCCeeecccc
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-------SRLRIIHRDLKASNILLDEKMNPRISDFG 675 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivH~Dlkp~NIll~~~~~~ki~DFG 675 (837)
|||+++|+|.+++... .+++..+..++.||++||.|||+. ...+|+||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999999999653 389999999999999999999987 01139999999999999999999999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH----
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDG-----VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKY---- 746 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~---- 746 (837)
+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||..............
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99887655443334446799999999999873 566789999999999999999999875443322111110
Q ss_pred -----HHHHhccCccccccccccccc-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 747 -----AWELWSDNKALEIVDSSMANS-CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 747 -----~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.......... .+.+... ........+.+++.+|++.||++|||++||++.|+.+
T Consensus 257 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 257 PSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111111 1111111 1234456688999999999999999999999999865
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=365.68 Aligned_cols=255 Identities=26% Similarity=0.435 Sum_probs=198.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCc----EEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|++.++||+|+||.||+|+.. +++ .||+|.+... .....+++.+|++++.+++||||+++++++.++ ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 46888899999999999999864 344 3688887543 345667899999999999999999999999865 4789
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|+||+++|+|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999997543 45899999999999999999999987 9999999999999999999999999998876
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
............+|..|+|||++.+..++.++|||||||++|||++ |+.|+..... ..+.... ..+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~----~~~~----- 236 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSIL----EKGE----- 236 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH----HTTC-----
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH---HHHHHHH----HcCC-----
Confidence 5544333344567889999999999999999999999999999999 9999864322 1121111 1111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
....+......+.+++.+|++.+|++||+|.||++.|+..
T Consensus 237 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111122234578899999999999999999999998653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.92 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=206.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.++|++.++||+|+||+||+|.. .+++.||||++........+.+.+|+.++.+++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35788999999999999999986 47899999999766666678889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999998653 4789999999999999999999998 99999999999999999999999999987654432
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
. .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ............. ..
T Consensus 172 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~-~~------ 236 (297)
T 3fxz_A 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP-EL------ 236 (297)
T ss_dssp C--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC-CC------
T ss_pred c--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-CC------
Confidence 2 2346799999999999999999999999999999999999999853211 1111111111100 00
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+......+.+++.+|++.||++|||++|+++
T Consensus 237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011122345778999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=374.63 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=207.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|.+.++||+|+||.||+|+.. +++.||||.++... ....+++.+|++++.+++||||+++++++..++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356778899999999999999886 78999999987542 2234567899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++|+|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999996532 34889999999999999999999998 9999999999999999999999999998755433
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.........++..|+|||.+.+..++.++|||||||++|||++ |+.|+..... .... .....+....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~~----- 335 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTR----EFVEKGGRLP----- 335 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHH----HHHHTTCCCC-----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHHcCCCCC-----
Confidence 2222222345778999999999999999999999999999998 9999864321 1111 1111111111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+......+.+++.+|++.||++|||+++|++.|+.+
T Consensus 336 ----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 336 ----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1111223577899999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=363.38 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=205.7
Q ss_pred cCCCcCCcccccCCeeEEEEEec----CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|.+.+.||+|+||.||+|++. .+..||||+++.. .....+.+.+|++++.+++||||+++++++.++...++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888899999999999999874 3456999999754 334456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 129 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred eeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 9999999999998543 235899999999999999999999988 99999999999999999999999999998754
Q ss_pred ccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 683 EEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 683 ~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
.... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+... ... +..
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~---~~~-~~~---- 272 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISS---VEE-GYR---- 272 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHH---HHT-TCC----
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHH---HHc-CCC----
Confidence 3222 12223456778999999999999999999999999999999 9999853221 111111 111 100
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
...+......+.+++..|++.+|++||||.+|+++|+.+..
T Consensus 273 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 273 -----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 01111223457889999999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=371.38 Aligned_cols=271 Identities=26% Similarity=0.404 Sum_probs=214.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEec--------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccC
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE 596 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 596 (837)
.++|.+.++||+|+||.||+|+.. .+..||||++.... ....+++.+|++++.++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357888899999999999999852 24579999997543 33457788999999999 899999999999999
Q ss_pred CccEEEEEecCCCChhhHhhhcCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 663 (837)
+..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999976432 235899999999999999999999987 9999999999999
Q ss_pred cCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003237 664 DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSN 742 (837)
Q Consensus 664 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 742 (837)
++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||+++||++ |+.|+.... ...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---~~~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEE 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHH
Confidence 9999999999999987765443333444667889999999999999999999999999999999 999985321 111
Q ss_pred HHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCcc
Q 003237 743 LIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVPSPKQPTFS 816 (837)
Q Consensus 743 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~~~~p~~p~~~ 816 (837)
+.. ....+.... . +......+.+++.+|++.+|++|||++||++.|+.+..........++
T Consensus 302 ~~~----~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 302 LFK----LLKEGHRMD-----K----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp HHH----HHHTTCCCC-----C----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred HHH----HHHcCCCCC-----C----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 111 111111111 1 111234578899999999999999999999999987555444444444
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=348.20 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=210.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.++|++.+.||+|+||.||+|+..++..||||++... ....+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 3568888999999999999999988889999999654 344678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999996542 34899999999999999999999988 999999999999999999999999999876554332
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
. .....+|..|+|||.+.+..++.++||||||++++||++ |+.|+..... . ........ +. ....+
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~---~~~~~~~~-~~--~~~~~--- 227 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---S---EVVLKVSQ-GH--RLYRP--- 227 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---H---HHHHHHHT-TC--CCCCC---
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---H---HHHHHHHc-CC--CCCCC---
Confidence 2 223456778999999999999999999999999999999 9999853321 1 11111111 11 00111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
......+.+++..|++.+|++|||+.||++.|+.+.+
T Consensus 228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 ----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1112357789999999999999999999999998654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=367.68 Aligned_cols=268 Identities=28% Similarity=0.407 Sum_probs=212.1
Q ss_pred cHHHHHHhhcCCCcCCcccccCCeeEEEEEe------cCCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeee
Q 003237 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLL 590 (837)
Q Consensus 519 ~~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~ 590 (837)
...+.....++|.+.++||+|+||.||+|++ .+++.||||+++... ....+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444445668899999999999999999973 246889999997643 23456789999999999 799999999
Q ss_pred cccccCCc-cEEEEEecCCCChhhHhhhcCC-------------------------------------------------
Q 003237 591 GCCLEEDE-NMLIYEFMPNKSLDYFIFDESR------------------------------------------------- 620 (837)
Q Consensus 591 ~~~~~~~~-~~lV~ey~~~gsL~~~l~~~~~------------------------------------------------- 620 (837)
+++.+.+. .++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99887654 8999999999999999976432
Q ss_pred --------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 621 --------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 621 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 122889999999999999999999998 999999999999999999999999999876554433
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.|+...... ..+.... ..+.... .
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~----~~~~~~~-----~- 317 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRL----KEGTRMR-----A- 317 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHHHHHH----HHTCCCC-----C-
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHHHHHH----HcCCCCC-----C-
Confidence 34445678999999999999999999999999999999998 99998643221 1111111 1111111 1
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+......+.+++..|++.+|++||||+||++.|+.+
T Consensus 318 ---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 318 ---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111223577899999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=369.24 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=195.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec----CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.+.||+|+||.||+|++. .+..||||+++.. .....+++.+|++++.+++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999875 5778999999754 334456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++|+|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999999643 335899999999999999999999987 99999999999999999999999999987654
Q ss_pred cccee-eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 683 EEILA-ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 683 ~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.|+.... ...+.... ..+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~---~~~~~~~i----~~~------ 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---NQDVIKAV----DEG------ 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC---HHHHHHHH----HTT------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HcC------
Confidence 32211 1222345778999999999999999999999999999998 999985322 11111111 111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.....+......+.+++.+|++.+|++||+|.+|+++|+.+
T Consensus 267 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 ---YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ---EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 11111122334678999999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=350.93 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=211.4
Q ss_pred eecHHHHHHhhcC----------CCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCC
Q 003237 517 FFELSTLLAATDN----------FSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585 (837)
Q Consensus 517 ~~~~~~l~~at~~----------~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n 585 (837)
.+..+++..+++. |+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++.+++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4566666666654 666679999999999999886 79999999998776677788999999999999999
Q ss_pred eeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC
Q 003237 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE 665 (837)
Q Consensus 586 Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~ 665 (837)
|+++++++...+..++||||+++++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999998853 34899999999999999999999987 999999999999999
Q ss_pred CCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHH
Q 003237 666 KMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745 (837)
Q Consensus 666 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~ 745 (837)
++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.... ......
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~~~~~ 251 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMK 251 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHH
T ss_pred CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH
Confidence 99999999999987654322 1234679999999999999999999999999999999999999985321 111111
Q ss_pred HHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 746 YAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 746 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... . . ..+.+.. .......+.+++.+|++.||++|||++||++
T Consensus 252 ~~~---~-~-----~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 RLR---D-S-----PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHH---H-S-----SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHh---c-C-----CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 1 1 0111110 1111235778899999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=350.24 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=207.6
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|++.+.||+|+||.||+|+..+++.||||++... ....+++.+|++++.+++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 467788999999999999999988999999999654 3446789999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 162 (269)
T 4hcu_A 89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 162 (269)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence 99999998643 345899999999999999999999988 999999999999999999999999999866543221
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......++..|+|||.+.+..++.++||||||++++||++ |+.|+..... ... ........ ... .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~---~~~~~~~~---~~~---~-- 228 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEV---VEDISTGF---RLY---K-- 228 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH---HHHHHTTC---CCC---C--
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHH---HHHHhcCc---cCC---C--
Confidence 1223456778999999999999999999999999999999 9999853211 111 11111110 000 1
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+......+.+++..|++.+|++|||++|+++.|+.+
T Consensus 229 --~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 229 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 111234577899999999999999999999999865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.95 Aligned_cols=266 Identities=26% Similarity=0.438 Sum_probs=203.5
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|++.+.||+|+||.||+|+.. ++.||||++... ...+.+.+|++++.+++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 46778899999999999999885 789999998643 34577899999999999999999999987 45899999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC-eeecccccceeccCccce
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN-PRISDFGTARVFGGEEIL 686 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~ki~DFGla~~~~~~~~~ 686 (837)
+++|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976554456788999999999999999999954345999999999999998887 799999999765432
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ......... .+.. +....
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~-~~~~-----~~~~~ 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVH-NGTR-----PPLIK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHH-TTCC-----CCCBT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHh-cCCC-----CCccc
Confidence 12346899999999999999999999999999999999999998643221 111111111 1111 11111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC-CCCCCCCCCCccc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE-TFVPSPKQPTFSV 817 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~-~~~~~p~~p~~~~ 817 (837)
.. ...+.+++.+|++.+|++|||+++|+++|+.+ ...+.++.|..+.
T Consensus 228 ~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~ 275 (307)
T 2eva_A 228 NL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275 (307)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCCE
T ss_pred cc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccccc
Confidence 22 23577899999999999999999999999875 4444444444443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=377.84 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=210.6
Q ss_pred hcCCCcCCcccccCCeeEEEEEecC-CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.++|.+.++||+|+||.||+|++.. +..||||.++.. ....++|.+|++++.+++|||||+++++|.+....+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3467778999999999999998874 889999999654 34578899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++|+|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999997543 345889999999999999999999988 99999999999999999999999999997654332
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. ......++..|+|||++.+..++.++|||||||++|||++ |+.|+..... ..+.... ..+ .
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~---------~ 436 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELL----EKD---------Y 436 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHH----HTT---------C
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcC---------C
Confidence 2 2233456789999999999999999999999999999999 9989864321 1222111 111 1
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
....+......+.+++.+||+.+|++||||.+|+++|+.+.
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11111222345778999999999999999999999998763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=353.03 Aligned_cols=263 Identities=25% Similarity=0.420 Sum_probs=203.2
Q ss_pred cCCCcCCcccccCCeeEEEEEe-----cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 600 (837)
++|++.++||+|+||.||++++ .+++.||||++........+.+.+|++++.+++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5688889999999999999984 36889999999876666677899999999999999999999998654 4579
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 9999999999999996543 34899999999999999999999987 999999999999999999999999999876
Q ss_pred cCccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------C-CcchHHHHHHHH
Q 003237 681 GGEEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFND--------D-DSSNLIKYAWEL 750 (837)
Q Consensus 681 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~--------~-~~~~l~~~~~~~ 750 (837)
...... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... . ............
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 543221 222334577789999999999999999999999999999999998753210 0 000000011111
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.... .....+......+.+++.+|++.+|++|||++||++.|+.+
T Consensus 245 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 245 LKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111 11111222234678899999999999999999999999865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=361.09 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=211.1
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 598 (837)
..++|.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++.+++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578899999999999999999875 34789999997543 3345678999999999999999999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcCC---------------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 003237 599 NMLIYEFMPNKSLDYFIFDESR---------------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 657 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 657 (837)
.++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 9999999999999999975321 146899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q 003237 658 ASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFN 736 (837)
Q Consensus 658 p~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~ 736 (837)
|+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987654433333344678899999999999999999999999999999999 999985321
Q ss_pred CCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 737 DDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 737 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
. ..+.. ....+.... . +......+.+++.+|++.+|++|||+.+|+++|+++..
T Consensus 282 ~---~~~~~----~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 H---EEVIY----YVRDGNILA-----C----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp H---HHHHH----HHHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred h---HHHHH----HHhCCCcCC-----C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 1 11111 111111111 1 11122457889999999999999999999999998643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=348.47 Aligned_cols=271 Identities=22% Similarity=0.281 Sum_probs=213.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC--ccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED--ENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~ 603 (837)
++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888899999999999999876 58999999997543 345677889999999999999999999987665 669999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE----cCCCCeeeccccccee
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTARV 679 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~ki~DFGla~~ 679 (837)
||+++++|.+++........+++..+..++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999977655555899999999999999999999998 9999999999999 7888899999999987
Q ss_pred ccCccceeeeccccccCCccCccccc--------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcc-hHHHHHHHH
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYAL--------DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS-NLIKYAWEL 750 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~ 750 (837)
...... .....||..|+|||++. +..++.++|||||||++|||++|+.||......... .........
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 654432 22357899999999986 578999999999999999999999999654332221 111111111
Q ss_pred hccCcccccc---------cc--ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 751 WSDNKALEIV---------DS--SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 751 ~~~~~~~~~~---------d~--~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
........+. .. .............+..++.+|++.||++|||++|+++...++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1111111000 00 111234456667788999999999999999999999988764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=366.62 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=206.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|.+.++||+|+||.||+|++. +++.||||++... ......++.+|+.++.+++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56788899999999999999853 4678999999654 3345567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcC----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC---Ceeecc
Q 003237 601 LIYEFMPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM---NPRISD 673 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ki~D 673 (837)
+||||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997643 2245889999999999999999999998 99999999999999554 599999
Q ss_pred cccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhc
Q 003237 674 FGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWS 752 (837)
Q Consensus 674 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 752 (837)
||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ...+... . .
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~~---i-~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEF---V-T 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHH---H-H
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH---H-H
Confidence 999986543332223334567899999999999999999999999999999998 999985322 1111111 1 1
Q ss_pred cCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 753 DNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 753 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+.... . +......+.+++.+|++.+|++|||+.+|++.|+..
T Consensus 301 ~~~~~~-----~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGRMD-----P----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCC-----C----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111111 1 111223577899999999999999999999999765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=375.43 Aligned_cols=257 Identities=28% Similarity=0.429 Sum_probs=208.1
Q ss_pred hhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
..++|.+.++||+|+||.||+|++.++..||||+++... ...+.|.+|++++.+++|||||++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 346788889999999999999999888999999996543 46788999999999999999999999986 6678999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++|+|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999996432 124788899999999999999999988 99999999999999999999999999987654322
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
.. .....++..|+|||++....++.++|||||||++|||++ |+.||.... ...+...+. .+...
T Consensus 340 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i~----~~~~~------- 404 (454)
T 1qcf_A 340 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALE----RGYRM------- 404 (454)
T ss_dssp HT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHH----HTCCC-------
T ss_pred ec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----cCCCC-------
Confidence 11 122456788999999999999999999999999999999 999986322 111111111 11000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
..+......+.+++.+|++.||++||||++|+++|+.+.
T Consensus 405 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 011112345788999999999999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=355.04 Aligned_cols=259 Identities=26% Similarity=0.409 Sum_probs=210.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEe------cCCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
.++|.+.+.||+|+||.||+|+. .++..||||++.... ....+.+.+|++++.+++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45788889999999999999976 245789999997543 34457788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCC---------------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCC
Q 003237 600 MLIYEFMPNKSLDYFIFDESR---------------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 658 (837)
++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976432 234889999999999999999999988 99999999
Q ss_pred CcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 003237 659 SNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFND 737 (837)
Q Consensus 659 ~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~ 737 (837)
+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999988765544333444567889999999999999999999999999999999 9999864322
Q ss_pred CCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 738 DDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 738 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..+.... ..+... . .+......+.+++.+|++.||++|||+.+|++.|+++
T Consensus 259 ---~~~~~~~----~~~~~~-----~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ---ERLFNLL----KTGHRM-----E----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp ---GGHHHHH----HTTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHh----hcCCcC-----C----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1222111 111111 1 1112234578899999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.11 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=201.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++..++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999876 78999999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999998853 234899999999999999999999988 99999999999999999999999999987654433
Q ss_pred eeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+. ..... ..+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~----~~~~~---~~~-- 230 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTY---LNP-- 230 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH----TTCTT---STT--
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh----ccccc---CCc--
Confidence 333445789999999999988775 7899999999999999999999965432211 111111 10000 000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
.......+.+++.+|++.||++|||+.|+++.
T Consensus 231 ----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01122346789999999999999999999763
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.28 Aligned_cols=255 Identities=23% Similarity=0.397 Sum_probs=205.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.++|.+.+.||+|+||.||+++..++..||||++... ....+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 3567888999999999999999998889999999654 344678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999999996532 34899999999999999999999988 999999999999999999999999999876543221
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+..... . ........ . .....
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~---~~~~~~~~-~-----~~~~~- 242 (283)
T 3gen_A 177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---S---ETAEHIAQ-G-----LRLYR- 242 (283)
T ss_dssp -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---H---HHHHHHHT-T-----CCCCC-
T ss_pred -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---h---HHHHHHhc-c-----cCCCC-
Confidence 1222456778999999999999999999999999999998 9999864321 1 11111111 1 00001
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+......+.+++.+|++.+|++|||++++++.|+.+
T Consensus 243 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 243 ---PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 111124577899999999999999999999999764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.91 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=208.9
Q ss_pred hhcCCCcCCcccccCCeeEEEEEe------cCCcEEEEEEecCC-CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCC
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 597 (837)
..++|.+.+.||+|+||.||+|+. .++..||||++... .....+.+.+|++++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346788899999999999999986 24668999999754 234457889999999999 8999999999999999
Q ss_pred ccEEEEEecCCCChhhHhhhcCCC--------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRK--------------------QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 657 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 657 (837)
..++||||+++|+|.+++...... ..+++..++.++.||++||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999754321 34789999999999999999999988 9999999
Q ss_pred CCcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q 003237 658 ASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFN 736 (837)
Q Consensus 658 p~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~ 736 (837)
|+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987755444334445667889999999999999999999999999999998 999986432
Q ss_pred CCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 737 DDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 737 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. ..... ....+.. . ..+......+.+++.+|++.||.+|||+.+|++.|+..
T Consensus 280 ~~--~~~~~----~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 280 VD--ANFYK----LIQNGFK-----M----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp CS--HHHHH----HHHTTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cH--HHHHH----HHhcCCC-----C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 21 11111 1111110 0 11111234577899999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=352.49 Aligned_cols=246 Identities=26% Similarity=0.367 Sum_probs=202.5
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++......++|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5788889999999999999987 47999999999654 33445678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++|+|.+++.... .+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 95 YASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999999986543 4889999999999999999999988 9999999999999999999999999998665432
Q ss_pred ceeeeccccccCCccCcccccCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFS-TKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
. ....+||+.|+|||++.+..+. .++|||||||++|||++|+.||.... ........... .. .
T Consensus 169 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~-~~------~ 232 (328)
T 3fe3_A 169 K---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRG-KY------R 232 (328)
T ss_dssp G---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC-CC------C
T ss_pred c---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhC-CC------C
Confidence 2 2346899999999999988875 79999999999999999999986321 11111111111 00 0
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+ +......+.+++.+|++.||.+|||++|+++
T Consensus 233 ~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 I----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp C----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred C----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 1112235678999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=346.23 Aligned_cols=262 Identities=23% Similarity=0.299 Sum_probs=202.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHH--hcCCCeeeeecccccC----CccE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAK--LQHRNLVKLLGCCLEE----DENM 600 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~~ 600 (837)
.++|++.++||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788899999999999999988 6899999998543 34566778887777 7899999999986543 4578
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHH--------hcCCCceeeCCCCCCcEEEcCCCCeeec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH--------QDSRLRIIHRDLKASNILLDEKMNPRIS 672 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 672 (837)
+||||+++|+|.+++.. ..+++..++.++.||++||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999943 35899999999999999999999 555 9999999999999999999999
Q ss_pred ccccceeccCcccee--eeccccccCCccCcccccCC------CCCCcccHHHHHHHHHHHHhC----------CCCCCC
Q 003237 673 DFGTARVFGGEEILA--ITKRVVGTYGYMSPEYALDG------VFSTKSDVFSFGVILLEIITG----------KKNTRI 734 (837)
Q Consensus 673 DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~------~~s~k~DV~S~Gvvl~elltG----------~~p~~~ 734 (837)
|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998765433221 12235799999999999877 456799999999999999999 777654
Q ss_pred CCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 735 FNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 735 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
....... ................+ ............+.+++.+|++.||++|||++||+++|+++
T Consensus 236 ~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPS-FEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCC-HHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcc-hhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3322221 11111111111111111 11112334567789999999999999999999999999753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=345.90 Aligned_cols=267 Identities=23% Similarity=0.349 Sum_probs=207.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 57888999999999999999865 68999999986543 233567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999998654 35899999999999999999999988 999999999999999999999999999876433
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ............. ..
T Consensus 165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~~-~~----- 231 (294)
T 4eqm_A 165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET------AVSIAIKHIQDSV-PN----- 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC------HHHHHHHHHSSCC-CC-----
T ss_pred cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhhccC-CC-----
Confidence 22 12234678999999999999999999999999999999999999985321 1111111111110 00
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccCCCCCCCCCC
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRP-SMSTVVFMLSNETFVPSPKQP 813 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-tm~eVv~~L~~~~~~~~p~~p 813 (837)
............+.+++.+|++.||++|| +++++.+.|+....-......
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 00111112234577899999999999998 999999999886554444333
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=348.93 Aligned_cols=261 Identities=27% Similarity=0.366 Sum_probs=201.3
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|++.++||+|+||+||+|+..+|+.||||++..... ...+.+.+|++++.+++||||+++++++.++...++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 57888999999999999999998899999999965422 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++ +|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 101 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 101 MEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 985 777777543 234889999999999999999999988 99999999999999999999999999987653322
Q ss_pred eeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc------
Q 003237 686 LAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE------ 758 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------ 758 (837)
......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ................
T Consensus 175 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 175 --SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp -----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGTT
T ss_pred --cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhhc
Confidence 1223578999999999876 568999999999999999999999997544332 2222222222111100
Q ss_pred ----------ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 ----------IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 ----------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+.............++.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000011112245788999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=372.11 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=202.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.++|.+.++||+|+||.||+|++.++..||||+++... ...++|.+|++++.+++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 35677889999999999999999888899999997543 446789999999999999999999999876 6789999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 261 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999996432 234889999999999999999999988 999999999999999999999999999876543221
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
......++..|+|||.+.+..++.++|||||||++|||++ |+.|+..... ..... .. ..+...
T Consensus 337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~---~i-~~~~~~-------- 400 (452)
T 1fmk_A 337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD---QV-ERGYRM-------- 400 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH---HH-HTTCCC--------
T ss_pred -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHH---HH-HcCCCC--------
Confidence 1223456789999999999999999999999999999999 9999853221 11111 11 111110
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
..+......+.+++.+|++.+|++|||+++|+++|+...
T Consensus 401 -~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 401 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 111122345778999999999999999999999999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=357.09 Aligned_cols=260 Identities=26% Similarity=0.413 Sum_probs=192.8
Q ss_pred hhcCCCcCCcccccCCeeEEEEEecCCc----EEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQ----EIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~~g~----~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
..++|++.+.||+|+||.||+|+..... .||||++... .....+.+.+|++++.+++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3467889999999999999999876432 7999998654 334567899999999999999999999999877655
Q ss_pred ------EEEEEecCCCChhhHhhhcCC---CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCee
Q 003237 600 ------MLIYEFMPNKSLDYFIFDESR---KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670 (837)
Q Consensus 600 ------~lV~ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 670 (837)
++||||+++|+|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 899999999999999865432 225899999999999999999999998 99999999999999999999
Q ss_pred ecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHH
Q 003237 671 ISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWE 749 (837)
Q Consensus 671 i~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 749 (837)
|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.|+..... ..+....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~-- 252 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---AEIYNYL-- 252 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH--
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh---HHHHHHH--
Confidence 999999987655443333334556789999999999999999999999999999999 8999864322 1111111
Q ss_pred HhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 750 LWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 750 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. +... ..+......+.+++.+|++.||++|||+.++++.|+++
T Consensus 253 -~~-~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 253 -IG-GNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp -HT-TCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hc-CCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 1100 01112234578999999999999999999999999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.22 Aligned_cols=253 Identities=31% Similarity=0.486 Sum_probs=195.0
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCC----ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.++||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++..++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56788899999999999999975 8999999986542 234578899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC--------CCCeeecccc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--------KMNPRISDFG 675 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--------~~~~ki~DFG 675 (837)
||+++++|.+++. ...+++..+..++.||++||.|||+.+..+|+||||||+|||++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999884 235899999999999999999999988666999999999999986 7789999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
+++....... ....|++.|+|||.+.+..++.++||||||++++||++|+.|+..... ............
T Consensus 162 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~ 231 (271)
T 3dtc_A 162 LAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNKL 231 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHTSCC
T ss_pred cccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhhcCCC
Confidence 9986543322 235789999999999999999999999999999999999999863221 111111111111
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
. .. .+......+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 232 ~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 A-----LP----IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C-----CC----CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 11 1112234578999999999999999999999999753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.62 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=210.6
Q ss_pred hcCCCcCCcccccCCeeEEEEEe------cCCcEEEEEEecCCCc-cCHHHHHHHHHHHHHh-cCCCeeeeecccccCCc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDE 598 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 598 (837)
.++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++.++ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35788889999999999999975 3568899999975432 3457789999999999 89999999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcCC---------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE
Q 003237 599 NMLIYEFMPNKSLDYFIFDESR---------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 663 (837)
.++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999976432 124899999999999999999999987 9999999999999
Q ss_pred cCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003237 664 DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSN 742 (837)
Q Consensus 664 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 742 (837)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||++++||++ |+.|+...... ..
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SK 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--hH
Confidence 9999999999999988765544334444567889999999999999999999999999999999 99998643221 11
Q ss_pred HHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 743 LIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 743 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
....... .. .... +......+.+++.+|++.||++|||+.||+++|++.
T Consensus 257 ~~~~~~~----~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 257 FYKMIKE----GF-----RMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HHHHHHH----TC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcc----CC-----CCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1111111 10 0001 111224577899999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.15 Aligned_cols=260 Identities=18% Similarity=0.213 Sum_probs=207.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|.+.+.||+|+||.||+|+. .+++.||||.+..... .+.+.+|++++.++ +||||+++++++..+...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788899999999999999986 4789999999865432 34688999999999 89999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC-----eeeccccccee
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN-----PRISDFGTARV 679 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~ki~DFGla~~ 679 (837)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998654 345899999999999999999999988 999999999999998887 99999999997
Q ss_pred ccCcccee-----eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC
Q 003237 680 FGGEEILA-----ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN 754 (837)
Q Consensus 680 ~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 754 (837)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 65433211 1234689999999999999999999999999999999999999997654333222222211110000
Q ss_pred ccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 755 KALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 755 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. ..+.... . .+.+++..|++.+|.+||++++|++.|+.+
T Consensus 240 ~~-----~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 240 PI-----EVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp CH-----HHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CH-----HHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00 0011111 1 678899999999999999999999998653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=368.15 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=203.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCC-ccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED-ENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~ey 605 (837)
.++|.+.++||+|+||.||+|+.. ++.||||+++... ..+.|.+|++++.+++|||||++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 356788899999999999999885 7899999997543 4578999999999999999999999987665 68999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++|+|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 99999999997643 334789999999999999999999988 999999999999999999999999999864322
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... .....+ ..+....
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i----~~~~~~~------ 406 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGYKMD------ 406 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THHHHH----HTTCCCC------
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCCC------
Confidence 122357889999999999999999999999999999998 99998644322 122111 1111111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+......+.+++..||+.||++|||+.+|++.|+.+
T Consensus 407 ---~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 407 ---APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112234577899999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=353.97 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=198.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc-------
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE------- 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------- 598 (837)
++|++.++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++.+++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 56888899999999999999886 79999999997543 3345788999999999999999999999865432
Q ss_pred --------------------------------------------------cEEEEEecCCCChhhHhhhcCCCCCCChhh
Q 003237 599 --------------------------------------------------NMLIYEFMPNKSLDYFIFDESRKQLLDWKK 628 (837)
Q Consensus 599 --------------------------------------------------~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~ 628 (837)
.++||||+++++|.+++..........+..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 689999999999999998766556677778
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce----------eeeccccccCCc
Q 003237 629 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL----------AITKRVVGTYGY 698 (837)
Q Consensus 629 ~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~----------~~~~~~~gt~~y 698 (837)
++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 8999999999999999988 999999999999999999999999999987644211 112335799999
Q ss_pred cCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHH
Q 003237 699 MSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQ 778 (837)
Q Consensus 699 ~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 778 (837)
+|||.+.+..++.++|||||||++|||++|..|.. ......... ..... + .........+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~~-~~~~~-----~----~~~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITDV-RNLKF-----P----LLFTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHHH-HTTCC-----C----HHHHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHHh-hccCC-----C----cccccCChhHHH
Confidence 99999999999999999999999999999876642 111111111 11100 0 011222345678
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 003237 779 VGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 779 l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
++.+|++.||++|||++|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.13 Aligned_cols=247 Identities=20% Similarity=0.283 Sum_probs=202.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||+++.. +|+.||||++++. .....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888899999999999999876 6899999999653 2345677889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999988653 34789999999999999999999988 999999999999999999999999999864322
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. ..... . ..
T Consensus 159 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~---~i~~~-~------~~ 223 (337)
T 1o6l_A 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFE---LILME-E------IR 223 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHC-C------CC
T ss_pred C--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHH---HHHcC-C------CC
Confidence 2 12334689999999999999999999999999999999999999985321 111111 11111 0 01
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
+... ....+.+++.+|++.||++|| +++||++
T Consensus 224 ~p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1111 224577899999999999999 8999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=353.81 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=208.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEec--------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccC
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS--------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE 596 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 596 (837)
.++|.+.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|++++.++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367888899999999999999863 46789999997543 33456788999999999 899999999999999
Q ss_pred CccEEEEEecCCCChhhHhhhcCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 663 (837)
+..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999975432 234889999999999999999999988 9999999999999
Q ss_pred cCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003237 664 DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSN 742 (837)
Q Consensus 664 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 742 (837)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+.... ...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---HHH
Confidence 9999999999999998765544333444567889999999999999999999999999999999 999985321 111
Q ss_pred HHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 743 LIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 743 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+.... ..+... .. +......+.+++.+|++.+|.+|||+.||++.|+++
T Consensus 268 ~~~~~----~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 268 LFKLL----KEGHRM-----DK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHH----HHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH----hcCCCC-----CC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111 111110 11 111224577899999999999999999999999876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.95 Aligned_cols=261 Identities=17% Similarity=0.206 Sum_probs=209.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|++++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35788899999999999999986 578999999986543 234678899999999 79999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC-----eeeccccccee
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN-----PRISDFGTARV 679 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~ki~DFGla~~ 679 (837)
|+ +++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999996542 34899999999999999999999987 999999999999987776 99999999987
Q ss_pred ccCccce-----eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC
Q 003237 680 FGGEEIL-----AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN 754 (837)
Q Consensus 680 ~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 754 (837)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7543221 12234679999999999999999999999999999999999999997654333322222221111111
Q ss_pred ccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 755 KALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 755 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
...+ +.... ...+.+++..|++.+|++||++++|++.|+++
T Consensus 241 ~~~~-----~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHH-----HHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 1111 11112 24577899999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.81 Aligned_cols=255 Identities=23% Similarity=0.377 Sum_probs=200.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcE----EEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQE----IAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|.+.++||+|+||.||+|+.. +++. ||+|.+.... ....+.+.+|+.++.+++||||+++++++. +...++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46778899999999999999864 4443 7888875432 334456788999999999999999999986 567889
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++|+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998643 345889999999999999999999998 9999999999999999999999999999876
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.... ........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~~~~~- 238 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLL----EKGERLAQ- 238 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHH----HTTCBCCC-
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHH----HcCCCCCC-
Confidence 5444333445678889999999999999999999999999999999 99998643321 111111 11111100
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+......+.+++.+|++.+|++|||+++|++.|+..
T Consensus 239 --------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 239 --------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp --------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred --------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001112356899999999999999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=348.45 Aligned_cols=251 Identities=18% Similarity=0.294 Sum_probs=203.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.++|.+.+.||+|+||.||+++.. +++.+|+|.+... ....+.+.+|++++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367888999999999999999876 5889999998643 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC--CCCeeecccccceeccCc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--KMNPRISDFGTARVFGGE 683 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~ki~DFGla~~~~~~ 683 (837)
+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999998543 235899999999999999999999988 999999999999997 789999999999887544
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... ........ .+..
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~---~i~~~~~~---~~~~ 225 (321)
T 1tki_A 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIE---NIMNAEYT---FDEE 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH---HHHHTCCC---CCHH
T ss_pred Cc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHH---HHHcCCCC---CChh
Confidence 32 2235789999999999999999999999999999999999999864221 11111 11111100 0000
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... .....+.+++.+|++.||++|||+.|+++
T Consensus 226 ~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 226 AFK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001 11245778999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=343.14 Aligned_cols=255 Identities=29% Similarity=0.457 Sum_probs=205.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.++|.+.+.||+|+||.||+|...++..||||++... ....+.+.+|++++.+++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 3567888999999999999999988889999999654 345678999999999999999999999986 45689999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++.... ...+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999985432 124889999999999999999999988 999999999999999999999999999877544322
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
......++..|+|||.+.+..++.++||||||++++||++ |+.|+..... ..+.. .. ..+. ....
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~---~~-~~~~-----~~~~- 231 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQ---NL-ERGY-----RMVR- 231 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH---HH-HTTC-----CCCC-
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHH---HH-hccc-----CCCC-
Confidence 2233456789999999998999999999999999999999 8988853211 11111 11 1110 0011
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+......+.+++..|++.+|++|||+++|+++|+..
T Consensus 232 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 111224577899999999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.41 Aligned_cols=251 Identities=24% Similarity=0.298 Sum_probs=203.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc------cCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
.+.|.+.+.||+|+||.||+++.. +|+.||||.+..... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457888999999999999999876 689999999975432 2357899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC----Ceeecccc
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM----NPRISDFG 675 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~ki~DFG 675 (837)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999854 345899999999999999999999988 99999999999998877 79999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. ..... .
T Consensus 165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---~~~~~~---~i~~~-~ 234 (361)
T 2yab_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLA---NITAV-S 234 (361)
T ss_dssp SCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHH---HHHTT-C
T ss_pred CceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HHHhc-C
Confidence 9987654321 234679999999999999999999999999999999999999985321 111111 11110 0
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. -+++..... ....+.+++..|++.||++|||+.|+++
T Consensus 235 ~--~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 Y--DFDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C--CCCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C--CCCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 001111111 1245778999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.52 Aligned_cols=263 Identities=26% Similarity=0.402 Sum_probs=211.1
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED 597 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 597 (837)
...++|.+.+.||+|+||.||+|+.. .++.||||.+.... ......+.+|++++.+++||||+++++++.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578888999999999999999764 36789999997543 234557889999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhHhhhcC-------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCee
Q 003237 598 ENMLIYEFMPNKSLDYFIFDES-------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 670 (837)
..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 9999999999999999986532 1245789999999999999999999998 99999999999999999999
Q ss_pred ecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHH
Q 003237 671 ISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWE 749 (837)
Q Consensus 671 i~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 749 (837)
|+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+.. .
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~---~ 252 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLR---F 252 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHH---H
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHHH---H
Confidence 999999987655443333344567889999999999999999999999999999999 8888853211 11111 1
Q ss_pred HhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 750 LWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 750 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
. ..+.... . +......+.+++.+|++.+|++|||+.||++.|+++..
T Consensus 253 ~-~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 253 V-MEGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp H-HTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H-HcCCcCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1 1111111 1 11122457789999999999999999999999987644
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=340.25 Aligned_cols=254 Identities=27% Similarity=0.418 Sum_probs=207.1
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|.+.+.||+|+||.||+++..+++.||||++.... ...+.+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 4677889999999999999999889999999996543 345789999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+++|.+++... ...+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++........
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 160 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 160 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc-
Confidence 99999998653 235789999999999999999999988 999999999999999999999999999866433211
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... . ......... +.. ..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~---~~~~~~i~~-~~~--~~------ 225 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---N---SEVVEDIST-GFR--LY------ 225 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---H---HHHHHHHHT-TCC--CC------
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---H---HHHHHHHhc-CCc--CC------
Confidence 1223456788999999999999999999999999999999 898885321 1 111111111 100 00
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+......+.+++.+|++.+|++|||++++++.|+.+
T Consensus 226 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 226 -KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111234577899999999999999999999999865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.79 Aligned_cols=254 Identities=28% Similarity=0.522 Sum_probs=200.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccC-------HHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQG-------IEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
++|++.+.||+|+||.||+|+.. +++.||||++....... .+.+.+|++++.+++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57888899999999999999875 78999999986543221 267889999999999999999999986554
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC-----eeeccc
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN-----PRISDF 674 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~ki~DF 674 (837)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ .+|+||||||+|||++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 7999999999999888653 345899999999999999999999975 34999999999999988776 999999
Q ss_pred ccceeccCccceeeeccccccCCccCcccc--cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc
Q 003237 675 GTARVFGGEEILAITKRVVGTYGYMSPEYA--LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS 752 (837)
Q Consensus 675 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~--~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 752 (837)
|+++..... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||....... .........
T Consensus 174 g~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~ 244 (287)
T 4f0f_A 174 GLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIRE 244 (287)
T ss_dssp TTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHH
T ss_pred Ccccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhc
Confidence 999854332 2336789999999998 45568999999999999999999999996433221 111111111
Q ss_pred cCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 753 DNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 753 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. ..+.+.. .....+.+++.+|++.||++|||++||++.|+++
T Consensus 245 ~~-----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 EG-----LRPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp SC-----CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cC-----CCCCCCc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 1111111 2234578999999999999999999999999763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.72 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=202.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc------cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|.+.+.||+|+||.||+++.. +|+.||||.+..... ...+.+.+|+.++.+++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56888899999999999999876 689999999875422 24678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC----Ceeeccccc
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM----NPRISDFGT 676 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~ki~DFGl 676 (837)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999854 345899999999999999999999988 99999999999999887 899999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 756 (837)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ...
T Consensus 165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~---~~~-- 233 (326)
T 2y0a_A 165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVS---AVN-- 233 (326)
T ss_dssp CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHH---HTC--
T ss_pred CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHH---hcC--
Confidence 987654321 2336799999999999999999999999999999999999999853211 11111111 000
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 757 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. ....... .....+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~-~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YE-FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CC-CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC-cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000001 11245678999999999999999999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=354.10 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=195.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcC--CCeeeeecccccCCccEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQH--RNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV 602 (837)
.++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++| +||+++++++.++...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568888999999999999999988999999998654 33445778999999999986 9999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5788999998653 35889999999999999999999988 99999999999997 57899999999987755
Q ss_pred ccceeeeccccccCCccCcccccC-----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 003237 683 EEILAITKRVVGTYGYMSPEYALD-----------GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELW 751 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 751 (837)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHh
Confidence 443333345679999999999865 6789999999999999999999999853211 111111111
Q ss_pred ccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 752 SDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 752 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. +......+......+.+++..|++.||++||||.||++
T Consensus 235 ~---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 235 D---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp C---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 1 11111111112245778999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=350.48 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=202.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC-----CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-----SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|++++.+++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56888999999999999999875 6899999998532 22356789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcC-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC---eeecccccc
Q 003237 602 IYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN---PRISDFGTA 677 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~ki~DFGla 677 (837)
||||+++++|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988876532 3345889999999999999999999988 999999999999986654 999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+... ... +...
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~---i~~-~~~~ 250 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEG---IIK-GKYK 250 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHH---HHH-TCCC
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHH---HHc-CCCC
Confidence 87754332 123457999999999999999999999999999999999999998632 1111111 111 1000
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+..... ....+.+++.+|++.||++|||+.|+++
T Consensus 251 --~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000011 1245778999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.01 Aligned_cols=244 Identities=22% Similarity=0.275 Sum_probs=191.7
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.++||+|+||+||+|+.. +++.||||++.... .....++..|+..+.++ +||||+++++++.++...++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57888999999999999999886 79999999986542 22334455666666666 8999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+ +++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 668888886543 35899999999999999999999987 999999999999999999999999999876543
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.. .....||+.|+|||++.+ .++.++|||||||++|||++|+.|+... . . ......+. ..+.
T Consensus 211 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~--~--~~~~~~~~----~~~~ 272 (311)
T 3p1a_A 211 GA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------E--G--WQQLRQGY----LPPE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------H--H--HHHHTTTC----CCHH
T ss_pred CC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------c--H--HHHHhccC----CCcc
Confidence 22 233568999999998875 7999999999999999999997765321 0 0 11111111 1111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+.. .....+.+++.+|++.||++|||++|+++
T Consensus 273 ~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111 12345789999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=353.03 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=208.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEecC-C-----cEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSN-G-----QEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDE 598 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~-g-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 598 (837)
.++|.+.+.||+|+||.||+|+... + ..||||.+.... ....+.+.+|++++.++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4678889999999999999998642 2 479999997543 23456789999999999 89999999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcCC-----------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC
Q 003237 599 NMLIYEFMPNKSLDYFIFDESR-----------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM 667 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~ 667 (837)
.++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 9999999999999999865321 235789999999999999999999987 99999999999999999
Q ss_pred CeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHH
Q 003237 668 NPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKY 746 (837)
Q Consensus 668 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 746 (837)
.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ......
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~ 279 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--SKFYKL 279 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--HHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--HHHHHH
Confidence 999999999987654433333344567889999999999999999999999999999999 88888643221 111111
Q ss_pred HHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 747 AWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 747 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. .... .. .+......+.+++..|++.+|.+|||+.||++.|+..
T Consensus 280 ~~----~~~~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 280 VK----DGYQ-----MA----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HH----HTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hh----cCCC-----CC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11 1100 00 1111124577899999999999999999999999754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=353.30 Aligned_cols=249 Identities=20% Similarity=0.331 Sum_probs=197.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.++||+|+||+||+++.. +++.||||++++.. ....+.+.+|..++.++ +|||||++++++.+.+..+||
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 56888899999999999999876 57899999997542 23345678899999887 899999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 132 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999998654 34899999999999999999999998 99999999999999999999999999986332
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCc--chHHHHHHHHhccCcccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDS--SNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~ 760 (837)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ................
T Consensus 206 ~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 279 (396)
T 4dc2_A 206 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 279 (396)
T ss_dssp TT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----
T ss_pred CC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----
Confidence 21 123447899999999999999999999999999999999999999965432211 1111111111111110
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSM 794 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 794 (837)
. .+......+.+++..|++.||++||++
T Consensus 280 --~----~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 --R----IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --C----CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --C----CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 111223457789999999999999995
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=352.77 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=197.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcE----EEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQE----IAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|++.++||+|+||.||+|+.. +++. ||+|.+... .....+++.+|+.++.+++||||+++++++... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceE
Confidence 57888899999999999999864 4443 577877543 345678899999999999999999999999765 4789
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|+||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999987543 35889999999999999999999998 9999999999999999999999999998775
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
............+|..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+.... .....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~----~~~~~---- 237 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSIL----EKGER---- 237 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH----HTTCC----
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHH----HcCCC----
Confidence 4433333334566889999999999999999999999999999999 9999864322 1122111 11110
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
...+......+.+++.+|++.+|++|||+.||++.|+.+.
T Consensus 238 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 238 -----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0011112335778999999999999999999999998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=351.80 Aligned_cols=256 Identities=23% Similarity=0.275 Sum_probs=188.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccc--------cCC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCL--------EED 597 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~--------~~~ 597 (837)
.+|.+.++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 46888899999999999999875 68999999997666666778899999999996 999999999983 334
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..++||||+. |+|.+++........+++..+..++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccc
Confidence 5789999996 789898876545556999999999999999999999875 35999999999999999999999999999
Q ss_pred eeccCcccee----------eeccccccCCccCcccc---cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 003237 678 RVFGGEEILA----------ITKRVVGTYGYMSPEYA---LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744 (837)
Q Consensus 678 ~~~~~~~~~~----------~~~~~~gt~~y~APE~~---~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 744 (837)
+......... ......+|+.|+|||++ .+..++.++|||||||++|||++|+.|+.......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----- 260 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----- 260 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----
Confidence 8765432211 11134689999999998 56778999999999999999999999985321110
Q ss_pred HHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 745 KYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 745 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. . ... ....... ....+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 261 -~~----~-~~~----~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 261 -IV----N-GKY----SIPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp -----------C----CCCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred -hh----c-Ccc----cCCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 0 000 0000011 112366899999999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=342.25 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=209.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.++|++.+.||+|+||.||+|... ++..||||.+... ....+.+.+|++++.+++||||+++++++.++...++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 457888899999999999999886 4889999999654 34467889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 91 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 91 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred CCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999996543 345899999999999999999999998 99999999999999999999999999987654432
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. ......+++.|+|||.+.+..++.++||||||++++||++ |+.|+..... ........ .. .
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~---~~~~~~~~----~~---------~ 229 (288)
T 3kfa_A 167 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLE----KD---------Y 229 (288)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHH----TT---------C
T ss_pred c-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh----cc---------C
Confidence 2 2233567889999999999999999999999999999999 9888854321 11221111 11 0
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
....+......+.+++..|++.+|++|||+++|+++|+..
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0111112234578899999999999999999999999753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=359.46 Aligned_cols=262 Identities=17% Similarity=0.232 Sum_probs=205.5
Q ss_pred HHHHHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeeccccc
Q 003237 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLE 595 (837)
Q Consensus 520 ~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 595 (837)
+.++....++|++.++||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4445556788999999999999999999886 47899999996421 2223458899999999999999999999999
Q ss_pred CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccc
Q 003237 596 EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (837)
Q Consensus 596 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFG 675 (837)
.+..+|||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999653 235899999999999999999999988 9999999999999999999999999
Q ss_pred cceeccCccceeeeccccccCCccCccccc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
+++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..... ..
T Consensus 221 la~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~---~i 293 (437)
T 4aw2_A 221 SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYG---KI 293 (437)
T ss_dssp TCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH---HH
T ss_pred hhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHH---hh
Confidence 99876544322 233468999999999997 56799999999999999999999999963221 11111 11
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTD--RPSMSTVVF 799 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPtm~eVv~ 799 (837)
........ -+...... ...+.+++.+|++.+|++ ||+++|+++
T Consensus 294 ~~~~~~~~--~p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 294 MNHKERFQ--FPTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HTHHHHCC--CCSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhcccccc--CCcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11100000 01111111 234667888888887877 999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.20 Aligned_cols=266 Identities=18% Similarity=0.223 Sum_probs=202.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEecC------CcEEEEEEecCCCccCH-----------HHHHHHHHHHHHhcCCCeeee
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSN------GQEIAVKRLSTTSGQGI-----------EELKNEVLLIAKLQHRNLVKL 589 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l 589 (837)
.++|.+.++||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578889999999999999998764 47899999865532111 122345555666789999999
Q ss_pred ecccccC----CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-
Q 003237 590 LGCCLEE----DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD- 664 (837)
Q Consensus 590 ~~~~~~~----~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~- 664 (837)
++++... ...+|||||+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9998775 3479999999 99999998653 345899999999999999999999997 99999999999999
Q ss_pred -CCCCeeecccccceeccCcccee-----eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 003237 665 -EKMNPRISDFGTARVFGGEEILA-----ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDD 738 (837)
Q Consensus 665 -~~~~~ki~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~ 738 (837)
.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998765432211 112345999999999999999999999999999999999999999743221
Q ss_pred CcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 739 DSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 739 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
........... ...+.+++++.+.... ....+.+++..|++.+|++||++++|+++|+.+
T Consensus 268 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 268 --PKYVRDSKIRY-RENIASLMDKCFPAAN---APGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp --HHHHHHHHHHH-HHCHHHHHHHHSCTTC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred --HHHHHHHHHHh-hhhHHHHHHHhccccc---CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 12222222111 1223344444332111 123577888999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=347.99 Aligned_cols=265 Identities=28% Similarity=0.414 Sum_probs=210.5
Q ss_pred HHHHhhcCCCcCCcccccCCeeEEEEEe------cCCcEEEEEEecCCCc-cCHHHHHHHHHHHHHh-cCCCeeeeeccc
Q 003237 522 TLLAATDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLLGCC 593 (837)
Q Consensus 522 ~l~~at~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 593 (837)
......++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++.++ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3334467899999999999999999974 3568899999976432 3456788999999999 699999999998
Q ss_pred ccCC-ccEEEEEecCCCChhhHhhhcCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCC
Q 003237 594 LEED-ENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKAS 659 (837)
Q Consensus 594 ~~~~-~~~lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 659 (837)
...+ ..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~ 177 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 177 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccc
Confidence 7755 48999999999999999975432 223788999999999999999999987 999999999
Q ss_pred cEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC
Q 003237 660 NILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDD 738 (837)
Q Consensus 660 NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~ 738 (837)
||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999999999999987655443334445677889999999999999999999999999999998 99998643221
Q ss_pred CcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 739 DSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 739 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..+.... ..+.... .... ....+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 258 --~~~~~~~----~~~~~~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 258 --EEFCRRL----KEGTRMR-----APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp --HHHHHHH----HHTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHh----ccCccCC-----CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111 1111111 1111 223577899999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.99 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=193.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--------------------------cCHHHHHHHHHHHHH
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--------------------------QGIEELKNEVLLIAK 580 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~~ 580 (837)
++|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++.+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888899999999999999875 688999999865421 123568899999999
Q ss_pred hcCCCeeeeeccccc--CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCC
Q 003237 581 LQHRNLVKLLGCCLE--EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 658 (837)
Q Consensus 581 l~H~nIv~l~~~~~~--~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 658 (837)
++||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999986 557899999999999987652 345899999999999999999999998 99999999
Q ss_pred CcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCC---CCCcccHHHHHHHHHHHHhCCCCCCCC
Q 003237 659 SNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV---FSTKSDVFSFGVILLEIITGKKNTRIF 735 (837)
Q Consensus 659 ~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~k~DV~S~Gvvl~elltG~~p~~~~ 735 (837)
+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999987654332 223467999999999998765 478899999999999999999998532
Q ss_pred CCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 736 NDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 736 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. .......... ... .. + .... ....+.+++.+|++.||++|||++||++
T Consensus 244 ~------~~~~~~~~~~-~~~-~~--~-~~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 R------IMCLHSKIKS-QAL-EF--P-DQPD----IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp S------HHHHHHHHHH-CCC-CC--C-SSSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c------HHHHHHHHhc-ccC-CC--C-Cccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 1111111111 100 00 0 0111 2235778999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=357.11 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=195.7
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhc--CCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQ--HRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~ 603 (837)
+.|.+.++||+|+||.||++....++.||||++... .....+.+.+|++++.+++ ||||+++++++...+..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458888999999999999999888999999998654 2345578899999999996 599999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 6788999998654 35788899999999999999999987 99999999999996 589999999999876544
Q ss_pred cceeeeccccccCCccCcccccC-----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc
Q 003237 684 EILAITKRVVGTYGYMSPEYALD-----------GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS 752 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 752 (837)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..........
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~ 282 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIID 282 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhC
Confidence 33333345679999999999875 4689999999999999999999999953221 1111112221
Q ss_pred cCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 753 DNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 753 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. .....+......+.+++.+|++.||++|||+.||++
T Consensus 283 ~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 283 PN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp TT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cc---------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 11 111111111245778999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=342.33 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=192.7
Q ss_pred cCCCcCCcccccCCeeEEEEEecC----CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.+.||+|+||.||+|.... +..||||++.... ....+.+.+|+.++.+++||||+++++++. ++..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 568888999999999999998742 4579999986543 334567889999999999999999999984 5678999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 94 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 9999999999999653 235899999999999999999999987 99999999999999999999999999987654
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ........ .....
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~---~~~~~~i~----~~~~~---- 236 (281)
T 1mp8_A 169 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIE----NGERL---- 236 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHH----TTCCC----
T ss_pred cccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH---HHHHHHHH----cCCCC----
Confidence 3221 1223456788999999999999999999999999999996 9999864322 12221111 11110
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+ +......+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 237 -~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 -PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 112234577899999999999999999999999764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=374.23 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=207.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.++|.+.++||+|+||.||+|++.++..||||+++... ...++|.+|+++|.+++|+|||++++++.+ ...+|||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 35677889999999999999999888899999997543 446789999999999999999999999876 6789999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++........
T Consensus 344 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred cCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999996432 234889999999999999999999988 999999999999999999999999999876543221
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
......++..|+|||.+.+..++.++|||||||+||||++ |+.||..... ..+... + ..+...
T Consensus 420 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~---i-~~~~~~-------- 483 (535)
T 2h8h_A 420 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQ---V-ERGYRM-------- 483 (535)
T ss_dssp -TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHH---H-HTTCCC--------
T ss_pred -cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---H-HcCCCC--------
Confidence 1122456788999999999999999999999999999999 8999853221 111111 1 111111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
..+......+.+++.+||+.+|++|||+++|+++|+.+.
T Consensus 484 -~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 484 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 011122345778999999999999999999999998763
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.98 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=197.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 601 (837)
.++|++.++||+|+||+||+++.. +++.||||++++. .....+.+.+|.+++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 367888999999999999999875 6899999999753 234556788999999998 69999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999998654 34889999999999999999999998 9999999999999999999999999998543
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ....... .
T Consensus 176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~---~~i~~~~-~----- 241 (353)
T 3txo_A 176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DDLF---EAILNDE-V----- 241 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHCC-C-----
T ss_pred cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HHHH---HHHHcCC-C-----
Confidence 222 223346899999999999999999999999999999999999999863221 1111 1111111 0
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSM------STVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm------~eVv~ 799 (837)
. .+......+.+++..|++.+|++||++ +|+++
T Consensus 242 -~----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -V----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -C----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -C----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 111122346789999999999999998 67764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=338.46 Aligned_cols=261 Identities=22% Similarity=0.354 Sum_probs=198.5
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|.+.++||+|+||.||+|+..+|+.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688889999999999999998889999999986543 23347788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++ +|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 888887543 235889999999999999999999987 99999999999999999999999999986643221
Q ss_pred eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc------cc
Q 003237 686 LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA------LE 758 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~ 758 (837)
......+|+.|+|||++.+. .++.++|||||||++|||++|+.||..... ................ .+
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHHCCCChhhchhhhc
Confidence 12235689999999999764 589999999999999999999999864321 1112222221111100 00
Q ss_pred --ccccccc-------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 --IVDSSMA-------NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 --~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..++... ..........+.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0111100 0111112345778999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.59 Aligned_cols=260 Identities=28% Similarity=0.458 Sum_probs=193.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|.+.++||+|+||.||+|+.. ..+|||+++... ....+.+.+|++++.+++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 457888899999999999999864 469999986542 33457789999999999999999999965 5567899999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999998543 345899999999999999999999988 9999999999999999999999999998655433
Q ss_pred ceeeeccccccCCccCccccc---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYAL---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.........||+.|+|||.+. +..++.++||||||++++||++|+.||..... ...+.... ..+.....+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~----~~~~~~~~~~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMV----GRGSLSPDLS 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHH----HHTSCCCCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHh----cccccCcchh
Confidence 223334467899999999987 66789999999999999999999999864322 11112111 1111111000
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
.+ .......+.+++..|++.+|++|||+.+|+++|+.+.
T Consensus 249 -~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 -KV----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -SS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -hc----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11 1122345789999999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=350.72 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=202.7
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.+.||+|+||.||++... +++.||||++.+. .....+.+.+|++++..++|||||++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888899999999999999876 5889999998643 2345678889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+.+|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999998643 35899999999999999999999998 999999999999999999999999999876543
Q ss_pred cceeeeccccccCCccCcccccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALD---GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
. .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+..... .. .
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~~-~----- 236 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---TT-V----- 236 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---HC-C-----
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---hc-c-----
Confidence 2 2234689999999999974 458999999999999999999999997544333222221111 00 0
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPS-MSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-m~eVv~ 799 (837)
. ..+......+.+++.+|++.+|++||+ +++|..
T Consensus 237 -~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -V----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -C----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -c----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 011112345778999999999999998 777764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=337.65 Aligned_cols=262 Identities=21% Similarity=0.318 Sum_probs=199.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|++.++||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++.+++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999875 689999999975432 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|++++ |...+... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~-l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQD-LKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEE-HHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCC-HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99864 44444332 245899999999999999999999998 9999999999999999999999999998765332
Q ss_pred ceeeeccccccCCccCcccccCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc-----
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE----- 758 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~----- 758 (837)
. ......+|+.|+|||++.+.. ++.++|||||||+++||++|+.|+... .....................
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~--~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG--NDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC--SSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC--CCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 1 223357899999999998766 899999999999999999999886322 122222222222222111000
Q ss_pred -cccc---------ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 -IVDS---------SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 -~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+. .............+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 0000111123345778999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.28 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=204.6
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeeccccc----CCccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~l 601 (837)
.++|.+.+.||+|+||.||+++. .+++.||||++........+.+.+|++++.+++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46788899999999999999987 4789999999876666667789999999999999999999999873 346789
Q ss_pred EEEecCCCChhhHhhhcC-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 602 IYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
||||+++|+|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999987532 2356899999999999999999999997 999999999999999999999999998765
Q ss_pred cCccce-------eeeccccccCCccCcccccCCC---CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 681 GGEEIL-------AITKRVVGTYGYMSPEYALDGV---FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 681 ~~~~~~-------~~~~~~~gt~~y~APE~~~~~~---~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
...... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+........ .+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~--- 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAV--- 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHH---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHh---
Confidence 321110 0011245799999999987654 78999999999999999999999853211111 111100
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
.. .............+.+++.+|++.||.+|||+++|++.|+.+..
T Consensus 261 -~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 261 -QN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -HC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -hc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00 00000011123457899999999999999999999999998653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.45 Aligned_cols=258 Identities=21% Similarity=0.268 Sum_probs=204.8
Q ss_pred HHHHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccC
Q 003237 521 STLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE 596 (837)
Q Consensus 521 ~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 596 (837)
.++....++|++.++||+|+||+||+++.. +++.||||++.+. .....+.+.+|+.++..++|||||++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455678999999999999999999876 5889999998642 122334578999999999999999999999999
Q ss_pred CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
...+|||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999998643 3788999999999999999999988 99999999999999999999999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCC----CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGV----FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS 752 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 752 (837)
++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......+..
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~ 287 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMN 287 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHT
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC------hhhHHHHHHh
Confidence 987654432 2233578999999999998765 8899999999999999999999986321 1111111111
Q ss_pred cCccccccccccccccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 003237 753 DNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTD--RPSMSTVVF 799 (837)
Q Consensus 753 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPtm~eVv~ 799 (837)
........+ ... ....+.+++.+|++.+|++ ||+++||++
T Consensus 288 ~~~~~~~p~---~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 288 HKNSLTFPD---DND----ISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHCCCCT---TCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ccccccCCC---ccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 100001000 001 1235678889999999988 999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.06 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=201.8
Q ss_pred cCCCcCCcccccCCeeEEEEEecC-C-------cEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN-G-------QEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
++|.+.+.||+|+||.||+|+... + ..||+|++........+.+.+|++++.+++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 567888999999999999997653 3 47999999776666778899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC--------eee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN--------PRI 671 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~ki 671 (837)
++||||+++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999996532 34889999999999999999999998 999999999999998887 999
Q ss_pred cccccceeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 672 SDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|..|+..... .. ......
T Consensus 163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~---~~~~~~ 231 (289)
T 4fvq_A 163 SDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQ---RKLQFY 231 (289)
T ss_dssp CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HH---HHHHHH
T ss_pred ccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hH---HHHHHh
Confidence 999998754332 22457889999999987 7799999999999999999996655432111 11 111111
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
..... +.... ...+.+++.+|++.||++|||++||++.|+.+..
T Consensus 232 ~~~~~--------~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDRHQ--------LPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTTCC--------CCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hccCC--------CCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 10111 2246789999999999999999999999998644
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=353.50 Aligned_cols=268 Identities=24% Similarity=0.378 Sum_probs=209.1
Q ss_pred cCCCcCCcccccCCeeEEEEEe-----cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeeccccc--CCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 600 (837)
++|++.++||+|+||.||++++ .+++.||||++........+.+.+|++++.+++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788889999999999999984 3688999999987666666789999999999999999999998864 45678
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999996532 24899999999999999999999987 999999999999999999999999999987
Q ss_pred cCccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH---HHHhccCcc
Q 003237 681 GGEEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYA---WELWSDNKA 756 (837)
Q Consensus 681 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~---~~~~~~~~~ 756 (837)
...... .......+|..|+|||.+.+..++.++||||||++++||++|+.|+...... ..... .........
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMGCERDVPALSRL 253 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC----CCHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhcccccccccHHHH
Confidence 544322 2223356788899999999999999999999999999999999987532110 00000 000000001
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 757 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+.+........+......+.+++.+|++.||++|||++||++.|+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111111112223345678999999999999999999999999876
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=346.76 Aligned_cols=262 Identities=25% Similarity=0.427 Sum_probs=196.3
Q ss_pred HHhhcCCCcCCcccccCCeeEEEEEec----CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC
Q 003237 524 LAATDNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED 597 (837)
Q Consensus 524 ~~at~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 597 (837)
....++|.+.+.||+|+||.||+|+.. .+..||||++... .....+.+.+|++++.+++||||+++++++.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 334577888999999999999999764 3458999998654 2334567899999999999999999999998765
Q ss_pred c-----cEEEEEecCCCChhhHhhhc---CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 598 E-----NMLIYEFMPNKSLDYFIFDE---SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 598 ~-----~~lV~ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
. .++||||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 3 48999999999999998543 23356899999999999999999999987 9999999999999999999
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 748 (837)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..... ........
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~ 263 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMYDYLL 263 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHH
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHH
Confidence 9999999987654433333334567889999999999999999999999999999999 8888754322 11221111
Q ss_pred HHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 749 ELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 749 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
. +... .. +......+.+++.+|++.+|++|||+++|++.|+.+
T Consensus 264 ---~-~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 264 ---H-GHRL-----KQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp ---T-TCCC-----CC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---c-CCCC-----CC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 1100 11 111224578899999999999999999999999865
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=354.33 Aligned_cols=204 Identities=28% Similarity=0.358 Sum_probs=176.9
Q ss_pred HHHHHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-----CCCeeeeeccc
Q 003237 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-----HRNLVKLLGCC 593 (837)
Q Consensus 520 ~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~~~~ 593 (837)
+.+.....++|.+.++||+|+||.||+|+.. +++.||||++... ....+.+..|++++..++ ||||+++++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 3333344678999999999999999999874 6889999999642 344567788999999997 99999999999
Q ss_pred ccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC--------
Q 003237 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-------- 665 (837)
Q Consensus 594 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-------- 665 (837)
...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEE
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccccc
Confidence 9999999999999 9999999875432 34889999999999999999999988 999999999999975
Q ss_pred -----------------CCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhC
Q 003237 666 -----------------KMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITG 728 (837)
Q Consensus 666 -----------------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG 728 (837)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 789999999999875432 2236789999999999999999999999999999999999
Q ss_pred CCCCCC
Q 003237 729 KKNTRI 734 (837)
Q Consensus 729 ~~p~~~ 734 (837)
+.||..
T Consensus 256 ~~pf~~ 261 (360)
T 3llt_A 256 SLLFRT 261 (360)
T ss_dssp SCSCCC
T ss_pred CCCCCC
Confidence 999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=352.95 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=204.8
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|++++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357888999999999999999875 6889999999766555567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC--CCCeeecccccceeccCc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--KMNPRISDFGTARVFGGE 683 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~ki~DFGla~~~~~~ 683 (837)
+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988543 235899999999999999999999988 999999999999974 578999999999987654
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... ....... ..++.
T Consensus 205 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~---~i~~~~~---~~~~~ 272 (387)
T 1kob_A 205 EIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQ---NVKRCDW---EFDED 272 (387)
T ss_dssp SCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH---HHHHCCC---CCCSS
T ss_pred cce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCCC---CCCcc
Confidence 322 235789999999999999999999999999999999999999863211 11111 1111100 01111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... .....+.+++.+|++.||++|||+.|+++
T Consensus 273 ~~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 273 AFS----SVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111 12245778999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=338.90 Aligned_cols=253 Identities=21% Similarity=0.358 Sum_probs=202.6
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 603 (837)
++|.+.++||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++.+++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46788899999999999999985 8999999997542 33456789999999999999999999999877 6789999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++.... ...+++..+..++.||++||.|||+.+ .+|+||||||+|||++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 9999999999996532 235899999999999999999999865 3599999999999999999999999988764322
Q ss_pred cceeeeccccccCCccCcccccCCCCCC---cccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFST---KSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~---k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
....+|+.|+|||.+.+..++. ++||||||+++|||++|+.|+..... ............
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~----- 228 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGL----- 228 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCC-----
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCC-----
Confidence 2356899999999998776554 79999999999999999999863221 111111111111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
.+.+... ....+.+++..|++.||++|||++||++.|+.+.
T Consensus 229 ~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 RPTIPPG----ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111112 2335778999999999999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=343.45 Aligned_cols=272 Identities=22% Similarity=0.241 Sum_probs=198.9
Q ss_pred cCCCcC-CcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTS-NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
+.|.+. +.||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456664 78999999999999864 7899999999876666678899999999995 79999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC---eeecccccceecc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN---PRISDFGTARVFG 681 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~ki~DFGla~~~~ 681 (837)
|+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999654 34889999999999999999999997 999999999999998776 9999999998654
Q ss_pred Cccc-----eeeeccccccCCccCcccccC-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchH--------
Q 003237 682 GEEI-----LAITKRVVGTYGYMSPEYALD-----GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNL-------- 743 (837)
Q Consensus 682 ~~~~-----~~~~~~~~gt~~y~APE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l-------- 743 (837)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111123468999999999875 5689999999999999999999999975433221100
Q ss_pred HHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCCCCCCCC
Q 003237 744 IKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETFVPSPK 811 (837)
Q Consensus 744 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~~~~~p~ 811 (837)
..........+.. .+... ... .....+.+++.+|++.||++|||++|+++ .+.+.......|
T Consensus 246 ~~~~~~~i~~~~~-~~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~ 309 (316)
T 2ac3_A 246 QNMLFESIQEGKY-EFPDK-DWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309 (316)
T ss_dssp HHHHHHHHHHCCC-CCCHH-HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---------
T ss_pred HHHHHHHHhccCc-ccCch-hcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCC
Confidence 0001111111100 00000 000 11245789999999999999999999997 455543333333
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=340.75 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=204.6
Q ss_pred cCCCcCCcccccCCeeEEEEEe-----cCCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccC--Ccc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 599 (837)
+.|++.++||+|+||.||++++ .+++.||||++... .....+.+.+|++++.+++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3577789999999999999983 36899999999754 334567899999999999999999999999876 567
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 89999999999999996543 34899999999999999999999988 99999999999999999999999999988
Q ss_pred ccCccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------CCCcchHHHHHHHH
Q 003237 680 FGGEEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFN--------DDDSSNLIKYAWEL 750 (837)
Q Consensus 680 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~--------~~~~~~l~~~~~~~ 750 (837)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.... ..............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7654322 22334568888999999999999999999999999999999998853210 00000000111111
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
...+ .....+......+.+++.+|++.||++|||+++|+++|+.+
T Consensus 256 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111 11111222334678999999999999999999999999764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.03 Aligned_cols=264 Identities=25% Similarity=0.369 Sum_probs=189.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|++.++||+|+||.||+|... +|+.||||++.... ....+.+.+|++++.+++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888999999999999999875 68999999997543 3345778899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcC---CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 605 FMPNKSLDYFIFDES---RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 605 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|++ ++|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58988886532 2235889999999999999999999987 9999999999999999999999999998765
Q ss_pred CccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc--c-c
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK--A-L 757 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--~-~ 757 (837)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ............... . .
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND---EEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCTTTCG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhHhh
Confidence 3321 1223578999999999976 4689999999999999999999999864322 122222222111100 0 0
Q ss_pred ---cc--ccccc------------ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 ---EI--VDSSM------------ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 ---~~--~d~~l------------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+ ..+.+ ...........+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 00000 00001112245789999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=352.42 Aligned_cols=267 Identities=25% Similarity=0.345 Sum_probs=204.3
Q ss_pred CCcCCcccccCCeeEEEEEec-----CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccC--CccEE
Q 003237 530 FSTSNKLGQGGFGPVYKGKLS-----NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE--DENML 601 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 601 (837)
|.+.++||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 477899999999999998653 68899999997653 23456789999999999999999999999874 56789
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999998543 3899999999999999999999998 9999999999999999999999999999876
Q ss_pred Cccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
..... .......+|..|+|||.+.+..++.++||||||++++||++|+.|+....... .....+...........+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHH
Confidence 54322 22334567888999999999999999999999999999999999975321100 00000000000000111111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+.......+......+.+++.+|++.||++|||++||+++|+.+
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111112222335688999999999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=358.51 Aligned_cols=252 Identities=23% Similarity=0.294 Sum_probs=201.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.++|++.++||+|+||.||++... +|+.+|+|++.... ....+.+.+|++++.+++||||+++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 467889999999999999999764 78999999987543 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc---CCCCeeecccccceec
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFGTARVF 680 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~DFGla~~~ 680 (837)
||+++|+|.+.+... ..+++..+..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 90 E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999998654 34899999999999999999999998 99999999999998 5678999999999876
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+..... .+.. ...
T Consensus 164 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~----~~~~-~~~ 233 (444)
T 3soa_A 164 EGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIK----AGAY-DFP 233 (444)
T ss_dssp CTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHH----HTCC-CCC
T ss_pred cCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHH----hCCC-CCC
Confidence 543221 233679999999999999999999999999999999999999985321 111111111 1110 000
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+ ... .....+.+++..|++.||++|||+.|+++
T Consensus 234 ~~-~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 SP-EWD----TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TT-TTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cc-ccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 001 11235778999999999999999999987
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=349.95 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=201.8
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467889999999999999999875 68999999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC---CCeeecccccceec
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK---MNPRISDFGTARVF 680 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~ki~DFGla~~~ 680 (837)
||+++|+|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.+ +.+||+|||++...
T Consensus 108 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999999988543 45899999999999999999999998 9999999999999865 45999999999876
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+..... . +.. ...
T Consensus 182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~---~-~~~-~~~ 250 (362)
T 2bdw_A 182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIK---A-GAY-DYP 250 (362)
T ss_dssp TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH---H-TCC-CCC
T ss_pred cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH---h-CCC-CCC
Confidence 54322 233679999999999999999999999999999999999999985321 111111111 1 110 000
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+ ... .....+.+++.+|++.||++|||+.|+++
T Consensus 251 ~~-~~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 251 SP-EWD----TVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp TT-GGG----GSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc-ccc----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 001 11235778999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=344.63 Aligned_cols=249 Identities=21% Similarity=0.337 Sum_probs=197.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46788899999999999999876 58899999997542 23345678899999998 899999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999998653 34889999999999999999999988 99999999999999999999999999986432
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcc--hHHHHHHHHhccCcccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS--NLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~ 760 (837)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ...............
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 21 1233468999999999999999999999999999999999999999653221110 111111111111110
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSM 794 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 794 (837)
.+ +......+.+++.+|++.||++||++
T Consensus 237 --~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 --RI----PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CC----CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --CC----CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 11123457789999999999999996
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=343.04 Aligned_cols=258 Identities=20% Similarity=0.264 Sum_probs=182.8
Q ss_pred CCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEecCCCC
Q 003237 533 SNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~~gs 610 (837)
.++||+|+||.||++... +++.||||++... ....+.+|++++..++ ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999875 6899999999643 3567789999999997 9999999999999999999999999999
Q ss_pred hhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC---CeeecccccceeccCcccee
Q 003237 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM---NPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ki~DFGla~~~~~~~~~~ 687 (837)
|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 99999653 35899999999999999999999988 99999999999998665 799999999987644322
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCc-chHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDS-SNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......+|+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... ..+... ...
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~~------~~~ 237 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDFS------FEG 237 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCCC------CCS
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCCC------CCc
Confidence 12335789999999999999999999999999999999999999965432211 1111111111 111110 000
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCCCCC
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETFVP 808 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~~~~ 808 (837)
.........+.+++..|++.||++|||++||++ .+++....+
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~ 281 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCC
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCC
Confidence 000112345788999999999999999999984 455444443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.55 Aligned_cols=245 Identities=20% Similarity=0.326 Sum_probs=199.8
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999987 47899999998643 1233467899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 68888888654 34899999999999999999999998 999999999999999999999999999876543
Q ss_pred cceeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.. ....+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........ ...+..
T Consensus 162 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~ 222 (336)
T 3h4j_B 162 NF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNS 222 (336)
T ss_dssp BT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCS
T ss_pred cc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHc
Confidence 32 234679999999999988876 7899999999999999999999964322111 000000
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. ...+......+.+++.+|++.||.+|||++|+++
T Consensus 223 ~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 223 CV-YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SC-CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CC-CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00 0011112345778999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=352.76 Aligned_cols=271 Identities=22% Similarity=0.280 Sum_probs=212.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC--ccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED--ENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~ 603 (837)
++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888899999999999999876 58999999997543 345677889999999999999999999988765 669999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE----cCCCCeeeccccccee
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL----DEKMNPRISDFGTARV 679 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~ki~DFGla~~ 679 (837)
||+++|+|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976555555899999999999999999999998 9999999999999 7888899999999987
Q ss_pred ccCccceeeeccccccCCccCcccccC--------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcc-hHHHHHHHH
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALD--------GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS-NLIKYAWEL 750 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~ 750 (837)
...... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 654432 223578999999999865 56788999999999999999999999754432222 111111111
Q ss_pred hccCcccccc---------cc--ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 751 WSDNKALEIV---------DS--SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 751 ~~~~~~~~~~---------d~--~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
........+. .. .............+..++..|++.||++||+++|+++.|+.+
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 1111110000 00 111223456667788999999999999999999999988765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=339.03 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=201.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||+++.. +|+.||||++++. .....+.+.+|+.++..++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888899999999999999875 6899999999653 2235677889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999653 34789999999999999999999988 999999999999999999999999999875432
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ . .
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~-~------~ 221 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAE-L------R 221 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCC-C------C
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-C------C
Confidence 234689999999999999999999999999999999999999985321 111111111111 0 0
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
+ +......+.+++.+|++.+|++|| +++||++
T Consensus 222 ~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 F----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp C----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1 111223577899999999999999 8999984
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=345.11 Aligned_cols=266 Identities=18% Similarity=0.198 Sum_probs=197.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec----CCcEEEEEEecCCCcc-----------CHHHHHHHHHHHHHhcCCCeeeeecc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTTSGQ-----------GIEELKNEVLLIAKLQHRNLVKLLGC 592 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~~~ 592 (837)
++|.+.+.||+|+||.||+|+.. .+..+|||++...... ..+.+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999875 5778999998755322 12345678888999999999999999
Q ss_pred ccc----CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-
Q 003237 593 CLE----EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM- 667 (837)
Q Consensus 593 ~~~----~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~- 667 (837)
+.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 987 67789999999 999999986543 5899999999999999999999987 99999999999999887
Q ss_pred -CeeecccccceeccCccce-----eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 003237 668 -NPRISDFGTARVFGGEEIL-----AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS 741 (837)
Q Consensus 668 -~~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~ 741 (837)
.+||+|||+++........ .......||..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-- 267 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP-- 267 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH--
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc--
Confidence 9999999999876533211 11134579999999999999999999999999999999999999995322111
Q ss_pred hHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 742 NLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 742 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
............. ....+...... ......+.+++..|++.+|++||++++|+++|+....
T Consensus 268 ~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VAVQTAKTNLLDE-LPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHHT-TTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHHhhccc-ccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111111110 00000000000 0122357889999999999999999999999987543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=350.81 Aligned_cols=272 Identities=18% Similarity=0.239 Sum_probs=204.7
Q ss_pred hcCCCcCCccccc--CCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 527 TDNFSTSNKLGQG--GFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G--~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
.++|++.++||+| +||.||+++.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578889999999 99999999886 69999999997542 3345678889999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999986542 234899999999999999999999988 9999999999999999999999999987643
Q ss_pred Cccc-----eeeeccccccCCccCcccccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc--
Q 003237 682 GEEI-----LAITKRVVGTYGYMSPEYALD--GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS-- 752 (837)
Q Consensus 682 ~~~~-----~~~~~~~~gt~~y~APE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-- 752 (837)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCcc
Confidence 2211 111223478899999999987 679999999999999999999999996433221 11111000000
Q ss_pred --c-----Cc-------------cccccc---cc------cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--h
Q 003237 753 --D-----NK-------------ALEIVD---SS------MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM--L 801 (837)
Q Consensus 753 --~-----~~-------------~~~~~d---~~------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~--L 801 (837)
. .. ..+.+. +. ............+.+++.+|++.||++|||++|+++. +
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 0 00 000000 00 0000111223457889999999999999999999853 5
Q ss_pred ccC
Q 003237 802 SNE 804 (837)
Q Consensus 802 ~~~ 804 (837)
+++
T Consensus 338 ~~~ 340 (389)
T 3gni_B 338 KQI 340 (389)
T ss_dssp GGC
T ss_pred HHH
Confidence 443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=337.66 Aligned_cols=254 Identities=24% Similarity=0.445 Sum_probs=203.8
Q ss_pred CCCcCC-cccccCCeeEEEEEec---CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 529 NFSTSN-KLGQGGFGPVYKGKLS---NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 529 ~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
+|.+.+ .||+|+||.||+|+.. ++..||||+++... ....+.+.+|++++.+++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 444455 8999999999999763 57889999997643 34567789999999999999999999999 556789999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 89 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp ECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 999999999998643 345899999999999999999999988 999999999999999999999999999887543
Q ss_pred cce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 684 EIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 684 ~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+.... ..+...
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i----~~~~~~---- 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFI----EQGKRM---- 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHH----HTTCCC----
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----hcCCcC----
Confidence 322 22223456889999999998999999999999999999998 9999864322 1111111 111111
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..+......+.+++..|++.+|++||++.+|++.|+.+
T Consensus 233 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 233 -----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11122234678899999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=348.43 Aligned_cols=246 Identities=26% Similarity=0.311 Sum_probs=195.2
Q ss_pred CCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCCh
Q 003237 533 SNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
.+.||+|+||.||+|+.. +|+.||||+++.......+++.+|++++.+++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999875 6899999999876556677899999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE--cCCCCeeecccccceeccCccceeee
Q 003237 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL--DEKMNPRISDFGTARVFGGEEILAIT 689 (837)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~ki~DFGla~~~~~~~~~~~~ 689 (837)
.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 99886532 34889999999999999999999988 9999999999999 5678899999999997654332 2
Q ss_pred ccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccC
Q 003237 690 KRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCL 769 (837)
Q Consensus 690 ~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 769 (837)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ......... . +.......
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~---~~~i~~~~~--~-~~~~~~~~-- 314 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AET---LNNILACRW--D-LEDEEFQD-- 314 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHH---HHHHHHTCC--C-SCSGGGTT--
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHH---HHHHHhccC--C-CChhhhcc--
Confidence 235699999999999999999999999999999999999999853321 111 111111110 0 00001111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 770 ASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 770 ~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....+.+++.+|++.||++|||+.|+++
T Consensus 315 --~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 --ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1245778999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=348.26 Aligned_cols=252 Identities=23% Similarity=0.281 Sum_probs=193.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.++|.+.++||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457888999999999999999876 78999999996543 3346788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC--eeecccccceeccCc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN--PRISDFGTARVFGGE 683 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~ki~DFGla~~~~~~ 683 (837)
+++|+|.+++.... .+++..+..++.||++||.|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999986543 4899999999999999999999988 999999999999987765 999999999753322
Q ss_pred cceeeeccccccCCccCcccccCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTK-SDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k-~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
. ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||....... .............. .
T Consensus 172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~--~---- 240 (361)
T 3uc3_A 172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKY--S---- 240 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCC--C----
T ss_pred C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCC--C----
Confidence 1 1233579999999999988888766 899999999999999999996543322 12222222211110 0
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+.. .......+.+++.+|++.+|++|||+.|+++
T Consensus 241 -~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 241 -IPD--DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp -CCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred -CCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 000 0011245778999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.23 Aligned_cols=262 Identities=21% Similarity=0.280 Sum_probs=203.4
Q ss_pred hhcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeeccc-ccCCccEEEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC-LEEDENMLIY 603 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~ 603 (837)
..++|.+.+.||+|+||.||+|+. .+++.||||++...... +++.+|++++..++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 57899999987554322 3578899999999988877777666 5566779999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE---cCCCCeeecccccceec
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVF 680 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~DFGla~~~ 680 (837)
||+ +++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 999999986432 34899999999999999999999998 9999999999999 78999999999999877
Q ss_pred cCccce-----eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 681 GGEEIL-----AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 681 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 544321 122346789999999999999999999999999999999999999976554443333322211111110
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
. +.+.... ...+.+++..|++.+|++|||+++|+++|+++
T Consensus 239 ~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 I-----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred h-----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0 0011111 23578899999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.02 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=206.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeeccc-ccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC-LEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~e 604 (837)
.++|.+.+.||+|+||.||+|+. .+++.||||++..... .+++.+|++++..++|++++..+.++ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788899999999999999986 5799999999865433 34688999999999998877766665 45567799999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE---cCCCCeeecccccceecc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFG 681 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~DFGla~~~~ 681 (837)
|+ +++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 999999986432 35899999999999999999999998 9999999999999 488999999999998765
Q ss_pred Ccccee-----eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc
Q 003237 682 GEEILA-----ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 682 ~~~~~~-----~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 756 (837)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 443211 123467999999999999999999999999999999999999999765444333333222211111000
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 757 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+.+.... ...+.+++.+|++.+|++|||+++|++.|+.+
T Consensus 240 -----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 240 -----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp -----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred -----HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0111112 23577899999999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.57 Aligned_cols=259 Identities=23% Similarity=0.338 Sum_probs=194.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc---
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN--- 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~--- 599 (837)
.++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|++++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788899999999999999986 4789999999976432 2345788999999999999999999998876554
Q ss_pred -EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 600 -MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 600 -~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 9999999999999999654 34899999999999999999999988 9999999999999999999999999998
Q ss_pred eccCccc-eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 679 VFGGEEI-LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 679 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC
Confidence 7654322 1223345789999999999999999999999999999999999999853211 11111111111100
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHhccC
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV-FMLSNE 804 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv-~~L~~~ 804 (837)
. ..... .....+.+++.+|++.||++||++.+++ ..|...
T Consensus 239 ~---~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 P---SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp H---HHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c---ccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 00001 1224577899999999999999766554 455443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.49 Aligned_cols=266 Identities=23% Similarity=0.340 Sum_probs=196.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|.+.++||+|+||.||+|+.. +++.||||++...... ....+.+|++++.+++||||+++++++..+...++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999876 6899999998644321 122445799999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
++ |+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 98 5888887653 345889999999999999999999988 99999999999999999999999999986543221
Q ss_pred eeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc---ccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA---LEIVD 761 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~d 761 (837)
......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ................ .....
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHhchhhhc
Confidence 1223568999999999876 5789999999999999999999999864322 2222222222211110 00000
Q ss_pred c---------cccc----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 003237 762 S---------SMAN----SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNE 804 (837)
Q Consensus 762 ~---------~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~ 804 (837)
. .... .........+.+++.+|++.||++|||++|+++ .+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 0 0000 001112245778999999999999999999987 55554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=344.87 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=197.7
Q ss_pred cCCCcCCcccccCCeeEEEEEecC-----CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN-----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|...+.||+|+||.||+|+... +..||||++.... ......+.+|++++.+++||||+++++++.+....++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677899999999999997653 2359999997543 3345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999998653 245899999999999999999999988 9999999999999999999999999998765
Q ss_pred Ccccee-eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 682 GEEILA-ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 682 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
...... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+.. .. ..+...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~---~~-~~~~~~-- 269 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMK---AI-NDGFRL-- 269 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH---HH-HTTCCC--
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHH---HH-HCCCcC--
Confidence 432211 1222346778999999999999999999999999999999 9999853221 11111 11 111100
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
. .+......+.+++.+|++.+|++||++.+|+++|+.+
T Consensus 270 ---~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 270 ---P----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp ---C----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---C----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 1112234577899999999999999999999999865
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=338.59 Aligned_cols=244 Identities=23% Similarity=0.254 Sum_probs=202.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||+++.. +|+.||||++.+. .....+.+.+|++++..++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56888899999999999999876 6899999998653 2245678889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999996543 4889999999999999999999988 999999999999999999999999999876543
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+. ..... +.. .
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~---~~i~~-~~~------~ 256 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIY---EKIVS-GKV------R 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH---HHHHH-CCC------C
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHHHH---HHHHc-CCC------C
Confidence 233679999999999999999999999999999999999999985321 11111 11111 110 1
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~eVv~ 799 (837)
+... ....+.+++.+|++.||++||+ ++||++
T Consensus 257 ~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 FPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1111 2245778999999999999998 888874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=336.36 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=200.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEecC----CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
.++|.+.+.||+|+||.||+|+... +..||||.+.... ....+.+.+|++++.+++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4578888999999999999998643 3469999987652 3446788999999999999999999999764 46789
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999996532 34889999999999999999999988 9999999999999999999999999998765
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ......... +....
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~---~~~~~~~~~----~~~~~-- 234 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN---KDVIGVLEK----GDRLP-- 234 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG---GGHHHHHHH----TCCCC--
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh---HHHHHHHhc----CCCCC--
Confidence 43221 1223456889999999999999999999999999999998 9999864322 122221111 11000
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.... ....+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 235 ---~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 235 ---KPDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ---CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 1111 123577899999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=339.76 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=198.3
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-----ccCHHHHHHHHHHHHHhc---CCCeeeeecccccC
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-----GQGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEE 596 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~ 596 (837)
..++|++.++||+|+||+||+|+.. +++.||||++.... ......+.+|++++.+++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3578999999999999999999864 68999999986432 122356778888887775 99999999999875
Q ss_pred C-----ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeee
Q 003237 597 D-----ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRI 671 (837)
Q Consensus 597 ~-----~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 671 (837)
. ..++||||+. ++|.+++..... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4689999998 599998865432 34899999999999999999999998 999999999999999999999
Q ss_pred cccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 003237 672 SDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELW 751 (837)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 751 (837)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHHHHHHH
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHh
Confidence 9999998654332 22346789999999999999999999999999999999999999854321 12222222221
Q ss_pred ccCccccc------cccccc-------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 752 SDNKALEI------VDSSMA-------NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 752 ~~~~~~~~------~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
........ ...... .....+....+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11100000 000000 0011122346788999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=346.20 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=187.4
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++.+++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3467888999999999999999886 57899999997543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC---CCCeeecccccceecc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTARVFG 681 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~DFGla~~~~ 681 (837)
|+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999998543 35899999999999999999999988 999999999999975 8999999999998764
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ..+.. ...... . ....
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~---~i~~~~-~-~~~~ 272 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFR---RILNCE-Y-YFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHH---HHHTTC-C-CCCT
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHH---HHHhCC-C-ccCC
Confidence 332 123467899999999999999999999999999999999999998532211 11111 111111 0 0000
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. .......+.+++.+|++.||++|||+.|+++
T Consensus 273 -~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 -PW----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -TT----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -ch----hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01 1112345778999999999999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.27 Aligned_cols=247 Identities=21% Similarity=0.296 Sum_probs=191.4
Q ss_pred cCCCcCCcccccCCeeEEEEEe----cCCcEEEEEEecCCC----ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
++|++.+.||+|+||.||+++. .+++.||||++++.. ......+.+|++++.+++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5688889999999999999987 478999999997542 23445678899999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++||||+++++|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999998653 34788999999999999999999998 99999999999999999999999999976
Q ss_pred ccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .... .......
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~---~~i~~~~----- 237 (327)
T 3a62_A 171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTI---DKILKCK----- 237 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHHHHTC-----
T ss_pred cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHhCC-----
Confidence 43222 122346799999999999999999999999999999999999999863211 1111 1111110
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
..+ +......+.+++.+|++.+|++|| ++.|+++
T Consensus 238 --~~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 --LNL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --CCC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --CCC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011 111224577899999999999999 7778875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=332.59 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=203.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++..++||||+++++++.++...++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357888999999999999999876 68999999986543 2345778999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++++|.+++.. ...+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999998853 235889999999999999999999988 9999999999999999999999999998765433
Q ss_pred ceeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.........|+..|+|||.+.+..+ +.++||||||++++||++|+.|+........ ....+. ..... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~~---~~-- 229 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTY---LN-- 229 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH----TTCTT---ST--
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh----hcccc---cC--
Confidence 3233344678999999999988765 7899999999999999999999965432211 111111 11000 00
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... .....+.+++.+|++.||++|||++||++
T Consensus 230 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 PWK----KIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TGG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chh----hcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001 11235678999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=344.34 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=201.6
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 600 (837)
..++|.+.+.||+|+||.||+|+.. +|+.||||++++.. ....+.+..|.+++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 3467888999999999999999876 68999999997532 34566788999999987 8999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999998653 34889999999999999999999998 999999999999999999999999999864
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ... .
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i---~~~-~----- 234 (345)
T 1xjd_A 169 MLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSI---RMD-N----- 234 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HHC-C-----
T ss_pred ccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH---HhC-C-----
Confidence 32221 2344789999999999999999999999999999999999999985321 11111111 111 0
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMS-TVV 798 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~-eVv 798 (837)
+..... ....+.+++.+|++.||++||++. +|.
T Consensus 235 -~~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -PFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -CCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -CCCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111111 224577899999999999999998 665
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=345.11 Aligned_cols=259 Identities=26% Similarity=0.441 Sum_probs=202.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEe------cCCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
.++|.+.+.||+|+||.||+|+. .++..||||++... ......++.+|+.++.+++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35788889999999999999984 25778999999654 334556788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC---CCCeeec
Q 003237 600 MLIYEFMPNKSLDYFIFDESR----KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRIS 672 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~ 672 (837)
++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 245889999999999999999999988 999999999999994 4569999
Q ss_pred ccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHh
Q 003237 673 DFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELW 751 (837)
Q Consensus 673 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 751 (837)
|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.... ...+... .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~---~- 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEF---V- 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHH---H-
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC---HHHHHHH---H-
Confidence 9999986544433333334567889999999999999999999999999999998 888885321 1111111 1
Q ss_pred ccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 752 SDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 752 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..+.... .... ....+.+++.+|++.+|.+||++.+|++.|+..
T Consensus 259 ~~~~~~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGRMD-----PPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCC-----CCCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111110 1111 223577899999999999999999999999865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=372.69 Aligned_cols=248 Identities=25% Similarity=0.443 Sum_probs=197.0
Q ss_pred cccccCCeeEEEEEec---CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCCCC
Q 003237 535 KLGQGGFGPVYKGKLS---NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKS 610 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 610 (837)
+||+|+||.||+|.+. ++..||||+++... ....+++.+|+++|.+++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 46679999997653 3467889999999999999999999999976 56899999999999
Q ss_pred hhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce-eee
Q 003237 611 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL-AIT 689 (837)
Q Consensus 611 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~-~~~ 689 (837)
|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++........ ...
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99998643 345899999999999999999999988 999999999999999999999999999876543221 112
Q ss_pred ccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccccc
Q 003237 690 KRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSC 768 (837)
Q Consensus 690 ~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 768 (837)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+... ...+.... .
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~----i~~~~~~~---------~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAF----IEQGKRME---------C 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHHHH----HHTTCCCC---------C
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHH----HHcCCCCC---------C
Confidence 22345689999999999999999999999999999998 9999864322 112211 11111111 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 769 LASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 769 ~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+......+.+++..||+.+|++||++.+|++.|+..
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 122234678999999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.53 Aligned_cols=266 Identities=24% Similarity=0.323 Sum_probs=200.4
Q ss_pred hhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHh--cCCCeeeeecccccC----Ccc
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL--QHRNLVKLLGCCLEE----DEN 599 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~----~~~ 599 (837)
..++|.+.++||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++... ...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3468999999999999999999886 899999998543 234455566666554 899999999999877 678
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcC-----CCceeeCCCCCCcEEEcCCCCeeeccc
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS-----RLRIIHRDLKASNILLDEKMNPRISDF 674 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~ki~DF 674 (837)
++||||+++|+|.+++... .+++..+..++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 9999999999999999543 4899999999999999999999871 123999999999999999999999999
Q ss_pred ccceeccCcccee--eeccccccCCccCcccccCCCCCCc------ccHHHHHHHHHHHHhC----------CCCCCCCC
Q 003237 675 GTARVFGGEEILA--ITKRVVGTYGYMSPEYALDGVFSTK------SDVFSFGVILLEIITG----------KKNTRIFN 736 (837)
Q Consensus 675 Gla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~k------~DV~S~Gvvl~elltG----------~~p~~~~~ 736 (837)
|+++......... ......||+.|+|||++.+.....+ +|||||||++|||++| +.|+....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9998765432211 1223579999999999988777665 9999999999999999 55554332
Q ss_pred CCCcchHHHHHHHHhccCccccccccccccc-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 737 DDDSSNLIKYAWELWSDNKALEIVDSSMANS-CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 737 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
..... ............ ..+.+... ........+.+++.+|++.||++|||+.||++.|+.+.
T Consensus 267 ~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 267 PSDPS--YEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CSSCC--HHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCc--hhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 22211 111111111111 11111111 12245667889999999999999999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=355.32 Aligned_cols=262 Identities=18% Similarity=0.224 Sum_probs=205.0
Q ss_pred cHHHHHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccc
Q 003237 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594 (837)
Q Consensus 519 ~~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 594 (837)
.+.++....++|++.++||+|+||+||+++.. +|+.||||++++.. ....+.+.+|+.++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34444556688999999999999999999885 68999999996531 223345789999999999999999999999
Q ss_pred cCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccc
Q 003237 595 EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (837)
Q Consensus 595 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DF 674 (837)
+.+..+|||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999996542 35889999999999999999999988 999999999999999999999999
Q ss_pred ccceeccCccceeeeccccccCCccCccccc-------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 003237 675 GTARVFGGEEILAITKRVVGTYGYMSPEYAL-------DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYA 747 (837)
Q Consensus 675 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 747 (837)
|+++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||..... .....
T Consensus 207 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~-- 280 (412)
T 2vd5_A 207 GSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---AETYG-- 280 (412)
T ss_dssp TTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH--
T ss_pred hhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---HHHHH--
Confidence 999876543321 223468999999999997 46789999999999999999999999953221 11111
Q ss_pred HHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 003237 748 WELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDR---PSMSTVVF 799 (837)
Q Consensus 748 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ptm~eVv~ 799 (837)
........ +..+...... ...+.+++.+|++ +|++| |+++||++
T Consensus 281 -~i~~~~~~--~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 281 -KIVHYKEH--LSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -HHHTHHHH--CCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -HHHhcccC--cCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11110000 0001111112 2357788999999 99998 69999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.89 Aligned_cols=250 Identities=18% Similarity=0.283 Sum_probs=202.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.++|.+.++||+|+||.||+|... ++..+|+|++........+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 356888899999999999999876 4778999999776666778999999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE---cCCCCeeecccccceeccC
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~DFGla~~~~~ 682 (837)
+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999988654 34889999999999999999999988 9999999999999 7889999999999987654
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
... .....+|+.|+|||.+.+ .++.++||||||++++||++|+.|+..... .... ..... +.. ... .
T Consensus 162 ~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~---~~~~~-~~~-~~~-~ 228 (277)
T 3f3z_A 162 GKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVM---LKIRE-GTF-TFP-E 228 (277)
T ss_dssp TSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHH-CCC-CCC-H
T ss_pred ccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHh-CCC-CCC-c
Confidence 332 233578999999998865 499999999999999999999999864221 1111 11111 100 000 0
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.... .....+.+++.+|++.+|++|||+.|+++
T Consensus 229 ~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDWL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 11245778999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=342.61 Aligned_cols=263 Identities=25% Similarity=0.424 Sum_probs=206.4
Q ss_pred cCCCcCCcccccCCeeEEEEEe-----cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCC--ccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-----SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED--ENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~ 600 (837)
++|.+.+.||+|+||.||+++. .+++.||||++........+.+.+|++++.+++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4677889999999999999984 368999999998766666778999999999999999999999987654 679
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||+++++|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 121 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 9999999999999996542 34899999999999999999999987 999999999999999999999999999887
Q ss_pred cCccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------CCCc-chHHHHHHHH
Q 003237 681 GGEEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFN--------DDDS-SNLIKYAWEL 750 (837)
Q Consensus 681 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~--------~~~~-~~l~~~~~~~ 750 (837)
...... .......++..|+|||.+.+..++.++||||||++++||++|+.|+.... .... ..........
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 544322 11223456778999999999999999999999999999999998875320 0000 0001111111
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
...+. ....+......+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 276 ~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 276 LKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11110 0011122234678899999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=336.92 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=198.6
Q ss_pred cCCCcCCcccccCCeeEEEEEecC----CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccc-cCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCL-EEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~l 601 (837)
.+|.+.++||+|+||.||+|+..+ ...+|||.+.... ....+.+.+|++++++++||||+++++++. .+...++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 357778999999999999998642 2358999987543 334577899999999999999999999865 4557899
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++|+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 99999999999999643 345789999999999999999999988 9999999999999999999999999998765
Q ss_pred Cccce--eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCC-CCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 682 GEEIL--AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKK-NTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 682 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
..... .......+|+.|+|||.+.+..++.++||||||++++||++|.. |+..... ........ . +..
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~~~~---~-~~~-- 250 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLL---Q-GRR-- 250 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---TTHHHHHH---T-TCC--
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHh---c-CCC--
Confidence 43321 12223567789999999999999999999999999999999554 5433221 11111111 1 100
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. ..... ...+.+++.+|++.+|++|||++||+++|+.+
T Consensus 251 ~~---~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 251 LL---QPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp CC---CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---CCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 01111 23577899999999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.48 Aligned_cols=261 Identities=21% Similarity=0.238 Sum_probs=199.4
Q ss_pred HHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC-----CccCHHHHHHHHHHHHHhcCCCeeeeecccccC
Q 003237 523 LLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-----SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE 596 (837)
Q Consensus 523 l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 596 (837)
+....++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++.+++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4455678999999999999999999875 6889999998643 234567889999999999999999999999999
Q ss_pred CccEEEEEecCCCChhhHhhhcC-------------------------------------CCCCCChhhHHHHHHHHHHH
Q 003237 597 DENMLIYEFMPNKSLDYFIFDES-------------------------------------RKQLLDWKKRFDIILGIARG 639 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~g 639 (837)
+..++||||+++|+|.+++.... ....+++..+..++.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884210 01123566778899999999
Q ss_pred HHHHHhcCCCceeeCCCCCCcEEEcCCC--CeeecccccceeccCccc--eeeeccccccCCccCcccccC--CCCCCcc
Q 003237 640 VLYLHQDSRLRIIHRDLKASNILLDEKM--NPRISDFGTARVFGGEEI--LAITKRVVGTYGYMSPEYALD--GVFSTKS 713 (837)
Q Consensus 640 L~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~ki~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~~~~--~~~s~k~ 713 (837)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++....... ........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999987643221 112234678999999999975 6789999
Q ss_pred cHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC
Q 003237 714 DVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPS 793 (837)
Q Consensus 714 DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt 793 (837)
||||||+++|||++|+.||..... .............. ..+. .......+.+++.+|++.+|++|||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND------ADTISQVLNKKLCF--ENPN-----YNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCT--TSGG-----GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhccccc--CCcc-----cccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999853321 11111121111100 0010 0111245778999999999999999
Q ss_pred HHHHHH
Q 003237 794 MSTVVF 799 (837)
Q Consensus 794 m~eVv~ 799 (837)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.05 Aligned_cols=260 Identities=18% Similarity=0.190 Sum_probs=197.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc---CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ---GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
.++|.+.+.||+|+||.||+++.. +++.||||++...... ..+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367888999999999999999875 6889999999754322 346788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999998654 34889999999999999999999988 99999999999999999999999999987654
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC-ccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN-KALEIVD 761 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d 761 (837)
.... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... . ......... ....
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~-~~~~~~~~~~~~~~--- 255 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------S-VMGAHINQAIPRPS--- 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------H-HHHHHHHSCCCCGG---
T ss_pred cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------H-HHHHHhccCCCCcc---
Confidence 3221 12235689999999999999999999999999999999999999863211 1 111111111 0000
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccCCCCC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRP-SMSTVVFMLSNETFVP 808 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-tm~eVv~~L~~~~~~~ 808 (837)
.. .......+.+++.+|++.||++|| +++++++.|+......
T Consensus 256 -~~----~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 256 -TV----RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -GT----STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -cc----CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 11 111223577899999999999999 9999999998764443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=339.49 Aligned_cols=261 Identities=22% Similarity=0.323 Sum_probs=196.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|++.++||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++.+++||||+++++++.+....++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888899999999999999886 589999999865432 234667899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++++|..++... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999998887543 34889999999999999999999998 9999999999999999999999999998765332
Q ss_pred ceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc----------
Q 003237 685 ILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD---------- 753 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---------- 753 (837)
. ......+|..|+|||.+.+ ..++.++||||||++++||++|+.|+...... ............
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV---DQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHHHHHH
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhcccccccccccc
Confidence 2 1233578999999999976 67899999999999999999999998643221 111111111110
Q ss_pred -Ccccc---ccccccccc---cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 -NKALE---IVDSSMANS---CLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 -~~~~~---~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..... +.++..... ........+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 000000000 00112345788999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.33 Aligned_cols=252 Identities=15% Similarity=0.134 Sum_probs=203.8
Q ss_pred hhcCCCcCCcccccCCeeEEEEE------ecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc---CCCeeeeecccccC
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGK------LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEE 596 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~ 596 (837)
..++|.+.++||+|+||.||+|. ..+++.||||++... ...++..|++++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34678888999999999999994 446889999999654 3567888888888887 99999999999999
Q ss_pred CccEEEEEecCCCChhhHhhhcC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC---------
Q 003237 597 DENMLIYEFMPNKSLDYFIFDES--RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--------- 665 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--------- 665 (837)
+..+|||||+++|+|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999997532 3456899999999999999999999987 999999999999998
Q ss_pred --CCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchH
Q 003237 666 --KMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNL 743 (837)
Q Consensus 666 --~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l 743 (837)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999987653333333445789999999999999999999999999999999999999985322110
Q ss_pred HHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhccC
Q 003237 744 IKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDR-PSMSTVVFMLSNE 804 (837)
Q Consensus 744 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R-Ptm~eVv~~L~~~ 804 (837)
..+...+..... ...+.+++..|++.+|.+| |+++++.+.|+..
T Consensus 293 --------------~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 --------------CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------------EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------------eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 001111111111 2345678888999999998 6888888888764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=336.89 Aligned_cols=255 Identities=28% Similarity=0.372 Sum_probs=200.8
Q ss_pred CCcCCcccccCCeeEEEEEecC----CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc-EEEE
Q 003237 530 FSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN-MLIY 603 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lV~ 603 (837)
|...++||+|+||.||+|+..+ +..+|+|.+.... ....+.+.+|++++.+++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 4556899999999999997642 2379999997543 34457788999999999999999999999877665 9999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+.+++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 103 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred ecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999653 345789999999999999999999998 999999999999999999999999999866543
Q ss_pred cce--eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 684 EIL--AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 684 ~~~--~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ....+...... ....
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~----~~~~---- 247 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLTHFLAQ----GRRL---- 247 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CGGGHHHHHHT----TCCC----
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--CHHHHHHHhhc----CCCC----
Confidence 321 22234567889999999999999999999999999999999766643221 12222221111 1100
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. +......+.+++.+|++.+|.+|||+++++++|+.+
T Consensus 248 -~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 248 -PQ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp -CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CC----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01 111224577899999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=336.52 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=202.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeeccccc----------
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE---------- 595 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~---------- 595 (837)
.++|++.+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356888899999999999999886 79999999996543 356789999999999999999998754
Q ss_pred ------CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 596 ------EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 596 ------~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 345789999999999999996542 345899999999999999999999987 9999999999999999999
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE 749 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 749 (837)
||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+.. ..... .
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--------~~~~~-~ 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--------TSKFF-T 229 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--------HHHHH-H
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--------HHHHH-H
Confidence 9999999987654322 2235689999999999999999999999999999999999987631 01111 1
Q ss_pred HhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 003237 750 LWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVP 808 (837)
Q Consensus 750 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~~~ 808 (837)
....+ .+....+ ..+.+++.+|++.||++|||+.|+++.|+.....+
T Consensus 230 ~~~~~--------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 230 DLRDG--------IISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHTT--------CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred Hhhcc--------cccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 11111 1111122 34678899999999999999999999998765443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=350.36 Aligned_cols=255 Identities=30% Similarity=0.462 Sum_probs=190.7
Q ss_pred CCCcCCcccccCCeeEEEEEec--CC--cEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeeccccc-CCccEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS--NG--QEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE-EDENMLI 602 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~--~g--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV 602 (837)
.|.+.++||+|+||.||+|+.. ++ ..||||.++.. .....+++.+|+.++.+++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566789999999999999864 22 36899998654 33456789999999999999999999998754 4577999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++|+|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999643 345789999999999999999999988 99999999999999999999999999987644
Q ss_pred cccee--eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 683 EEILA--ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 683 ~~~~~--~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
..... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..|+...... ....... .+.. .
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~~----~~~~--~ 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLL----QGRR--L 315 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHHH----TTCC--C
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHHH----cCCC--C
Confidence 32211 1223457788999999999999999999999999999999 66666543221 2221111 1111 0
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. ...+ ...+.+++.+|++.+|++|||++||++.|+.+
T Consensus 316 ~~---p~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 316 LQ---PEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp CC---CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---CCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 1112 23577899999999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=356.91 Aligned_cols=253 Identities=25% Similarity=0.321 Sum_probs=205.6
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
.++|.+.+.||+|+||.||+++.. +|+.||||++.+. .....+.+.+|++++.+++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888899999999999999875 6999999999653 234556788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++|+|..++.... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999986543 234899999999999999999999998 99999999999999999999999999987654
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ...... ..
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~--~~i~~~-------~~ 406 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--RLVKEV-------PE 406 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH--HHHHHC-------CC
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH--HHhhcc-------cc
Confidence 332 223589999999999999999999999999999999999999997543322111111 111110 00
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
. .+......+.+++.+|++.||++|| +++||++
T Consensus 407 ~----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 E----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred c----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1 1111234577899999999999999 7888874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=333.28 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=198.6
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
+|.....||+|+||.||+|+.. +++.||||.+........+.+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3444569999999999999864 688999999987666667889999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC-CCCeeecccccceeccCccce
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~DFGla~~~~~~~~~ 686 (837)
+++|.+++........+++..+..++.||++||.|||+.+ |+|+||||+||+++. ++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 9999999976544445678888999999999999999987 999999999999987 89999999999987653221
Q ss_pred eeeccccccCCccCcccccCCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGV--FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~--~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
......|+..|+|||++.+.. ++.++||||||+++|||++|+.|+...... .......... ...+.+
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~-------~~~~~~ 247 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---QAAMFKVGMF-------KVHPEI 247 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---HHHHHHHHHH-------CCCCCC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---hHHHHhhccc-------cccccc
Confidence 123457899999999997654 889999999999999999999998533211 1110000000 011111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... ....+.+++.+|++.||++|||+.++++
T Consensus 248 ~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 PES----MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CTT----SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112 2345778999999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=335.77 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=200.6
Q ss_pred cCCCcCC-cccccCCeeEEEEEec---CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSN-KLGQGGFGPVYKGKLS---NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|.+.+ .||+|+||.||+|... .++.||||++.... ....+++.+|++++.+++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 9999999999999542 46889999997543 22357889999999999999999999999 6677899
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 99999999999999653 34889999999999999999999998 9999999999999999999999999998775
Q ss_pred Ccccee-eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 682 GEEILA-ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 682 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+.. ....+...
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~~-- 239 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTA----MLEKGERM-- 239 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH----HHHTTCCC--
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHHcCCCC--
Confidence 443221 1223456788999999999899999999999999999999 9999864221 11111 11111111
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
. .+......+.+++..|++.||++||++.+|++.|++.
T Consensus 240 ---~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 240 ---G----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ---C----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 1112234578899999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=353.68 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=204.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999885 69999999996532 244677889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 604 EFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
||+++|+|..++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999875432 346899999999999999999999988 99999999999999999999999999987654
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............ .
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~~-~------ 410 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQA-V------ 410 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHCC-C------
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhcc-c------
Confidence 332 12335899999999999999999999999999999999999999965432211 111111111110 0
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSM-----STVV 798 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm-----~eVv 798 (837)
. .+......+.+++.+|++.||++||++ ++|.
T Consensus 411 ~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 411 T----YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp C----CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred C----CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 0 111223456789999999999999975 5665
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=342.36 Aligned_cols=267 Identities=23% Similarity=0.305 Sum_probs=193.8
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHH--HHHhcCCCeeeeecccc-----cCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLL--IAKLQHRNLVKLLGCCL-----EEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~-----~~~~~~ 600 (837)
++|.+.++||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+. .....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 5788889999999999999987 58999999996432 3344444444 44589999999997443 233568
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcC------CCceeeCCCCCCcEEEcCCCCeeeccc
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS------RLRIIHRDLKASNILLDEKMNPRISDF 674 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~ki~DF 674 (837)
+||||+++|+|.+++... ..++..+..++.||++||.|||+.. ..+|+||||||+|||++.++.+||+||
T Consensus 89 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 999999999999999543 2488999999999999999999981 113999999999999999999999999
Q ss_pred ccceeccCccc------eeeeccccccCCccCcccccC-------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 003237 675 GTARVFGGEEI------LAITKRVVGTYGYMSPEYALD-------GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS 741 (837)
Q Consensus 675 Gla~~~~~~~~------~~~~~~~~gt~~y~APE~~~~-------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~ 741 (837)
|+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987654321 111223579999999999987 45678999999999999999998776433221111
Q ss_pred -hH-H---------HHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 742 -NL-I---------KYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 742 -~l-~---------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. . ...............+.... .........+.+++.+||+.||++|||++||++.|+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 00 0 00011111111111111100 11223455788999999999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=358.18 Aligned_cols=248 Identities=20% Similarity=0.276 Sum_probs=192.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
.++|++.++||+|+||.||+++.. +|+.||||++... .......+.+|++++..++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357888999999999999999875 6899999999653 333456678899999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|||+++|+|..++... ..+++..+..++.||++||.|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999998654 358999999999999999999998 76 9999999999999999999999999998643
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. ......
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~---~i~~~~------- 365 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFE---LILMEE------- 365 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHCC-------
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHH---HHHhCC-------
Confidence 222 12334789999999999999999999999999999999999999985321 111111 111110
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
..+... ....+.+++.+|++.||++|| +++|+++
T Consensus 366 ~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 IRFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 001111 224577899999999999999 9999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.04 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=196.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|.+.++||+|+||.||+++.. ++..+|+|++.... ....+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56888899999999999999875 68899999987543 34568899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE---cCCCCeeecccccceecc
Q 003237 606 MPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFG 681 (837)
Q Consensus 606 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~DFGla~~~~ 681 (837)
+++++|.+++... .....+++..+..++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988653 22356899999999999999999999988 9999999999999 456889999999998765
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.... .....+|+.|+|||.+. ..++.++||||||++++||++|+.||..... ..... ...........
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~---~~~~~~~~~~~-- 246 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQ---KATYKEPNYAV-- 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHCCCCCCC--
T ss_pred Cccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHh---hhccCCccccc--
Confidence 4322 23467899999999875 5789999999999999999999999863221 11111 11111000000
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.... ....+.+++.+|++.||++|||+.||++
T Consensus 247 --~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 --ECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001 1235678999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=332.57 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=198.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
.++|++.+.||+|+||.||+|... ++..||||++... .....+.+.+|++++.+++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467888899999999999999876 5779999998543 223456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999986542 4889999999999999999999987 99999999999999999999999999865433
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.. .....+++.|+|||.+.+..++.++||||||++++||++|+.|+..... ..... ..... ..
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~---~~~~~-------~~ 224 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYK---RISRV-------EF 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH---HHHHT-------CC
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---HHHHH---HHHhC-------CC
Confidence 22 2235789999999999999999999999999999999999999863211 11111 11110 00
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. +......+.+++.+|++.+|++|||++||++
T Consensus 225 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 225 TF----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 1112235678999999999999999999996
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.77 Aligned_cols=248 Identities=25% Similarity=0.423 Sum_probs=181.5
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688889999999999999987 478999999986432 234577899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 999999999998643 245899999999999999999999988 999999999999999999999999999876533
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
... .....|++.|+|||.+.+..++.++||||||++++||++|+.|+......+. . ... .. .+..
T Consensus 166 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~~----~~---~~~~ 230 (278)
T 3cok_A 166 HEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L---NKV----VL---ADYE 230 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------C----CS---SCCC
T ss_pred CCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H---HHH----hh---cccC
Confidence 211 1235689999999999999999999999999999999999999864322111 0 000 00 0111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+.. .....+.+++.+|++.||++|||+++|++
T Consensus 231 ~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPS----FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Ccc----ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111 12245778999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.73 Aligned_cols=242 Identities=21% Similarity=0.313 Sum_probs=199.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--------cCHHHHHHHHHHHHHhcCCCeeeeecccccCC
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEED 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 597 (837)
.++|.+.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++.+++||||+++++++.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 467999999999999999999864 689999999975421 13345778999999999999999999999999
Q ss_pred ccEEEEEecCCC-ChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 598 ENMLIYEFMPNK-SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 598 ~~~lV~ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
..++||||+..| +|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999877 999888543 34899999999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------~ 236 (335)
T 3dls_A 177 AAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------------T 236 (335)
T ss_dssp CEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------G
T ss_pred ceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------H
Confidence 987654432 223578999999999998877 8899999999999999999999853211 0
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
....... +......+.+++..|++.+|++|||++|+++.
T Consensus 237 ~~~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 VEAAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTTCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HhhccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00112357789999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=345.06 Aligned_cols=245 Identities=28% Similarity=0.451 Sum_probs=196.8
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
+.|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++.+++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999986 4789999999975432 23457889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+. |+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9998 6777777543 245899999999999999999999998 999999999999999999999999999865432
Q ss_pred cceeeeccccccCCccCccccc---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYAL---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
....||+.|+|||++. ...++.++|||||||+++||++|+.|+.... ............. ....
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~-~~~~ 274 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNES-PALQ 274 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCC-CCCC
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCC-CCCC
Confidence 2357899999999985 5679999999999999999999999985321 1111111111111 0000
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.... ...+.+++.+|++.+|++|||++++++
T Consensus 275 ----~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 275 ----SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCC----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1111 234678899999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=333.65 Aligned_cols=251 Identities=24% Similarity=0.291 Sum_probs=203.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc------cCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
.++|.+.+.||+|+||.||+++.. +|+.||||.+..... ...+++.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888899999999999999876 689999999875432 1467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC----Ceeecccc
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM----NPRISDFG 675 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~ki~DFG 675 (837)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999998643 35889999999999999999999988 99999999999999888 79999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+..... ... ........
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~---~~~i~~~~- 234 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QET---LANITSVS- 234 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHH---HHHHHTTC-
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHH---HHHHHhcc-
Confidence 9987654321 2335789999999999999999999999999999999999999853211 111 11111100
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...++..... ....+.+++.+|++.||++|||+.|+++
T Consensus 235 --~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 --YDFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --cccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011111111 1235778999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=343.67 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=200.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 601 (837)
.++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+..|.+++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 357888999999999999999886 4789999999754 234567788999999988 79999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999986543 4889999999999999999999988 9999999999999999999999999998643
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. ..... ..
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~---~i~~~-~~----- 238 (353)
T 2i0e_A 173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQ---SIMEH-NV----- 238 (353)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHC-CC-----
T ss_pred cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHH---HHHhC-CC-----
Confidence 222 12334689999999999999999999999999999999999999985321 111111 11111 00
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~eVv~ 799 (837)
.+ +......+.+++.+|++.||++||+ +++|++
T Consensus 239 -~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 -AY----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -CC----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -CC----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01 1112345778999999999999995 477764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=336.05 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=206.1
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHH--hcCCCeeeeecccccCC----c
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAK--LQHRNLVKLLGCCLEED----E 598 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~ 598 (837)
...++|.+.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++.... .
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 4457899999999999999999988 4899999999543 34677889999988 68999999999998776 7
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHH--------hcCCCceeeCCCCCCcEEEcCCCCee
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH--------QDSRLRIIHRDLKASNILLDEKMNPR 670 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~k 670 (837)
.++||||+++|+|.+++... .+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+|
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEE
T ss_pred eEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEE
Confidence 89999999999999999642 4889999999999999999999 555 99999999999999999999
Q ss_pred ecccccceeccCcccee--eeccccccCCccCcccccCC------CCCCcccHHHHHHHHHHHHhC----------CCCC
Q 003237 671 ISDFGTARVFGGEEILA--ITKRVVGTYGYMSPEYALDG------VFSTKSDVFSFGVILLEIITG----------KKNT 732 (837)
Q Consensus 671 i~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~------~~s~k~DV~S~Gvvl~elltG----------~~p~ 732 (837)
|+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.|+
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999998765443221 22345799999999999876 334789999999999999999 6666
Q ss_pred CCCCCCCcchHHHHHHHHhccCccccccccccccc-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 733 RIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS-CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 733 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
........ ...... ....... ..+.+... ...+....+.+++.+|++.||++|||+.||++.|+.+
T Consensus 268 ~~~~~~~~-~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 268 YDLVPSDP-SVEEMR-KVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTSCSSC-CHHHHH-HHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCcCcc-cHHHHH-HHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 54322221 111111 1111111 11112111 2335566788999999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=371.36 Aligned_cols=247 Identities=27% Similarity=0.438 Sum_probs=195.2
Q ss_pred CcccccCCeeEEEEEec---CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|++++.+++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 46789999997542 334678999999999999999999999986 4568899999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce-e
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL-A 687 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~-~ 687 (837)
|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++........ .
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999643 35899999999999999999999988 999999999999999999999999999876543321 2
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......+|..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+. .....+....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~----~~i~~~~~~~-------- 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVT----AMLEKGERMG-------- 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHH----HHHHTTCCCC--------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHHcCCCCC--------
Confidence 2223456788999999999999999999999999999998 9999864321 1111 1111111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.+......+.+++..|++.||++||++++|+++|+.
T Consensus 593 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 593 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 112223467889999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=334.99 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=195.1
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccC-CccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-DENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~ey~ 606 (837)
++|.+.+.||+|+||.||+++.. |+.||||.++.. ...+.+.+|++++.+++||||+++++++.+. ...++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 56888899999999999999875 889999999654 3457889999999999999999999987654 4789999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++++|.+++.... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 9999999986532 223788999999999999999999988 9999999999999999999999999988654321
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
....++..|+|||.+.+..++.++||||||++++||++ |+.|+..... ..+.... ..+. ....
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~----~~~~-----~~~~- 235 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EKGY-----KMDA- 235 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH----TTTC-----CCCC-
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----hcCC-----CCCC-
Confidence 22457889999999999999999999999999999998 9999864321 1111111 1111 0111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+......+.+++..|++.||++|||+.|+++.|+.+
T Consensus 236 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 112234577899999999999999999999999865
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=350.55 Aligned_cols=264 Identities=23% Similarity=0.361 Sum_probs=190.5
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhc-CCCeeeeecccccCC--cc
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEED--EN 599 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~ 599 (837)
..++|++.++||+|+||.||+|... +|+.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3468999999999999999999865 6899999998643 2334567789999999997 999999999987544 67
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++||||++ ++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 588888854 35889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCcc-------------------ceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCC
Q 003237 680 FGGEE-------------------ILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD 739 (837)
Q Consensus 680 ~~~~~-------------------~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~ 739 (837)
..... ........+||+.|+|||++.+ ..++.++|||||||+++||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-- 236 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-- 236 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 64311 0111233579999999999987 6799999999999999999999999864321
Q ss_pred cchHHHHHHHHhccCccccc-----------c----------cccccccc------------CHHHHHHHHHHHHHcccC
Q 003237 740 SSNLIKYAWELWSDNKALEI-----------V----------DSSMANSC------------LASEALRCIQVGLLCVQD 786 (837)
Q Consensus 740 ~~~l~~~~~~~~~~~~~~~~-----------~----------d~~l~~~~------------~~~~~~~l~~l~~~Cl~~ 786 (837)
..................+ + .......+ .......+.+++.+|++.
T Consensus 237 -~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 -MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp -HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred -HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 1111111111111110000 0 00000000 001124578999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003237 787 RTTDRPSMSTVVFM 800 (837)
Q Consensus 787 ~P~~RPtm~eVv~~ 800 (837)
||++|||++|+++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.48 Aligned_cols=245 Identities=22% Similarity=0.324 Sum_probs=197.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 602 (837)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .....++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467888999999999999999876 79999999987542 33456788999999999 899999999999999999999
Q ss_pred EEecCCCChhhHhhhcCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC----------------
Q 003237 603 YEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---------------- 665 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---------------- 665 (837)
|||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999965422 245899999999999999999999988 999999999999984
Q ss_pred ---CCCeeecccccceeccCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 003237 666 ---KMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS 741 (837)
Q Consensus 666 ---~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~ 741 (837)
...+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||+++||++|+.++...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------ 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------
Confidence 4479999999998765432 24589999999999876 6678999999999999999998775311
Q ss_pred hHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 742 NLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 742 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... .....+.. +.+.... ...+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~----~~~~~~~~-----~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 DQW----HEIRQGRL-----PRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHH----HHHHTTCC-----CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHH----HHHHcCCC-----CCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111 11111111 1111122 235778999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=352.85 Aligned_cols=258 Identities=22% Similarity=0.263 Sum_probs=192.8
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC------
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 597 (837)
.++|++.++||+|+||+||+|... +++.||||++... .....+.+.+|+++++.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467889999999999999999765 6899999999754 3344567889999999999999999999986553
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..+|||||++++ |...+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 469999999875 545542 23789999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc--
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK-- 755 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-- 755 (837)
+...... ......||+.|+|||++.+..++.++|||||||+++||++|+.||..... ......+........
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCHH
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHH
Confidence 8765432 22346789999999999999999999999999999999999999864321 111111111111000
Q ss_pred -----------------------cccccccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 756 -----------------------ALEIVDSSMA---NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 756 -----------------------~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....+...+. ..........+.+++.+|++.||++|||++|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 0011112456889999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=339.59 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=198.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|++.+.||+|+||.||++... +++.||||++.+.... ..+|++++.++ +||||+++++++.++...++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 457888999999999999999876 6899999999765332 35688888888 79999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC----CCeeecccccceec
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK----MNPRISDFGTARVF 680 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~ki~DFGla~~~ 680 (837)
|+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+..+ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999998643 35899999999999999999999998 9999999999998543 34999999999876
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+..... .+...
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~~--- 241 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKFS--- 241 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCCC---
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCcc---
Confidence 54322 2234678999999999988889999999999999999999999997433322222222111 11110
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+...........+.+++.+|++.||++|||+.||++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001111112345778999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=339.17 Aligned_cols=260 Identities=22% Similarity=0.367 Sum_probs=196.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 46888899999999999999864 78999999997532 334567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 604 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
||+++++|.+++... .....+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999998642 23456889999999999999999999988 99999999999999999999999999986543
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
... ......++..|+|||.+.+..++.++||||||++++||++|+.|+..... ......... ........
T Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~~~~~~~~--- 258 (310)
T 2wqm_A 189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI-EQCDYPPL--- 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHH-HTTCSCCC---
T ss_pred CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHh-hcccCCCC---
Confidence 321 12235689999999999999999999999999999999999999853221 111111111 11111110
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
.... ....+.+++.+|++.||++|||+++|+++|+++.
T Consensus 259 -~~~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 259 -PSDH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp -CTTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cccc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0011 1235778999999999999999999999998863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=329.30 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=201.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++.+++||||+++++++.++...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888999999999999999875 5899999998654 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC---eeecccccceec
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN---PRISDFGTARVF 680 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~ki~DFGla~~~ 680 (837)
||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998888654 34889999999999999999999988 999999999999986655 999999999876
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
..... .....||+.|+|||.+.+..++.++||||||++++||++|+.|+.... ........ .. +.. ...
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~---~~-~~~-~~~ 227 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQI---KA-GAY-DYP 227 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HH-TCC-CCC
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHH---Hh-ccc-cCC
Confidence 54332 223678999999999999999999999999999999999999985321 11111111 11 100 000
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+ .... ....+.+++.+|++.+|++|||++|+++
T Consensus 228 ~~-~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SP-EWDT----VTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TT-TTTT----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ch-hhcc----cCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 0011 1235778999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=343.13 Aligned_cols=261 Identities=14% Similarity=0.151 Sum_probs=201.5
Q ss_pred cCCCcCCcccccCCeeEEEEEecC---------CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeee----------
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN---------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVK---------- 588 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~---------- 588 (837)
++|.+.+.||+|+||.||+|+... ++.||||.+... +.+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578888999999999999998763 789999999654 46789999999999999998
Q ss_pred -----eeccccc-CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEE
Q 003237 589 -----LLGCCLE-EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 662 (837)
Q Consensus 589 -----l~~~~~~-~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIl 662 (837)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.||++||.|||+.+ |+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 4555554 56789999999 999999997542 345899999999999999999999997 999999999999
Q ss_pred EcCCC--CeeecccccceeccCcccee-----eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 003237 663 LDEKM--NPRISDFGTARVFGGEEILA-----ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIF 735 (837)
Q Consensus 663 l~~~~--~~ki~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 735 (837)
++.++ .+||+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 99999999998765432211 112357899999999999999999999999999999999999999754
Q ss_pred CCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 736 NDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 736 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.... ..+......... ....+.+...... .....+.+++.+|++.||++|||+++|+++|+++
T Consensus 272 ~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 272 LPNT-EDIMKQKQKFVD--KPGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp TTCH-HHHHHHHHHHHH--SCCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CcCH-HHHHHHHHhccC--ChhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 3211 112222111111 1111111111100 1124577899999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=354.41 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=204.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46888899999999999999876 79999999996432 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999854 345899999999999999999999988 999999999999999999999999999886543
Q ss_pred cceeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.. ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ...+.. .... +..
T Consensus 170 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~---~i~~-~~~------ 233 (476)
T 2y94_A 170 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH---VPTLFK---KICD-GIF------ 233 (476)
T ss_dssp CC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS---SHHHHH---HHHT-TCC------
T ss_pred cc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC---HHHHHH---HHhc-CCc------
Confidence 32 234679999999999998776 689999999999999999999986322 111111 1111 110
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhcc
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSN 803 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~ 803 (837)
...... ...+.+++.+|++.||++|||++||++ .++.
T Consensus 234 ~~p~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 234 YTPQYL----NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp CCCTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred CCCccC----CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 001111 235778999999999999999999986 4544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=333.02 Aligned_cols=248 Identities=24% Similarity=0.420 Sum_probs=203.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+.|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46788899999999999999865 68999999997543 34568899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 102 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 102 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 999999999843 35899999999999999999999988 99999999999999999999999999987654332
Q ss_pred eeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
. .....|+..|+|||.+.+..++.++||||||++++||++|+.|+..... ..... .. .... .+.+.
T Consensus 175 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~---~~-~~~~-----~~~~~ 240 (303)
T 3a7i_A 175 K--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLF---LI-PKNN-----PPTLE 240 (303)
T ss_dssp C--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH---HH-HHSC-----CCCCC
T ss_pred c--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHH---Hh-hcCC-----CCCCc
Confidence 1 2335789999999999999999999999999999999999999853221 11111 11 1111 11112
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
...+ ..+.+++..|++.+|++|||+.||++.
T Consensus 241 ~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 GNYS----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2222 347789999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.29 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=200.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcE--EEEEEecCC-CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQE--IAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|.+.+.||+|+||.||+|+.. ++.. +|||++... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888899999999999999875 5664 499998653 234456789999999999 899999999999999999999
Q ss_pred EEecCCCChhhHhhhcC-------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 603 YEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
|||+++++|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996542 2346899999999999999999999988 9999999999999999999
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 748 (837)
||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .....
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYE 252 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHHHH
Confidence 99999998743221 11223456889999999999999999999999999999998 9999853211 11111
Q ss_pred HHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 749 ELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 749 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
....+. .... +......+.+++.+|++.+|++|||++|+++.|+.+
T Consensus 253 -~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 253 -KLPQGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp -HGGGTC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HhhcCC-----CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111110 0011 111224577899999999999999999999999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=334.67 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=202.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccc--cCCccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCL--EEDENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~~l 601 (837)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++.+++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888899999999999999875 68999999997542 334567889999999999999999999874 3567899
Q ss_pred EEEecCCCChhhHhhhcC-CCCCCChhhHHHHHHHHHHHHHHHHhcC--CCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 602 IYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDS--RLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997532 2345899999999999999999999976 2349999999999999999999999999998
Q ss_pred eccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 679 VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 679 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ..+.... ..+...
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i----~~~~~~- 234 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKI----REGKFR- 234 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHTCCC-
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHH----hhcccc-
Confidence 7543321 12235689999999999999999999999999999999999999864321 1111111 111111
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.+... ....+.+++.+|++.+|++|||++||++.+..
T Consensus 235 ----~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 ----RIPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ----CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----cCCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11111 23457789999999999999999999987753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.95 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=201.2
Q ss_pred cCCCcCCcccccCCeeEEEEEe----cCCcEEEEEEecCCC----ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLSTTS----GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDE 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 598 (837)
++|.+.++||+|+||.||+++. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788899999999999999987 368999999986432 23445677899999999 59999999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.++||||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999654 34889999999999999999999987 9999999999999999999999999998
Q ss_pred eccCccceeeeccccccCCccCcccccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc
Q 003237 679 VFGGEEILAITKRVVGTYGYMSPEYALD--GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 679 ~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 756 (837)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ............
T Consensus 208 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~-- 282 (355)
T 1vzo_A 208 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE-- 282 (355)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC--
T ss_pred ecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC--
Confidence 76433222 1233679999999999986 3578999999999999999999999965433222 112211111110
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 003237 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVFML 801 (837)
Q Consensus 757 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~~L 801 (837)
+.. +......+.+++.+|++.||++|| +++|+++..
T Consensus 283 -----~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 -----PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----CCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111 111224567899999999999999 999998643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=348.99 Aligned_cols=261 Identities=21% Similarity=0.271 Sum_probs=205.6
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcC-CCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH-RNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|.+.++||+|+||.||+|+. .+++.||||++..... ..++..|++++..++| ++|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46789999999999999999986 4689999998865432 2457899999999987 556666666677788899999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE---cCCCCeeecccccceecc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFG 681 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~DFGla~~~~ 681 (837)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 999999986432 35899999999999999999999998 9999999999999 688999999999999875
Q ss_pred Cccce-----eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc
Q 003237 682 GEEIL-----AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 682 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 756 (837)
..... .......||..|+|||.+.+..++.++|||||||+||||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 44321 1122467999999999999999999999999999999999999999765443333322222111111111
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 757 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.. +...+ ..++.+++..|++.+|++||++++|+++|+.+
T Consensus 238 ~~-----l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EA-----LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH-----HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HH-----HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11 11112 24578999999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=342.84 Aligned_cols=250 Identities=20% Similarity=0.229 Sum_probs=189.1
Q ss_pred cCCCcC-CcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeeccccc----CCccE
Q 003237 528 DNFSTS-NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE----EDENM 600 (837)
Q Consensus 528 ~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~~ 600 (837)
++|.+. +.||+|+||+||++... +++.||||++... ..+.+|++++.++ +||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 355554 68999999999999875 6889999999532 4677899887554 79999999998865 55689
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC---CCCeeecccccc
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTA 677 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~DFGla 677 (837)
|||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999996532 245899999999999999999999987 999999999999997 789999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcc-hHHHHHHHHhccCcc
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS-NLIKYAWELWSDNKA 756 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~ 756 (837)
+....... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... .+..
T Consensus 212 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~ 284 (400)
T 1nxk_A 212 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC
T ss_pred cccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc
Confidence 87643321 23467899999999999999999999999999999999999999654332211 1111111 0000
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 757 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....+ . .......+.+++..|++.||++|||+.||++
T Consensus 285 -~~~~~-~----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 285 -EFPNP-E----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -CCCTT-T----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cCCCc-c----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 0 0112245778999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=328.35 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=199.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc------cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|.+.+.||+|+||.||+++.. +++.||||.+..... ...+.+.+|++++.+++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888899999999999999886 689999999865421 24678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC----Ceeeccccc
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM----NPRISDFGT 676 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~ki~DFGl 676 (837)
+||||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999998653 34899999999999999999999987 99999999999999877 899999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 756 (837)
+........ .....+++.|+|||.+.+..++.++||||||++++||++|+.|+..... ... ...... ...
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~---~~~~~~-~~~ 228 (283)
T 3bhy_A 159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QET---LTNISA-VNY 228 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHH---HHHHHT-TCC
T ss_pred ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHH---HHHhHh-ccc
Confidence 987654321 2235689999999999999999999999999999999999999853221 111 111111 000
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 757 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
........ .....+.+++.+|++.||++|||+.|+++
T Consensus 229 --~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 --DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp --CCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00011111 11245778999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=336.96 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=199.2
Q ss_pred hhcCCCcC-CcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccE
Q 003237 526 ATDNFSTS-NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 526 at~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 600 (837)
..+.|.+. +.||+|+||.||+|... +++.||||++... ......++.+|+.++.+++ ||||+++++++.+....+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 34566666 78999999999999876 6899999998754 2345678999999999995 699999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC---CCCeeecccccc
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTA 677 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~DFGla 677 (837)
+||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp EEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred EEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 999999999999998543 2345899999999999999999999988 999999999999998 789999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .......... . .
T Consensus 182 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~-~-~--- 250 (327)
T 3lm5_A 182 RKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQV-N-V--- 250 (327)
T ss_dssp EEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT-C-C---
T ss_pred cccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhc-c-c---
Confidence 87654322 2335789999999999999999999999999999999999999854221 1111111110 0 0
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.............+.+++.+|++.||++|||++|+++
T Consensus 251 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 251 -----DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0000111112345778999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=334.04 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=204.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
.++|.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888899999999999999876 57899999986542 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988653 35889999999999999999999988 99999999999999999999999999987653
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..... .......... . .
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~-~------~ 258 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKN-E------Y 258 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHT-C------C
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcC-C------C
Confidence 322 12335789999999999999999999999999999999999999863221 1111111111 0 0
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhcc
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSN 803 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~ 803 (837)
.+.... ...+.+++.+|++.||++|||++|+++ .+..
T Consensus 259 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 259 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 111112 234678999999999999999999986 4543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=352.09 Aligned_cols=242 Identities=17% Similarity=0.164 Sum_probs=187.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCC---CccCHHHHHHHH---HHHHHhcCCCeeeeec-------c
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT---SGQGIEELKNEV---LLIAKLQHRNLVKLLG-------C 592 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~~-------~ 592 (837)
.++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +++.+++|||||++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45788889999999999999986 46999999999743 233457888999 5555668999999984 4
Q ss_pred cccCC-----------------ccEEEEEecCCCChhhHhhhcCC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCce
Q 003237 593 CLEED-----------------ENMLIYEFMPNKSLDYFIFDESR----KQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651 (837)
Q Consensus 593 ~~~~~-----------------~~~lV~ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 651 (837)
+.+.+ ..+|||||+ +|+|.+++..... ...+++..++.++.||++||.|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 33332 268999999 6899999975321 123446888899999999999999998 9
Q ss_pred eeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCC-----------CCCCcccHHHHHH
Q 003237 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG-----------VFSTKSDVFSFGV 720 (837)
Q Consensus 652 vH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~k~DV~S~Gv 720 (837)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986433 1233567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 721 ILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 721 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
++|||++|+.||........ ...+.. .. ... ...+.+++.+|++.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~---------------~~~~~~-~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---------------SEWIFR-SC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC---------------SGGGGS-SC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc---------------hhhhhh-hc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999854322111 011111 00 112 235778999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.68 Aligned_cols=262 Identities=23% Similarity=0.368 Sum_probs=197.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|++++.+++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57888899999999999999876 589999999865432 234567899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999998876432 34899999999999999999999998 9999999999999999999999999998654332
Q ss_pred ceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH----------Hhcc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE----------LWSD 753 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~----------~~~~ 753 (837)
. ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+...... .+..
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI--DQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHHHHH
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhhhHhhh
Confidence 1 12335789999999999875 7899999999999999999999998643221 111111110 0000
Q ss_pred C-ccccccccccccccC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 N-KALEIVDSSMANSCL-----ASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 ~-~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. .......+.+..... ......+.+++.+|++.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 001111111111111 122356889999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=348.57 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=189.9
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--------ccCHHHHHHHHHHHHHhcCCCeeeeecccccC
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--------GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE 596 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 596 (837)
..++|.+.++||+|+||.||+|... +++.||||++.... ......+.+|++++.+++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4578999999999999999999875 68999999986531 112235789999999999999999999975 4
Q ss_pred CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC---CCeeecc
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK---MNPRISD 673 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~ki~D 673 (837)
+..++||||+++|+|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.+ ..+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 567999999999999988854 345899999999999999999999988 9999999999999754 4599999
Q ss_pred cccceeccCccceeeeccccccCCccCcccccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 674 FGTARVFGGEEILAITKRVVGTYGYMSPEYALD---GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 674 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+....
T Consensus 286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i--- 357 (419)
T 3i6u_A 286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI--- 357 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHH---
T ss_pred cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHH---
Confidence 99998765432 2234679999999999864 678899999999999999999999986432221 111111
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+... . .+.... .....+.+++.+|++.||++|||++|+++
T Consensus 358 -~~~~~~-~-~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 -TSGKYN-F-IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HTTCCC-C-CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -hcCCCC-C-Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111100 0 000001 11345788999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.32 Aligned_cols=255 Identities=18% Similarity=0.292 Sum_probs=198.1
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeeccccc--CCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLE--EDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lV~ 603 (837)
++|++.++||+|+||.||+|+. .+++.||||++... ..+.+.+|++++.+++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6788899999999999999976 47899999999643 3578899999999997 9999999999987 55679999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-CeeecccccceeccC
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGG 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~DFGla~~~~~ 682 (837)
||+++++|..++. .+++..+..++.||++||.|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999998873 2788899999999999999999988 99999999999999776 899999999987654
Q ss_pred ccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc-
Q 003237 683 EEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV- 760 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~- 760 (837)
... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.|+...... ...+... ..........+.+
T Consensus 184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~-~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRI-AKVLGTEDLYDYID 258 (330)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHH-HHHHCHHHHHHHHH
T ss_pred CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHH-HHhcCCchhhhHHH
Confidence 332 223578999999999987 67999999999999999999999998533221 1111111 1111111110000
Q ss_pred ----------------------ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 ----------------------DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 ----------------------d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...............+.+++.+|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000011111112356789999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=328.74 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=195.2
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeeccccc----CCccEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENML 601 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~l 601 (837)
.|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|++++.+++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4666788999999999999875 6789999998643 23445678899999999999999999998765 345789
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-CCCCeeecccccceec
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVF 680 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~DFGla~~~ 680 (837)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 99999999999999653 34889999999999999999999875 3599999999999998 8899999999999765
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
.... .....||+.|+|||.+. +.++.++||||||++++||++|+.|+..... ........ ..+.....
T Consensus 183 ~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~-~~~~~~~~- 250 (290)
T 1t4h_A 183 RASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRV-TSGVKPAS- 250 (290)
T ss_dssp CTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHH-TTTCCCGG-
T ss_pred cccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHHH-hccCCccc-
Confidence 4332 22357899999999876 5699999999999999999999999853221 11111111 11111111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.... ....+.+++..|++.+|++|||++||++
T Consensus 251 ---~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 ---FDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cCCC----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111 1235788999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=329.21 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=203.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.++|.+.+.||+|+||.||+++.. +|+.||||.+........+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 356888899999999999999875 6899999999766555556789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE---cCCCCeeecccccceeccC
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~DFGla~~~~~ 682 (837)
+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999998654 34789999999999999999999988 9999999999999 7889999999999976443
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.|+.... ...+.... .. +.. . ...
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i---~~-~~~-~-~~~ 228 (304)
T 2jam_A 162 GI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKI---KE-GYY-E-FES 228 (304)
T ss_dssp BT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHH---HH-CCC-C-CCT
T ss_pred Cc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHH---Hc-CCC-C-CCc
Confidence 21 223568999999999999999999999999999999999999985321 11111111 11 100 0 001
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCCCC
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETFV 807 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~~~ 807 (837)
.. .......+.+++.+|++.||++|||++|+++ .+++...+
T Consensus 229 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (304)
T 2jam_A 229 PF----WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271 (304)
T ss_dssp TT----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred cc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence 11 1112345778999999999999999999986 55554443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=339.04 Aligned_cols=263 Identities=20% Similarity=0.295 Sum_probs=197.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccC--------
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-------- 596 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-------- 596 (837)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+.+|++++.+++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57888899999999999999874 78999999986543 23356788999999999999999999998774
Q ss_pred CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
...++||||+++ +|...+.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 457899999986 6666664432 34899999999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccc--eeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc
Q 003237 677 ARVFGGEEI--LAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD 753 (837)
Q Consensus 677 a~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 753 (837)
++....... ........||+.|+|||++.+ ..++.++|||||||+++||++|+.|+..... .............
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCGS 247 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Confidence 987653221 122234578999999999876 4689999999999999999999999864321 1222222221111
Q ss_pred Cc---cccc-----ccc---ccccccC-HHH------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 NK---ALEI-----VDS---SMANSCL-ASE------ALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 ~~---~~~~-----~d~---~l~~~~~-~~~------~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. .... .+. ....... .+. ...+.+++.+|++.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 10 0000 000 0000000 111 234778999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=346.01 Aligned_cols=244 Identities=21% Similarity=0.251 Sum_probs=188.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHH-HHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLL-IAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|..+ +..++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888899999999999999876 58899999997543 2234456667776 4678999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++|+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999998653 34788888999999999999999988 99999999999999999999999999986432
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~-~------ 256 (373)
T 2r5t_A 192 HN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNILNKP-L------ 256 (373)
T ss_dssp CC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB------HHHHHHHHHHSC-C------
T ss_pred CC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhcc-c------
Confidence 21 12345789999999999999999999999999999999999999985321 111111111110 0
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMST 796 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~e 796 (837)
.+... ....+.+++.+|++.||++||++.+
T Consensus 257 ~~~~~----~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 QLKPN----ITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCCSS----SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCCC----CCHHHHHHHHHHcccCHHhCCCCCC
Confidence 01111 2235678999999999999999854
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.17 Aligned_cols=262 Identities=21% Similarity=0.247 Sum_probs=201.8
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhc--------CCCeeeeecccc---
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ--------HRNLVKLLGCCL--- 594 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~--- 594 (837)
.++|.+.++||+|+||.||+|+.. +++.||||++... ....+.+.+|++++.+++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367899999999999999999764 6889999999643 344567889999999996 788999999987
Q ss_pred -cCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEEcCCC-----
Q 003237 595 -EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKM----- 667 (837)
Q Consensus 595 -~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NIll~~~~----- 667 (837)
.....++||||+ +++|.+.+.... ...+++..+..++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 556789999999 556656654432 24589999999999999999999998 6 99999999999999775
Q ss_pred --------------------------------------------CeeecccccceeccCccceeeeccccccCCccCccc
Q 003237 668 --------------------------------------------NPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703 (837)
Q Consensus 668 --------------------------------------------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 703 (837)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999876532 223578999999999
Q ss_pred ccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHH---HHHHHHhccC--------c-cccccccc--------
Q 003237 704 ALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI---KYAWELWSDN--------K-ALEIVDSS-------- 763 (837)
Q Consensus 704 ~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---~~~~~~~~~~--------~-~~~~~d~~-------- 763 (837)
+.+..++.++|||||||++|||++|+.||......+..... .......... . ..+.+...
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999765443322111 1111111110 0 00000000
Q ss_pred -----------cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 -----------MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 -----------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
-...........+.+++.+|++.||++|||++||++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001234556678899999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=344.59 Aligned_cols=253 Identities=10% Similarity=0.068 Sum_probs=180.7
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHh--cCCCeeeeeccc-------c
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKL--QHRNLVKLLGCC-------L 594 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~H~nIv~l~~~~-------~ 594 (837)
..|.+.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++..+ +||||++++..+ .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45777899999999999999875 789999999976532 3455677886666666 599988855332 2
Q ss_pred cC-----------------CccEEEEEecCCCChhhHhhhcCCCCCCChhhH------HHHHHHHHHHHHHHHhcCCCce
Q 003237 595 EE-----------------DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKR------FDIILGIARGVLYLHQDSRLRI 651 (837)
Q Consensus 595 ~~-----------------~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i 651 (837)
.. ...+|||||++ |+|.+++..... .+.+..+ +.++.||++||.|||+++ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 21 33799999999 899999976422 3466666 788899999999999988 9
Q ss_pred eeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccC--CCCCCcccHHHHHHHHHHHHhCC
Q 003237 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD--GVFSTKSDVFSFGVILLEIITGK 729 (837)
Q Consensus 652 vH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~k~DV~S~Gvvl~elltG~ 729 (837)
+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998764321 13556799999999987 68999999999999999999999
Q ss_pred CCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 730 KNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 730 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.||.......... +........................+.+++.+|++.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9997543321110 0000000000111111111122345778999999999999999999964
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=335.43 Aligned_cols=254 Identities=21% Similarity=0.328 Sum_probs=202.1
Q ss_pred HHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc--------CHHHHHHHHHHHHHh-cCCCeeeeeccc
Q 003237 524 LAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ--------GIEELKNEVLLIAKL-QHRNLVKLLGCC 593 (837)
Q Consensus 524 ~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 593 (837)
....++|.+.+.||+|+||.||+|++. +|+.||||++...... ..+.+.+|+.++.++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344567999999999999999999886 7999999998654321 135678899999999 799999999999
Q ss_pred ccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecc
Q 003237 594 LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673 (837)
Q Consensus 594 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 673 (837)
......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence 9999999999999999999998653 34899999999999999999999987 99999999999999999999999
Q ss_pred cccceeccCccceeeeccccccCCccCcccccC------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 003237 674 FGTARVFGGEEILAITKRVVGTYGYMSPEYALD------GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYA 747 (837)
Q Consensus 674 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 747 (837)
||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ........
T Consensus 244 fG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i 317 (365)
T 2y7j_A 244 FGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRMI 317 (365)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH
T ss_pred cCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHHH
Confidence 999987654322 234679999999999863 368999999999999999999999985321 11111111
Q ss_pred HHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 748 WELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 748 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. +... ...+. ... ....+.+++.+|++.||++|||+.|+++
T Consensus 318 ---~~-~~~~-~~~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 ---ME-GQYQ-FSSPE-WDD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HH-TCCC-CCHHH-HSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---Hh-CCCC-CCCcc-ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 1000 00000 001 1235778999999999999999999986
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=315.64 Aligned_cols=217 Identities=13% Similarity=0.169 Sum_probs=167.7
Q ss_pred ccccccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEE
Q 003237 21 TSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLH 100 (837)
Q Consensus 21 ~~~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~ 100 (837)
++.|+|++||+|++|++| ++|.|+|||+.+++ +.+ |.. +|+||+|||+.| .++.|+|+.||||||.
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS---DVRVWASNTAGA---TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EES---SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence 567999999999999999 59999999998776 334 443 699999999998 5678999999999999
Q ss_pred ecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCcccc-ccCCcccccc-cCCC-----cceee
Q 003237 101 ERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTV-LPNMRFGWDK-RTGL-----NRYVT 173 (837)
Q Consensus 101 ~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtl-Lpg~~l~~~~-~tg~-----~~~l~ 173 (837)
| +.+.+||+|++... .....|+|+|+|||||++ .++||||||||||+ ||+| |.|. .+|+ ++.|+
T Consensus 72 d--~~~~~vW~s~~~~~-~~~~~~~l~d~Gnlvl~~----~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 72 T--AQNTIRWSSGTKGS-IGNYVLVLQPDRTVTIYG----PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp C--TTTCCSCCCCCCCC-SSCCEEEECSSSCEEEEC----SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred c--CCCcEEEeCCcccc-CCcEEEEEeCCCCEEEec----CCEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 5 45678999996432 234579999999999983 28999999999887 6665 5555 5555 56787
Q ss_pred ecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCCCCCccccCccCceeeeeeEEEEEeCCCeeEEEeeccCCcee
Q 003237 174 AWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIFNITYIDNQDEVYLCDGLNDLSTI 253 (837)
Q Consensus 174 Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 253 (837)
+ .+||++|.|++.++++| +++++++..+||++++|++. +...+.+.....+ +.|..++++++.++..... ..
T Consensus 143 s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl-~ly~~~~~~vw~s~~~~~~-~~ 214 (236)
T 1dlp_A 143 A---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM-DVLTNQNIAVWTSGNSRSA-GR 214 (236)
T ss_dssp S---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE-EEEETTTEEEEECCCCCSS-SC
T ss_pred c---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE-EEEeCCCcEEEEeCCCCCC-CC
Confidence 5 78999999999999999 57888888899999999754 5555555422211 2233345566666654433 46
Q ss_pred EEEEEcccccEEEEE
Q 003237 254 ARMILNETGFLQRFT 268 (837)
Q Consensus 254 ~rl~Ld~~G~l~~~~ 268 (837)
.|++||+||++++|.
T Consensus 215 ~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 215 YVFVLQPDRNLAIYG 229 (236)
T ss_dssp CEEEECSSSCEEEEC
T ss_pred EEEEEcCCCcEEEeC
Confidence 899999999999994
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=340.62 Aligned_cols=261 Identities=22% Similarity=0.325 Sum_probs=195.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC------
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 597 (837)
.++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++.+++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357888999999999999999874 6899999999653 2233567889999999999999999999987653
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 7899998864 24789999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc-
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK- 755 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~- 755 (837)
+..... .....+|+.|+|||++.+ ..++.++||||+||+++||++|+.||..... ...............
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence 876432 223578999999999887 6899999999999999999999999864321 111111111111000
Q ss_pred -c---------ccc-------cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 003237 756 -A---------LEI-------VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNE 804 (837)
Q Consensus 756 -~---------~~~-------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~ 804 (837)
. ... ....+ ..........+.+++.+|++.||++|||++|+++ .++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0 000 00000 0011122345778999999999999999999987 46554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.03 Aligned_cols=262 Identities=23% Similarity=0.299 Sum_probs=191.8
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc--cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG--QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
..++|.+.++||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++.+++||||+++++++.++...++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3468999999999999999999865 789999999965432 2345678999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-----CCCCeeecccccc
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-----EKMNPRISDFGTA 677 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-----~~~~~ki~DFGla 677 (837)
|||+++ +|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|||++
T Consensus 112 ~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999985 898888653 24889999999999999999999988 99999999999994 5556999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 756 (837)
+....... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||..... ................
T Consensus 185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCT
T ss_pred cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCCCch
Confidence 87643321 12235679999999999875 589999999999999999999999854221 1111111111111000
Q ss_pred cc----------------ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 757 LE----------------IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 757 ~~----------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. .....+...........+.+++.+|++.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 00000000000112245779999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=341.97 Aligned_cols=268 Identities=21% Similarity=0.292 Sum_probs=198.1
Q ss_pred HHHHHHhhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCcc-----------CHHHHHHHHHHHHHhcCCCeee
Q 003237 520 LSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ-----------GIEELKNEVLLIAKLQHRNLVK 588 (837)
Q Consensus 520 ~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~ 588 (837)
+.++....++|.+.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|++++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677788999999999999999999999888999999998643211 1377899999999999999999
Q ss_pred eeccccc-----CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE
Q 003237 589 LLGCCLE-----EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 663 (837)
Q Consensus 589 l~~~~~~-----~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 663 (837)
+++++.. ....++||||++ |+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 9999854 335699999998 5787777643 345899999999999999999999998 9999999999999
Q ss_pred cCCCCeeecccccceeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 003237 664 DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSN 742 (837)
Q Consensus 664 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~ 742 (837)
+.++.+||+|||+++....... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~ 241 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF---YN 241 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HH
T ss_pred cCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH---HH
Confidence 9999999999999985443221 223578899999999887 6799999999999999999999999864321 11
Q ss_pred HHHHHHHHhccCccc-----------cccccccc-------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 743 LIKYAWELWSDNKAL-----------EIVDSSMA-------NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 743 l~~~~~~~~~~~~~~-----------~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
............... +.+...+. ..........+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 122121111111110 00000000 0011112345789999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.70 Aligned_cols=197 Identities=26% Similarity=0.409 Sum_probs=173.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|++.++||+|+||.||++... +++.||+|++.... ....+.+.+|++++.+++||||+++++++.++...++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56888899999999999999876 68999999997652 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
+++++|.+++.... .+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999996543 478999999999999999999985 6 999999999999999999999999998755322
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRI 734 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 734 (837)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12335789999999999999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=328.89 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=197.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.++|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++.+++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467888999999999999999886 5889999999776666788999999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999886532 34899999999999999999999987 9999999999999999999999999976432111
Q ss_pred eeeeccccccCCccCcccc-----cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 686 LAITKRVVGTYGYMSPEYA-----LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~-----~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
.......|+..|+|||++ ....++.++||||||+++|||++|+.|+..... ........... .....
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~~~ 243 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSD-PPTLL 243 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CCCCS
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccC-CcccC
Confidence 111235689999999998 467789999999999999999999999864321 11111111111 11110
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+......+.+++.+|++.+|++|||+.++++
T Consensus 244 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 -------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01111235778999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=327.15 Aligned_cols=245 Identities=22% Similarity=0.314 Sum_probs=201.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999876 5789999998643 1234567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++.... .+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999986543 4789999999999999999999987 999999999999999999999999999765432
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
. .....|++.|+|||.+.+..++.++||||||++++||++|+.|+..... .......... +..
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~-------~~~ 230 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNV-------DLK 230 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTT-------CCC
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhcc-------ccC
Confidence 2 2235789999999999999999999999999999999999999864221 1111111110 011
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+... ....+.+++.+|++.+|.+|||++|+++
T Consensus 231 ~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 FPPF----LSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCc----CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1111 2245678999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.81 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=195.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec--CCc--EEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS--NGQ--EIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|++.+.||+|+||.||+|++. +++ .||||+++.. .....+.+.+|++++.+++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888899999999999999863 333 6899998654 2334678899999999999999999999987654 88
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+|+||+++++|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 9999999999999986542 34889999999999999999999987 999999999999999999999999999877
Q ss_pred cCccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 681 GGEEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 681 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
...... .......++..|+|||.+.+..++.++||||||++++||++ |+.|+..... . ..............
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~---~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---S---QILHKIDKEGERLP 245 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H---HHHHHHHTSCCCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---H---HHHHHHHccCCCCC
Confidence 544322 22233567888999999999899999999999999999999 9999853321 1 11111111111100
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
. .......+.+++.+|++.+|++|||+.+|++.|++..
T Consensus 246 -----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 246 -----R----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp -----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----C----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1 1112345788999999999999999999999998754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.32 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=202.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
.++|.+.+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888899999999999999876 57889999986542 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988643 35889999999999999999999988 99999999999999999999999999987653
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
... ......|++.|+|||.+.+..++.++||||||++++||++|+.|+..... ......... .. .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~-~~------~ 232 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKK-NE------Y 232 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHT-TC------C
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhh-cc------C
Confidence 322 12335789999999999999999999999999999999999999864221 111111111 10 0
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+.... ...+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCcccc----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111111 235678999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.66 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=196.2
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc-----CHHHHHHHHHHHHHhcCCCeeeeecccccCCcc
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ-----GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 599 (837)
..++|.+.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++.+++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3467999999999999999999875 5899999998643221 134678999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++||||+++ +|..++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 788877543 345888999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
...... ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.|+.... ...................
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~---~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCTTT
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHcCCCChhh
Confidence 643321 12335789999999999764 58999999999999999999999875322 1112222222111111000
Q ss_pred ------cccc---ccccccC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 759 ------IVDS---SMANSCL-----ASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 759 ------~~d~---~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
+.+. ......+ ......+.+++.+|++.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 0000001 1123567899999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=348.60 Aligned_cols=196 Identities=24% Similarity=0.390 Sum_probs=153.8
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccC-----Cc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-----DE 598 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 598 (837)
.++|++.++||+|+||.||+|... +++.||||++... .....+.+.+|+++|.+++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999765 6899999999653 233456788999999999999999999998543 46
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 799999985 688888753 345899999999999999999999998 9999999999999999999999999998
Q ss_pred eccCccce-------------------------eeeccccccCCccCcccc-cCCCCCCcccHHHHHHHHHHHHhCC
Q 003237 679 VFGGEEIL-------------------------AITKRVVGTYGYMSPEYA-LDGVFSTKSDVFSFGVILLEIITGK 729 (837)
Q Consensus 679 ~~~~~~~~-------------------------~~~~~~~gt~~y~APE~~-~~~~~s~k~DV~S~Gvvl~elltG~ 729 (837)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 76432110 112335789999999986 4567999999999999999999943
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=332.49 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=184.8
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+++.+|++++.+++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 467888999999999999999864 68899999986442 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhc-----CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 605 FMPNKSLDYFIFDE-----SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 605 y~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
|+++++|.+++... .....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 99999999998642 12345899999999999999999999987 99999999999999999999999999876
Q ss_pred ccCccc---eeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC-
Q 003237 680 FGGEEI---LAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN- 754 (837)
Q Consensus 680 ~~~~~~---~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 754 (837)
...... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ...... .....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~--~~~~~~ 245 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM---KVLMLT--LQNDPP 245 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHH--HTSSCC
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh---hHHHHH--hccCCC
Confidence 543211 111233578999999999876 56899999999999999999999998643221 111111 10100
Q ss_pred cc-ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 755 KA-LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 755 ~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. ....++.+....+ ..+.+++.+|++.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 1111111222222 35778999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=324.26 Aligned_cols=255 Identities=21% Similarity=0.276 Sum_probs=198.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC----ccCHHHHHHHHHHHHHhcCCCeeeeecccc--cCCcc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS----GQGIEELKNEVLLIAKLQHRNLVKLLGCCL--EEDEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~ 599 (837)
.++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999875 68899999986432 234577899999999999999999999984 45578
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++||||++++ |.+++.... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 666665432 345899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccceeeeccccccCCccCcccccCCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALDGV--FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
..............|+..|+|||++.+.. ++.++||||||+++|||++|+.|+.... ........ ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i-~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENI-GKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHH-HHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHH-hcCCC-
Confidence 65433333334467899999999987654 4789999999999999999999986321 11111111 11110
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhcc
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSN 803 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~ 803 (837)
.+.... ...+.+++.+|++.||++|||++|+++ .+++
T Consensus 231 -----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 231 -----AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp -----CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred -----CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 111122 235678999999999999999999996 4544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=341.83 Aligned_cols=199 Identities=24% Similarity=0.412 Sum_probs=166.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccC-----Cc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-----DE 598 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 598 (837)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++.+++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467889999999999999999875 6889999999653 233456788999999999999999999999776 56
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.++||||++ ++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 799999987 599988854 345899999999999999999999998 9999999999999999999999999999
Q ss_pred eccCccce--------------------eeeccccccCCccCcccc-cCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 003237 679 VFGGEEIL--------------------AITKRVVGTYGYMSPEYA-LDGVFSTKSDVFSFGVILLEIITGKKNT 732 (837)
Q Consensus 679 ~~~~~~~~--------------------~~~~~~~gt~~y~APE~~-~~~~~s~k~DV~S~Gvvl~elltG~~p~ 732 (837)
........ .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76543211 112446889999999986 4567999999999999999999865554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=330.52 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=184.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc-c-CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-Q-GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.++|++.+.||+|+||.||+++.. +++.||||++..... . ..+.+.++...+..++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 367888899999999999999874 789999999965422 2 2233445555677789999999999999999999999
Q ss_pred EecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 604 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 604 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||+++ +|.+++... .....+++..+..++.||+.||.|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99984 887777542 2345689999999999999999999997 7 9999999999999999999999999998765
Q ss_pred CccceeeeccccccCCccCcccc----cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYA----LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~----~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
.... .....||+.|+|||.+ .+..++.++||||||++++||++|+.|+..... . .............
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~-~~~~~~~~~~~~~- 232 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT----P-FQQLKQVVEEPSP- 232 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC----H-HHHHHHHHHSCCC-
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc----h-HHHHHHHhccCCC-
Confidence 4322 2234689999999996 566789999999999999999999999863221 1 1111111111110
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. .. .......+.+++.+|++.+|++|||+.||++
T Consensus 233 ~-----~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 Q-----LP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C-----CC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-----cc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 00 1112235778999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=342.71 Aligned_cols=198 Identities=23% Similarity=0.291 Sum_probs=171.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh------cCCCeeeeecccccCCcc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL------QHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~~~ 599 (837)
.++|++.++||+|+||.||+|... +++.||||++... ....+++.+|++++..+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 357888999999999999999775 5899999999643 33456778899999888 467999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC--eeecccccc
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN--PRISDFGTA 677 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~ki~DFGla 677 (837)
++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999997 58888886543 234899999999999999999999998 999999999999999887 999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIF 735 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 735 (837)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 765432 22357899999999999999999999999999999999999998643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=342.50 Aligned_cols=259 Identities=19% Similarity=0.296 Sum_probs=194.6
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc------cEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE------NML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~l 601 (837)
.+|.+.++||+|+||.||+|+...+..+|+|++...... ..+|+++++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 468888999999999999999987778999998654322 2369999999999999999999865433 679
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-CCCCeeecccccceec
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVF 680 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~DFGla~~~ 680 (837)
||||++++.+............+++..+..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999998665554433334556899999999999999999999988 99999999999999 7999999999999876
Q ss_pred cCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc---
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA--- 756 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 756 (837)
..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.... ........
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~l~~i~-~~~g~p~~~~~ 266 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG--IDQLVEII-KVLGTPSREQI 266 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH-HHHCCCCHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH-HHhCCCCHHHH
Confidence 44322 1235789999999998765 589999999999999999999999864321 11122211 11111100
Q ss_pred -------ccccccc-----cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 757 -------LEIVDSS-----MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 757 -------~~~~d~~-----l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+..-+. ............+.+++.+|++.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000 000111112346789999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=331.89 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=194.4
Q ss_pred hhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhc--CCCeeeeecccccCCccEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQ--HRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~l 601 (837)
..++|.+.+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ |+||+++++++......++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34678889999999999999999888999999998654 2344578899999999997 5999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||| +.+++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||+++ +.+||+|||+++...
T Consensus 106 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 6788999998653 35789999999999999999999987 999999999999975 889999999998765
Q ss_pred CccceeeeccccccCCccCcccccC-----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALD-----------GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
............|++.|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ........
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~ 252 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI 252 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHH
Confidence 4433323334678999999999875 4788999999999999999999999853221 11111112
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.... .....+......+.+++.+|++.||++||+++||++
T Consensus 253 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 253 IDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Hhcc---------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111 111111111245778999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=360.20 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=202.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 601 (837)
.++|++.++||+|+||.||+|+.. +++.||||++++. .....+.+..|.+++..+ +||||+++++++.+.+..+|
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467888999999999999999876 5888999999753 234456788899999987 69999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999997543 4899999999999999999999998 9999999999999999999999999998643
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+ ...+.... .
T Consensus 494 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~---~~~i~~~~-~----- 559 (674)
T 3pfq_A 494 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDEL---FQSIMEHN-V----- 559 (674)
T ss_dssp CTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH---HHHHHSSC-C-----
T ss_pred cCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---HHHH---HHHHHhCC-C-----
Confidence 3222 2345789999999999999999999999999999999999999996421 1111 11111111 0
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSM-----STVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm-----~eVv~ 799 (837)
.++......+.+++..|++.||++||++ +||.+
T Consensus 560 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0111223457789999999999999998 77763
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=332.39 Aligned_cols=268 Identities=23% Similarity=0.377 Sum_probs=197.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|++.+.||+|+||.||+|+... .+|+|++... .....+.+.+|++++.+++||||+++++++.+....++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4678889999999999999998753 5999998643 22334567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999998543 235889999999999999999999988 99999999999998 6799999999987653221
Q ss_pred c---eeeeccccccCCccCcccccC---------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc
Q 003237 685 I---LAITKRVVGTYGYMSPEYALD---------GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS 752 (837)
Q Consensus 685 ~---~~~~~~~~gt~~y~APE~~~~---------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 752 (837)
. ........|++.|+|||.+.. ..++.++||||||+++|||++|+.|+..... . .......
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~---~~~~~~~- 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---E---AIIWQMG- 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---H---HHHHHHH-
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHhc-
Confidence 1 112223468999999999874 4578999999999999999999999863221 1 1111111
Q ss_pred cCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC-CCCCCCCCccc
Q 003237 753 DNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF-VPSPKQPTFSV 817 (837)
Q Consensus 753 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~-~~~p~~p~~~~ 817 (837)
.+........ .. ...+.+++..|++.+|++|||+.+|+++|+.+.. ......|..++
T Consensus 257 ~~~~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~ 314 (319)
T 2y4i_B 257 TGMKPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314 (319)
T ss_dssp TTCCCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred cCCCCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence 1111111110 11 1246789999999999999999999999998733 33334444443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.65 Aligned_cols=246 Identities=23% Similarity=0.372 Sum_probs=193.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.+.||+|+||.||+|+.. +++.||||.+... .....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888899999999999999886 7899999998643 2234668899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++.... .+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999986542 4789999999999999999999998 999999999999999999999999999876543
Q ss_pred cceeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.. .....+++.|+|||.+.+..+ +.++||||||++++||++|+.|+.... ...+.... ..+..
T Consensus 165 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~----~~~~~------ 228 (276)
T 2h6d_A 165 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKI----RGGVF------ 228 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH----HHCCC------
T ss_pred cc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHh----hcCcc------
Confidence 22 223568999999999988765 689999999999999999999985321 11111111 11100
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+.... ...+.+++.+|++.||++|||++||++
T Consensus 229 ~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 YIPEYL----NRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCchhc----CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011111 234678999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=338.03 Aligned_cols=267 Identities=20% Similarity=0.252 Sum_probs=188.3
Q ss_pred HHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc---
Q 003237 523 LLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE--- 598 (837)
Q Consensus 523 l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--- 598 (837)
.....++|.+.+.||+|+||.||+|+.. +++.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3455688999999999999999999875 68999999986543 333456788899999999999999999865433
Q ss_pred ----cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHH--hcCCCceeeCCCCCCcEEEcC-CCCeee
Q 003237 599 ----NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH--QDSRLRIIHRDLKASNILLDE-KMNPRI 671 (837)
Q Consensus 599 ----~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dlkp~NIll~~-~~~~ki 671 (837)
.++||||++++.+............+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+||
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence 6899999997533333222334456889999999999999999999 766 999999999999996 899999
Q ss_pred cccccceeccCccceeeeccccccCCccCcccccCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 672 SDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 672 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ..........
T Consensus 174 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~~~~~ 247 (360)
T 3e3p_A 174 CDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS---AGQLHEIVRV 247 (360)
T ss_dssp CCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHH
T ss_pred eeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh---HHHHHHHHHH
Confidence 99999987654332 22357899999999987654 89999999999999999999999864321 1111111111
Q ss_pred hccCc------------ccccccc------ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 751 WSDNK------------ALEIVDS------SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 751 ~~~~~------------~~~~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..... .....+. .............+.+++.+|++.||++|||+.||++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11100 0000000 0001111223467889999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=330.18 Aligned_cols=258 Identities=20% Similarity=0.273 Sum_probs=201.2
Q ss_pred cCCCcCCcccccCCeeEEEEEe--cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCC------eeeeecccccCCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL--SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN------LVKLLGCCLEEDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~~ 599 (837)
++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|++++..++|+| ++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5788899999999999999986 36889999999643 344567889999999998765 99999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC--------------
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-------------- 665 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-------------- 665 (837)
++||||+ +++|.+++.... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999 889999886543 235789999999999999999999988 999999999999987
Q ss_pred -----CCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 003237 666 -----KMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDS 740 (837)
Q Consensus 666 -----~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~ 740 (837)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--- 239 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS--- 239 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH---
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh---
Confidence 678999999999875432 2235789999999999999999999999999999999999999864322
Q ss_pred chHHHHHHHHhccCc--------cccc---------------------cccc-cccccCHHHHHHHHHHHHHcccCCCCC
Q 003237 741 SNLIKYAWELWSDNK--------ALEI---------------------VDSS-MANSCLASEALRCIQVGLLCVQDRTTD 790 (837)
Q Consensus 741 ~~l~~~~~~~~~~~~--------~~~~---------------------~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~P~~ 790 (837)
............... .... ..+. -...........+.+++.+|++.||++
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 111111111111000 0000 0000 000112344567889999999999999
Q ss_pred CCCHHHHHH
Q 003237 791 RPSMSTVVF 799 (837)
Q Consensus 791 RPtm~eVv~ 799 (837)
|||++||++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=322.94 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=198.0
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
..++|++.+.||+|+||.||+|... +|+.||||.+.... ..+.+.+|++++.+++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3467888999999999999999876 58999999997543 45788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999998632 245899999999999999999999988 9999999999999999999999999998765432
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... .......... ......
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~~~~---- 246 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPTN-PPPTFR---- 246 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS-CCCCCS----
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcC-CCcccC----
Confidence 2 12335789999999999999999999999999999999999999863221 1111111111 000000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+......+.+++.+|++.||++|||+.++++
T Consensus 247 ---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 ---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01111245778999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.53 Aligned_cols=262 Identities=19% Similarity=0.307 Sum_probs=199.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccC-----Ccc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-----DEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 599 (837)
.++|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 467889999999999999999875 68899999997543 23346788999999999999999999998655 357
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++||||+++ +|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 899999984 888888542 4889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCcccee-eeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 680 FGGEEILA-ITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 680 ~~~~~~~~-~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ................
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG---GHHHHHHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH---HHHHHHHHHhCCCCHH
Confidence 65432211 1234579999999998764 45899999999999999999999998643321 2222221111111100
Q ss_pred c---ccc--------ccc-ccc-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 E---IVD--------SSM-ANS-----CLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 ~---~~d--------~~l-~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. ..+ ... ... ........+.+++.+|++.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000 000 000 00112245789999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.90 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=201.8
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccC-----------------HHHHHHHHHHHHHhcCCCeeeee
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQG-----------------IEELKNEVLLIAKLQHRNLVKLL 590 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l~ 590 (837)
++|.+.+.||+|+||.||+|+. +++.||||++....... .+.+.+|++++.+++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5788899999999999999998 89999999986432111 17899999999999999999999
Q ss_pred cccccCCccEEEEEecCCCChhhH------hhhcCCCCCCChhhHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEE
Q 003237 591 GCCLEEDENMLIYEFMPNKSLDYF------IFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILL 663 (837)
Q Consensus 591 ~~~~~~~~~~lV~ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll 663 (837)
+++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ |+||||||+||++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 999999999999999999999998 432 124568999999999999999999998 77 9999999999999
Q ss_pred cCCCCeeecccccceeccCccceeeeccccccCCccCcccccCC-CCCC-cccHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 003237 664 DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG-VFST-KSDVFSFGVILLEIITGKKNTRIFNDDDSS 741 (837)
Q Consensus 664 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~-k~DV~S~Gvvl~elltG~~p~~~~~~~~~~ 741 (837)
+.++.+||+|||++...... ......++..|+|||.+.+. .++. ++||||||++++||++|+.|+...... .
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~ 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--V 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--H
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--H
Confidence 99999999999999876543 23346789999999999887 6766 999999999999999999998643321 1
Q ss_pred hHHHHHHHHhccCccccc------ccccc---ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 742 NLIKYAWELWSDNKALEI------VDSSM---ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 742 ~l~~~~~~~~~~~~~~~~------~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+.. .. ..+..... ..+.. ...........+.+++.+|++.||++|||+.|+++
T Consensus 260 ~~~~---~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ELFN---NI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHH---HH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHH---HH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 11 11111000 00000 00000122345788999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=350.03 Aligned_cols=249 Identities=27% Similarity=0.341 Sum_probs=195.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|.+.++||+|+||+||+|+.. ++..||||++.... ....+.+.+|++++..++|||||++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46888999999999999999876 68899999997542 3346788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC---CCCeeecccccceecc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTARVFG 681 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~DFGla~~~~ 681 (837)
|+++|+|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 117 ~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999888654 34889999999999999999999988 999999999999976 4559999999998765
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.... .....||+.|+|||++. ..++.++|||||||++|||++|+.||..... ..+...+ .. +.. . .+
T Consensus 191 ~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i---~~-~~~-~-~~ 257 (494)
T 3lij_A 191 NQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKV---EK-GKY-T-FD 257 (494)
T ss_dssp TTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HH-TCC-C-CC
T ss_pred CCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---Hh-CCC-C-CC
Confidence 4322 23367999999999876 5799999999999999999999999864221 1111111 11 100 0 00
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...... ....+.+++.+|++.+|++|||+.|+++
T Consensus 258 ~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhccc----CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000011 1235778999999999999999999984
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.17 Aligned_cols=268 Identities=22% Similarity=0.358 Sum_probs=201.3
Q ss_pred hhcCCCcCCcccccCCeeEEEEEe--cCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHh---cCCCeeeeecccc----
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKL--SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKL---QHRNLVKLLGCCL---- 594 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~--~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~---- 594 (837)
+.++|.+.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++..+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 368899999986432 22234566788777776 7999999999987
Q ss_pred -cCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecc
Q 003237 595 -EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673 (837)
Q Consensus 595 -~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 673 (837)
.....++||||++ |+|.+++.... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69999886543 234889999999999999999999988 99999999999999999999999
Q ss_pred cccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc
Q 003237 674 FGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD 753 (837)
Q Consensus 674 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 753 (837)
||+++...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... .............
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCC
Confidence 99998764332 12235789999999999999999999999999999999999999864321 1112222111111
Q ss_pred Ccccc----------ccc---cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 003237 754 NKALE----------IVD---SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNE 804 (837)
Q Consensus 754 ~~~~~----------~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~ 804 (837)
..... .+. ..............+.+++.+|++.||++|||+.|+++ .+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 00000 000 00001111122345778999999999999999999984 45443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=348.42 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=199.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.++|.+.++||+|+||+||+++.. +++.||||++... .......+.+|++++.+++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 357888999999999999999875 7899999998643 2345678899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc---CCCCeeecccccceec
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFGTARVF 680 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~DFGla~~~ 680 (837)
||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999988654 34889999999999999999999998 99999999999995 5668999999999866
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..+.. ...........
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~---~i~~~~~~~~~- 243 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILK---RVETGKYAFDL- 243 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHTCCCSCS-
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCCCCCCC-
Confidence 4432 1233579999999998875 599999999999999999999999853211 11111 11111000000
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+ . .......+.+++.+|++.+|++|||+.|+++
T Consensus 244 -~-~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 244 -P-Q----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -G-G----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -c-c----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0 0111245778999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=334.68 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=196.0
Q ss_pred HHHHhhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeeccccc----
Q 003237 522 TLLAATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE---- 595 (837)
Q Consensus 522 ~l~~at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~---- 595 (837)
++....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 33445678999999999999999999874 78999999986543 3457889999999999 79999999999976
Q ss_pred --CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecc
Q 003237 596 --EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673 (837)
Q Consensus 596 --~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 673 (837)
....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 457899999999999999986542 345889999999999999999999988 99999999999999999999999
Q ss_pred cccceeccCccceeeeccccccCCccCccccc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 003237 674 FGTARVFGGEEILAITKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 674 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 748 (837)
||++........ ......|++.|+|||++. +..++.++||||||+++|||++|+.|+..... .....
T Consensus 173 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~ 244 (326)
T 2x7f_A 173 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALF 244 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHH
T ss_pred CcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHH
Confidence 999987543221 122357899999999987 56789999999999999999999999853221 11111
Q ss_pred HHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 749 ELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 749 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...... ..... .... ...+.+++.+|++.||++|||++++++
T Consensus 245 ~~~~~~-~~~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 245 LIPRNP-APRLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHSC-CCCCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhcCc-cccCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111 11110 1111 235778999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=347.62 Aligned_cols=250 Identities=28% Similarity=0.364 Sum_probs=198.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc-------------cCHHHHHHHHHHHHHhcCCCeeeeecc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-------------QGIEELKNEVLLIAKLQHRNLVKLLGC 592 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~~~ 592 (837)
.++|.+.++||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++.+++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467889999999999999999876 588999999865421 345678999999999999999999999
Q ss_pred cccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC---Ce
Q 003237 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM---NP 669 (837)
Q Consensus 593 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ 669 (837)
+.+....++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999988654 34899999999999999999999988 99999999999998775 69
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE 749 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 749 (837)
||+|||+++....... .....||+.|+|||++. +.++.++||||+||++|||++|+.||..... ..+...+
T Consensus 189 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i-- 259 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDIIKKV-- 259 (504)
T ss_dssp EECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH--
T ss_pred EEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH--
Confidence 9999999987654322 23367999999999876 5699999999999999999999999864221 1111111
Q ss_pred HhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 750 LWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 750 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. +... .+...... ....+.+++.+|++.||.+|||++|+++
T Consensus 260 -~~-~~~~--~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 -EK-GKYY--FDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -HH-CCCC--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -Hc-CCCC--CCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11 1100 00000011 1245778999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=336.88 Aligned_cols=261 Identities=20% Similarity=0.263 Sum_probs=194.3
Q ss_pred HhhcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccC-------
Q 003237 525 AATDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------- 596 (837)
Q Consensus 525 ~at~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------- 596 (837)
...++|.+.++||+|+||.||+|+. .+|+.||||++...... ..+|+++++.++|||||++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 3467899999999999999999986 47899999998654322 24799999999999999999998543
Q ss_pred -------------------------------CccEEEEEecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHH
Q 003237 597 -------------------------------DENMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLH 644 (837)
Q Consensus 597 -------------------------------~~~~lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH 644 (837)
...++||||++ ++|.+.+... .....+++..+..++.||++||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 23689999999 5887777542 23456899999999999999999999
Q ss_pred hcCCCceeeCCCCCCcEEEc-CCCCeeecccccceeccCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHH
Q 003237 645 QDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVIL 722 (837)
Q Consensus 645 ~~~~~~ivH~Dlkp~NIll~-~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl 722 (837)
+.+ |+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 987 99999999999998 688999999999987654332 2235689999999998875 489999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc----------cccccc-----cccccCHHHHHHHHHHHHHcccCC
Q 003237 723 LEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL----------EIVDSS-----MANSCLASEALRCIQVGLLCVQDR 787 (837)
Q Consensus 723 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----------~~~d~~-----l~~~~~~~~~~~l~~l~~~Cl~~~ 787 (837)
|||++|+.||..... ...+.... ......... +..-+. .....+......+.+++.+|++.|
T Consensus 233 ~ell~g~~pf~~~~~--~~~~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETS--IDQLVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSH--HHHHHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCCh--HHHHHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999864321 11122211 111111100 000000 001111222345789999999999
Q ss_pred CCCCCCHHHHHH
Q 003237 788 TTDRPSMSTVVF 799 (837)
Q Consensus 788 P~~RPtm~eVv~ 799 (837)
|++|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=331.51 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=201.0
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-----------CCCeeeeeccccc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-----------HRNLVKLLGCCLE 595 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~ 595 (837)
++|.+.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++.+++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788889999999999999987 47899999999643 334567889999999887 8999999999876
Q ss_pred CC----ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEEc------
Q 003237 596 ED----ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLD------ 664 (837)
Q Consensus 596 ~~----~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NIll~------ 664 (837)
.. ..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 54 678999999 899999986543 23488999999999999999999997 7 99999999999994
Q ss_pred CCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcc---
Q 003237 665 EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS--- 741 (837)
Q Consensus 665 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~--- 741 (837)
..+.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4457999999999876532 22357899999999999999999999999999999999999999754322111
Q ss_pred hHHHHHHHHhccC------------------ccccccc--------ccc--ccccCHHHHHHHHHHHHHcccCCCCCCCC
Q 003237 742 NLIKYAWELWSDN------------------KALEIVD--------SSM--ANSCLASEALRCIQVGLLCVQDRTTDRPS 793 (837)
Q Consensus 742 ~l~~~~~~~~~~~------------------~~~~~~d--------~~l--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt 793 (837)
............. .....+. ..+ ....+......+.+++.+|++.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 1111111111100 0000000 000 11234566778899999999999999999
Q ss_pred HHHHHH--HhccC
Q 003237 794 MSTVVF--MLSNE 804 (837)
Q Consensus 794 m~eVv~--~L~~~ 804 (837)
++||++ .+.+.
T Consensus 328 ~~ell~hp~f~~~ 340 (373)
T 1q8y_A 328 AGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHTCGGGTTC
T ss_pred HHHHhhChhhhcc
Confidence 999997 55554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=332.54 Aligned_cols=257 Identities=23% Similarity=0.279 Sum_probs=189.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCC------c
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------E 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~ 598 (837)
++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57888999999999999999865 6899999999753 2234567889999999999999999999987654 6
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred eEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7999999985 6777764 23789999999999999999999988 9999999999999999999999999998
Q ss_pred eccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhc------
Q 003237 679 VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWS------ 752 (837)
Q Consensus 679 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~------ 752 (837)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............
T Consensus 176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCCCHHH
T ss_pred cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHH
Confidence 754322 12235789999999999999999999999999999999999999864321 111111100000
Q ss_pred -------------c-Cc-----ccccccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 753 -------------D-NK-----ALEIVDSSMAN---SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 753 -------------~-~~-----~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. .. ....+...... .........+.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 00 00000000000 011223467889999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=332.67 Aligned_cols=265 Identities=22% Similarity=0.319 Sum_probs=193.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccc------------
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL------------ 594 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~------------ 594 (837)
++|.+.+.||+|+||.||+|... +++.||||++........+++.+|++++.+++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57888899999999999999886 48999999997766666788999999999999999999998863
Q ss_pred --cCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-CCCCeee
Q 003237 595 --EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRI 671 (837)
Q Consensus 595 --~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki 671 (837)
+....++||||++ |+|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++ +++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3456789999998 699988843 34789999999999999999999988 99999999999997 5679999
Q ss_pred cccccceeccCccc-eeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 003237 672 SDFGTARVFGGEEI-LAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE 749 (837)
Q Consensus 672 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 749 (837)
+|||+++....... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .........
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~~~~ 239 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQLILE 239 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHH
Confidence 99999987643221 112233567899999998875 6789999999999999999999999864321 111111111
Q ss_pred Hhcc---Cccccc-------cccccc-c-----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhcc
Q 003237 750 LWSD---NKALEI-------VDSSMA-N-----SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSN 803 (837)
Q Consensus 750 ~~~~---~~~~~~-------~d~~l~-~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~ 803 (837)
.... ....++ +..... . .........+.+++.+|++.||++|||++|+++ .++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 1000 000000 000000 0 001112346789999999999999999999986 4543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=337.95 Aligned_cols=265 Identities=23% Similarity=0.348 Sum_probs=181.4
Q ss_pred CCCc-CCcccccCCeeEEEEEec---CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccc--cCCccEEE
Q 003237 529 NFST-SNKLGQGGFGPVYKGKLS---NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL--EEDENMLI 602 (837)
Q Consensus 529 ~~~~-~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~~lV 602 (837)
.|++ .++||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++.+++|||||++++++. .....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3554 568999999999999865 57899999996442 2357889999999999999999999995 46678999
Q ss_pred EEecCCCChhhHhhhcC------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE----cCCCCeeec
Q 003237 603 YEFMPNKSLDYFIFDES------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL----DEKMNPRIS 672 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~ki~ 672 (837)
|||+++ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999985 6777664221 1224889999999999999999999998 9999999999999 778999999
Q ss_pred ccccceeccCccc-eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCC------cchHH
Q 003237 673 DFGTARVFGGEEI-LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDD------SSNLI 744 (837)
Q Consensus 673 DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~------~~~l~ 744 (837)
|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+. .....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987653321 1223346789999999999874 58999999999999999999999996543211 01111
Q ss_pred HHHHHHhccCcc---ccc------------cccccccccCH---------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 745 KYAWELWSDNKA---LEI------------VDSSMANSCLA---------SEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 745 ~~~~~~~~~~~~---~~~------------~d~~l~~~~~~---------~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
............ ..+ +.......... .....+.+++.+|++.||++|||++|+++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111111100 000 00000000000 01235678999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=329.05 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=194.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--------ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--------GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 597 (837)
.++|.+.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++.+++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467889999999999999999875 58899999986432 122345789999999999999999999986554
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC---eeeccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN---PRISDF 674 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~ki~DF 674 (837)
.++||||+++++|.+++.. ...+++.....++.||++||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999998854 345889999999999999999999988 999999999999987654 999999
Q ss_pred ccceeccCccceeeeccccccCCccCccccc---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 003237 675 GTARVFGGEEILAITKRVVGTYGYMSPEYAL---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELW 751 (837)
Q Consensus 675 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 751 (837)
|+++....... .....||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+......
T Consensus 162 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~-- 234 (322)
T 2ycf_A 162 GHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS-- 234 (322)
T ss_dssp TTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHH--
T ss_pred ccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHh--
Confidence 99987654321 22356899999999974 5678999999999999999999999986433221 12211111
Q ss_pred ccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 752 SDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 752 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+... ..+..... ....+.+++.+|++.||++|||+.++++
T Consensus 235 --~~~~--~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 --GKYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --TCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --Cccc--cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1100 00111111 1245778999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=342.37 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=191.0
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccC------CccEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------DENML 601 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l 601 (837)
+|++.+.||+|+||.||+|+.. +|+.||||++..... .+.+|++++++++|||||++++++... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5777899999999999999885 689999999865432 234799999999999999999988542 12569
Q ss_pred EEEecCCCChhhHhhh-cCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC-CCeeeccccccee
Q 003237 602 IYEFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARV 679 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~DFGla~~ 679 (837)
||||+++ +|...+.. ......+++..+..++.||++||.|||+.+ |+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 55555432 223456899999999999999999999987 9999999999999965 5689999999987
Q ss_pred ccCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC----
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN---- 754 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---- 754 (837)
...... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+..... .....
T Consensus 207 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~-~lg~p~~~~ 280 (420)
T 1j1b_A 207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIK-VLGTPTREQ 280 (420)
T ss_dssp CCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH-HHCSCCHHH
T ss_pred cccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH-HhCCCCHHH
Confidence 654322 1235789999999999765 799999999999999999999999864221 122222221 11111
Q ss_pred ------cccccccccccc-----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 755 ------KALEIVDSSMAN-----SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 755 ------~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...+...+.+.. .+.......+.+++.+|++.||++|||+.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 001111111110 011122356789999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=338.47 Aligned_cols=257 Identities=25% Similarity=0.333 Sum_probs=181.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccC------C
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------D 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 597 (837)
.++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++..++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367889999999999999999864 6899999999653 223456788999999999999999999998654 4
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999999 6899888753 35899999999999999999999988 999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 756 (837)
+..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||..... ................
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence 875432 223578999999999987 6899999999999999999999999864321 1112222221111100
Q ss_pred -----------cccccccc-ccccC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 757 -----------LEIVDSSM-ANSCL-----ASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 757 -----------~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...+.... ..... ......+.+++.+|++.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000 00000 011245778999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=322.13 Aligned_cols=251 Identities=23% Similarity=0.296 Sum_probs=200.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---------cCHHHHHHHHHHHHHhc-CCCeeeeeccccc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---------QGIEELKNEVLLIAKLQ-HRNLVKLLGCCLE 595 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~ 595 (837)
.++|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 367888999999999999999875 689999999965431 12456788999999996 9999999999999
Q ss_pred CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccc
Q 003237 596 EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (837)
Q Consensus 596 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFG 675 (837)
....++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999653 34889999999999999999999988 9999999999999999999999999
Q ss_pred cceeccCccceeeeccccccCCccCccccc------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYAL------DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE 749 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 749 (837)
++........ .....+++.|+|||++. ...++.++||||||++++||++|+.|+..... .... ..
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~---~~ 240 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLML---RM 240 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HH
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHH---HH
Confidence 9987654322 23357899999999985 45789999999999999999999999853211 1111 11
Q ss_pred HhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 750 LWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 750 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... +... ...+ ........+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~-~~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMS-GNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH-TCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Hhc-CCcc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111 1100 0000 01112345789999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=349.76 Aligned_cols=250 Identities=28% Similarity=0.365 Sum_probs=201.5
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
.++|.+.++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++.+++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888899999999999999876 78999999986542 34577899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE---cCCCCeeeccccccee
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARV 679 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~DFGla~~ 679 (837)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999988643 34889999999999999999999998 9999999999999 5678999999999987
Q ss_pred ccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
...... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..+.. ...........
T Consensus 179 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~---~i~~~~~~~~~ 248 (484)
T 3nyv_A 179 FEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILK---KVEKGKYTFEL 248 (484)
T ss_dssp BCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHCCCCCCS
T ss_pred cccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHcCCCCCCC
Confidence 654321 233579999999998865 799999999999999999999999864221 11111 11111100000
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+ ........+.+++.+|++.+|++|||+.|+++
T Consensus 249 --~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 --P-----QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp --G-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 00112245778999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.31 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=193.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCcc----
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDEN---- 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---- 599 (837)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++..++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888899999999999999865 68999999997542 23356788999999999999999999999877655
Q ss_pred --EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 600 --MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 600 --~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
++||||+. ++|...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 57877762 23899999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc-
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK- 755 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~- 755 (837)
+..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||..... ...............
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGT 263 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCH
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCcH
Confidence 865432 233578999999999987 6899999999999999999999999864221 111111111111000
Q ss_pred -ccccc------------cccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 756 -ALEIV------------DSSMAN---SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 756 -~~~~~------------d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....+ ...... .........+.+++.+|++.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000 000000 001112356789999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=360.55 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=200.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEec----CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
.++|.+.+.||+|+||.||+|++. .+..||||++.... ....+.+.+|+.++.+++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 467888899999999999999874 25679999986543 334567899999999999999999999985 456899
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+++|+|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 468 v~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 99999999999999643 235889999999999999999999988 9999999999999999999999999998765
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ....... .. +...
T Consensus 543 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i---~~-~~~~--- 611 (656)
T 2j0j_A 543 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRI---EN-GERL--- 611 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH---HH-TCCC---
T ss_pred CCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHH---Hc-CCCC---
Confidence 43322 1223456789999999999999999999999999999997 9999853221 1111111 11 1111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+ +......+.+++.+|++.||++|||+.+|++.|+.+
T Consensus 612 --~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 --PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp --CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 01 111224577899999999999999999999999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=332.65 Aligned_cols=267 Identities=22% Similarity=0.293 Sum_probs=199.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccC-----Ccc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-----DEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 599 (837)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++.+++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999876 68999999996432 23456778999999999999999999987654 567
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++||||+. ++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999998 589888854 34899999999999999999999988 99999999999999999999999999987
Q ss_pred ccCcccee--------eeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 680 FGGEEILA--------ITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 680 ~~~~~~~~--------~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
........ ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||..... ..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY---RHQLLLIFGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHH
Confidence 65332111 1123578999999998765 6799999999999999999999999864321 1111111111
Q ss_pred hccCccc------------cccccc--c----ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 003237 751 WSDNKAL------------EIVDSS--M----ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNE 804 (837)
Q Consensus 751 ~~~~~~~------------~~~d~~--l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~ 804 (837)
....... +.+... . ...........+.+++.+|++.||++|||++|+++ .++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 1111000 000000 0 00000112345779999999999999999999987 45543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=329.22 Aligned_cols=199 Identities=25% Similarity=0.358 Sum_probs=169.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CC-----CeeeeecccccCCcc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HR-----NLVKLLGCCLEEDEN 599 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~~~~~~~~~~ 599 (837)
.++|.+.++||+|+||+||+|+.. +++.||||+++.. .....++..|++++..++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 468889999999999999999875 6889999999643 334567788999999886 55 499999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc--CCCCeeecccccc
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--EKMNPRISDFGTA 677 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~ki~DFGla 677 (837)
++||||++ ++|.+++..... ..+++..+..++.||+.||.|||.+. .+|+||||||+|||++ .++.+||+|||++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999996 499998865432 34899999999999999999999531 2499999999999994 5788999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRI 734 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 734 (837)
+..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 876532 2236789999999999999999999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=326.62 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=176.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHH-HHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVL-LIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|.+.+.||+|+||.||+|... +|+.||||++.... .....++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888899999999999999885 68999999997643 233445556666 6667799999999999999999999999
Q ss_pred ecCCCChhhHhhh--cCCCCCCChhhHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 605 FMPNKSLDYFIFD--ESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 605 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
|+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9986 77777653 12245689999999999999999999998 7 9999999999999999999999999998764
Q ss_pred CccceeeeccccccCCccCcccc----cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYA----LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~----~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
.... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.|+....... ... . ...
T Consensus 178 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~----~--~~~ 243 (327)
T 3aln_A 178 DSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQL----T--QVV 243 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--CCC
T ss_pred cccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHH----H--HHh
Confidence 3321 2234689999999998 46678999999999999999999999986432110 000 0 000
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....+.+...........+.+++.+|++.||++|||+.+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000111111111122345789999999999999999999965
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=321.28 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=190.8
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeeccccc----------
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE---------- 595 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~---------- 595 (837)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++.+++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457888999999999999999875 7899999999543 3445778899999999999999999998765
Q ss_pred ---CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeec
Q 003237 596 ---EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (837)
Q Consensus 596 ---~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 672 (837)
....++||||+++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 345789999999999999997532 34678889999999999999999998 9999999999999999999999
Q ss_pred ccccceeccCccc------------eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCC
Q 003237 673 DFGTARVFGGEEI------------LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDD 739 (837)
Q Consensus 673 DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~ 739 (837)
|||++........ ........|+..|+|||.+.+. .++.++||||||+++|||++ |+...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---- 231 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---- 231 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence 9999987643210 1112335689999999999864 78999999999999999998 43211
Q ss_pred cchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 740 SSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 740 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
............ . ...+...........+.+++.+|++.||++|||+.++++
T Consensus 232 -~~~~~~~~~~~~-~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 -MERVNILKKLRS-V------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHHHHHHHS-T------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhHHHHHHhccc-c------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 011111111111 0 111112222333445778999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=329.02 Aligned_cols=255 Identities=21% Similarity=0.319 Sum_probs=193.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc------
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE------ 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------ 598 (837)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++.+++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888899999999999999875 68999999996542 2335678899999999999999999999987654
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.++||||++ ++|.+++. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999998 58877763 23889999999999999999999988 9999999999999999999999999998
Q ss_pred eccCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc--
Q 003237 679 VFGGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK-- 755 (837)
Q Consensus 679 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-- 755 (837)
..... .....+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||..... ...............
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGTE 246 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCBCCHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHH
Confidence 65432 223578999999999887 6789999999999999999999999864321 111111111111000
Q ss_pred cc---------cc---cccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 756 AL---------EI---VDSSMA---NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 756 ~~---------~~---~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. .. +..... ..........+.+++.+|++.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00 000000 0111223456789999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.94 Aligned_cols=258 Identities=19% Similarity=0.278 Sum_probs=197.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CC-cEEEEEEecCCCccCHHHHHHHHHHHHHhcCCC------eeeeecccccCCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NG-QEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN------LVKLLGCCLEEDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~~ 599 (837)
++|.+.+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|++++.+++|++ ++.+++++......
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 57888999999999999999875 34 78999999643 344567889999999998766 89999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEE----------------
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---------------- 663 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---------------- 663 (837)
++||||+ +++|.+++.... ...+++..+..++.||++||.|||+.+ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 9999999 566666665432 235899999999999999999999987 9999999999999
Q ss_pred ---cCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 003237 664 ---DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDS 740 (837)
Q Consensus 664 ---~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~ 740 (837)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--- 244 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN--- 244 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---
Confidence 67889999999999875432 2235789999999999999999999999999999999999999964322
Q ss_pred chHHHHHHHHhccC--------ccccc-cccc---------------------cccccCHHHHHHHHHHHHHcccCCCCC
Q 003237 741 SNLIKYAWELWSDN--------KALEI-VDSS---------------------MANSCLASEALRCIQVGLLCVQDRTTD 790 (837)
Q Consensus 741 ~~l~~~~~~~~~~~--------~~~~~-~d~~---------------------l~~~~~~~~~~~l~~l~~~Cl~~~P~~ 790 (837)
.............. ..... .... ........+...+.+++.+|++.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 11111111111100 00000 0000 000112234557889999999999999
Q ss_pred CCCHHHHHH
Q 003237 791 RPSMSTVVF 799 (837)
Q Consensus 791 RPtm~eVv~ 799 (837)
|||+.||++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.86 Aligned_cols=261 Identities=21% Similarity=0.227 Sum_probs=175.1
Q ss_pred hcCCCcCC-cccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeeccccc----CCccE
Q 003237 527 TDNFSTSN-KLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENM 600 (837)
Q Consensus 527 t~~~~~~~-~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 600 (837)
.++|.+.+ .||+|+||.||+|+.. +++.||||++... .....+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 45777744 6999999999999876 6899999999643 1222233344566789999999999876 34578
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC---CCCeeecccccc
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTA 677 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~DFGla 677 (837)
+||||+++|+|.+++.... ...+++..+..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999997543 245899999999999999999999998 999999999999986 456999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
+...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.|+........... ........
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~--- 248 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLG--- 248 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhcc---
Confidence 8754322 2235789999999999999999999999999999999999999864332211000 00000000
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCCCCC
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETFVP 808 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~~~~ 808 (837)
. ..............+.+++.+|++.||++|||++|+++ .+.+....+
T Consensus 249 ~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 298 (336)
T 3fhr_A 249 Q---YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred c---cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence 0 00000001112345778999999999999999999997 555543333
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=335.41 Aligned_cols=252 Identities=22% Similarity=0.258 Sum_probs=185.9
Q ss_pred CCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEecC
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++.++...++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34446789999999998776668999999998643 345678999999987 89999999999999999999999996
Q ss_pred CCChhhHhhhcCCCC----CCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC-------------CCee
Q 003237 608 NKSLDYFIFDESRKQ----LLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK-------------MNPR 670 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-------------~~~k 670 (837)
|+|.+++....... ...+..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996543211 1234456789999999999999988 9999999999999754 4899
Q ss_pred ecccccceeccCccce--eeeccccccCCccCcccccC-------CCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 003237 671 ISDFGTARVFGGEEIL--AITKRVVGTYGYMSPEYALD-------GVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDS 740 (837)
Q Consensus 671 i~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~-------~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~ 740 (837)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.|+.....
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--- 245 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS--- 245 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT---
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh---
Confidence 9999999987644321 11234579999999999976 678999999999999999999 9999853221
Q ss_pred chHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 741 SNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 741 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
........... . +.+...........+.+++.+|++.||++|||+.||++
T Consensus 246 -~~~~i~~~~~~---~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 -RESNIIRGIFS---L-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HHHHHHHTCCC---C-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hHHHHhcCCCC---c-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111110000 0 01111123344567889999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.86 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=199.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
.++|.+.++||+|+||.||+|+.. +++.||||++... .....+.+.+|++++.+++||||+++++++.+....++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 467899999999999999999876 6899999998654 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCC---CCeeecccccceec
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK---MNPRISDFGTARVF 680 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~ki~DFGla~~~ 680 (837)
||+++++|.+++.... .+++..+..++.||++||.|||+.+ |+|+||||+||+++.+ +.+||+|||++...
T Consensus 101 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999998886543 4889999999999999999999987 9999999999999754 47999999999865
Q ss_pred cCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
..... .....+++.|+|||.+.+ .++.++||||||++++||++|+.|+.... ...+.. .... +....
T Consensus 175 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~---~~~~-~~~~~-- 241 (287)
T 2wei_A 175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILK---RVET-GKYAF-- 241 (287)
T ss_dssp CCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHH-CCCCC--
T ss_pred cCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHH---HHHc-CCCCC--
Confidence 43321 122458899999998865 58999999999999999999999985322 111111 1111 11100
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+...... ....+.+++.+|++.+|++|||+.|+++
T Consensus 242 ~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DLPQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CSGGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cchhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000011 1235778999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.93 Aligned_cols=241 Identities=22% Similarity=0.380 Sum_probs=189.9
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc------CHHHHHHHHHHHHHh----cCCCeeeeecccc
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ------GIEELKNEVLLIAKL----QHRNLVKLLGCCL 594 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~~~~~ 594 (837)
..++|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.++ +|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3467999999999999999999874 6889999999654321 223456799999999 8999999999999
Q ss_pred cCCccEEEEEe-cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-CCCCeeec
Q 003237 595 EEDENMLIYEF-MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRIS 672 (837)
Q Consensus 595 ~~~~~~lV~ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~ 672 (837)
..+..++|+|| +.+++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||+++ .++.+||+
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEE
Confidence 99999999999 7999999999653 24899999999999999999999998 99999999999999 88999999
Q ss_pred ccccceeccCccceeeeccccccCCccCcccccCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 003237 673 DFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFS-TKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELW 751 (837)
Q Consensus 673 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 751 (837)
|||+++....... ....|+..|+|||++.+..+. .++||||||+++|||++|+.|+.... . ..
T Consensus 183 dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~----~~ 246 (312)
T 2iwi_A 183 DFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E----IL 246 (312)
T ss_dssp CCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----HH
T ss_pred EcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H----Hh
Confidence 9999987654322 235689999999999877664 58999999999999999999985210 0 00
Q ss_pred ccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 752 SDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 752 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... ..+.. .....+.+++.+|++.+|++|||++||++
T Consensus 247 ~~~-------~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 EAE-------LHFPA----HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HTC-------CCCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhc-------cCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00111 12235778999999999999999999997
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.76 Aligned_cols=240 Identities=23% Similarity=0.375 Sum_probs=196.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc------CHHHHHHHHHHHHHhc--CCCeeeeecccccCC
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ------GIEELKNEVLLIAKLQ--HRNLVKLLGCCLEED 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~ 597 (837)
.++|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++.+++ |+||+++++++..++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 467888999999999999999764 6899999998654221 2245678999999996 599999999999999
Q ss_pred ccEEEEEecCC-CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-CCCCeeecccc
Q 003237 598 ENMLIYEFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFG 675 (837)
Q Consensus 598 ~~~lV~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~DFG 675 (837)
..++|+||+.+ ++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++ +++.+||+|||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999986 8999998653 34889999999999999999999988 99999999999999 78999999999
Q ss_pred cceeccCccceeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC
Q 003237 676 TARVFGGEEILAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN 754 (837)
Q Consensus 676 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 754 (837)
+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+.... . .....
T Consensus 196 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~----~~~~~ 259 (320)
T 3a99_A 196 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E----IIRGQ 259 (320)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----HHHCC
T ss_pred ccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h----hhccc
Confidence 998765432 223568999999999987766 688999999999999999999985310 0 00000
Q ss_pred ccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 755 KALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 755 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. ...... ...+.+++.+|++.||++|||++||++
T Consensus 260 -~------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 -V------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -C------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -c------cccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011112 235778999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=331.10 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=185.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
..+|...++||+|+||+|+.....+++.||||++..... ..+.+|++++.++ +|||||++++++.+....+|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 345777889999999997665556799999999965432 2356899999999 799999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC-----CCCeeecccccceec
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-----KMNPRISDFGTARVF 680 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~ki~DFGla~~~ 680 (837)
++ |+|.+++..... .+.......++.||++||.|||+.+ |+||||||+|||++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 97 599999865432 2445567789999999999999988 999999999999953 346789999999876
Q ss_pred cCccc-eeeeccccccCCccCccccc---CCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 681 GGEEI-LAITKRVVGTYGYMSPEYAL---DGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 681 ~~~~~-~~~~~~~~gt~~y~APE~~~---~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
..... ........||+.|+|||++. ...++.++|||||||+++||++ |+.|+..... ..........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~- 245 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------RQANILLGAC- 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------HHHHHHTTCC-
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------HHHHHHhccC-
Confidence 54321 12233467999999999998 4567889999999999999999 8989853211 1111111111
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...... ........+.+++.+|++.||++|||++||++
T Consensus 246 ~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111111 11223445678999999999999999999983
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=344.39 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=197.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeeccccc------CCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE------EDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~~ 599 (837)
++|.+.++||+|+||.||+|... +|+.||||++... .....+.+.+|++++.+++||||+++++++.. +...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999874 6899999998654 33445678999999999999999999998765 6677
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCC---eeeccccc
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMN---PRISDFGT 676 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~ki~DFGl 676 (837)
++||||+++|+|.+++........+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999977555556899999999999999999999988 999999999999997665 89999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 756 (837)
+........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ....|..........
T Consensus 171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC-----
T ss_pred ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccch
Confidence 987654332 234678999999999999999999999999999999999999985321 111110000000000
Q ss_pred ----cccc------cc--ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 003237 757 ----LEIV------DS--SMANSCLASEALRCIQVGLLCVQDRTTDRPSMST 796 (837)
Q Consensus 757 ----~~~~------d~--~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~e 796 (837)
.+.. .. .............+.+++..|++.||++|||+.|
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000 00 0111233345567889999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.84 Aligned_cols=250 Identities=20% Similarity=0.350 Sum_probs=175.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc-C-HHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ-G-IEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|++.+.||+|+||.||+|+.. +|+.||||++...... . .+.+.++..++..++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 56788899999999999999885 6899999999754322 2 2334455567788899999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
|+ ++.+..+.... ...+++..+..++.||++||.|||+. + |+|+||||+|||++.++.+||+|||++......
T Consensus 105 ~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 44454444322 24588999999999999999999985 7 999999999999999999999999999765433
Q ss_pred cceeeeccccccCCccCccccc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 684 EILAITKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
.. .....+++.|+|||++. ...++.++||||||+++|||++|+.|+..... . ............
T Consensus 179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~---~~~~~~~~~~~~--- 247 (318)
T 2dyl_A 179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--D---FEVLTKVLQEEP--- 247 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--H---HHHHHHHHHSCC---
T ss_pred cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--c---HHHHHHHhccCC---
Confidence 21 22356899999999994 56789999999999999999999999863221 1 111111111110
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+.+... ......+.+++.+|++.||.+|||++||++
T Consensus 248 ---~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ---PLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ---CCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 001000 011235778999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=344.54 Aligned_cols=237 Identities=18% Similarity=0.277 Sum_probs=190.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec--CCcEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCc-----c
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS--NGQEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE-----N 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-----~ 599 (837)
++|.+.++||+|+||.||+|... +++.||||++... .....+.+.+|++++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57888999999999999999875 6899999998654 23445678899999999999999999999987665 6
Q ss_pred EEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 600 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
+|||||+++++|.+++.. .+++..++.++.||++||.|||+++ |+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999887643 5899999999999999999999988 9999999999999986 899999999987
Q ss_pred ccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
.... ....||+.|+|||++.+.. +.++|||||||+++||++|..|+....... +
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~ 284 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------L 284 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------C
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------c
Confidence 6533 3367999999999987654 899999999999999999988764211100 0
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHhcc
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPS-MSTVVFMLSN 803 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-m~eVv~~L~~ 803 (837)
. ...........+.+++.+|++.||++||+ ++++...|.+
T Consensus 285 ~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 00011112245778999999999999995 6666665543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.71 Aligned_cols=228 Identities=11% Similarity=0.051 Sum_probs=180.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57888999999999999999876 489999999976532 23467899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++... ....+...++.||++||.|||+++ |+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999998432 245567889999999999999998 9999999999999999999997443
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
|++| ++.++|||||||++|||++|+.||......+... .....+...
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~~ 221 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAGQ 221 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTSC
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhccC
Confidence 3333 6889999999999999999999997533221100 000000000
Q ss_pred c--ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 764 M--ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 764 l--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
. ...........+.+++.+|++.||++| |+.|+++.|+...
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0 000111122457889999999999999 9999999998753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=321.24 Aligned_cols=241 Identities=17% Similarity=0.163 Sum_probs=178.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhcC-CCeeeeecc---------
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQH-RNLVKLLGC--------- 592 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H-~nIv~l~~~--------- 592 (837)
+..|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++..++| +|...+..+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345666789999999999999854 79999999987432 2346789999999999987 332221111
Q ss_pred ------------ccc-----CCccEEEEEecCCCChhhHhhh----cCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCce
Q 003237 593 ------------CLE-----EDENMLIYEFMPNKSLDYFIFD----ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 651 (837)
Q Consensus 593 ------------~~~-----~~~~~lV~ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 651 (837)
... ....+++|++ .+++|.+++.. ......+++..++.++.||++||.|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 111 1124566665 56899888842 122345788899999999999999999988 9
Q ss_pred eeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccc----------cCCCCCCcccHHHHHHH
Q 003237 652 IHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYA----------LDGVFSTKSDVFSFGVI 721 (837)
Q Consensus 652 vH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~s~k~DV~S~Gvv 721 (837)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999875432 233567 999999999 55678999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003237 722 LLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798 (837)
Q Consensus 722 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv 798 (837)
+|||++|+.||........ ...++... ...+ ..+.+++..|++.||++|||+.+++
T Consensus 307 l~elltg~~Pf~~~~~~~~---------------~~~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG---------------SEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC---------------SGGGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhh---------------HHHHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999864322111 11111100 1122 4578899999999999999977664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=299.98 Aligned_cols=235 Identities=20% Similarity=0.250 Sum_probs=179.4
Q ss_pred cCCCcC-CcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHH-HHhcCCCeeeeeccccc----CCccE
Q 003237 528 DNFSTS-NKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLI-AKLQHRNLVKLLGCCLE----EDENM 600 (837)
Q Consensus 528 ~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~~ 600 (837)
++|.+. +.||+|+||.||++... +++.||||++.. ...+.+|++++ ..++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 455555 67999999999999874 689999999954 24677899988 55589999999999876 66789
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC---CCCeeecccccc
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTA 677 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~DFGla 677 (837)
+||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999997643 235899999999999999999999988 999999999999998 789999999998
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
.... +..++.++|||||||++|||++|+.||........ ......
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~ 212 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKT 212 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHH
Confidence 6532 24567899999999999999999999854322110 000000
Q ss_pred cccccccccccC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCCCCC
Q 003237 758 EIVDSSMANSCL----ASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETFVP 808 (837)
Q Consensus 758 ~~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~~~~ 808 (837)
.+..... ..+ ......+.+++.+|++.||++|||++|+++ .+.+....+
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 213 RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp SSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred HHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 0000000 011 112345788999999999999999999997 455443333
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.34 Aligned_cols=241 Identities=15% Similarity=0.147 Sum_probs=182.7
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCC--------ccCHHHHHHHHHHHHHhc----------------
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--------GQGIEELKNEVLLIAKLQ---------------- 582 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------------- 582 (837)
.++|++.++||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688889999999999999988 68999999997542 234578999999999997
Q ss_pred ----------CCCeeeeeccccc-------------CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHH
Q 003237 583 ----------HRNLVKLLGCCLE-------------EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639 (837)
Q Consensus 583 ----------H~nIv~l~~~~~~-------------~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 639 (837)
||||+++++++.+ ....+|||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 5555666666654 6788999999999977666632 457899999999999999
Q ss_pred HHHHH-hcCCCceeeCCCCCCcEEEcCCC--------------------CeeecccccceeccCccceeeeccccccCCc
Q 003237 640 VLYLH-QDSRLRIIHRDLKASNILLDEKM--------------------NPRISDFGTARVFGGEEILAITKRVVGTYGY 698 (837)
Q Consensus 640 L~yLH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y 698 (837)
|.||| +.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 887 99999999999999887 8999999999876532 24789999
Q ss_pred cCcccccCCCCCCcccHHHHHHH-HHHHHhCCCCCCCCCCCCcchHHHHHH-HHhccCccccccccccccccCHHHHHHH
Q 003237 699 MSPEYALDGVFSTKSDVFSFGVI-LLEIITGKKNTRIFNDDDSSNLIKYAW-ELWSDNKALEIVDSSMANSCLASEALRC 776 (837)
Q Consensus 699 ~APE~~~~~~~s~k~DV~S~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~l 776 (837)
+|||++.+.. +.++||||++++ .+++++|..|+... ....... ....... ................+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~----~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMT----FKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCC----CSSCCCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhc----cCcccchhhhhhcCHHH
Confidence 9999998766 899999998777 77888999887310 0000011 1110000 00111111223455678
Q ss_pred HHHHHHcccCCCCCCCCHHHHH
Q 003237 777 IQVGLLCVQDRTTDRPSMSTVV 798 (837)
Q Consensus 777 ~~l~~~Cl~~~P~~RPtm~eVv 798 (837)
.+++.+|++.+ |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 89999999965 999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-28 Score=282.04 Aligned_cols=184 Identities=16% Similarity=0.150 Sum_probs=129.3
Q ss_pred cccccCCeeEEEEE-ecCCcEEEEEEecCCC----------ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEE
Q 003237 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTS----------GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 602 (837)
.++.|++|.+..++ .--|+.+|||.+.+.. ....++|.+|+++|+++ .|+||+++++++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45666777666553 2358899999986542 12346799999999999 699999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||++|++|.+.|.... .++.. +|+.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999996542 35543 58999999999999998 99999999999999999999999999987654
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCC
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKK 730 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~ 730 (837)
... .....+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 322 2334689999999998865 56778999999999988876543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-25 Score=257.21 Aligned_cols=184 Identities=18% Similarity=0.213 Sum_probs=147.4
Q ss_pred cCCcccccCCeeEEEEEecCCcEEEEEEecCCCcc--------CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 532 TSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ--------GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 532 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
..++||+|+||.||+|+. .++.+++|+....... ..+.+.+|++++.+++||||+++..++...+..+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999955 4788999986443211 1345789999999999999997777777888889999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++++|.+++.. +..++.||++||.|||+++ |+||||||+|||++. .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999854 4579999999999999988 999999999999999 9999999999987654
Q ss_pred ccee-----eeccccccCCccCcccccC--CCCCCcccHHHHHHHHHHHHhCCCCC
Q 003237 684 EILA-----ITKRVVGTYGYMSPEYALD--GVFSTKSDVFSFGVILLEIITGKKNT 732 (837)
Q Consensus 684 ~~~~-----~~~~~~gt~~y~APE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~ 732 (837)
.... ......||+.|||||++.. ..|+.++|+||..+-.++-+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3221 1235689999999999987 56888999999999999988887766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3e-22 Score=213.01 Aligned_cols=155 Identities=19% Similarity=0.166 Sum_probs=125.0
Q ss_pred ecHHHHHHhhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCc------------------cCHHHHHHHHHHHH
Q 003237 518 FELSTLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG------------------QGIEELKNEVLLIA 579 (837)
Q Consensus 518 ~~~~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~ 579 (837)
+.+..+......|.+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|++++.
T Consensus 80 ~~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~ 159 (282)
T 1zar_A 80 YSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 159 (282)
T ss_dssp HHHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHH
Confidence 344555666677778899999999999999987799999999964321 12456889999999
Q ss_pred HhcCCCeeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCC
Q 003237 580 KLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKAS 659 (837)
Q Consensus 580 ~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 659 (837)
+++ | +++.+++ +.+..++||||+++++|.+ +. ......++.||++||.|||+.+ |+||||||+
T Consensus 160 ~l~--~-~~v~~~~-~~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~ 222 (282)
T 1zar_A 160 KLQ--G-LAVPKVY-AWEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQY 222 (282)
T ss_dssp HTT--T-SSSCCEE-EEETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred hcc--C-CCcCeEE-eccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHH
Confidence 999 5 6666654 3466799999999999987 41 1234569999999999999988 999999999
Q ss_pred cEEEcCCCCeeecccccceeccCccceeeeccccccCCccCccccc
Q 003237 660 NILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705 (837)
Q Consensus 660 NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~ 705 (837)
|||++ ++.+||+|||+++. +..++|||++.
T Consensus 223 NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred HEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999 99999999999874 34578999875
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=5.6e-20 Score=167.43 Aligned_cols=108 Identities=19% Similarity=0.355 Sum_probs=92.1
Q ss_pred ccccccCCCCccCCCCeEE--eCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceE
Q 003237 21 TSIDTISLSQPIKDGDVIV--SSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLV 98 (837)
Q Consensus 21 ~~~~~~~~~~~l~~~~~l~--S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~ 98 (837)
++.|+|.+||+|.+|++|+ |++|.|+|+|+.+++ | +||++ .++||+|||+.| +.++.++|..|||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC---CEEEEeCCCccC--CCceEEEEccCCEEE
Confidence 4679999999999999999 999999999999887 3 58875 799999999977 345789999999999
Q ss_pred EEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeec
Q 003237 99 LHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (837)
Q Consensus 99 l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqS 146 (837)
|.| +.+.++|+|++.. +.+...++|+|+|||||++ .++|||
T Consensus 75 l~d--~~~~~lW~S~~~~-~~g~~~l~l~~~Gnlvl~~----~~~W~S 115 (119)
T 1b2p_A 75 VIT--NENVTVWQSPVAG-KAGHYVLVLQPDRNVVIYG----DALWAT 115 (119)
T ss_dssp EEC--TTCCEEEECSCCC-CSSCEEEEECTTSCEEEEE----SEEEEC
T ss_pred EEe--CCCcEEEcCCCCC-CCCCEEEEEECCCcEEEEC----ccEeCC
Confidence 995 4567899998643 3345679999999999985 389998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-19 Score=162.78 Aligned_cols=110 Identities=21% Similarity=0.365 Sum_probs=92.1
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEec
Q 003237 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHER 102 (837)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 102 (837)
+|+|.+||+|.+|++|+ ++|.|+|+|+..|+ | |+|+ ..++||.||++.|. .++.++|..||||||.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~- 67 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYD- 67 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEEC-
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC--CcEEEEEeCCCCEEEEC-
Confidence 48999999999999999 99999999998887 3 6786 36999999998773 45789999999999995
Q ss_pred CCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCc
Q 003237 103 NQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPT 151 (837)
Q Consensus 103 ~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~Pt 151 (837)
..+.++|+|++.. +.+...++|+|+|||||++ . .+||||+||.
T Consensus 68 -~~~~~~W~S~t~~-~~g~~~l~l~~dGnlvl~~-~---~~W~S~~~~~ 110 (110)
T 3a0c_A 68 -QSNRVIWQTKTNG-KEDHYVLVLQQDRNVVIYG-P---VVWATGSGPA 110 (110)
T ss_dssp -TTCCEEEECCCCC-SSSCCEEEECTTSCEEEEC-S---EEEECSCCC-
T ss_pred -CCCcEEEecCCCC-CCCCEEEEEeCCccEEEEC-C---CEecCCCcCC
Confidence 4567899998653 2345579999999999984 2 7999999983
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.5e-19 Score=159.29 Aligned_cols=104 Identities=17% Similarity=0.353 Sum_probs=88.1
Q ss_pred cccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEecC
Q 003237 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERN 103 (837)
Q Consensus 24 ~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~ 103 (837)
|+|.+||.|.+|++|+| |.|.|.|...+| |.++.. .++||+|||++|..+ .+.|+|+.||||||. +
T Consensus 2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~~----~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~--d 67 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYDH----STSTWASNTEIGGKS-GCSAVLQSDGNFVVY--D 67 (105)
T ss_dssp CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET----TEEEEECCCCCTTCC-SCEEEECTTSCEEEE--C
T ss_pred CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEEC----CEEEEEecCCCCCCc-cEEEEEeCCccEEEE--C
Confidence 78999999999999998 889999998888 788653 589999999999754 468999999999999 4
Q ss_pred CCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeec
Q 003237 104 QSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (837)
Q Consensus 104 ~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqS 146 (837)
+.+.+||+|+++. .....+|+|+|+|||||++ ..||||
T Consensus 68 ~~~~~vWss~t~~-~~~~~~l~L~ddGNlVly~----~~~W~S 105 (105)
T 4h3o_A 68 SSGRSLWASHSTR-GSGNYILILQDDGNVIIYG----SDIWST 105 (105)
T ss_dssp TTCCEEEECCCCC-CSSCEEEEECTTSCEEEEE----SEEEEC
T ss_pred CCcEEEEEecCCC-CCCCEEEEEeCCCeEEEEC----CcEecC
Confidence 5667899999653 3345679999999999984 469998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=7.6e-19 Score=159.41 Aligned_cols=110 Identities=18% Similarity=0.281 Sum_probs=90.7
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEec
Q 003237 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHER 102 (837)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 102 (837)
.|||.+||+|.+|++|+ +|.|+|+|+.+++ |- +|+ ..++||+||++.|. .++.|+|..+|||||.|
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d- 67 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYD- 67 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----EE-EEE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEEC-
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----EE-EEe---CCEEEEeCCCCCCC--CceEEEECCCCcEEEEC-
Confidence 58999999999999998 8999999998876 32 465 37999999999883 45789999999999995
Q ss_pred CCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCcc
Q 003237 103 NQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTD 152 (837)
Q Consensus 103 ~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtD 152 (837)
+.+.++|+|+... +.+...++|+|+|||||++ . ++||||.+++.
T Consensus 68 -~~~~~vW~S~~~~-~~g~~~l~l~~dGnlvl~~-~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 68 -HNNNDVWGSACWG-DNGKYALVLQKDGRFVIYG-P---VLWSLGPNGCR 111 (115)
T ss_dssp -TTCCEEEECCCCC-SSSCCEEEECTTSCEEEEC-S---EEECSSTTCBC
T ss_pred -CCceEEEEcCCCC-CCCCEEEEEeCCCeEEEEC-C---CEEECCCCCCc
Confidence 4457899998642 2345579999999999983 2 89999988754
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-18 Score=155.08 Aligned_cols=110 Identities=19% Similarity=0.417 Sum_probs=90.9
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEec
Q 003237 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHER 102 (837)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 102 (837)
+|||.+||+|.+|++| ++|.|+|+|+.+++ | +||++ .++||.||++.+ +.++.++|..+|||||.+
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence 4899999999999999 58999999999987 3 45765 689999999864 345789999999999996
Q ss_pred CCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCC
Q 003237 103 NQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHP 150 (837)
Q Consensus 103 ~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~P 150 (837)
.+.++|+|+... +.+...++|+++|||||++ ..+.++||||++.
T Consensus 67 --~~~~~W~S~~~~-~~g~~~l~l~~dGnlvl~~-~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 --GSRAIWASNTNR-QNGNYYLILQRDRNVVIYD-NSNNAIWATHTNV 110 (112)
T ss_dssp --TTEEEEECCCCC-SCCCCEEEECTTSCEEEEC-TTSCEEEECCCCC
T ss_pred --CCEEEEECCccC-CCCCEEEEEeCCCcEEEEC-CCCceEEECCCcc
Confidence 457899998543 2344579999999999984 4568999999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.8e-18 Score=179.01 Aligned_cols=139 Identities=17% Similarity=0.175 Sum_probs=107.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcE--EEEEEecCCCcc------------------------CHHHHHHHHHHHH
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQE--IAVKRLSTTSGQ------------------------GIEELKNEVLLIA 579 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~ 579 (837)
..-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++++.
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 33466778999999999999988 68889 999987543111 0135788999999
Q ss_pred HhcCCCe--eeeecccccCCccEEEEEecCC-C----ChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHH-hcCCCce
Q 003237 580 KLQHRNL--VKLLGCCLEEDENMLIYEFMPN-K----SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH-QDSRLRI 651 (837)
Q Consensus 580 ~l~H~nI--v~l~~~~~~~~~~~lV~ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~i 651 (837)
+++|+++ ..++.. ...+|||||+.+ | +|.+.... .++.....++.||+.||.||| +.+ |
T Consensus 126 ~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---i 192 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---L 192 (258)
T ss_dssp HHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---E
T ss_pred HHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 9998864 333332 467899999953 4 56555422 234567789999999999999 877 9
Q ss_pred eeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 652 IHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 652 vH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||||+|||++. .++|+|||++...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 9999999999764
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.6e-17 Score=147.72 Aligned_cols=103 Identities=22% Similarity=0.418 Sum_probs=85.0
Q ss_pred cccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEecC
Q 003237 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERN 103 (837)
Q Consensus 24 ~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~ 103 (837)
+||.+||.|.+|++|+ +|.|+|+|+..|+ |-+ |+. .++||.+|++.+ +.++.|+|..||||||.+
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~-- 66 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYS-- 66 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET---TEEEEECCCTTS--SSSCEEEECTTSCEEEEC--
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEEC--
Confidence 6899999999999997 7999999998887 444 654 589999999876 445789999999999995
Q ss_pred CCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeec
Q 003237 104 QSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (837)
Q Consensus 104 ~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqS 146 (837)
+.+.++|+|++... ....+|+|+|+|||||++ ..+|||
T Consensus 67 ~~~~~~W~S~t~~~-~~~~~~~L~ddGNlvly~----~~~W~s 104 (109)
T 3dzw_A 67 PRNNPIWASNTGGE-NGNYVCVLQKDRNVVIYG----TARWAT 104 (109)
T ss_dssp TTSCEEEECCCCCS-SSCEEEEECTTSCEEEEE----SCCCCC
T ss_pred CCCCEEEECCCCCC-CCCEEEEEeCCCEEEEEC----CCEEeC
Confidence 44578999986432 234679999999999984 389998
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.64 E-value=4e-16 Score=139.85 Aligned_cols=105 Identities=18% Similarity=0.291 Sum_probs=84.1
Q ss_pred ccccccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEE
Q 003237 21 TSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLH 100 (837)
Q Consensus 21 ~~~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~ 100 (837)
.+.|||.+||.|..|++|+| |.|.|-|...|+ |.+ |.. ++||.+|++.. +.++.|+|..||||||.
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 47899999999999999998 559997766665 666 654 48999999863 34578999999999999
Q ss_pred ecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeec
Q 003237 101 ERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (837)
Q Consensus 101 ~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqS 146 (837)
+ +.+.++|+|++.. ..+..+|+|+|+|||||++ ..+|+|
T Consensus 70 d--~~~~~iW~S~t~~-~~~~~~~~L~~dGNlvly~----~~~W~t 108 (110)
T 3r0e_B 70 D--DDFKTIWSSRSSS-KQGEYVLILQDDGFGVIYG----PAIFET 108 (110)
T ss_dssp C--TTCCEEEECCCCC-SSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred e--CCCCEEEEcCCcC-CCCCEEEEEcCCccEEEec----CCEecC
Confidence 5 4557899998643 2234689999999999984 489987
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=3.8e-16 Score=170.38 Aligned_cols=149 Identities=15% Similarity=0.161 Sum_probs=104.5
Q ss_pred HHHHHhhcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCc--------------cCHHHHHHHHHHHHHhcCCCe
Q 003237 521 STLLAATDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSG--------------QGIEELKNEVLLIAKLQHRNL 586 (837)
Q Consensus 521 ~~l~~at~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~nI 586 (837)
..+....--|++.++||+|+||.||+|...+|+.||||+++.... ........++++.....|+|+
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 344444445889999999999999999999999999998753210 011222233333333445555
Q ss_pred eeeeccccc------CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 003237 587 VKLLGCCLE------EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 660 (837)
Q Consensus 587 v~l~~~~~~------~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 660 (837)
++++..... ....+|||||++++.|.... .......++.||+.+|.|||+.+ ||||||||.|
T Consensus 168 ~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~N 235 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFN 235 (397)
T ss_dssp HHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred HHHHhcCCCCCeeeeccCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 554433221 12347999999998886543 12234568899999999999987 9999999999
Q ss_pred EEEcCCCC----------eeecccccceecc
Q 003237 661 ILLDEKMN----------PRISDFGTARVFG 681 (837)
Q Consensus 661 Ill~~~~~----------~ki~DFGla~~~~ 681 (837)
|||++++. +.|+||+-+....
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99988763 8899999876543
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.60 E-value=4.5e-15 Score=133.81 Aligned_cols=107 Identities=16% Similarity=0.267 Sum_probs=86.9
Q ss_pred cccccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEe
Q 003237 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHE 101 (837)
Q Consensus 22 ~~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~ 101 (837)
+.|+|.+||.|..|+.|.+ |.|.|-|...|+ |.++..+ ..++||.+|+..+ +..+.|.|..||||||.+
T Consensus 5 ~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~~--~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKGS--KTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEETT--TTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred cCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEECC--CCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 6799999999999999974 889999988777 7775321 3689999999876 345789999999999995
Q ss_pred cCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeec
Q 003237 102 RNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (837)
Q Consensus 102 ~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqS 146 (837)
+.+.++|+|++... .+..+|+|+|+|||||++ ..+|+|
T Consensus 74 --~~~~~iW~S~t~~~-~~~~~~~L~~dGnlvly~----~~~W~s 111 (113)
T 3mez_B 74 --DRLNTVFVSNTVGQ-EGDYVLILQINGQAVVYG----PAVWST 111 (113)
T ss_dssp --TTSCEEEECSCCCS-SSCCEEEECTTSCEEEEC----SEEEES
T ss_pred --CCCCEEEECCCcCC-CCCEEEEEcCCceEEEec----CCEecC
Confidence 44578999996432 234689999999999984 689997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.6e-15 Score=135.45 Aligned_cols=97 Identities=21% Similarity=0.433 Sum_probs=77.7
Q ss_pred CCCCCCCceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCc
Q 003237 80 NPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMR 159 (837)
Q Consensus 80 ~p~~~~~~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~ 159 (837)
.|+.+....|.|..||||+|.+. +.+||++|.... ..+..|+|+|+|||||++ .+.++||||+
T Consensus 14 ~~L~~~~~~L~~~~dgnlvl~~~---~~~vW~sn~~~~-~~~~~l~l~~~GNLvl~d--~~~~~W~S~~----------- 76 (112)
T 1xd5_A 14 GSLAEGGYLFIIQNDCNLVLYDN---NRAVWASGTNGK-ASGCVLKMQNDGNLVIYS--GSRAIWASNT----------- 76 (112)
T ss_dssp CEEEETTEEEEECTTSCEEEEET---TEEEEECCCTTS-CSSEEEEECTTSCEEEEE--TTEEEEECCC-----------
T ss_pred CEEeCCCEEEEEcCCCcEEEEEC---CEEEEeCCCcCC-CCCEEEEEeCCCCEEEEc--CCEEEEECCc-----------
Confidence 34445567899999999999853 578999996532 234689999999999995 6689999993
Q ss_pred ccccccCCCcceeeecCCCCCCCCcceEEEecCCCCCcceeec-CCeeEEecCCCCC
Q 003237 160 FGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYK-DDVKLWRAGPWTG 215 (837)
Q Consensus 160 l~~~~~tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~-~~~~yw~sg~w~g 215 (837)
+|++|.|++.++++|. +++|. ...+||++++|+|
T Consensus 77 --------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 --------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp --------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred --------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999998 66775 4679999999986
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.2e-14 Score=130.31 Aligned_cols=90 Identities=23% Similarity=0.412 Sum_probs=72.7
Q ss_pred CCCceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCccccc
Q 003237 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWD 163 (837)
Q Consensus 84 ~~~~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~ 163 (837)
+....|.|..||||+|.+ .+.+||++|....+ ....++|+|+|||||++ .++.++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~---~~~~vW~sn~~~~~-~~~~l~l~~dGNLVl~~-~~~~~~W~S~---------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD---SGKPVWASNTGGLG-SGCRLTLHNNGNLVIYD-QSNRVIWQTK---------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE---TTEEEEECCCTTSC-SSCEEEECTTSCEEEEC-TTCCEEEECC----------------
T ss_pred CCCEEEEEcCCCcEEEEE---CCEEEEECCCCCCC-CcEEEEEeCCCCEEEEC-CCCcEEEecC----------------
Confidence 345689999999999995 25789999965332 34579999999999984 4678999999
Q ss_pred ccCCCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCCC
Q 003237 164 KRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPW 213 (837)
Q Consensus 164 ~~tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~w 213 (837)
+++++|.|++.++++|. +++|+. .||+++++
T Consensus 78 ---------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ---------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ---------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ---------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 34567999999999998 677775 89999874
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.7e-14 Score=128.99 Aligned_cols=108 Identities=19% Similarity=0.322 Sum_probs=85.9
Q ss_pred cccccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEe
Q 003237 22 SIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHE 101 (837)
Q Consensus 22 ~~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~ 101 (837)
+.|||.+||.|..|+.| .+|.|.|.|...+| |-+ |.. +|.+|+..+ +..+.|+|..||||||.|
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG------NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT------TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC------eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 67999999999999999 57999999988877 444 432 699998865 346789999999999995
Q ss_pred cCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccC
Q 003237 102 RNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPN 157 (837)
Q Consensus 102 ~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg 157 (837)
+.+.++|+|++.. .....+|+|+|+|||||++ ..+|+| .|.+||
T Consensus 66 --~~~~~vWss~t~~-~~~~~~~~L~~dGNlvly~----~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 --GDGSTVWKSGAQS-VKGNYAAVVHPDGRLVVFG----PSVFKI-----DPWVRG 109 (109)
T ss_dssp --TTSCEEEECCCCC-SSSCCEEEEETTTEEEEEC----SEEEEE-----CTTSCC
T ss_pred --CCCCEEEcCCCcC-CCcCEEEEEcCCCeEEEEe----cCEECC-----CCccCC
Confidence 4557899998643 2345579999999999983 689998 555554
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=125.64 Aligned_cols=86 Identities=24% Similarity=0.409 Sum_probs=70.0
Q ss_pred ceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCcccccccC
Q 003237 87 GVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRT 166 (837)
Q Consensus 87 ~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 166 (837)
..|.|..||||+|.+ + +.+||++|....+ ....++|+|+|||||++ .++.++||||
T Consensus 32 ~~L~~~~dgnlvly~--~-~~~vW~sn~~~~~-~~~~l~l~~dGNLVl~d-~~~~~lW~S~------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYD--N-NNPIWATNTGGLG-NGCRAVLQPDGVLVVIT-NENVTVWQSP------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEE--T-TEEEEECCCTTSC-SSCEEEECTTSCEEEEC-TTCCEEEECS-------------------
T ss_pred EEEEEecCCCEEEEE--C-CEEEEeCCCccCC-CceEEEEccCCEEEEEe-CCCcEEEcCC-------------------
Confidence 468888999999985 3 5789999965332 34579999999999984 5678999999
Q ss_pred CCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCC
Q 003237 167 GLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (837)
Q Consensus 167 g~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~ 212 (837)
+||++|.|++.++++|. +++|. .+||++|+
T Consensus 88 ------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 ------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp ------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred ------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 35678999999999998 67776 38999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.6e-13 Score=124.30 Aligned_cols=91 Identities=24% Similarity=0.445 Sum_probs=73.4
Q ss_pred CceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCccccccc
Q 003237 86 SGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKR 165 (837)
Q Consensus 86 ~~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~ 165 (837)
...|.|..||||+|.+ .+.++|++|..... .+..++|+|+|||||++ .++.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~---~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl~d-~~~~~vW~S~~~---------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ---NGRQIWASNTDRRG-SGCRLTLLSDGNLVIYD-HNNNDVWGSACW---------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE---TTEEEEECSCTTSC-SSCEEEECTTSCEEEEC-TTCCEEEECCCC----------------
T ss_pred CEEEEEcCCCcEEEEe---CCEEEEeCCCCCCC-CceEEEECCCCcEEEEC-CCceEEEEcCCC----------------
Confidence 4578888999999985 35789999965332 34579999999999984 467899999997
Q ss_pred CCCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCCCCCc
Q 003237 166 TGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQ 216 (837)
Q Consensus 166 tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~w~g~ 216 (837)
+++|.|++.++++|. +++|+. .||++++|...
T Consensus 80 ---------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ---------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ---------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ---------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 356789999999998 677765 89999999654
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.44 E-value=3.4e-13 Score=120.95 Aligned_cols=105 Identities=21% Similarity=0.316 Sum_probs=82.5
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEec
Q 003237 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHER 102 (837)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 102 (837)
.|+|.+||.|.+|+.| .+|.|.|-|...|+ |.+ |.. .. ||.+|+..+ +....|.|..||||||.+.
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEeC
Confidence 5899999999999999 47999999988777 555 543 23 999999876 3357899999999999954
Q ss_pred CCCcceeeeccccc-CCCCceEEEEecCCCEEEEecCCCceeeec
Q 003237 103 NQSTVPVWQANISE-ASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (837)
Q Consensus 103 ~~~~~~~Wst~~~~-~~~~~~~a~lld~GNlVl~~~~~~~~lWqS 146 (837)
++ ..++|+|++.. ...+..+++|+|+|||||++ ..+|+|
T Consensus 68 ~~-~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~----~~~W~s 107 (111)
T 3mez_A 68 NS-NTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG----PAIWST 107 (111)
T ss_dssp SC-SSCSEEESSSCCCCSSCCEEEECTTSCEEEEC----SEEEEC
T ss_pred CC-CEEEEEeccccCCCCcCEEEEECCCCeEEEec----cCEEcc
Confidence 32 24699998532 23345689999999999984 689987
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=4.6e-11 Score=125.07 Aligned_cols=144 Identities=16% Similarity=0.080 Sum_probs=113.0
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.+.|.....++.|+.+.||+.... ++.+++|+...........+.+|++++..+. |..+.++++++......++||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 356777778888999999999864 6899999986432223346889999999995 67788899998888888999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc---------------------------------------
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD--------------------------------------- 646 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------- 646 (837)
++|.+|...+. +......++.+++++|..||+.
T Consensus 92 i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999876531 1223446889999999999981
Q ss_pred -----------------CCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 647 -----------------SRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 647 -----------------~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
.+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114489999999999998766667999998753
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.18 E-value=7.6e-11 Score=106.02 Aligned_cols=96 Identities=23% Similarity=0.387 Sum_probs=70.6
Q ss_pred CCCCCCCCceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCC
Q 003237 79 NNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNM 158 (837)
Q Consensus 79 ~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~ 158 (837)
+.|+.+...+|.+..||||||.+.+ .+.++|++++.... ....++|+|+|||||++ .++.++|||=.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~-~~~~vWssnt~~~~-~~~~l~l~~dGNLVl~d-~~~~~iW~S~t~--------- 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGS-KTNIVWESGTSGRG-QHCFMRLGHSGELDITD-DRLNTVFVSNTV--------- 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETT-TTEEEEECCCTTSC-SSCEEEECTTSCEEEEC-TTSCEEEECSCC---------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECC-CCEEEEECCcccCC-cCEEEEEeCCCcEEEEC-CCCCEEEECCCc---------
Confidence 4555556678999999999998532 46789999965322 34579999999999984 456899998210
Q ss_pred cccccccCCCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCC
Q 003237 159 RFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (837)
Q Consensus 159 ~l~~~~~tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~ 212 (837)
+ ..|.|.+.++.+|. +++|. .+.|.+|+
T Consensus 86 --------~--------------~~~~~~~~L~~dGn--lvly~--~~~W~s~~ 113 (113)
T 3mez_B 86 --------G--------------QEGDYVLILQINGQ--AVVYG--PAVWSTAA 113 (113)
T ss_dssp --------C--------------SSSCCEEEECTTSC--EEEEC--SEEEESCC
T ss_pred --------C--------------CCCCEEEEEcCCce--EEEec--CCEecCCC
Confidence 0 12458899999998 56665 57898875
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=9e-11 Score=122.85 Aligned_cols=113 Identities=16% Similarity=0.293 Sum_probs=84.7
Q ss_pred ccccccCCCCc----cCCCCeEEeCCCeEEEEEEcCC--CCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeec
Q 003237 21 TSIDTISLSQP----IKDGDVIVSSRKIYALGFFSPG--NSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQ 94 (837)
Q Consensus 21 ~~~~~~~~~~~----l~~~~~l~S~~g~F~lgFf~~~--~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~ 94 (837)
..+||+.||+. |..|++|+|+ ..++.|+|+.. ...+ +-+ |.+ ..+++|.+++.++ +. ..|.+..+
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGn--lvL-y~~--~~~~yW~Sgt~~~--~~-~~l~l~~d 204 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGN--LVA-YGP--NGAATWNAGTQGK--GA-VRAVFQGD 204 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSC--EEE-ECT--TSSEEEECCCTTT--TC-CEEEECTT
T ss_pred ccccccccccccccccccCcccccC-CCCCCceEEEeecCCce--EEE-EeC--CCeEEEECCCCCC--cc-EEEEEcCC
Confidence 46799999999 8899999664 56666666542 1222 334 332 2589999999877 22 68999999
Q ss_pred cceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccC
Q 003237 95 GNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDH 149 (837)
Q Consensus 95 G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~ 149 (837)
|+|++.+ +.+.++|+++... ....+|+|+++|||||+.. +++||||||
T Consensus 205 GnLvl~d--~~~~~vWsS~t~~--~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~ 252 (276)
T 3m7h_A 205 GNLVVYG--AGNAVLWHSHTGG--HASAVLRLQANGSIAILDE---KPVWARFGF 252 (276)
T ss_dssp SCEEEEC--TTSCEEEECSCTT--CTTCEEEECTTSCEEEEEE---EEEEESSSC
T ss_pred CeEEEEe--CCCcEEEEecCCC--CCCEEEEEcCCccEEEEcC---CCeEEccCc
Confidence 9999995 3447899998642 2346899999999999953 689999987
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.10 E-value=2.8e-10 Score=101.87 Aligned_cols=95 Identities=19% Similarity=0.291 Sum_probs=67.5
Q ss_pred CCCCCCCceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCc
Q 003237 80 NPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMR 159 (837)
Q Consensus 80 ~p~~~~~~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~ 159 (837)
.++.+....|.+..||||||.+. .+ +|++++.... ....++|+|+|||||++.+...++|||.-+
T Consensus 15 ~~L~~g~~~L~~q~dGnLvl~~~--~~--vW~snt~~~~-~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~---------- 79 (111)
T 3mez_A 15 NQLSYESAAFVMQGDCNLVLYNE--AG--GFQSNTHGRG-VDCTLRLNNRGQLEIHSANSNTPVWVYPRS---------- 79 (111)
T ss_dssp CEEEETTEEEEECTTSCEEEECS--SC--CEECCCTTSC-SSCEEEECTTSCEEEECSSCSSCSEEESSS----------
T ss_pred CEEecCCEEEEEccCCeEEEECC--CC--EEECCcccCC-cCEEEEEcCCCcEEEEeCCCCEEEEEeccc----------
Confidence 33444556899999999999853 33 9999965332 235799999999999853333459999611
Q ss_pred ccccccCCCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCC
Q 003237 160 FGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (837)
Q Consensus 160 l~~~~~tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~ 212 (837)
.....|.|.+.++.+|. +++|. .++|.+++
T Consensus 80 -------------------~~~~~~~~~l~Lq~dGN--lvly~--~~~W~s~t 109 (111)
T 3mez_A 80 -------------------VNTVRGNYAATLGPDQH--VTIYG--PAIWSTPA 109 (111)
T ss_dssp -------------------CCCCSSCCEEEECTTSC--EEEEC--SEEEECCC
T ss_pred -------------------cCCCCcCEEEEECCCCe--EEEec--cCEEccCC
Confidence 01134789999999998 56665 68998874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.5e-10 Score=120.66 Aligned_cols=129 Identities=19% Similarity=0.175 Sum_probs=98.3
Q ss_pred cccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCC--eeeeecccccCCccEEEEEecCCCChhhH
Q 003237 537 GQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN--LVKLLGCCLEEDENMLIYEFMPNKSLDYF 614 (837)
Q Consensus 537 G~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~ 614 (837)
+.|..+.||+....+|..+++|..... ....+.+|++++..+.+.+ +.+++++...++..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998877888999997543 2345788999999997555 455888877777789999999998884
Q ss_pred hhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 003237 615 IFDESRKQLLDWKKRFDIILGIARGVLYLHQDS----------------------------------------------- 647 (837)
Q Consensus 615 l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------------- 647 (837)
.. . . ....++.++++.|..||+..
T Consensus 104 ~~-~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 SS-H-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp TS-C-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cC-c-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 21 1 1 12357778888888888643
Q ss_pred --------CCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 648 --------RLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 648 --------~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.97 E-value=2.1e-09 Score=95.95 Aligned_cols=85 Identities=24% Similarity=0.393 Sum_probs=63.2
Q ss_pred CceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCccccccc
Q 003237 86 SGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKR 165 (837)
Q Consensus 86 ~~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~ 165 (837)
...|.+..||||+|.+ + .++|+++....+ ....++|+|+|||||++ .++.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~--~--~~vW~snt~~~~-~~~~l~l~~dGNLvl~d-~~~~~iW~S~t~~--------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYG--G--KYGWQSNTHGNG-EHCFLRLNHKGELIIKD-DDFKTIWSSRSSS--------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEEC--S--SSCEECCCTTSS-SSCEEEECTTSCEEEEC-TTCCEEEECCCCC---------------
T ss_pred CEEEEEcCCCeEEEEC--C--eEEEECCCcCCC-cCEEEEEeCCCcEEEEe-CCCCEEEEcCCcC---------------
Confidence 4678999999999984 3 479999965322 23579999999999984 4678999984210
Q ss_pred CCCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecC
Q 003237 166 TGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAG 211 (837)
Q Consensus 166 tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg 211 (837)
..|.|.+.++.+|. +++|. ...|.+|
T Consensus 84 ----------------~~~~~~~~L~~dGN--lvly~--~~~W~t~ 109 (110)
T 3r0e_B 84 ----------------KQGEYVLILQDDGF--GVIYG--PAIFETS 109 (110)
T ss_dssp ----------------SSSCCEEEECTTSC--EEEEC--SEEEESC
T ss_pred ----------------CCCCEEEEEcCCcc--EEEec--CCEecCC
Confidence 12458899999998 56666 3789876
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.92 E-value=3.3e-09 Score=94.52 Aligned_cols=92 Identities=24% Similarity=0.450 Sum_probs=67.6
Q ss_pred CCCCCCCCceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCC
Q 003237 79 NNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNM 158 (837)
Q Consensus 79 ~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~ 158 (837)
+.|+.+....|.+..||||||.+ + +|+|++...+ ....++|+++|||||++ .++.++|+|- |
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~--~----~Wssnt~~~~-~~~~l~l~~dGnLvl~d-~~~~~vWss~-----t----- 76 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYN--G----NWQSNTANNG-RDCKLTLTDYGELVIKN-GDGSTVWKSG-----A----- 76 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEET--T----TEECCCTTSC-SSCEEEECTTSCEEEEC-TTSCEEEECC-----C-----
T ss_pred CCEeECCCEEEEEecCCeEEEEe--C----eEEcCCCCCC-CcEEEEEcCCCeEEEEe-CCCCEEEcCC-----C-----
Confidence 34444556789999999999983 3 7999965432 34579999999999984 4568999762 1
Q ss_pred cccccccCCCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCCC
Q 003237 159 RFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPW 213 (837)
Q Consensus 159 ~l~~~~~tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~w 213 (837)
....+.|.+.++.+|+ +++|. .+.|.+++|
T Consensus 77 ---------------------~~~~~~~~~~L~~dGN--lvly~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 ---------------------QSVKGNYAAVVHPDGR--LVVFG--PSVFKIDPW 106 (109)
T ss_dssp ---------------------CCSSSCCEEEEETTTE--EEEEC--SEEEEECTT
T ss_pred ---------------------cCCCcCEEEEEcCCCe--EEEEe--cCEECCCCc
Confidence 0023567899999998 45665 678999987
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=4.2e-09 Score=94.02 Aligned_cols=87 Identities=23% Similarity=0.409 Sum_probs=64.0
Q ss_pred CceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCccccccc
Q 003237 86 SGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKR 165 (837)
Q Consensus 86 ~~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~ 165 (837)
...|.|..||||+|.+. +.++|+++..... ....++|+|+|||||++ .++.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~---~~~vW~snt~~~~-~~~~l~l~~dGNLvl~~-~~~~~~W~S~t~~--------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV---DKPIWATNTGGLD-RRCHLSMQSDGNLVVYS-PRNNPIWASNTGG--------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET---TEEEEECCCTTSS-SSCEEEECTTSCEEEEC-TTSCEEEECCCCC---------------
T ss_pred CEEEEEcCCCcEEEEeC---CEEEEECCcccCC-CCEEEEEeCCCCEEEEC-CCCCEEEECCCCC---------------
Confidence 45789999999999853 4789999965322 34579999999999984 4568999984211
Q ss_pred CCCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCC
Q 003237 166 TGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (837)
Q Consensus 166 tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~ 212 (837)
..+.|.+.++.+|. +++|.. +.|.+|.
T Consensus 80 ----------------~~~~~~~~L~ddGN--lvly~~--~~W~s~t 106 (109)
T 3dzw_A 80 ----------------ENGNYVCVLQKDRN--VVIYGT--ARWATGT 106 (109)
T ss_dssp ----------------SSSCEEEEECTTSC--EEEEES--CCCCCCC
T ss_pred ----------------CCCCEEEEEeCCCE--EEEECC--CEEeCCC
Confidence 12467899999998 456654 6677763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=6.8e-09 Score=113.85 Aligned_cols=141 Identities=16% Similarity=0.218 Sum_probs=106.3
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEec--CCC-ccCHHHHHHHHHHHHHhc--CCCeeeeecccccC---CccEEEEE
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLS--TTS-GQGIEELKNEVLLIAKLQ--HRNLVKLLGCCLEE---DENMLIYE 604 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~---~~~~lV~e 604 (837)
.+.|+.|.++.||+.+..+ ..+++|+.. ... ......+.+|++++..+. +..+.+++.++.+. ...++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999998764 678888875 321 123456788999999997 45678888888766 34799999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS------------------------------------- 647 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 647 (837)
|+++..+.+.. ...++...+..++.++++.|..||...
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998874322 123567788889999999999999731
Q ss_pred ------------------CCceeeCCCCCCcEEEcCCCC--eeeccccccee
Q 003237 648 ------------------RLRIIHRDLKASNILLDEKMN--PRISDFGTARV 679 (837)
Q Consensus 648 ------------------~~~ivH~Dlkp~NIll~~~~~--~ki~DFGla~~ 679 (837)
+..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999999875
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.76 E-value=4e-08 Score=86.82 Aligned_cols=84 Identities=27% Similarity=0.531 Sum_probs=62.3
Q ss_pred ceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCcccccccC
Q 003237 87 GVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRT 166 (837)
Q Consensus 87 ~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 166 (837)
-+|.+..||||||.+ .+.+||++|..........+.|.++|||||+ +.+++++|.|=
T Consensus 21 y~l~~q~DgNLvly~---~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~-d~~~~~vWss~------------------- 77 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYD---HSTSTWASNTEIGGKSGCSAVLQSDGNFVVY-DSSGRSLWASH------------------- 77 (105)
T ss_dssp EEEEECTTSCEEEEE---TTEEEEECCCCCTTCCSCEEEECTTSCEEEE-CTTCCEEEECC-------------------
T ss_pred EEEEECCCCeEEEEE---CCEEEEEecCCCCCCccEEEEEeCCccEEEE-CCCcEEEEEec-------------------
Confidence 468889999999985 2468999997655555567999999999998 56678999861
Q ss_pred CCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEe
Q 003237 167 GLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWR 209 (837)
Q Consensus 167 g~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~ 209 (837)
+....|.+.+.|+.+|. +++|.. ..|.
T Consensus 78 ------------t~~~~~~~~l~L~ddGN--lVly~~--~~W~ 104 (105)
T 4h3o_A 78 ------------STRGSGNYILILQDDGN--VIIYGS--DIWS 104 (105)
T ss_dssp ------------CCCCSSCEEEEECTTSC--EEEEES--EEEE
T ss_pred ------------CCCCCCCEEEEEeCCCe--EEEECC--cEec
Confidence 01134668899999998 456643 4564
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.74 E-value=6.2e-09 Score=111.36 Aligned_cols=187 Identities=18% Similarity=0.213 Sum_probs=121.1
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCC--eeeeecccccCC---ccEEEEEec
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRN--LVKLLGCCLEED---ENMLIYEFM 606 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~~~~~~~~---~~~lV~ey~ 606 (837)
.+.++.|....||+.. ..+++|+.... .....+.+|.+++..+. +.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3578999999999863 56888886432 34567889999999984 333 334454443333 347899999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc----------------------------------------
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD---------------------------------------- 646 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 646 (837)
+|..|...... .++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99988754321 256666777888888888888851
Q ss_pred ---------------CCCceeeCCCCCCcEEEcC--CCCeeecccccceeccCccceeeecc------------ccccCC
Q 003237 647 ---------------SRLRIIHRDLKASNILLDE--KMNPRISDFGTARVFGGEEILAITKR------------VVGTYG 697 (837)
Q Consensus 647 ---------------~~~~ivH~Dlkp~NIll~~--~~~~ki~DFGla~~~~~~~~~~~~~~------------~~gt~~ 697 (837)
.+..++|+|++|.||++++ ...+.|+||+.+..-........... .....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1245899999999999998 45678999999876432111100000 000001
Q ss_pred ccC-cccccCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 003237 698 YMS-PEYALDGVFSTKSDVFSFGVILLEIITGKKNT 732 (837)
Q Consensus 698 y~A-PE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~ 732 (837)
... |+.... .....+.|+++.+++++.+|+.++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 221110 112258999999999999998654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.60 E-value=1.1e-07 Score=97.62 Aligned_cols=87 Identities=26% Similarity=0.410 Sum_probs=64.2
Q ss_pred ceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCcccccccC
Q 003237 87 GVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRT 166 (837)
Q Consensus 87 ~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 166 (837)
-.|.|..+|+|+|.+ + ..+||.+|.... ....++|.++|||||+ +.++.+||+|+.+.
T Consensus 28 f~l~f~~~gnl~ly~--~-~~~vW~an~~~~--~~~~l~l~~dGnLvl~-d~~~~~vW~s~~~~---------------- 85 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFD--S-DVRVWASNTAGA--TGCRAVLQSDGLLVIL-TAQNTIRWSSGTKG---------------- 85 (236)
T ss_dssp EEEEECTTSCEEEEE--S-SSEEECCCCCSC--SCCBCCBCSSSCBCCB-CTTTCCSCCCCCCC----------------
T ss_pred EEEEECCCCcEEEEE--C-CEEEEECCCCCC--CCeEEEEcCCCcEEEE-cCCCcEEEeCCccc----------------
Confidence 356677789999985 3 578999996433 4456899999999998 45678999998641
Q ss_pred CCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCCCC
Q 003237 167 GLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWT 214 (837)
Q Consensus 167 g~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~w~ 214 (837)
++|.|.+.++.+|. ++++.. .+|.+..+.
T Consensus 86 ---------------~~~~~~~~l~d~Gn--lvl~~~--~~W~S~~~p 114 (236)
T 1dlp_A 86 ---------------SIGNYVLVLQPDRT--VTIYGP--GLWDSGTSN 114 (236)
T ss_dssp ---------------CSSCCEEEECSSSC--EEEECS--EEEECSCCC
T ss_pred ---------------cCCcEEEEEeCCCC--EEEecC--CEEECCCCC
Confidence 23567888988888 455533 789987664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=7.6e-06 Score=87.30 Aligned_cols=135 Identities=21% Similarity=0.194 Sum_probs=91.4
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCC---Ceeeeecccc-cCCccEEEEEecCCC
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHR---NLVKLLGCCL-EEDENMLIYEFMPNK 609 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lV~ey~~~g 609 (837)
+.++.|....||+. |..+++|+... ......+.+|.++|..+.+. .+.+.+.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 46788999999988 57788888532 23356788999999999752 2455555553 344578999999998
Q ss_pred ChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 003237 610 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD------------------------------------------- 646 (837)
Q Consensus 610 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 646 (837)
.|...... .++...+..++.++++.|..||+.
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88653211 123333344444444444444432
Q ss_pred --------------CCCceeeCCCCCCcEEEcC---CCCe-eeccccccee
Q 003237 647 --------------SRLRIIHRDLKASNILLDE---KMNP-RISDFGTARV 679 (837)
Q Consensus 647 --------------~~~~ivH~Dlkp~NIll~~---~~~~-ki~DFGla~~ 679 (837)
.+..++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999997 4554 8999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1e-05 Score=84.40 Aligned_cols=135 Identities=18% Similarity=0.175 Sum_probs=95.5
Q ss_pred cccccCCe-eEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEecCCCCh
Q 003237 535 KLGQGGFG-PVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 535 ~LG~G~fG-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|..+. +--+-++++++.+++..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 58988765 4667888986432 3457888999999885 43466788888888889999999999887
Q ss_pred hhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 003237 612 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS-------------------------------------------- 647 (837)
Q Consensus 612 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 647 (837)
.+..... ......++.++++.|.-||...
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 6654221 1223345555566666665321
Q ss_pred -----------CCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 648 -----------RLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 648 -----------~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
+..++|+|+.+.|||++.+..+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11279999999999999887778999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=5.7e-06 Score=90.24 Aligned_cols=79 Identities=5% Similarity=-0.029 Sum_probs=55.8
Q ss_pred Ccc-cccCCeeEEEEEec-------CCcEEEEEEecCCC---ccCHHHHHHHHHHHHHhc-C--CCeeeeecccccC---
Q 003237 534 NKL-GQGGFGPVYKGKLS-------NGQEIAVKRLSTTS---GQGIEELKNEVLLIAKLQ-H--RNLVKLLGCCLEE--- 596 (837)
Q Consensus 534 ~~L-G~G~fG~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~--- 596 (837)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.++..+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 467 88989999998764 26778888764322 111245778999998885 3 3466777776655
Q ss_pred CccEEEEEecCCCChh
Q 003237 597 DENMLIYEFMPNKSLD 612 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~ 612 (837)
...++||||+++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999987765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=4.9e-05 Score=84.14 Aligned_cols=75 Identities=12% Similarity=0.218 Sum_probs=50.6
Q ss_pred CCcccccCCeeEEEEEec-CCcEEEEEEecCCCc-------cCHHHHHHHHHHHHHhcC--CCee-eeecccccCCccEE
Q 003237 533 SNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG-------QGIEELKNEVLLIAKLQH--RNLV-KLLGCCLEEDENML 601 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~nIv-~l~~~~~~~~~~~l 601 (837)
.+.||.|..+.||+++.. +++.++||....... ...+.+..|.+++..+.+ +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357999999999999764 468899998643211 234566789999988853 3333 45543 4456789
Q ss_pred EEEecCCC
Q 003237 602 IYEFMPNK 609 (837)
Q Consensus 602 V~ey~~~g 609 (837)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.87 E-value=7.5e-05 Score=80.55 Aligned_cols=141 Identities=17% Similarity=0.231 Sum_probs=82.6
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcC--CCeeeeecc------cccCCccEEEEEe
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH--RNLVKLLGC------CLEEDENMLIYEF 605 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~------~~~~~~~~lV~ey 605 (837)
+.|+.|..+.||+....+| .+++|+.... ..++..|+.++..+.. -.+.+++.. ....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3566677899999987654 5889988642 2445566666666642 223444431 1234567899999
Q ss_pred cCCCChh--------------hHhhhcCC----C-------CCCChhhHH------------------------------
Q 003237 606 MPNKSLD--------------YFIFDESR----K-------QLLDWKKRF------------------------------ 630 (837)
Q Consensus 606 ~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~~------------------------------ 630 (837)
+++..+. ..+|.... . ....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987653 11221111 0 112342211
Q ss_pred -HHHHHHHHHHHHHHh----------cCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 631 -DIILGIARGVLYLHQ----------DSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 631 -~i~~~ia~gL~yLH~----------~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
.+...+.+++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011123445666763 1245699999999999998888999999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00028 Score=74.27 Aligned_cols=78 Identities=18% Similarity=0.241 Sum_probs=58.1
Q ss_pred CCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-C--CCeeeeecccccCCccEEEEEec
Q 003237 530 FSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-H--RNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 530 ~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
....+.+|.|..+.||+.++.+|+.+.||+...........|..|++.|+.+. . --+.+++++ +..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence 34456899999999999999999999999876554444556889999999884 2 123444443 2458999999
Q ss_pred CCCCh
Q 003237 607 PNKSL 611 (837)
Q Consensus 607 ~~gsL 611 (837)
+.+..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00043 Score=73.61 Aligned_cols=138 Identities=17% Similarity=0.126 Sum_probs=92.4
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc---CCCeeeeecccccCCccEEEEEecCCC
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ---HRNLVKLLGCCLEEDENMLIYEFMPNK 609 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~ey~~~g 609 (837)
.+.|+.|....+|+... ++..+++|+.... ....+..|.+.|..+. ...+.+++.++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 35789999999999986 4678889987532 3567889999999885 256778888887777889999999998
Q ss_pred Chhh-----------HhhhcCC-C------------------CCCChhhHH---HHHH----------------HHHHH-
Q 003237 610 SLDY-----------FIFDESR-K------------------QLLDWKKRF---DIIL----------------GIARG- 639 (837)
Q Consensus 610 sL~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~g- 639 (837)
.+.. .||.... . -.-+|...+ ++.. .+.+-
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 1232211 0 012454322 1111 11111
Q ss_pred HHHHHh-cCCCceeeCCCCCCcEEEcCCCCeeecccc
Q 003237 640 VLYLHQ-DSRLRIIHRDLKASNILLDEKMNPRISDFG 675 (837)
Q Consensus 640 L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~DFG 675 (837)
...|.. ..++.++|+|+.+.||+++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223322 2356799999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00054 Score=76.31 Aligned_cols=80 Identities=8% Similarity=-0.040 Sum_probs=48.2
Q ss_pred CCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCC---CCCCcccHHHHHHHHHH
Q 003237 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG---VFSTKSDVFSFGVILLE 724 (837)
Q Consensus 648 ~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~s~k~DV~S~Gvvl~e 724 (837)
+..++|+|++|.|||++.++ ++|+||+.+..-.........- ..-...|.+|+..... .-....++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45699999999999999876 9999999987643211100000 0011346666654311 11123455677888888
Q ss_pred HHhCC
Q 003237 725 IITGK 729 (837)
Q Consensus 725 lltG~ 729 (837)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.002 Score=68.65 Aligned_cols=143 Identities=15% Similarity=0.109 Sum_probs=82.2
Q ss_pred CcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCC--eeeeeccc------ccCCccEEEEEe
Q 003237 534 NKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN--LVKLLGCC------LEEDENMLIYEF 605 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~------~~~~~~~lV~ey 605 (837)
+.|+.|....+|+....+| .+++|..... ...+++..|+.++..+.... +.+++... ...+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4567788899999987655 6888988642 12245667888888875322 33344221 123456899999
Q ss_pred cCCCChhh--------------HhhhcCCC---------CCCChhhHHH------------HHHHHHHHHHHHHhc----
Q 003237 606 MPNKSLDY--------------FIFDESRK---------QLLDWKKRFD------------IILGIARGVLYLHQD---- 646 (837)
Q Consensus 606 ~~~gsL~~--------------~l~~~~~~---------~~l~~~~~~~------------i~~~ia~gL~yLH~~---- 646 (837)
+++..+.. .+|..... ....|...+. +...+.+.+..++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99876421 11211100 0112332111 011244455566532
Q ss_pred CCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 647 ~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
.+..++|+|+++.|||++.+..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234699999999999999876668999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0011 Score=73.99 Aligned_cols=72 Identities=19% Similarity=0.315 Sum_probs=50.4
Q ss_pred CcccccCCeeEEEEEecC--------CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCe-eeeecccccCCccEEEEE
Q 003237 534 NKLGQGGFGPVYKGKLSN--------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-VKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~e 604 (837)
+.|+.|....||+....+ +..+++|+.... ...+.+.+|..++..+...++ .++++.+.. .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 578888899999998753 478888887432 122566689999998864444 566665532 38999
Q ss_pred ecCCCCh
Q 003237 605 FMPNKSL 611 (837)
Q Consensus 605 y~~~gsL 611 (837)
|+++..|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0014 Score=69.40 Aligned_cols=138 Identities=12% Similarity=0.120 Sum_probs=76.7
Q ss_pred CCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCe-eeeecccccCCccEEEEEec-CCCC
Q 003237 533 SNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-VKLLGCCLEEDENMLIYEFM-PNKS 610 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ey~-~~gs 610 (837)
.+.|+.|....+|+. ..+++|+........ ....+|+.++..+....+ .+++++ ..+..++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 468899999999998 568888875432221 123568888888753333 355544 344467899999 6655
Q ss_pred hhhH------------------hhhcCCC--CCCChhhHH-HHH--------------HHHHHHHH----HHHh-cCCCc
Q 003237 611 LDYF------------------IFDESRK--QLLDWKKRF-DII--------------LGIARGVL----YLHQ-DSRLR 650 (837)
Q Consensus 611 L~~~------------------l~~~~~~--~~l~~~~~~-~i~--------------~~ia~gL~----yLH~-~~~~~ 650 (837)
|... +|..... ...+...++ ... ..+.+.+. .|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 5321 1111100 000111100 000 00111111 1111 22345
Q ss_pred eeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 651 IIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 651 ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667789999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0022 Score=70.05 Aligned_cols=141 Identities=18% Similarity=0.207 Sum_probs=83.3
Q ss_pred CcccccCCeeEEEEEecC--------CcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEE
Q 003237 534 NKLGQGGFGPVYKGKLSN--------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 604 (837)
+.|..|-...+|+....+ ++.+++|+.... ......+.+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 467778888999998752 468888886332 234566778999999885 3323566666543 29999
Q ss_pred ecCCCChhhH-----------------hhhcC--CCCCCC--hhhHHHHHHHHH-------------------HHHHHHH
Q 003237 605 FMPNKSLDYF-----------------IFDES--RKQLLD--WKKRFDIILGIA-------------------RGVLYLH 644 (837)
Q Consensus 605 y~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia-------------------~gL~yLH 644 (837)
|+++..|..- ||... ..+... |.+..++..++. +.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665321 11111 011122 333333333321 1233332
Q ss_pred ----hc-CCCceeeCCCCCCcEEEcCC----CCeeeccccccee
Q 003237 645 ----QD-SRLRIIHRDLKASNILLDEK----MNPRISDFGTARV 679 (837)
Q Consensus 645 ----~~-~~~~ivH~Dlkp~NIll~~~----~~~ki~DFGla~~ 679 (837)
.. .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 23468999999999999876 7899999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0056 Score=65.58 Aligned_cols=142 Identities=15% Similarity=0.134 Sum_probs=73.5
Q ss_pred CcccccCCee-EEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcC--CCeeeeecccccCCccEEEEEecCCCC
Q 003237 534 NKLGQGGFGP-VYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH--RNLVKLLGCCLEEDENMLIYEFMPNKS 610 (837)
Q Consensus 534 ~~LG~G~fG~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~ey~~~gs 610 (837)
+.|+.|.... +|+.+..++..+++|....... +.+..|+.++..+.. -.+.+++.+..+ ..+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence 4565554444 6677654467777776533221 234567777777742 234556665332 3378999998766
Q ss_pred hhhHhhhc---------------------CCC--CCCChhhHH-------H-------------HHHHHHHHHHHHH---
Q 003237 611 LDYFIFDE---------------------SRK--QLLDWKKRF-------D-------------IILGIARGVLYLH--- 644 (837)
Q Consensus 611 L~~~l~~~---------------------~~~--~~l~~~~~~-------~-------------i~~~ia~gL~yLH--- 644 (837)
+.+.+... ... ..++..... . ....+.+.+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65433211 000 111110000 0 0001112222221
Q ss_pred hcCCCceeeCCCCCCcEEEcCC----CCeeecccccceec
Q 003237 645 QDSRLRIIHRDLKASNILLDEK----MNPRISDFGTARVF 680 (837)
Q Consensus 645 ~~~~~~ivH~Dlkp~NIll~~~----~~~ki~DFGla~~~ 680 (837)
...+..++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1224569999999999999875 67899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0035 Score=70.31 Aligned_cols=73 Identities=19% Similarity=0.142 Sum_probs=48.2
Q ss_pred CcccccCCeeEEEEEecC-CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCe-eeeecccccCCccEEEEEecCCCCh
Q 003237 534 NKLGQGGFGPVYKGKLSN-GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-VKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
+.|+.|-...+|+....+ +..+++|+......... ...+|..++..+...++ .++++.+. ..+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCccC
Confidence 578888899999998865 47888887743322211 12579999999975555 46666653 2359999997554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.01 Score=63.34 Aligned_cols=141 Identities=12% Similarity=0.143 Sum_probs=83.3
Q ss_pred cccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCC--eeeeecc-----cccCCccEEEEEecC
Q 003237 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN--LVKLLGC-----CLEEDENMLIYEFMP 607 (837)
Q Consensus 535 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~-----~~~~~~~~lV~ey~~ 607 (837)
.|+ |....||+....+|+.+++|..... ....+.+..|..++..+.... +.+++.. ...++..++||||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 7788999988777878999998533 224567778999888885322 4455543 111334578999999
Q ss_pred CCChhh----H----------hhhcC------CCCCCChhhH----HHH---------------HHHHHHHHHHHHhc--
Q 003237 608 NKSLDY----F----------IFDES------RKQLLDWKKR----FDI---------------ILGIARGVLYLHQD-- 646 (837)
Q Consensus 608 ~gsL~~----~----------l~~~~------~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~-- 646 (837)
+..+.. . +|... .....++... ..+ ...+.+.+..+...
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 865421 0 11110 0111222111 000 01111223333221
Q ss_pred --CCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 647 --SRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 647 --~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
.+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 334589999999999999 4 899999988754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0033 Score=68.58 Aligned_cols=73 Identities=11% Similarity=0.157 Sum_probs=44.6
Q ss_pred CcccccCCeeEEEEEecC---------CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCe-eeeecccccCCccEEEE
Q 003237 534 NKLGQGGFGPVYKGKLSN---------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-VKLLGCCLEEDENMLIY 603 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ 603 (837)
+.|+.|..-.+|+....+ +..+++|+....... ......|.+++..+...++ .++++.. ...+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 467788888999998754 267888876443221 1234678888888864343 3565443 247899
Q ss_pred EecCCCCh
Q 003237 604 EFMPNKSL 611 (837)
Q Consensus 604 ey~~~gsL 611 (837)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998644
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.32 E-value=0.013 Score=62.89 Aligned_cols=68 Identities=10% Similarity=0.117 Sum_probs=44.2
Q ss_pred cccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcC---CCeeeeeccc------ccCCccEEEEEecC
Q 003237 537 GQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH---RNLVKLLGCC------LEEDENMLIYEFMP 607 (837)
Q Consensus 537 G~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~~~~------~~~~~~~lV~ey~~ 607 (837)
|.|....||+....+| .+++|+...... ..|+.++..+.. +.+.+++... ......++||+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3444678999987777 899998754331 356666666642 2245555431 22456689999999
Q ss_pred CCCh
Q 003237 608 NKSL 611 (837)
Q Consensus 608 ~gsL 611 (837)
+..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.60 E-value=0.045 Score=60.50 Aligned_cols=73 Identities=16% Similarity=0.201 Sum_probs=48.3
Q ss_pred CcccccCCeeEEEEEecC--------CcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCe-eeeecccccCCccEEEEE
Q 003237 534 NKLGQGGFGPVYKGKLSN--------GQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL-VKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~e 604 (837)
+.|..|-...+|+....+ +..+++|+....... .-...+|.+++..+.-.++ .++++.+ ...+|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEE
Confidence 467778888999998763 578888886443222 1233578888888853333 4555433 2478999
Q ss_pred ecCCCCh
Q 003237 605 FMPNKSL 611 (837)
Q Consensus 605 y~~~gsL 611 (837)
|+++..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.49 E-value=0.089 Score=51.85 Aligned_cols=101 Identities=11% Similarity=0.059 Sum_probs=63.7
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccceee
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAI 688 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 688 (837)
-+|.+.|... ..+++..+.+.++.|.+++|.-+-... .+ ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 3677887543 457999999999999999987762211 01 1233457899999999887764 1111
Q ss_pred eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCC
Q 003237 689 TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK 729 (837)
Q Consensus 689 ~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~ 729 (837)
.....+.|||... ...+.+.=|||+|+++|.-+-=.
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1123466888653 34567889999999999887633
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.92 E-value=0.69 Score=50.60 Aligned_cols=30 Identities=33% Similarity=0.423 Sum_probs=25.4
Q ss_pred ceeeCCCCCCcEEE------cCCCCeeeccccccee
Q 003237 650 RIIHRDLKASNILL------DEKMNPRISDFGTARV 679 (837)
Q Consensus 650 ~ivH~Dlkp~NIll------~~~~~~ki~DFGla~~ 679 (837)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998864
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=82.42 E-value=0.53 Score=32.29 Aligned_cols=26 Identities=31% Similarity=0.494 Sum_probs=13.9
Q ss_pred ceeeehhHHHHHHHHHHHHHHhhhhh
Q 003237 445 RLALIIVAIVLGVILLGLCFFFLRRR 470 (837)
Q Consensus 445 ~~~iii~~~v~~~~ll~l~~~~~~~r 470 (837)
.++-++++.++++++++.+.++++||
T Consensus 12 aIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 12 EIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred ceeeeehHHHHHHHHHHHHHHHHeec
Confidence 34445555555655555555555544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.50 E-value=0.23 Score=55.63 Aligned_cols=59 Identities=10% Similarity=0.092 Sum_probs=17.4
Q ss_pred CCcccccCCeeEEEEEecC-CcEEEE------EEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccc
Q 003237 533 SNKLGQGGFGPVYKGKLSN-GQEIAV------KRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~-g~~vav------K~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 594 (837)
.++|| ||.||+|.+.. ..+||| |.++.. ..+....+.+|..++..++|+|+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 46777 99999998864 367888 766542 2233456788999999999999999987754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.16 E-value=2.8 Score=41.11 Aligned_cols=116 Identities=10% Similarity=0.065 Sum_probs=76.3
Q ss_pred cCCCeeeeecccccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcE
Q 003237 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNI 661 (837)
Q Consensus 582 ~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 661 (837)
.||+.+.. .+-.+++...+.|+.-+ +...+-. -+.++...+++++.+|+....+++. -+|--|+|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 57888765 34445555555555433 2222221 1236788899999999888766554 47889999999
Q ss_pred EEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 003237 662 LLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTR 733 (837)
Q Consensus 662 ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~ 733 (837)
+++.++.+++.-.|+-.. ++|. .+++..=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999987776332 2222 11222334467788999999998875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 837 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-24 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 9e-17 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 0.001 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 9e-14 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 8e-13 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 3e-12 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 6e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 2e-70
Identities = 69/277 (24%), Positives = 130/277 (46%), Gaps = 20/277 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ ++G G FG VYKGK + + ++ + Q ++ KNEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+G + ++ ++ SL + + K + K DI A+G+ YLH S
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL-- 705
IIHRDLK++NI L E + +I DFG A V +++ G+ +M+PE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 706 -DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764
+S +SDV++FG++L E++TG+ +++ ++ + I + + D S
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ---LPYSNINNRDQIIFMV-----GRGYLSPDLSK 233
Query: 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801
S R + C++ + +RP ++ +
Sbjct: 234 VRSNCPKAMKRLM---AECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-65
Identities = 74/276 (26%), Positives = 130/276 (47%), Gaps = 22/276 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ +LG G FG V+ G + ++AVK L S + E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L ++ +I E+M N SL F+ S +L K D+ IA G+ ++ + +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
IHRDL+A+NIL+ + ++ +I+DFG AR+ E A + +PE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 708 VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767
F+ KSDV+SFG++L EI+T + + ++ + ++ ++
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 230
Query: 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
+ Q+ LC ++R DRP+ + +L +
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 2e-65
Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 22/275 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ ++G G FG V+ G N ++A+K + E+ E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L G CLE+ L++EFM + L ++ +++ L + + L + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
+IHRDL A N L+ E ++SDFG R ++ + + SPE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 708 VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767
+S+KSDV+SFGV++ E+ + K +E S+++ +E + +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEG---------------KIPYENRSNSEVVEDISTGFRLY 222
Query: 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802
+ Q+ C ++R DRP+ S ++ L+
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 4e-64
Identities = 63/291 (21%), Positives = 119/291 (40%), Gaps = 28/291 (9%)
Query: 535 KLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCL 594
+G+G FG V++GK G+E+AVK S+ + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 595 EEDEN----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD---- 646
+++ L+ ++ + SL ++ + + + + L A G+ +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 647 -SRLRIIHRDLKASNILLDEKMNPRISDFGTARVF--GGEEILAITKRVVGTYGYMSPEY 703
+ I HRDLK+ NIL+ + I+D G A + I VGT YM+PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 704 ALDGV------FSTKSDVFSFGVILLEIITGKKNTRIFNDDD----SSNLIKYAWELWSD 753
D + ++D+++ G++ EI I D + E
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 754 NKALEIVDSSMANSCLASEALRCI-QVGLLCVQDRTTDRPSMSTVVFMLSN 803
+ + ++ N + EALR + ++ C R + + LS
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 3e-63
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 14/220 (6%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGI-EELKNEVLLIAKLQH 583
D+F ++LG G G V+K +G +A K + I ++ E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
+V G + E + E M SLD + R + + + + + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703
+ +I+HRD+K SNIL++ + ++ DFG + VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 704 ALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNL 743
+S +SD++S G+ L+E+ G+ D+ L
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR---YPIPPPDAKEL 211
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 6e-63
Identities = 76/287 (26%), Positives = 129/287 (44%), Gaps = 23/287 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
++ KLGQG FG V+ G + +A+K L + E E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L E+ ++ E+M SL F+ E+ K L + D+ IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER-- 131
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
+ +HRDL+A+NIL+ E + +++DFG AR+ E A + + +PE AL G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYG 189
Query: 708 VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767
F+ KSDV+SFG++L E+ T + + + + L+ V+
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNREVLDQVERGYRMP 234
Query: 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVPSPK-QP 813
C + C + +RP+ + L + P+ QP
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 7e-63
Identities = 58/276 (21%), Positives = 122/276 (44%), Gaps = 22/276 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+ + +LG G FG V GK ++A+K + S +E E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
+L G C ++ +I E+M N L ++ + + ++ ++ + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDG 707
+ +HRDL A N L++++ ++SDFG +R +E + + PE +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYS 176
Query: 708 VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767
FS+KSD+++FGV++ EI + K +E +++++ E + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLG---------------KMPYERFTNSETAEHIAQGLRLY 221
Query: 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
+ + + C ++ +RP+ ++ + +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (530), Expect = 7e-62
Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 22/277 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+ + +KLG G +G VY+G +AVK L + + +EE E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
V+LLG C E +I EFM +L ++ E +Q + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD 706
+ IHRDL A N L+ E +++DFG +R+ G+ A + +PE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 707 GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766
FS KSDV++FGV+L EI T + + ++ E+++
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRM 235
Query: 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
+ ++ C Q +DRPS + +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (530), Expect = 1e-61
Identities = 71/311 (22%), Positives = 122/311 (39%), Gaps = 46/311 (14%)
Query: 519 ELSTLLAATDNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLS-TTSGQGIEEL 571
+L +L +N +G+G FG V++ + +AVK L S +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 572 KNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQL-------- 623
+ E L+A+ + N+VKLLG C L++E+M L+ F+ S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 624 -------------LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPR 670
L ++ I +A G+ YL + + +HRDL N L+ E M +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 671 ISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKK 730
I+DFG +R + +M PE ++T+SDV+++GV+L EI +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 731 NTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTD 790
+ + +I D L + + L + LC D
Sbjct: 241 --QPYYGMAHEEVI----YYVRDGNILACPE---------NCPLELYNLMRLCWSKLPAD 285
Query: 791 RPSMSTVVFML 801
RPS ++ +L
Sbjct: 286 RPSFCSIHRIL 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-61
Identities = 63/285 (22%), Positives = 121/285 (42%), Gaps = 27/285 (9%)
Query: 523 LLAATDNFSTSN-KLGQGGFGPVYKGKL---SNGQEIAVKRLSTTSGQG-IEELKNEVLL 577
L DN ++ +LG G FG V +G ++A+K L + + EE+ E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 578 IAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIA 637
+ +L + +V+L+G C + + ML+ E L F+ +++ + +++ ++
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVS 119
Query: 638 RGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI-LAITKRVVGTY 696
G+ YL + +HRDL A N+LL + +ISDFG ++ G ++
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 697 GYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756
+ +PE FS++SDV+S+GV + E ++ + + + ++ K
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ--KPYKKMKGPEVM----AFIEQGKR 230
Query: 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801
+E L + C + DRP TV +
Sbjct: 231 MECPPE-------CPPELY--ALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (526), Expect = 4e-61
Identities = 68/316 (21%), Positives = 125/316 (39%), Gaps = 39/316 (12%)
Query: 512 KVDVTFFELSTLLAATDNFSTS---------NKLGQGGFGPVYKGKL----SNGQEIAVK 558
K+ + F A F+ +G G FG V G L +A+K
Sbjct: 1 KIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIK 60
Query: 559 RL-STTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD 617
L S + + + +E ++ + H N++ L G + M+I EFM N SLD F+
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 618 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677
+ + ++ GIA G+ YL + +HRDL A NIL++ + ++SDFG +
Sbjct: 121 NDGQF--TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLS 175
Query: 678 RVFGGEEILAITKRVVG---TYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRI 734
R + +G + +PE F++ SDV+S+G+++ E+++
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG----- 230
Query: 735 FNDDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSM 794
+ + ++ + ++ Q+ L C Q RP
Sbjct: 231 ----------ERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 795 STVVFMLSNETFVPSP 810
+V L + + +P
Sbjct: 281 GQIVNTL--DKMIRNP 294
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-61
Identities = 65/277 (23%), Positives = 111/277 (40%), Gaps = 28/277 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV 587
+G+G FG V G G ++AVK + + + E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 588 KLLGCCLEEDENM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+LLG +EE + ++ E+M SL ++ R +L L + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 647 SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD 706
+HRDL A N+L+ E ++SDFG + + +PE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALRE 174
Query: 707 GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766
FSTKSDV+SFG++L EI + + + +++ ++ D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVV----PRVEKGYKMDAPDG---- 224
Query: 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
A+ +V C RPS + L +
Sbjct: 225 ---CPPAVY--EVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-59
Identities = 71/321 (22%), Positives = 137/321 (42%), Gaps = 28/321 (8%)
Query: 523 LLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQE----IAVKRLS-TTSGQGIEELKNEVL 576
+L T+ F LG G FG VYKG + G++ +A+K L TS + +E+ +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 577 LIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
++A + + ++ +LLG C LI + MP L ++ + + + + I
Sbjct: 64 VMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQI 120
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY 696
A+G+ YL R++HRDL A N+L+ + +I+DFG A++ G EE +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 697 GYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756
+M+ E L +++ +SDV+S+GV + E++T ++ ++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFG---------------SKPYDGIPASEI 222
Query: 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVPSPKQPTFS 816
I++ + + + C RP ++ S P
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282
Query: 817 VRRTEIDTDNSSSGIKSSVNE 837
R + + S+ ++ ++E
Sbjct: 283 DERMHLPSPTDSNFYRALMDE 303
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-59
Identities = 66/305 (21%), Positives = 117/305 (38%), Gaps = 45/305 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKG------KLSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAK 580
+N LG G FG V K ++AVK L + E L +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 581 L-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRK------------------ 621
L H N+V LLG C LI+E+ L ++ + K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 622 --QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679
+L ++ +A+G+ +L +HRDL A N+L+ +I DFG AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDD 739
+ + +M+PE +G+++ KSDV+S+G++L EI + +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--NPYPGIP 271
Query: 740 SSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799
++L + ++ A+E + + C + RPS +
Sbjct: 272 VDANF---YKLIQNGFKMDQPFY-------ATEEIY--IIMQSCWAFDSRKRPSFPNLTS 319
Query: 800 MLSNE 804
L +
Sbjct: 320 FLGCQ 324
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 8e-59
Identities = 65/300 (21%), Positives = 112/300 (37%), Gaps = 40/300 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTSGQG-IEELKNEVLLIAK 580
+ S LG G FG V + +AVK L ++ E L +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 581 L-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFD---------------ESRKQLL 624
L H N+V LLG C ++I E+ L F+ E + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
D + +A+G+ +L IHRDL A NILL +I DFG AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744
+ +M+PE + V++ +SDV+S+G+ L E+ + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 745 KYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804
+ D+K +++ + C RP+ +V ++ +
Sbjct: 247 -PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (511), Expect = 8e-59
Identities = 70/279 (25%), Positives = 124/279 (44%), Gaps = 34/279 (12%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG---IEELKNEVLLIAKLQ 582
FS ++G G FG VY + + N + +A+K++S + Q +++ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H N ++ GC L E L+ E+ + D K+ L + + G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
LH +IHRD+KA NILL E ++ DFG+A I+A VGT +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWMAPE 181
Query: 703 YAL---DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759
L +G + K DV+S G+ +E+ K + ++ + + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK---PPLFNMNAMSALY---------HIAQN 229
Query: 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798
++ + + + C+Q DRP+ ++
Sbjct: 230 ESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLL 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-58
Identities = 71/282 (25%), Positives = 128/282 (45%), Gaps = 30/282 (10%)
Query: 529 NFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQH 583
+F+ +G+G FG VY G L + AVK L+ + G + + E +++ H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 584 RNLVKLLGCCLEEDEN-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
N++ LLG CL + + +++ +M + L FI +E+ + F + +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVGTYGYMS 700
+ + + +HRDL A N +LDEK +++DFG AR +E ++ + +M+
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 701 PEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760
E F+TKSDV+SFGV+L E++T + D ++ ++ Y +
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGA--PPYPDVNTFDITVYLLQ----------- 249
Query: 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802
+ + L +V L C + RPS S +V +S
Sbjct: 250 GRRLLQPEYCPDPLY--EVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 64/276 (23%), Positives = 115/276 (41%), Gaps = 28/276 (10%)
Query: 534 NKLGQGGFGPVYKGKLSN---GQEIAVKRLSTTSGQG--IEELKNEVLLIAKLQHRNLVK 588
+LG G FG V KG + +AVK L + +EL E ++ +L + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 589 LLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 648
++G C E + ML+ E L+ ++ + K +++ ++ G+ YL +
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES-- 126
Query: 649 LRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITK-RVVGTYGYMSPEYALDG 707
+HRDL A N+LL + +ISDFG ++ +E + + +PE
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 708 VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767
FS+KSDV+SFGV++ E + + + ++ +++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYG---------------QKPYRGMKGSEVTAMLEKGERMG 230
Query: 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
C A + LC +RP + V L N
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-58
Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 26/279 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL--STTSGQGIEELKNEVLLIAKLQHR 584
+++ +G G +G K + S+G+ + K L + + + L +EV L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 585 NLVKLLGCCLEEDENML--IYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVL 641
N+V+ ++ L + E+ L I ++ +Q LD + ++ + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 642 YLHQ--DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
H+ D ++HRDLK +N+ LD K N ++ DFG AR+ + + K VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759
SPE ++ KSD++S G +L E+ F L + K I
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALM---PPFTAFSQKELAG----KIREGKFRRI 234
Query: 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798
+ E I + + RPS+ ++
Sbjct: 235 ------PYRYSDELNEIIT---RMLNLKDYHRPSVEEIL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-57
Identities = 67/290 (23%), Positives = 125/290 (43%), Gaps = 29/290 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQE-----IAVKRLSTTSGQG-IEELKNEVLLIAKL 581
+ +G G FG VYKG L +A+K L + + E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 582 QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL 641
H N+++L G + M+I E+M N +LD F+ + + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 642 YLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF-GGEEILAITKRVVGTYGYMS 700
YL + +HRDL A NIL++ + ++SDFG +RV E T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 701 PEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760
PE F++ SDV+SFG+++ E++T + + S+++ ++ +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYG---------------ERPYWELSNHEVMKAI 226
Query: 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVPSP 810
+ Q+ + C Q RP + +V +L + + +P
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL--DKLIRAP 274
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-57
Identities = 74/312 (23%), Positives = 132/312 (42%), Gaps = 44/312 (14%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNG---QEIAVKRLS-TTSGQGIEELKNEVLLIAKL-Q 582
++ + +G+G FG V K ++ + A+KR+ S + E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFI-------------FDESRKQLLDWKKR 629
H N++ LLG C L E+ P+ +L F+ S L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 630 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAIT 689
+ARG+ YL Q + IHRDL A NIL+ E +I+DFG +R G+E+
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 690 KRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWE 749
+M+ E V++T SDV+S+GV+L EI++ + + L + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--TPYCGMTCAELYEKLPQ 241
Query: 750 LWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN-----E 804
+ K L D + C +++ +RPS + ++ L+ +
Sbjct: 242 GYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
Query: 805 TFVPSPKQPTFS 816
T+V + F+
Sbjct: 289 TYVNTTLYEKFT 300
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 6e-57
Identities = 65/273 (23%), Positives = 108/273 (39%), Gaps = 23/273 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGI-EELKNEVLLIAKLQHRN 585
+++ LG+G +G V + +AVK + E +K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+VK G E + L E+ L I + + GV+YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
+ I HRD+K N+LLDE+ N +ISDFG A VF + ++ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 706 DGVFST-KSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764
F DV+S G++L ++ G+ DS E + + +D
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKID--- 233
Query: 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTV 797
S L + + + + R ++ +
Sbjct: 234 ------SAPLALLH---KILVENPSARITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 8e-57
Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 16/225 (7%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
D + +LG G FG VYK + A K + T S + +E+ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+VKLL E+ ++ EF ++D + + ++ L + + + YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
+IIHRDLKA NIL + +++DFG + +GT +M+PE +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVM 183
Query: 706 -----DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
D + K+DV+S G+ L+E+ + ++ + ++
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE---PPHHELNPMRVLL 225
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-56
Identities = 61/273 (22%), Positives = 115/273 (42%), Gaps = 31/273 (11%)
Query: 534 NKLGQGGFGPVYKGKL-SNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLL 590
++G+G F VYKG E+A L + + K E ++ LQH N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 591 GCCLEEDEN----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+ +L+ E M + +L ++ R +++ K I +G+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 647 SRLRIIHRDLKASNILL-DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
+ IIHRDLK NI + + +I D G A + K V+GT +M+PE
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-Y 185
Query: 706 DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765
+ + DV++FG+ +LE+ T + +++ ++ I + V +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSE---YPYSECQNAAQIY--------RRVTSGVKPASF 234
Query: 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798
+ E I+ C++ +R S+ ++
Sbjct: 235 DKVAIPEVKEIIE---GCIRQNKDERYSIKDLL 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 72/303 (23%), Positives = 126/303 (41%), Gaps = 33/303 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLS-TTSGQGIEELKNEVLLIAK 580
+ + S +LGQG FG VY+G +A+K ++ S + E NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIF-------DESRKQLLDWKKRFDII 633
++V+LLG + ++I E M L ++ + K +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 634 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVV 693
IA G+ YL+ + + +HRDL A N ++ E +I DFG R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 694 GTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD 753
+MSPE DGVF+T SDV+SFGV+L EI T + + + + + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGLSNEQV----LRFVME 250
Query: 754 NKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETFVPSPKQP 813
L+ D+ ++ +C Q RPS ++ + E P ++
Sbjct: 251 GGLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEE-MEPGFREV 300
Query: 814 TFS 816
+F
Sbjct: 301 SFY 303
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-56
Identities = 69/288 (23%), Positives = 113/288 (39%), Gaps = 28/288 (9%)
Query: 522 TLLAATDNFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLS---TTSGQGIEELKNE 574
T L + KLG G FG V +G+ +AVK L + + +++ E
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 575 VLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 634
V + L HRNL++L G ++ E P SL + LL R +
Sbjct: 62 VNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAV 118
Query: 635 GIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG-GEEILAITKRVV 693
+A G+ YL R IHRDL A N+LL + +I DFG R ++ + +
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 694 GTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD 753
+ + +PE FS SD + FGV L E+ T + + + S ++ ++ +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ--EPWIGLNGSQIL---HKIDKE 230
Query: 754 NKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFML 801
+ L + V + C + DRP+ + L
Sbjct: 231 GERLPRPEDCPQ---------DIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-55
Identities = 64/283 (22%), Positives = 113/283 (39%), Gaps = 34/283 (12%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
++F LG+G FG VY + + +A+K L +L+ EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
N+++L G + LI E+ P ++ + S+ D ++ I +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703
H R+IHRD+K N+LL +I+DFG + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 704 ALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763
+ K D++S GV+ E + GK F + K I
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETYK------------RISRVE 220
Query: 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV---FMLSN 803
+E R + ++ + RP + V+ ++ +N
Sbjct: 221 FTFPDFVTEGAR--DLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-54
Identities = 58/272 (21%), Positives = 119/272 (43%), Gaps = 24/272 (8%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRN 585
++ K+GQG G VY ++ GQE+A+++++ E + NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+V L L DE ++ E++ SL + + D + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
++IHRD+K+ NILL + +++DFG E+ + +VGT +M+PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVT 189
Query: 706 DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765
+ K D++S G++ +E+I G+ + +++ + A
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE---PPYLNENPLRALY--------LIATNGTPELQN 238
Query: 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTV 797
L++ + C+ R S +
Sbjct: 239 PEKLSAIFRDFLN---RCLDMDVEKRGSAKEL 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-53
Identities = 74/298 (24%), Positives = 115/298 (38%), Gaps = 39/298 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKG------KLSNGQEIAVKRLSTTSGQG--IEELKNEVLLIA 579
D LG+G FG V + K + + +AVK L + + +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 580 KLQHRNLVKLLGCCLEEDEN-MLIYEFMPNKSLDYFIF-------------DESRKQLLD 625
H N+V LLG C + M+I EF +L ++ ++ K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 626 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685
+ +A+G+ +L + IHRDL A NILL EK +I DFG AR +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 686 LAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+M+PE D V++ +SDV+SFGV+L EI + + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDE 244
Query: 746 YAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
+ + D + Q L C + RP+ S +V L N
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 13/222 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
++F LG+G F V + L+ +E A+K L + + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
VKL ++++ + N L +I D I + YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703
H IIHRDLK NILL+E M+ +I+DFGTA+V E A VGT Y+SPE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 704 ALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+ SD+++ G I+ +++ G F + + +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL---PPFRAGNEYLIFQ 220
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-51
Identities = 69/299 (23%), Positives = 121/299 (40%), Gaps = 41/299 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL--------SNGQEIAVKRL-STTSGQGIEELKNEVLLI 578
D LG+G FG V + + ++AVK L S + + + +L +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 579 AKL-QHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQL-------------L 624
+ +H+N++ LLG C ++ +I E+ +L ++ L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 625 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684
K +ARG+ YL + IHRDL A N+L+ E +I+DFG AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744
T +M+PE D +++ +SDV+SFGV+L EI T + L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEEL- 246
Query: 745 KYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
++L + ++ + + C + RP+ +V L
Sbjct: 247 ---FKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (454), Expect = 2e-50
Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 14/221 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
D++ +LG G FG V++ + G A K + T E ++ E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
V L +++E ++IYEFM L + DE K + + + + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 647 SRLRIIHRDLKASNILLDEKMNPRI--SDFGTARVFGGEEILAITKRVVGTYGYMSPEYA 704
+H DLK NI+ K + + DFG ++ K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 705 LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+D++S GV+ +++G F ++ ++
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL---SPFGGENDDETLR 235
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-50
Identities = 55/281 (19%), Positives = 102/281 (36%), Gaps = 27/281 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTSGQGI-EELKNEVLLIAKLQ 582
+ +G+G FG V++G + +A+K + + E+ E L + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H ++VKL+G E+ +I E L F+ LD ++ + Y
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
L R +HRD+ A N+L+ ++ DFG +R + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPE 179
Query: 703 YALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762
F++ SDV+ FGV + EI+ ++ + + L + +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPN 233
Query: 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
L + C + RP + + LS
Sbjct: 234 -------CPPTLY--SLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (446), Expect = 2e-49
Identities = 49/221 (22%), Positives = 94/221 (42%), Gaps = 14/221 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
D + +LG G FG V++ + G+ K ++T +KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+ L ++ E +LI EF+ L I + + + + + G+ ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 647 SRLRIIHRDLKASNILLDEKMNPRI--SDFGTARVFGGEEILAITKRVVGTYGYMSPEYA 704
I+H D+K NI+ + K + DFG A +E I K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV 200
Query: 705 LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+D+++ GV+ +++G F +D ++
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL---SPFAGEDDLETLQ 238
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (427), Expect = 1e-46
Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 18/234 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQ- 582
++FS +G+GGFG VY + G+ A+K L QG NE ++++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 583 --HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 640
+V + D+ I + M L Y + S+ + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMS 700
++H +++RDLK +NILLDE + RISD G A F ++ VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 701 PEYALDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD 753
PE GV + + +D FS G +L +++ G R D + + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (423), Expect = 1e-46
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 18/222 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
+F LG G FG V+ + NG+ A+K L + +E +E L+++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
++++ G + + +I +++ L + R K + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703
II+RDLK NILLD+ + +I+DFG A+ T + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEV 172
Query: 704 ALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
++ D +SFG+++ E++ G F D ++ +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT---PFYDSNTMKTYE 211
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-46
Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 7/222 (3%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG-IEELKNEVLLIAKLQHR 584
++ + +G+G +G V N +A+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N++ + + ++ + ++ + Q L + I RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG-GEEILAITKRVVGTYGYMSPEY 703
++HRDLK SN+LL+ + +I DFG ARV + V T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 704 ALDGVFSTKS-DVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744
L+ TKS D++S G IL E+++ + + D N I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (414), Expect = 6e-46
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 18/228 (7%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG---IEELKNEVLLIAKLQ 582
+D + LG GG V+ + L +++AVK L + + E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 583 HRNLVKLLGCCLEEDEN----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
H +V + E ++ E++ +L + E + K+ ++I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG-GEEILAITKRVVGTYG 697
+ + H + IIHRD+K +NI++ ++ DFG AR + T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 698 YMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
Y+SPE A +SDV+S G +L E++TG+ F D ++
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE---PPFTGDSPVSVAY 224
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 8e-45
Identities = 45/221 (20%), Positives = 97/221 (43%), Gaps = 15/221 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+ + + LG+G FG V++ S+ + K + G +K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNI 63
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+ L +E ++I+EF+ + I + L+ ++ + + + +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 647 SRLRIIHRDLKASNILLDEKMNPR--ISDFGTARVFGGEEILAITKRVVGTYGYMSPEYA 704
I H D++ NI+ + + I +FG AR + + + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 705 LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
V ST +D++S G ++ +++G F + + +I+
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI---NPFLAETNQQIIE 213
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 1e-44
Identities = 57/285 (20%), Positives = 97/285 (34%), Gaps = 25/285 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+ + K+G G FG +Y G ++ G+E+A+K + +L E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+ + C E + ++ + SL+ SRK K + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120
Query: 647 SRLRIIHRDLKASNIL---LDEKMNPRISDFGTARVFGGEEILAI-----TKRVVGTYGY 698
IHRD+K N L + I DFG A+ + K + GT Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758
S L S + D+ S G +L+ G + + E
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
+ SE + C R D+P S + + N
Sbjct: 240 L------CKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 1e-44
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 17/224 (7%)
Query: 527 TDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-LKNEVLLIAKLQHR 584
D + + LG G F V + + +A+K ++ + +G E ++NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N+V L LI + + L I K + +I + V YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 645 QDSRLRIIHRDLKASNILL---DEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSP 701
I+HRDLK N+L DE ISDFG +++ +L GT GY++P
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAP 178
Query: 702 EYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
E +S D +S GVI ++ G F D++ + L +
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGY---PPFYDENDAKLFE 219
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 16/224 (7%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEV-LLIAKLQ 582
++F LG+G FG V+ + Q A+K L +E E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 583 HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 642
H L + ++ + E++ L Y I D + I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 643 LHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
LH I++RDLK NILLD+ + +I+DFG + + A T GT Y++PE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPE 173
Query: 703 YALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKY 746
L ++ D +SFGV+L E++ G+ F+ D L
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ---SPFHGQDEEELFHS 214
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 156 bits (396), Expect = 2e-43
Identities = 62/287 (21%), Positives = 110/287 (38%), Gaps = 39/287 (13%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGI---------EELKNEVLL 577
+N+ LG+G V + +E AVK + T G E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 578 IAKLQ-HRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
+ K+ H N+++L L+++ M L ++ + K L K+ I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTY 696
+ LH +L I+HRDLK NILLD+ MN +++DFG + E + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 697 GYMSPEYALDGV------FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750
Y++PE + + + D++S GVI+ ++ G F +++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---PPFWHRKQMLMLRMIMSG 230
Query: 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTV 797
+ E D S + + + R +
Sbjct: 231 NYQFGSPEWDDYS-------DTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-42
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 18/219 (8%)
Query: 534 NKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEE-----LKNEVLLIAKLQHRNLV 587
+ LG+G F VYK + + Q +A+K++ ++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 588 KLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 647
LL + L+++FM +L +L +G+ YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALD- 706
I+HRDLK +N+LLDE +++DFG A+ FG V T Y +PE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGA 175
Query: 707 GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
++ D+++ G IL E++ D + +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV---PFLPGDSDLDQLT 211
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-42
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 14/222 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHR 584
+NF K+G+G +G VYK + G+ +A+K RL T + E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N+VKLL E++ L++EF+ + D S + + + +G+ + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE-Y 703
R++HRDLK N+L++ + +++DFG AR FG V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEIL 174
Query: 704 ALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+ST D++S G I E++T + +F D + +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDSEIDQLF 213
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-42
Identities = 66/292 (22%), Positives = 121/292 (41%), Gaps = 26/292 (8%)
Query: 526 ATDNFSTSNKLGQGGFGPVYKGK--LSNGQEIAVKRLSTTSGQG--IEELKNEVLLIAKL 581
A + ++G+G +G V+K + + G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 582 ---QHRNLVKLLGCCLEEDENMLIYEFMPNKSLD---YFIFDESRKQLLDWKKRFDIILG 635
+H N+V+L C + + + +D D+ + + + D++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 636 IARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGT 695
+ RG+ +LH R++HRDLK NIL+ +++DFG AR++ + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVT 178
Query: 696 YGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYA-----WEL 750
Y +PE L ++T D++S G I E+ K R +D D I E
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLL-----CVQDRTTDRPSMSTV 797
W + AL ++ + + I C+ R S +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-41
Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
+++ + +G G FG VY+ KL +G+ +A+K++ Q E+ ++ KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 587 VKLLGCCLEEDENM------LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 640
V+L E L+ +++P KQ L + + R +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
Y+H I HRD+K N+LLD ++ DFG+A+ E + + Y
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYR 189
Query: 700 SPEYALDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+PE +++ DV+S G +L E++ G+ IF D + +
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ---PIFPGDSGVDQLV 233
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (381), Expect = 3e-41
Identities = 44/287 (15%), Positives = 96/287 (33%), Gaps = 27/287 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL 586
++ ++G+G FG +++G L N Q++A+K S +L++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 587 VKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 646
+ + +E + ++ + SL+ + + + K + V +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 647 SRLRIIHRDLKASNILLDEKMNP-----RISDFGTARVFGGEE-----ILAITKRVVGTY 696
+++RD+K N L+ + + DFG + + K + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 697 GYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756
YMS L S + D+ + G + + + G + + + E
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803
E+ E + + P + + S
Sbjct: 238 RELCAG------FPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (380), Expect = 3e-41
Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 14/221 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHRN 585
+ + K+G+G +G VYK + + G+ A+K RL E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+VKL + +L++E + E L+ +L + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 646 DSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYAL 705
R++HRDLK N+L++ + +I+DFG AR FG + T Y +P+ +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 706 -DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+ST D++S G I E++ G +F ++ +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT---PLFPGVSEADQLM 211
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-39
Identities = 59/293 (20%), Positives = 111/293 (37%), Gaps = 48/293 (16%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKN------EVLLIAKLQ--HRN 585
LG GGFG VY G +S+ +A+K + EL N EV+L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 586 LVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 645
+++LL D +LI E + + + L + + V + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 646 DSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYA 704
++HRD+K NIL+D + ++ DFG+ + + GT Y PE+
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWI 181
Query: 705 LDGVFSTKS-DVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763
+ +S V+S G++L +++ G F D+ + + ++ ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD---IPFEHDEEIIRGQVFFRQRVSSECQHLIRW- 237
Query: 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF--VPSPKQPT 814
C+ R +DRP+ + ++ V P++
Sbjct: 238 -------------------CLALRPSDRPTFEEI---QNHPWMQDVLLPQETA 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 64/281 (22%), Positives = 116/281 (41%), Gaps = 33/281 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRL------STTSGQGIEELKNEVLLIAK 580
D + T +LG G F V K + S G + A K + S+ G E+++ EV ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 581 LQHRNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 640
+QH N++ L + + +LI E + L F+ K+ L ++ + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNPR----ISDFGTARVFGGEEILAITKRVVGTY 696
++ L+I H DLK NI+L ++ P+ I DFG A K + GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTP 180
Query: 697 GYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756
+++PE ++D++S GVI +++G F D E ++ A
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTK-------QETLANVSA 230
Query: 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTV 797
+ S ++ A I+ + R ++
Sbjct: 231 VNYEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-39
Identities = 48/222 (21%), Positives = 92/222 (41%), Gaps = 15/222 (6%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQH 583
++F LG+G FG V + + G+ A+K L + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 584 RNLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
L L D + E+ L + + SR+++ ++ I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---L 118
Query: 644 HQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEY 703
+++RD+K N++LD+ + +I+DFG + + A K GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEV 176
Query: 704 ALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
D + D + GV++ E++ G+ F + D L +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR---LPFYNQDHERLFE 215
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-38
Identities = 54/323 (16%), Positives = 126/323 (39%), Gaps = 34/323 (10%)
Query: 528 DNFSTSNK-LGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHR 584
D++ +++ LG G G V + ++ A+K L Q + + EV L + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 65
Query: 585 NLVKLLGCC----LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 640
++V+++ +++ E + L I + Q ++ +I+ I +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAI 124
Query: 641 LYLHQDSRLRIIHRDLKASNILLDEKMNP---RISDFGTARVFGGEEILAITKRVVGTYG 697
YLH + I HRD+K N+L K +++DFG A+ T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPY 178
Query: 698 YMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757
Y++PE + D++S GVI+ ++ G F + + + + +
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY---PPFYSNHGLAIS---PGMKTRIRMG 232
Query: 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV---FMLSNETFVPSPKQPT 814
+ + S ++ E I+ ++ T R +++ + +++ + +P +
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
Query: 815 FSVRRTEIDTDNSSSGIKSSVNE 837
++ + ++ + S++
Sbjct: 290 RVLKEDKERWEDVKEEMTSALAT 312
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (359), Expect = 8e-38
Identities = 61/263 (23%), Positives = 102/263 (38%), Gaps = 19/263 (7%)
Query: 491 SSTRFSEREASISTKGNKEIRKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-L 549
++ + SE+E S+ K + S A D F LG G FG V K
Sbjct: 5 AAKKGSEQE-SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 550 SNGQEIAVKRLS---TTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606
+G A+K L + IE NE ++ + LVKL + ++ E++
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEK 666
+ + R I YLH L +I+RDLK N+L+D++
Sbjct: 124 AGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQ 177
Query: 667 MNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEII 726
+++DFG A+ G T + GT ++PE L ++ D ++ GV++ E+
Sbjct: 178 GYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 727 TGKKNTRIFNDDDSSNLIKYAWE 749
G F D + +
Sbjct: 233 AGY---PPFFADQPIQIYEKIVS 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 53/232 (22%), Positives = 100/232 (43%), Gaps = 20/232 (8%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQG--IEELKNEVLLIAKLQHR 584
+ K+GQG FG V+K + GQ++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 585 NLVKLLGCCLEEDENM--------LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 636
N+V L+ C + L+++F + + L + K+ ++L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL-- 127
Query: 637 ARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR--VVG 694
L+ R +I+HRD+KA+N+L+ +++DFG AR F + + V
Sbjct: 128 ----NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 695 TYGYMSPEYAL-DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
T Y PE L + + D++ G I+ E+ T + + LI
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 51/227 (22%), Positives = 99/227 (43%), Gaps = 12/227 (5%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVK--RLSTTSGQGIEELKNEVLLIAKLQHR 584
+ K+G+G +G V+K K + +A+K RL E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 585 NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 644
N+V+L + + L++EF YF + + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH 118
Query: 645 QDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYA 704
++HRDLK N+L++ ++++FG AR F G + + VV +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 705 LDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELW 751
++ST D++S G I E+ + +F +D + +K + L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR--PLFPGNDVDDQLKRIFRLL 219
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-34
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 26/228 (11%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHR 584
+ +G G +G V G ++A+K+L S + E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 585 NLVKLLGCCLEED------ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
N++ LL ++ + L+ FM + + L + ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
G+ Y+H IIHRDLK N+ ++E +I DFG AR E V T Y
Sbjct: 133 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWY 184
Query: 699 MSPEYALDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
+PE L+ + ++ D++S G I+ E+ITGK +F D + +K
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK---TLFKGSDHLDQLK 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 56/229 (24%), Positives = 91/229 (39%), Gaps = 21/229 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGKL----SNGQEIAVKRLS----TTSGQGIEELKNEVLLIA 579
+NF LG G +G V+ + G+ A+K L + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 580 KLQHR-NLVKLLGCCLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
++ LV L E + LI +++ L + R + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
VL L +L II+RD+K NILLD + ++DFG ++ F +E GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEY 196
Query: 699 MSPEYALDGV--FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
M+P+ G D +S GV++ E++TG F D N
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA---SPFTVDGEKNSQA 242
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (318), Expect = 2e-32
Identities = 44/208 (21%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRN 585
D++ KLG+G + V++ ++N +++ VK L +++K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 586 LVKLLGCCLEEDENM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 643
++ L + L++E + N Q L + I + + Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 644 HQDSRLRIIHRDLKASNILLDEK-MNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPE 702
H + I+HRD+K N+++D + R+ D+G A + + V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPE 199
Query: 703 YALD-GVFSTKSDVFSFGVILLEIITGK 729
+D ++ D++S G +L +I K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-31
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 21/226 (9%)
Query: 528 DNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLS--TTSGQGIEELKNEVLLIAKLQHR 584
+ +G G G V + +A+K+LS + + E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 585 NLVKLLGCCL------EEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 638
N++ LL E + L+ E M + LD ++ ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130
Query: 639 GVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGY 698
G+ +LH IIHRDLK SNI++ +I DFG AR G + V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYY 184
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744
+PE L + D++S G I+ E++ K + D N +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-30
Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 22/240 (9%)
Query: 511 RKVDVTFFELSTLLAATDNFSTSNKLGQGGFGPVYKGK-LSNGQEIAVKRLSTT--SGQG 567
++++ T +E+ + + + +G G +G V G +AVK+LS S
Sbjct: 7 QELNKTIWEV------PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60
Query: 568 IEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI-YEFMPNKSLDYFIFDESRKQLLDW 626
+ E+ L+ ++H N++ LL ++ + + + + Q L
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 627 KKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686
+I I RG+ Y+H IIHRDLK SN+ ++E +I DFG AR E
Sbjct: 121 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 174
Query: 687 AITKRVVGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIK 745
V T Y +PE L+ + ++ D++S G I+ E++TG+ +F D + +K
Sbjct: 175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR---TLFPGTDHIDQLK 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (289), Expect = 1e-28
Identities = 45/245 (18%), Positives = 89/245 (36%), Gaps = 21/245 (8%)
Query: 535 KLGQGGFGPVYKGK-LSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCC 593
KLG G F V+ K + N +A+K + E ++E+ L+ ++ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 594 LE-------------EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 640
+ ++ F + + + + I + G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 641 LYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYM 699
Y+H+ R IIH D+K N+L++ + A + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 700 SPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759
SPE L + +D++S ++ E+ITG +F D+ + K + + L
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD---FLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 760 VDSSM 764
+ S +
Sbjct: 254 LPSYL 258
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 98.3 bits (244), Expect = 4e-24
Identities = 43/206 (20%), Positives = 70/206 (33%), Gaps = 35/206 (16%)
Query: 534 NKLGQGGFGPVYKGKLSNGQEIAVK--RLSTTSGQ--------GIEELKNEVLLIAKLQH 583
+G+G V+ E VK ++ TS + G + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 584 RNLVKLLGCC----LEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 639
R L KL G + N ++ E + K L + + ++ I
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE----------VLDMILEE 115
Query: 640 VLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILAITKR-VVGTYGY 698
V + I+H DL N+L+ E I DF + G E I +R V Y
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITY 171
Query: 699 MSPEYALDGVFSTKSDVFSFGVILLE 724
S Y T+ D+ S +L+
Sbjct: 172 FSRTY------RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 74.6 bits (183), Expect = 9e-17
Identities = 20/126 (15%), Positives = 44/126 (34%), Gaps = 19/126 (15%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
+ ++ + + G + Y N V ++ + T +W +N
Sbjct: 2 NLLTNGEGLYAGQSLDVEP--YHFIMQEDCNLV-----LYDHS----TSVWASNTGILGK 50
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
+ GN V++ + +W ++ GN V L + GN+V+ G +
Sbjct: 51 KGCK-AVLQSDGNFVVY--DAEGRSLWASHSV-RGNGNYVLVLQEDGNVVIY----GSDI 102
Query: 144 WQSFDH 149
W + +
Sbjct: 103 WSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 71.5 bits (175), Expect = 1e-15
Identities = 18/96 (18%), Positives = 31/96 (32%), Gaps = 7/96 (7%)
Query: 62 IWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGN 121
I Y+ + + + LS+ NLVL +R+ VW N +
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDD---RVWSTNTA-GKGTG 67
Query: 122 TVAQLLDTGNLVLVRNDTGETLWQSFD--HPTDTVL 155
A L G + + + +W S + V
Sbjct: 68 CRAVLQPNGRMDV-LTNQNIAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 37.2 bits (86), Expect = 0.001
Identities = 19/110 (17%), Positives = 36/110 (32%), Gaps = 10/110 (9%)
Query: 87 GVLSVNIQGNLVLHERNQSTVPVWQANISEA-SAGNTVAQLLDTGNLVLVRNDTGETLWQ 145
G + V GN +L+ + + +++ + NLVL D + +W
Sbjct: 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVL--FDRDDRVWS 58
Query: 146 SFDHPTDTVLPNMRFGWDKRTGL----NRYVTAWKSPDDPGSGNFSFTLD 191
T R + N+ + W S + +G + F L
Sbjct: 59 ---TNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQ 105
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 66.0 bits (160), Expect = 9e-14
Identities = 21/129 (16%), Positives = 45/129 (34%), Gaps = 18/129 (13%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
D ++ + G + Y + N V W + N +
Sbjct: 2 DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNLVLYDNNRAV---------WASGTNGKAS 50
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
VL + GNLV++ ++ +W +N + GN L N+V+ +++ +
Sbjct: 51 GC--VLKMQNDGNLVIYSGSR---AIWASNTNR-QNGNYYLILQRDRNVVI-YDNSNNAI 103
Query: 144 WQSFDHPTD 152
W + + +
Sbjct: 104 WATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 63.1 bits (153), Expect = 8e-13
Identities = 27/126 (21%), Positives = 42/126 (33%), Gaps = 20/126 (15%)
Query: 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPIN 83
+ + + + G+ + + N V V W N
Sbjct: 2 NILYSGETLSTGEFLNYGS--FVFIMQEDCNLVLYDVDKPI---------WATNTGGL-- 48
Query: 84 DTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETL 143
S LS+ GNLV++ N S P+W +N GN V L N+V+ G
Sbjct: 49 SRSCFLSMQTDGNLVVY--NPSNKPIWASNTG-GQNGNYVCILQKDRNVVIY----GTDR 101
Query: 144 WQSFDH 149
W + H
Sbjct: 102 WATGTH 107
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 61.9 bits (150), Expect = 3e-12
Identities = 17/88 (19%), Positives = 30/88 (34%), Gaps = 6/88 (6%)
Query: 62 IWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGN 121
I + + + + + +S ++ NLVL + + VW +N + A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDV---RVWASNTA--GATG 57
Query: 122 TVAQLLDTGNLVLVRNDTGETLWQSFDH 149
A L G LV+ W S
Sbjct: 58 CRAVLQSDGLLVI-LTAQNTIRWSSGTK 84
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 52.7 bits (126), Expect = 6e-09
Identities = 24/135 (17%), Positives = 42/135 (31%), Gaps = 22/135 (16%)
Query: 12 LFFQFSQISTSIDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLT 71
+ F + ++ ++ I+ +Y + N V
Sbjct: 3 IIFSKQPDDNHPQILHATESLE----ILFGTHVYRFIMQTDCNLVLYDNN---------N 49
Query: 72 LLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGN 131
+W N N + G LV+ V VWQ+ AG+ V L N
Sbjct: 50 PIWATNTGGLGNGCR--AVLQPDGVLVVI--TNENVTVWQSP-VAGKAGHYVLVLQPDRN 104
Query: 132 LVLVRNDTGETLWQS 146
+V+ G+ LW +
Sbjct: 105 VVI----YGDALWAT 115
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 837 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.8 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.77 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.76 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.63 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.49 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.48 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.22 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.87 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.79 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.76 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.64 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.38 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.72 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.79 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.13 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.14 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.77 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 84.88 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 82.99 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 82.67 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.99 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=417.22 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=198.7
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|++.++||+|+||+||+|++.+++.||||+++.. ....++|.+|++++.+++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467778999999999999999988999999999653 4556889999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+|+|.+++... ...+++..++.++.|||+||.|||+.+ |+||||||+||||++++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999998643 345899999999999999999999988 9999999999999999999999999998765443222
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
.....||+.|+|||++.+..++.++|||||||++|||+|+..|+... .....+...+.. +. ....+
T Consensus 159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~----~~--~~~~p----- 224 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--RSNSEVVEDIST----GF--RLYKP----- 224 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--CCHHHHHHHHHH----TC--CCCCC-----
T ss_pred -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC--CCHHHHHHHHHh----cC--CCCCc-----
Confidence 23357899999999999999999999999999999999965544221 111222222211 11 01111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.....++.+++.+||+.||++||||+||++.|+++
T Consensus 225 --~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 225 --RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11224578999999999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=414.80 Aligned_cols=259 Identities=27% Similarity=0.421 Sum_probs=201.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|++.++||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++.+++|||||++++++.+ +..+||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 357888999999999999999875 36999998654 34456789999999999999999999998754 56899999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++|+|.+++.... ..+++..++.++.|||+||.|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999996532 35899999999999999999999987 9999999999999999999999999998776544
Q ss_pred ceeeeccccccCCccCcccccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALD---GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.........||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... ...+..........+...
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~~~~~~~~~~p~~~---- 232 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDLS---- 232 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHHTSCCCCGG----
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCcch----
Confidence 4344455789999999999864 3589999999999999999999999864321 111111111111111111
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..... ....+.+++.+||+.||++||||+||++.|+.+
T Consensus 233 -~~~~~----~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 233 -KVRSN----CPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp -GSCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hcccc----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11112 234577899999999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-49 Score=414.19 Aligned_cols=254 Identities=29% Similarity=0.458 Sum_probs=205.5
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|++.++||+|+||+||+|++++++.||||+++.. ....++|.+|++++.+++|||||++++++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 467778999999999999999988899999999654 3456789999999999999999999998854 56799999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+|+|.+++.... ...++|..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+|+........
T Consensus 91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~- 165 (272)
T d1qpca_ 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 165 (272)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred CCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc-
Confidence 999999875432 234899999999999999999999987 999999999999999999999999999987654332
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
......||+.|+|||++.++.++.++|||||||++|||+||+.|+.... ....+...+ ..+.. +.....
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~~~~i----~~~~~-----~~~p~~ 234 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNL----ERGYR-----MVRPDN 234 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHH----HTTCC-----CCCCTT
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHHHHHH----HhcCC-----CCCccc
Confidence 2334678999999999999999999999999999999999766653221 111122111 11111 111112
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
+ ...+.+++.+||+.||++||||+||+++|+.
T Consensus 235 ~----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 235 C----PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2 2357889999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-48 Score=413.83 Aligned_cols=256 Identities=28% Similarity=0.399 Sum_probs=210.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
++|++.++||+|+||+||+|++. +++.||||+++.. ....++|.+|+++|++++|||||+++++|.+++..++||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 46777889999999999999886 5889999999654 445788999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|.+++.... ...+++..++.++.|||+||.|||+++ |+||||||+||||++++.+||+|||+++........
T Consensus 96 ~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 96 TYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp TTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred cCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999986543 346899999999999999999999987 999999999999999999999999999876554332
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......|++.|+|||++.+..++.++|||||||++|||++|+.|+....+ ...+. .....+...
T Consensus 172 -~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~----~~i~~~~~~--------- 235 (287)
T d1opja_ 172 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVY----ELLEKDYRM--------- 235 (287)
T ss_dssp -EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHH----HHHHTTCCC---------
T ss_pred -eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHH----HHHhcCCCC---------
Confidence 22335688999999999999999999999999999999998777642211 11111 111111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..+......+.+++..||+.||++||||+||+++|+.+
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122234578999999999999999999999999865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=408.89 Aligned_cols=252 Identities=24% Similarity=0.312 Sum_probs=202.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56888899999999999999875 68999999997543 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+++|+|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999853 345899999999999999999999988 99999999999999999999999999998765444
Q ss_pred eeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 686 LAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
.......+||+.|||||++.+..+ +.++|||||||++|||++|+.||........ .... .........
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~~---~~~~~~~~~------ 227 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSD---WKEKKTYLN------ 227 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHHH---HHTTCTTST------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHHH---HhcCCCCCC------
Confidence 444455789999999999988876 5789999999999999999999965432211 1111 111111000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
........+.+++.+|++.||++|||++|+++
T Consensus 228 ---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111235668899999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=402.69 Aligned_cols=253 Identities=23% Similarity=0.421 Sum_probs=210.5
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|++.++||+|+||+||+|++++++.||||++++. ....++|.+|++++.+++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 578889999999999999999998999999999754 3456789999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+|+|..++.... ..+++..+.+++.|||+||.|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999976543 35789999999999999999999987 9999999999999999999999999998765543332
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
.....+|..|+|||.+.+..++.|+|||||||++|||+| |+.||..... ..+... . ..+.. ...+
T Consensus 158 -~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~---i-~~~~~--~~~p---- 223 (258)
T d1k2pa_ 158 -SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEH---I-AQGLR--LYRP---- 223 (258)
T ss_dssp -CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHH---H-HTTCC--CCCC----
T ss_pred -ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHH---H-HhCCC--CCCc----
Confidence 223578999999999999999999999999999999998 8989864322 122221 1 11111 1111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
......+.+++.+||+.||++||||++|++.|..
T Consensus 224 ---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 ---HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1122457899999999999999999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-48 Score=415.08 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=195.4
Q ss_pred cCCCcCCcccccCCeeEEEEEecC-C---cEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN-G---QEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.++||+|+||+||+|++.. + ..||||++... .....++|.+|+++|++++|||||+++++|.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 346667899999999999998752 3 35899998654 334567899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++|+|.+++... ...++|.+++.++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999988643 345899999999999999999999987 99999999999999999999999999987754
Q ss_pred ccceee---eccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 683 EEILAI---TKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 683 ~~~~~~---~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
...... .....+|+.|||||.+.++.++.++|||||||++|||+| |+.||..... ..+...+ . .+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i---~-~~~~-- 251 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAI---E-QDYR-- 251 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH---H-TTCC--
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHH---H-cCCC--
Confidence 332211 122457899999999999999999999999999999998 8999853221 1222211 1 1111
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
...+......+.+++.+||+.||++||||+||++.|+.+
T Consensus 252 -------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 252 -------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 011122234578899999999999999999999999865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=405.70 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=202.1
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMP 607 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 607 (837)
++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++.+++|||||+++++|.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 467888999999999999999998889999999644 4556889999999999999999999999854 56899999999
Q ss_pred CCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcccee
Q 003237 608 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEILA 687 (837)
Q Consensus 608 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 687 (837)
+|+|..++.... ...++|..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++........
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 999998886543 235899999999999999999999988 999999999999999999999999999876544322
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMANS 767 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 767 (837)
......||+.|+|||++.++.++.++|||||||++|||++|+.|+..... ...+...+ ..+.. ......
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i----~~~~~-----~~~~~~ 238 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQV----ERGYR-----MPCPPE 238 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH----HTTCC-----CCCCTT
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHH----HhcCC-----CCCCcc
Confidence 22336789999999999999999999999999999999998776543211 11122211 11111 111112
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 768 CLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 768 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
...++.+++.+||+.||++||||++|+++|+..-
T Consensus 239 ----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 239 ----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ----cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 2345789999999999999999999999998753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=414.11 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=206.2
Q ss_pred cCCCcCCcccccCCeeEEEEEecC-C-----cEEEEEEecCC-CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN-G-----QEIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~-g-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 599 (837)
++|++.++||+|+||+||+|+... + ..||||++... .......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578888999999999999998643 2 36999998654 334556789999999998 899999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcCC--------------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCC
Q 003237 600 MLIYEFMPNKSLDYFIFDESR--------------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKAS 659 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 659 (837)
+|||||+++|+|.++|..... ...+++..++.++.||++||.|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999965422 235899999999999999999999987 999999999
Q ss_pred cEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC
Q 003237 660 NILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDD 738 (837)
Q Consensus 660 NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~ 738 (837)
|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~- 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999988765544444455678999999999999999999999999999999998 8999864322
Q ss_pred CcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003237 739 DSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 802 (837)
Q Consensus 739 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~ 802 (837)
...+... ...+... ..+......+.+++.+||+.||++||||+||+++|.
T Consensus 273 -~~~~~~~----~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 -DANFYKL----IQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -SHHHHHH----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHHH----HhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1112221 1111111 111122345789999999999999999999999984
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=408.45 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=199.4
Q ss_pred cCCCcCCcccccCCeeEEEEEecCC-----cEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNG-----QEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
..|+..++||+|+||+||+|.++.. ..||||+++... ....++|.+|++++.+++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3566778999999999999987642 379999996543 3345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
||||+.+++|.+++.... ..++|..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999998876533 45899999999999999999999987 9999999999999999999999999998765
Q ss_pred Cccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
..... .......||+.|+|||++.++.++.++|||||||++|||++|+.|+.... ....+... ...+..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~----i~~~~~---- 231 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKA----INDGFR---- 231 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHH----HHTTCC----
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHH----HhccCC----
Confidence 43322 22333568999999999999999999999999999999999776653221 11112211 111111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
...+......+.+++.+||+.+|++||||+||+++|+.+..
T Consensus 232 -----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11122223457899999999999999999999999987543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=398.94 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=206.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
++|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47899999999999999999864 69999999997665566788999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999988754 24899999999999999999999988 99999999999999999999999999998754332
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. .........+.. .+ .
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~---~~~~~~~~~~~~-~~---~--- 237 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PL---RALYLIATNGTP-EL---Q--- 237 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HH---HHHHHHHHHCSC-CC---S---
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC---HH---HHHHHHHhCCCC-CC---C---
Confidence 2234679999999999999999999999999999999999999985321 11 111111111110 00 0
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+......+.+++.+|++.||++|||++|+++
T Consensus 238 -~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112345778999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=403.74 Aligned_cols=254 Identities=25% Similarity=0.459 Sum_probs=204.4
Q ss_pred cCCCcCC-cccccCCeeEEEEEec---CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSN-KLGQGGFGPVYKGKLS---NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|.+.+ +||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|.+++|||||++++++.+ +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455555 4999999999999764 35579999997543 3446789999999999999999999999864 568999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++|+|.+++... +..+++..++.++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999987543 345899999999999999999999987 99999999999999999999999999998765
Q ss_pred ccce-eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 683 EEIL-AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 683 ~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||..... ..+... ...+...+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~----i~~~~~~~-- 232 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAF----IEQGKRME-- 232 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHH----HHTTCCCC--
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcCCCCC--
Confidence 4332 22334578999999999999999999999999999999998 8999864322 122221 12222111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
....+ ...+.+++.+||+.+|++||||.+|++.|+.
T Consensus 233 ---~p~~~----~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 233 ---CPPEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ---CCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCcC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11122 2457789999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=398.03 Aligned_cols=245 Identities=23% Similarity=0.354 Sum_probs=203.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999875 6889999998643 2345678899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999998653 34899999999999999999999988 999999999999999999999999999876543
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. .... .. ..
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~---~i~~-~~------~~ 222 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYK---RISR-VE------FT 222 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHH---HHHT-TC------CC
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---HHHHHH---HHHc-CC------CC
Confidence 2 234679999999999999999999999999999999999999985321 111111 1111 11 01
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+... ....+.+++.+|++.||++|||++||++
T Consensus 223 ~p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPDF----VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcc----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111 2235678999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=402.92 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=193.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeeccccc--CCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLE--EDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV 602 (837)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++.+++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57888999999999999999875 68999999997543 3345678899999999999999999999865 3457899
Q ss_pred EEecCCCChhhHhhhc-CCCCCCChhhHHHHHHHHHHHHHHHHhcCC--CceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 603 YEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSR--LRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
|||+++|+|.+++... .....+++..+..++.||+.||.|||+.+. .+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998653 234568999999999999999999998652 3599999999999999999999999999987
Q ss_pred ccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 680 FGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 680 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ..+....
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i----~~~~~~~- 233 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKI----REGKFRR- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHH----HHTCCCC-
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHH----HcCCCCC-
Confidence 654322 2334789999999999999999999999999999999999999986322 11222111 1111111
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
+...+ ..++.+++.+|++.||++|||++|+++
T Consensus 234 ----~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ----IPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11122 235778999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=400.65 Aligned_cols=247 Identities=27% Similarity=0.441 Sum_probs=196.9
Q ss_pred CcccccCCeeEEEEEecC---CcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEecCC
Q 003237 534 NKLGQGGFGPVYKGKLSN---GQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFMPN 608 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 608 (837)
++||+|+||+||+|.+.+ ++.||||+++... ....++|.+|++++++++|||||+++++|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998653 5689999996542 2335689999999999999999999999854 567899999999
Q ss_pred CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce-e
Q 003237 609 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL-A 687 (837)
Q Consensus 609 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~-~ 687 (837)
|+|.+++... ..+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999998643 35899999999999999999999987 999999999999999999999999999987654332 2
Q ss_pred eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccccccccc
Q 003237 688 ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMAN 766 (837)
Q Consensus 688 ~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 766 (837)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ...+.. ....+.... ...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~~~~----~i~~~~~~~-----~p~ 233 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTA----MLEKGERMG-----CPA 233 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHH----HHHTTCCCC-----CCT
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC---HHHHHH----HHHcCCCCC-----CCc
Confidence 2334678999999999999999999999999999999998 899986322 111111 112221111 111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 767 SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 767 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
.+ ...+.+++.+||+.||++||||++|+++|+.
T Consensus 234 ~~----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 234 GC----PREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cc----CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 22 2457789999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-47 Score=407.87 Aligned_cols=261 Identities=27% Similarity=0.440 Sum_probs=210.6
Q ss_pred hhcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCCc-cCHHHHHHHHHHHHHhcCCCeeeeecccccCCc
Q 003237 526 ATDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTSG-QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE 598 (837)
Q Consensus 526 at~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 598 (837)
..++|++.++||+|+||+||+|+.. +++.||||+++.... ...++|.+|++++++++||||++++++|.+...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999864 357899999975433 345679999999999999999999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcC---------------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 003237 599 NMLIYEFMPNKSLDYFIFDES---------------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 657 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 657 (837)
.++||||+++|+|.+++.... ....+++..++.++.||++||+|||+.+ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999996432 1234889999999999999999999988 9999999
Q ss_pred CCcEEEcCCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCC-CCCCCC
Q 003237 658 ASNILLDEKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKK-NTRIFN 736 (837)
Q Consensus 658 p~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~-p~~~~~ 736 (837)
|+||||+.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++|.. |+...
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~- 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM- 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC-
Confidence 9999999999999999999987755544444445678999999999999999999999999999999999964 55432
Q ss_pred CCCcchHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 737 DDDSSNLIKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 737 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
....+... ...+.... ..... ..++.+++.+||+.+|++||||.||+++|+++.
T Consensus 247 --~~~e~~~~----v~~~~~~~-----~p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 --AHEEVIYY----VRDGNILA-----CPENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp --CHHHHHHH----HHTTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CHHHHHHH----HHcCCCCC-----CCccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11222221 12222211 11122 235789999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=399.34 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=205.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
+.|++.++||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46788899999999999999875 68999999998776677788999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|..++.+.. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 9999999876543 35899999999999999999999998 9999999999999999999999999998654321
Q ss_pred eeeccccccCCccCccccc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 687 AITKRVVGTYGYMSPEYAL-----DGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.......||+.|+|||++. +..|+.++|||||||++|||++|+.||..... ...... ..... ...+.
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~---~~~~~~---i~~~~-~~~~~- 236 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRVLLK---IAKSE-PPTLA- 236 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGHHHH---HHHSC-CCCCS-
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHH---HHcCC-CCCCC-
Confidence 1223468999999999984 45689999999999999999999999864322 122111 11111 10110
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.+......+.+++.+||+.||++|||++|+++
T Consensus 237 ------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 ------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112345778999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=398.89 Aligned_cols=248 Identities=25% Similarity=0.320 Sum_probs=201.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46888999999999999999875 6899999998643 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988654 34899999999999999999999998 999999999999999999999999999987654
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+. ...... . ..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~---~~i~~~-~------~~ 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIF---QKIIKL-E------YD 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH---HHHHTT-C------CC
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHH---HHHHcC-C------CC
Confidence 44444445789999999999999999999999999999999999999996321 11111 111111 1 01
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVV 798 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv 798 (837)
+.... ...+.+++.+|++.||++|||++|++
T Consensus 229 ~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 FPEKF----FPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCccC----CHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11122 23577899999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=406.74 Aligned_cols=199 Identities=26% Similarity=0.391 Sum_probs=176.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|++.++||+|+||+||+|+.. +|+.||||+++... ....+++.+|+.+|++++|||||++++++.++++.+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467889999999999999999875 68999999997653 3335678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
|+++|+|.+++.... .+++..+..++.||++||.|||+. + |+||||||+||||+.++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999997543 489999999999999999999974 6 999999999999999999999999999875432
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIF 735 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 735 (837)
. ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 159 ~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 159 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp T----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred c----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2 23468999999999999999999999999999999999999999653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=391.30 Aligned_cols=246 Identities=23% Similarity=0.372 Sum_probs=193.9
Q ss_pred CcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeeccccc----CCccEEEE
Q 003237 531 STSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE----EDENMLIY 603 (837)
Q Consensus 531 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 603 (837)
...++||+|+||+||+|+.. +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ ....+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999875 6889999998654 33345678999999999999999999999865 34568999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc-CCCCeeecccccceeccC
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EKMNPRISDFGTARVFGG 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~DFGla~~~~~ 682 (837)
||+++|+|.+++... ..+++..+..++.||++||.|||+++ .+|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999653 35899999999999999999999875 4599999999999996 588999999999986543
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
.. .....||+.|||||++.+ .++.++|||||||++|||++|+.||..... ...+.. .. ..+... .
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~---~i-~~~~~~----~ 232 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYR---RV-TSGVKP----A 232 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHH---HH-TTTCCC----G
T ss_pred Cc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHH---HH-HcCCCC----c
Confidence 32 234689999999998865 699999999999999999999999853221 111111 11 111111 1
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...... ..++.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111112 234678999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=398.64 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=200.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCc----EEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ----EIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 601 (837)
++|++.++||+|+||+||+|++. +|+ .||||+++.. .....++|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888899999999999999875 444 5899998654 445678899999999999999999999999764 5678
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceecc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFG 681 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~ 681 (837)
++||+.+|+|.+++... ...+++..++.++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999999888654 345899999999999999999999987 9999999999999999999999999999876
Q ss_pred CccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccccc
Q 003237 682 GEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIV 760 (837)
Q Consensus 682 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 760 (837)
............||+.|+|||++.++.++.++|||||||++|||+| |+.|+..... ..+...+.. +...
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---~~~~~~i~~----~~~~--- 232 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEK----GERL--- 232 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---GGHHHHHHH----TCCC---
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHc----CCCC---
Confidence 5554444445678999999999999999999999999999999998 7888764322 222222211 1110
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 761 DSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 761 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..+......+.+++.+|++.||++||||.||++.|+.+
T Consensus 233 ------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11112234577899999999999999999999887643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=389.97 Aligned_cols=249 Identities=25% Similarity=0.394 Sum_probs=195.9
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccC-CccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-DENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~ey~ 606 (837)
++|++.++||+|+||.||+|+++ |..||||++++. ...++|.+|++++++++|||||+++|+|.++ +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45677789999999999999985 789999999653 3457899999999999999999999998654 5679999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|.++|.... ...++|..+++++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999996532 235899999999999999999999987 999999999999999999999999999865432
Q ss_pred eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccccccc
Q 003237 687 AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSMA 765 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 765 (837)
.....++..|+|||++.++.++.++|||||||++|||+| |+.|+... ...++...+ ..+...+ .
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i----~~~~~~~-----~- 221 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRV----EKGYKMD-----A- 221 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHH----TTTCCCC-----C-
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHHH----HcCCCCC-----C-
Confidence 223567899999999999999999999999999999998 67776532 222333322 1111111 1
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 766 NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 766 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
+.....++.+++.+||+.||++||||.+|+++|+.+
T Consensus 222 ---~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 222 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 112224577899999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.5e-45 Score=398.78 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=206.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
++|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|.+++|||||++++++.+++..+||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57888999999999999999875 69999999997766666778899999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc--CCCCeeecccccceeccCcc
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--EKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~ki~DFGla~~~~~~~ 684 (837)
++|+|.+++... ...+++..+..++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999998543 235899999999999999999999998 99999999999996 46889999999999876543
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||.... ...+.. ........ ++...
T Consensus 181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~---~i~~~~~~---~~~~~ 248 (350)
T d1koaa2 181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLR---NVKSCDWN---MDDSA 248 (350)
T ss_dssp C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHTCCC---SCCGG
T ss_pred c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HHHHHH---HHHhCCCC---CCccc
Confidence 2 233679999999999999999999999999999999999999985321 111121 11111100 01111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFM 800 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~ 800 (837)
. ......+.+++.+|++.||++|||++|+++.
T Consensus 249 ~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 F----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp G----GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred c----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1112356789999999999999999999983
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-45 Score=390.11 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=190.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
+.|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|.+++|||||++++++.+++..+|||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56888999999999999999875 68999999997543 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc---CCCCeeecccccceeccC
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFGTARVFGG 682 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~DFGla~~~~~ 682 (837)
+++|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||+. +++.+||+|||+++....
T Consensus 89 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 89 VSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred cCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999964 345899999999999999999999988 99999999999995 578999999999987654
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ...+. ......... +..
T Consensus 163 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~---~~i~~~~~~---~~~ 230 (307)
T d1a06a_ 163 GSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLF---EQILKAEYE---FDS 230 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH---HHHHTTCCC---CCT
T ss_pred CCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHH---HHHhccCCC---CCC
Confidence 322 234679999999999999999999999999999999999999985321 11111 111111100 001
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCC
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNET 805 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~ 805 (837)
.. .......+.+++.+|++.||++|||++|+++ .+.+..
T Consensus 231 ~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 231 PY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp TT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred cc----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 11 1112245778999999999999999999998 465543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.1e-46 Score=397.02 Aligned_cols=244 Identities=27% Similarity=0.458 Sum_probs=198.3
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
.|+..++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+++..+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888899999999999999864 788999999975532 234578899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 99999997766432 35899999999999999999999998 999999999999999999999999999865432
Q ss_pred ceeeeccccccCCccCcccccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALD---GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
....||+.|||||++.+ +.|+.++|||||||++|||++|+.||.... . ........... ...+..
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~---~~~~~~i~~~~-~~~~~~ 236 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---A---MSALYHIAQNE-SPALQS 236 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---H---HHHHHHHHHSC-CCCCSC
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---H---HHHHHHHHhCC-CCCCCC
Confidence 23679999999999864 468999999999999999999999985321 1 11111111111 111111
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... ...+.+++.+|++.||++|||++|+++
T Consensus 237 ----~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 ----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111 235778999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=395.47 Aligned_cols=260 Identities=28% Similarity=0.403 Sum_probs=198.2
Q ss_pred hcCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccC-C
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEE-D 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 597 (837)
.++|++.++||+|+||.||+|+.. +++.||||+++... ....+++.+|..++.++ +|+|||++++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 357888999999999999999763 34689999997543 33456788888888887 589999999998765 4
Q ss_pred ccEEEEEecCCCChhhHhhhcCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 664 (837)
..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ ||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 67999999999999999965321 345899999999999999999999988 99999999999999
Q ss_pred CCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCC-CCCCCCCCCcchH
Q 003237 665 EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKK-NTRIFNDDDSSNL 743 (837)
Q Consensus 665 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~-p~~~~~~~~~~~l 743 (837)
+++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|.. |+..... ...+
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~--~~~~ 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEF 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC--SHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence 999999999999987765544444555789999999999999999999999999999999999754 6643221 1122
Q ss_pred HHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 744 IKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 744 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.... ..+.... .... ...++.+++.+||+.||++||||+||++.|+++
T Consensus 247 ~~~~----~~~~~~~-----~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 247 CRRL----KEGTRMR-----APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHH----HHTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH----hcCCCCC-----CCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2211 1111111 1111 223578999999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=394.45 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=209.2
Q ss_pred cCCCcCCcccccCCeeEEEEEe------cCCcEEEEEEecCCC-ccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCcc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL------SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDEN 599 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 599 (837)
++|++.++||+|+||.||+|++ .+++.||||+++... .....+|.+|+.++.++ +|||||+++++|.++...
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5677889999999999999975 246789999997643 33456788999999999 699999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcC---------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc
Q 003237 600 MLIYEFMPNKSLDYFIFDES---------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (837)
Q Consensus 600 ~lV~ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 664 (837)
+|||||+++|+|.+++.... ....+++..++.++.||++||.|||+++ ||||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999997543 2235889999999999999999999998 99999999999999
Q ss_pred CCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 003237 665 EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLI 744 (837)
Q Consensus 665 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 744 (837)
.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|++.|+....... ..+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HHHH
Confidence 999999999999998776555455556789999999999999999999999999999999999555443222111 1111
Q ss_pred HHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 745 KYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 745 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
..+ ..+. ....+......+.+++.+||+.||++||||+||+++|++
T Consensus 259 ~~i----~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 259 KMI----KEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHH----HHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH----hcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 1111 111111223457899999999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.7e-45 Score=395.57 Aligned_cols=256 Identities=21% Similarity=0.288 Sum_probs=208.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
++|++.++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|.+++|||||++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 56888999999999999999874 79999999997765555677889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc--CCCCeeecccccceeccCcc
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--EKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~ki~DFGla~~~~~~~ 684 (837)
++|+|.+++... ...+++.+...++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+|+......
T Consensus 109 ~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 999998877432 335899999999999999999999988 99999999999998 67899999999999876543
Q ss_pred ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ...... . ..
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~---~i~~~~-~------~~ 247 (352)
T d1koba_ 184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQ---NVKRCD-W------EF 247 (352)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH---HHHHCC-C------CC
T ss_pred c---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCC-C------CC
Confidence 2 2336789999999999999999999999999999999999999853211 11111 111110 0 00
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNE 804 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~ 804 (837)
...........+.+++.+|++.||++|||++|+++ .+++.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11111112245778999999999999999999987 36543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=392.53 Aligned_cols=259 Identities=26% Similarity=0.421 Sum_probs=206.3
Q ss_pred cCCCcCCcccccCCeeEEEEEecC--------CcEEEEEEecCCCc-cCHHHHHHHHHHHHHh-cCCCeeeeecccccCC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN--------GQEIAVKRLSTTSG-QGIEELKNEVLLIAKL-QHRNLVKLLGCCLEED 597 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 597 (837)
++|++.++||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 567788999999999999997632 34799999976543 4457888999999998 7999999999999999
Q ss_pred ccEEEEEecCCCChhhHhhhcCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 664 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 664 (837)
..++||||+++|+|.++|..... ...+++..++.++.||+.||.|||+.+ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 99999999999999999965432 245899999999999999999999998 99999999999999
Q ss_pred CCCCeeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchH
Q 003237 665 EKMNPRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNL 743 (837)
Q Consensus 665 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 743 (837)
.++.+||+|||+++...............+|+.|+|||.+.++.|+.++|||||||++|||++ |+.|+.... ...+
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---~~~~ 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEEL 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC---HHHH
Confidence 999999999999998766554444555788999999999999999999999999999999998 677774221 1111
Q ss_pred HHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003237 744 IKYAWELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 805 (837)
Q Consensus 744 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~ 805 (837)
......+.... .... ....+.+++.+|++.||++||||.||+++|+++.
T Consensus 247 ----~~~i~~~~~~~-----~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 247 ----FKLLKEGHRMD-----KPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ----HHHHHTTCCCC-----CCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHcCCCCC-----CCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 12222222111 1111 2245789999999999999999999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=386.77 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=193.9
Q ss_pred cCCCcCCcccccCCeeEEEEEecC----CcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSN----GQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.+.||+|+||.||+|++.. +..||||+++... ....+.|.+|++++++++|||||++++++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 568888999999999999998742 4568999986543 334567999999999999999999999985 4678999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++|+|..++... ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 9999999999987543 345899999999999999999999988 99999999999999999999999999987654
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD 761 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 761 (837)
.... ......||+.|+|||++.+..++.++|||||||++|||++ |+.|+..... ..+...+. .+....
T Consensus 161 ~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i~----~~~~~~--- 229 (273)
T d1mp8a_ 161 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIE----NGERLP--- 229 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHH----TTCCCC---
T ss_pred Ccce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHHH----cCCCCC---
Confidence 3322 2334678999999999999999999999999999999998 8888864322 22222221 111111
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 762 SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 762 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
..... ...+.+++.+||+.||++||||+||++.|+.+
T Consensus 230 --~~~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 230 --MPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp --CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122 24578899999999999999999999998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=391.76 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=211.0
Q ss_pred cCCCcCCcccccCCeeEEEEEec------CCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS------NGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|++.++||+|+||+||+|++. +++.||||+++... ......|.+|++++.+++|||||+++++|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56778899999999999999763 35789999997543 334456899999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhc-------CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecc
Q 003237 601 LIYEFMPNKSLDYFIFDE-------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISD 673 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 673 (837)
+||||+++|+|.+++... .....+++..++.++.|||+||.|||+.+ |+||||||+||||++++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 999999999999998642 22235789999999999999999999987 99999999999999999999999
Q ss_pred cccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCC-CCCCCCCCCCcchHHHHHHHHhc
Q 003237 674 FGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGK-KNTRIFNDDDSSNLIKYAWELWS 752 (837)
Q Consensus 674 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~ 752 (837)
||+++...............+|+.|+|||.+.+..++.++||||||+++|||+||+ .|+... . .......+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~---~~~~~~~i~- 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---S---NEQVLRFVM- 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---C---HHHHHHHHH-
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---C---HHHHHHHHH-
Confidence 99999876655555555567899999999999999999999999999999999986 555321 1 111111111
Q ss_pred cCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003237 753 DNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETF 806 (837)
Q Consensus 753 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~~~ 806 (837)
.+...... ..+ ...+.+++.+||+.+|++||||+||+++|++..+
T Consensus 250 ~~~~~~~p-----~~~----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDKP-----DNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCCCc-----ccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 22211111 112 2458899999999999999999999999987644
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=382.62 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=203.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC------ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS------GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57899999999999999999874 78999999986432 224678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC----Ceeeccccc
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM----NPRISDFGT 676 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~ki~DFGl 676 (837)
|||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999998654 35899999999999999999999998 99999999999998776 599999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 756 (837)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...... ...... .
T Consensus 164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~---~i~~~~-~ 233 (293)
T d1jksa_ 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLA---NVSAVN-Y 233 (293)
T ss_dssp CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHTTC-C
T ss_pred hhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHHH---HHHhcC-C
Confidence 988754322 233678999999999999999999999999999999999999986321 111111 111110 0
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 757 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. ..+.. .......+.+++.+||+.||++|||++|+++
T Consensus 234 -~-~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 -E-FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -C-CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -C-CCchh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00001 1112245678999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=386.02 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=195.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec--CC--cEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS--NG--QEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~--~g--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|++.+.||+|+||+||+|++. ++ ..||||++.+. .....++|.+|++++.+++|||||+++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45788899999999999999864 22 37899998654 23345789999999999999999999999965 4678
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
+||||+++|+|.+++.... ..+++..++.++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999998876532 35899999999999999999999987 999999999999999999999999999987
Q ss_pred cCcccee-eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 681 GGEEILA-ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIIT-GKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 681 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
....... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||.... .......+...+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC------HHHHHHHHHhCCCCCC
Confidence 6543322 2334567889999999999999999999999999999998 899985321 1222222222221111
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003237 759 IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 803 (837)
Q Consensus 759 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~ 803 (837)
. .... ...+.+++.+||+.||++||||+||+++|++
T Consensus 236 ~-----~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 R-----PEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C-----cccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 1112 2357799999999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=393.29 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=201.2
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCc--EEEEEEecCC-CccCHHHHHHHHHHHHHh-cCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQ--EIAVKRLSTT-SGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.++||+|+||+||+|++. +|. .||||+++.. .....++|.+|+++|.++ +|||||+++++|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56778899999999999999876 344 5788888644 334567899999999999 799999999999999999999
Q ss_pred EEecCCCChhhHhhhc-------------CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCe
Q 003237 603 YEFMPNKSLDYFIFDE-------------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNP 669 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 669 (837)
|||+++|+|.++|+.. .....+++..++.++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999653 23456899999999999999999999987 9999999999999999999
Q ss_pred eecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCC-CCCCCCCCCcchHHHHHH
Q 003237 670 RISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKK-NTRIFNDDDSSNLIKYAW 748 (837)
Q Consensus 670 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~ 748 (837)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. |+... ....+..
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~~~--- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYE--- 237 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHH---
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHHHH---
Confidence 999999998654322 1223568999999999999999999999999999999999765 45321 1111111
Q ss_pred HHhccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 749 ELWSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 749 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+ ..+.. +.. +.....++.+++.+||+.||++||||+||++.|+++
T Consensus 238 ~i-~~~~~-----~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 238 KL-PQGYR-----LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HG-GGTCC-----CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-HhcCC-----CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 11111 111 111234678899999999999999999999999876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=388.01 Aligned_cols=252 Identities=29% Similarity=0.449 Sum_probs=200.0
Q ss_pred CCcccccCCeeEEEEEecCC----cEEEEEEecCC-CccCHHHHHHHHHHHHHhcCCCeeeeecccccC-CccEEEEEec
Q 003237 533 SNKLGQGGFGPVYKGKLSNG----QEIAVKRLSTT-SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-DENMLIYEFM 606 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~ey~ 606 (837)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++.+++|||||+++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36899999999999987532 36899999753 444567899999999999999999999998764 5789999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
++|+|.+++... ...+++..++.++.|||+||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999988653 335778889999999999999999988 999999999999999999999999999987554332
Q ss_pred e--eeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccccc
Q 003237 687 A--ITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSSM 764 (837)
Q Consensus 687 ~--~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 764 (837)
. ......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... ..++...+ . .+... ..+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i---~-~g~~~--~~p-- 256 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYL---L-QGRRL--LQP-- 256 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---H-TTCCC--CCC--
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHH---H-cCCCC--CCc--
Confidence 2 22235689999999999999999999999999999999998888753221 11112211 1 11111 111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 765 ANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 765 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
... ...+.+++.+||+.||++||+|.||++.|+++
T Consensus 257 -~~~----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 257 -EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp -TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -ccC----cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 23577899999999999999999999999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=384.53 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=199.2
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHH--HHHHHHHHhcCCCeeeeecccccCC----ccEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELK--NEVLLIAKLQHRNLVKLLGCCLEED----ENML 601 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~--~E~~~l~~l~H~nIv~l~~~~~~~~----~~~l 601 (837)
+.|.+.++||+|+||.||+|++ +|+.||||+++... .+++. .|+..+.+++|||||+++++|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3566778999999999999997 58999999995432 23333 4555556789999999999998654 4689
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhc-----CCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-----SRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
||||+++|+|.++|... .++|..++.++.|+|.||.|||+. ...+|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999653 489999999999999999999974 234699999999999999999999999999
Q ss_pred ceeccCccce--eeeccccccCCccCcccccCCC------CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcc-------
Q 003237 677 ARVFGGEEIL--AITKRVVGTYGYMSPEYALDGV------FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSS------- 741 (837)
Q Consensus 677 a~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~------~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~------- 741 (837)
++........ .......||+.|+|||++.+.. ++.|+|||||||+||||+||..|+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9987543322 1233468999999999987643 677999999999999999999877543221110
Q ss_pred -hHHHHHHHHhccCcccccccccccccc-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 742 -NLIKYAWELWSDNKALEIVDSSMANSC-LASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 742 -~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
............+ .+++.+.... ..+....+.+++.+||+.||++||||.||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0111111111111 1222222222 234456688999999999999999999999999865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=385.90 Aligned_cols=247 Identities=19% Similarity=0.281 Sum_probs=203.3
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.+.||+|+||.||+|+.. +|+.||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56888999999999999999874 7999999999753 2345678899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|..++.... .+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999986543 4788888999999999999999998 999999999999999999999999999875433
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ...+... ... +.. .
T Consensus 159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~---i~~-~~~------~ 223 (337)
T d1o6la_ 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFEL---ILM-EEI------R 223 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH---HHH-CCC------C
T ss_pred Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHH---Hhc-CCC------C
Confidence 22 2334789999999999999999999999999999999999999986422 1112111 111 110 1
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~eVv~ 799 (837)
+.... ..++.+++.+|++.||++||+ ++|+++
T Consensus 224 ~p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11122 235678999999999999995 788875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-43 Score=381.08 Aligned_cols=244 Identities=22% Similarity=0.305 Sum_probs=201.8
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.++||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999875 6999999999643 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+++|+|..++.... .+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999998886543 4678888889999999999999988 999999999999999999999999999986543
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ...+ ........ . .
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~---~~~i~~~~-~------~ 219 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKT---YEKILNAE-L------R 219 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHH---HHHHHHCC-C------C
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC---HHHH---HHHHHcCC-C------C
Confidence 234789999999999999999999999999999999999999996321 1111 11111111 0 1
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
..... ...+.+++.+|++.||++|| |++++++
T Consensus 220 ~p~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 FPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11112 23467899999999999996 8999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.3e-44 Score=376.39 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=199.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc---cCHHHHHHHHHHHHHhcCCCeeeeecccccCCc----
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG---QGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDE---- 598 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---- 598 (837)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367889999999999999999864 799999999975432 334578999999999999999999999876543
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.+|||||+++++|..++... ..+++.++..++.||++||.|||+.+ |+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 68999999999999988654 34899999999999999999999988 9999999999999999999999999988
Q ss_pred eccCcc-ceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 679 VFGGEE-ILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 679 ~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.... ...............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCC
Confidence 654332 2223344689999999999999999999999999999999999999985321 111222222221111
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccC
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRP-SMSTVVFMLSNE 804 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-tm~eVv~~L~~~ 804 (837)
. ...... ....+.+++.+|++.||++|| |++++.+.|.++
T Consensus 234 ~---~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 P---SARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp G---GGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C---chhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0 011111 224577899999999999999 899999888653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-43 Score=381.91 Aligned_cols=244 Identities=23% Similarity=0.269 Sum_probs=202.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 603 (837)
++|++.++||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47888999999999999999875 7999999998643 2345678899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCc
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGE 683 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~ 683 (837)
||+.+|+|..++.... .+++.....++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999986543 4899999999999999999999988 999999999999999999999999999986543
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.....||+.|||||++.+..++.++|||||||++|||++|+.||... ....+.. ..... .. .
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~---~i~~~-~~------~ 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYE---KIVSG-KV------R 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH---HHHHC-CC------C
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHH---HHhcC-CC------C
Confidence 22367999999999999999999999999999999999999998532 1111111 11111 00 1
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCC-----CCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDR-----PSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~R-----Ptm~eVv~ 799 (837)
..... ...+.+++.+|++.||++| ||++|+++
T Consensus 257 ~p~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11112 2357789999999999999 48999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=377.61 Aligned_cols=260 Identities=23% Similarity=0.282 Sum_probs=196.3
Q ss_pred CCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc-----CHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEec
Q 003237 533 SNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ-----GIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEFM 606 (837)
Q Consensus 533 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 606 (837)
.++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999875 6899999998654221 1346889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccce
Q 003237 607 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEIL 686 (837)
Q Consensus 607 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~~ 686 (837)
.++++..+.. ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9987766653 3345888999999999999999999988 999999999999999999999999999876543322
Q ss_pred eeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccc----
Q 003237 687 AITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVD---- 761 (837)
Q Consensus 687 ~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---- 761 (837)
.....||+.|+|||++... .++.++|||||||++|||++|+.||....+ .+......+...........+
T Consensus 157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp --CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred --ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchhcc
Confidence 2336799999999998754 579999999999999999999999854321 222222222221111100000
Q ss_pred --c---ccccccC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhcc
Q 003237 762 --S---SMANSCL-----ASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSN 803 (837)
Q Consensus 762 --~---~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~ 803 (837)
. ......+ ......+.+++.+|++.||++|||++|+++ .|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0 0000011 112346789999999999999999999987 5654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-42 Score=367.15 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=201.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCcc---------CHHHHHHHHHHHHHhc-CCCeeeeecccccC
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQ---------GIEELKNEVLLIAKLQ-HRNLVKLLGCCLEE 596 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~ 596 (837)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57888999999999999999874 7899999999754321 1235788999999997 99999999999999
Q ss_pred CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
+..+|||||+++|+|.++|... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999654 35899999999999999999999988 99999999999999999999999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccC------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALD------GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWEL 750 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 750 (837)
++....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ..... ..
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~~---~i 227 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLR---MI 227 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HH
T ss_pred eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHHHH---HH
Confidence 998754322 233679999999999863 3578899999999999999999999963221 11111 11
Q ss_pred hccCccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 751 WSDNKALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 751 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
... ... .. .........++.+++.+|++.+|++|||++||++
T Consensus 228 ~~~-~~~-~~-----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSG-NYQ-FG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHT-CCC-CC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhC-CCC-CC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 110 00 0011112245778999999999999999999865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-43 Score=384.36 Aligned_cols=248 Identities=26% Similarity=0.336 Sum_probs=196.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHH---HHHHHHhcCCCeeeeecccccCCccE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNE---VLLIAKLQHRNLVKLLGCCLEEDENM 600 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E---~~~l~~l~H~nIv~l~~~~~~~~~~~ 600 (837)
++|++.++||+|+||.||+|+.. +|+.||||++.+. .......+.+| +++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57888999999999999999875 6999999998643 12233444444 55666667999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
|||||+++|+|.++|... ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999654 34788999999999999999999998 999999999999999999999999999977
Q ss_pred cCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccc
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEI 759 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 759 (837)
.... .....||+.|+|||++.. ..|+.++|||||||++|||++|+.||......+. ......... .
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~~~~-~----- 224 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLT-M----- 224 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHHHSSS-C-----
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccc-C-----
Confidence 5432 234689999999999975 5689999999999999999999999975433221 111111100 0
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003237 760 VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 799 (837)
Q Consensus 760 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~eVv~ 799 (837)
........ ...+.+++.+|++.||++||| ++|+++
T Consensus 225 -~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -AVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -CCCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01111112 234778999999999999999 688864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=377.09 Aligned_cols=251 Identities=18% Similarity=0.286 Sum_probs=202.6
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
.++|++.+.||+|+||+||+|... +++.||||.++... .....+.+|+++|.+++|||||++++++.+++..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367889999999999999999875 68899999996543 3345688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC--CCCeeecccccceeccCc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--KMNPRISDFGTARVFGGE 683 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~ki~DFGla~~~~~~ 683 (837)
+++|+|.+++... ...+++.+...++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999998543 235899999999999999999999988 999999999999985 458999999999886544
Q ss_pred cceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccccccccc
Q 003237 684 EILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDSS 763 (837)
Q Consensus 684 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 763 (837)
.. .....+|+.|+|||.+.+..++.++||||+||++|||++|+.||..... ..+.. ........ ++..
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~---~i~~~~~~---~~~~ 225 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIE---NIMNAEYT---FDEE 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH---HHHHTCCC---CCHH
T ss_pred Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCCCC---CChh
Confidence 32 2235789999999999999999999999999999999999999863221 11111 11111100 0000
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 764 MANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 764 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.... ...++.+++..|++.||++|||++|+++
T Consensus 226 ~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKE----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1011 1235778999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-43 Score=377.49 Aligned_cols=251 Identities=20% Similarity=0.209 Sum_probs=195.8
Q ss_pred cCCCcCC-cccccCCeeEEEEEe-cCCcEEEEEEecCCCccCHHHHHHHHHHHHHh-cCCCeeeeeccccc----CCccE
Q 003237 528 DNFSTSN-KLGQGGFGPVYKGKL-SNGQEIAVKRLSTTSGQGIEELKNEVLLIAKL-QHRNLVKLLGCCLE----EDENM 600 (837)
Q Consensus 528 ~~~~~~~-~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~~ 600 (837)
++|.+.+ .||+|+||+||+|+. .+++.||||+++.. +.+.+|++++.++ +|||||++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5677664 599999999999987 47899999999642 5678899987665 79999999999865 45679
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC---CCCeeecccccc
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---KMNPRISDFGTA 677 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~DFGla 677 (837)
||||||++|+|.++|.... ...+++.+...++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 9999999999999996532 245899999999999999999999998 999999999999985 567999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL 757 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 757 (837)
+....... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||......... ......... .
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~---~ 232 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRM---G 232 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCS---C
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhc---C
Confidence 87654432 23467999999999999999999999999999999999999999643322111 000000000 0
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 EIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. ..+..........++.+++.+|++.||++|||+.|+++
T Consensus 233 ~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 Q---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp S---SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C---CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 00111111122356788999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-43 Score=376.21 Aligned_cols=247 Identities=22% Similarity=0.329 Sum_probs=200.6
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC---CccCHHHHHHHHHHHH-HhcCCCeeeeecccccCCccEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT---SGQGIEELKNEVLLIA-KLQHRNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV 602 (837)
++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999875 6899999999643 2344566777877766 58999999999999999999999
Q ss_pred EEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccC
Q 003237 603 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGG 682 (837)
Q Consensus 603 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~ 682 (837)
|||+++|+|..++.... .++......++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999996543 4788899999999999999999998 99999999999999999999999999986654
Q ss_pred ccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccccccc
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALEIVDS 762 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 762 (837)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+. . +. +
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~---~-~~------~ 220 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIR---M-DN------P 220 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH---H-CC------C
T ss_pred ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHH---c-CC------C
Confidence 322 2334689999999999999999999999999999999999999996321 112221111 1 11 1
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 003237 763 SMANSCLASEALRCIQVGLLCVQDRTTDRPSMS-TVVF 799 (837)
Q Consensus 763 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~-eVv~ 799 (837)
...... ...+.+++.+|++.||++|||+. ||++
T Consensus 221 ~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111112 23477899999999999999996 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=368.08 Aligned_cols=268 Identities=23% Similarity=0.348 Sum_probs=200.5
Q ss_pred cCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|++.++||+|+||+||+|+. .+|+.||||+++... ....+++.+|++++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788899999999999999987 479999999996542 2346788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
|+.++.+...... ....+++..+..++.||++||.|||+++ ||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9987655433322 3345899999999999999999999988 9999999999999999999999999998765432
Q ss_pred ceeeeccccccCCccCcccccCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc-c----cc
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK-A----LE 758 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-~----~~ 758 (837)
. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||..... ...+............ . ..
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH--HHHHHHHHHhcCCCchhhcccccc
Confidence 2 223357999999999887766 58899999999999999999999864321 1111111111111000 0 00
Q ss_pred ccc--ccc----ccc---cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 003237 759 IVD--SSM----ANS---CLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNE 804 (837)
Q Consensus 759 ~~d--~~l----~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~ 804 (837)
..+ ... ... ........+.+++.+|++.||++|||++|+++ .++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000 000 000 00112246778999999999999999999997 36544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-42 Score=367.72 Aligned_cols=261 Identities=21% Similarity=0.336 Sum_probs=200.0
Q ss_pred cCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEEe
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
++|++.++||+|+||+||+|+.++|+.||||+++... ....+.+.+|+.+|++++|||||++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999999999999996542 33467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCccc
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEEI 685 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~~ 685 (837)
+.++.+..+... ...++...+..++.||++||.|||+.+ ||||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 998877666532 345899999999999999999999987 99999999999999999999999999987654322
Q ss_pred eeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCccc------c
Q 003237 686 LAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKAL------E 758 (837)
Q Consensus 686 ~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------~ 758 (837)
. .....+++.|+|||.+.+. .++.++|||||||+++||++|+.||..... .+............... .
T Consensus 156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCChhhccchhh
Confidence 1 2335689999999998764 579999999999999999999999864321 11121111111111000 0
Q ss_pred c---------cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 759 I---------VDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 759 ~---------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. ..+.............+.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000001111112345778999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=362.43 Aligned_cols=239 Identities=23% Similarity=0.368 Sum_probs=193.4
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCc------cCHHHHHHHHHHHHHhc--CCCeeeeecccccCCc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSG------QGIEELKNEVLLIAKLQ--HRNLVKLLGCCLEEDE 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~ 598 (837)
++|++.++||+|+||+||+|+.. +|+.||||++.+... ....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57888999999999999999875 789999999865321 12234678999999997 8999999999999999
Q ss_pred cEEEEEecCC-CChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC-CCCeeeccccc
Q 003237 599 NMLIYEFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-KMNPRISDFGT 676 (837)
Q Consensus 599 ~~lV~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~DFGl 676 (837)
.++||||+.+ +++.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 5777776543 35899999999999999999999988 999999999999985 47899999999
Q ss_pred ceeccCccceeeeccccccCCccCcccccCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc
Q 003237 677 ARVFGGEEILAITKRVVGTYGYMSPEYALDGVF-STKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK 755 (837)
Q Consensus 677 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 755 (837)
++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ......
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~- 220 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQ- 220 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCC-
T ss_pred ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcc-
Confidence 98764432 234679999999999987765 577999999999999999999985310 011100
Q ss_pred cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 756 ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 756 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
..+....+ .++.+++.+|++.||++|||++|+++
T Consensus 221 ------~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01111222 35778999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-42 Score=366.20 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=195.3
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-C-CcEEEEEEecCCC--ccCHHHHHHHHHHHHHh---cCCCeeeeeccccc----
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-N-GQEIAVKRLSTTS--GQGIEELKNEVLLIAKL---QHRNLVKLLGCCLE---- 595 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~---- 595 (837)
.++|++.++||+|+||+||+|+.. + ++.||||+++... ......+.+|+.+++.+ +|||||++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999873 4 6679999986432 22233566777777766 79999999999853
Q ss_pred -CCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccc
Q 003237 596 -EDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDF 674 (837)
Q Consensus 596 -~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DF 674 (837)
....+++|||++++.+..... .....+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 345789999999987765443 23345889999999999999999999988 999999999999999999999999
Q ss_pred ccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC
Q 003237 675 GTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN 754 (837)
Q Consensus 675 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 754 (837)
|+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||..... ..............
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLP 234 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCC
Confidence 9998654332 22346899999999999999999999999999999999999999964321 11222222211111
Q ss_pred cccc----------ccc---cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 755 KALE----------IVD---SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 755 ~~~~----------~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.... ... ..............+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 000 00000111112345678899999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=364.73 Aligned_cols=263 Identities=21% Similarity=0.292 Sum_probs=194.5
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeeeecccccC------CccEE
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------DENML 601 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l 601 (837)
.|+..++||+|+||+||+|+.. +|+.||||++...... +.+|+++|++++|||||++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4666789999999999999875 6999999999765322 24799999999999999999998543 23689
Q ss_pred EEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-Ceeecccccceec
Q 003237 602 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVF 680 (837)
Q Consensus 602 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~DFGla~~~ 680 (837)
||||++++.+..+.........+++..+..++.||++||.|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999997765555443344556899999999999999999999987 99999999999999775 8999999999877
Q ss_pred cCccceeeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC-----
Q 003237 681 GGEEILAITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN----- 754 (837)
Q Consensus 681 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----- 754 (837)
..... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+..... .....
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~--~~~l~~i~~-~~g~~~~~~~ 247 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIK-VLGTPTREQI 247 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHH-HHCCCCHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH--HHHHHHHHH-HhCCChHHhh
Confidence 54432 223678999999998875 4789999999999999999999999864321 111111111 11000
Q ss_pred -----cccc-----ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 003237 755 -----KALE-----IVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNE 804 (837)
Q Consensus 755 -----~~~~-----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~ 804 (837)
.... .................+.+++.+|++.||++|||+.|+++ .++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0000 00000000111122345778899999999999999999986 34443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=359.15 Aligned_cols=263 Identities=19% Similarity=0.283 Sum_probs=194.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCC--CccCHHHHHHHHHHHHHhcCCCeeeeeccccc--------C
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTT--SGQGIEELKNEVLLIAKLQHRNLVKLLGCCLE--------E 596 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~ 596 (837)
++|++.++||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67888999999999999999874 7999999998543 33456778899999999999999999998755 3
Q ss_pred CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeeccccc
Q 003237 597 DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGT 676 (837)
Q Consensus 597 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGl 676 (837)
...++||||+.++.+..... ....+.......++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 45789999999887765542 2345788888999999999999999988 99999999999999999999999999
Q ss_pred ceeccCcccee--eeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc
Q 003237 677 ARVFGGEEILA--ITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD 753 (837)
Q Consensus 677 a~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 753 (837)
++......... .....+||+.|+|||.+.+. .++.++|||||||++|||++|+.||....+ .............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCGS 240 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH---HHHHHHHHHhcCC
Confidence 98765433221 22235799999999998865 689999999999999999999999864221 1111122222111
Q ss_pred Cc--cccc---------cccccccccCHHH-------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 NK--ALEI---------VDSSMANSCLASE-------ALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 ~~--~~~~---------~d~~l~~~~~~~~-------~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
.. .... +...........+ ...+++++.+|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 0000 0000000111111 234568899999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-40 Score=351.03 Aligned_cols=261 Identities=21% Similarity=0.248 Sum_probs=195.8
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCeeee-ecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLVKL-LGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l-~~~~~~~~~~~lV~e 604 (837)
.++|++.++||+|+||+||+|+.. +|+.||||++..... .+++..|++++.+++|+|+|.. .++..+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 357899999999999999999874 689999999865432 2457889999999987765555 455566778889999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEc---CCCCeeecccccceecc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EKMNPRISDFGTARVFG 681 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~DFGla~~~~ 681 (837)
|+.+ +|...+... ...+++..++.++.||++||+|||+++ |+||||||+|||++ .+..+||+|||+|+...
T Consensus 84 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLGP-SLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCCC-BHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcCC-chhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9854 555554332 235899999999999999999999998 99999999999986 45679999999999875
Q ss_pred Cccce-----eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc
Q 003237 682 GEEIL-----AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 682 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 756 (837)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~- 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-
Confidence 43321 123346899999999999999999999999999999999999999975544332222211111100000
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 757 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
.+.+...++ .++.+++..|++.+|++||+++++.+.|+..
T Consensus 237 ----~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 ----IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ----HHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ----hhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 011111222 3477889999999999999999999988754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=361.55 Aligned_cols=267 Identities=18% Similarity=0.274 Sum_probs=197.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCC-ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC----ccE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS-GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED----ENM 600 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~ 600 (837)
+++|++.++||+|+||+||+|+. .+|+.||||++.+.. ....+.+++|+++|.+++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45788999999999999999976 479999999997543 334567889999999999999999999987654 345
Q ss_pred EEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceec
Q 003237 601 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVF 680 (837)
Q Consensus 601 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~ 680 (837)
++++|+.+|+|.+++... .+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 666778899999998542 4899999999999999999999998 999999999999999999999999999876
Q ss_pred cCccce-eeeccccccCCccCcccccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcccc
Q 003237 681 GGEEIL-AITKRVVGTYGYMSPEYALD-GVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKALE 758 (837)
Q Consensus 681 ~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 758 (837)
...... .......||+.|+|||.+.. ..++.++||||+||+++||++|+.||...... .................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH---HHHHHHhhhccCCChhh
Confidence 543322 22344679999999999854 56789999999999999999999998643221 11111111111110000
Q ss_pred -----------cc--ccccccccC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccC
Q 003237 759 -----------IV--DSSMANSCL-----ASEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNE 804 (837)
Q Consensus 759 -----------~~--d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~--L~~~ 804 (837)
.. .+.. ...+ .....++.+++.+|++.||++|||++|+++. |+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00 0000 0000 0112357889999999999999999999974 5543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-39 Score=347.54 Aligned_cols=261 Identities=17% Similarity=0.195 Sum_probs=204.9
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhcC-CCeeeeecccccCCccEEEEE
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH-RNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 604 (837)
.++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+|++++..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 357899999999999999999875 68999999986543 22457789999999975 899999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcC-----CCCeeeccccccee
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-----KMNPRISDFGTARV 679 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~ki~DFGla~~ 679 (837)
|+ +++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 689988875533 35899999999999999999999998 999999999999974 57899999999998
Q ss_pred ccCccce-----eeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccC
Q 003237 680 FGGEEIL-----AITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDN 754 (837)
Q Consensus 680 ~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 754 (837)
....... .......||+.|||||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6543211 12334679999999999999999999999999999999999999997544433322222211111111
Q ss_pred ccccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003237 755 KALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 804 (837)
Q Consensus 755 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~~L~~~ 804 (837)
... .+...++ .++.+++..|++.+|++||+++.+.+.|+..
T Consensus 236 ~~~-----~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 PLR-----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CHH-----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ChH-----HhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111 1112222 3467888899999999999999998888653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=360.66 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=193.1
Q ss_pred hcCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCC------
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEED------ 597 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 597 (837)
.++|++.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 357888999999999999999875 69999999997542 233567889999999999999999999987655
Q ss_pred ccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccc
Q 003237 598 ENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTA 677 (837)
Q Consensus 598 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla 677 (837)
..++||||+ +.+|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 4566666533 34899999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCc-
Q 003237 678 RVFGGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNK- 755 (837)
Q Consensus 678 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~- 755 (837)
+...... ....||+.|+|||.+.+. .++.++||||+||++|||++|+.|+..... ...............
T Consensus 169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 169 RQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPPA 240 (346)
T ss_dssp EECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCH
T ss_pred eccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh---HHHHHHHHhccCCCcH
Confidence 8765432 346789999999998764 579999999999999999999999854321 111111111100000
Q ss_pred -----------------cccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCC
Q 003237 756 -----------------ALEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNET 805 (837)
Q Consensus 756 -----------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~~ 805 (837)
..+.....+. .........+.+++.+|++.||++|||++|+++ .|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000000000 011112235678999999999999999999997 376654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=346.62 Aligned_cols=262 Identities=22% Similarity=0.320 Sum_probs=202.5
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccCCccEEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEEDENMLIYE 604 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 604 (837)
++|++.++||+|+||+||+|+.. +++.||||+++... ....+++.+|+.+++.++|||||++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47888999999999999999874 78899999996543 2346788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccceeccCcc
Q 003237 605 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTARVFGGEE 684 (837)
Q Consensus 605 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~~~~~~ 684 (837)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999998877743 345788999999999999999999988 9999999999999999999999999999875433
Q ss_pred ceeeeccccccCCccCcccccCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc------c
Q 003237 685 ILAITKRVVGTYGYMSPEYALDGV-FSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA------L 757 (837)
Q Consensus 685 ~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~ 757 (837)
.. .....++..|+|||.+.... ++.++|||||||+++||++|+.|+.... +................. .
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhhhhhh
Confidence 22 22346778899999988765 6999999999999999999999974322 222222222222221110 0
Q ss_pred ccccc---------ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 758 EIVDS---------SMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 758 ~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
...+. .-...........+.+++.+|++.||++|||++||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000111122345678899999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=350.92 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=199.1
Q ss_pred cCCCcCCcccccCCeeEEEEEec----CCcEEEEEEecCC----CccCHHHHHHHHHHHHHhcC-CCeeeeecccccCCc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS----NGQEIAVKRLSTT----SGQGIEELKNEVLLIAKLQH-RNLVKLLGCCLEEDE 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~ 598 (837)
++|++.++||+|+||+||+|+.. +|+.||||.+++. .....+.+.+|++++.+++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56888999999999999999752 4789999998643 22345678899999999977 899999999999999
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.++||||+.+|+|..++.... .+.......++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999986543 3567788889999999999999988 9999999999999999999999999998
Q ss_pred eccCccceeeeccccccCCccCcccccCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc
Q 003237 679 VFGGEEILAITKRVVGTYGYMSPEYALDG--VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA 756 (837)
Q Consensus 679 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 756 (837)
.+....... .....|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+....+ ........
T Consensus 178 ~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~~~-- 252 (322)
T d1vzoa_ 178 EFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSE-- 252 (322)
T ss_dssp ECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHCC--
T ss_pred hhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcccCC--
Confidence 765433222 2346799999999999765 4788999999999999999999999755433322111 11111110
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003237 757 LEIVDSSMANSCLASEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 799 (837)
Q Consensus 757 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~eVv~ 799 (837)
+. .+.....++.+++.+|++.||++|| |++|+++
T Consensus 253 -----~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -----PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 01 1112234677899999999999999 4788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-39 Score=349.38 Aligned_cols=255 Identities=19% Similarity=0.287 Sum_probs=194.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccC--CccEEEE
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEE--DENMLIY 603 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~ 603 (837)
++|++.++||+|+||+||+|+.. +|+.||||+++.. ..+++.+|+++|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999874 7899999999643 3567899999999996 99999999998744 4578999
Q ss_pred EecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCC-CeeecccccceeccC
Q 003237 604 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKM-NPRISDFGTARVFGG 682 (837)
Q Consensus 604 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~DFGla~~~~~ 682 (837)
||+++++|..+. +.++...+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997653 24889999999999999999999998 99999999999998655 589999999987654
Q ss_pred ccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhcc--------
Q 003237 683 EEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSD-------- 753 (837)
Q Consensus 683 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-------- 753 (837)
... .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.|+....+... .... .......
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~-~~~~-i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVR-IAKVLGTEDLYDYID 257 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHH-HHHHHCHHHHHHHHH
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH-HHHH-HHHHHCCchhhhhhh
Confidence 432 2346789999999998875 479999999999999999999999864432111 1111 1111000
Q ss_pred ----C---ccccccc--------cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 754 ----N---KALEIVD--------SSMANSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 754 ----~---~~~~~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
. ....... .............++.+++.+|++.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000000 00000011112245778999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=347.46 Aligned_cols=258 Identities=22% Similarity=0.255 Sum_probs=187.9
Q ss_pred cCCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccC------Cc
Q 003237 528 DNFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE------DE 598 (837)
Q Consensus 528 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~ 598 (837)
++|++.++||+|+||+||+|... +|+.||||++.... ....+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57888999999999999999875 69999999997542 33445788999999999999999999998643 56
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.++||||+.++.+... . ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~-~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-Q-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHH-T-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhh-h-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 7999999987655433 2 24789999999999999999999998 9999999999999999999999999988
Q ss_pred eccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH----------
Q 003237 679 VFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAW---------- 748 (837)
Q Consensus 679 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------- 748 (837)
...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||..... ...+.....
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~--~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHH
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH--HHHHHHHHHhccCCCHHHH
Confidence 765432 22346789999999999999999999999999999999999999853321 111111110
Q ss_pred --------HHhccCc------cccccccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003237 749 --------ELWSDNK------ALEIVDSSMA---NSCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF 799 (837)
Q Consensus 749 --------~~~~~~~------~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~ 799 (837)
....... .......... ..........+.+++.+|++.||++|||++||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 0001111111 1112334567889999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-39 Score=351.96 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=195.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEe-cCCcEEEEEEecCCC--ccCHHHHHHHHHHHHHhcCCCeeeeecccccC-----Cc
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKL-SNGQEIAVKRLSTTS--GQGIEELKNEVLLIAKLQHRNLVKLLGCCLEE-----DE 598 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 598 (837)
.++|++.++||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999986 479999999997543 23445788999999999999999999998643 34
Q ss_pred cEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeecccccce
Q 003237 599 NMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRISDFGTAR 678 (837)
Q Consensus 599 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~ 678 (837)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5777888899999998843 34899999999999999999999998 9999999999999999999999999997
Q ss_pred eccCccceeeeccccccCCccCcccccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhccCcc-
Q 003237 679 VFGGEEILAITKRVVGTYGYMSPEYALDG-VFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSNLIKYAWELWSDNKA- 756 (837)
Q Consensus 679 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~- 756 (837)
..... .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ................
T Consensus 170 ~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~---~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 170 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPGAE 241 (348)
T ss_dssp CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCHH
T ss_pred ccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChH
Confidence 65432 2236789999999987765 468999999999999999999999864321 1111111111110000
Q ss_pred -c---------ccccc--cccc----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 003237 757 -L---------EIVDS--SMAN----SCLASEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNE 804 (837)
Q Consensus 757 -~---------~~~d~--~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~eVv~--~L~~~ 804 (837)
. ..... .... .........+.+++.+|++.||++|||++|+++ .+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0 00000 0000 000111245678999999999999999999997 56654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-35 Score=322.27 Aligned_cols=278 Identities=19% Similarity=0.249 Sum_probs=201.6
Q ss_pred CCCcCCcccccCCeeEEEEEec-CCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-----------CCCeeeeecccccC
Q 003237 529 NFSTSNKLGQGGFGPVYKGKLS-NGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-----------HRNLVKLLGCCLEE 596 (837)
Q Consensus 529 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~~ 596 (837)
+|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++ |+|||++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5888999999999999999874 79999999996542 33467788999998886 47899999887653
Q ss_pred --CccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEEcCCCC-----
Q 003237 597 --DENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEKMN----- 668 (837)
Q Consensus 597 --~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~----- 668 (837)
...+++++++..+..............+++..+..++.||++||.|||+ .+ |+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 4556777777666554444444555668888999999999999999998 55 999999999999986653
Q ss_pred -eeecccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCCcch----H
Q 003237 669 -PRISDFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVILLEIITGKKNTRIFNDDDSSN----L 743 (837)
Q Consensus 669 -~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~----l 743 (837)
+|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||.......... +
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 899999999865432 234679999999999999999999999999999999999999986543221111 1
Q ss_pred HHHHHHHhcc--------Cc-cccccc---------c----------ccccccCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 003237 744 IKYAWELWSD--------NK-ALEIVD---------S----------SMANSCLASEALRCIQVGLLCVQDRTTDRPSMS 795 (837)
Q Consensus 744 ~~~~~~~~~~--------~~-~~~~~d---------~----------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~ 795 (837)
.... ..+.. .. .....+ . .............+.+++.+|++.||++|||++
T Consensus 245 ~~~~-~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 245 AQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHH-HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111 11100 00 000000 0 001123455667889999999999999999999
Q ss_pred HHHHH--hcc---CCCCCCCCCCCcc
Q 003237 796 TVVFM--LSN---ETFVPSPKQPTFS 816 (837)
Q Consensus 796 eVv~~--L~~---~~~~~~p~~p~~~ 816 (837)
|+++. +++ ..+++.|+.|.+.
T Consensus 324 e~L~Hp~f~~~~~~~~~~~p~~~~~~ 349 (362)
T d1q8ya_ 324 GLVNHPWLKDTLGMEEIRVPDRELYG 349 (362)
T ss_dssp HHHTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred HHhcCcccCCCCCcccCCCCCcccCC
Confidence 99873 543 3566666666664
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=4.2e-22 Score=196.88 Aligned_cols=168 Identities=23% Similarity=0.216 Sum_probs=120.7
Q ss_pred CcCCcccccCCeeEEEEEecCCcEEEEEEecCCCcc------------------CHHHHHHHHHHHHHhcCCCeeeeecc
Q 003237 531 STSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQ------------------GIEELKNEVLLIAKLQHRNLVKLLGC 592 (837)
Q Consensus 531 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~------------------~~~~~~~E~~~l~~l~H~nIv~l~~~ 592 (837)
.+.++||+|+||+||+|+..+|+.||||+++..... ....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356899999999999999889999999987532100 01234568889999999999988765
Q ss_pred cccCCccEEEEEecCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEEcCCCCeeec
Q 003237 593 CLEEDENMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEKMNPRIS 672 (837)
Q Consensus 593 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 672 (837)
. ..+++|||+++..+.. ++......++.|++++|.|||+.+ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 3489999999866532 344555679999999999999988 99999999999999764 8999
Q ss_pred ccccceeccCccceeeeccccccCCccCcccccCCCCCCcccHHHHHHH
Q 003237 673 DFGTARVFGGEEILAITKRVVGTYGYMSPEYALDGVFSTKSDVFSFGVI 721 (837)
Q Consensus 673 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DV~S~Gvv 721 (837)
|||+|.............+.+. .-.|. ..+.|+.++|+||..--
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~----~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR----NIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH----HHHHH-HHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHH----HHHHH-HcCCCCCcccHHHHHHH
Confidence 9999987643321110000000 00111 23678889999997543
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.80 E-value=1.2e-19 Score=161.67 Aligned_cols=112 Identities=19% Similarity=0.386 Sum_probs=92.8
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEec
Q 003237 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHER 102 (837)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 102 (837)
+|||.+||.|..|++|+| |.|+|+|+..|| |.|++. .++||.||++.|. ....|.|+.||+|+|.+
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~~--~~~~l~l~~dGnLvl~~- 66 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN----NRAVWASGTNGKA--SGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET----TEEEEECCCTTSC--SSEEEEECTTSCEEEEE-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEcC----CcEEEEccCccCC--CCcEEEEeccccEEEEe-
Confidence 599999999999999984 999999999888 777653 4899999999884 34679999999999995
Q ss_pred CCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCcc
Q 003237 103 NQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTD 152 (837)
Q Consensus 103 ~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtD 152 (837)
+ +.++|+++.+. ..+..+|+|+|+|||||+ +.++.++|||+.+|+|
T Consensus 67 -~-~~~~w~s~t~~-~~~~~~l~L~ddGNlvly-~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 67 -G-SRAIWASNTNR-QNGNYYLILQRDRNVVIY-DNSNNAIWATHTNVGN 112 (112)
T ss_dssp -T-TEEEEECCCCC-SCCCCEEEECTTSCEEEE-CTTSCEEEECCCCCCC
T ss_pred -c-CCeEEEEeecc-CCCceEEEEcCCCCEEEE-CCCCcEEecCCCccCC
Confidence 3 34678777543 334558999999999999 4567899999999975
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.77 E-value=5.3e-19 Score=155.87 Aligned_cols=107 Identities=22% Similarity=0.375 Sum_probs=89.8
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEec
Q 003237 23 IDTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHER 102 (837)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 102 (837)
.|+|.+||.|.+|++|. +|.|+|.|+.+|| |.||.. .++||.||++.| +..+.|.+..+|+|+|.
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~-- 65 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV----DKPIWATNTGGL--SRSCFLSMQTDGNLVVY-- 65 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET----TEEEEECCCTTS--CSSCEEEECTTSCEEEE--
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEeC----CceeeEeCCCCC--CCccEEEEeccceEEEE--
Confidence 37899999999999995 6999999999998 888763 489999999988 34568999999999999
Q ss_pred CCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccC
Q 003237 103 NQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDH 149 (837)
Q Consensus 103 ~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~ 149 (837)
++.+.+||+|++.. .....+|+|+|+|||||++ ..+||||+|
T Consensus 66 ~~~g~~vWsS~t~~-~~~~~~l~L~ddGNlVly~----~~~W~S~t~ 107 (108)
T d1jpca_ 66 NPSNKPIWASNTGG-QNGNYVCILQKDRNVVIYG----TDRWATGTH 107 (108)
T ss_dssp CTTCCEEEECCCCC-SCSCEEEEECTTSCEEEEE----CCCCCCCCC
T ss_pred CCCccceEEccccC-CCCcEEEEEcCCCCEEEeC----CCcccCCCC
Confidence 56678999998543 3345578999999999994 359999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.76 E-value=1.6e-18 Score=152.77 Aligned_cols=107 Identities=17% Similarity=0.298 Sum_probs=88.5
Q ss_pred cccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEecC
Q 003237 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERN 103 (837)
Q Consensus 24 ~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~ 103 (837)
|+|.+||.|.+|++|+ +|.|.|+|...++ |.++. ..++||+||++.|... .+.|.|+.||+|+|.+
T Consensus 2 ~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~-- 67 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYD-- 67 (109)
T ss_dssp CEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-CCEEEECTTSCEEEEC--
T ss_pred CCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEe--
Confidence 7899999999999997 5889999998877 66654 3489999999999754 5689999999999994
Q ss_pred CCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccC
Q 003237 104 QSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDH 149 (837)
Q Consensus 104 ~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~ 149 (837)
+.+.+||+|+++. +.+..+|+|+|+|||||++ ..+|||+-|
T Consensus 68 ~~g~~vW~s~t~~-~~~~~~l~L~ddGNlvly~----~~~W~S~t~ 108 (109)
T d1kj1a_ 68 AEGRSLWASHSVR-GNGNYVLVLQEDGNVVIYG----SDIWSTGTY 108 (109)
T ss_dssp SSSCEEEECCCCC-CSSCCEEEECTTSCEEEEC----CEEEECCCC
T ss_pred CCCcEEEEEeeEC-CCCCEEEEEeCCCcEEEEC----CCEecCCCc
Confidence 5668899998653 3355679999999999983 469999854
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.63 E-value=2.4e-16 Score=140.97 Aligned_cols=104 Identities=19% Similarity=0.296 Sum_probs=84.1
Q ss_pred eeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCC
Q 003237 61 GIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTG 140 (837)
Q Consensus 61 giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~ 140 (837)
-|||.++++++++|++|++.|+.....+|.+..||||+|.+ + +.++|+++....+ ....|.|+|+|||||+ +.++
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~--~-~~~vW~s~t~~~~-~~~~~~l~~~GnLvl~-d~~~ 85 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD--R-DDRVWSTNTAGKG-TGCRAVLQPNGRMDVL-TNQN 85 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEB--T-TBCCSCCCCCSSC-SSCEEEEETTTEEEEE-ETTT
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEec--C-CcEEEEEccccCC-CcEEEEEeCCeeEEEE-cCCC
Confidence 59999999999999999999998878899999999999985 2 4578999864332 3457999999999998 4567
Q ss_pred ceeeecccCCccccccCCcccccccCCCcceeeecCCCCCCCCcceEEEecCCCCCcceeec
Q 003237 141 ETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYK 202 (837)
Q Consensus 141 ~~lWqSFd~PtDtlLpg~~l~~~~~tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~ 202 (837)
++|||||. +.++|.|.+.|+++|. +++|.
T Consensus 86 ~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGn--lvlY~ 114 (120)
T d1dlpa2 86 IAVWTSGN-------------------------------SRSAGRYVFVLQPDRN--LAIYG 114 (120)
T ss_dssp EEEEECCC-------------------------------CCSSSCCEEEECSSSC--EEEEC
T ss_pred CEEEEeCC-------------------------------CCCCCcEEEEECCCCc--EEEeC
Confidence 99999972 2366889999999998 45563
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.49 E-value=7.8e-15 Score=129.54 Aligned_cols=111 Identities=23% Similarity=0.339 Sum_probs=90.9
Q ss_pred eeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCC
Q 003237 61 GIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTG 140 (837)
Q Consensus 61 giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~ 140 (837)
.|||.-.++.+..|..+.+.++.....+|.+..||||||.+ .+.++|++++. ...+..+.|+|+|||||+ +.++
T Consensus 2 ~~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~---~~~~vW~s~t~--~~~~~~l~l~~dGNLvl~-d~~~ 75 (115)
T d1dlpa1 2 NILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD---SDVRVWASNTA--GATGCRAVLQSDGLLVIL-TAQN 75 (115)
T ss_dssp CCCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE---SSSEEECCCCC--SCSCCBCCBCSSSCBCCB-CTTT
T ss_pred cEEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc---CCeeEEEcccC--CCCceEEEEeccCCEEEE-ccCC
Confidence 37888778888899999999998888899999999999985 24679999854 344567999999999998 5677
Q ss_pred ceeeecccCCccccccCCcccccccCCCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCC
Q 003237 141 ETLWQSFDHPTDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (837)
Q Consensus 141 ~~lWqSFd~PtDtlLpg~~l~~~~~tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~ 212 (837)
.+||||+- +.+.|.|.+.|+++|. +++|. .++|.+|.
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGN--lvlY~--~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRT--VTIYG--PGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSC--EEEEC--SEEEECSC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCc--EEEeC--CCeecCCC
Confidence 89999862 3468999999999998 46663 47899874
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.48 E-value=4.3e-14 Score=125.63 Aligned_cols=103 Identities=19% Similarity=0.375 Sum_probs=79.9
Q ss_pred cccCCCCccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEecC
Q 003237 24 DTISLSQPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERN 103 (837)
Q Consensus 24 ~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~ 103 (837)
++|.++|+| .+.+..|.|.|.|...|| |.++ + ..++||.||+..|. ....|.|..||+|+|. +
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVLy-~---~~~~vWssnt~~~~--~~~~l~l~~dGnLvL~--d 77 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVLY-D---NNNPIWATNTGGLG--NGCRAVLQPDGVLVVI--T 77 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEEE-E---TTEEEEECCCTTSC--SSCEEEECTTSCEEEE--C
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEEE-E---CCeEEEEecCCCCC--cceEEEEEeCCCEEEE--C
Confidence 455555555 357789999999999999 6663 3 35899999998774 3468999999999999 5
Q ss_pred CCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeeccc
Q 003237 104 QSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFD 148 (837)
Q Consensus 104 ~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd 148 (837)
+.+.+||++++. ...+..+++|+|+|||||+. ..+|||-.
T Consensus 78 ~~g~~vWsS~t~-~~~~~~~l~Lq~DGNlvlYg----~~~W~S~T 117 (119)
T d1b2pa_ 78 NENVTVWQSPVA-GKAGHYVLVLQPDRNVVIYG----DALWATQT 117 (119)
T ss_dssp TTCCEEEECSCC-CCSSCEEEEECTTSCEEEEE----SEEEECCC
T ss_pred CCCcEEEECCCc-CCCCceEEEEcCCCCEEEEC----CCEeccCC
Confidence 566789999854 23345579999999999983 47999953
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.22 E-value=1.1e-11 Score=108.99 Aligned_cols=97 Identities=20% Similarity=0.306 Sum_probs=73.5
Q ss_pred CccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEecCCCccee
Q 003237 30 QPIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPV 109 (837)
Q Consensus 30 ~~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~~ 109 (837)
|.|.+++.| .+|.|.|.|...|| |.|+.. .++||.+|...+ ..+.+.|..+|||||. ++.+.+|
T Consensus 15 ~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~~----~~~vW~s~t~~~---~~~~l~l~~dGNLvl~--d~~~~~v 78 (115)
T d1dlpa1 15 QTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS----DVRVWASNTAGA---TGCRAVLQSDGLLVIL--TAQNTIR 78 (115)
T ss_dssp SCCCTTCEE--CSTTEEEEECTTSC-----EEEEES----SSEEECCCCCSC---SCCBCCBCSSSCBCCB--CTTTCCS
T ss_pred ceecCCCcE--EcCCEEEEECCCCe-----EEEEcC----CeeEEEcccCCC---CceEEEEeccCCEEEE--ccCCCEE
Confidence 444444445 46889999999998 877642 478999997643 3568999999999998 4566789
Q ss_pred eecccccCCCCceEEEEecCCCEEEEecCCCceeeecc
Q 003237 110 WQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSF 147 (837)
Q Consensus 110 Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSF 147 (837)
|++.+.. +.+..+++|+++|||||+ +..+|+|-
T Consensus 79 WsS~t~~-~~g~y~l~Lq~DGNlvlY----~~~~Wssg 111 (115)
T d1dlpa1 79 WSSGTKG-SIGNYVLVLQPDRTVTIY----GPGLWDSG 111 (115)
T ss_dssp CCCCCCC-CSSCCEEEECSSSCEEEE----CSEEEECS
T ss_pred EEcCCCC-CCCCEEEEECCCCcEEEe----CCCeecCC
Confidence 9998643 335557999999999998 25799985
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.87 E-value=2.1e-09 Score=95.12 Aligned_cols=96 Identities=20% Similarity=0.316 Sum_probs=68.4
Q ss_pred ccCCCCeEEeCCCeEEEEEEcCCCCCcceeeeeeeeCCCCeEEEecCCCCCCCCCCceEEEeeccceEEEecCCCcceee
Q 003237 31 PIKDGDVIVSSRKIYALGFFSPGNSVKRYVGIWYNQISQLTLLWVANRNNPINDTSGVLSVNIQGNLVLHERNQSTVPVW 110 (837)
Q Consensus 31 ~l~~~~~l~S~~g~F~lgFf~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~~W 110 (837)
.|..++.| ..|.|.|.|-..|+ |.|+. ...+||.+|-. ..+....+.|..+|||||.+ ..+.++|
T Consensus 25 ~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d--~~~~~lW 89 (120)
T d1dlpa2 25 TLHATQSL--QLSPYRLSMETDCN-----LVLFD----RDDRVWSTNTA--GKGTGCRAVLQPNGRMDVLT--NQNIAVW 89 (120)
T ss_dssp EECSSCCC--BCSSCEEEEETTTE-----EEEEB----TTBCCSCCCCC--SSCSSCEEEEETTTEEEEEE--TTTEEEE
T ss_pred EEcCCCee--EcCCEEEEEcCCCc-----EEEec----CCcEEEEEccc--cCCCcEEEEEeCCeeEEEEc--CCCCEEE
Confidence 33344444 35668888887777 76754 23678998843 33455689999999999995 4567899
Q ss_pred ecccccCCCCceEEEEecCCCEEEEecCCCceeeec
Q 003237 111 QANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQS 146 (837)
Q Consensus 111 st~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqS 146 (837)
+|++.. ..+...+.|.++|||||+. ..+|.|
T Consensus 90 ~S~t~~-~~~~~~l~Lq~DGnlvlY~----~~~W~t 120 (120)
T d1dlpa2 90 TSGNSR-SAGRYVFVLQPDRNLAIYG----GALWTT 120 (120)
T ss_dssp ECCCCC-SSSCCEEEECSSSCEEEEC----CCCCBC
T ss_pred EeCCCC-CCCcEEEEECCCCcEEEeC----CCcccC
Confidence 998643 3345578999999999982 468875
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.79 E-value=1.4e-08 Score=88.25 Aligned_cols=88 Identities=27% Similarity=0.528 Sum_probs=65.7
Q ss_pred ceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCcccccccC
Q 003237 87 GVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRT 166 (837)
Q Consensus 87 ~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 166 (837)
-.|.+..||||+|.. .+.+||++|..........+.|.++|||||+ +.++.++|+|=
T Consensus 21 ~~l~~q~dgnLvl~~---~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~-~~~g~~vW~s~------------------- 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD---HSTSVWASNTGILGKKGCKAVLQSDGNFVVY-DAEGRSLWASH------------------- 77 (109)
T ss_dssp EEEEECTTSCEEEEE---TTEEEEECCCCCTTCCCCEEEECTTSCEEEE-CSSSCEEEECC-------------------
T ss_pred EEEEecCCCeEEEEe---CCEEEEEeCCCCCCceeEEEEEcCCceEEEE-eCCCcEEEEEe-------------------
Confidence 467888999999984 3467999987654555567999999999998 56778999871
Q ss_pred CCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCCC
Q 003237 167 GLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPW 213 (837)
Q Consensus 167 g~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~w 213 (837)
+..+.|.|.+.|+++|. +++|. .+.|.|+.+
T Consensus 78 ------------t~~~~~~~~l~L~ddGN--lvly~--~~~W~S~t~ 108 (109)
T d1kj1a_ 78 ------------SVRGNGNYVLVLQEDGN--VVIYG--SDIWSTGTY 108 (109)
T ss_dssp ------------CCCCSSCCEEEECTTSC--EEEEC--CEEEECCCC
T ss_pred ------------eECCCCCEEEEEeCCCc--EEEEC--CCEecCCCc
Confidence 11134678899999998 45664 358887753
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.76 E-value=1.6e-08 Score=89.01 Aligned_cols=85 Identities=25% Similarity=0.433 Sum_probs=63.2
Q ss_pred eEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCcccccccCC
Q 003237 88 VLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRTG 167 (837)
Q Consensus 88 ~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~tg 167 (837)
.|.+..||||||.+ + +.++|+++.... .....+.|.++|||||+ +..+.+||+|.
T Consensus 33 ~l~mQ~DGNLVLy~--~-~~~vWssnt~~~-~~~~~l~l~~dGnLvL~-d~~g~~vWsS~-------------------- 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYD--N-NNPIWATNTGGL-GNGCRAVLQPDGVLVVI-TNENVTVWQSP-------------------- 87 (119)
T ss_dssp EEEECTTSCEEEEE--T-TEEEEECCCTTS-CSSCEEEECTTSCEEEE-CTTCCEEEECS--------------------
T ss_pred EEEECCCCcEEEEE--C-CeEEEEecCCCC-CcceEEEEEeCCCEEEE-CCCCcEEEECC--------------------
Confidence 57788999999984 2 457999986432 23467999999999998 56778999762
Q ss_pred CcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCC
Q 003237 168 LNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGP 212 (837)
Q Consensus 168 ~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~ 212 (837)
+.-+.|.|.+.|+++|. +++|. .+.|.|+.
T Consensus 88 -----------t~~~~~~~~l~Lq~DGN--lvlYg--~~~W~S~T 117 (119)
T d1b2pa_ 88 -----------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp -----------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred -----------CcCCCCceEEEEcCCCC--EEEEC--CCEeccCC
Confidence 11145678999999998 45664 46898874
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.64 E-value=5.8e-08 Score=84.08 Aligned_cols=85 Identities=26% Similarity=0.472 Sum_probs=62.1
Q ss_pred ceEEEeeccceEEEecCCCcceeeecccccCCCCceEEEEecCCCEEEEecCCCceeeecccCCccccccCCcccccccC
Q 003237 87 GVLSVNIQGNLVLHERNQSTVPVWQANISEASAGNTVAQLLDTGNLVLVRNDTGETLWQSFDHPTDTVLPNMRFGWDKRT 166 (837)
Q Consensus 87 ~~l~~~~~G~L~l~~~~~~~~~~Wst~~~~~~~~~~~a~lld~GNlVl~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 166 (837)
-+|.+..||||||.+ .+.+||+++....+ ....+.|.++|||||+ +.++.++|.|
T Consensus 21 ~~l~~q~DGNLvly~---~~~~vW~s~~~~~~-~~~~l~l~~~Gnlvl~-~~~g~~vWsS-------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD---VDKPIWATNTGGLS-RSCFLSMQTDGNLVVY-NPSNKPIWAS-------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEE---TTEEEEECCCTTSC-SSCEEEECTTSCEEEE-CTTCCEEEEC--------------------
T ss_pred EEEEECCCCeEEEEe---CCceeeEeCCCCCC-CccEEEEeccceEEEE-CCCccceEEc--------------------
Confidence 367888999999984 34689999965332 3447999999999998 5678999986
Q ss_pred CCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecC
Q 003237 167 GLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAG 211 (837)
Q Consensus 167 g~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg 211 (837)
.+..+.+.|.+.|+.+|. +++|.. +.|.|+
T Consensus 76 -----------~t~~~~~~~~l~L~ddGN--lVly~~--~~W~S~ 105 (108)
T d1jpca_ 76 -----------NTGGQNGNYVCILQKDRN--VVIYGT--DRWATG 105 (108)
T ss_dssp -----------CCCCSCSCEEEEECTTSC--EEEEEC--CCCCCC
T ss_pred -----------cccCCCCcEEEEEcCCCC--EEEeCC--CcccCC
Confidence 111245678899999998 456643 356665
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.38 E-value=7.8e-07 Score=77.41 Aligned_cols=111 Identities=12% Similarity=0.154 Sum_probs=69.6
Q ss_pred ccccccCCcccccccCCCcceeeecCCCCCCCCcceEEEecCCCCCcceeecCCeeEEecCCCCCccccCccCceeeeee
Q 003237 151 TDTVLPNMRFGWDKRTGLNRYVTAWKSPDDPGSGNFSFTLDLAGFPQPLLYKDDVKLWRAGPWTGQRFSGTPEMTRTFIF 230 (837)
Q Consensus 151 tDtlLpg~~l~~~~~tg~~~~l~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~~~~~~~~~~~~~ 230 (837)
||||+|||.|..+.. |+ +|.|+|.++.+|. +++|....++|.++...... + ........=
T Consensus 1 tDtL~~gq~L~~g~~------l~---------~g~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~~--~-~~l~l~~dG 60 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGS------LA---------EGGYLFIIQNDCN--LVLYDNNRAVWASGTNGKAS--G-CVLKMQNDG 60 (112)
T ss_dssp CCEEETTEEECTTCE------EE---------ETTEEEEECTTSC--EEEEETTEEEEECCCTTSCS--S-EEEEECTTS
T ss_pred CCEecCCCEecCCCE------EE---------ECCEEEEEcCCCC--EEEEcCCcEEEEccCccCCC--C-cEEEEeccc
Confidence 799999999987643 54 3999999999998 67788889999887532111 1 000000000
Q ss_pred EEEEEeCCCeeEEEeeccCCceeEEEEEcccccEEEEEEecCCCceEEEEeccCCCC
Q 003237 231 NITYIDNQDEVYLCDGLNDLSTIARMILNETGFLQRFTWNNRDRRWIGYWTAPAERC 287 (837)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~s~~~rl~Ld~~G~l~~~~w~~~~~~W~~~~~~p~~~C 287 (837)
++...+ .+...............+++|+.||+|++|.- .....|+...+.|
T Consensus 61 nLvl~~-~~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~-----~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 61 NLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNVG 111 (112)
T ss_dssp CEEEEE-TTEEEEECCCCCSCCCCEEEECTTSCEEEECT-----TSCEEEECCCCCC
T ss_pred cEEEEe-cCCeEEEEeeccCCCceEEEEcCCCCEEEECC-----CCcEEecCCCccC
Confidence 111222 33444443334444557999999999999941 2346787766655
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.33 E-value=1.2e-06 Score=88.56 Aligned_cols=144 Identities=17% Similarity=0.100 Sum_probs=97.4
Q ss_pred hcCCCcCCcccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhc-CCCeeeeecccccCCccEEEEEe
Q 003237 527 TDNFSTSNKLGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQ-HRNLVKLLGCCLEEDENMLIYEF 605 (837)
Q Consensus 527 t~~~~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey 605 (837)
-..|...+..+.++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+...++..++||++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 34555544444444578999875 46677888876554444556788999988875 44456777777778888999999
Q ss_pred cCCCChhhHhhhcCCCCCCChhhHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 003237 606 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS-------------------------------------- 647 (837)
Q Consensus 606 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 647 (837)
+++..+....... .....++.++++.+..||+..
T Consensus 92 l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 92 ADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred ccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9998875543211 112234455555555555321
Q ss_pred ------------------CCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 648 ------------------RLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 648 ------------------~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
...++|+|+.|.|||++++...-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11279999999999999877677999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.72 E-value=7e-05 Score=74.66 Aligned_cols=142 Identities=19% Similarity=0.145 Sum_probs=85.7
Q ss_pred cccccCC-eeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcC--CCeeeeecccccCCccEEEEEecCCCCh
Q 003237 535 KLGQGGF-GPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQH--RNLVKLLGCCLEEDENMLIYEFMPNKSL 611 (837)
Q Consensus 535 ~LG~G~f-G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~ey~~~gsL 611 (837)
.+..|.. +.||+...+++..+++|.-..... ..+..|+..+..+.. -.+.+++.+..+++..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 679999988888889998654432 346778888887753 3355677777777888999999988765
Q ss_pred hhHh--------------hhcCC----CCCCC--hhhHHHHH--------------------HHHHHHHHHHHhc----C
Q 003237 612 DYFI--------------FDESR----KQLLD--WKKRFDII--------------------LGIARGVLYLHQD----S 647 (837)
Q Consensus 612 ~~~l--------------~~~~~----~~~l~--~~~~~~i~--------------------~~ia~gL~yLH~~----~ 647 (837)
.... ..-.. ..... +.....-. ......+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 3311 00000 00000 00000000 0011223333322 1
Q ss_pred CCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 648 RLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 648 ~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 22389999999999999877778999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.28 E-value=0.00069 Score=72.01 Aligned_cols=75 Identities=11% Similarity=0.175 Sum_probs=49.4
Q ss_pred CcccccCCeeEEEEEecC-CcEEEEEEecCC-------CccCHHHHHHHHHHHHHhc-C--CCeeeeecccccCCccEEE
Q 003237 534 NKLGQGGFGPVYKGKLSN-GQEIAVKRLSTT-------SGQGIEELKNEVLLIAKLQ-H--RNLVKLLGCCLEEDENMLI 602 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~lV 602 (837)
+.||.|....||+.+..+ ++.++||.-... -....+....|.+.|..+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998764 678999964321 1123445667888887774 3 234455543 55677899
Q ss_pred EEecCCCC
Q 003237 603 YEFMPNKS 610 (837)
Q Consensus 603 ~ey~~~gs 610 (837)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.79 E-value=0.0038 Score=64.17 Aligned_cols=135 Identities=13% Similarity=0.164 Sum_probs=79.4
Q ss_pred eeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCe--eeeecc-----cccCCccEEEEEecCCCChhh-
Q 003237 542 GPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL--VKLLGC-----CLEEDENMLIYEFMPNKSLDY- 613 (837)
Q Consensus 542 G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~~~-----~~~~~~~~lV~ey~~~gsL~~- 613 (837)
-.||+.+.++|+.+++|..+.. ....+++..|...+..|....| +..+.. .......+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999998643 3456788899999988863332 222211 122345678999988754321
Q ss_pred ---H----------hhhc------CCCCCCChh-------------------hHHHHHHHHHHHHHHHHh----cCCCce
Q 003237 614 ---F----------IFDE------SRKQLLDWK-------------------KRFDIILGIARGVLYLHQ----DSRLRI 651 (837)
Q Consensus 614 ---~----------l~~~------~~~~~l~~~-------------------~~~~i~~~ia~gL~yLH~----~~~~~i 651 (837)
. +|.. ..+..+++. .+-.+...+.+.+..+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 1110 011112211 111122222233333322 234568
Q ss_pred eeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 652 IHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 652 vH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.13 E-value=0.0062 Score=64.39 Aligned_cols=72 Identities=19% Similarity=0.298 Sum_probs=49.4
Q ss_pred CcccccCCeeEEEEEecCC--------cEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCee-eeecccccCCccEEEEE
Q 003237 534 NKLGQGGFGPVYKGKLSNG--------QEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNLV-KLLGCCLEEDENMLIYE 604 (837)
Q Consensus 534 ~~LG~G~fG~Vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~e 604 (837)
++|+.|-.=.+|+...+++ +.|.+++.. . ........+|.++++.+.-.+++ ++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 5788888899999987543 345555553 2 23344567899999988633444 6777664 368999
Q ss_pred ecCCCCh
Q 003237 605 FMPNKSL 611 (837)
Q Consensus 605 y~~~gsL 611 (837)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.14 E-value=0.12 Score=51.89 Aligned_cols=157 Identities=14% Similarity=0.013 Sum_probs=81.7
Q ss_pred HHHHHHhhcCCCcCCc-----ccccCCeeEEEEEecCCcEEEEEEecCCCccCHHHHHHHHHHHHHhcCCCe--eeeecc
Q 003237 520 LSTLLAATDNFSTSNK-----LGQGGFGPVYKGKLSNGQEIAVKRLSTTSGQGIEELKNEVLLIAKLQHRNL--VKLLGC 592 (837)
Q Consensus 520 ~~~l~~at~~~~~~~~-----LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~~~ 592 (837)
.+++.....+|.+.+. |..|---+.|+.+..+| .+++|+..... ..+++..|++++..+.+.++ ...+..
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccccee
Confidence 3455555566766543 34566677899987665 58899875432 23456667888888753322 222111
Q ss_pred ------cccCCccEEEEEecCCCChhhH--------------hhhcCC----CC--------------------CCChhh
Q 003237 593 ------CLEEDENMLIYEFMPNKSLDYF--------------IFDESR----KQ--------------------LLDWKK 628 (837)
Q Consensus 593 ------~~~~~~~~lV~ey~~~gsL~~~--------------l~~~~~----~~--------------------~l~~~~ 628 (837)
.........++.++.+...... ++.... .. ......
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 1112344566777666433110 010000 00 000111
Q ss_pred HHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEEcCCCCeeeccccccee
Q 003237 629 RFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEKMNPRISDFGTARV 679 (837)
Q Consensus 629 ~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~DFGla~~ 679 (837)
....+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 11222222222222222 2244699999999999999988778999998763
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.77 E-value=0.013 Score=37.03 Aligned_cols=33 Identities=45% Similarity=1.036 Sum_probs=26.9
Q ss_pred CCCCcCCCCCCCccccCCCCCCcccccCCCCCcCC
Q 003237 285 ERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEPKY 319 (837)
Q Consensus 285 ~~C~~~g~CG~~g~C~~~~~~~~~C~C~~gf~~~~ 319 (837)
|+|.+-..|| ||.|+. -.++..|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtN-viGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKN-VIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEE-CSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-Cceeee-cccceEEeecCCcCCCc
Confidence 7899999998 688964 34558899999999964
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.88 E-value=0.14 Score=34.46 Aligned_cols=33 Identities=27% Similarity=0.764 Sum_probs=25.6
Q ss_pred CCCCCc-CCCCCCCccccCCCCCCcccccCCCCCc
Q 003237 284 AERCDY-YGHCGPNSNCNLNLTDGFECTCLPGFEP 317 (837)
Q Consensus 284 ~~~C~~-~g~CG~~g~C~~~~~~~~~C~C~~gf~~ 317 (837)
-|+|.. ...|..+|.|... ..+.+|.|++||+-
T Consensus 3 ideC~~~~~pC~n~g~C~n~-~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINT-LGSFECQCLQGYTG 36 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEEC-SSSEEEECCTTEES
T ss_pred CccccCCCCCCCCCcEeECC-CCCEEeECCCCCcC
Confidence 367875 5789999999754 44589999999963
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.99 E-value=0.4 Score=32.30 Aligned_cols=32 Identities=16% Similarity=0.463 Sum_probs=24.2
Q ss_pred CCCCCcCCCCCCCccccCCCCCCcccccCCCCCc
Q 003237 284 AERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEP 317 (837)
Q Consensus 284 ~~~C~~~g~CG~~g~C~~~~~~~~~C~C~~gf~~ 317 (837)
.|+|... .|+.++.|... .++..|.|++||..
T Consensus 5 idEC~~~-~~~~~~~C~Nt-~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEP-DVCKHGQCINT-DGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSST-TSCSSSCCCCC-SSCCCCCCCTTEEE
T ss_pred eeccCCc-CCCCCCEeECC-CCCeEeECCCCccc
Confidence 4789754 45578999754 44589999999976
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.67 E-value=0.27 Score=32.35 Aligned_cols=31 Identities=35% Similarity=0.955 Sum_probs=23.7
Q ss_pred CCCCcCCCCCCCccccCCCCCCcccccCCCCCc
Q 003237 285 ERCDYYGHCGPNSNCNLNLTDGFECTCLPGFEP 317 (837)
Q Consensus 285 ~~C~~~g~CG~~g~C~~~~~~~~~C~C~~gf~~ 317 (837)
|+|. ...|...|.|.... .+..|.|++||+-
T Consensus 1 D~C~-~~PC~ngg~C~~~~-~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGL-GEYTCTCLEGFEG 31 (39)
T ss_dssp CTTT-TCCCCSSCEECCCS-SSCCEECCTTEET
T ss_pred CcCC-CCCCCCCcEEECCC-CCEEEECCCCCCc
Confidence 4565 47899999997643 4589999999964
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.99 E-value=0.26 Score=33.38 Aligned_cols=34 Identities=26% Similarity=0.749 Sum_probs=24.2
Q ss_pred CCCCCcC-CCCCCCccccCCCCCCcccccCCCCCcCC
Q 003237 284 AERCDYY-GHCGPNSNCNLNLTDGFECTCLPGFEPKY 319 (837)
Q Consensus 284 ~~~C~~~-g~CG~~g~C~~~~~~~~~C~C~~gf~~~~ 319 (837)
-|+|... ..| .++.|... .++..|.|++||+...
T Consensus 3 idEC~~~~~~C-~~~~C~Nt-~Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 3 IDECRISPDLC-GRGQCVNT-PGDFECKCDEGYESGF 37 (44)
T ss_dssp CCTTTTCSSTT-TTSCEEEE-TTEEEECCCSSEEECT
T ss_pred ccccCCCCCCC-CCCEeEcC-CCCeEEeCCCCCccCC
Confidence 3678764 456 47899744 4458999999997643
|